
<html lang="en"     class="pb-page"  data-request-id="719e2959-239f-4c12-ae7e-6b6090b562a4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-10;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.1c00325;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors" /></meta><meta name="dc.Creator" content="Chenshu  Xu" /></meta><meta name="dc.Creator" content="Yi-nan  Wang" /></meta><meta name="dc.Creator" content="Haiqiang  Wu" /></meta><meta name="dc.Description" content="Pyroglutamate (pE) modification, catalyzed mainly by glutaminyl cyclase (QC), is prevalent throughout nature and is particularly important in mammals including humans for the maturation of hormones..." /></meta><meta name="Description" content="Pyroglutamate (pE) modification, catalyzed mainly by glutaminyl cyclase (QC), is prevalent throughout nature and is particularly important in mammals including humans for the maturation of hormones..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 18, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00325" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00325" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00325" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00325" /></link>
        
    
    

<title>Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00325" /></meta><meta property="og:title" content="Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0009.jpeg" /></meta><meta property="og:description" content="Pyroglutamate (pE) modification, catalyzed mainly by glutaminyl cyclase (QC), is prevalent throughout nature and is particularly important in mammals including humans for the maturation of hormones, peptides, and proteins. In humans, the upregulation of QC is involved in multiple diseases and conditions including Alzheimer’s disease, Huntington’s disease, melanomas, thyroid carcinomas, accelerated atherosclerosis, septic arthritics, etc. This upregulation catalyzes the generation of modified mediators such as pE-amyloid beta (Aß) and pE-chemokine ligand 2 (CCL2) peptides. Not surprisingly, QC has emerged as a reasonable target for the development of therapeutics to combat these diseases and conditions. In this manuscript the deleterious effects of upregulated QC resulting in disease manifestation are reviewed, along with progress on the development of QC inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00325"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00325">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00325&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00325&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00325&amp;href=/doi/10.1021/acs.jmedchem.1c00325" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 6549-6565</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00028" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00698" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chenshu Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chenshu Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chenshu++Xu">Chenshu Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8799-1913" title="Orcid link">https://orcid.org/0000-0002-8799-1913</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi-nan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi-nan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi-nan++Wang">Yi-nan Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Haiqiang Wu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiqiang Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, China</div></div><span class="conrtib-corresp"><strong>*</strong><a href="/cdn-cgi/l/email-protection#087f7d6079487b727d266d6c7d266b66"><span class="__cf_email__" data-cfemail="6710120f1627141d1249020312490409">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiqiang++Wu">Haiqiang Wu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-3979-7304" title="Orcid link">https://orcid.org/0000-0003-3979-7304</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00325&amp;href=/doi/10.1021%2Facs.jmedchem.1c00325" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 6549–6565</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 17, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 February 2021</li><li><span class="item_label"><b>Published</b> online</span>18 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00325</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6549%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChenshu%2BXu%252C%2BYi-nan%2BWang%252C%2BHaiqiang%2BWu%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D10%26contentID%3Dacs.jmedchem.1c00325%26title%3DGlutaminyl%2BCyclase%252C%2BDiseases%252C%2Band%2BDevelopment%2Bof%2BGlutaminyl%2BCyclase%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6565%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00325"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">516</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00325" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chenshu&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Yi-nan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Haiqiang&quot;,&quot;last_name&quot;:&quot;Wu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6549-6565&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00325&quot;},&quot;abstract&quot;:&quot;Pyroglutamate (pE) modification, catalyzed mainly by glutaminyl cyclase (QC), is prevalent throughout nature and is particularly important in mammals including humans for the maturation of hormones, peptides, and proteins. In humans, the upregulation of QC is involved in multiple diseases and conditions including Alzheimer’s disease, Huntington’s disease, melanomas, thyroid carcinomas, accelerated atherosclerosis, septic arthritics, etc. This upregulation catalyzes the generation of modified mediators such as pE-amyloid beta (Aß) and pE-chemokine ligand 2 (CCL2) peptides. Not surprisingly, QC has emerged as a reasonable target for the development of therapeutics to combat these diseases and conditions. In this manuscript the deleterious effects of upregulated QC resulting in disease manifestation are reviewed, along with progress on the development of QC inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00325&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00325" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00325&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00325" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00325&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00325" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00325&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00325&amp;href=/doi/10.1021/acs.jmedchem.1c00325" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00325" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00325" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00325%26sid%3Dliteratum%253Aachs%26pmid%3D34000808%26genre%3Darticle%26aulast%3DXu%26date%3D2021%26atitle%3DGlutaminyl%2BCyclase%252C%2BDiseases%252C%2Band%2BDevelopment%2Bof%2BGlutaminyl%2BCyclase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D10%26spage%3D6549%26epage%3D6565%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/jmcmar.2021.64.issue-10/20210527/jmcmar.2021.64.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pyroglutamate (pE) modification, catalyzed mainly by glutaminyl cyclase (QC), is prevalent throughout nature and is particularly important in mammals including humans for the maturation of hormones, peptides, and proteins. In humans, the upregulation of QC is involved in multiple diseases and conditions including Alzheimer’s disease, Huntington’s disease, melanomas, thyroid carcinomas, accelerated atherosclerosis, septic arthritics, etc. This upregulation catalyzes the generation of modified mediators such as pE-amyloid beta (Aß) and pE-chemokine ligand 2 (CCL2) peptides. Not surprisingly, QC has emerged as a reasonable target for the development of therapeutics to combat these diseases and conditions. In this manuscript the deleterious effects of upregulated QC resulting in disease manifestation are reviewed, along with progress on the development of QC inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Glutaminyl Cyclase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.1.  Introduction</h3><div class="NLM_p">In 1963, the first glutaminyl cyclase (QC, also known as glutaminyl-peptide cyclotransferase, QPCT, EC 2.3.2.5) was isolated form the latex of a tropical plant (<i>Carica papaya</i>).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Since then, proteins catalyzing the same reaction have been identified and isolated from a wide range of pro- and eukaryotes. For example, these proteins, with molecular weights ranging between 33 and 40 kDa, have been identified in rat brain, porcine pituitary, bovine pituitary and spleen, human B lymphocytes, snake venom, bacterial pathogens, and even recently in cone snails.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3−7)</a> QCs from different species exhibit overlapping but distinct homologies, structure, and characteristics.<a onclick="showRef(event, 'ref3 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref3 ref8 ref9 ref10 ref11">(3,8−11)</a> The similarity in amino acid sequence, for instance, between the QC from the plant bacterial pathogen <i>Xanthomonas campestris</i> and the host plant is ∼20–30%,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> whereas the similarity in the amino acid sequence between QCs isolated from snake and human is ∼75%.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The specificity constraints of QCs are dependent on the size and composition of the substrates. All these proteins catalyze the formation of pyroglutamate (pE)-modified peptides and proteins. QCs from plants also catalyze the cyclization of a methylated glutamine residue, while human QCs mainly catalyze the cyclization of N-terminal glutamate/glutamine.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Noteworthy, mammalian glutaminyl cyclase isoenzymes (iso-QCs) were identified in 2008, including human iso-QC and murine iso-QC.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> QC, which is secreted by secretory granules into the neuronal extracellular space, and iso-QC, which is localized within the Golgi complex, are encoded by different genes in humans. The gene encoding QC is located on chromosome 2p22.3, and the gene encoding iso-QC is located on chromosome 19q13.32.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, human QC is composed of 361 amino acids and possesses an N-terminal secretion signal, whereas iso-QC is composed of 382 amino acids and carries an N-terminal signal anchor. Both QC and iso-QC, however, contain catalytic domains of similar size (∼330 residues) and share a sequence identity of ∼45%. Both QC and iso-QC catalyze the N-terminal pE modification, but iso-QC exhibits 2- to 15-fold less catalytic activity with several synthetic substrates compared with that of QC. Furthermore, the expression of QC is higher in neuronal tissues, whereas the expression of iso-QC shows no significant difference between different tissues and organs. In nine different mouse strains, the highest enzymatic QC/iso-QC activity is in the ventral brain, followed by the cortex and hippocampus.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The QC knockout (KO) dramatically reduces the QC activity in the mouse brain, especially in the hypothalamus and plasma, although activity is still detectable in peripheral organs such as the liver and spleen, which is likely the result of the expression of iso-QC.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In the KO mouse serum, the concentration of a gonadotropin-releasing hormone and testosterone are not changed, but the serum thyroxine is slightly decreased. The adult KO mice are fertile and behave indistinguishably from the wild-type mice, indicating the potential therapeutic effect for drug development by inhibiting QC activity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Primary sequence alignment of human QC (361 amino acids) and iso-QC (382 amino acids).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The sequence identity between human QC and iso-QC is 45%. The residues involved in zinc complexation in the active site (Asp-Glu-His) are conserved in both proteins. Iso-QC possesses two potential start methionine residues designated as Met I and Met II. The major differences between these two sequences are at the N-terminus. QC possesses a signal sequence directing the protein to the secretory pathway, whereas iso-QC carries a putative signal anchor. Moreover, iso-QC lacks N-glycosylation sites, while two such sites are identified in QC.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p last">A variety of methods has been developed to measure the enzymatic activity of QC and iso-QC, including isocratic reversed-phase high-performance liquid chromatography with fluorometric detection, which monitors the formation of pGlu-Leu-Tyr-Glu-Asn-Lys-epsilon-(Dns)–OH chromatographically separated from the fluorescent substrate Gln-Leu-Tyr-Glu-Asn-Lys-epsilon-(Dns)–OH.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Radioimmunoassay is also used to detect the formation of pyroGlu-His-Pro-NH<sub>2</sub> from a thyrotropin-releasing hormone substrate.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Other methods include coupled enzymatic assays to detect the release of ammonia from the cyclization of the Gln-Gln dipeptide substrate and UV adsorption to detect the change induced by the formation of an intramolecular amide bond during pE modification.<a onclick="showRef(event, 'ref10 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref10 ref19 ref20 ref21 ref22 ref23">(10,19−23)</a> Coupled continuous assays, which use pyroglutamyl aminopeptidase or glutamate dehydrogenase as auxiliary enzymes, are also widely applied by determining the release of chromophores or fluorophores and the conversion of NADH/H<sup>+</sup> into NAD<sup>+</sup>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.2.  The Structure of QC</h3><div class="NLM_p">On the basis of the homology analysis, human QC (hQC) shares certain similarities with an exopeptidase family, which includes <i>Aeromonas proteolytica</i> aminopeptidase (ApAP), <i>Streptomyces griseus</i> aminopeptidase (SgAP), and carboxypeptidase G<sub>2</sub> (CPG<sub>2</sub>). All these proteins share a conserved scaffold with hQC but differ in structure particularly in the loops surrounding the active-site pockets. As a one-zinc ion-dependent monomeric glycoprotein, hQC is composed of a signal peptide containing 27 or 28 amino acid residues, a positively charged N-terminal region, a central hydrophobic region containing 10 amino acid residues, and a C-terminal region containing a critical nonpolar amino acid residue (Ser27 or Gly28).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The signal peptide plays a key role in the transportation of immature QC from ribosomes to the endoplasmic reticulum to complete the folding of the polypeptide chain, including the formation of six β-sheets and 10 α-helices, glycosylation of Asp46 and 296, and the formation of a disulfide bond between Cys139 and 149.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11,13)</a> This signal peptide also contributes to the transportation of QC to the target secretory granules.</div><div class="NLM_p">The catalytic domain of hQC is composed of ∼330 residues. The high-resolution crystal structure of hQC residues 33–361 from bone marrow exhibits an open-sandwich topology comprising a central six-stranded β-sheet surrounded by two and six α-helices on the opposite sides and flanked by two α-helices at one edge of the β-sheet (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The twisted β-sheet is formed by two antiparallel and four parallel strands, acting as the hydrophobic core of the molecule. The coil and loop regions of the structure cover 42% of the total residues, and approximately half of these regions contribute to the formation of the active site, in which six loops between these surrounded α-helices are near the C-terminal edge of the central parallel strands. The lone Zn<sup>2+</sup> ion is located at the bottom of the narrow hydrophobic pocket near Asp159, Glu202, and His330 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). To maintain the catalytic activity, it is important to coordinate the Zn<sup>2+</sup> with residues Glu201, Trp207, Asp248, Asp305, Phe325, and Trp329, hydrogen bonds between Glu201, Asp248, and Asp305, and a peptide bond between Asp159 and Ser160, which is further stabilized by hydrogen bonds Asp159-His140, Ser160-Asp248, Asp159-water, and Ser160-water. Iso-QC is also a one-zinc ion-dependent cyclase. Compared with hQC, the crystal structure of iso-QC demonstrates a relatively wide-open and negatively charged active site with a large loop movement in the active site upon inhibitor binding (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The lone zinc ion is also located at the bottom of the pocket by Asp186, Glu226, and His351 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of QC and iso-QC. (A) A ribbon diagram of the overall structure of QC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>). The central six β-strands are colored yellow. The surrounding 10 α-helices located on the top, bottom, and edge are colored blue. The zinc ion is shown as a golden sphere. The coils and loops are colored light pink. (B) A stereo view of the QC catalytic region. The main residues coordinated with the zinc ion are labeled. (C) A ribbon diagram of the overall structure of iso-QC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PB7">3PB7</a>). (D) A stereo view of the iso-QC catalytic region.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structures of other mammalian and insect QCs exhibit high degrees of similarity with that of hQC, in which the main core of the tertiary structure is formed by a central six-stranded β-sheet surrounded by several α-helices. The structure of N-glycosylated QC from human and mouse is stabilized by the disulfide bond between the two conserved cysteine residues at the bottom of the pocket and the two surface loops near the active site.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The conserved tryptophan residue Trp207, which lies at the entrance of the active site, shows a single conformation in both N-glycosylated human and murine QCs and affects substrate conversion significantly.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> QC from <i>Drosophila melanogaster</i> (fruit fly) has an overall fold similar to that of mammalian QCs.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, plant and bacterial QCs adopt a five-bladed β-propeller fold, and the biological functions of these QCs have not been elucidated until recently.<a onclick="showRef(event, 'ref9 ref28'); return false;" href="javascript:void(0);" class="ref ref9 ref28">(9,28)</a> Ligand-free QC from <i>Drosophila melanogaster</i> exhibits a typical α/β-hydrolase topology, which is different from the structure of QC when binding with inhibitors, and this form of QC would be helpful for the structural studies of novel inhibitor-binding modes.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">A metal-independent QC has been identified from the black-legged tick <i>Ixodes scapularis</i>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Interestingly, the crystal structure demonstrated the typical scaffold of mammalian QCs but with two extra disulfide bonds to stabilize the central β-sheet. The catalytic activity can be inhibited by imidazole-derived inhibitors designed for the Zn<sup>2+</sup>-dependent QC.</div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">1.3.  pE-Modification in the Pocket of QC</h3><div class="NLM_p">N-Terminal pE in mammals is required for the maturation and/or function of newly formed peptides, hormones, cytokines, and proteins in the secretory pathway. The pE modifications appear to be important for a proper conformation for binding with receptors and/or to protect the N termini from exopeptidase degradation.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> pE modification also improves the functions of peptides; for example, pE-serpinin, which is derived from chromogranin A (CgA) and identified in secretory granules of endocrine and neuro-endocrine cells, exhibits antiapoptotic effects.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The presence of pE could also enhance the stability and strengthen the activity of recombinant proteins, such as cellulose Cel7A.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a></div><div class="NLM_p">The N-terminal glutamine and/or glutamate is cyclized to pyroglutamate in the presence of phosphate ions by facilitating synchronized proton transfers.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> As an important post-translational or cotranslational event, N-terminal pE modification was previously thought to proceed spontaneously. However, it has been demonstrated recently that QC mainly catalyzes the conversion of the N-terminal glutamine (Glu, Q) residue and glutamate to pyroglutamate (pE) in vitro and in vivo.<a onclick="showRef(event, 'ref8 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref8 ref37 ref38 ref39">(8,37−39)</a> Compared with the nonenzymatic catalysis, QC accelerates the pE-modification by promoting a synchronized proton transfer in a concerted four-step mechanism: (A) Zn<sup>2+</sup> polarizes the γ-amido carbonyl of the substrate based on the cation–anion interaction between Zn<sup>2+</sup> and oxygen; (B) Zn<sup>2+</sup> stabilizes the oxygen ions that resulted from the electrophilic attack by the positively charged α-amino group; (C) a proton is transferred to the γ-amide through the assistance of Glu201; (D) Asp248 improves the leaving of γ-amide amino in the presence of H<sub>2</sub>O (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref14 ref40'); return false;" href="javascript:void(0);" class="ref ref14 ref40">(14,40)</a> Positively charged Zn<sup>2+</sup> acts as the key mediator for the conversion, and the central triad formed by Glu201-Asp305-Asp248 is necessary for the catalytic activity. Consequently, proton transfer(s) have been assigned as the rate-limiting step.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Possible catalyzing process in the QC active pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is confirmed that the conversions of Glu and Gln are favored at pH 6.0 and 8.0, respectively.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The conformations of Asp248 and Asp305 are affected by Ser160 and His319, respectively, indicating the importance of proton transfer between Glu201, Asp305, and Asp248.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Furthermore, the mutation of His140 and His330 into glutamic acid results in the loss of activity. In contrast, the mutation of His307 and His319 into glutamic acid significantly increases the Michaelis–Menten constant (<i>K</i><sub>m</sub>) of QC.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This observation demonstrated that His140 and His330 are directly involved in the catalysis, while His307 and His319 are involved in substrate recognition. Disulfide bonds between cysteine residues are also important for the maintenance of protein conformation and activity, which is broken by treatment with 15 mM dithiothreitol (DTT).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These results directly and indirectly support the catalyzing process in the QC active pocket.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">2.  Upregulated QC and Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Under normal conditions, pE modification at the N-termini mediated by QC or iso-QC is necessary for the maturation and physiological activity of newly formed peptides, hormones, cytokines, and proteins. However, an abnormal upregulation of QC or iso-QC and excessive pyroglutamination are hallmarks of multiple diseases and conditions involving neurodegeneration, inflammation, uncontrolled cell division, and others, by catalyzing the generation of excessive levels of pE-modified mediators (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Upregulated QC contributes to the initiation of diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.1.  Neurodegenerative Diseases</h3><div class="NLM_p">Mounting evidence confirms that the post-translational pE modification catalyzed by QC could be supposed as a crucial pathological mechanism leading to increased aggregation and enhanced toxicity of amyloid peptides in a number of degenerative diseases. Neurodegenerative diseases include Alzheimer’s (AD), Parkinson’s (PD), Huntington’s (HD), etc. AD, characterized by a gradual decline in learning and memory ability, is the most common of these and accounts for more than 65% of total neurodegenerative cases. With the increasing number of aging population worldwide, the health, economic, and social impact of AD is expected to rise significantly. While progress is being made to understand the pathogenesis, there are still no treatments for AD that can cure or halt the progression of the disease.</div><div class="NLM_p">As one of the major pathological hallmarks, senile plaques composed of β-amyloid (Aβ) peptides were previously thought to be the main cause of AD. However, there is no direct correlation between the formation of senile plaques in brains and the development of AD. On the contrary, it has now been demonstrated that pE-modified Aβs, for example, pE-Aβ<sub>3–40</sub> and pE-Aβ<sub>3–42</sub>, are the main components of senile plaques.<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43−45)</a> These pE-modified Aβs account for more than 50% of total Aβ plaques in AD brains and are absent in matching normal brains. Aβs truncated at the N-terminal position 3 (AβpN3) are also detected in canine brains in a concentration/age-dependent manner, and in other animal species as well, such as Japanese macaque, American black bear, and woodpecker.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> pE modification increases the hydrophobicity, changes the pH-dependent solubility profiles of Aβs, and results in different biochemical and biophysical properties of Aβs.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Compared with Aβ, pE-Aβs aggregate more rapidly, confer enhanced stability and proteolytic resistance, and seed further Aβ aggregation. For instance, pE-Aβ co-oligomerizes with excess Aβs and forms oligomers that are structurally distinct and more cytotoxic than oligomers made from Aβs alone. Structural and conformational features of small, medium, and large aggregates of pE-Aβ are different from that of Aβ.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> As a result, pE-Aβs exhibit greater neurotoxicity and contribute to the dysfunction of neurons and initiation of AD (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref43 ref48 ref49 ref50 ref51 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref43 ref48 ref49 ref50 ref51 ref52 ref53 ref54">(43,48−54)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Generation and roles of pE-Aβ in the initiation of AD. A: The generation of pE-Aβ catalyzed by upregulated QC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of the enhanced hydrophobicity, pE-Aβ peptides bind to and are more toxic to neurons than Aβ peptides.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In neurons, pE-Aβs induce lipid peroxidation, trigger Ca<sup>2+</sup> influx, and cause the loss of plasma membrane integrity. Abnormally generated pE-Aβs exhibit neuron toxicity in a number of transgenic murine AD models. These models include 5XFAD mice, which coexpress five familial AD mutations, and 5XFAD/hQC and ETNA (E at the truncated N-terminus of Aβ) mice, which express truncated human Aβ<sub>3–42</sub> and ETNA-hQC, respectively.<a onclick="showRef(event, 'ref54 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref54 ref56 ref57">(54,56,57)</a> More importantly, the level of IgM autoantibodies against pE-Aβ correlates with the cognitive decline in human AD.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">In a post-mortem human brain, pE-Aβ aggregates mainly accumulate in the lysosomes of both neurons and glia cells and increase in an age-dependent manner.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The cytotoxicity of pE-Aβ is tau protein and/or hyperphosphorylated tau protein dependent, and the influence of pE-Aβ aggregated in the frontal cortex on both the severity of AD neuropathology and clinical symptoms of dementia is confirmed in humans.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> Interestingly, active and passive immunization targeting pE-Aβs exhibits remarkable effects on reducing plaques and improving cognitive potency in a murine AD model.<a onclick="showRef(event, 'ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref64">(62−64)</a> Therefore, the generation of pE-Aβs is now confirmed as a key inducer in the initiation of AD and plays a crucial role in the development of the disease.<a onclick="showRef(event, 'ref65 ref66 ref67 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67 ref68 ref69">(65−69)</a></div><div class="NLM_p">It is now appreciated that the deposition of pE-Aβs in the hippocampus, piriform cortex, and amygdala is accompanied by the endogenous expression of QC in APP-transgenic Tg2576 mice expressing human APP.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The dependence of pE-Aβ generation on QC was observed in transgenic TBA2.1 and TBA2.2 mice with truncated mutant human Aβ, APP-transgenic Tg2576 mice with human APP, 5XFAD/hQC bigenic AD mice, and transgenic ETNA and double transgenic ETNA-hQC mice.<a onclick="showRef(event, 'ref54 ref56 ref57 ref70'); return false;" href="javascript:void(0);" class="ref ref54 ref56 ref57 ref70">(54,56,57,70)</a> pE-Aβs, QC, and Aβs along with certain neuropeptides and catecholamines were also identified in isolated dense core secretory vesicles (DCSV), and cosecretion of cellular pE-Aβs and QC with Aβs, enkephalin, and galanin was inhibited in the presence of the QC inhibitor, PQ529.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The generation of pE in rat cortex was inhibited significantly by an intracortical microinjection of PBD150, another QC inhibitor.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> More importantly, in AD patients, QC was overexpressed by urocortin-1 and cholinergic Edinger-Westphal neurons, and by locus coeruleus and nucleus basalis Meynert neurons in subcortical brain.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The intraneuronal pE-Aβ immunoreactivity, a morphological sign of degeneration, and extracellular pE-Aβ deposits were displayed in these neuronal populations. These observations indicated the involvement of upregulated QC in the initiation of AD by catalyzing the generation of pE-Aβ peptides. Positive correlations between the QC mRNA levels and the amount of pE-Aβ aggregates, but not Aβ, in human post-mortem brain further addressed the role of QC in AD.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Upregulated QC also induces the regulation of Aβ38, Aβ40, and angiogenesis mediators such as Flt1, Tie2, VEGFD, VCAM-1, and ICAM-1 in AD patients.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">Although the causes inducing the upregulation of QC are not clear, evidence is accumulating to reveal the underlying mechanism. For instance, it has been demonstrated that perturbed intracellular Ca<sup>2+</sup> homeostasis induces the upregulation of QC in vitro because of a putative binding site for the Ca<sup>2+</sup>-dependent transcription factors c-fos and c-jun contained within the QC promoter.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Besides, the levels of QC mRNA, together with those of BACE1 and cathepsin B, were significantly upregulated in mouse brain after a transient global cerebral ischemia, which may contribute to the understanding of the relationship between cerebral ischemia and AD.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Note that the levels of QC mRNA and QC protein were higher in peripheral blood from AD patients than those in blood from age-matched controls, and the expression of QC was positively correlated with the severity of dementia.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> QC activity in human cerebrospinal fluid and levels of mRNA and protein in peripheral blood could be supposed as new biomarkers for the clinical diagnosis of AD.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> As a conclusion, considering the positive correlation between the activity of QC and the development of AD, the upregulation of QC is now considered by many as a crucial pathological signal in the initiation of AD at an early stage and as a reasonable target for the discovery of novel anti-AD agents.</div><div class="NLM_p">HD is a neurodegenerative disease caused by an expanded CAG trinucleotide repeat expansion in the gene encoding for Huntington (HTT) protein and characterized by a combination of motor, cognitive, and behavioral features.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> Small interfering RNA (siRNA) screening of human cells demonstrated that upregulated QC enhances the neurotoxicity induced by the trinucleotide repeats and plays crucial roles in the development of HD in a <i>Drosophila</i> model, although the details of the mechanism need to be further studied.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p last">Familial British dementia (FBD) is an autosomal dominant neurodegenerative disorder.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The accumulation of amyloid Bri (ABri), another amyloidogenic fragment resulting from the abnormal stop of an Arg mutation in the BRI gene, was detected in FBD brains. pE-modified ABri and amyloid-Dan (ADan), another amyloid peptide cleaved in familial Danish dementia (FDD), were present in extracellular plaques, vascular, and parenchymal deposits in human FBD and FDD brains, respectively.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Besides, ABri1–34pE takes a large proportion in water- and formic acid-soluble ABri molecules extracted from FBD brains, and in soluble and fibrillary ABri molecules extracted from systemic organs such as uterus, skeletal muscles, and pancreas.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> These results indicated that pE-modified inducers also contribute to the initiation of FBD and FDD, and pE modification at the N-terminal of ABri and ADan is performed at the beginning of FBD and FDD amyloid deposition.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.2.  Inflammation</h3><div class="NLM_p">Compared with the contribution of upregulated QC to the development of neurodegenerative diseases, the upregulation of iso-QC appears to trigger inflammatory reactions mainly by pE-modifying the CC chemokine ligand 2 (CCL2, also known as monocyte chemoattractant protein-1, MCP-1).<a onclick="showRef(event, 'ref16 ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref16 ref87 ref88 ref89">(16,87−89)</a> Produced by Aβ-stimulated microglia and astrocytes and a variety of immune cells, CCL2 deficiency results in accelerated β-amyloidosis, reduced neurogenesis in the dentate gyrus of hippocampus, and consequently memory impairment.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In contrast, patients with mild cognitive impairment (MCI) in which CCL2 expression is upregulated in the frontal cortex, are at high risk for developing AD.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> The level of CCL2 in cerebrospinal fluid (CSF) is positively correlated with a faster cognitive decline in patients with prodromal AD, and there is a correlation between the plasma CCL2 concentrations and the severity of traumatic brain injury (TBI).<a onclick="showRef(event, 'ref91 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref91 ref92 ref93">(91−93)</a> Therefore, in addition to tau, p-tau, and Aβ, CSF CCL2 could also be applied as a potential biomarker to predict the rate of cognitive decline and the conversion of prodromal AD to AD.</div><div class="NLM_p">Usually, CCL2 induces chemotaxis of monocytes and microglia through binding with chemokine receptor CCR2, a seven transmembrane spanning Gαi protein-coupled receptor constitutively expressed on monocytes and macrophages.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> By the mobilization of bone marrow monocytes and the recruitment of monocytes to sites of infection and inflammation, the CCL2-CCR2 pathway plays a pivotal role in acute and chronic inflammatory disorders and related diseases such as atherosclerosis, fibrosis, and AD.<a onclick="showRef(event, 'ref96 ref97 ref98 ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref96 ref97 ref98 ref99 ref100 ref101">(96−101)</a> Considering the regulations involved in innate immune reactions, the CCL2-CCR2 pathway is suggested as a potential target for the therapeutics of inflammatory diseases.<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a></div><div class="NLM_p">Research has further demonstrated that an intact N-terminus is necessary for CCL2 to activate CCR2, and the N-terminus is more susceptible to degradation by aminopeptidases such as DPP-4.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> CCL2, with an artificial elongation or truncation, loses the ability to recruit circulating monocytes to the sites of infection and inflammation. Interestingly, the N-terminus of human CCL2 is predominantly cyclized, and the levels of pE-CCL2 are higher than those of CCL2 in inflammatory reactions. pE modification significantly enhances the hydrophobicity of CCL2, and this in turn improves the interaction between CCL2 and CCR2.<a onclick="showRef(event, 'ref32 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref32 ref106 ref107">(32,106,107)</a> Compared with CCL2, pE-CCL2 is a stronger CCR2 ligand and more active in chemotaxis assays, displaying a higher functional activity. Meanwhile, the presence of pE confers resistance to degradation and significantly increases the in vivo half-life of CCL2. As a result, inflammatory reactions are overactivated.</div><div class="NLM_p">It has been confirmed in vitro that the generation of pE-CCL2 is catalyzed by both QC and iso-QC. However, iso-QC mainly contributes to the pE-CCL2 formation, monocyte infiltration, and CCL2-driven inflammation in vivo.<a onclick="showRef(event, 'ref87 ref88 ref108'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref108">(87,88,108)</a> Considering the roles of iso-QC/QC in monocyte infiltration in inflammatory conditions, the positive correlation between the upregulation of QC, generation of pE-CCL2, and development of inflammation might support the discovery of novel agents for the treatment of inflammatory diseases such as septic arthritis induced by <i>Staphylococcus aureus</i> by inhibiting QC activity (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111">(109−111)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Generation and roles of pE-CCL2 in the initiation of inflammatory reactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">CX3CL1, also known as fractalkine, is another mediator for the attraction and migration of monocytes in inflammatory processes.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a> CX3CL1 mediates the integrin-independent adhesion by binding with CX3CR1 (fractalkine receptor 1).<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a> On the basis of the regulation of leucocyte recruitment and intercellular communication, the CX3CL1-CX3CR1 pathway exhibits the necessary potency to spark the initiation and development of inflammation.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Similar to CCL2, there is a glutamine at the N-terminus of CX3CL1, which could be pE post-translationally modified by both QC and iso-QC. Furthermore, pE is required for CX3CL1 to activate other pathways such as ERK1/2, p38, and Akt kinases.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> These results further support the role for iso-QC/QC in inflammatory processes.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3.  Cancer and Other Diseases</h3><div class="NLM_p">In addition to neurodegenerative diseases and inflammation, abnormally upregulated QC/iso-QC might act as the main cause of thyroid carcinomas. Compared to the expression in goiter tissues, the expression of QC, not iso-QC, in tissues of patients was upregulated significantly and positively correlated with the level of CCL2, and all CCL2 were secreted as pE-CCL2 in the supernatant of thyroid cancer cells.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The increased functional activity of CCL2 triggers the development of thyroid carcinomas by recruiting monocytes/macrophages to the sites of inflammation.</div><div class="NLM_p">CD47, a transmembrane protein ligand for myeloid cells, is overexpressed in various cancers and exhibits potency in the development of these cancers. The binding of CD47 to signal regulatory protein alpha (SIRPα) protects cancer cells from phagocytosis by forming the “don’t eat me” signal.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Gln19 at the N-terminus of CD47 could be modified to pE by iso-QC in vitro, and the presence of pE contributed to the binding of CD47 to SIRPα more efficiently.<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119,120)</a> Therefore, iso-QC is a potential therapeutic target for the treatment of cancers through the regulation of the CD47-SIRPα axis.</div><div class="NLM_p">On the basis of Principal Components Analyses with 90 cancer cell lines from three microarray data sets, a defined melanoma component is identified that contains a gene coding for the highly expressed QC.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> QC may interfere with the tumor destructive process of vaccines using peptides carrying glutamine or glutamic acid at their N-termini. So, the inhibition of QC activity may improve the efficacy of the melanoma vaccine. Interestingly, the QPCT gene is methylated in more than 95% of uncultured melanoma tumor samples.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121,122)</a></div><div class="NLM_p">Analysis of genotypes or haplotypes in 384 Japanese adult women with low radical bone mineral density (BMD) indicated that the genetic variations in QC mainly contributed to the susceptibility to osteoporosis by modifying peptide hormones, for example, GnRH.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Gene expression profiling of peripheral blood mononuclear cells (PBMCs) in 29 patients with rheumatoid arthritis and 21 controls demonstrated that the abnormal expression of QC might also be involved in the development of rheumatoid arthritis.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><div class="NLM_p last">QCs from the oral pathogens <i>Porphyromonas gingivalis</i>, <i>Tannerella forsythia</i>, and <i>Prevotella intermedia</i> represent attractive target enzymes for small-molecule inhibitor development. These QCs possess sequences corresponding to type II QCs, observed hitherto only in animals, and exhibit comparable catalytic efficiencies and are inhibited by metal chelators. Crystal structures of these QCs reveal a tertiary structure composed of an eight-stranded β-sheet surrounded by seven α-helices, and an active site Zn ion is tetrahedrally coordinated by conserved residues. These studies indicate that mammalian-type QC from certain pathogens is also a potential drug target for the treatment of periodontitis and associated diseases.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">3.  Discovery and Development of QC Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Considering the widespread and pervasive homeostatic consequences of upregulated QC, reducing the generation of pE-modified mediators by inhibiting QC may be a novel approach to the prevention and treatment of diseases including AD, inflammation, and cancer. In the past decades, a series of compounds has been developed and determined as QC inhibitors.<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">3.1.  Imidazole-Containing Chemicals</h3><div class="NLM_p">In 1987 it was reported that, in vivo, the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is mainly catalyzed by QC based on an assay measuring the rate of conversion of Gln-His-Pro-NH<sub>2</sub> to pyroGlu-His-Pro-NH<sub>2</sub> (TRH).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Then, it was shown that the activity of hQC is reduced by 1,10-phenanthroline and dipicolinic acid in a time-dependent inhibition manner, thus identifying imidazole and imidazole derivatives as competitive QC inhibitors. These metal chelators inhibit the activity, which is reversed by the addition of Zn<sup>2+</sup>, and the addition of other metal ions such as Co<sup>2+</sup> and Mn<sup>2+</sup> partially reactivate the activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Together, hQC was revealed as a metal-dependent enzyme based on the pH-dependent inhibition by imidazole derivatives and the kinetic parameter <i>K</i><sub>m</sub> of the QC-catalyzed conversion.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Bidentate heterocyclic compounds have the ability to bind with most metal ions to form stable coordinated complexes. However, these agents also trigger the destruction of multiple biochemical reactions in vivo because of their potency and promiscuous binding affinities. To discover new QC inhibitors, many phenanthroline-type heterocyclic compounds, including five- and six-membered ring systems, have been screened for QC inhibition. Imidazole and its derivatives are more potent than others (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). A structure–activity relationship (SAR) analysis indicated that imidazole is the important motif to inhibit the activity of QC, and it does so by binding to the Zn<sup>2+</sup> located at the bottom of the pocket.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Modifications of the imidazole moiety significantly affect the inhibitory potency. Methylation and benzylation of the nitrogen atom at position 1 of imidazole resulted in a 3- and 14-fold potency increase, respectively. However, the introduction of phenylalanine at the same position significantly lowered the potency, and phenylation of the same position and methylation of the carbon atom at position 2 also reduced the inhibitory potency.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. QC inhibitors based on imidazole and triazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To improve potency and specificity, a ligand-based optimization approach has been employed. On the basis of the screening of designed thiourea derivatives, imidazole-1-yl-alkyl thiourea was developed as a leading scaffold, and 1-(3-(1<i>H</i>-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl) thiourea (<b>53</b>, also named as PBD150, <i>K</i><sub>i</sub> = 0.06 ± 0.0002 μM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) proved to be a potent inhibitor. According to a docking analysis, Zn<sup>2+</sup> could be coordinated by imidazole. The donor nitrogen of the thiourea is found to form the essential H bond. The phenyl part of the inhibitor fits the hydrophobic pocket. And the methoxy substituents on the aromatic motif exhibit a big impact on the inhibitory bonding.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Subsequently, imidazole-propyl-thioamides were demonstrated as another class of potential inhibitors carrying the same scaffold, such as compound <b>2</b>, <i>K</i><sub>i</sub> = 0.09 ± 0.0002 μM (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> The site-directed mutagenesis of hQC has also been used to explore the detailed specific interactions between test compounds and QC. Replacing the alanine or asparagine of hQC with F325 and I303 resulted in an 800-fold decrease in the inhibitory activity of PBD150. In contrast, exchanging S323 with alanine or valine resulted in a 20-fold increase in the inhibitory activity of the same compound.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> This result further confirmed the binding of imidazole to Zn<sup>2+</sup> in the active pocket as shown in the proposed docking model.</div><div class="NLM_p">A homology model of QC was developed to support the discovery of new QC inhibitors. Replacements of thiourea with cyanoguanidine or nitrovinyldiamine exhibited no significant effect on potency. However, the replacement of 3,4-dimethoxyphenyl with saturated carbocyclic substituents exhibited a slight positive effect, partly because of the different binding mode. Incorporation of thiourea into thioxopyrimidine was helpful for increasing the potency in the presence of the favored annulated saturated ring. Interestingly, compared with their corresponding 4-methylimidazole analogues, 5-methylimidazole thioureas, cyanoguanidines, nitrovinyldiamines, and thioxopyrinidines exhibited an improvement on the inhibitory potency; for example, the introduction of a methyl at position 5 resulted in an elevation of 10- and 35-fold for compounds <b>9</b> (<i>K</i><sub>i</sub> = 6.3 ± 0.45 nM) and <b>11</b> (<i>K</i><sub>i</sub> = 2.6 ± 0.08 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), in comparison to PBD150, respectively.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Compared to other parts of these compounds, the binding of 5-methylimidazole with the Zn<sup>2+</sup> exhibits a higher inhibitory effect.</div><div class="NLM_p">Another series of compounds has been prepared in which benzimidazole connected to 1,3,4-oxadiazole was presented as the metal binding motif. A pharmacophore-based screen confirmed the potency of this novel scaffold. Among them, <b>8h</b> (<i>K</i><sub>i</sub> = 23 ± 1 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) exhibited potent QC inhibitory activity.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Considering the docking mode of the preferred substrate with QC and the structure of PBD150, heterocycles were introduced to the aromatic moiety region in <i>N</i>-aryl-<i>N</i>-(5-methyl-1<i>H</i>-imidazol-1-yl) propyl thioureas. The half-maximal inhibitory concentration (IC<sub>50</sub>) value of compound <b>52</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was 58 nM, showing an improvement of more than twofold in comparison to that of PBD150.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><div class="NLM_p">Interestingly, <b>PQ912</b> ([(<i>S</i>)-1-(1<i>H</i>-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one], <i>K</i><sub>i</sub> = 24.6 ± 0.7 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was reported as a new QC inhibitor.<a onclick="showRef(event, 'ref133 ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref133 ref134 ref135">(133−135)</a> Different from the scaffolds mentioned above, benzoimidazol, presented as Zn<sup>2+</sup> binding motif at position 1 of imidazolidine-2-one, is located near to an <i>o</i>-substituted 4-propoxyphenyl at position 5. The development of <b>PQ912</b>, which is the first QC inhibitor undergoing a clinical trial against AD, will hopefully lead to the discovery of novel and clinically effective QC inhibitors.</div><div class="NLM_p">To discover novel scaffolds, a series of diphenyl conjugated imidazole derivatives (DPCIs) have been prepared, guided by rational design based on the crystal structure of hQC.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> To reduce the flexibility and improve the blood-brain barrier (BBB) penetrability, a diphenyl moiety was generated by introducing one more phenyl ring to the phenyl motif and an imidazole functional linker at the ortho position of the new phenyl ring. Analogues exhibited remarkable QC inhibitory activity, and anti-AD potency is expected, for example, compound <b>28</b> (IC<sub>50</sub> = 1.23 μM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The chelation between the imidazole ring and Zn<sup>2+</sup> at the bottom of the pocket was conserved, which contributed to the improved BBB penetration and potency of these agents. In addition to the enhanced inflexibility of the molecule induced by the middle aromatic motif, the π–π stacking between the terminal aromatic motif and Phe325 at the hydrophobic entrance also contributed to the improved BBB penetration and potency of these agents.</div><div class="NLM_p">According to the binding mode of pE-Aβ<sub>3–42</sub> in the pocket of QC, another scaffold was designed based on the structure of PBD150. A series of motifs was added to mimic the guanidine moiety of Arg contained in Aβ<sub>3–42</sub>, the enhanced potency of which was confirmed. This included a 5–40-fold increase compared to that of PBD150. Particularly, compound <b>212</b> (IC<sub>50</sub> = 4.5 ± 1.4 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) reduced the generation of pE-Aβ and total Aβ and restored cognitive functions in AD mice.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> The potency improvement was thought to result from the strong interaction between the compound and the carboxylic acid group of Glu327 at the active site.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This scaffold was developed further to improve the potency and BBB penetration by replacing the linker with different Arg mimetic groups that could form an additional hydrophobic interaction in the pocket. Compound 202 was shown as a potential candidate with an IC<sub>50</sub> of 6.2 ± 2.9 nM.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> In the following research, 3-aminoalkyloxy-4-methoxyphenyl and 4-aminoalkyloxyphenyl groups were introduced as Arg-mimetic pharmacophores. Treatment of compound 53 reduced the generation of pE-Aβ<sub>3–40</sub> significantly in acute AD mice with reasonable BBB penetration and low cytotoxicity.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> The slat bridge interaction and hydrogen bonding of the protonated amine group with Glu327 and Pro326 were thought to contribute to the potency of these molecules.</div><div class="NLM_p"><b>SEN177</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), a designed compound composed of a triazine ring as the hQC-binding motif, exhibited remarkable hQC inhibitory potency (<i>K</i><sub>i</sub> = 20 nM).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> This molecule has already shown interesting pharmacological properties against HTT aggregation. Together with the peculiar-binding mode, this new scaffold may provide clues to the discovery of new high-affinity QC inhibitors targeting AD.</div><div class="NLM_p">A series of N-substituted thiourea/urea analogues of compound <b>9</b> was prepared based on a rigidification strategy, and different alkyl groups and aromatic and heteroaromatic functional groups were introduced to generate the bent conformation of <b>9</b>. SAR analyses indicated that these conformationally restrained compounds had improved QC inhibitory potency, and the <i>Z</i>-<i>E</i> conformation of the compound at the active site was critical for activity. For example, compound <b>90</b> (IC<sub>50</sub> = 6.1 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) showed promising efficacy and significantly reduced the brain concentrations of pE-Aβ and total Aβ in the 5XFAD mouse model.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><div class="NLM_p">Related studies have pushed the discovery of yet other novel QC inhibitors. For instance, a small molecule, <b>1</b>, was synthesized, which exhibited an IC<sub>50</sub> value of 5.11 μM (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> A comparative molecular field analysis (CoMFA) of 50 imidazole derivatives demonstrated that a benzene ring at the para- and meta-positions improved the inhibitory potency.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Two-dimensional-autocorrelation (2D AUTO) and atom-centered fragment (ACF) descriptors were prepared to aid the design of new molecules.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Fragment-based drug discovery has also been applied in the development of novel QC inhibitors through the preparation of a QC fragment library, screening of lead compounds in the library in vitro, and performing binding interaction analysis.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Through a pharmacophore-assisted high-throughput virtual screening, piperidine-4-carboxamide was indicated as a new scaffold for the development of QC inhibitors based on the unique binding model at the active site of QC.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><div class="NLM_p last">The conclusions drawn from the above-mentioned information are that QC inhibitory potency requires two predominant features: (1) a Zn<sup>2+</sup> binding motif is required, which binds to the active zinc ion located at the bottom of the pocket, and (2) a large hydrophobic residue is necessary to occupy the penultimate position to the N-terminal glutamine. These two rules should be considered when designing and developing novel QC inhibitors regardless of the presence of an imidazole moiety.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.2.  Other Chemicals</h3><div class="NLM_p">Natural products are also a source of material for the discovery and development of novel QC inhibitors. The aggregation and cytotoxicity of pE-Aß and QC activity in vitro and in vivo, were all reduced/inhibited in the presence of oleuropein aglycone (OLE) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), a natural phenol abundant in extra virgin olive oil. Memory and behavioral performance in aged TgCRND8 AD mice was improved significantly after OLE treatment.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Moreover, for the inhibitory effects of crude algal extracts on QC activity, three sulfolipids, for example, <b>S1</b> shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, were identified as potential QC inhibitors using a reverse metabolomics technique including an activity-correlation analysis.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Sulfolipids could be thought of as a novel scaffold in which the sulfonate group might act as the important pharmacophore that binds to Zn<sup>2+</sup>. In another report, a series of apigenin derivatives modified at phenol-4′ (R<sub>1</sub>), C5-OH (R<sub>2</sub>), and C7-OH (R<sub>3</sub>) exhibited remarkable hQC inhibitory potency. For example, the IC<sub>50</sub> value of compound <b>A1</b> was ∼16.1 ± 2.0 μM (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> An SAR analysis demonstrated that C7-OH was required for binding with Zn<sup>2+</sup> and that C5-OH was favored, whereas phenol-4′ was tolerant for the inhibitory activity. So, new scaffolds and active compounds based on natural products could be the focus for the development of novel anti-AD agents targeting QC.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Natural products exhibited QC inhibitory potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Moreover, a most recent study identified novel strategies in the design of potent and highly selective QC inhibitors by employing hydrazides as the metal-binding warhead. The structural basis of hydrazide inhibition was illuminated by an X-ray structure analysis of human QC in a complex with a hydrazide-bearing peptide inhibitor and revealed a pentacoordinated Zn complex.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Efficiency Evaluation of QC Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because of the crucial role of abnormally upregulated QC in the initiation of multiple diseases such as AD, inflammation, and cancer, by catalyzing the generation of pE-Aβ and pE-CCL2, QC could be supposed as a reasonable target for the future development of novel and useful pharmacological agents. As expected, the potency of a few QC inhibitors has been amply demonstrated both in vitro and in vivo.</div><div class="NLM_p">To explore new therapeutics, the application of QC inhibitors is gaining increasing attention for the treatment of AD. In mammalian cells, glutamine and glutamic acid cyclization were inhibited, and the toxicity of pE-Aβs was reduced notably in the presence of QC inhibitors.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> The amyloidogenic processing of APP was blocked, and the generation of pE-Aβ<sub>3–40/42</sub> was reduced by inhibiting QC activity.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> An oral application of PBD150 reduced the generation of pE-Aβ<sub>3–42</sub> and Aβ<sub>x-40/42</sub>, diminished the formation of plaques in brains, reduced gliosis, and improved the performance in Tg2576 (B6/SJL, human APPsw695-transgene) and TASD-41 mice (C57/Bl6 hybrid) and in a new <i>Drosophila</i> model.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> γ-Secretase activity was modulated, and the aggregation of pE-Aβ<sub>3–42</sub> was lowered remarkably in the 5XFAD mice treated with a QC inhibitor.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> In B6C3-Tg mice, treatment with DPCI-28 resulted in a dose-dependent decrease of QC activity and pE-Aβ<sub>3–42</sub> aggregates in the hippocampus, cortex, and total brain. And a significant behavioral improvement in treated B6C3-Tg mice was observed compared with the mice in the control group.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><div class="NLM_p">More importantly, PQ912, the first oral QC inhibitor, is already in clinical trials for the treatment of AD. The randomized, double-blind, placebo-controlled, single- and multiple-dose oral dose studies on the safety, pharmacokinetics, and pharmacodynamics of PQ912 in healthy nonelderly and elderly volunteers confirmed that PQ912 is safe and well-tolerated.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The Phase I clinical trial of PQ912 was conducted in 2015. The Phase 2a study demonstrated that QC activity was inhibited significantly after the treatment of PQ912, which resulted in an average target occupancy of more than 90% and a significant improvement in the One Back test of the Neuropsychological Test Battery.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> These results indicated the application of the QC inhibitor as a new agent for the prevention and treatment of AD.</div><div class="NLM_p">Liver inflammation is frequently characterized by the upregulation of CCL2 and other chemokine pathways. The effects of PQ529 and PBD150 on inflammation were evaluated in mouse models of nonalcoholic fatty liver disease (NAFLD). It was found that circulating alanine aminotransferase, NAFLD activity score, the number of F4/80-positive macrophages, and liver fibrosis were all significantly reduced or attenuated after the treatment of QC inhibitors.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Monocyte and cell migration were both attenuated significantly in the presence of PBD150.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Monocyte infiltration was inhibited in inflammatory models such as thioglycollate-induced peritonitis, and atherosclerotic pathology was also attenuated in ApoE3*Leiden mice after the treatment of PQ50/PQ529. Therefore, the application of the QC inhibitor may present a new strategy for the treatment of nonalcoholic steatohepatitis and inflammatory diseases.</div><div class="NLM_p last">Besides, the efficacy of two QC inhibitors, PBD155 and PQ529, was evaluated, and the onset of clinical symptoms of arthritis was significantly delayed in a mouse model of septic arthritis.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Treatment of QC inhibitors, for example, SEN177, slowed the pathology in cells, flies, and a zebrafish model of HD.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Inhibiting QC and iso-QC by PQ50 and PQ529 also attenuated an atherosclerotic pathology in accelerated atherosclerotic models.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> These observations indicated that QC could also serve as a possible target for the treatment of these diseases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">5.  Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Because of the generation of pE-modified mediators catalyzed mainly by QC and the positive correlation between the upregulation of QC and the initiation of multiple diseases, identifying small molecule inhibitors of QC is becoming a promising therapeutic strategy to treat upregulated QC-related diseases. Over the past decades, a series of compounds carrying different scaffolds has been developed as potential QC inhibitors. The promising efficiency of some QC inhibitors in these diseases and conditions has been confirmed both in vitro and in vivo. However, there remain issues that need to be addressed. One major concern is the specificity of effects. Because pE is the N-terminus of numerous proteins essential to life, an overactivity of QC may result in widespread homeostatic disturbances that affect multiple areas of cellular biochemistry in a number of pathways and organs. Therefore, unpredictable side effects that may be inevitable, at least to some degree, should be noted and avoided in the process of inhibitor development. It is demonstrated that <sup>11</sup>C-labeled PBD150 does not penetrate the BBB in mice.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> This indicates that the anti-AD effects of the QC inhibitor in vivo may not be due to the direct central nervous system (CNS) effects. The possible underlying pathways or mechanisms of QC inhibitors require further investigation. In view of the difference between the roles of QC and that of iso-QC in different conditions, improved target selectivity and BBB penetrability are both essential for the discovery and evaluation of novel and clinically useful QC inhibitors.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00325" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiqiang Wu</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences,
Health Science Center, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-3979-7304" title="Orcid link">https://orcid.org/0000-0003-3979-7304</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#384f4d5049784b424d165d5c4d165b56"><span class="__cf_email__" data-cfemail="611614091021121b144f0405144f020f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenshu Xu</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences,
Health Science Center, Shenzhen University, Shenzhen 518060, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8799-1913" title="Orcid link">https://orcid.org/0000-0002-8799-1913</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi-nan Wang</span> - <span class="hlFld-Affiliation affiliation">School of Pharmaceutical Sciences,
Health Science Center, Shenzhen University, Shenzhen 518060, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Chenshu Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=BIO-d7e1368-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Chenshu Xu</b> is the Director of Clinical Pharmacy Division at School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, China. She received her B.S. in Pharmacy from Sun Yat-sen University in China and Ph.D. in Pharmacology and Toxicology from University of Kansas in the United States. Her research interests include nuclear receptor-mediated drug metabolism and drug interactions, molecular mechanisms underlying small-molecule glutaminyl cyclase inhibitors against different diseases, such as Alzheimer’s disease, cancers, etc., and rational drug use in medical institutes.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Yi-nan Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=BIO-d7e1373-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yi-nan Wang</b> received her B.S. degree in Pharmacy from Tianjin University in 2011 and Ph.D. degree in Pharmaceutical Analysis from Fudan University in 2017. Now she works as an assistant professor in School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, China. Her research interests are focused on the development of novel fluorescent strategies for the detection of biomarkers related with diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Haiqiang Wu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=BIO-d7e1378-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Haiqiang Wu</b> is a group leader at School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, China, where he leads a multidisciplinary team with research spanning computational & medicinal chemistry, natural product chemistry, pharmaceutics, biochemistry, cell biology, and pharmacology. His research interests focus on the discovery of components for the therapeutics of complex diseases and the design and development of anti-AD agents. Particularly, his medicinal chemistry research program investigates the discovery and development of small-molecule inhibitors targeting glutaminyl cyclase (QC). As the Principal Investigator, he is also interested in the identification of unique function for QC and the understanding of therapeutic mechanisms of QC inhibitors.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the grants of National Natural Science Foundation of China (No. 51973121), Science and Technology Planning Project of Shenzhen City (Nos. JCYJ20170818141722713, JCYJ20180305163554458, and JCYJ20180305163332507), and SZU medical young scientists program (No. 71201-000001).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">2D AUTO</td><td class="NLM_def"><p class="first last">two-dimensional-autocorrelation</p></td></tr><tr><td class="NLM_term">ABri</td><td class="NLM_def"><p class="first last">amyloid Bri</p></td></tr><tr><td class="NLM_term">ACF</td><td class="NLM_def"><p class="first last">atom-centered fragment</p></td></tr><tr><td class="NLM_term">ADan</td><td class="NLM_def"><p class="first last">amyloid-Dan</p></td></tr><tr><td class="NLM_term">AMC</td><td class="NLM_def"><p class="first last">7-amino-4-methylcoumarin</p></td></tr><tr><td class="NLM_term">ApAP</td><td class="NLM_def"><p class="first last">Aeromonas proteolytica aminopeptidase</p></td></tr><tr><td class="NLM_term">BMD</td><td class="NLM_def"><p class="first last">bone mineral density</p></td></tr><tr><td class="NLM_term">CCL2</td><td class="NLM_def"><p class="first last">chemokine ligand 2</p></td></tr><tr><td class="NLM_term">CgA</td><td class="NLM_def"><p class="first last">chromogranin A</p></td></tr><tr><td class="NLM_term">CPG2</td><td class="NLM_def"><p class="first last">carboxypeptidase G2</p></td></tr><tr><td class="NLM_term">DCSV</td><td class="NLM_def"><p class="first last">dense core secretory vesicles</p></td></tr><tr><td class="NLM_term">DPCIs</td><td class="NLM_def"><p class="first last">diphenyl conjugated imidazole derivatives</p></td></tr><tr><td class="NLM_term">ETNA</td><td class="NLM_def"><p class="first last">E at the truncated N-terminus of Aβ</p></td></tr><tr><td class="NLM_term">FBD</td><td class="NLM_def"><p class="first last">Familial British dementia</p></td></tr><tr><td class="NLM_term">FDD</td><td class="NLM_def"><p class="first last">familial Danish dementia</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">HTT</td><td class="NLM_def"><p class="first last">Huntington</p></td></tr><tr><td class="NLM_term">isoQCs</td><td class="NLM_def"><p class="first last">glutaminyl cyclase isoenzymes</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">MCP-1</td><td class="NLM_def"><p class="first last">monocyte chemoattractant protein-1</p></td></tr><tr><td class="NLM_term">NAFLD</td><td class="NLM_def"><p class="first last">nonalcoholic fatty liver disease</p></td></tr><tr><td class="NLM_term">OLE</td><td class="NLM_def"><p class="first last">oleuropein aglycone</p></td></tr><tr><td class="NLM_term">PBMCs</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">pE</td><td class="NLM_def"><p class="first last">pyroglutamate</p></td></tr><tr><td class="NLM_term">QC</td><td class="NLM_def"><p class="first last">glutaminyl cyclase</p></td></tr><tr><td class="NLM_term">QPCT</td><td class="NLM_def"><p class="first last">glutaminyl-peptide cyclotransferase</p></td></tr><tr><td class="NLM_term">SiRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SgAP</td><td class="NLM_def"><p class="first last"><i>Streptomyces griseus</i> aminopeptidase</p></td></tr><tr><td class="NLM_term">TBI</td><td class="NLM_def"><p class="first last">traumatic brain injury</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 157 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens-Volant, D.</span></span> <span> </span><span class="NLM_article-title">Detection of three wound-induced proteins in papaya latex</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2003.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.phytochem.2003.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15003415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=525-34&author=M.+Azarkanauthor=R.+Wintjensauthor=Y.+Loozeauthor=D.+Baeyens-Volant&title=Detection+of+three+wound-induced+proteins+in+papaya+latex&doi=10.1016%2Fj.phytochem.2003.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of three wound-induced proteins in papaya latex</span></div><div class="casAuthors">Azarkan, Mohamed; Wintjens, Rene; Looze, Yvan; Baeyens-Volant, Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">525-534</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The effects of routine mech. wounding for latex collection from unripe fruits of the tropical Carica papaya tree were investigated.  For that purpose, the protein compn. of three different latexes was analyzed.  The first one, com. available, was provided in the form of a spray-dried powder, the second one was harvested from fully grown but unripe papaya fruits that are regularly tapped for latex prodn. and the last one, was obtained from similar fruits wounded for the first time.  Repeated mech. wounding profoundly affected the protein content of the latex inducing, among others, activation of papain.  Regularly tapped latexes also accumulated several low-mol.-wt. proteins not yet identified, as well as three proteins identified as a trypsin inhibitor, a class-II chitinase and a glutaminyl cyclase on the basis of their enzymic or inhibitory activities and chromatog. elution profiles.  This latter was found here, for the first time, to be a wound-induced protein.  The roles of these proteins in the plant defense mechanism are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmBwW_0nMArLVg90H21EOLACvtfcHk0lj4M4MaxvxBBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslehsLo%253D&md5=b1c6f5b612fc016601fbcba24be326c9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2003.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2003.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DLooze%26aufirst%3DY.%26aulast%3DBaeyens-Volant%26aufirst%3DD.%26atitle%3DDetection%2520of%2520three%2520wound-induced%2520proteins%2520in%2520papaya%2520latex%26jtitle%3DPhytochemistry%26date%3D2004%26volume%3D65%26spage%3D525%26epage%3D34%26doi%3D10.1016%2Fj.phytochem.2003.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messer, M.</span></span> <span> </span><span class="NLM_article-title">Enzymatic cyclization of L-glutamine and L-glutaminyl peptides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">1299</span>, <span class="refDoi"> DOI: 10.1038/1971299a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F1971299a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=13935130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaF3sXnsVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1963&pages=1299&author=M.+Messer&title=Enzymatic+cyclization+of+L-glutamine+and+L-glutaminyl+peptides&doi=10.1038%2F1971299a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic cyclization of L-glutamine and L-glutaminyl peptides</span></div><div class="casAuthors">Messer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1299</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">At the optimum pH of 10, 1 mg. of the sol. fraction of crude papain (I) liberated 0.057 micromole NH3/min. from a 0.025M L-glutamine (II) soln. at 30°.  Paper chromatography showed that II was converted to a ninhydrin-neg. compd. which had the same Rf as proline.  D-Glutamine was not affected and I was made inactive by heating for 20 min. at 90°.  Dialysis of I or pretreatment with iodoacetate or ethylenediaminetetraacetic acid had no effect and pure I and chymopapain were inactive.  L-Glutaminyl dipeptides were deamidated and cyclized more rapidly and at a lower pH than II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ay7t_MIodrVg90H21EOLACvtfcHk0lj4M4MaxvxBBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXnsVCqtw%253D%253D&md5=a0fbeb450c6d1992be19930ff36f8176</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F1971299a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1971299a0%26sid%3Dliteratum%253Aachs%26aulast%3DMesser%26aufirst%3DM.%26atitle%3DEnzymatic%2520cyclization%2520of%2520L-glutamine%2520and%2520L-glutaminyl%2520peptides%26jtitle%3DNature%26date%3D1963%26volume%3D197%26spage%3D1299%26doi%3D10.1038%2F1971299a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockers, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-53&author=T.+M.+Bockersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eZjLFplaV1Szrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DBockers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D53%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, I. H.</span></span> <span> </span><span class="NLM_article-title">Snake venom glutaminyl cyclases: purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.toxicon.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24814012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=40-50&author=Y.+M.+Wangauthor=K.+F.+Huangauthor=I.+H.+Tsai&title=Snake+venom+glutaminyl+cyclases%3A+purification%2C+cloning%2C+kinetic+study%2C+recombinant+expression%2C+and+comparison+with+the+human+enzyme&doi=10.1016%2Fj.toxicon.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Snake venom glutaminyl cyclases: Purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme</span></div><div class="casAuthors">Wang, Ying-Ming; Huang, Kai-Fa; Tsai, Inn-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among various snake venom components, glutaminyl cyclase (vQC) is one of the least understood protein family and none of its members has been purified or characterized.  Here we confirmed the presence of vQC activity in a wide spectrum of venom species via enzymic assay using a synthetic fluorogenic substrate.  We have also cloned novel vQC cDNAs from seven species including Crotalus atrox.  The results revealed more than 96% sequence similarities among vQCs and ∼75% sequence identities between vQCs and human secretory QC (hQC).  The vQC glycoprotein of 43 kDa was isolated from C. atrox venom, and its N-terminal sequence was detd.  The optimal pH range for vQC reaction was 7.5-8.0, and the enzymes were stable up to 50 °C.  Similar to hQC, vQCs were substantially inactivated by 1 mM 1,10-phenanthroline but slightly affected by 20 mM EDTA, suggestive of a similar zinc-catalytic environment for these enzymes.  Although their catalytic residues were highly conserved, vQCs were less susceptible to inhibition by synthetic imidazole derivs. which potently inhibited hQC.  The 3D-models revealed that vQC and hQC structures display different surface charge distributions around the active sites, which might affect substrate and inhibitor binding affinities.  The recombinant vQCs prepd. from Escherichia coli displayed weaker substrate binding affinities relative to the native vQCs, possibly due to the lack of glycosylation.  The present report offers new structural and functional insights into vQCs and sheds light on the specificity differences between vQCs and hQC.  Eight nucleotide sequences encoding the vQCs of Crotalus atrox, Micrurus fulvius, Cerrophidion godmani, Daboia russelii, Trimeresurus gracilis, Protobothrops mucrosquamatus, and Sistrurus catenatus tergeminus have been deposited in GenBank with the accession nos. JF979132-JF979139.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_hWv4ACaTvLVg90H21EOLACvtfcHk0lhGLTKaD9qMGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWqsLrE&md5=88cce226e13aea8f914edf63a094c2d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DTsai%26aufirst%3DI.%2BH.%26atitle%3DSnake%2520venom%2520glutaminyl%2520cyclases%253A%2520purification%252C%2520cloning%252C%2520kinetic%2520study%252C%2520recombinant%2520expression%252C%2520and%2520comparison%2520with%2520the%2520human%2520enzyme%26jtitle%3DToxicon%26date%3D2014%26volume%3D86%26spage%3D40%26epage%3D50%26doi%3D10.1016%2Fj.toxicon.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayasarathy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basheer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaram, P.</span></span> <span> </span><span class="NLM_article-title">Cone snail glutaminyl cyclase sequences from transcriptomic analysis and mass spectrometric characterization of two pyroglutamyl conotoxins</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2695</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/acs.jproteome.8b00132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jproteome.8b00132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fit1Khtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2695-2703&author=M.+Vijayasarathyauthor=S.+M.+Basheerauthor=P.+Balaram&title=Cone+snail+glutaminyl+cyclase+sequences+from+transcriptomic+analysis+and+mass+spectrometric+characterization+of+two+pyroglutamyl+conotoxins&doi=10.1021%2Facs.jproteome.8b00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cone Snail Glutaminyl Cyclase Sequences from Transcriptomic Analysis and Mass Spectrometric Characterization of Two Pyroglutamyl Conotoxins</span></div><div class="casAuthors">Vijayasarathy Marimuthu; Basheer Soorej M; Balaram Padmanabhan; Vijayasarathy Marimuthu; Balaram Padmanabhan; Basheer Soorej M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of proteome research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2695-2703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The post-translational modification of N-terminal glutamine (Q) to a pyroglutamyl (Z) residue is observed in the conotoxins produced by marine cone snails.  This conversion requires the action of the enzyme glutaminyl cyclase (QC).  Four complete QC sequences from the species C. araneosus, C. frigidus, C. litteratus, and C. monile and two partial sequences from C. amadis and C. miles have been obtained by analysis of transcriptomic data.  Comparisons with mammalian enzyme sequences establish a high level of identity and complete conservation of functional active site residues, including a cluster of hydrogen-bonded acidic side chains.  Mass spectrometric analysis of crude venom samples coupled to conotoxin precursor protein sequences obtained from transcriptomic data establishes the presence of pyroglutamyl conotoxins in the venom of C. frigidus and C. amadis.  The C. frigidus peptide belongs to the M superfamily, with cysteine framework III, whereas the C. amadis peptide belongs to the divergent superfamily with cysteine framework VI/VII.  Additionally, gamma carboxylation of glutamic acid and hydroxylation of proline are observed in the C. frigidus peptide.  Mass spectral data are available via ProteomeXchange with identifier PXD009006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnaHX7csKbJ6cY7HFp97qMfW6udTcc2eZu_vCQHdC4sLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fit1Khtw%253D%253D&md5=6e236da3ba3997cea4ed84020453e4d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jproteome.8b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jproteome.8b00132%26sid%3Dliteratum%253Aachs%26aulast%3DVijayasarathy%26aufirst%3DM.%26aulast%3DBasheer%26aufirst%3DS.%2BM.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DCone%2520snail%2520glutaminyl%2520cyclase%2520sequences%2520from%2520transcriptomic%2520analysis%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520two%2520pyroglutamyl%2520conotoxins%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2018%26volume%3D17%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Facs.jproteome.8b00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for tissue-specific forms of glutaminyl cyclase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00872-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0014-5793%2899%2900872-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10428492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXltFWnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=1999&pages=159-61&author=P.+A.+Sykesauthor=S.+J.+Watsonauthor=J.+S.+Templeauthor=R.+J.+Bateman&title=Evidence+for+tissue-specific+forms+of+glutaminyl+cyclase&doi=10.1016%2FS0014-5793%2899%2900872-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for tissue-specific forms of glutaminyl cyclase</span></div><div class="casAuthors">Sykes, Paul A.; Watson, Stephanie J.; Temple, Jeffrey S.; Bateman, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">159-161</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) is responsible for the presence of pyroglutamyl residues in many neuroendocrine peptides.  An examn. of the bovine tissue distribution of QC immunoreactivity, enzyme activity, and mRNA confirmed that QC was abundant in brain and pituitary by all three measures.  However, enzymic activity was considerably more widespread than either immunoreactivity or mRNA, suggesting multiple enzyme forms.  Partially purified QC from bovine spleen differed significantly from the known bovine pituitary QC in phys. and catalytic properties.  We propose that this form of glutaminyl cyclase plays a role in the posttranslational processing of constitutively secreted pGlu-contg. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAVzEsGk7lzLVg90H21EOLACvtfcHk0lhGLTKaD9qMGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFWnur0%253D&md5=6a10132cc48d48f352b96c0d531d25e3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900872-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900872-8%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DTemple%26aufirst%3DJ.%2BS.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DEvidence%2520for%2520tissue-specific%2520forms%2520of%2520glutaminyl%2520cyclase%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D455%26spage%3D159%26epage%3D61%26doi%3D10.1016%2FS0014-5793%2899%2900872-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and functional analysis of the glutaminyl cyclase from <i>Xanthomonas campestris</i></span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2010.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20558177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFOnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2010&pages=374-88&author=W.+L.+Huangauthor=Y.+R.+Wangauthor=T.+P.+Koauthor=C.+Y.+Chiaauthor=K.+F.+Huangauthor=A.+H.+Wang&title=Crystal+structure+and+functional+analysis+of+the+glutaminyl+cyclase+from+Xanthomonas+campestris&doi=10.1016%2Fj.jmb.2010.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure and Functional Analysis of the Glutaminyl Cyclase from Xanthomonas campestris</span></div><div class="casAuthors">Huang, Wei-Lin; Wang, Yu-Ruei; Ko, Tzu-Ping; Chia, Cho-Yun; Huang, Kai-Fa; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-388</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) (EC 2.3.2.5) catalyze the formation of pyroglutamate (pGlu) at the N-terminus of many proteins and peptides, a crit. step for the maturation of these bioactive mols.  Proteins having QC activity have been identified in animals and plants, but not in bacteria.  Here, we report the first bacterial QC from the plant pathogen Xanthomonas campestris (Xc).  The crystal structure of the enzyme was solved and refined to 1.44-Å resoln.  The structure shows a five-bladed β-propeller and exhibits a scaffold similar to that of papaya QC (pQC), but with some sequence deletions and conformational changes.  In contrast to the pQC structure, the active site of XcQC has a wider substrate-binding pocket, but its accessibility is modulated by a protruding loop acting as a flap.  Enzyme activity analyses showed that the wild-type XcQC possesses only 3% QC activity compared to that of pQC.  Superposition of those two structures revealed that an active-site glutamine residue in pQC is substituted by a glutamate (Glu45) in XcQC, although position 45 is a glutamine in most bacterial QC sequences.  The E45Q mutation increased the QC activity by an order of magnitude, but the mutation E45A led to a drop in the enzyme activity, indicating the crit. catalytic role of this residue.  Further mutagenesis studies support the catalytic role of Glu89 as proposed previously and confirm the importance of several conserved amino acids around the substrate-binding pocket.  XcQC was shown to be weakly resistant to guanidine hydrochloride, extreme pH, and heat denaturations, in contrast to the extremely high stability of pQC, despite their similar scaffold.  On the basis of structure comparison, the low stability of XcQC may be attributed to the absence of both a disulfide linkage and some hydrogen bonds in the closure of β-propeller structure.  These results significantly improve our understanding of the catalytic mechanism and extreme stability of type I QCs, which will be useful in further applications of QC enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5lSDy2DJ5ELVg90H21EOLACvtfcHk0ljnJE-PLEJIbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFOnsLk%253D&md5=da272da9d25ebcc7254e8a565eef6f91</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DKo%26aufirst%3DT.%2BP.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCrystal%2520structure%2520and%2520functional%2520analysis%2520of%2520the%2520glutaminyl%2520cyclase%2520from%2520Xanthomonas%2520campestris%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D401%26spage%3D374%26epage%3D88%26doi%3D10.1016%2Fj.jmb.2010.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruysschaert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolders, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerhouni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span> <span> </span><span class="NLM_article-title">Papaya glutamine cyclase, a plant enzyme highly resistant to proteolysis, adopts an all-beta conformation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.1998.2580214.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1046%2Fj.1432-1327.1998.2580214.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9851712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1998&pages=214-22&author=K.+A.+Obergauthor=J.+M.+Ruysschaertauthor=M.+Azarkanauthor=N.+Smoldersauthor=S.+Zerhouniauthor=R.+Wintjensauthor=A.+Amraniauthor=Y.+Looze&title=Papaya+glutamine+cyclase%2C+a+plant+enzyme+highly+resistant+to+proteolysis%2C+adopts+an+all-beta+conformation&doi=10.1046%2Fj.1432-1327.1998.2580214.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Papaya glutamine cyclase, a plant enzyme highly resistant to proteolysis, adopts an all-β conformation</span></div><div class="casAuthors">Oberg, Keith A.; Ruysschaert, Jean-Marie; Azarkan, Mohamed; Smolders, Nicole; Zerhouni, Samira; Wintjens, Rene; Amrani, Amina; Looze, Yvan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-222</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Glutamine cyclase (EC 2.3.2.5) (I) catalyzes the conversion of L-glutaminyl-peptides into 5-oxoprolyl-peptides with the concomitant liberation of NH3.  Here, the biophys. characterization of I present in the laticiferous cells of Carica papaya is reported.  After purifn. to near homogeneity, I was subjected to limited proteolysis and found to exhibit a high resistance to degrdn. and nicking.  The structural reasons for this property were examd. using CD and IR spectroscopies.  By combining the analyses of the IR and CD spectra of papaya I, its susceptibility to proteolysis, and its H-D exchange characteristics, it was concluded that I contains extensive β-sheet structure and is likely to have only short immobile loops connecting its β-strands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqix5YuYvuoTLVg90H21EOLACvtfcHk0ljnJE-PLEJIbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCnsbk%253D&md5=460130fc378466d6b833b6f6274202ca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1998.2580214.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1998.2580214.x%26sid%3Dliteratum%253Aachs%26aulast%3DOberg%26aufirst%3DK.%2BA.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DSmolders%26aufirst%3DN.%26aulast%3DZerhouni%26aufirst%3DS.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DAmrani%26aufirst%3DA.%26aulast%3DLooze%26aufirst%3DY.%26atitle%3DPapaya%2520glutamine%2520cyclase%252C%2520a%2520plant%2520enzyme%2520highly%2520resistant%2520to%2520proteolysis%252C%2520adopts%2520an%2520all-beta%2520conformation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1998%26volume%3D258%26spage%3D214%26epage%3D22%26doi%3D10.1046%2Fj.1432-1327.1998.2580214.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belrhali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clantin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bompard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens-Volant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeret, V.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of papaya glutaminyl cyclase, an archetype for plant and bacterial glutaminyl cyclases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2005.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16438985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2006&pages=457-70&author=R.+Wintjensauthor=H.+Belrhaliauthor=B.+Clantinauthor=M.+Azarkanauthor=C.+Bompardauthor=D.+Baeyens-Volantauthor=Y.+Loozeauthor=V.+Villeret&title=Crystal+structure+of+papaya+glutaminyl+cyclase%2C+an+archetype+for+plant+and+bacterial+glutaminyl+cyclases&doi=10.1016%2Fj.jmb.2005.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Papaya Glutaminyl Cyclase, an Archetype for Plant and Bacterial Glutaminyl Cyclases</span></div><div class="casAuthors">Wintjens, Rene; Belrhali, Hassan; Clantin, Bernard; Azarkan, Mohamed; Bompard, Coralie; Baeyens-Volant, Danielle; Looze, Yvan; Villeret, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-470</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) (E.C. 2.3.2.5) catalyze the intramol. cyclization of protein N-terminal glutamine residues into pyroglutamic acid with the concomitant liberation of ammonia.  QCs may be classified in two groups contg., resp., the mammalian enzymes, and the enzymes from plants, bacteria, and parasites.  The crystal structure of the QC from the latex of Carica papaya (PQC) has been detd. at 1.7 Å resoln.  The structure was solved by the single wavelength anomalous diffraction technique using sulfur and zinc as anomalous scatterers.  The enzyme folds into a five-bladed β-propeller, with two addnl. α-helixes and one β hairpin.  The propeller closure is achieved via an original mol. velcro, which links the last two blades into a large eight stranded β-sheet.  The zinc ion present in the PQC is bound via an octahedral coordination into an elongated cavity located along the pseudo 5-fold axis of the β-propeller fold.  This zinc ion presumably plays a structural role and may contribute to the exceptional stability of PQC, along with an extended hydrophobic packing, the absence of long loops, the three-joint mol. velcro and the overall folding itself.  Multiple sequence alignments combined with structural analyses have allowed us to tentatively locate the active site, which is filled in the crystal structure either by a Tris mol. or an acetate ion.  These analyses are further supported by the exptl. evidence that Tris is a competitive inhibitor of PQC.  The active site is located at the C-terminal entrance of the PQC central tunnel.  W83, W110, W169, Q24, E69, N155, K225, F22 and F67 are highly conserved residues in the C-terminal entrance, and their putative role in catalysis is discussed.  The PQC structure is representative of the plants, bacterial and parasite enzymes and contrasts with that of mammalian enzymes, that may possibly share a conserved scaffold of the bacterial aminopeptidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAbHbFLn_XvbVg90H21EOLACvtfcHk0ljnJE-PLEJIbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGhsbc%253D&md5=7223abf4574b696d2a18286e962130d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DBelrhali%26aufirst%3DH.%26aulast%3DClantin%26aufirst%3DB.%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DBompard%26aufirst%3DC.%26aulast%3DBaeyens-Volant%26aufirst%3DD.%26aulast%3DLooze%26aufirst%3DY.%26aulast%3DVilleret%26aufirst%3DV.%26atitle%3DCrystal%2520structure%2520of%2520papaya%2520glutaminyl%2520cyclase%252C%2520an%2520archetype%2520for%2520plant%2520and%2520bacterial%2520glutaminyl%2520cyclases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D357%26spage%3D457%26epage%3D70%26doi%3D10.1016%2Fj.jmb.2005.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugele, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">10059</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-63&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0lgqQ_k1bV8FFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D63%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">10849</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1021/bi0260381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0260381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10849-57&author=S.+Schillingauthor=T.+Hoffmannauthor=F.+Roscheauthor=S.+Manhartauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Heterologous+expression+and+characterization+of+human+glutaminyl+cyclase%3A+evidence+for+a+disulfide+bond+with+importance+for+catalytic+activity&doi=10.1021%2Fbi0260381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heterologous Expression and Characterization of Human Glutaminyl Cyclase: Evidence for a Disulfide Bond with Importance for Catalytic Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Rosche, Fred; Manhart, Susanne; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10849-10857</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC, EC 2.3.2.5) catalyzes the formation of pyroglutamate residues from glutamine at the N-terminus of peptides and proteins.  In the current study, human QC was functionally expressed in the secretory pathway of Pichia pastoris, yielding milligram quantities after purifn. from the supernatant of a 5 L fermn.  Initial characterization studies of the recombinant QC using MALDI-TOF mass spectrometry revealed correct proteolytic processing and N-glycosylation at both potential sites with similar 2 kDa extensions.  CD spectral anal. indicated a high α-helical content, which contrasts with plant QC from Carica papaya.  The kinetic parameters for conversion of H-Gln-Tyr-Ala-OH by recombinant human QC were almost identical to those previously reported for purified bovine pituitary QC.  However, the results obtained for conversion of H-Gln-Gln-OH, H-Gln-NH2, and H-Gln-AMC were found to be contradictory to previous studies on human QC expressed intracellularly in E. coli.  Expression of QC in E. coli showed that approx. 50% of the protein did not contain a disulfide bond that is present in the entire QC expressed in P. pastoris.  Further, the enzyme was consistently inactivated by treatment with 15 mM DTT, whereas deglycosylation had no effect on enzymic activity.  Anal. of the fluorescence spectra of the native, reduced, and unfolded human QC point to a conformational change of the protein upon treatment with DTT.  In terms of the different enzymic properties, the consequences of QC expression in different environments are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJohsxahWb8bVg90H21EOLACvtfcHk0lgqQ_k1bV8FFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D&md5=c7d449a36576aec362a0b17bb7de2d4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi0260381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0260381%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DHeterologous%2520expression%2520and%2520characterization%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520evidence%2520for%2520a%2520disulfide%2520bond%2520with%2520importance%2520for%2520catalytic%2520activity%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10849%26epage%3D57%26doi%3D10.1021%2Fbi0260381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of glutaminyl cyclases from plants and animals</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">1583</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1515%2FBC.2003.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=14719800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1583-92&author=S.+Schillingauthor=S.+Manhartauthor=T.+Hoffmannauthor=H.+H.+Ludwigauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Substrate+specificity+of+glutaminyl+cyclases+from+plants+and+animals&doi=10.1515%2FBC.2003.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of glutaminyl cyclases from plants and animals</span></div><div class="casAuthors">Schilling, Stephan; Manhart, Susanne; Hoffmann, Torsten; Ludwig, Hans-henning; Wasternack, Claus; Demuth, Hans-ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1583-1592</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QC) catalyze the intramol. cyclization of N-terminal glutamine residues of peptides and proteins.  For a comparison of the substrate specificity of human and papaya QC enzymes, a novel continuous assay was established by adapting an existing discontinuous method.  Specificity consts. (kcat/Km) of dipeptides and dipeptide surrogates were higher for plant QC, whereas the selectivity for oligopeptides was similar for both enzymes.  However, only the specificity consts. of mammalian QC were dependent on size and compn. of the substrates.  Specificity consts. of both enzymes were equally pH-dependent in the acidic pH-region, revealing a pKa value identical to the pKa of the substrate, suggesting similarities in the substrate conversion mode.  Accordingly, both QCs converted the L-βhomoglutaminyl residue in the peptide H-βhomoGln-Phe-Lys-Arg-Leu-Ala-NH2 and the glutaminyl residues of the branched peptide H-Gln-Lys(Gln)-Arg-Leu-Ala-NH2 as well as the partially cyclized peptide H-Gln-cyclo(Nε-Lys-Arg-Pro-Ala-Gly-Phe).  In contrast, only QC from C. papaya was able to cyclize a methylated glutamine residue, while this compd. did not even inhibit human QC-catalysis, suggesting distinct substrate recognition pattern.  The conversion of the potential physiol. substrates [Gln1]-gastrin, [Gln1]-neurotensin and [Gln1]-fertilization promoting peptide indicates that human QC may play a key role in posttranslational modification of most if not all pGlu-contg. hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs7SWbYbyQLVg90H21EOLACvtfcHk0lgqQ_k1bV8FFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D&md5=3e011093800699f46513a309b29647c8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.175%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DSubstrate%2520specificity%2520of%2520glutaminyl%2520cyclases%2520from%2520plants%2520and%2520animals%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1583%26epage%3D92%26doi%3D10.1515%2FBC.2003.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.03.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2008.03.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18486145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=966-80&author=H.+Cynisauthor=J.+U.+Rahfeldauthor=A.+Stephanauthor=A.+Kehlenauthor=B.+Kochauthor=M.+Wermannauthor=H.+U.+Demuthauthor=S.+Schilling&title=Isolation+of+an+isoenzyme+of+human+glutaminyl+cyclase%3A+retention+in+the+Golgi+complex+suggests+involvement+in+the+protein+maturation+machinery&doi=10.1016%2Fj.jmb.2008.03.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of an Isoenzyme of Human Glutaminyl Cyclase: Retention in the Golgi Complex Suggests Involvement in the Protein Maturation Machinery</span></div><div class="casAuthors">Cynis, Holger; Rahfeld, Jens-Ulrich; Stephan, Anett; Kehlen, Astrid; Koch, Birgit; Wermann, Michael; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">966-980</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mammalian glutaminyl cyclase isoenzymes (isoQCs) were identified.  The anal. of the primary structure of human isoQC (h-isoQC) revealed conservation of the zinc-binding motif of the human QC (hQC).  In contrast to hQC, h-isoQC carries an N-terminal signal anchor.  The cDNAs of human and murine isoQCs were isolated and h-isoQC, lacking the N-terminal signal anchor and the short cytosolic tail, was expressed as a fusion protein in Escherichia coli. h-isoQC exhibits 10-fold lower activity compared to hQC.  Similar to hQC, h-isoQC was competitively inhibited by imidazoles and cysteamines.  Inactivation by metal chelators suggests a conserved metal-dependent catalytic mechanism of both isoenzymes.  A comparison of the expression pattern of m-isoQC and murine QC revealed ubiquitous expression of both enzymes.  However, murine QC transcript formation was higher in neuronal tissue, whereas the amt. of m-isoQC transcripts did not vary significantly between different organs. h-isoQC was exclusively localized within the Golgi complex, obviously retained by the N-terminus.  Similar resident enzymes of the Golgi complex are the glycosyltransferases.  Golgi app. retention implies a "housekeeping" protein maturation machinery conducting glycosylation and pyroglutamyl formation.  For these enzymes, apparently similar strategies evolved to retain the proteins in the Golgi complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZeVmaPE9cw7Vg90H21EOLACvtfcHk0lgqQ_k1bV8FFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtL4%253D&md5=707e10bf9a6f5b84ac8c455dd86ec4cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.03.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.03.078%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsolation%2520of%2520an%2520isoenzyme%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520retention%2520in%2520the%2520Golgi%2520complex%2520suggests%2520involvement%2520in%2520the%2520protein%2520maturation%2520machinery%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D966%26epage%3D80%26doi%3D10.1016%2Fj.jmb.2008.03.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niestroj, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunkel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">49773</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1074/jbc.M309077200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M309077200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=14522962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49773-9&author=S.+Schillingauthor=A.+J.+Niestrojauthor=J.+U.+Rahfeldauthor=T.+Hoffmannauthor=M.+Wermannauthor=K.+Zunkelauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Identification+of+human+glutaminyl+cyclase+as+a+metalloenzyme.+Potent+inhibition+by+imidazole+derivatives+and+heterocyclic+chelators&doi=10.1074%2Fjbc.M309077200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Glutaminyl Cyclase as a Metalloenzyme: Potent inhibition by imidazole derivatives and heterocyclic chelators</span></div><div class="casAuthors">Schilling, Stephan; Niestroj, Andre J.; Rahfeld, Jens-Ulrich; Hoffmann, Torsten; Wermann, Michael; Zunkel, Katrin; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">49773-49779</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human glutaminyl cyclase (QC) was identified as a metalloenzyme as suggested by the time-dependent inhibition by the heterocyclic chelators 1,10-phenanthroline and dipicolinic acid.  The effect of EDTA on QC catalysis was negligible.  Inactivated enzyme could be fully restored by the addn. of Zn2+ in the presence of equimolar concns. of EDTA.  Little reactivation was obsd. with Co2+ and Mn2+.  Other metal ions such as K+, Ca2+, and Ni2+ were inactive under the same conditions.  Addnl., imidazole and imidazole derivs. were identified as competitive inhibitors of QC.  An initial structure activity-based inhibitor screening of imidazole-derived compds. revealed potent inhibition of QC by imidazole N-1 derivs.  Subsequent data base screening led to the identification of two highly potent inhibitors, 3-[3-(1H-imidazol-1-yl)propyl]-2-thioxoimidazolidin-4-one and 1,4-bis-(imidazol-1-yl)-methyl-2,5-dimethylbenzene, which exhibited resp. Ki values of 818 and 295 nM.  The binding properties of the imidazole derivs. were further analyzed by the pH dependence of QC inhibition.  The kinetically obtained pKa values of 6.94, 6.93, and 5.60 for imidazole, methylimidazole, and benzimidazole, resp., match the values obtained by titrimetric pKa detn., indicating the requirement for an unprotonated nitrogen for binding to QC.  Similarly, the pH dependence of the kinetic parameter Km for the QC-catalyzed conversion of H-Gln-7-amino-4-methylcoumarin also implies that only N-terminally unprotonated substrate mols. are bound to the active site of the enzyme, whereas turnover is not affected.  The results reveal human QC as a metal-dependent transferase, suggesting that the active site-bound metal is a potential site for interaction with novel, highly potent competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRoNA9eEuXrVg90H21EOLACvtfcHk0lgECuAV7flciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D&md5=372bdb3cf7603da16c3c2cc888a54cb1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309077200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309077200%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DIdentification%2520of%2520human%2520glutaminyl%2520cyclase%2520as%2520a%2520metalloenzyme.%2520Potent%2520inhibition%2520by%2520imidazole%2520derivatives%2520and%2520heterocyclic%2520chelators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49773%26epage%3D9%26doi%3D10.1074%2Fjbc.M309077200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bohlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07337.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1742-4658.2009.07337.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19804409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6522-36&author=A.+Stephanauthor=M.+Wermannauthor=A.+von+Bohlenauthor=B.+Kochauthor=H.+Cynisauthor=H.+U.+Demuthauthor=S.+Schilling&title=Mammalian+glutaminyl+cyclases+and+their+isoenzymes+have+identical+enzymatic+characteristics&doi=10.1111%2Fj.1742-4658.2009.07337.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics</span></div><div class="casAuthors">Stephan, Anett; Wermann, Michael; von Bohlen, Alex; Koch, Birgit; Cynis, Holger; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6522-6536</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminly cyclases (QCs) catalyze the formation of pyroglutamate residues at the N-terminus of several peptides and proteins from plants and animals.  Recently, isoenzymes of mammalian QCs have been identified.  In order to gain further insight into the biochem. characteristics of isoQCs, the human and murine enzymes were expressed in the secretory pathway of Pichia pastoris.  Replacement of the N-terminal signal anchor by an α-factor prepropeptide from Saccharomyces cerevisiae resulted in poor secretion of the protein.  Insertion of an N-terminal glycosylation site and shortening of the N-terminus improved isoQC secretion 100-fold.  A comparison of different recombinant isoQC proteins did not reveal an influence of mutagenic changes on catalytic activity.  An initial characterization showed identical modes of substrate conversion of human isoQC and murine isoQC.  Both proteins displayed a broad substrate specificity and preference for hydrophobic substrates, similar to the related QC.  Likewise, a detn. of the zinc content and reactivation of the apo-isoQC revealed equimolar zinc present in QC and isoQC.  Far-UV CD spectroscopic anal. of murine QC and isoQC indicated virtually identical structural components.  The present investigation provides the first enzymic characterization of mammalian isoQCs.  QC and isoQC represent very similar proteins, which are both present in the secretory pathway of cells.  The functions of QCs and isoQC probably complement each other, suggesting a pivotal role of pyroglutamate modification for protein and peptide maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMUn-pkjU0rVg90H21EOLACvtfcHk0lgECuAV7flciQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsL3E&md5=33eaa1762bd0916b96f6fc4087515b27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07337.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07337.x%26sid%3Dliteratum%253Aachs%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3Dvon%2BBohlen%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DMammalian%2520glutaminyl%2520cyclases%2520and%2520their%2520isoenzymes%2520have%2520identical%2520enzymatic%2520characteristics%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6522%26epage%3D36%26doi%3D10.1111%2Fj.1742-4658.2009.07337.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indrischek, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopcke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span> <span> </span><span class="NLM_article-title">Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2014.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.ijdevneu.2014.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24886834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2cjnvFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=64-73&author=C.+Hoflingauthor=H.+Indrischekauthor=T.+Hopckeauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=S.+Schillingauthor=M.+Morawskiauthor=H.+U.+Demuthauthor=S.+Rossnerauthor=M.+Hartlage-Rubsamen&title=Mouse+strain+and+brain+region-specific+expression+of+the+glutaminyl+cyclases+QC+and+isoQC&doi=10.1016%2Fj.ijdevneu.2014.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC</span></div><div class="casAuthors">Hofling Corinna; Indrischek Henrike; Hopcke Theodor; Waniek Alexander; Morawski Markus; Hartlage-Rubsamen Maike; Cynis Holger; Koch Birgit; Schilling Stephan; Demuth Hans-Ulrich; Rossner Steffen</div><div class="citationInfo"><span class="NLM_cas:title">International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) from glutamine precursors at the N-terminus of a number of peptide hormones, neuropeptides and chemokines.  This post-translational modification stabilizes these peptides, protects them from proteolytical degradation or is important for their biological activity.  However, QC is also involved in a pathogenic pGlu modification of peptides accumulating in protein aggregation disorders such as Alzheimer's disease and familial Danish and familial British dementia.  Its isoenzyme (isoQC) was shown to contribute to aspects of inflammation by pGlu-modifying and thereby stabilizing the monocyte chemoattractant protein CCL2.  For the generation of respective animal models and for pharmacological treatment studies the characterization of the mouse strain and brain region-specific expression of QC and isoQC is indispensible.  In order to address this issue, we used enzymatic activity assays and specific antibodies to detect both QC variants by immunohistochemistry in nine different mouse strains.  Comparing different brain regions, the highest enzymatic QC/isoQC activity was detected in ventral brain, followed by cortex and hippocampus.  Immunohistochemical stainings revealed that QC/isoQC activity in cortex mostly arises from isoQC expression.  For most brain regions, the highest QC/isoQC activity was detected in C3H and FVB mice, whereas low QC/isoQC activity was present in CD1, SJL and C57 mice.  Quantification of QC- and isoQC-immunoreactive cells by unbiased stereology revealed a higher abundance of isoQC- than of QC-immunoreactive neurons in Edinger-Westphal nucleus and in substantia nigra.  In the locus coeruleus, however, there were comparable densities of QC- and of isoQC-immunoreactive neurons.  These observations are of considerable importance with regard to the selection of appropriate mouse strains for the study of QC/isoQC relevance in mouse models of neurodegeneration and neuroinflammation and for the testing of therapeutical interventions in these models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnyg1T54g0JQaK-_ZudimnfW6udTcc2eZDp2mvrNdE6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjnvFOktQ%253D%253D&md5=5978f4ce52b53f6fb3873f9d984842ac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2014.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2014.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DHofling%26aufirst%3DC.%26aulast%3DIndrischek%26aufirst%3DH.%26aulast%3DHopcke%26aufirst%3DT.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26atitle%3DMouse%2520strain%2520and%2520brain%2520region-specific%2520expression%2520of%2520the%2520glutaminyl%2520cyclases%2520QC%2520and%2520isoQC%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2014%26volume%3D36%26spage%3D64%26epage%3D73%26doi%3D10.1016%2Fj.ijdevneu.2014.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">14199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.229385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M111.229385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21330373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=14199-208&author=S.+Schillingauthor=S.+Kohlmannauthor=C.+Bauscherauthor=R.+Sedlmeierauthor=B.+Kochauthor=R.+Eichentopfauthor=A.+Beckerauthor=H.+Cynisauthor=T.+Hoffmannauthor=S.+Bergauthor=E.+J.+Freyseauthor=S.+von+Horstenauthor=S.+Rossnerauthor=S.+Graubnerauthor=H.+U.+Demuth&title=Glutaminyl+cyclase+knock-out+mice+exhibit+slight+hypothyroidism+but+no+hypogonadism%3A+implications+for+enzyme+function+and+drug+development&doi=10.1074%2Fjbc.M111.229385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase Knock-out Mice Exhibit Slight Hypothyroidism but No Hypogonadism: Implications for Enzyme Function and Drug Development</span></div><div class="casAuthors">Schilling, Stephan; Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Koch, Birgit; Eichentopf, Rico; Becker, Andreas; Cynis, Holger; Hoffmann, Torsten; Berg, Sabine; Freyse, Ernst-Joachim; von Hoersten, Stephan; Rossner, Steffen; Graubner, Sigrid; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14199-14208</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) residues at the N terminus of peptides and proteins.  Hypothalamic pGlu hormones, such as TSH-releasing hormone and gonadotropin-releasing hormone are essential for regulation of metab. and fertility in the hypothalamic pituitary thyroid and gonadal axes, resp.  Here, we analyzed the consequences of constitutive genetic QC ablation on endocrine functions and on the behavior of adult mice.  Adult homozygous QC knock-out mice are fertile and behave indistinguishably from wild type mice in tests of motor function, cognition, general activity, and ingestion behavior.  The QC knock-out results in a dramatic drop of enzyme activity in the brain, esp. in hypothalamus and in plasma.  Other peripheral organs like liver and spleen still contain QC activity, which is most likely caused by its homolog isoQC.  The serum gonadotropin-releasing hormone, TSH, and testosterone concns. were not changed by QC depletion.  The serum thyroxine was decreased by 24% in homozygous QC knock-out animals, suggesting a mild hypothyroidism.  QC knock-out mice were indistinguishable from wild type with regard to blood glucose and glucose tolerance, thus differing from reports of TSH-releasing hormone knock-out mice significantly.  The results suggest a significant formation of the hypothalamic pGlu hormones by alternative mechanisms, like spontaneous cyclization or conversion by isoQC.  The different effects of QC depletion on the hypothalamic pituitary thyroid and gonadal axes might indicate slightly different modes of substrate conversion of both enzymes.  The absence of significant abnormalities in QC knock-out mice suggests the presence of a therapeutic window for suppression of QC activity in current drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCNjZy_kF7J7Vg90H21EOLACvtfcHk0ljseN4dv7nlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWju7g%253D&md5=5eb82b2b939e6adc4cf8970155237aaf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.229385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.229385%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclase%2520knock-out%2520mice%2520exhibit%2520slight%2520hypothyroidism%2520but%2520no%2520hypogonadism%253A%2520implications%2520for%2520enzyme%2520function%2520and%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D14199%26epage%3D208%26doi%3D10.1074%2Fjbc.M111.229385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouet, P.</span></span> <span> </span><span class="NLM_article-title">Deciphering key features in protein structures with the new ENDscript server</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">W320</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1093/nar/gku316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Fnar%2Fgku316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24753421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=W320-4&author=X.+Robertauthor=P.+Gouet&title=Deciphering+key+features+in+protein+structures+with+the+new+ENDscript+server&doi=10.1093%2Fnar%2Fgku316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering key features in protein structures with the new ENDscript server</span></div><div class="casAuthors">Robert, Xavier; Gouet, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W320-W324</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ENDscript 2 is a friendly Web server for extg. and rendering a comprehensive anal. of primary to quaternary protein structure information in an automated way.  This major upgrade has been fully re-engineered to enhance speed, accuracy and usability with interactive 3D visualization.  It takes advantage of the new version 3 of ESPript, our well-known sequence alignment renderer, improved to handle a large no. of data with reduced computation time.  From a single PDB entry or file, ENDscript produces high quality figures displaying multiple sequence alignment of proteins homologous to the query, colored according to residue conservation.  Furthermore, the exptl. secondary structure elements and a detailed set of relevant biophys. and structural data are depicted.  All this information and more are now mapped on interactive 3D PyMOL representations.  Thanks to its adaptive and rigorous algorithm, beginner to expert users can modify settings to fine-tune ENDscript to their needs.  ENDscript has also been upgraded as an open platform for the visualization of multiple biochem. and structural data coming from external biotool Web servers, with both 2D and 3D representations.  ENDscript 2 and ESPript 3 are freely available at http://endscript.ibcp.fr and http://espript.ibcp.fr, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5lD0RT2rA9rVg90H21EOLACvtfcHk0ljseN4dv7nlVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs7vK&md5=96c315b6732a2be7fb72fa44be3511da</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku316%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DX.%26aulast%3DGouet%26aufirst%3DP.%26atitle%3DDeciphering%2520key%2520features%2520in%2520protein%2520structures%2520with%2520the%2520new%2520ENDscript%2520server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DW320%26epage%3D4%26doi%3D10.1093%2Fnar%2Fgku316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Consalvo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, P. P.</span></span> <span> </span><span class="NLM_article-title">A rapid fluorometric assay for N-terminal glutaminyl cyclase activity using high-performance liquid chromatography</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(88)90370-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0003-2697%2888%2990370-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3245563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXltleqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1988&pages=131-8&author=A.+P.+Consalvoauthor=S.+D.+Youngauthor=B.+N.+Jonesauthor=P.+P.+Tamburini&title=A+rapid+fluorometric+assay+for+N-terminal+glutaminyl+cyclase+activity+using+high-performance+liquid+chromatography&doi=10.1016%2F0003-2697%2888%2990370-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid fluorometric assay for N-terminal glutaminyl cyclase activity using high-performance liquid chromatography</span></div><div class="casAuthors">Consalvo, Angelo P.; Young, Stanley D.; Jones, Barry N.; Tamburini, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-8</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A rapid, sensitive method for the quantification of glutaminyl cyclase activity has been developed.  The assay involves enzymic conversion of the model peptide Gln-Leu-Tyr-Glu-Asn-Lys-ε-(Dns)-OH (DNS = dansyl) to pyroglutamyl-Leu-Tyr-Glu-Asn-Lys-ε-(Dns)-OH.  Both the product and substrate of this reaction are detected in a single assay in quantities as low as 100 fmol using isocratic reverse-phase HPLC with fluorometric detection.  The method is highly reproducible and ideally suited for the rapid anal. of large nos. of samples.  The applications of the assay to both the detection of glutaminyl cyclase activity during enzyme purifn. and the more rigorous enzymol. studies dependent on the precise measurement of initial reaction velocities are demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbxYTBka9XZrVg90H21EOLACvtfcHk0lgvb0TsZ0mN0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltleqtQ%253D%253D&md5=f1eb108267eab034391b490a18d05bfd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2888%2990370-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252888%252990370-3%26sid%3Dliteratum%253Aachs%26aulast%3DConsalvo%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DJones%26aufirst%3DB.%2BN.%26aulast%3DTamburini%26aufirst%3DP.%2BP.%26atitle%3DA%2520rapid%2520fluorometric%2520assay%2520for%2520N-terminal%2520glutaminyl%2520cyclase%2520activity%2520using%2520high-performance%2520liquid%2520chromatography%26jtitle%3DAnal.%2520Biochem.%26date%3D1988%26volume%3D175%26spage%3D131%26epage%3D8%26doi%3D10.1016%2F0003-2697%2888%2990370-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busby, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">8532</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)47446-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0021-9258%2818%2947446-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-6&author=W.+J.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes&doi=10.1016%2FS0021-9258%2818%2947446-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lgvb0TsZ0mN0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2947446-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252947446-7%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BJ.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D6%26doi%3D10.1016%2FS0021-9258%2818%2947446-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koger, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">Assay of glutaminylpeptide cyclase</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/0076-6879(89)68027-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0076-6879%2889%2968027-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=2498615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXktVejsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1989&pages=358-65&author=J.+B.+Kogerauthor=J.+Hummauthor=J.+S.+Kizer&title=Assay+of+glutaminylpeptide+cyclase&doi=10.1016%2F0076-6879%2889%2968027-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Assay of glutaminylpeptide cyclase</span></div><div class="casAuthors">Koger, Jeanne B.; Humm, Jane; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">Horm. Action:  Pt. K</span>),
    <span class="NLM_cas:pages">358-65</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A RIA for the title enzyme is described which is applicable to a no. of different tissues.  The assay is based on the conversion of the substrate, Gln-His-Pro-NH2, to the product, TSH-releasing hormone (TRH).  The assay is complicated by the presence of prolyl endopeptidase (EC 3.4.21.26) and approaches to resolving the problem are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FEhRnx0Y2rVg90H21EOLACvtfcHk0lgvb0TsZ0mN0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVejsb8%253D&md5=58b0934b8352d180b5b501e820217a94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2889%2968027-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252889%252968027-5%26sid%3Dliteratum%253Aachs%26aulast%3DKoger%26aufirst%3DJ.%2BB.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAssay%2520of%2520glutaminylpeptide%2520cyclase%26jtitle%3DMethods%2520Enzymol.%26date%3D1989%26volume%3D168%26spage%3D358%26epage%3D65%26doi%3D10.1016%2F0076-6879%2889%2968027-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(89)90070-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0165-0270%2889%2990070-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=2811431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXmt1Oltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=23-8&author=R.+J.+Bateman&title=A+spectrophotometric+assay+for+glutaminyl-peptide+cyclizing+enzymes&doi=10.1016%2F0165-0270%2889%2990070-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes</span></div><div class="casAuthors">Bateman, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-8</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Current assays for the glutaminyl-peptide cyclizing enzyme, glutaminyl cyclase, have several shortcomings.  In this report, a rapid spectrophotometric assay for cyclization of glutaminyl-peptides to pyroglutamyl-peptides by glutaminyl cyclase is described which overcomes many of these shortcomings.  This coupled assay utilizes glutamate dehydrogenase, α-ketoglutarate, and NADH to measure the NH3 released during cyclization of the dipeptide substrate, Gln-Gln.  Glutaminyl cyclase from bovine pituitary gland, partially purified by ion-exchange chromatog., exhibited a Km for this substrate of 0.6 mM and a Vmax of 9.6 nmol/min/mg protein.  These values were comparable to those previously reported using other glutaminyl-peptide substrates and either RIA or HPLC to measure glutaminyl cyclase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsV8sQEnSvGbVg90H21EOLACvtfcHk0lin6Zu9MAA4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmt1Oltrw%253D&md5=43a7a246d089a3d2fcc6e098c0c18360</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2889%2990070-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252889%252990070-8%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DA%2520spectrophotometric%2520assay%2520for%2520glutaminyl-peptide%2520cyclizing%2520enzymes%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1989%26volume%3D30%26spage%3D23%26epage%3D8%26doi%3D10.1016%2F0165-0270%2889%2990070-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gololobov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">Steady-state kinetics of glutamine cyclotransferase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1006/abbi.1994.1117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1006%2Fabbi.1994.1117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=8135542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFOgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1994&pages=300-7&author=M.+Gololobovauthor=I.+Songauthor=W.+Wangauthor=R.+J.+Bateman&title=Steady-state+kinetics+of+glutamine+cyclotransferase&doi=10.1006%2Fabbi.1994.1117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Steady-state kinetics of glutamine cyclotransferase</span></div><div class="casAuthors">Gololobov, Mikhail Yu.; Song, Inseok; Wang, Wenying; Bateman, Robert C., Mr.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-7</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The reaction mechanism of papaya latex glutamine cyclotransferase (EC 2.3.2.5) (I) was studied using pH and temp. dependencies, a proton inventory technique, and mol. modeling.  The pH-dependence of the Michaelis-Menten parameters showed that the published pH dependence of the enzyme activity was mainly the result of pH-dependent change in the active (unprotonated) substrate concn.  I activity as such changed very slightly in the pH range of 4.5-10.  The solvent kinetic isotope effect reflected a change in Vmax, whereas the proton inventory was found to be linear with a fractionation factor of the exchangeable proton(s) in the transition state of 0.785.  The results were not consistent with an acyl-enzyme mechanism, but rather favored a simple intramol. cyclization of the glutamine residue to the pyroglutamic acid residue.  The proposed mechanism consisted of the following main steps: (1) intramol. nucleophilic attack on the γ-C:O C atom by the N atom of the α-NH2 group, (2) transfer of a proton from the α-NH2 group to the N atom of the amide group, facilitated by an acidic group of the enzyme, and (3) expulsion of the NH3-leaving group promoted by this or another acidic enzyme group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7tjE-wpstLVg90H21EOLACvtfcHk0lin6Zu9MAA4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFOgtb0%253D&md5=02f9a0b7c654a64372bf9b3a69ddde6c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1994.1117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1994.1117%26sid%3Dliteratum%253Aachs%26aulast%3DGololobov%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DSteady-state%2520kinetics%2520of%2520glutamine%2520cyclotransferase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1994%26volume%3D309%26spage%3D300%26epage%3D7%26doi%3D10.1006%2Fabbi.1994.1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0lin6Zu9MAA4vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.pep.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16084398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVGhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=65-72&author=K.+F.+Huangauthor=Y.+L.+Liuauthor=A.+H.+Wang&title=Cloning%2C+expression%2C+characterization%2C+and+crystallization+of+a+glutaminyl+cyclase+from+human+bone+marrow%3A+a+single+zinc+metalloenzyme&doi=10.1016%2Fj.pep.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: A single zinc metalloenzyme</span></div><div class="casAuthors">Huang, Kai-Fa; Liu, Yi-Liang; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) catalyzes the N-terminal pyroglutamate formation of numerous hormones and peptides from their glutaminyl precursor.  Pyroglutamate is a posttranslational or cotranslational modification important in many physiol. and pathol. processes.  Here, we present the cloning of a QC cDNA from human bone marrow cDNA library.  The protein was expressed in Escherichia coli system with the yields higher than ∼10 mg/L bacterial culture, using a thioredoxin-tagged expression vector with several modifications.  Based on high histidine content (∼5%) of the protein, a convenient purifn. step by Ni-affinity chromatog. was designed, leading to near homogeneity of the purified human QC.  The identity of the recombinant human QC was confirmed by mass spectrometry and CD spectroscopy.  The enzyme was active on both synthetic and physiol. substrates, and the activity could be inhibited by several imidazole, triazole, and tetrazole derivs.  An at. absorption anal. demonstrated that human QC contains one zinc ion per protein mol.  We also obtained the human QC crystals, which belong to cubic, tetragonal, and rhombohedral forms.  Our works are useful to acquire new insights into human and animal QCs, particularly for future structural anal. and inhibitor designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX278EZGXHh7Vg90H21EOLACvtfcHk0lhDwoXiSHA2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVGhsbc%253D&md5=e65da5ffd4de19644c081b0bd147ecbf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCloning%252C%2520expression%252C%2520characterization%252C%2520and%2520crystallization%2520of%2520a%2520glutaminyl%2520cyclase%2520from%2520human%2520bone%2520marrow%253A%2520a%2520single%2520zinc%2520metalloenzyme%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D43%26spage%3D65%26epage%3D72%26doi%3D10.1016%2Fj.pep.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13117</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504184102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.0504184102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16135565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaqu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13117-22&author=K.+F.+Huangauthor=Y.+L.+Liuauthor=W.+J.+Chengauthor=T.+P.+Koauthor=A.+H.+Wang&title=Crystal+structures+of+human+glutaminyl+cyclase%2C+an+enzyme+responsible+for+protein+N-terminal+pyroglutamate+formation&doi=10.1073%2Fpnas.0504184102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation</span></div><div class="casAuthors">Huang, Kai-Fa; Liu, Yi-Liang; Cheng, Wei-Ju; Ko, Tzu-Ping; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13117-13122</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from its glutaminyl (or glutamyl) precursor is required in the maturation of numerous bioactive peptides.  The aberrant formation of pGlu may be related to several pathol. processes, such as osteoporosis and amyloidotic diseases.  This N-terminal cyclization reaction, once thought to proceed spontaneously, is greatly facilitated by the enzyme glutaminyl cyclase (QC).  To probe this important but poorly understood modification, we present here the structure of human QC in free form and bound to a substrate and three imidazole-derived inhibitors.  The structure reveals an α/β scaffold akin to that of two-zinc exopeptidases but with several insertions and deletions, particularly in the active-site region.  The relatively closed active site displays alternate conformations due to the different indole orientations of Trp-207, resulting in two substrate (glutamine t-Bu ester)-binding modes.  The single zinc ion in the active site is coordinated to three conserved residues and one water mol., which is replaced by an imidazole nitrogen upon binding of the inhibitors.  Together with structural and kinetic analyses of several active-site-mutant enzymes, a catalytic mechanism of the formation of protein N-terminal pGlu is proposed.  Our results provide a structural basis for the rational design of inhibitors against QC-assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv1HJxZ-pQn7Vg90H21EOLACvtfcHk0lhDwoXiSHA2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaqu7fO&md5=916fc9856ef63c399bc32eace3123d88</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504184102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504184102%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BL.%26aulast%3DCheng%26aufirst%3DW.%2BJ.%26aulast%3DKo%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520human%2520glutaminyl%2520cyclase%252C%2520an%2520enzyme%2520responsible%2520for%2520protein%2520N-terminal%2520pyroglutamate%2520formation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13117%26epage%3D22%26doi%3D10.1073%2Fpnas.0504184102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">12439</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-49&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lgsIgxsKq31LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D49%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Carrillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6280</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bi200249h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200249h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6280-8&author=D.+Ruiz-Carrilloauthor=B.+Kochauthor=C.+Parthierauthor=M.+Wermannauthor=T.+Dambeauthor=M.+Buchholzauthor=H.+H.+Ludwigauthor=U.+Heiserauthor=J.+U.+Rahfeldauthor=M.+T.+Stubbsauthor=S.+Schillingauthor=H.+U.+Demuth&title=Structures+of+glycosylated+mammalian+glutaminyl+cyclases+reveal+conformational+variability+near+the+active+center&doi=10.1021%2Fbi200249h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Glycosylated Mammalian Glutaminyl Cyclases Reveal Conformational Variability near the Active Center</span></div><div class="casAuthors">Ruiz-Carrillo, David; Koch, Birgit; Parthier, Christoph; Wermann, Michael; Dambe, Tresfore; Buchholz, Mirko; Ludwig, Hans-Henning; Heiser, Ulrich; Rahfeld, Jens-Ulrich; Stubbs, Milton T.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6280-6288</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Formation of N-terminal pyroglutamate (pGlu or pE) from glutaminyl or glutamyl precursors is catalyzed by glutaminyl cyclases (QC).  As the formation of pGlu-amyloid has been linked with Alzheimer's disease, inhibitors of QCs are currently the subject of intense development.  Here, we report three crystal structures of N-glycosylated mammalian QC from humans (hQC) and mice (mQC).  Whereas the overall structures of the enzymes are similar to those reported previously, two surface loops in the neighborhood of the active center exhibit conformational variability.  Furthermore, two conserved cysteine residues form a disulfide bond at the base of the active center that was not present in previous reports of hQC structure.  Site-directed mutagenesis suggests a structure-stabilizing role of the disulfide bond.  At the entrance to the active center, the conserved tryptophan residue, W207, which displayed multiple orientations in previous structure, shows a single conformation in both glycosylated human and murine QCs.  Although mutagenesis of W207 into leucine or glutamine altered substrate conversion significantly, the binding consts. of inhibitors such as the highly potent PQ50 (PBD150) were minimally affected.  The crystal structure of PQ50 bound to the active center of murine QC reveals principal binding determinants provided by the catalytic zinc ion and a hydrophobic funnel.  This study presents a first comparison of two mammalian QCs contg. typical, conserved post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrsCCptP2CFLVg90H21EOLACvtfcHk0lgsIgxsKq31LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D&md5=2306b3661a368105f6f2dd84f8527efb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi200249h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200249h%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carrillo%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDambe%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DStructures%2520of%2520glycosylated%2520mammalian%2520glutaminyl%2520cyclases%2520reveal%2520conformational%2520variability%2520near%2520the%2520active%2520center%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6280%26epage%3D8%26doi%3D10.1021%2Fbi200249h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz Carrillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of glutaminyl cyclases (QCs) from <i>Drosophila melanogaster</i> reveal active site conservation between insect and mammalian QCs</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7383</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/bi300687g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300687g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7383-7392&author=B.+Kochauthor=P.+Kolenkoauthor=M.+Buchholzauthor=D.+Ruiz+Carrilloauthor=C.+Parthierauthor=M.+Wermannauthor=J.-U.+Rahfeldauthor=G.+Reuterauthor=S.+Schillingauthor=M.+T.+Stubbsauthor=H.-U.+Demuth&title=Crystal+structures+of+glutaminyl+cyclases+%28QCs%29+from+Drosophila+melanogaster+reveal+active+site+conservation+between+insect+and+mammalian+QCs&doi=10.1021%2Fbi300687g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Glutaminyl Cyclases (QCs) from Drosophila melanogaster Reveal Active Site Conservation between Insect and Mammalian QCs</span></div><div class="casAuthors">Koch, Birgit; Kolenko, Petr; Buchholz, Mirko; Ruiz Carrillo, David; Parthier, Christoph; Wermann, Michael; Rahfeld, Jens-Ulrich; Reuter, Gunter; Schilling, Stephan; Stubbs, Milton T.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">7383-7392</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs), which catalyze the formation of pyroglutamic acid (pGlu) at the N-terminus of a variety of peptides and proteins, have attracted particular attention for their potential role in Alzheimer's disease.  In a transgenic Drosophila melanogaster (Dm) fruit fly model, oral application of the potent competitive QC inhibitor PBD150 was shown to reduce the burden of pGlu-modified Aβ.  In contrast to mammals such as humans and rodents, there are at least three DmQC species, one of which (isoDromeQC) is localized to mitochondria, whereas DromeQC and an isoDromeQC splice variant possess signal peptides for secretion.  Here we present the recombinant expression, characterization, and crystal structure detn. of mature DromeQC and isoDromeQC, revealing an overall fold similar to that of mammalian QCs.  In the case of isoDromeQC, the putative extended substrate binding site might be affected by the proximity of the N-terminal residues.  PBD150 inhibition of DromeQC is roughly 1 order of magnitude weaker than that of the human and murine QCs.  The inhibitor binds to isoDromeQC in a fashion similar to that obsd. for human QCs, whereas it adopts alternative binding modes in a DromeQC variant lacking the conserved cysteines near the active center and shows a disordered dimethoxyphenyl moiety in wild-type DromeQC, providing an explanation for the lower affinity.  Our biophys. and structural data suggest that isoDromeQC and human QC are similar with regard to functional aspects.  The two Dm enzymes represent a suitable model for further in-depth anal. of the catalytic mechanism of animal QCs, and isoDromeQC might serve as a model system for the structure-based design of potential AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbLPrG5mFkZ7Vg90H21EOLACvtfcHk0lh66jMA-paMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrjO&md5=165e52a111bb9a9667851a1b02d9eb94</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi300687g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300687g%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DKolenko%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DRuiz%2BCarrillo%26aufirst%3DD.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DCrystal%2520structures%2520of%2520glutaminyl%2520cyclases%2520%2528QCs%2529%2520from%2520Drosophila%2520melanogaster%2520reveal%2520active%2520site%2520conservation%2520between%2520insect%2520and%2520mammalian%2520QCs%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7383%26epage%3D7392%26doi%3D10.1021%2Fbi300687g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span> <span> </span><span class="NLM_article-title">Structure of glutaminyl cyclase from <i>Drosophila melanogaster</i> in space group I4</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1107/S1744309113005575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1107%2FS1744309113005575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23545638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=358-61&author=P.+Kolenkoauthor=B.+Kochauthor=J.+U.+Rahfeldauthor=S.+Schillingauthor=H.+U.+Demuthauthor=M.+T.+Stubbs&title=Structure+of+glutaminyl+cyclase+from+Drosophila+melanogaster+in+space+group+I4&doi=10.1107%2FS1744309113005575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of glutaminyl cyclase from Drosophila melanogaster in space group I4</span></div><div class="casAuthors">Kolenko, Petr; Koch, Birgit; Rahfeld, Jens-Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">358-361</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The structure of ligand-free glutaminyl cyclase (QC) from Drosophila melanogaster (DmQC) has been detd. in a novel crystal form.  The protein crystd. in space group I4, with unit-cell parameters a = b = 122.3, c = 72.7 Å.  The crystal diffracted to a resoln. of 2 Å at the home source.  The structure was solved by mol. replacement and was refined to an R factor of 0.169.  DmQC exhibits a typical α/β-hydrolase fold.  The electron d. of three monosaccharides could be localized.  The accessibility of the active site will facilitate structural studies of novel inhibitor-binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr36ap5VtSWoLVg90H21EOLACvtfcHk0lh66jMA-paMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOkurc%253D&md5=893be471a2da90d4c37cb2855187053e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS1744309113005575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309113005575%26sid%3Dliteratum%253Aachs%26aulast%3DKolenko%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26atitle%3DStructure%2520of%2520glutaminyl%2520cyclase%2520from%2520Drosophila%2520melanogaster%2520in%2520space%2520group%2520I4%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D358%26epage%3D61%26doi%3D10.1107%2FS1744309113005575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structural and functional analyses of a glutaminyl cyclase from Ixodes scapularis reveal metal-independent catalysis and inhibitor binding</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1107/S1399004713033488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1107%2FS1399004713033488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24598748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVOrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=789-801&author=K.+F.+Huangauthor=H.+L.+Hsuauthor=S.+Karimauthor=A.+H.+Wang&title=Structural+and+functional+analyses+of+a+glutaminyl+cyclase+from+Ixodes+scapularis+reveal+metal-independent+catalysis+and+inhibitor+binding&doi=10.1107%2FS1399004713033488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analyses of a glutaminyl cyclase from Ixodes scapularis reveal metal-independent catalysis and inhibitor binding</span></div><div class="casAuthors">Huang, Kai-Fa; Hsu, Hui-Ling; Karim, Shahid; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-801</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">1399-0047</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) from mammals and Drosophila are zinc-dependent enzymes that catalyze N-terminal pyroglutamate formation of numerous proteins and peptides.  These enzymes have been found to be crit. for the oviposition and embryogenesis of ticks, implying that they are possible physiol. targets for tick control.  Here, 1.10-1.15 Å resoln. structures of a metal-independent QC from the black-legged tick Ixodes scapularis (Is-QC) are reported.  The structures exhibit the typical scaffold of mammalian QCs but have two extra disulfide bridges that stabilize the central β-sheet, resulting in an increased thermal stability.  Is-QC contains ∼0.5 stoichiometric zinc ions, which could be removed by 1 mM EDTA.  Compared with the Zn-bound form, apo-Is-QC has a nearly identical active-site structure and stability, but unexpectedly possesses significantly increased QC activities towards both synthetic and physiol. substrates.  Enzyme-kinetic anal. revealed that apo-Is-QC has a stronger substrate-binding affinity, suggesting that bound zinc interferes with substrate binding during catalysis.  The structures of Is-QC bound to the inhibitor PBD150 revealed similar binding modes to both forms of Is-QC, with the exception of the inhibitor imidazole ring, which is consistent with the comparable inhibition activities of the inhibitor towards both forms of Is-QC.  These findings have implications for the design of new QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq10MjczEJAYLVg90H21EOLACvtfcHk0lh66jMA-paMqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVOrtbY%253D&md5=9c8f62caf9841bef66fc49eb79f5178f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS1399004713033488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004713033488%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DHsu%26aufirst%3DH.%2BL.%26aulast%3DKarim%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructural%2520and%2520functional%2520analyses%2520of%2520a%2520glutaminyl%2520cyclase%2520from%2520Ixodes%2520scapularis%2520reveal%2520metal-independent%2520catalysis%2520and%2520inhibitor%2520binding%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3D70%26spage%3D789%26epage%3D801%26doi%3D10.1107%2FS1399004713033488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podell, D. N.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">90</span>, Spec No <span class="refDoi"> DOI: 10.1007/BF00235695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2FBF00235695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=6117006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL3MXlvVagsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1981&pages=181-90&author=G.+N.+Abrahamauthor=D.+N.+Podell&title=Pyroglutamic+acid.+Non-metabolic+formation%2C+function+in+proteins+and+peptides%2C+and+characteristics+of+the+enzymes+effecting+its+removal&doi=10.1007%2FBF00235695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamic acid.  Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal</span></div><div class="casAuthors">Abraham, George N.; Podell, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-90</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    </div><div class="casAbstract">A review with 47 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMLXS-HyhxmbVg90H21EOLACvtfcHk0lgUlu6sZjJqqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvVagsbc%253D&md5=283bf5d569fe662a06f9f7a7c3e3c670</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF00235695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00235695%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DG.%2BN.%26aulast%3DPodell%26aufirst%3DD.%2BN.%26atitle%3DPyroglutamic%2520acid.%2520Non-metabolic%2520formation%252C%2520function%2520in%2520proteins%2520and%2520peptides%252C%2520and%2520characteristics%2520of%2520the%2520enzymes%2520effecting%2520its%2520removal%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D1981%26volume%3D38%26spage%3D181%26epage%3D90%26doi%3D10.1007%2FBF00235695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.6.3827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.275.6.3827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10660533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12gsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=3827-34&author=S.+A.+Hinkeauthor=J.+A.+Pospisilikauthor=H.+U.+Demuthauthor=S.+Mannhartauthor=K.+Kuhn-Wacheauthor=T.+Hoffmannauthor=E.+Nishimuraauthor=R.+A.+Pedersonauthor=C.+H.+McIntosh&title=Dipeptidyl+peptidase+IV+%28DPIV%2FCD26%29+degradation+of+glucagon.+Characterization+of+glucagon+degradation+products+and+DPIV-resistant+analogs&doi=10.1074%2Fjbc.275.6.3827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs</span></div><div class="casAuthors">Hinke, Simon Amadeus; Pospisilik, J. Andrew; Demuth, Hans-Ulrich; Mannhart, Susanne; Kuhn-Wache, Kerstin; Hoffmann, Torsten; Nishimura, Erica; Pederson, Raymond A.; McIntosh, Christopher H. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3827-3834</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Over the past decade, numerous studies have been targeted at defining structure-activity relationships of glucagon.  Recently, the authors have found that glucagon1-29 is hydrolyzed by dipeptidyl peptidase IV (DPIV) to produce glucagon3-29 and glucagon5-29; in human serum, [pyroglutamyl (pGlu)3]glucagon3-29 is formed from glucagon3-29, and this prevents further hydrolysis of glucagon by DPIV.  In the current study, the biol. activity of these peptides was examd. in vitro.  The N-terminally truncated peptides all behaved as partial agonists in cAMP stimulation assays, with Chinese hamster ovary K1 cells overexpressing the human glucagon receptor (potency: glucagon1-29 > [pGlu3]glucagon3-29 > glucagon3-29 > glucagon5-29 > [Glu9]glucagon2-29).  In competition binding expts., [pGlu3]glucagon3-29 and glucagon5-29 both demonstrated 5-fold lower affinity for the receptor than glucagon1-29, whereas glucagon3-29 exhibited 18-fold lower affinity.  Of the peptides tested, only glucagon5-29 showed antagonist activity, and this was weak compared with the classical glucagon antagonist, [Glu9]glucagon2-29.  Hence, DPIV hydrolysis of glucagon yields low affinity agonists of the glucagon receptor.  As a corollary to evidence indicating that DPIV degrades glucagon, DPIV-resistant analogs were synthesized.  Matrix-assisted laser desorption/ionization-time of flight mass spectrometry was used to assess DPIV resistance, and it allowed kinetic anal. of degrdn.  Of several analogs generated, only [D-Ser2] and [Gly2]glucagon retained high affinity binding and biol. potency, similar to native glucagon in vitro.  [D-Ser2]Glucagon exhibited enhanced hyperglycemic activity in a bioassay, whereas [Gly2]glucagon was not completely resistant to DPIV degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtJF8IaVlxU7Vg90H21EOLACvtfcHk0lgUlu6sZjJqqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12gsrw%253D&md5=a6d31a71cd5a3410df7b5dcc9213a9fe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.6.3827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.6.3827%26sid%3Dliteratum%253Aachs%26aulast%3DHinke%26aufirst%3DS.%2BA.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DMannhart%26aufirst%3DS.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DE.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528DPIV%252FCD26%2529%2520degradation%2520of%2520glucagon.%2520Characterization%2520of%2520glucagon%2520degradation%2520products%2520and%2520DPIV-resistant%2520analogs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D3827%26epage%3D34%26doi%3D10.1074%2Fjbc.275.6.3827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koshimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawley, N. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yergy, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, Y. P.</span></span> <span> </span><span class="NLM_article-title">Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.1007/s12031-011-9521-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs12031-011-9521-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21537909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2011&pages=294-303&author=H.+Koshimizuauthor=N.+X.+Cawleyauthor=A.+L.+Yergyauthor=Y.+P.+Loh&title=Role+of+pGlu-serpinin%2C+a+novel+chromogranin+A-derived+peptide+in+inhibition+of+cell+death&doi=10.1007%2Fs12031-011-9521-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pGlu-Serpinin, a Novel Chromogranin A-Derived Peptide in Inhibition of Cell Death</span></div><div class="casAuthors">Koshimizu, Hisatsugu; Cawley, Niamh X.; Yergy, Alfred L.; Loh, Y. Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">294-303</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Chromogranin A (CgA) is a member of the granin family of mols. found in secretory granules of endocrine and neuro-endocrine cells.  Here, we have identified a new 23-mer CgA-derived peptide secreted from pituitary AtT-20 cells, which we named pyroGlu-serpinin (pGlu-serpinin).  LC-MS studies of peptides in conditioned medium of AtT-20 cells indicate that pGlu-serpinin is derived from initial processing of mouse CgA at paired basic residues, Arg461-Arg462 and Arg433-Arg434, to yield a previously described 26 amino acid peptide, serpinin.  Three amino acids are then cleaved from the N terminus of serpinin, yielding a peptide with an N-terminal glutamine, which is then subsequently pyroglutaminated.  Immunocytochem. showed co-localization of pGlu-serpinin with ACTH in secretory granules of AtT-20 cells, and it was released in an activity-dependent manner.  Functional studies demonstrated that pGlu-serpinin was able to prevent radical oxygen species (hydrogen peroxide)-induced cell death of AtT-20 cells and cultured rat cerebral cortical neurons at a concn. of 1 and 10 nM, resp.  These data indicate that pGlu-serpinin has anti-apoptotic effects that may be important in neuroprotection of central nervous system neurons and pituitary cells.  Furthermore, pGlu-serpinin added to the media of AtT-20 cells up-regulated the transcription of the serine protease inhibitor, protease nexin-1 (PN-1) mRNA.  PGlu-serpinin's ability to increase levels of PN-1, a potent inhibitor of plasmin released during inflammatory processes causing cell death, may play a role in protecting cells under adverse pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprmtQBBn1KtbVg90H21EOLACvtfcHk0lgUlu6sZjJqqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtr3I&md5=7608895439ab095571925f5fe48f0617</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs12031-011-9521-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-011-9521-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoshimizu%26aufirst%3DH.%26aulast%3DCawley%26aufirst%3DN.%2BX.%26aulast%3DYergy%26aufirst%3DA.%2BL.%26aulast%3DLoh%26aufirst%3DY.%2BP.%26atitle%3DRole%2520of%2520pGlu-serpinin%252C%2520a%2520novel%2520chromogranin%2520A-derived%2520peptide%2520in%2520inhibition%2520of%2520cell%2520death%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D45%26spage%3D294%26epage%3D303%26doi%3D10.1007%2Fs12031-011-9521-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dana, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson-Fagerstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kal, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chokhawala, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. S.</span></span> <span> </span><span class="NLM_article-title">The importance of pyroglutamate in cellulase Cel7A</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1002/bit.25178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fbit.25178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24375151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=842-7&author=C.+M.+Danaauthor=A.+Dotson-Fagerstromauthor=C.+M.+Rocheauthor=S.+M.+Kalauthor=H.+A.+Chokhawalaauthor=H.+W.+Blanchauthor=D.+S.+Clark&title=The+importance+of+pyroglutamate+in+cellulase+Cel7A&doi=10.1002%2Fbit.25178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of pyroglutamate in cellulase Cel7A</span></div><div class="casAuthors">Dana, Craig M.; Dotson-Fagerstrom, Alexandra; Roche, Christine M.; Kal, Sarala M.; Chokhawala, Harshal A.; Blanch, Harvey W.; Clark, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">842-847</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The commercialization of lignocellulosic biofuels relies in part on the ability to engineer cellulase enzymes to have properties compatible with practical processing conditions.  The cellulase Cel7A has been a common engineering target because it is present in very high concns. in com. cellulase cocktails.  Significant effort has thus been focused on its recombinant expression.  In particular, the yeast Saccharomyces cerevisiae has often been used both in the engineering and basic study of Cel7A.  However, the expression titer and extent of glycosylation of Cel7A expressed in S. cerevisiae vary widely for Cel7A genes from different organisms, and the recombinant enzymes tend to be less active and less stable than their native counterparts.  These observations motivate further study of recombinant expression of Cel7A in S. cerevisiae.  Here, we compare the properties of Cel7A from Talaromyces emersonii expressed in both the budding yeast S. cerevisiae and the filamentous fungus Neurospora crassa.  The Cel7A expressed in N. crassa had a higher melting temp. (by 10°C) and higher specific activity (twofold at 65°C) than the Cel7A expressed in S. cerevisiae.  We examd. several post-translational modifications and found that the underlying cause of this disparity was the lack of N-terminal glutamine cyclization in the Cel7A expressed in S. cerevisiae.  Treating the enzyme in vitro with glutaminyl cyclase improved the properties of Cel7A expressed in S. cerevisiae to match those of Cel7A expressed in N. crassa.  Biotechnol Bioeng. 2014;111: 842-847. © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJU_uVOSzwYbVg90H21EOLACvtfcHk0ljM9izrF6QTCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12jt78%253D&md5=58807cfea81e0f978223da5d86fcc07f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fbit.25178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.25178%26sid%3Dliteratum%253Aachs%26aulast%3DDana%26aufirst%3DC.%2BM.%26aulast%3DDotson-Fagerstrom%26aufirst%3DA.%26aulast%3DRoche%26aufirst%3DC.%2BM.%26aulast%3DKal%26aufirst%3DS.%2BM.%26aulast%3DChokhawala%26aufirst%3DH.%2BA.%26aulast%3DBlanch%26aufirst%3DH.%2BW.%26aulast%3DClark%26aufirst%3DD.%2BS.%26atitle%3DThe%2520importance%2520of%2520pyroglutamate%2520in%2520cellulase%2520Cel7A%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2014%26volume%3D111%26spage%3D842%26epage%3D7%26doi%3D10.1002%2Fbit.25178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shih, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94812</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0094812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24733552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Y.+P.+Shihauthor=C.+C.+Chouauthor=Y.+L.+Chenauthor=K.+F.+Huangauthor=A.+H.+Wang&title=Linked+production+of+pyroglutamate-modified+proteins+via+self-cleavage+of+fusion+tags+with+TEV+protease+and+autonomous+N-terminal+cyclization+with+glutaminyl+cyclase+in+vivo&doi=10.1371%2Fjournal.pone.0094812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo</span></div><div class="casAuthors">Shih, Yan-Ping; Chou, Chi-Chi; Chen, Yi-Ling; Huang, Kai-Fa; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94812/1-e94812/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Overprodn. of N-terminal pyroglutamate (pGlu)-modified proteins utilizing Escherichia coli or eukaryotic cells is a challenging work owing to the fact that the recombinant proteins need to be recovered by proteolytic removal of fusion tags to expose the N-terminal glutaminyl or glutamyl residue, which is then converted into pGlu catalyzed by the enzyme glutaminyl cyclase.  Herein we describe a new method for prodn. of N-terminal pGlu-contg. proteins in vivo via intracellular self-cleavage of fusion tags by tobacco etch virus (TEV) protease and then immediate N-terminal cyclization of passenger target proteins by a bacterial glutaminyl cyclase.  To combine with the sticky-end PCR cloning strategy, this design allows the gene of target proteins to be efficiently inserted into the expression vector using two unique cloning sites (i.e., SnaB I and Xho I), and the sol. and N-terminal pGlu-contg. proteins are then produced in vivo.  Our method has been successfully applied to the prodn. of pGlu-modified enhanced green fluorescence protein and monocyte chemoattractant proteins.  This design will facilitate the prodn. of protein drugs and drug target proteins that possess an N-terminal pGlu residue required for their physiol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrcimU5vrYbVg90H21EOLACvtfcHk0ljM9izrF6QTCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemtbzP&md5=705f4101ecbb5811c6196f196d2f6e95</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094812%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DY.%2BP.%26aulast%3DChou%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DLinked%2520production%2520of%2520pyroglutamate-modified%2520proteins%2520via%2520self-cleavage%2520of%2520fusion%2520tags%2520with%2520TEV%2520protease%2520and%2520autonomous%2520N-terminal%2520cyclization%2520with%2520glutaminyl%2520cyclase%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tittmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bioorg.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntlWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=98-101&author=F.+Seifertauthor=H.+U.+Demuthauthor=T.+Weichlerauthor=H.+H.+Ludwigauthor=K.+Tittmannauthor=S.+Schilling&title=Phosphate+ions+and+glutaminyl+cyclases+catalyze+the+cyclization+of+glutaminyl+residues+by+facilitating+synchronized+proton+transfers&doi=10.1016%2Fj.bioorg.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers</span></div><div class="casAuthors">Seifert, Franziska; Demuth, Hans-Ulrich; Weichler, Teresa; Ludwig, Hans-Henning; Tittmann, Kai; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-101</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphate ions and glutaminyl cyclase (QC) both catalyze the formation of pyroglutamate (pE, pGlu) from N-terminal glutamine residues of peptides and proteins.  Here, we studied the mechanism of glutamine cyclization using kinetic secondary deuterium and solvent isotope effects.  The data suggest that proton transfer(s) are rate detg. for the spontaneous reaction, and that phosphate and QC accelerating the reaction by promoting synchronized proton transfers in a concerted mechanism.  Thus, non-enzymic and enzymic catalysis of pyroglutamate formation exploit a similar mode of transition-state stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAWnU0v0_IwbVg90H21EOLACvtfcHk0ljEg0RtpiNTnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntlWnsrk%253D&md5=0540ccf95e5434c3125c43d85277e403</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DWeichler%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DTittmann%26aufirst%3DK.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DPhosphate%2520ions%2520and%2520glutaminyl%2520cyclases%2520catalyze%2520the%2520cyclization%2520of%2520glutaminyl%2520residues%2520by%2520facilitating%2520synchronized%2520proton%2520transfers%26jtitle%3DBioorg.%2520Chem.%26date%3D2015%26volume%3D60%26spage%3D98%26epage%3D101%26doi%3D10.1016%2Fj.bioorg.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">3628</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1073/pnas.84.11.3628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.84.11.3628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3473473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL2sXksFKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=3628-32&author=W.+H.+Fischerauthor=J.+Spiess&title=Identification+of+a+mammalian+glutaminyl+cyclase+converting+glutaminyl+into+pyroglutamyl+peptides&doi=10.1073%2Fpnas.84.11.3628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides</span></div><div class="casAuthors">Fischer, Wolfgang H.; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3628-32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Exts. from bovine pituitary were found to contain an activity catalyzing the conversion of glutaminyl peptides such as [Gln1]gonadotropin-releasing hormone, [Gln1, Gly4]TRH (H-Gln-His-Pro-Gly-OH), and H-Gln-Tyr-Ala-OH to the resp. pyroglutamyl peptides.  The TRH precursor fragment H-Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-OH and the D-glutaminyl stereoisomer of H-Gln-Tyr-Ala-OH did not react under the same conditions.  The conversion products were identified by Edman degrdn., amino acid anal., and reversed-phase HPLC.  That this activity was exhibited by an enzyme, glutaminyl cyclase (I), was concluded from the protein character of the activity (revealed by its abolition with trypsin and heat), the Michaelis-Menten relationship between substrate concn. and conversion rate, and the substrate specificity.  I was detd. to have mol. wt. of 43,000-50,000, a pH optimum at pH 8, and Km and Vmax values in the range of 60-130 μM and 390-690 pmol/μg/h, resp.  I was not obsd. to require ATP and could be inhibited with 1.0M NH4Cl, which increased the Km and decreased the Vmax value.  The subcellular distribution of I corresponded to that of peptidylglycine α-amidating monooxygenase believed to catalyze C-terminal amidations during posttranslational precursor processing.  The formation of pyroglutamyl from glutaminyl peptides was also obsd. to occur nonenzymically; however, the enzymic reaction carried out with crude ext. was found to be ≈70-fold faster than the nonenzymic reaction enhanced by phosphate.  Hence, I, may participate in the posttranslational processing of hormonal precursors to pyroglutamyl peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8xCeLL2CMc7Vg90H21EOLACvtfcHk0ljEg0RtpiNTnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFKhu7w%253D&md5=23063d67c7719362641c12bb3836d2e7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.11.3628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.11.3628%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%2BH.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520mammalian%2520glutaminyl%2520cyclase%2520converting%2520glutaminyl%2520into%2520pyroglutamyl%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D3628%26epage%3D32%26doi%3D10.1073%2Fpnas.84.11.3628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>563</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00300-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0014-5793%2804%2900300-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15063747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2004&pages=191-6&author=S.+Schillingauthor=T.+Hoffmannauthor=S.+Manhartauthor=M.+Hoffmannauthor=H.+U.+Demuth&title=Glutaminyl+cyclases+unfold+glutamyl+cyclase+activity+under+mild+acid+conditions&doi=10.1016%2FS0014-5793%2804%2900300-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Manhart, Susanne; Hoffmann, Matthias; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from glutaminyl precursors is a posttranslational event in the processing of bioactive neuropeptides such as TSH-releasing hormone and neurotensin during their maturation in the secretory pathway.  The reaction is facilitated by glutaminyl cyclase (QC), an enzyme highly abundant in mammalian brain.  Here, we describe for the first time that human and papaya QC also catalyze N-terminal glutamate cyclization.  Surprisingly, the enzymic Glu1 conversion is favored at pH 6.0 while Gln1 conversion occurs with an optimum at pH 8.0.  This unexpected finding might be of importance for deciphering the events leading to deposition of highly toxic pyroglutamyl peptides in amyloidotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU5BTU0iZI7Vg90H21EOLACvtfcHk0ljEg0RtpiNTnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D&md5=43c6d9f6def6e4a6948171a58e961471</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900300-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900300-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclases%2520unfold%2520glutamyl%2520cyclase%2520activity%2520under%2520mild%2520acid%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D563%26spage%3D191%26epage%3D6%26doi%3D10.1016%2FS0014-5793%2804%2900300-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvaresi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottoni, A.</span></span> <span> </span><span class="NLM_article-title">Computational evidence for the catalytic mechanism of glutaminyl cyclase. A DFT investigation</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1002/prot.22061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fprot.22061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18470930" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=527-38&author=M.+Calvaresiauthor=M.+Garavelliauthor=A.+Bottoni&title=Computational+evidence+for+the+catalytic+mechanism+of+glutaminyl+cyclase.+A+DFT+investigation&doi=10.1002%2Fprot.22061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fprot.22061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22061%26sid%3Dliteratum%253Aachs%26aulast%3DCalvaresi%26aufirst%3DM.%26aulast%3DGaravelli%26aufirst%3DM.%26aulast%3DBottoni%26aufirst%3DA.%26atitle%3DComputational%2520evidence%2520for%2520the%2520catalytic%2520mechanism%2520of%2520glutaminyl%2520cyclase.%2520A%2520DFT%2520investigation%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2008%26volume%3D73%26spage%3D527%26epage%3D38%26doi%3D10.1002%2Fprot.22061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1042/BJ20071073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20071073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18072935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=181-90&author=K.+F.+Huangauthor=Y.+R.+Wangauthor=E.+C.+Changauthor=T.+L.+Chouauthor=A.+H.+Wang&title=A+conserved+hydrogen-bond+network+in+the+catalytic+centre+of+animal+glutaminyl+cyclases+is+critical+for+catalysis&doi=10.1042%2FBJ20071073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span></div><div class="casAuthors">Huang, Kai-Fa; Wang, Yu-Ruei; Chang, En-Cheng; Chou, Tsung-Lin; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QCs (glutaminyl cyclases; glutaminyl-peptide cyclotransferases, E.C. 2.3.2.5) catalyze N-terminal pyroglutamate formation in numerous bioactive peptides and proteins.  The enzymes were reported to be involved in several pathol. conditions such as amyloidotic disease, osteoporosis, rheumatoid arthritis and melanoma.  The crystal structure of human QC revealed an unusual H-bond (hydrogen-bond) network in the active site, formed by several highly conserved residues (Ser160, Glu201, Asp248, Asp305 and His319), within which Glu201 and Asp248 were found to bind to substrate.  In the present study we combined steady-state enzyme kinetic and x-ray structural analyses of 11 single-mutation human QCs to investigate the roles of the H-bond network in catalysis.  Our results showed that disrupting one or both of the central H-bonds, i.e., Glu201···Asp305 and Asp248···Asp305, reduced the steady-state catalysis dramatically.  The roles of these two COOH···COOH bonds on catalysis could be partly replaced by COOH···water bonds, but not by COOH···CONH2 bonds, reminiscent of the low-barrier Asp···Asp H-bond in the active site of pepsin-like aspartic peptidases.  Mutations on Asp305, a residue located at the center of the H-bond network, raised the Km value of the enzyme by 4.4-19-fold, but decreased the kcat value by 79-2842-fold, indicating that Asp305 primarily plays a catalytic role.  In addn., results from mutational studies on Ser160 and His319 suggest that these two residues might help to stabilize the conformations of Asp248 and Asp305 resp.  These data allow us to propose an essential proton transfer between Glu201, Asp305 and Asp248 during the catalysis by animal QCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4EKjUIwutAbVg90H21EOLACvtfcHk0lhIP5srOM59BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D&md5=2e5104776acc97f920d9502be3a041b4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2FBJ20071073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071073%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DChang%26aufirst%3DE.%2BC.%26aulast%3DChou%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DA%2520conserved%2520hydrogen-bond%2520network%2520in%2520the%2520catalytic%2520centre%2520of%2520animal%2520glutaminyl%2520cyclases%2520is%2520critical%2520for%2520catalysis%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D181%26epage%3D90%26doi%3D10.1042%2FBJ20071073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misquitta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, R. E.</span></span> <span> </span><span class="NLM_article-title">Evidence for essential histidines in human pituitary glutaminyl cyclase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">11246</span>– <span class="NLM_lpage">11250</span>, <span class="refDoi"> DOI: 10.1021/bi011177o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011177o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFGju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11246-11250&author=R.+J.+Batemanauthor=J.+S.+Templeauthor=S.+A.+Misquittaauthor=R.+E.+Booth&title=Evidence+for+essential+histidines+in+human+pituitary+glutaminyl+cyclase&doi=10.1021%2Fbi011177o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for essential histidines in human pituitary glutaminyl cyclase</span></div><div class="casAuthors">Bateman, Robert C., Jr.; Temple, Jeffrey S.; Misquitta, Stephanie A.; Booth, Rachell E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11246-11250</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (EC 2.3.2.5) (I) catalyzes the formation of the pyroglutamyl residue present at the N-terminus of numerous secretory peptides and proteins.  Treatment with di-Et pyrocarbonate inactivated recombinant human I with the apparent modification of 3 essential His residues.  Comparisons of the protein sequences of I from a variety of eukaryotic species showed 4 completely conserved His residues.  Mutation of each of these residues to Gln resulted in 2 mutant enzymes that were inactive (H140Q and H330Q), suggesting a role in catalysis, and 2 that exhibited increased Km values (H307Q and H319Q), suggesting a role in substrate binding.  Consistent with these results was the prediction that I possessed a Zn-aminopeptidase domain in which the 4 His residues identified here were present in the active site.  Mammalian I may, therefore, have structural and catalytic similarities to a family of bacterial Zn-aminopeptidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm51nCGNk_sLVg90H21EOLACvtfcHk0lhIP5srOM59BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFGju7c%253D&md5=c4b4e68d5158d5619d269a41668ea963</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi011177o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011177o%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DTemple%26aufirst%3DJ.%2BS.%26aulast%3DMisquitta%26aufirst%3DS.%2BA.%26aulast%3DBooth%26aufirst%3DR.%2BE.%26atitle%3DEvidence%2520for%2520essential%2520histidines%2520in%2520human%2520pituitary%2520glutaminyl%2520cyclase%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11246%26epage%3D11250%26doi%3D10.1021%2Fbi011177o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giliberto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrassa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaton, M.</span></span> <span> </span><span class="NLM_article-title">beta-amyloid is different in normal aging and in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">34186</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501694200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M501694200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16103127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKitr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=34186-92&author=A.+Picciniauthor=C.+Russoauthor=A.+Gliozziauthor=A.+Reliniauthor=A.+Vitaliauthor=R.+Borghiauthor=L.+Gilibertoauthor=A.+Armirottiauthor=C.+D%E2%80%99Arrigoauthor=A.+Bachiauthor=A.+Cattaneoauthor=C.+Canaleauthor=S.+Torrassaauthor=T.+C.+Saidoauthor=W.+Markesberyauthor=P.+Gambettiauthor=M.+Tabaton&title=beta-amyloid+is+different+in+normal+aging+and+in+Alzheimer+disease&doi=10.1074%2Fjbc.M501694200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid Is Different in Normal Aging and in Alzheimer Disease</span></div><div class="casAuthors">Piccini, Alessandra; Russo, Claudio; Gliozzi, Alessandra; Relini, Annalisa; Vitali, Antonella; Borghi, Roberta; Giliberto, Luca; Armirotti, Andrea; D'Arrigo, Cristina; Bachi, Angela; Cattaneo, Angela; Canale, Claudio; Torrassa, Silvia; Saido, Takaomi C.; Markesbery, William; Gambetti, Pierluigi; Tabaton, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">34186-34192</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism of neurodegeneration caused by β-amyloid in Alzheimer disease is controversial.  Neuronal toxicity is exerted mostly by various species of sol. β-amyloid oligomers that differ in their N- and C-terminal domains.  However, abundant accumulation of β-amyloid also occurs in the brains of cognitively normal elderly people, in the absence of obvious neuronal dysfunction.  We postulated that neuronal toxicity depends on the mol. compn., rather than the amt., of the sol. β-amyloid oligomers.  Here we show that sol. β-amyloid aggregates that accumulate in Alzheimer disease are different from those of normal aging in regard to the compn. as well as the aggregation and toxicity properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqsevn1QyAbVg90H21EOLACvtfcHk0lh76-I8RfKdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKitr7K&md5=cec2b2f5f959c6de421968d24a4f4176</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501694200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501694200%26sid%3Dliteratum%253Aachs%26aulast%3DPiccini%26aufirst%3DA.%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DGliozzi%26aufirst%3DA.%26aulast%3DRelini%26aufirst%3DA.%26aulast%3DVitali%26aufirst%3DA.%26aulast%3DBorghi%26aufirst%3DR.%26aulast%3DGiliberto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DCanale%26aufirst%3DC.%26aulast%3DTorrassa%26aufirst%3DS.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DMarkesbery%26aufirst%3DW.%26aulast%3DGambetti%26aufirst%3DP.%26aulast%3DTabaton%26aufirst%3DM.%26atitle%3Dbeta-amyloid%2520is%2520different%2520in%2520normal%2520aging%2520and%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D34186%26epage%3D92%26doi%3D10.1074%2Fjbc.M501694200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span> <span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-66&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lh76-I8RfKdjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D66%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nochlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellenberg, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brundin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliymani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span> <span> </span><span class="NLM_article-title">The Arctic AbetaPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Abeta</span>. <i>Acta Neuropathol Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/2051-5960-1-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F2051-5960-1-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24252272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c3mvFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=60&author=H.+Kalimoauthor=M.+Lalowskiauthor=N.+Bogdanovicauthor=O.+Philipsonauthor=T.+D.+Birdauthor=D.+Nochlinauthor=G.+D.+Schellenbergauthor=R.+Brundinauthor=T.+Olofssonauthor=R.+Soliymaniauthor=M.+Baumannauthor=O.+Wirthsauthor=T.+A.+Bayerauthor=L.+N.+Nilssonauthor=H.+Basunauthor=L.+Lannfeltauthor=M.+Ingelsson&title=The+Arctic+AbetaPP+mutation+leads+to+Alzheimer%E2%80%99s+disease+pathology+with+highly+variable+topographic+deposition+of+differentially+truncated+Abeta&doi=10.1186%2F2051-5960-1-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ</span></div><div class="casAuthors">Kalimo Hannu; Lalowski Maciej; Bogdanovic Nenad; Philipson Ola; Bird Thomas D; Nochlin David; Schellenberg Gerard D; Brundin Rosemarie; Olofsson Tommie; Soliymani Rabah; Baumann Marc; Wirths Oliver; Bayer Thomas A; Nilsson Lars N G; Basun Hans; Lannfelt Lars; Ingelsson Martin</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Arctic mutation (p.E693G/p.E22G)fs within the β-amyloid (Aβ) region of the β-amyloid precursor protein gene causes an autosomal dominant disease with clinical picture of typical Alzheimer's disease.  Here we report the special character of Arctic AD neuropathology in four deceased patients.  RESULTS:  Aβ deposition in the brains was wide-spread (Thal phase 5) and profuse.  Virtually all parenchymal deposits were composed of non-fibrillar, Congo red negative Aβ aggregates.  Congo red only stained angiopathic vessels.  Mass spectrometric analyses showed that Aβ deposits contained variably truncated and modified wild type and mutated Aβ species.  In three of four Arctic AD brains, most cerebral cortical plaques appeared targetoid with centres containing C-terminally (beyond aa 40) and variably N-terminally truncated Aβ surrounded by coronas immunopositive for Aβx-42.  In the fourth patient plaque centres contained almost no Aβ making the plaques ring-shaped.  The architectural pattern of plaques also varied between different anatomic regions.  Tau pathology corresponded to Braak stage VI, and appeared mainly as delicate neuropil threads (NT) enriched within Aβ plaques.  Dystrophic neurites were scarce, while neurofibrillary tangles were relatively common.  Neuronal perikarya within the Aβ plaques appeared relatively intact.  CONCLUSIONS:  In Arctic AD brain differentially truncated abundant Aβ is deposited in plaques of variable numbers and shapes in different regions of the brain (including exceptional targetoid plaques in neocortex).  The extracellular non-fibrillar Aβ does not seem to cause overt damage to adjacent neurons or to induce formation of neurofibrillary tangles, supporting the view that intracellular Aβ oligomers are more neurotoxic than extracellular Aβ deposits.  However, the enrichment of NTs within plaques suggests some degree of intra-plaque axonal damage including accumulation of hp-tau, which may impair axoplasmic transport, and thereby contribute to synaptic loss.  Finally, similarly as the cotton wool plaques in AD resulting from exon 9 deletion in the presenilin-1 gene, the Arctic plaques induced only modest glial and inflammatory tissue reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrC1-S7O0marFU0A1HOshhfW6udTcc2eYViV0_kMI6Urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3mvFKlsg%253D%253D&md5=2ad58213d689cb0a3ccaef01898ddc45</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F2051-5960-1-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-5960-1-60%26sid%3Dliteratum%253Aachs%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DLalowski%26aufirst%3DM.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DPhilipson%26aufirst%3DO.%26aulast%3DBird%26aufirst%3DT.%2BD.%26aulast%3DNochlin%26aufirst%3DD.%26aulast%3DSchellenberg%26aufirst%3DG.%2BD.%26aulast%3DBrundin%26aufirst%3DR.%26aulast%3DOlofsson%26aufirst%3DT.%26aulast%3DSoliymani%26aufirst%3DR.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DNilsson%26aufirst%3DL.%2BN.%26aulast%3DBasun%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DIngelsson%26aufirst%3DM.%26atitle%3DThe%2520Arctic%2520AbetaPP%2520mutation%2520leads%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathology%2520with%2520highly%2520variable%2520topographic%2520deposition%2520of%2520differentially%2520truncated%2520Abeta%26jtitle%3DActa%2520Neuropathol%2520Commun.%26date%3D2013%26volume%3D1%26spage%3D60%26doi%3D10.1186%2F2051-5960-1-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutsuga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of AbetapN3 deposition in the brains of dogs of various ages and other animal species</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.3109/13506129.2011.570385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3109%2F13506129.2011.570385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21557687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=63-71&author=J.+K.+Chambersauthor=M.+Mutsugaauthor=K.+Uchidaauthor=H.+Nakayama&title=Characterization+of+AbetapN3+deposition+in+the+brains+of+dogs+of+various+ages+and+other+animal+species&doi=10.3109%2F13506129.2011.570385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AβpN3 deposition in the brains of dogs of various ages and other animal species</span></div><div class="casAuthors">Chambers, James K.; Mutsuga, Mayu; Uchida, Kazuyuki; Nakayama, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Senile plaques (SP) are characteristic histopathol. manifestations of Alzheimer's disease (AD), but are also found in normal aging (NA).  Recent studies have demonstrated that beta amyloid (Aβ) proteins that have been truncated at the N-terminal position 3 (AβpN3) are the predominant component of SP in AD, but not in NA.  The present study revealed that AβpN3 was deposited in an age-dependent manner in canine brains.  Moreover, AβpN3 was the main component of the SP that developed in very old dogs.  The deposition of AβpN3 increased in accordance with the no. of SP, but that of N-terminally intact Aβ (AβN1) did not.  In addn., AβpN3 was also deposited in the SP of a Japanese macaque and an American black bear, but not in a feline brain.  Focal microvascular cerebral amyloid angiopathy was also obsd. in the deep cortices and the white matter of the dogs and a woodpecker.  Those were always composed of both AβpN3 and AβN1.  In conclusion, though non-human animals do not develop full pathol. of AD of the human type, AβpN3 is widely deposited in the brains of senescent vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaat2PPPj2frVg90H21EOLACvtfcHk0ljd013WCYYN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWktLg%253D&md5=77c621b6495fe4bf0e9448bcf204acf3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F13506129.2011.570385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13506129.2011.570385%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DJ.%2BK.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520AbetapN3%2520deposition%2520in%2520the%2520brains%2520of%2520dogs%2520of%2520various%2520ages%2520and%2520other%2520animal%2520species%26jtitle%3DAmyloid%26date%3D2011%26volume%3D18%26spage%3D63%26epage%3D71%26doi%3D10.3109%2F13506129.2011.570385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willbold, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7072</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-8&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0ljd013WCYYN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D8%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galante, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbrana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassalli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span> <span> </span><span class="NLM_article-title">Differential toxicity, conformation and morphology of typical initial aggregation states of Abeta1–42 and Abetapy3–42 beta-amyloids</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2085</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2012.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.biocel.2012.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22903022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKku7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=2085-93&author=D.+Galanteauthor=A.+Corsaroauthor=T.+Florioauthor=S.+Vellaauthor=A.+Paganoauthor=F.+Sbranaauthor=M.+Vassalliauthor=A.+Pericoauthor=C.+D%E2%80%99Arrigo&title=Differential+toxicity%2C+conformation+and+morphology+of+typical+initial+aggregation+states+of+Abeta1%E2%80%9342+and+Abetapy3%E2%80%9342+beta-amyloids&doi=10.1016%2Fj.biocel.2012.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids</span></div><div class="casAuthors">Galante, Denise; Corsaro, Alessandro; Florio, Tullio; Vella, Serena; Pagano, Aldo; Sbrana, Francesca; Vassalli, Massimo; Perico, Angelo; D'Arrigo, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2085-2093</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among the different species of water-sol. β-peptides (Aβ1-42, Aβ1-40 and N-terminal truncated Aβ-peptides), Aβpy3-42 is thought to play a relevant role in Alzheimer's pathogenesis due to its abundance, resistance to proteolysis, fast aggregation kinetics, dynamic structure and high neurotoxicity.  To evaluate the specific structural characteristics and neurotoxicity of Aβpy3-42, we sepd. different aggregation states of Aβ1-42 and Aβpy3-42 using fast protein liq. chromatog., isolating in both cases three peaks that corresponded to sa (small), ma (medium) and la (large) aggregates.  Conformational anal., by CD showed a prevailing random coil conformation for sa and ma, and typical β-sheet conformation for la.  AFM and TEM show differential structural features between the three aggregates of a given β-peptide and among the aggregate of the two β-peptides.  The potential toxic effects of the different aggregates were evaluated using human neuroblastoma SH-SY5Y cells in the MTT redn., in the xCELLigence System, and in the Annexin V binding expts.  In the case of Aβ1-42 the most toxic aggregate is la, while in the case of Aβpy3-42 both sa and la are equally toxic.  Aβ aggregates were found to be internalized in the cells, as estd. by confocal immunofluorescence microscopy, with a higher effect obsd. for Aβpy3-42, showing a good correlation with the toxic effects.  Together these expts. allowed the discrimination of the intermediate states more responsible of oligomer toxicity, providing new insights on the correlation between the aggregation process and the toxicity and confirming the peculiar role in the pathogenesis of Alzheimer disease of Aβpy3-42 peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoegpcu687lKrVg90H21EOLACvtfcHk0ljd013WCYYN7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKku7nE&md5=f716bfe0a7f64e951ed4d228f4ef26a1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DGalante%26aufirst%3DD.%26aulast%3DCorsaro%26aufirst%3DA.%26aulast%3DFlorio%26aufirst%3DT.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DPagano%26aufirst%3DA.%26aulast%3DSbrana%26aufirst%3DF.%26aulast%3DVassalli%26aufirst%3DM.%26aulast%3DPerico%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26atitle%3DDifferential%2520toxicity%252C%2520conformation%2520and%2520morphology%2520of%2520typical%2520initial%2520aggregation%2520states%2520of%2520Abeta1%25E2%2580%259342%2520and%2520Abetapy3%25E2%2580%259342%2520beta-amyloids%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D2085%26epage%3D93%26doi%3D10.1016%2Fj.biocel.2012.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otvos, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span> <span> </span><span class="NLM_article-title">Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1097/00005072-199811000-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1097%2F00005072-199811000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9825946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXnslSnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1998&pages=1089-95&author=R.+Hosodaauthor=T.+C.+Saidoauthor=L.+J.+Otvosauthor=T.+Araiauthor=D.+M.+Mannauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=T.+Iwatsubo&title=Quantification+of+modified+amyloid+beta+peptides+in+Alzheimer+disease+and+Down+syndrome+brains&doi=10.1097%2F00005072-199811000-00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of modified amyloid β peptides in Alzheimer disease and Down syndrome brains</span></div><div class="casAuthors">Hosoda, Ritsuko; Saido, Takaomi C.; Otvos, Laszlo, Jr.; Arai, Takao; Mann, David M. A.; Lee, Virginia M. -Y.; Trojanowski, John Q.; Iwatsubo, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1089-1095</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">To gain insights into the different forms of modified amyloid β peptides (Aβ) in the Alzheimer disease (AD) and Down syndrome (DS) brain, the authors used two-site ELISAs with antibodies specific for isomerized ( Aβ with L-isoaspartate at positions 1 and 7) and pyroglutamate-modified (Aβ beginning with pyroglutamate at position 3) forms of Aβ to quantitate the levels of these different Aβ peptides in formic acid exts. of AD and DS frontal cortex.  Despite variations in the proportions of distinct forms of Aβ in AD and DS frontal cortex, the major species of Aβ in these samples were AβN3(pyroGlu)-42 as well as Aβx-42 (where x is a residue at position 2 or less in Aβ), whereas isomerized Aβ was a minor species.  Further, the levels of isomerized and pyroglutamate-modified forms of Aβ terminating at amino acid 42 were higher than those ending at amino acid 40.  The abundance of the distinct forms of Aβ reported here in formic acid exts. of AD and DS frontal cortex suggests that these Aβ species could play important roles in the deposition of Aβ in AD and DS brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYOTtqyCCqLVg90H21EOLACvtfcHk0lhc11FLcH6LjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslSnt7s%253D&md5=d7d44778fd35d7fbf1a645c8581fc934</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1097%2F00005072-199811000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199811000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DHosoda%26aufirst%3DR.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DOtvos%26aufirst%3DL.%2BJ.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DQuantification%2520of%2520modified%2520amyloid%2520beta%2520peptides%2520in%2520Alzheimer%2520disease%2520and%2520Down%2520syndrome%2520brains%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1998%26volume%3D57%26spage%3D1089%26epage%3D95%26doi%3D10.1097%2F00005072-199811000-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venezia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolcini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benatti, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schettini, G.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)-- strongly affect cultured neuron and astrocyte survival</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-9&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+beta-peptides%2D%2DAbetaN3%28pE%29%2D%2D+strongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0lhc11FLcH6LjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520beta-peptides--AbetaN3%2528pE%2529--%2520strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D9%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaupp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">On the seeding and oligomerization of pGlu-amyloid peptides (in vitro)</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12393</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1021/bi0612667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0612667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12393-9&author=S.+Schillingauthor=T.+Lauberauthor=M.+Schauppauthor=S.+Manhartauthor=E.+Scheelauthor=G.+Bohmauthor=H.+U.+Demuth&title=On+the+seeding+and+oligomerization+of+pGlu-amyloid+peptides+%28in+vitro%29&doi=10.1021%2Fbi0612667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">On the Seeding and Oligomerization of pGlu-Amyloid Peptides (in vitro)</span></div><div class="casAuthors">Schilling, Stephan; Lauber, Thomas; Schaupp, Michael; Manhart, Susanne; Scheel, Eike; Boehm, Gerald; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12393-12399</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligomerization of amyloid β (Aβ) peptides is the decisive event in the development of Alzheimer's disease (AD), the most common neuro-generative disorder in developed countries.  Recent evidence links this conformation-driven process to primary- and secondary-structure modifications of Aβ.  The N and C terminus of deposited Aβ has been shown to possess conspicuous heterogeneity.  While the C-terminally longer form of Aβ, i.e., Aβ (42), is considered more amyloidogenic, the role of the N-terminal modifications, e.g., truncation and glutamate cyclization accounting for the majority of the deposited peptides, is less understood.  In the present study, we characterized the oligomerization and seeding capacity of pGlu-amyloid peptides using two unrelated techniques based on flow cytometry or fluorescence dye binding.  Under different conditions and irresp. of the C terminus of Aβ, i.e., Aβ40 or 42, pGlu-modified peptides displayed an up to 250-fold accelerated initial formation of aggregates compared to unmodified Aβ.  The accelerated seed formation is accompanied by a change in the oligomerization kinetics because of N-terminal pGlu formation.  Furthermore, the formation of mixed aggregates consisting of either pGlu-Aβ (3-42) or ADan or ABri and Aβ (1-42) was investigated by Aβ fluorescence labeling in flow cytometry.  The results suggest that pGlu-modified peptides are potential seeding species of aggregate formation in vivo.  The data presented here and the abundance of pGlu peptides in amyloidoses, such as FBD and AD, suggest pGlu-amyloid peptides as a species with biophys. characteristics that might be in particular crucial for the initiation of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6CurUnBcAULVg90H21EOLACvtfcHk0ljRev1ZNWOKHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D&md5=3c41f4ad0b1cbe27a9dbc55bab2be8f4</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi0612667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0612667%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DLauber%26aufirst%3DT.%26aulast%3DSchaupp%26aufirst%3DM.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DBohm%26aufirst%3DG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DOn%2520the%2520seeding%2520and%2520oligomerization%2520of%2520pGlu-amyloid%2520peptides%2520%2528in%2520vitro%2529%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12393%26epage%3D9%26doi%3D10.1021%2Fbi0612667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Kolk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vingtdeux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Steeg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ret, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobecq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonici, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delacourte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benavides, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradier, L.</span></span> <span> </span><span class="NLM_article-title">Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63388-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0002-9440%2810%2963388-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15466394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=1289-300&author=C.+Casasauthor=N.+Sergeantauthor=J.+M.+Itierauthor=V.+Blanchardauthor=O.+Wirthsauthor=N.+van+der+Kolkauthor=V.+Vingtdeuxauthor=E.+van+de+Steegauthor=G.+Retauthor=T.+Cantonauthor=H.+Drobecqauthor=A.+Clarkauthor=B.+Boniciauthor=A.+Delacourteauthor=J.+Benavidesauthor=C.+Schmitzauthor=G.+Trempauthor=T.+A.+Bayerauthor=P.+Benoitauthor=L.+Pradier&title=Massive+CA1%2F2+neuronal+loss+with+intraneuronal+and+N-terminal+truncated+Abeta42+accumulation+in+a+novel+Alzheimer+transgenic+model&doi=10.1016%2FS0002-9440%2810%2963388-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model</span></div><div class="casAuthors">Casas, Caty; Sergean, Nicolas; Itier, Jean-Michel; Blanchard, Veronique; Wirths, Oliver; van der Kolk, Nicolien; Vingtdeux, Valerie; van de Steeg, Evita; Ret, Gwenaelle; Canton, Thierry; Drobecq, Herve; Clark, Allan; Bonici, Bruno; Delacourte, Andre; Benavides, Jesus; Schmitz, Christoph; Tremp, Gunter; Bayer, Thomas A.; Benoit, Patrick; Pradier, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1289-1300</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by a substantial degeneration of pyramidal neurons and the appearance of neuritic plaques and neurofibrillary tangles.  Here we present a novel transgenic mouse model, APPSLPS1KI that closely mimics the development of AD-related neuropathol. features including a significant hippocampal neuronal loss.  This transgenic mouse model carries M233T/L235P knocked-in mutations in presenilin-1 and overexpresses mutated human β-amyloid (Aβ) precursor protein.  Aβx-42 is the major form of Aβ species present in this model with progressive development of a complex pattern of N-truncated variants and dimers, similar to those obsd. in AD brain.  At 10 mo of age, an extensive neuronal loss (>50%) is present in the CA1/2 hippocampal pyramidal cell layer that correlates with strong accumulation of intraneuronal Aβ and thioflavine-S-pos. intracellular material but not with extracellular Aβ deposits.  A strong reactive astrogliosis develops together with the neuronal loss.  This loss is already detectable at 6 mo of age and is PSIK1 gene dosage-dependent.  Thus, APPSLPS1KI mice further confirm the crit. role of intraneuronal Aβ42 in neuronal loss and provide an excellent tool to investigate therapeutic strategies designed to prevent AD neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptm502eRFGE7Vg90H21EOLACvtfcHk0ljRev1ZNWOKHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFSmtbc%253D&md5=702535c93c978acadadbc6b9f9acad54</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963388-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963388-3%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DC.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DItier%26aufirst%3DJ.%2BM.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3Dvan%2Bder%2BKolk%26aufirst%3DN.%26aulast%3DVingtdeux%26aufirst%3DV.%26aulast%3Dvan%2Bde%2BSteeg%26aufirst%3DE.%26aulast%3DRet%26aufirst%3DG.%26aulast%3DCanton%26aufirst%3DT.%26aulast%3DDrobecq%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%26aulast%3DBonici%26aufirst%3DB.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DBenavides%26aufirst%3DJ.%26aulast%3DSchmitz%26aufirst%3DC.%26aulast%3DTremp%26aufirst%3DG.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DBenoit%26aufirst%3DP.%26aulast%3DPradier%26aufirst%3DL.%26atitle%3DMassive%2520CA1%252F2%2520neuronal%2520loss%2520with%2520intraneuronal%2520and%2520N-terminal%2520truncated%2520Abeta42%2520accumulation%2520in%2520a%2520novel%2520Alzheimer%2520transgenic%2520model%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D1289%26epage%3D300%26doi%3D10.1016%2FS0002-9440%2810%2963388-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38825</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-32&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0ljRev1ZNWOKHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D32%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiepour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouter, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkkoniemi-Ahola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody</span>. <i>Acta Neuropathol Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/2051-5960-1-56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F2051-5960-1-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24252153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c3mvFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=56&author=G.+Antoniosauthor=N.+Saiepourauthor=Y.+Bouterauthor=B.+C.+Richardauthor=A.+Paetauauthor=A.+Verkkoniemi-Aholaauthor=L.+Lannfeltauthor=M.+Ingelssonauthor=G.+G.+Kovacsauthor=T.+Pillotauthor=O.+Wirthsauthor=T.+A.+Bayer&title=N-truncated+Abeta+starting+with+position+four%3A+early+intraneuronal+accumulation+and+rescue+of+toxicity+using+NT4X-167%2C+a+novel+monoclonal+antibody&doi=10.1186%2F2051-5960-1-56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody</span></div><div class="casAuthors">Antonios Gregory; Saiepour Nasrin; Bouter Yvonne; Richard Bernhard C; Paetau Anders; Verkkoniemi-Ahola Auli; Lannfelt Lars; Ingelsson Martin; Kovacs Gabor G; Pillot Thierry; Wirths Oliver; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The amyloid hypothesis in Alzheimer disease (AD) considers amyloid β peptide (Aβ) deposition causative in triggering down-stream events like neurofibrillary tangles, cell loss, vascular damage and memory decline.  In the past years N-truncated Aβ peptides especially N-truncated pyroglutamate AβpE3-42 have been extensively studied.  Together with full-length Aβ1-42 and Aβ1-40, N-truncated AβpE3-42 and Aβ4-42 are major variants in AD brain.  Although Aβ4-42 has been known for a much longer time, there is a lack of studies addressing the question whether AβpE3-42 or Aβ4-42 may precede the other in Alzheimer's disease pathology.  RESULTS:  Using different Aβ antibodies specific for the different N-termini of N-truncated Aβ, we discovered that Aβ4-x preceded AβpE3-x intraneuronal accumulation in a transgenic mouse model for AD prior to plaque formation.  The novel Aβ4-x immunoreactive antibody NT4X-167 detected high molecular weight aggregates derived from N-truncated Aβ species.  While NT4X-167 significantly rescued Aβ4-42 toxicity in vitro no beneficial effect was observed against Aβ1-42 or AβpE3-42 toxicity.  Phenylalanine at position four of Aβ was imperative for antibody binding, because its replacement with alanine or proline completely prevented binding.  Although amyloid plaques were observed using NT4X-167 in 5XFAD transgenic mice, it barely reacted with plaques in the brain of sporadic AD patients and familial cases with the Arctic, Swedish and the presenilin-1 PS1Δ9 mutation.  A consistent staining was observed in blood vessels in all AD cases with cerebral amyloid angiopathy.  There was no cross-reactivity with other aggregates typical for other common neurodegenerative diseases showing that NT4X-167 staining is specific for AD.  CONCLUSIONS:  Aβ4-x precedes AβpE3-x in the well accepted 5XFAD AD mouse model underlining the significance of N-truncated species in AD pathology.  NT4X-167 therefore is the first antibody reacting with Aβ4-x and represents a novel tool in Alzheimer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrC1-S7O0maj69zv1FsJFMfW6udTcc2eZpKFAqtVp6QLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3mvFKgtw%253D%253D&md5=75219c438a3b1ee3422a7b75b1f45ed3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2F2051-5960-1-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-5960-1-56%26sid%3Dliteratum%253Aachs%26aulast%3DAntonios%26aufirst%3DG.%26aulast%3DSaiepour%26aufirst%3DN.%26aulast%3DBouter%26aufirst%3DY.%26aulast%3DRichard%26aufirst%3DB.%2BC.%26aulast%3DPaetau%26aufirst%3DA.%26aulast%3DVerkkoniemi-Ahola%26aufirst%3DA.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DKovacs%26aufirst%3DG.%2BG.%26aulast%3DPillot%26aufirst%3DT.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DN-truncated%2520Abeta%2520starting%2520with%2520position%2520four%253A%2520early%2520intraneuronal%2520accumulation%2520and%2520rescue%2520of%2520toxicity%2520using%2520NT4X-167%252C%2520a%2520novel%2520monoclonal%2520antibody%26jtitle%3DActa%2520Neuropathol%2520Commun.%26date%3D2013%26volume%3D1%26spage%3D56%26doi%3D10.1186%2F2051-5960-1-56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johanssen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta peptide Abeta3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">6134</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.655183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M115.655183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26697885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6134-45&author=A.+P.+Gunnauthor=B.+X.+Wongauthor=T.+Johanssenauthor=J.+C.+Griffithauthor=C.+L.+Mastersauthor=A.+I.+Bushauthor=K.+J.+Barnhamauthor=J.+A.+Duceauthor=R.+A.+Cherny&title=Amyloid-beta+peptide+Abeta3pE-42+induces+lipid+peroxidation%2C+membrane+permeabilization%2C+and+calcium+influx+in+neurons&doi=10.1074%2Fjbc.M115.655183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons</span></div><div class="casAuthors">Gunn, Adam P.; Wong, Bruce X.; Johanssen, Timothy; Griffith, James C.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6134-6145</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified amyloid-β (pE-Aβ) is a highly neurotoxic amyloid-β (Aβ) isoform and is enriched in the brains of individuals with Alzheimer disease compared with healthy aged controls.  Pyroglutamate formation increases the rate of Aβ oligomerization and alters the interactions of Aβ with Cu2+ and lipids; however, a link between these properties and the toxicity of pE-Aβ peptides has not been established.  We report here that Aβ3pE-42 has an enhanced capacity to cause lipid peroxidn. in primary cortical mouse neurons compared with the full-length isoform (Aβ(1-42)).  In contrast, Aβ(1-42) caused a significant elevation in cytosolic reactive oxygen species, whereas Aβ3pE-42 did not.  We also report that Aβ3pE-42 preferentially assocs. with neuronal membranes and triggers Ca2+ influx that can be partially blocked by the N-methyl-D-aspartate receptor antagonist MK-801.  Aβ3pE-42 further caused a loss of plasma membrane integrity and remained bound to neurons at significantly higher levels than Aβ(1-42) over extended incubations.  Pyroglutamate formation was addnl. found to increase the relative efficiency of Aβ-dityrosine oligomer formation mediated by copper-redox cycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrC0SqkhFqZrVg90H21EOLACvtfcHk0ljYNSavjrFWIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVShsLg%253D&md5=4a396499836d982384e8ca3d01e39212</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.655183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.655183%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DWong%26aufirst%3DB.%2BX.%26aulast%3DJohanssen%26aufirst%3DT.%26aulast%3DGriffith%26aufirst%3DJ.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DAmyloid-beta%2520peptide%2520Abeta3pE-42%2520induces%2520lipid%2520peroxidation%252C%2520membrane%2520permeabilization%252C%2520and%2520calcium%2520influx%2520in%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D6134%26epage%3D45%26doi%3D10.1074%2Fjbc.M115.655183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-60&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0ljYNSavjrFWIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D60%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canneva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-14-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F1471-2202-14-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24083638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FisFOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=108&author=A.+Beckerauthor=S.+Kohlmannauthor=A.+Alexandruauthor=W.+Jaglaauthor=F.+Cannevaauthor=C.+Bauscherauthor=H.+Cynisauthor=R.+Sedlmeierauthor=S.+Graubnerauthor=S.+Schillingauthor=H.+U.+Demuthauthor=S.+von+Horsten&title=Glutaminyl+cyclase-mediated+toxicity+of+pyroglutamate-beta+amyloid+induces+striatal+neurodegeneration&doi=10.1186%2F1471-2202-14-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration</span></div><div class="casAuthors">Becker Andreas; Kohlmann Stephanie; Alexandru Anca; Jagla Wolfgang; Canneva Fabio; Bauscher Christoph; Cynis Holger; Sedlmeier Reinhard; Graubner Sigrid; Schilling Stephan; Demuth Hans-Ulrich; von Horsten Stephan</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties.  One of these modifications is N-terminal pyroglutamate (pE) formation.  Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ.  Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic.  In addition, it accelerates aggregation of other Aβ species.  To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3-42) were generated and comprehensively characterized.  To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice.  RESULTS:  Expression of truncated Aβ(3-42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ.  This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation.  Neuropathology in ETNA mice was associated with behavioral alterations.  In particular, hyperactivity and impaired acoustic sensorimotor gating were detected.  Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss.  CONCLUSIONS:  ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ.  Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology.  The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAH7LIm5FQO9LIORRPd5lbfW6udTcc2eaa0ql1Kw4aK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FisFOnsw%253D%253D&md5=2d2b53b9af3975fbe5c43ce490f2559d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-14-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-14-108%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DCanneva%26aufirst%3DF.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase-mediated%2520toxicity%2520of%2520pyroglutamate-beta%2520amyloid%2520induces%2520striatal%2520neurodegeneration%26jtitle%3DBMC%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D108%26doi%3D10.1186%2F1471-2202-14-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Axmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman-Gunnarsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Abeta in plasma of patients with Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19781815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1379-87&author=A.+Marcelloauthor=O.+Wirthsauthor=T.+Schneider-Axmannauthor=M.+Degerman-Gunnarssonauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Reduced+levels+of+IgM+autoantibodies+against+N-truncated+pyroglutamate+Abeta+in+plasma+of+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease</span></div><div class="casAuthors">Marcello, Andrea; Wirths, Oliver; Schneider-Axmann, Thomas; Degerman-Gunnarsson, Malin; Lannfelt, Lars; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1379-1387</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In the present work, we investigated the level of IgM autoantibodies directed against different Aβ epitopes as potential diagnostic biomarker for Alzheimer's disease (AD).  Anti-Aβ autoantibody levels were measured in 75 plasma samples from patients with AD, individuals with mild cognitive impairment (MCI), and healthy age- and sex-matched controls (HC).  To validate the presence of anti-Aβ IgMs, pooled plasma samples were subjected to gel-filtration anal.  The mean level of pGluAβ-IgM (N-terminal truncated starting at position three with pyroglutamate) was significantly decreased in AD patients as compared to HC.  In the group of MCI patients there was a significant pos. correlation between pGluAβ-IgM and cognitive decline analyzed by MMSE (rho = 0.58, d.f. = 13, p = 0.022).  These observations indicate that the level of IgM autoantibodies against pGluAβ is a promising plasma biomarker for AD and correlates with the cognitive status of individuals at risk to develop AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphObmvQ1IrErVg90H21EOLACvtfcHk0lh3-N8NYN2WlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWhsLw%253D&md5=86e0d9d00a9ee4a8f637c6e6cdfe54e9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DMarcello%26aufirst%3DA.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchneider-Axmann%26aufirst%3DT.%26aulast%3DDegerman-Gunnarsson%26aufirst%3DM.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DReduced%2520levels%2520of%2520IgM%2520autoantibodies%2520against%2520N-truncated%2520pyroglutamate%2520Abeta%2520in%2520plasma%2520of%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D1379%26epage%3D87%26doi%3D10.1016%2Fj.neurobiolaging.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Kimpe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haastert, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoozemans, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, W.</span></span> <span> </span><span class="NLM_article-title">Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Abeta pathology at the lysosome</span>. <i>Age (Dordr)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1007/s11357-012-9403-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs11357-012-9403-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22477259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC38risVClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=673-87&author=L.+De%0AKimpeauthor=E.+S.+van+Haastertauthor=A.+Kaminariauthor=R.+Zwartauthor=H.+Rutjesauthor=J.+J.+Hoozemansauthor=W.+Scheper&title=Intracellular+accumulation+of+aggregated+pyroglutamate+amyloid+beta%3A+convergence+of+aging+and+Abeta+pathology+at+the+lysosome&doi=10.1007%2Fs11357-012-9403-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome</span></div><div class="casAuthors">De Kimpe Line; van Haastert Elise S; Kaminari Archontia; Zwart Rob; Rutjes Helma; Hoozemans Jeroen J M; Scheper Wiep</div><div class="citationInfo"><span class="NLM_cas:title">Age (Dordrecht, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Deposition of aggregated amyloid beta (Aβ) is a major hallmark of Alzheimer's disease (AD)-a common age-related neurodegenerative disorder.  Typically, Aβ is generated as a peptide of varying lengths.  However, a major fraction of Aβ peptides in the brains of AD patients has undergone posttranslational modifications, which often radically change the properties of the peptides.  Aβ3(pE)-42 is an N-truncated, pyroglutamate-modified variant that is abundantly present in AD brain and was suggested to play a role early in the pathogenesis.  Here we show that intracellular accumulation of oligomeric aggregates of Aβ3(pE)-42 results in loss of lysosomal integrity.  Using a novel antibody specific for aggregates of AβpE3, we show that in postmortem human brain tissue, aggregated AβpE3 is predominantly found in the lysosomes of both neurons and glial cells.  Our data further demonstrate that AβpE3 is relatively resistant to lysosomal degradation, which may explain its accumulation in the lysosomes.  The intracellular AβpE3 aggregates increase in an age-dependent manner.  The results presented in this study support a model where Aβ pathology and aging converge, leading to accumulation of the degradation-resistant pE-modified Aβ in the lysosomes, lysosomal dysfunction, and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRWm6uxvJOLUPI-fCgwosgfW6udTcc2ea_j5fO4svcerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38risVClsQ%253D%253D&md5=406886b2162c06a3de2a838ef80c285e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs11357-012-9403-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11357-012-9403-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DL.%26aulast%3Dvan%2BHaastert%26aufirst%3DE.%2BS.%26aulast%3DKaminari%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DR.%26aulast%3DRutjes%26aufirst%3DH.%26aulast%3DHoozemans%26aufirst%3DJ.%2BJ.%26aulast%3DScheper%26aufirst%3DW.%26atitle%3DIntracellular%2520accumulation%2520of%2520aggregated%2520pyroglutamate%2520amyloid%2520beta%253A%2520convergence%2520of%2520aging%2520and%2520Abeta%2520pathology%2520at%2520the%2520lysosome%26jtitle%3DAge%2520%2528Dordr%2529%26date%3D2013%26volume%3D35%26spage%3D673%26epage%3D87%26doi%3D10.1007%2Fs11357-012-9403-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsanut, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-5&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0lidZL2BKIS_yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D5%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhaya, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colloby, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamylated amyloid-beta is associated with hyperphosphorylated tau and severity of Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1296-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-014-1296-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24861310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2014&pages=67-79&author=M.+Mandlerauthor=L.+Walkerauthor=R.+Santicauthor=P.+Hansonauthor=A.+R.+Upadhayaauthor=S.+J.+Collobyauthor=C.+M.+Morrisauthor=D.+R.+Thalauthor=A.+J.+Thomasauthor=A.+Schneebergerauthor=J.+Attems&title=Pyroglutamylated+amyloid-beta+is+associated+with+hyperphosphorylated+tau+and+severity+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1296-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease</span></div><div class="casAuthors">Mandler, Markus; Walker, Lauren; Santic, Radmila; Hanson, Peter; Upadhaya, Ajeet Rijal; Colloby, Sean J.; Morris, Christopher M.; Thal, Dietmar R.; Thomas, Alan J.; Schneeberger, Achim; Attems, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-79</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Pyroglutamylated amyloid-β (pE(3)-Aβ) has been suggested to play a major role in Alzheimer's disease (AD) pathogenesis as amyloid-β (Aβ) oligomers contg. pE(3)-Aβ might initiate tau-dependent cytotoxicity.  We aimed to further elucidate the assocns. among pE(3)-Aβ, full-length Aβ and hyperphosphorylated tau (HP-τ) in human brain tissue.  We examd. 41 post mortem brains of both AD (n = 18) and controls.  Sections from frontal and entorhinal cortices were stained with pE(3)-Aβ, HP-τ and full-length Aβ antibodies.  The resp. loads were assessed using image anal. and western blot anal. was performed in a subset of cases.  All loads were significantly higher in AD, but when using Aβ loads as independent variables only frontal pE(3)-Aβ load predicted AD.  In frontal and entorhinal cortices pE(3)-Aβ load independently predicted HP-τ load while non-pE(3)-Aβ failed to do so.  All loads correlated with the severity of AD neuropathol.  However, partial correlation anal. revealed resp. correlations in the frontal cortex only for pE(3)-Aβ load only while in the entorhinal cortex resp. correlations were seen for both HP-τ and non-pE(3)-Aβ loads.  Mini Mental State Examn. scores were independently predicted by entorhinal HP-τ load and by frontal pE(3)-Aβ load.  Here, we report an assocn. between pE(3)-Aβ and HP-τ in human brain tissue and an influence of frontal pE(3)-Aβ on both the severity of AD neuropathol. and clin. dementia.  Our findings further support the notion that pE(3)-Aβ may represent an important link between Aβ and HP-τ, and investigations into its role as diagnostic and therapeutic target in AD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVA8GD8hapLVg90H21EOLACvtfcHk0lidZL2BKIS_yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVehtrg%253D&md5=917c2c678b84af1626e2cb3668fde987</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1296-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1296-9%26sid%3Dliteratum%253Aachs%26aulast%3DMandler%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%26aulast%3DSantic%26aufirst%3DR.%26aulast%3DHanson%26aufirst%3DP.%26aulast%3DUpadhaya%26aufirst%3DA.%2BR.%26aulast%3DColloby%26aufirst%3DS.%2BJ.%26aulast%3DMorris%26aufirst%3DC.%2BM.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DThomas%26aufirst%3DA.%2BJ.%26aulast%3DSchneeberger%26aufirst%3DA.%26aulast%3DAttems%26aufirst%3DJ.%26atitle%3DPyroglutamylated%2520amyloid-beta%2520is%2520associated%2520with%2520hyperphosphorylated%2520tau%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D128%26spage%3D67%26epage%3D79%26doi%3D10.1007%2Fs00401-014-1296-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span> <span> </span><span class="NLM_article-title">Prophylactic vaccine based on pyroglutamate-3 amyloid beta generates strong antibody response and rescues cognitive decline in Alzheimer’s disease model mice</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=454-459&author=G.+Liauthor=Z.+W.+Huauthor=P.+G.+Chenauthor=Z.+Y.+Sunauthor=Y.+X.+Chenauthor=Y.+F.+Zhaoauthor=Y.+M.+Li&title=Prophylactic+vaccine+based+on+pyroglutamate-3+amyloid+beta+generates+strong+antibody+response+and+rescues+cognitive+decline+in+Alzheimer%E2%80%99s+disease+model+mice&doi=10.1021%2Facschemneuro.6b00336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic vaccine based on pyroglutamate-3 amyloid β generates strong antibody response and rescues cognitive decline in Alzheimer's disease model mice</span></div><div class="casAuthors">Li, Gao; Hu, Zhi-Wen; Chen, Pu-Guang; Sun, Zhan-Yi; Chen, Yong-Xiang; Zhao, Yu-Fen; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clearance of amyloid β (Aβ) by immunotherapy is one of the fancy methods to treat Alzheimer's disease (AD).  However, the failure of some clin. trials suggested that there may be something ignored in the past development of immunotherapy.  Pyroglutamate-3 Aβ (AβpE3-X), which was found to be abundant in the patients' brain, has attracted much attention after the report that AβpE3-42 could serve as a template to exacerbate the aggregation of Aβ.  In addn., AβpE3-X could not be recognized by the antibodies targeting the N-terminus of Aβ, suggesting that AβpE3-X maybe the ignored one.  Indeed, passive immunization targeting AβpE3-X has shown some beneficial results, while active immunotherapy has not been extensively studied.  In the present study, we designed and synthesized a novel peptide vaccine targeting AβpE3-X, which contains AβpE3-15 as B cell epitope and P2 as T cell epitope.  We showed that this vaccine could induce strong antibody response to AβpE3-X.  We also showed that prophylactic immunization of AD model mice with our vaccine could reduce Aβ plaques and rescue cognitive decline.  This new kind of Aβ vaccine will open up new directions for AD immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZXohuDfFI7Vg90H21EOLACvtfcHk0lj3Jx1A97H4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSmurvK&md5=4939d98accb4a9080fe7f8fb22a7e218</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00336%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DP.%2BG.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BX.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DProphylactic%2520vaccine%2520based%2520on%2520pyroglutamate-3%2520amyloid%2520beta%2520generates%2520strong%2520antibody%2520response%2520and%2520rescues%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D454%26epage%3D459%26doi%3D10.1021%2Facschemneuro.6b00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crehan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemere, C. A.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy targeting pyroglutamate-3 Abeta: prospects and challenges</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/s13024-016-0115-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13024-016-0115-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=27363697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=48&author=H.+Cynisauthor=J.+L.+Frostauthor=H.+Crehanauthor=C.+A.+Lemere&title=Immunotherapy+targeting+pyroglutamate-3+Abeta%3A+prospects+and+challenges&doi=10.1186%2Fs13024-016-0115-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges</span></div><div class="casAuthors">Cynis, Holger; Frost, Jeffrey L.; Crehan, Helen; Lemere, Cynthia A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/11</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Immunization against amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) has shown considerable therapeutic effect in animal models however, the translation into human Alzheimer's patients is challenging.  In recent years, a no. of promising Aβ immunotherapy trials failed to reach primary study endpoints.  Aside from uncertainties in the selection of patients and the start and duration of treatment, these results also suggest that the mechanisms underlying AD are still not fully understood.  Thorough characterizations of protein aggregates in AD brain have revealed a conspicuous heterogeneity of Aβ peptides enabling the study of the toxic potential of each of the major forms.  One such form, amino-terminally truncated and modified pyroglutamate (pGlu)-3 Aβ peptide appears to play a seminal role for disease initiation, qualifying it as novel target for immunotherapy approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8P-lGVQnDbVg90H21EOLACvtfcHk0lj3Jx1A97H4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWltr3E&md5=70a2e8e30e1375163078899d6e0f228b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1186%2Fs13024-016-0115-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-016-0115-2%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DFrost%26aufirst%3DJ.%2BL.%26aulast%3DCrehan%26aufirst%3DH.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26atitle%3DImmunotherapy%2520targeting%2520pyroglutamate-3%2520Abeta%253A%2520prospects%2520and%2520challenges%26jtitle%3DMol.%2520Neurodegener.%26date%3D2016%26volume%3D11%26spage%3D48%26doi%3D10.1186%2Fs13024-016-0115-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acero, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoutcharian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilevko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munguia, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govezensky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luz-Madrigal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkian, G.</span></span> <span> </span><span class="NLM_article-title">Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2009.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jneuroim.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19545911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Whs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2009&pages=39-46&author=G.+Aceroauthor=K.+Manoutcharianauthor=V.+Vasilevkoauthor=M.+E.+Munguiaauthor=T.+Govezenskyauthor=G.+Coronasauthor=A.+Luz-Madrigalauthor=D.+H.+Cribbsauthor=G.+Gevorkian&title=Immunodominant+epitope+and+properties+of+pyroglutamate-modified+Abeta-specific+antibodies+produced+in+rabbits&doi=10.1016%2Fj.jneuroim.2009.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits</span></div><div class="casAuthors">Acero, G.; Manoutcharian, K.; Vasilevko, V.; Munguia, M. E.; Govezensky, T.; Coronas, G.; Luz-Madrigal, A.; Cribbs, D. H.; Gevorkian, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD.  Although the pathol. significance of these shortened forms Aβ is not completely understood, previous studies have demonstrated that these peptides are significantly more resistant to degrdn., aggregate more rapidly in vitro and exhibit similar or, in some cases, increased toxicity in hippocampal neuronal cultures compared to the full length peptides.  In the present study we further investigated the mechanisms of toxicity of one of the most abundant N-truncated/modified Aβ peptide bearing amino-terminal pyroglutamate at position 3 (AβN3(pE)).  We demonstrated that AβN3(pE) oligomers induce phosphatidyl serine externalization and membrane damage in SH-SY5Y cells.  Also, we produced AβN3(pE)-specific polyclonal antibodies in rabbit and identified an immunodominant epitope recognized by anti-AβN3(pE) antibodies.  Our results are important for developing new immunotherapeutic compds. specifically targeting AβN3(pE) aggregates since the most commonly used immunogens in the majority of vaccines for AD have been shown to induce antibodies that recognize the N-terminal immunodominant epitope (EFRH) of the full length Aβ, which is absent in N-amino truncated peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPGPTix89HrVg90H21EOLACvtfcHk0lj3Jx1A97H4hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Whs7g%253D&md5=0b9a1bee6ba2f766c253ef687ce54c18</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAcero%26aufirst%3DG.%26aulast%3DManoutcharian%26aufirst%3DK.%26aulast%3DVasilevko%26aufirst%3DV.%26aulast%3DMunguia%26aufirst%3DM.%2BE.%26aulast%3DGovezensky%26aufirst%3DT.%26aulast%3DCoronas%26aufirst%3DG.%26aulast%3DLuz-Madrigal%26aufirst%3DA.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DGevorkian%26aufirst%3DG.%26atitle%3DImmunodominant%2520epitope%2520and%2520properties%2520of%2520pyroglutamate-modified%2520Abeta-specific%2520antibodies%2520produced%2520in%2520rabbits%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2009%26volume%3D213%26spage%3D39%26epage%3D46%26doi%3D10.1016%2Fj.jneuroim.2009.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman-Gunnarsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitinga, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">41517</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.178707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20971852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wju7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=41517-24&author=O.+Wirthsauthor=C.+Erckauthor=H.+Martensauthor=A.+Harmeierauthor=C.+Geumannauthor=S.+Jawharauthor=S.+Kumarauthor=G.+Multhaupauthor=J.+Walterauthor=M.+Ingelssonauthor=M.+Degerman-Gunnarssonauthor=H.+Kalimoauthor=I.+Huitingaauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Identification+of+low+molecular+weight+pyroglutamate+A%7Bbeta%7D+oligomers+in+Alzheimer+disease%3A+a+novel+tool+for+therapy+and+diagnosis&doi=10.1074%2Fjbc.M110.178707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease: A Novel Tool for Therapy and Diagnosis</span></div><div class="casAuthors">Wirths, Oliver; Erck, Christian; Martens, Henrik; Harmeier, Anja; Geumann, Constanze; Jawhar, Sadim; Kumar, Sathish; Multhaup, Gerd; Walter, Jochen; Ingelsson, Martin; Degerman-Gunnarsson, Malin; Kalimo, Hannu; Huitinga, Inge; Lannfelt, Lars; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">41517-41524</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-terminally truncated Aβ peptides starting with pyroglutamate (AβpE3) represent a major fraction of all Aβ peptides in the brain of Alzheimer disease (AD) patients.  AβpE3 has a higher aggregation propensity and stability and shows increased toxicity compared with full-length Aβ.  In the present work, we generated a novel monoclonal antibody (9D5) that selectively recognizes oligomeric assemblies of AβpE3 and studied the potential involvement of oligomeric AβpE3 in vivo using transgenic mouse models as well as human brains from sporadic and familial AD cases.  9D5 showed an unusual staining pattern with almost nondetectable plaques in sporadic AD patients and non-demented controls.  Interestingly, in sporadic and familial AD cases prominent intraneuronal and blood vessel staining was obsd.  Using a novel sandwich ELISA significantly decreased levels of oligomers in plasma samples from patients with AD compared with healthy controls were identified.  Moreover, passive immunization of 5XFAD mice with 9D5 significantly reduced overall Aβ plaque load and AβpE3 levels, and normalized behavioral deficits.  These data indicate that 9D5 is a therapeutically and diagnostically effective monoclonal antibody targeting low mol. wt. AβpE3 oligomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru1picri8TbrVg90H21EOLACvtfcHk0lg-quBLhTCWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wju7nI&md5=60f258b115f9ef56f3592c641fdd2e9d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178707%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DErck%26aufirst%3DC.%26aulast%3DMartens%26aufirst%3DH.%26aulast%3DHarmeier%26aufirst%3DA.%26aulast%3DGeumann%26aufirst%3DC.%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DDegerman-Gunnarsson%26aufirst%3DM.%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DHuitinga%26aufirst%3DI.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520low%2520molecular%2520weight%2520pyroglutamate%2520A%257Bbeta%257D%2520oligomers%2520in%2520Alzheimer%2520disease%253A%2520a%2520novel%2520tool%2520for%2520therapy%2520and%2520diagnosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D41517%26epage%3D24%26doi%3D10.1074%2Fjbc.M110.178707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-Abeta: role in the natural history of Alzheimer’s disease</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2010.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.biocel.2010.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20833262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1915-8&author=A.+P.+Gunnauthor=C.+L.+Mastersauthor=R.+A.+Cherny&title=Pyroglutamate-Abeta%3A+role+in+the+natural+history+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2010.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease</span></div><div class="casAuthors">Gunn, Adam P.; Masters, Colin L.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The accumulation of amyloid-beta (Aβ) peptides is believed to be a central contributor to the neurodegeneration typically seen in Alzheimer's disease (AD) brain.  Aβ extd. from AD brains invariably possesses extensive truncations, yielding peptides of differing N- and C-terminal compn.  While Aβ is often abundant in the brains of cognitively normal elderly people, the brains of AD patients are highly enriched for N-terminally truncated Aβ bearing the pyroglutamate modification.  Pyroglutamate-Aβ (pE-Aβ) has a higher propensity for oligomerization and aggregation than full-length Aβ, potentially seeding the accumulation of neurotoxic Aβ oligomers and amyloid deposits.  In addn., pE-Aβ has increased resistance to clearance by peptidases, causing these peptides to persist in biol. fluids and tissues.  The extensive deposition of pE-Aβ in human AD brain is under-represented in many transgenic mouse models of AD, reflecting major differences in the prodn. and processing of Aβ peptides in these models compared to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorztlGScimnrVg90H21EOLACvtfcHk0lg-quBLhTCWLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO&md5=1139e1d56c89eed8e3ac3b08bd3b89ed</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DPyroglutamate-Abeta%253A%2520role%2520in%2520the%2520natural%2520history%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1915%26epage%3D8%26doi%3D10.1016%2Fj.biocel.2010.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucassen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esparza, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases</span>. <i>J. Neural Transm (Vienna)</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1007/s00702-009-0314-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00702-009-0314-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19823761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fjs12rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=85-96&author=O.+Wirthsauthor=T.+Bethgeauthor=A.+Marcelloauthor=A.+Harmeierauthor=S.+Jawharauthor=P.+J.+Lucassenauthor=G.+Multhaupauthor=D.+L.+Brodyauthor=T.+Esparzaauthor=M.+Ingelssonauthor=H.+Kalimoauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Pyroglutamate+Abeta+pathology+in+APP%2FPS1KI+mice%2C+sporadic+and+familial+Alzheimer%E2%80%99s+disease+cases&doi=10.1007%2Fs00702-009-0314-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases</span></div><div class="casAuthors">Wirths Oliver; Bethge Tobias; Marcello Andrea; Harmeier Anja; Jawhar Sadim; Lucassen Paul J; Multhaup Gerd; Brody David L; Esparza Thomas; Ingelsson Martin; Kalimo Hannu; Lannfelt Lars; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of Abeta(pE3) (N-terminal truncated Abeta starting with pyroglutamate) in Alzheimer's disease (AD) has received considerable attention since the discovery that this peptide represents a dominant fraction of Abeta peptides in senile plaques of AD brains.  This was later confirmed by other reports investigating AD and Down's syndrome postmortem brain tissue.  Importantly, Abeta(pE3) has a higher aggregation propensity, and stability, and shows an increased toxicity compared to full-length Abeta.  We have recently shown that intraneuronal accumulation of Abeta(pE3) peptides induces a severe neuron loss and an associated neurological phenotype in the TBA2 mouse model for AD.  Given the increasing interest in Abeta(pE3), we have generated two novel monoclonal antibodies which were characterized as highly specific for Abeta(pE3) peptides and herein used to analyze plaque deposition in APP/PS1KI mice, an AD model with severe neuron loss and learning deficits.  This was compared with the plaque pattern present in brain tissue from sporadic and familial AD cases.  Abundant plaques positive for Abeta(pE3) were present in patients with sporadic AD and familial AD including those carrying mutations in APP (arctic and Swedish) and PS1.  Interestingly, in APP/PS1KI mice we observed a continuous increase in Abeta(pE3) plaque load with increasing age, while the density for Abeta(1-x ) plaques declined with aging.  We therefore assume that, in particular, the peptides starting with position 1 of Abeta are N-truncated as disease progresses, and that, Abeta(pE3) positive plaques are resistant to age-dependent degradation likely due to their high stability and propensity to aggregate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjW5Q4fJpSSJp6t8nS6Nc3fW6udTcc2eZgj0YXkQg0jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fjs12rsA%253D%253D&md5=3ba8522b5584f2ec517d51607c939f4b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00702-009-0314-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-009-0314-x%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBethge%26aufirst%3DT.%26aulast%3DMarcello%26aufirst%3DA.%26aulast%3DHarmeier%26aufirst%3DA.%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DLucassen%26aufirst%3DP.%2BJ.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DBrody%26aufirst%3DD.%2BL.%26aulast%3DEsparza%26aufirst%3DT.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520Abeta%2520pathology%2520in%2520APP%252FPS1KI%2520mice%252C%2520sporadic%2520and%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520cases%26jtitle%3DJ.%2520Neural%2520Transm%2520%2528Vienna%2529%26date%3D2010%26volume%3D117%26spage%3D85%26epage%3D96%26doi%3D10.1007%2Fs00702-009-0314-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Oligomeric pyroglutamate amyloid-beta is present in microglia and a subfraction of vessels in patients with Alzheimer’s disease: implications for immunotherapy</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.3233/JAD-121945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-121945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23481684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=741-9&author=O.+Wirthsauthor=A.+Hillmannauthor=L.+Pradierauthor=W.+Hartigauthor=T.+A.+Bayer&title=Oligomeric+pyroglutamate+amyloid-beta+is+present+in+microglia+and+a+subfraction+of+vessels+in+patients+with+Alzheimer%E2%80%99s+disease%3A+implications+for+immunotherapy&doi=10.3233%2FJAD-121945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy</span></div><div class="casAuthors">Wirths Oliver; Hillmann Antje; Pradier Laurent; Hartig Wolfgang; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-terminally truncated pyroglutamate amyloid-β (Aβ) starting at position 3 (AβpE3) represents a major fraction of Aβ peptides in Alzheimer's disease (AD).  Recently, we have identified low molecular weight AβpE3 oligomers, which can be detected by 9D5, a novel mouse monoclonal antibody.  In the present study, we analyzed the immunohistochemical staining profile in the brain of patients with AD and in the APP/PS1KI mouse model, as well as in aged rhesus monkeys. 9D5-positive microglia and blood vessels were found in many AD cases, in the transgenic mouse model, and in an aged macaque.  The presence of 9D5-immunoreactivity in microglia indicates that low molecular weight AβpE3 oligomers may be phagocytosed, since in the APP/PS1KI model, Aβ is exclusively produced in neurons due to neuronal expression of transgenic AβPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSrGT8hETg2JZoeNcnHOQ9fW6udTcc2eZgj0YXkQg0jrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D&md5=944c79a17a2570d10b12d39fdf73c264</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3233%2FJAD-121945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121945%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DHillmann%26aufirst%3DA.%26aulast%3DPradier%26aufirst%3DL.%26aulast%3DHartig%26aufirst%3DW.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOligomeric%2520pyroglutamate%2520amyloid-beta%2520is%2520present%2520in%2520microglia%2520and%2520a%2520subfraction%2520of%2520vessels%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520immunotherapy%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D741%26epage%3D9%26doi%3D10.3233%2FJAD-121945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lg5RPBfCkHoHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluhm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofling, C.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical evidence from APP-transgenic mice for glutaminyl cyclase as drug target to diminish pE-Abeta formation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">924</span>, <span class="refDoi"> DOI: 10.3390/molecules23040924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3390%2Fmolecules23040924" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=924&author=M.+Hartlage-Rubsamenauthor=A.+Bluhmauthor=A.+Piechottaauthor=M.+Linnertauthor=J.+U.+Rahfeldauthor=H.+U.+Demuthauthor=I.+Luesauthor=P.+H.+Kuhnauthor=S.+F.+Lichtenthalerauthor=S.+Rossnerauthor=C.+Hofling&title=Immunohistochemical+evidence+from+APP-transgenic+mice+for+glutaminyl+cyclase+as+drug+target+to+diminish+pE-Abeta+formation&doi=10.3390%2Fmolecules23040924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23040924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23040924%26sid%3Dliteratum%253Aachs%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DBluhm%26aufirst%3DA.%26aulast%3DPiechotta%26aufirst%3DA.%26aulast%3DLinnert%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DHofling%26aufirst%3DC.%26atitle%3DImmunohistochemical%2520evidence%2520from%2520APP-transgenic%2520mice%2520for%2520glutaminyl%2520cyclase%2520as%2520drug%2520target%2520to%2520diminish%2520pE-Abeta%2520formation%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D924%26doi%3D10.3390%2Fmolecules23040924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funkelstein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toneff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hook, V.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-amyloid-beta and glutaminyl cyclase are colocalized with amyloid-beta in secretory vesicles and undergo activity-dependent, regulated secretion</span>. <i>Neurodegener. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1159/000358430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1159%2F000358430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24943989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVeisbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=85-97&author=H.+Cynisauthor=L.+Funkelsteinauthor=T.+Toneffauthor=C.+Mosierauthor=M.+Zieglerauthor=B.+Kochauthor=H.+U.+Demuthauthor=V.+Hook&title=Pyroglutamate-amyloid-beta+and+glutaminyl+cyclase+are+colocalized+with+amyloid-beta+in+secretory+vesicles+and+undergo+activity-dependent%2C+regulated+secretion&doi=10.1159%2F000358430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Amyloid-β and Glutaminyl Cyclase Are Colocalized with Amyloid-β in Secretory Vesicles and Undergo Activity-Dependent, Regulated Secretion</span></div><div class="casAuthors">Cynis, Holger; Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Ziegler, Michael; Koch, Birgit; Demuth, Hans-Ulrich; Hook, Vivian</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background and Aims: N-truncated pyroglutamate (pGlu)-amyloid-β [Aβ(3-40/42)] peptides are key components that promote Aβ peptide accumulation, leading to neurodegeneration and memory loss in Alzheimer's disease.  Because Aβ deposition in the brain occurs in an activity-dependent manner, it is important to define the subcellular organelle for pGlu-Aβ(3-40/42) prodn. by glutaminyl cyclase (QC) and their colocalization with full-length Aβ(1-40/42) peptides for activity-dependent, regulated secretion.  Therefore, the objective of this study was to investigate the hypothesis that pGlu-Aβ and QC are colocalized with Aβ in dense-core secretory vesicles (DCSV) for activity-dependent secretion with neurotransmitters.  Methods: Purified DCSV were assessed for pGlu-Aβ(3-40/42), Aβ(1-40/42), QC, and neurotransmitter secretion.  Neuron-like chromaffin cells were analyzed for cosecretion of pGlu-Aβ, QC, Aβ, and neuropeptides.  The cells were treated with a QC inhibitor, and pGlu-Aβ prodn. was measured.  Human neuroblastoma cells were also examd. for pGlu-Aβ and QC secretion.  Results: Isolated DCSV contain pGlu-Aβ(3-40/42), QC, and Aβ(1-40/42) with neuropeptide and catecholamine neurotransmitters.  Cellular pGlu-Aβ and QC undergo activity-dependent cosecretion with Aβ and enkephalin and galanin neurotransmitters.  The QC inhibitor decreased the level of secreted pGlu-Aβ.  The human neuroblastoma cells displayed regulated secretion of pGlu-Aβ that was colocalized with QC.  Conclusions: pGlu-Aβ and QC are present with Aβ in DCSV and undergo activity-dependent, regulated cosecretion with neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBgzRae5qNo7Vg90H21EOLACvtfcHk0ljObfMDt671ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVeisbfL&md5=f9e004a29d90cc16d8aac5ca75c981eb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1159%2F000358430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000358430%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DFunkelstein%26aufirst%3DL.%26aulast%3DToneff%26aufirst%3DT.%26aulast%3DMosier%26aufirst%3DC.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHook%26aufirst%3DV.%26atitle%3DPyroglutamate-amyloid-beta%2520and%2520glutaminyl%2520cyclase%2520are%2520colocalized%2520with%2520amyloid-beta%2520in%2520secretory%2520vesicles%2520and%2520undergo%2520activity-dependent%252C%2520regulated%2520secretion%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D85%26epage%3D97%26doi%3D10.1159%2F000358430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Hrsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-36&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Hrstenauthor=H.-U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0ljObfMDt671ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHrsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D36%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeer, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0685-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-010-0685-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20383514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=195-207&author=M.+Morawskiauthor=M.+Hartlage-Rubsamenauthor=C.+Jagerauthor=A.+Waniekauthor=S.+Schillingauthor=C.+Schwabauthor=P.+L.+McGeerauthor=T.+Arendtauthor=H.+U.+Demuthauthor=S.+Rossner&title=Distinct+glutaminyl+cyclase+expression+in+Edinger-Westphal+nucleus%2C+locus+coeruleus+and+nucleus+basalis+Meynert+contributes+to+pGlu-Abeta+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-010-0685-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer's disease</span></div><div class="casAuthors">Morawski, Markus; Hartlage-Ruebsamen, Maike; Jaeger, Carsten; Waniek, Alexander; Schilling, Stephan; Schwab, Claudia; McGeer, Patrick L.; Arendt, Thomas; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) was discovered recently as the enzyme catalyzing the pyroglutamate (pGlu or pE) modification of N-terminally truncated Alzheimer's disease (AD) Aβ peptides in vivo.  This modification confers resistance to proteolysis, rapid aggregation and neurotoxicity and can be prevented by QC inhibitors in vitro and in vivo, as shown in transgenic animal models.  However, in mouse brain QC is only expressed by a relatively low proportion of neurons in most neocortical and hippocampal subregions.  Here, we demonstrate that QC is highly abundant in subcortical brain nuclei severely affected in AD.  In particular, QC is expressed by virtually all urocortin-1-pos., but not by cholinergic neurons of the Edinger-Westphal nucleus, by noradrenergic locus coeruleus and by cholinergic nucleus basalis magnocellularis neurons in mouse brain.  In human brain, QC is expressed by both, urocortin-1 and cholinergic Edinger-Westphal neurons and by locus coeruleus and nucleus basalis Meynert neurons.  In brains from AD patients, these neuronal populations displayed intraneuronal pE-Aβ immunoreactivity and morphol. signs of degeneration as well as extracellular pE-Aβ deposits.  Adjacent AD brain structures lacking QC expression and brains from control subjects were devoid of such aggregates.  This is the first demonstration of QC expression and pE-Aβ formation in subcortical brain regions affected in AD.  Our results may explain the high vulnerability of defined subcortical neuronal populations and their central target areas in AD as a consequence of QC expression and pE-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0C-HGTvXnbVg90H21EOLACvtfcHk0lj9oO5EKSTyUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKnsb0%253D&md5=63307c6e13e3b0f367da4f35da4b020f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0685-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0685-y%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DSchwab%26aufirst%3DC.%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DDistinct%2520glutaminyl%2520cyclase%2520expression%2520in%2520Edinger-Westphal%2520nucleus%252C%2520locus%2520coeruleus%2520and%2520nucleus%2520basalis%2520Meynert%2520contributes%2520to%2520pGlu-Abeta%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D120%26spage%3D195%26epage%3D207%26doi%3D10.1007%2Fs00401-010-0685-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.3233/JAD-131535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-131535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0lj9COT1SUTsaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400%26doi%3D10.3233%2FJAD-131535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koel-Simmelink, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teunissen, C. E.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase activity correlates with levels of Abeta peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.1186/s13195-017-0266-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13195-017-0266-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVOmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=38&author=C.+Bridelauthor=T.+Hoffmannauthor=A.+Meyerauthor=S.+Durieuxauthor=M.+A.+Koel-Simmelinkauthor=M.+Orthauthor=P.+Scheltensauthor=I.+Luesauthor=C.+E.+Teunissen&title=Glutaminyl+cyclase+activity+correlates+with+levels+of+Abeta+peptides+and+mediators+of+angiogenesis+in+cerebrospinal+fluid+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1186%2Fs13195-017-0266-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients</span></div><div class="casAuthors">Bridel, Claire; Hoffmann, Torsten; Meyer, Antje; Durieux, Sisi; Koel-Simmelink, Marleen A.; Orth, Matthias; Scheltens, Philip; Lues, Inge; Teunissen, Charlotte E.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38/1-38/10</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Pyroglutamylation of truncated Aβ peptides, which is catalyzed by enzyme glutaminyl cyclase (QC), generates pE-Aβ species with enhanced aggregation propensities and resistance to most amino-peptidases and endo-peptidases.  PE-Aβ species have been identified as major constituents of Aβ plaques and redn. of pE-Aβ species is assocd. with improvement of cognitive tasks in animal models of Alzheimer's disease (AD).  Pharmacol. inhibition of QC has thus emerged as a promising therapeutic approach for AD.  Here, we question whether cerebrospinal fluid (CSF) QC enzymic activity differs between AD patients and controls and whether inflammatory or angiogenesis mediators, some of which are potential QC substrates, and/or Aβ peptides may serve as pharmacodynamic read-outs for QC inhibition.  QC activity, Aβ peptides and inflammatory or angiogenesis mediators were measured in CSF of a clin. well-characterized cohort of 20 mild AD patients, 20 moderate AD patients and 20 subjective memory complaints (SMC) controls.  Correlation of these parameters with core diagnostic CSF AD biomarkers (Aβ42, tau and p-tau) and clin. features was evaluated.  QC activity shows a tendency to decrease with AD progression (p = 0.129).  The addn. of QC activity to biomarkers tau and p-tau significantly increases diagnostic power (ROC-AUCTAU = 0.878, ROC-AUCTAU&QC = 0.939 and ROC-AUCpTAU = 0.820, ROC-AUCpTAU&QC = 0.948).  In AD and controls, QC activity correlates with Aβ38 (r = 0.83, p < 0.0001) and Aβ40 (r = 0.84, p < 0.0001), angiogenesis mediators (Flt1, Tie2, VEGFD, VCAM-1 and ICAM-1, r > 0.5, p < 0.0001) and core diagnostic biomarkers (r > 0.35, p = <0.0057).  QC activity does not correlate with MMSE or ApoE genotype.  Aβ38, Aβ40 and angiogenesis mediators (Flt1, Tie2, VEGFD, VCAM-1 and ICAM-1) are potential pharmacodynamic markers of QC inhibition, because their levels closely correlate with QC activity in AD patients.  The addn. of QC activity to core diagnostic CSF biomarkers may be of specific interest in clin. cases with discordant imaging and biochem. biomarker results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNvF7vzkCkWbVg90H21EOLACvtfcHk0lj9COT1SUTsaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVOmsLs%253D&md5=f330a6c4c5bed6b837fa92d269e181e1</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2Fs13195-017-0266-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-017-0266-6%26sid%3Dliteratum%253Aachs%26aulast%3DBridel%26aufirst%3DC.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DDurieux%26aufirst%3DS.%26aulast%3DKoel-Simmelink%26aufirst%3DM.%2BA.%26aulast%3DOrth%26aufirst%3DM.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DTeunissen%26aufirst%3DC.%2BE.%26atitle%3DGlutaminyl%2520cyclase%2520activity%2520correlates%2520with%2520levels%2520of%2520Abeta%2520peptides%2520and%2520mediators%2520of%2520angiogenesis%2520in%2520cerebrospinal%2520fluid%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2017%26volume%3D9%26spage%3D38%26doi%3D10.1186%2Fs13195-017-0266-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Kimpe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haastert, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoozemans, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, W.</span></span> <span> </span><span class="NLM_article-title">Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer’s disease in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e44674</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0044674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0044674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22970285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=L.+De%0AKimpeauthor=A.+Bennisauthor=R.+Zwartauthor=E.+S.+van+Haastertauthor=J.+J.+Hoozemansauthor=W.+Scheper&title=Disturbed+Ca2%2B+homeostasis+increases+glutaminyl+cyclase+expression%3B+connecting+two+early+pathogenic+events+in+Alzheimer%E2%80%99s+disease+in+vitro&doi=10.1371%2Fjournal.pone.0044674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro</span></div><div class="casAuthors">De Kimpe, Line; Bennis, Anna; Zwart, Rob; van Haastert, Elise S.; Hoozemans, Jeroen J. M.; Scheper, Wiep</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e44674</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A major neuropathol. hallmark of Alzheimer's disease (AD) is the deposition of aggregated β amyloid (Aβ) peptide in the senile plaques.  Aβ is a peptide of 38-43 amino acids and its accumulation and aggregation plays a key role early in the disease.  A large fraction of β amyloid is N-terminally truncated rendering a glutamine that can subsequently be cyclized into pyroglutamate (pE).  This makes the peptide more resistant to proteases, more prone to aggregation and increases its neurotoxicity.  The enzyme glutaminyl cyclase (QC) catalyzes this conversion of glutamine to pE.  In brains of AD patients, the expression of QC is increased in the earliest stages of pathol., which may be an important event in the pathogenesis.  In this study we aimed to investigate the regulatory mechanism underlying the upregulation of QC expression in AD.  Using differentiated SK-N-SH as a neuronal cell model, we found that neither the presence of Aβ peptides nor the unfolded protein response, two early events in AD, leads to increased QC levels.  In contrast, we demonstrated increased QC mRNA levels and enzyme activity in response to another pathogenic factor in AD, perturbed intracellular Ca2+ homeostasis.  The QC promoter contains a putative binding site for the Ca2+ dependent transcription factors c-fos and c-jun.  C-fos and c-jun are induced by the same Ca2+-related stimuli as QC and their upregulation precedes QC expression.  We show that in the human brain QC is predominantly expressed by neurons.  Interestingly, the Ca2+-dependent regulation of both c-fos and QC is not obsd. in non-neuronal cells.  Our results indicate that perturbed Ca2+ homeostasis results in upregulation of QC selectively in neuronal cells via Ca2+-dependent transcription factors.  This suggests that disruption of Ca2+ homeostasis may contribute to the formation of the neurotoxic pE Aβ peptides in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5j7sYAbAS7Vg90H21EOLACvtfcHk0lj9COT1SUTsaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGksrjI&md5=87f90269d2c55ab7693b19e945b13442</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044674%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DL.%26aulast%3DBennis%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DR.%26aulast%3Dvan%2BHaastert%26aufirst%3DE.%2BS.%26aulast%3DHoozemans%26aufirst%3DJ.%2BJ.%26aulast%3DScheper%26aufirst%3DW.%26atitle%3DDisturbed%2520Ca2%252B%2520homeostasis%2520increases%2520glutaminyl%2520cyclase%2520expression%253B%2520connecting%2520two%2520early%2520pathogenic%2520events%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0044674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. Q.</span></span> <span> </span><span class="NLM_article-title">Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1456</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1097/WNR.0b013e328332024a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1097%2FWNR.0b013e328332024a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19809370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1456-60&author=J.+T.+Yeauthor=R.+B.+Piauthor=X.+X.+Maoauthor=X.+H.+Chenauthor=J.+Qinauthor=S.+W.+Xuauthor=P.+Q.+Liu&title=Alterations+in+mRNA+expression+of+BACE1%2C+cathepsin+B%2C+and+glutaminyl+cyclase+in+mice+ischemic+brain&doi=10.1097%2FWNR.0b013e328332024a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain</span></div><div class="casAuthors">Ye, Jian-tao; Pi, Rong-biao; Mao, Xue-xuan; Chen, Xiao-hong; Qin, Jian; Xu, Suo-wen; Liu, Pei-qing</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1456-1460</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The relationship between cerebral ischemia and Alzheimer's disease has been evaluated extensively.  However, the assocn. between cerebral ischemia and the deposition of β-amyloid (Aβ) remains to be clarified.  Here, we used mice bilateral common carotid artery ligation model to investigate the alterations in mRNA expression of Aβ precursor protein cleavage enzyme 1(BACE1), cathepsin B, and glutaminyl cyclase after transient global cerebral ischemia.  The reverse-transcriptase PCR assay showed that the expressions of these three Aβ-metab.-related genes were upregulated in brain with different manner.  It indicates that all these three Aβ-metab.-related genes may participate in the acute and chronic Aβ generation after transient cerebral ischemia, and will be helpful to understand the mechanisms underlying the linkage of brain ischemia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQgZre7NsIbVg90H21EOLACvtfcHk0lh3Ve0LaJc7NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymsL7P&md5=be92b2291e5d9ea22d155a5cee9dbe47</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1097%2FWNR.0b013e328332024a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNR.0b013e328332024a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BT.%26aulast%3DPi%26aufirst%3DR.%2BB.%26aulast%3DMao%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DP.%2BQ.%26atitle%3DAlterations%2520in%2520mRNA%2520expression%2520of%2520BACE1%252C%2520cathepsin%2520B%252C%2520and%2520glutaminyl%2520cyclase%2520in%2520mice%2520ischemic%2520brain%26jtitle%3DNeuroReport%26date%3D2009%26volume%3D20%26spage%3D1456%26epage%3D60%26doi%3D10.1097%2FWNR.0b013e328332024a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanatta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innamorati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pampanin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanusso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbonare, L. D.</span></span> <span> </span><span class="NLM_article-title">Increased glutaminyl cyclase expression in peripheral blood of Alzheimer’s disease patients</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.3233/JAD-120517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-120517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23207485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=263-71&author=M.+T.+Valentiauthor=S.+Bologninauthor=C.+Zanattaauthor=L.+Donatelliauthor=G.+Innamoratiauthor=M.+Pampaninauthor=G.+Zanussoauthor=P.+Zattaauthor=L.+D.+Carbonare&title=Increased+glutaminyl+cyclase+expression+in+peripheral+blood+of+Alzheimer%E2%80%99s+disease+patients&doi=10.3233%2FJAD-120517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Glutaminyl Cyclase Expression in Peripheral Blood of Alzheimer's Disease Patients</span></div><div class="casAuthors">Valenti, Maria Teresa; Bolognin, Silvia; Zanatta, Cristina; Donatelli, Luca; Innamorati, Giulio; Pampanin, Maria; Zanusso, Gianluigi; Zatta, Paolo; Dalle Carbonare, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-271</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid-β (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) brain.  Among them, the most abundant N-truncated peptide starts with pyroglutamyl at residue 3 (AβpE3).  AβpE3 has increased aggregation potential and toxicity and its abundance has been reported to correlate with the severity of the clin. phenotype in AD patients.  N-terminal glutamate conversion generating AβpE3 is catalyzed by glutaminyl cyclase.  This enzyme was found to be upregulated in the cortex of patients with AD.  In the present study, we investigated glutaminyl cyclase mRNA and protein expression in peripheral blood from AD patients and age-matched controls.  Higher levels of glutaminyl cyclase mRNA and protein were present in AD patients compared with controls.  Interestingly, we obsd. a correlation between glutaminyl cyclase expression and the severity of dementia (value of Mini-Mental State Examn.).  Therefore, we propose glutaminyl cyclase dosage in peripheral blood as a potential biomarker of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4A4V35WXLrVg90H21EOLACvtfcHk0lh3Ve0LaJc7NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D&md5=3dbaabc4cc2a16e1b3589040578591c1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3233%2FJAD-120517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-120517%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DM.%2BT.%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DZanatta%26aufirst%3DC.%26aulast%3DDonatelli%26aufirst%3DL.%26aulast%3DInnamorati%26aufirst%3DG.%26aulast%3DPampanin%26aufirst%3DM.%26aulast%3DZanusso%26aufirst%3DG.%26aulast%3DZatta%26aufirst%3DP.%26aulast%3DCarbonare%26aufirst%3DL.%2BD.%26atitle%3DIncreased%2520glutaminyl%2520cyclase%2520expression%2520in%2520peripheral%2520blood%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D263%26epage%3D71%26doi%3D10.3233%2FJAD-120517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gontsarova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dressel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmuller, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunert-Keil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmeier, H.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2007.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.cca.2007.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18187042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=152-9&author=A.+Gontsarovaauthor=E.+Kaufmannauthor=H.+Tumaniauthor=A.+Dresselauthor=F.+Mandelauthor=K.+H.+Wiesmullerauthor=C.+Kunert-Keilauthor=H.+Brinkmeier&title=Glutaminyl+cyclase+activity+is+a+characteristic+feature+of+human+cerebrospinal+fluid&doi=10.1016%2Fj.cca.2007.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid</span></div><div class="casAuthors">Gontsarova, Anastassia; Kaufmann, Eckhard; Tumani, Hayrettin; Dressel, Alexander; Mandel, Friedrich; Wiesmueller, Karl-Heinz; Kunert-Keil, Christiane; Brinkmeier, Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">152-159</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Proteins and peptides occurring in human body fluids can be useful biol. markers for neurol. diseases and can even contribute to the pathogenesis of such diseases.  However, proteins and peptides are potential substrates of proteases and other enzymes.  Proteolysis and enzymic modification may lead to their degrdn. and modification.  Using mass spectrometry we investigated the degrdn. and modification of indicator peptides in the presence of cerebrospinal fluid (CSF).  We further applied a fluorometric assay to study the activity of the presumed enzyme glutaminyl cyclase.  In CSF we obsd. an aminopeptidase activity that could partially be inhibited by protease inhibitors and EDTA.  In addn., the formation of pyroglutamate (pGlu) from N-terminal glutamine (Gln) was regularly obsd.  The reaction to pGlu was rapid and protected the indicator peptides from further N-terminal degrdn.  The conversion of Gln to pGlu could be attributed to the activity of the enzyme glutaminyl cyclase (QC).  The QC activity was a characteristic feature of all 45 CSF samples collected from multiple sclerosis patients and controls.  Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.  The presence of QC in CSF can stabilize peptides from degrdn. by aminopeptidases.  This may have impact for neurol. disorders that are characterized by both, the presence of QC and the occurrence of appropriate peptide substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4sKaCoJ94bbVg90H21EOLACvtfcHk0lh3Ve0LaJc7NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyju74%253D&md5=c42851f4ac40788e0ef63d724a8f89b4</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2007.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2007.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DGontsarova%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DE.%26aulast%3DTumani%26aufirst%3DH.%26aulast%3DDressel%26aufirst%3DA.%26aulast%3DMandel%26aufirst%3DF.%26aulast%3DWiesmuller%26aufirst%3DK.%2BH.%26aulast%3DKunert-Keil%26aufirst%3DC.%26aulast%3DBrinkmeier%26aufirst%3DH.%26atitle%3DGlutaminyl%2520cyclase%2520activity%2520is%2520a%2520characteristic%2520feature%2520of%2520human%2520cerebrospinal%2520fluid%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D389%26spage%3D152%26epage%3D9%26doi%3D10.1016%2Fj.cca.2007.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agopyan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutekunst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LePiane, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosemond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">A YAC mouse model for Huntington’s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80764-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0896-6273%2800%2980764-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10402204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=181-92&author=J.+G.+Hodgsonauthor=N.+Agopyanauthor=C.+A.+Gutekunstauthor=B.+R.+Leavittauthor=F.+LePianeauthor=R.+Singarajaauthor=D.+J.+Smithauthor=N.+Bissadaauthor=K.+McCutcheonauthor=J.+Nasirauthor=L.+Jamotauthor=X.+J.+Liauthor=M.+E.+Stevensauthor=E.+Rosemondauthor=J.+C.+Roderauthor=A.+G.+Phillipsauthor=E.+M.+Rubinauthor=S.+M.+Herschauthor=M.+R.+Hayden&title=A+YAC+mouse+model+for+Huntington%E2%80%99s+disease+with+full-length+mutant+huntingtin%2C+cytoplasmic+toxicity%2C+and+selective+striatal+neurodegeneration&doi=10.1016%2FS0896-6273%2800%2980764-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A YAC mouse model for Huntington's disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration</span></div><div class="casAuthors">Hodgson, J. Graeme; Agopyan, Nadia; Gutekunst, Claire-Anne; Leavitt, Blair R.; LePiane, Fred; Singaraja, Roshni; Smith, Desmond J.; Bissada, Nagat; McCutcheon, Krista; Nasir, Jamal; Jamot, Laure; Li, Xiao-Jiang; Stevens, Mary E.; Rosemond, Erica; Roder, John C.; Phillips, Anthony G.; Rubin, Edward M.; Hersch, Steven M.; Hayden, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have produced yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant (YAC46 and YAC72) huntingtin (htt) in a developmental and tissue-specific manner identical to that obsd. in Huntington's disease (HD).  YAC46 and YAC72 mice show early electrophysiol. abnormalities, indicating cytoplasmic dysfunction prior to obsd. nuclear inclusions or neurodegeneration.  By 12 mo of age, YAC72 mice have a selective degeneration of medium spiny neurons in the lateral striatum assocd. with the translocation of N-terminal htt fragments to the nucleus.  Neurodegeneration can be present in the absence of macro- or microaggregates, clearly showing that aggregates are not essential to initiation of neuronal death.  These mice demonstrate that initial neuronal cytoplasmic toxicity is followed by cleavage of htt, nuclear translocation of htt N-terminal fragments, and selective neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp622XRIsJp3LVg90H21EOLACvtfcHk0ljET5fnL1W29g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVSjurw%253D&md5=b46803cd9543251d6581473599d9097b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980764-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980764-3%26sid%3Dliteratum%253Aachs%26aulast%3DHodgson%26aufirst%3DJ.%2BG.%26aulast%3DAgopyan%26aufirst%3DN.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DLePiane%26aufirst%3DF.%26aulast%3DSingaraja%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%2BJ.%26aulast%3DBissada%26aufirst%3DN.%26aulast%3DMcCutcheon%26aufirst%3DK.%26aulast%3DNasir%26aufirst%3DJ.%26aulast%3DJamot%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BJ.%26aulast%3DStevens%26aufirst%3DM.%2BE.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DRoder%26aufirst%3DJ.%2BC.%26aulast%3DPhillips%26aufirst%3DA.%2BG.%26aulast%3DRubin%26aufirst%3DE.%2BM.%26aulast%3DHersch%26aufirst%3DS.%2BM.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DA%2520YAC%2520mouse%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%2520with%2520full-length%2520mutant%2520huntingtin%252C%2520cytoplasmic%2520toxicity%252C%2520and%2520selective%2520striatal%2520neurodegeneration%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D181%26epage%3D92%26doi%3D10.1016%2FS0896-6273%2800%2980764-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuccato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, E.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms and potential therapeutical targets in Huntington’s disease</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1152/physrev.00041.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1152%2Fphysrev.00041.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20664076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyku7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=905-81&author=C.+Zuccatoauthor=M.+Valenzaauthor=E.+Cattaneo&title=Molecular+mechanisms+and+potential+therapeutical+targets+in+Huntington%E2%80%99s+disease&doi=10.1152%2Fphysrev.00041.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and potential therapeutical targets in Huntington's disease</span></div><div class="casAuthors">Zuccato, Chiara; Valenza, Marta; Cattaneo, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">905-981</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the gene encoding for huntingtin protein.  A lot has been learned about this disease since its first description in 1872 and the identification of its causative gene and mutation in 1993.  We now know that the disease is characterized by several mol. and cellular abnormalities whose precise timing and relative roles in pathogenesis have yet to be understood.  HD is triggered by the mutant protein, and both gain-of-function (of the mutant protein) and loss-of-function (of the normal protein) mechanisms are involved.  Here we review the data that describe the emergence of the ancient huntingtin gene and of the polyglutamine trait during the last 800 million years of evolution.  We focus on the known functions of wild-type huntingtin that are fundamental for the survival and functioning of the brain neurons that predominantly degenerate in HD.  We summarize data indicating how the loss of these beneficial activities reduces the ability of these neurons to survive.  We also review the different mechanisms by which the mutation in huntingtin causes toxicity.  This may arise both from cell-autonomous processes and dysfunction of neuronal circuitries.  We then focus on novel therapeutical targets and pathways and on the attractive option to counteract HD at its primary source, i.e., by blocking the prodn. of the mutant protein.  Strategies and technologies used to screen for candidate HD biomarkers and their potential application are presented.  Furthermore, we discuss the opportunities offered by intracerebral cell transplantation and the likely need for these multiple routes into therapies to converge at some point as, ideally, one would wish to stop the disease process and, at the same time, possibly replace the damaged neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIVf2Q0bRrHrVg90H21EOLACvtfcHk0ljET5fnL1W29g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyku7rN&md5=91ce71cab5ce8c79a4877629e9441e4a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00041.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00041.2009%26sid%3Dliteratum%253Aachs%26aulast%3DZuccato%26aufirst%3DC.%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DMolecular%2520mechanisms%2520and%2520potential%2520therapeutical%2520targets%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D905%26epage%3D81%26doi%3D10.1152%2Fphysrev.00041.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnichsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imarisio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarditi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ed Dami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Couto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamanti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satagopam, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Kane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">siRNA screen identifies QPCT as a druggable target for Huntington’s disease</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnchembio.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25848931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=347-354&author=M.+Jimenez-Sanchezauthor=W.+Lamauthor=M.+Hannusauthor=B.+Sonnichsenauthor=S.+Imarisioauthor=A.+Flemingauthor=A.+Tarditiauthor=F.+Menziesauthor=T.+Ed+Damiauthor=C.+Xuauthor=E.+Gonzalez-Coutoauthor=G.+Lazzeroniauthor=F.+Heitzauthor=D.+Diamantiauthor=L.+Massaiauthor=V.+P.+Satagopamauthor=G.+Marconiauthor=C.+Caramelliauthor=A.+Nenciniauthor=M.+Andreiniauthor=G.+L.+Sardoneauthor=N.+P.+Caradonnaauthor=V.+Porcariauthor=C.+Scaliauthor=R.+Schneiderauthor=G.+Pollioauthor=C.+J.+O%E2%80%99Kaneauthor=A.+Caricasoleauthor=D.+C.+Rubinsztein&title=siRNA+screen+identifies+QPCT+as+a+druggable+target+for+Huntington%E2%80%99s+disease&doi=10.1038%2Fnchembio.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA screen identifies QPCT as a druggable target for Huntington's disease</span></div><div class="casAuthors">Jimenez-Sanchez, Maria; Lam, Wun; Hannus, Michael; Sonnichsen, Birte; Imarisio, Sara; Fleming, Angeleen; Tarditi, Alessia; Menzies, Fiona; Ed Dami, Teresa; Xu, Catherine; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Satagopam, Venkata P.; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Schneider, Reinhard; Pollio, Giuseppe; O'Kane, Cahir J.; Caricasole, Andrea; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT).  We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed by hit validation in Drosophila.  We focused on glutaminyl cyclase (QPCT), which had one of the strongest effects on mutant HTT-induced toxicity and aggregation in the cell-based siRNA screen and also rescued these phenotypes in Drosophila.  We found that QPCT inhibition induced the levels of the mol. chaperone αB-crystallin and reduced the aggregation of diverse proteins.  We generated new QPCT inhibitors using in silico methods followed by in vitro screening, which rescued the HD-related phenotypes in cell, Drosophila and zebrafish HD models.  Our data reveal a new HD druggable target affecting mutant HTT aggregation and provide proof of principle for a discovery pipeline from druggable genome screen to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5Pncahjf0LVg90H21EOLACvtfcHk0lirVnzjZ-HKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D&md5=1566a7af4210e871931ed7bbae6ba42a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1790%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Sanchez%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DSonnichsen%26aufirst%3DB.%26aulast%3DImarisio%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DTarditi%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%26aulast%3DEd%2BDami%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGonzalez-Couto%26aufirst%3DE.%26aulast%3DLazzeroni%26aufirst%3DG.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DDiamanti%26aufirst%3DD.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DSatagopam%26aufirst%3DV.%2BP.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DC.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DSardone%26aufirst%3DG.%2BL.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DPorcari%26aufirst%3DV.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPollio%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DC.%2BJ.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DsiRNA%2520screen%2520identifies%2520QPCT%2520as%2520a%2520druggable%2520target%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D347%26epage%3D354%26doi%3D10.1038%2Fnchembio.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span> <span> </span><span class="NLM_article-title">Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63993-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0002-9440%2810%2963993-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=11159188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=515-26&author=J.+L.+Holtonauthor=J.+Ghisoauthor=T.+Lashleyauthor=A.+Rostagnoauthor=C.+J.+Guerinauthor=G.+Gibbauthor=H.+Houldenauthor=H.+Aylingauthor=L.+Martinianauthor=B.+H.+Andertonauthor=N.+W.+Woodauthor=R.+Vidalauthor=G.+Plantauthor=B.+Frangioneauthor=T.+Revesz&title=Regional+distribution+of+amyloid-Bri+deposition+and+its+association+with+neurofibrillary+degeneration+in+familial+British+dementia&doi=10.1016%2FS0002-9440%2810%2963993-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia</span></div><div class="casAuthors">Holton, Janice L.; Ghiso, Jorge; Lashley, Tammaryn; Rostagno, Agueda; Guerin, Christopher J.; Gibb, Graham; Houlden, Henry; Ayling, Hilary; Martinian, Lillian; Anderton, Brian H.; Wood, Nicholas W.; Vidal, Ruben; Plant, Gordon; Frangione, Blas; Revesz, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Familial British dementia (FBD), pathol. characterized by cerebral amyloid angiopathy (CAA), amyloid plaques, and neurofibrillary degeneration, is assocd. with a stop codon mutation in the BRI gene resulting in the prodn. of an amyloidogenic fragment, amyloid-Bri (ABri).  The aim of this study was to assess the distribution of ABri fibrillar and nonfibrillar lesions and their relation to neurofibrillary pathol., astroglial and microglial response using immunohistochem., confocal microscopy, and immunoelectron microscopy in five cases of FBD.  Abnormal tau was studied with immunoblotting.  The authors present evidence that ABri is deposited throughout the central nervous system in blood vessels and parenchyma where both amyloid (fibrillar) and preamyloid (nonfibrillar) lesions are formed.  Ultrastructurally amyloid lesions appear as bundles of fibrils recognized by an antibody raised against ABri, whereas Thioflavin S-neg. diffuse deposits consist of amorphous electron-dense material with sparse, dispersed fibrils.  In contrast to nonfibrillar lesions, fibrillar ABri is assocd. with a marked astrocytic and microglial response.  Neurofibrillary tangles and neuropil threads occurring mainly in limbic structures, are found in areas affected by all types of ABri lesions whereas abnormal neurites are present around amyloid lesions.  Immunoblotting for tau revealed a triplet electrophoretic migration pattern.  The authors' observations confirm a close link between Abri deposition and neurodegeneration in FBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Uc6ChjDtFbVg90H21EOLACvtfcHk0lirVnzjZ-HKgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFWmt7o%253D&md5=5fc204aace9a06bcd00a36c7d86a997f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963993-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963993-4%26sid%3Dliteratum%253Aachs%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGuerin%26aufirst%3DC.%2BJ.%26aulast%3DGibb%26aufirst%3DG.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DAyling%26aufirst%3DH.%26aulast%3DMartinian%26aufirst%3DL.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DVidal%26aufirst%3DR.%26aulast%3DPlant%26aufirst%3DG.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DRegional%2520distribution%2520of%2520amyloid-Bri%2520deposition%2520and%2520its%2520association%2520with%2520neurofibrillary%2520degeneration%2520in%2520familial%2520British%2520dementia%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D158%26spage%3D515%26epage%3D26%26doi%3D10.1016%2FS0002-9440%2810%2963993-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coomaraswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2012.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23261769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWhtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1416-25&author=A.+Saulauthor=T.+Lashleyauthor=T.+Reveszauthor=J.+Holtonauthor=J.+A.+Ghisoauthor=J.+Coomaraswamyauthor=O.+Wirths&title=Abundant+pyroglutamate-modified+ABri+and+ADan+peptides+in+extracellular+and+vascular+amyloid+deposits+in+familial+British+and+Danish+dementias&doi=10.1016%2Fj.neurobiolaging.2012.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias</span></div><div class="casAuthors">Saul, Anika; Lashley, Tammaryn; Revesz, Tamas; Holton, Janice; Ghiso, Jorge A.; Coomaraswamy, Janaky; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1416-1425</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Familial British and familial Danish dementia (FDD) are progressive neurodegenerative disorders characterized by cerebral deposition of the amyloidogenic peptides ABri and ADan, resp.  These amyloid peptides start with an N-terminal glutamate residue, which can be posttranslationally converted into a pyroglutamate (pGlu) modified form, a mechanism which has been extensively described to be relevant for amyloid-beta (Aβ) peptides in Alzheimer's disease.  Like pGlu-Aβ peptides, pGlu-ABri peptides have an increased aggregation propensity and show higher toxicity on human neuroblastoma cells as their nonmodified counterparts.  We have generated novel N-terminal specific antibodies detecting the pGlu-modified forms of ABri and ADan peptides.  With these antibodies we were able to identify abundant extracellular amyloid plaques, vascular, and parenchymal deposits in human familial British dementia and FDD brain tissue, and in a mouse model for FDD.  Double-stainings using C-terminal specific antibodies in human samples revealed that highly aggregated pGlu-ABri and pGlu-ADan peptides are mainly present in plaque cores and central vascular deposits, leading to the assumption that these peptides have seeding properties.  Furthermore, in an FDD-mouse model ADan peptides were detected in presynaptic terminals of the hippocampus where they might contribute to impaired synaptic transmission.  These similarities of ABri and ADan to Aβ in Alzheimer's disease suggest that the posttranslational pGlu-modification of amyloid peptides might represent a general pathol. mechanism leading to increased aggregation and toxicity in these forms of degenerative dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowwpcn4AtF5LVg90H21EOLACvtfcHk0lgE8SBzlSijrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWhtL3F&md5=85dbf0acfc50170d4af3f1918aeef051</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DHolton%26aufirst%3DJ.%26aulast%3DGhiso%26aufirst%3DJ.%2BA.%26aulast%3DCoomaraswamy%26aufirst%3DJ.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DAbundant%2520pyroglutamate-modified%2520ABri%2520and%2520ADan%2520peptides%2520in%2520extracellular%2520and%2520vascular%2520amyloid%2520deposits%2520in%2520familial%2520British%2520and%2520Danish%2520dementias%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1416%26epage%3D25%26doi%3D10.1016%2Fj.neurobiolaging.2012.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomidokoro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation at the N-termini of Abri molecules in Familial British Dementia is not restricted to the central nervous system</span>. <i>Hirosaki Igaku</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">S262</span>– <span class="NLM_lpage">S269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21037969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2nt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=S262-S269&author=Y.+Tomidokoroauthor=A.+Tamaokaauthor=J.+L.+Holtonauthor=T.+Lashleyauthor=B.+Frangioneauthor=T.+Reveszauthor=A.+Rostagnoauthor=J.+Ghiso&title=Pyroglutamate+formation+at+the+N-termini+of+Abri+molecules+in+Familial+British+Dementia+is+not+restricted+to+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate formation at the N-termini of Abri molecules in familial British dementia is not restricted to the central nervous system</span></div><div class="casAuthors">Tomidokoro, Yasushi; Tamaoka, Akira; Holton, Janice L.; Lashley, Tammaryn; Frangione, Blas; Revesz, Tamas; Rostagno, Agueda; Ghiso, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Hirosaki Igaku</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Supplement</span>),
    <span class="NLM_cas:pages">S262-S269</span>CODEN:
                <span class="NLM_cas:coden">HIRIA6</span>;
        ISSN:<span class="NLM_cas:issn">0439-1721</span>.
    
            (<span class="NLM_cas:orgname">Hirosaki Daigaku Shuppankai</span>)
        </div><div class="casAbstract">Amyloid mols. harboring pyroglutamate (pGlu) residue at the N-termini are considered to be important for the development of cerebral amyloidosis such as Alzheimer's disease and thought to be either spontaneously generated or being catalyzed by glutaminyl cyclase.  Familial British dementia (FBD) is an autosomal dominant form of dementia neuropathol. characterized by parenchymal amyloid and preamyloid deposits, extensive cerebral amyloid angiopathy, and neurofibrillary tangles.  FBD is caused by a stop to Arg mutation in the BRI2 gene, generating de novo created amyloid mol. ABri which accumulates in FBD brains but is not present in the normal population.  Sol. ABri mols. present in the circulation of carriers of the BRI2 mutation are 34 amino acids long exclusively harboring Glu residue at the N-termini (ABri1-34E), whereas water- and formic acid-sol. ABri mols. extd. from FBD brains have abundant ABri species bearing pGlu residue (ABri1-34pE), suggesting that pyroglutamate formation occurs at the site of deposition.  In order to further clarify the mechanism (s) of ABri deposition, we studied whether pyroglutamate formation indeed occurs outside the central nervous system taking advantage that FBD is also a systemic amyloidosis.  Sol. and fibrillar ABri mols. extd. from systemic organs and analyzed biochem. using a combination of immunopptn., mass spectrometry, and western blot anal. were oligomeric in size and contained a large proportion of ABri1-34pE.  The data indicate that pyroglutamate formation at the N-termini of ABri mols. is an early step in the process of FBD amyloid deposition, and its formation is not restricted to the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovfx0TSR1d0bVg90H21EOLACvtfcHk0lgE8SBzlSijrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2nt7jI&md5=fd8742ef59fc8c6fb3f2bb8ac2857dd4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomidokoro%26aufirst%3DY.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26atitle%3DPyroglutamate%2520formation%2520at%2520the%2520N-termini%2520of%2520Abri%2520molecules%2520in%2520Familial%2520British%2520Dementia%2520is%2520not%2520restricted%2520to%2520the%2520central%2520nervous%2520system%26jtitle%3DHirosaki%2520Igaku%26date%3D2010%26volume%3D61%26spage%3DS262%26epage%3DS269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojsen-Moller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braendgaard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span> <span> </span><span class="NLM_article-title">A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4920</span>– <span class="NLM_lpage">4925</span>, <span class="refDoi"> DOI: 10.1073/pnas.080076097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.080076097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10781099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4920-4925&author=R.+Vidalauthor=T.+Reveszauthor=A.+Rostagnoauthor=E.+Kimauthor=J.+L.+Holtonauthor=T.+Bekauthor=M.+Bojsen-Mollerauthor=H.+Braendgaardauthor=G.+Plantauthor=J.+Ghisoauthor=B.+Frangione&title=A+decamer+duplication+in+the+3%E2%80%B2+region+of+the+BRI+gene+originates+an+amyloid+peptide+that+is+associated+with+dementia+in+a+Danish+kindred&doi=10.1073%2Fpnas.080076097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred</span></div><div class="casAuthors">Vidal, Ruben; Revesz, Tamas; Rostagno, Agueda; Kim, Eugene; Holton, Janice L.; Bek, Toke; Bojsen-Moller, Marie; Braendgaard, Hans; Plant, Gordon; Ghiso, Jorge; Frangione, Blas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4920-4925</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Familial Danish dementia (FDD), also known as heredopathia ophthalmo-oto-encephalica, is an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia.  Neuropathol. findings include severe widespread cerebral amyloid angiopathy, hippocampal plaques, and neurofibrillary tangles, similar to Alzheimer's disease.  N-terminal sequence anal. of isolated leptomeningeal amyloid fibrils revealed homol. to ABri, the peptide originated by a point mutation at the stop codon of gene BRI in familial British dementia.  Mol. genetic anal. of the BRI gene in the Danish kindred showed a different defect, namely the presence of a 10-nt duplication (795-796insTTTAATTTGT) between codons 265 and 266, one codon before the normal stop codon 267.  The decamer duplication mutation produces a frame-shift in the BRI sequence generating a larger-than-normal precursor protein, of which the amyloid subunit (designated ADan) comprises the last 34 C-terminal amino acids.  This de novo-created amyloidogenic peptide, assocd. with a genetic defect in the Danish kindred, stresses the importance of amyloid formation as a causative factor in neurodegeneration and dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9RGX9PDH5LVg90H21EOLACvtfcHk0lgE8SBzlSijrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFKisr8%253D&md5=864d3b966321d563365d2b57b1c2c955</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1073%2Fpnas.080076097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.080076097%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DR.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DBek%26aufirst%3DT.%26aulast%3DBojsen-Moller%26aufirst%3DM.%26aulast%3DBraendgaard%26aufirst%3DH.%26aulast%3DPlant%26aufirst%3DG.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DFrangione%26aufirst%3DB.%26atitle%3DA%2520decamer%2520duplication%2520in%2520the%25203%25E2%2580%25B2%2520region%2520of%2520the%2520BRI%2520gene%2520originates%2520an%2520amyloid%2520peptide%2520that%2520is%2520associated%2520with%2520dementia%2520in%2520a%2520Danish%2520kindred%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4920%26epage%3D4925%26doi%3D10.1073%2Fpnas.080076097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quax, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trautwein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1002/emmm.201100158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Femmm.201100158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21774078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=545-58&author=H.+Cynisauthor=T.+Hoffmannauthor=D.+Friedrichauthor=A.+Kehlenauthor=K.+Gansauthor=M.+Kleinschmidtauthor=J.+U.+Rahfeldauthor=R.+Wolfauthor=M.+Wermannauthor=A.+Stephanauthor=M.+Haegeleauthor=R.+Sedlmeierauthor=S.+Graubnerauthor=W.+Jaglaauthor=A.+Mullerauthor=R.+Eichentopfauthor=U.+Heiserauthor=F.+Seifertauthor=P.+H.+Quaxauthor=M.+R.+de+Vriesauthor=I.+Hesseauthor=D.+Trautweinauthor=U.+Wollertauthor=S.+Bergauthor=E.+J.+Freyseauthor=S.+Schillingauthor=H.+U.+Demuth&title=The+isoenzyme+of+glutaminyl+cyclase+is+an+important+regulator+of+monocyte+infiltration+under+inflammatory+conditions&doi=10.1002%2Femmm.201100158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions</span></div><div class="casAuthors">Cynis, Holger; Hoffmann, Torsten; Friedrich, Daniel; Kehlen, Astrid; Gans, Kathrin; Kleinschmidt, Martin; Rahfeld, Jens-Ulrich; Wolf, Raik; Wermann, Michael; Stephan, Anett; Haegele, Monique; Sedlmeier, Reinhard; Graubner, Sigrid; Jagla, Wolfgang; Mueller, Anke; Eichentopf, Rico; Heiser, Ulrich; Seifert, Franziska; Quax, Paul H. A.; de Vries, Margreet R.; Hesse, Isabel; Trautwein, Daniela; Wollert, Ulrich; Berg, Sabine; Freyse, Ernst-Joachim; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acute and chronic inflammatory disorders are characterized by detrimental cytokine and chemokine expression.  Frequently, the chemotactic activity of cytokines depends on a modified N-terminus of the polypeptide.  Among those, the N-terminus of monocyte chemoattractant protein 1 (CCL2 and MCP-1) is modified to a pyroglutamate (pE-) residue protecting against degrdn. in vivo.  Here, we show that the N-terminal pE-formation depends on glutaminyl cyclase activity.  The pE-residue increases stability against N-terminal degrdn. by aminopeptidases and improves receptor activation and signal transduction in vitro.  Genetic ablation of the glutaminyl cyclase iso-enzymes QC (QPCT) or isoQC (QPCTL) revealed a major role of isoQC for pE1-CCL2 formation and monocyte infiltration.  Consistently, administration of QC-inhibitors in inflammatory models, such as thioglycollate-induced peritonitis reduced monocyte infiltration.  The pharmacol. efficacy of QC/isoQC-inhibition was assessed in accelerated atherosclerosis in ApoE3*Leiden mice, showing attenuated atherosclerotic pathol. following chronic oral treatment.  Current strategies targeting CCL2 are mainly based on antibodies or spiegelmers.  The application of small, orally available inhibitors of glutaminyl cyclases represents an alternative therapeutic strategy to treat CCL2-driven disorders such as atherosclerosis/restenosis and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-5dgkTUSzbVg90H21EOLACvtfcHk0lidO3LoCVGgDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7nM&md5=84ba6e9618d7ad05e2f79d0c29354693</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100158%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DGans%26aufirst%3DK.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DWolf%26aufirst%3DR.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DQuax%26aufirst%3DP.%2BH.%26aulast%3Dde%2BVries%26aufirst%3DM.%2BR.%26aulast%3DHesse%26aufirst%3DI.%26aulast%3DTrautwein%26aufirst%3DD.%26aulast%3DWollert%26aufirst%3DU.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520isoenzyme%2520of%2520glutaminyl%2520cyclase%2520is%2520an%2520important%2520regulator%2520of%2520monocyte%2520infiltration%2520under%2520inflammatory%2520conditions%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D545%26epage%3D58%26doi%3D10.1002%2Femmm.201100158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Coillie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aelst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polfliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opdenakker, G.</span></span> <span> </span><span class="NLM_article-title">Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">12672</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/bi980497d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi980497d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXltFKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=12672-80&author=E.+Van%0ACoillieauthor=P.+Proostauthor=I.+Van+Aelstauthor=S.+Struyfauthor=M.+Polflietauthor=I.+De+Meesterauthor=D.+J.+Harveyauthor=J.+Van+Dammeauthor=G.+Opdenakker&title=Functional+comparison+of+two+human+monocyte+chemotactic+protein-2+isoforms%2C+role+of+the+amino-terminal+pyroglutamic+acid+and+processing+by+CD26%2Fdipeptidyl+peptidase+IV&doi=10.1021%2Fbi980497d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV</span></div><div class="casAuthors">Van Coillie, Els; Proost, Paul; Van Aelst, Ilse; Struyf, Sofie; Polfliet, Machteld; De Meester, Ingrid; Harvey, David J.; Van Damme, Jo; Opdenakker, Ghislain</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12672-12680</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human Monocyte Chemotactic Protein (MCP)-2 has originally been isolated from stimulated osteosarcoma cells as a chemokine coproduced with MCP-1 and MCP-3.  Here, a 5'-end extended MCP-2 cDNA was cloned from a human testis cDNA library.  It encoded a 76 residue MCP-2 protein, but differed from the reported bone marrow-derived MCP-2 cDNA sequence in codon 46, which coded for a Lys instead of a Gln.  This MCP-2Lys46 variant, caused by a single nucleotide polymorphism (SNP), was biol. compared with MCP-2Gln46.  The coding regions were subcloned into the bacterial expression vector pHEN1, and after transformation of Escherichia coli, the two MCP-2 protein variants were recovered from the periplasm.  The recombinant proteins were purified to homogeneity by heparin-Sepharose affinity chromatog. and reversed-phase HPLC.  Edman degrdn. revealed a Gln residue at the NH2 terminus instead of a pGlu.  To evaluate the influence of the cyclization, this Gln was chem. converted into pGlu in both MCP-2 variants.  The conversion was confirmed by electrospray mass spectrometry.  RMCP-2Gln46 and rMCP-2Lys46 and the NH2-terminal cyclic counterparts were tested on monocytic cells in calcium mobilization and chemotaxis assays.  No significant difference in biol. activity was obsd. between the rMCP-2Gln46 and rMCP-2Lys46 isoforms.  However, for both MCP-2 variants the NH2-terminal pyroglutamate was shown to be essential for chemotaxis, but not for calcium mobilization.  NH2-terminal truncation of rMCP-2Lys46 by the serine protease CD26/dipeptidyl peptidase IV (CD26/DPP IV) resulted in the cleavage of the NH2-terminal Gln-Pro dipeptide, whereas synthetic MCP-2 with an amino-terminal pGlu remained unaffected.  CD26/DPP IV-clipped rMCP-2Lys46(3-76) was almost completely inactive in both chemotaxis and signaling assays.  These observations indicate that the NH2-terminal pGlu in MCP-2 is necessary for chemotactic activity but also that it protects the protein against degrdn. by CD26/DPP IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ObUqyDOb9rVg90H21EOLACvtfcHk0lidO3LoCVGgDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFKqtbs%253D&md5=e7e265f6200b804239240868b255443f</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fbi980497d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980497d%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCoillie%26aufirst%3DE.%26aulast%3DProost%26aufirst%3DP.%26aulast%3DVan%2BAelst%26aufirst%3DI.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DPolfliet%26aufirst%3DM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHarvey%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DOpdenakker%26aufirst%3DG.%26atitle%3DFunctional%2520comparison%2520of%2520two%2520human%2520monocyte%2520chemotactic%2520protein-2%2520isoforms%252C%2520role%2520of%2520the%2520amino-terminal%2520pyroglutamic%2520acid%2520and%2520processing%2520by%2520CD26%252Fdipeptidyl%2520peptidase%2520IV%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D12672%26epage%3D80%26doi%3D10.1021%2Fbi980497d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>397</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0lidO3LoCVGgDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiyota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendelman, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span> <span> </span><span class="NLM_article-title">CCL2 affects beta-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2012.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23040664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1060-8&author=T.+Kiyotaauthor=H.+E.+Gendelmanauthor=R.+A.+Weirauthor=E.+E.+Higginsauthor=G.+Zhangauthor=M.+Jain&title=CCL2+affects+beta-amyloidosis+and+progressive+neurocognitive+dysfunction+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2012.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Kiyota, Tomomi; Gendelman, Howard E.; Weir, Robert A.; Higgins, E. Elizabeth; Zhang, Gang; Jain, Mohit</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1060-1068</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neuroinflammation affects the pathobiol. of Alzheimer's disease (AD).  Notably, β-amyloid (Aβ) deposition induces microglial activation and the subsequent prodn. of proinflammatory neurotoxic factors.  In maintaining brain homeostasis, microglial plasticity also enables phenotypic transition between toxic and trophic activation states.  One important control for such cell activation is through the CC-chemokine ligand 2 (CCL2) and its receptor, the CC-chemokine receptor 2.  Both affect microglia and peripheral macrophage immune responses and for the latter, cell ingress across the blood-brain barrier.  However, how CCL2-CC-chemokine receptor 2 signaling contributes to AD pathogenesis is not well understood.  To this end, we now report that CCL2 deficiency influences behavioral abnormalities and disease progression in Aβ precursor protein/presenilin-1 double-transgenic mice.  Here, increased cortical and hippocampal Aβ deposition is coincident with the formulation of Aβ oligomers.  Deficits in peripheral Aβ clearance and in scavenger, neuroprogenitor, and microglial cell functions are linked to deficient Aβ uptake.  All serve to accelerate memory dysfunction.  Taken together, these data support a role of CCL2 in innate immune functions relevant to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotXohpUrd7QLVg90H21EOLACvtfcHk0lgv3VTLSU-j9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgtL%252FE&md5=466d072afebe8d092e3a8279ced94dd1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DKiyota%26aufirst%3DT.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DWeir%26aufirst%3DR.%2BA.%26aulast%3DHiggins%26aufirst%3DE.%2BE.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DM.%26atitle%3DCCL2%2520affects%2520beta-amyloidosis%2520and%2520progressive%2520neurocognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1060%26epage%3D8%26doi%3D10.1016%2Fj.neurobiolaging.2012.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dams-O’Connor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peskind, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yemul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutunian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasinetti, G. M.</span></span> <span> </span><span class="NLM_article-title">Elevated plasma MCP-1 concentration following traumatic brain injury as a potential “predisposition” factor associated with an increased risk for subsequent development of Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.3233/JAD-2012-120598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-2012-120598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22543850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC38rptVSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=301-13&author=L.+Hoauthor=W.+Zhaoauthor=K.+Dams-O%E2%80%99Connorauthor=C.+Y.+Tangauthor=W.+Gordonauthor=E.+R.+Peskindauthor=S.+Yemulauthor=V.+Haroutunianauthor=G.+M.+Pasinetti&title=Elevated+plasma+MCP-1+concentration+following+traumatic+brain+injury+as+a+potential+%E2%80%9Cpredisposition%E2%80%9D+factor+associated+with+an+increased+risk+for+subsequent+development+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2012-120598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease</span></div><div class="casAuthors">Ho Lap; Zhao Wei; Dams-O'Connor Kristen; Tang Cheuk Y; Gordon Wayne; Peskind Elaine R; Yemul Shrishailam; Haroutunian Vahram; Pasinetti Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We explored whether changes in the expression profile of peripheral blood plasma proteins may provide a clinical, readily accessible "window" into the brain, reflecting molecular alterations following traumatic brain injury (TBI) that might contribute to TBI complications.  We recruited fourteen TBI and ten control civilian participants for the study, and also analyzed banked plasma specimens from 20 veterans with TBI and 20 control cases.  Using antibody arrays and ELISA assays, we explored differentially-regulated protein species in the plasma of TBI compared to healthy controls from the two independent cohorts.  We found three protein biomarker species, monocyte chemotactic protein-1 (MCP-1), insulin-like growth factor-binding protein-3, and epidermal growth factor receptor, that are differentially regulated in plasma specimens of the TBI cases.  A three-biomarker panel using all three proteins provides the best potential criterion for separating TBI and control cases.  Plasma MCP-1 contents are correlated with the severity of TBI and the index of compromised axonal fiber integrity in the frontal cortex.  Based on these findings, we evaluated postmortem brain specimens from 7 mild cognitive impairment (MCI) and 7 neurologically normal cases.  We found elevated MCP-1 expression in the frontal cortex of MCI cases that are at high risk for developing Alzheimer's disease.  Our findings suggest that additional application of the three-biomarker panel to current diagnostic criteria may lead to improved TBI detection and more sensitive outcome measures for clinical trials.  Induction of MCP-1 in response to TBI might be a potential predisposing factor that may increase the risk for development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQS_ypfbdTpNHELvajU9pjPfW6udTcc2eaSWGp25S4EEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rptVSmug%253D%253D&md5=55e5a6bf5334658aa8829d6e9065e33b</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120598%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DDams-O%25E2%2580%2599Connor%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DC.%2BY.%26aulast%3DGordon%26aufirst%3DW.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DYemul%26aufirst%3DS.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DElevated%2520plasma%2520MCP-1%2520concentration%2520following%2520traumatic%2520brain%2520injury%2520as%2520a%2520potential%2520%25E2%2580%259Cpredisposition%25E2%2580%259D%2520factor%2520associated%2520with%2520an%2520increased%2520risk%2520for%2520subsequent%2520development%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D301%26epage%3D13%26doi%3D10.3233%2FJAD-2012-120598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchhave, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minthon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janciauskiene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, O.</span></span> <span> </span><span class="NLM_article-title">CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e30525</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0030525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0030525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22303443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XisV2nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+Westinauthor=P.+Buchhaveauthor=H.+Nielsenauthor=L.+Minthonauthor=S.+Janciauskieneauthor=O.+Hansson&title=CCL2+is+associated+with+a+faster+rate+of+cognitive+decline+during+early+stages+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0030525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease</span></div><div class="casAuthors">Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Janciauskiene, Sabina; Hansson, Oskar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e30525</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemokine (C-C motif) receptor 2 (CCR2)-signaling can mediate accumulation of microglia at sites affected by neuroinflammation.  CCR2 and its main ligand CCL2 (MCP-1) might also be involved in the altered metab. of beta-amyloid (Aβ) underlying Alzheimer's disease (AD).  We therefore measured the levels of CCL2 and three other CCR2 ligands, i.e. CCL11 (eotaxin), CCL13 (MCP-4) and CCL26 (eotaxin-3), in the cerebrospinal fluid (CSF) and plasma of 30 controls and 119 patients with mild cognitive impairment (MCI) at baseline.  During clin. follow-up 52 MCI patients were clin. stable for five years, 47 developed AD (i.e. cases with prodromal AD at baseline) and 20 developed other dementias.  Only CSF CCL26 was statistically significantly elevated in patients with prodromal AD when compared to controls (p = 0.002).  However, in patients with prodromal AD, the CCL2 levels in CSF at baseline correlated with a faster cognitive decline during follow-up (rs = 0.42, p = 0.004).  Furthermore, prodromal AD patients in the highest tertile of CSF CCL2 exhibited a significantly faster cognitive decline (p < 0.001) and developed AD dementia within a shorter time period (p < 0.003) compared to those in the lowest tertile.  Finally, in the entire MCI cohort, CSF CCL2 could be combined with CSF Tau, P-tau and Aβ42 to predict both future conversion to AD and the rate of cognitive decline.  If these results are corroborated in future studies, CCL2 in CSF could be a candidate biomarker for prediction of future disease progression rate in prodromal AD.  Moreover, CCR2-related signaling pathways might be new therapeutic targets for therapies aiming at slowing down the disease progression rate of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryprsiw1HXTLVg90H21EOLACvtfcHk0lgv3VTLSU-j9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisV2nsr8%253D&md5=c8e6db182e8466aafa2f79cce2280826</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030525%26sid%3Dliteratum%253Aachs%26aulast%3DWestin%26aufirst%3DK.%26aulast%3DBuchhave%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DH.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DJanciauskiene%26aufirst%3DS.%26aulast%3DHansson%26aufirst%3DO.%26atitle%3DCCL2%2520is%2520associated%2520with%2520a%2520faster%2520rate%2520of%2520cognitive%2520decline%2520during%2520early%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0030525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kauwe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridge, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staley, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruchaga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscough, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertelsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A. M.</span></span> <span> </span><span class="NLM_article-title">Genome-wide association study of CSF levels of 59 alzheimer’s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004758</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1004758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pgen.1004758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25340798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyiu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=J.+S.+Kauweauthor=M.+H.+Baileyauthor=P.+G.+Ridgeauthor=R.+Perryauthor=M.+E.+Wadsworthauthor=K.+L.+Hoytauthor=L.+A.+Staleyauthor=C.+M.+Karchauthor=O.+Harariauthor=C.+Cruchagaauthor=B.+J.+Ainscoughauthor=K.+Balesauthor=E.+H.+Pickeringauthor=S.+Bertelsenauthor=A.+M.+Faganauthor=D.+M.+Holtzmanauthor=J.+C.+Morrisauthor=A.+M.+Goate&title=Genome-wide+association+study+of+CSF+levels+of+59+alzheimer%E2%80%99s+disease+candidate+proteins%3A+significant+associations+with+proteins+involved+in+amyloid+processing+and+inflammation&doi=10.1371%2Fjournal.pgen.1004758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation</span></div><div class="casAuthors">Kauwe, John S. K.; Bailey, Matthew H.; Ridge, Perry G.; Perry, Rachel; Wadsworth, Mark E.; Hoyt, Kaitlyn L.; Staley, Lyndsay A.; Karch, Celeste M.; Harari, Oscar; Cruchaga, Carlos; Ainscough, Benjamin J.; Bales, Kelly; Pickering, Eve H.; Bertelsen, Sarah; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.; Weiner, Michael; Aisen, Paul; Petersen, Ronald; Jack, Clifford R.; Jagust, William; Trojanowki, John Q.; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Saykin, Andrew J.; Shaw, Leslie M.; Morris, John</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004758/1-e1004758/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cerebrospinal fluid (CSF) 42 amino acid species of amyloid beta (Aβ42) and tau levels are strongly correlated with the presence of Alzheimer's disease (AD) neuropathol. including amyloid plaques and neurodegeneration and have been successfully used as endophenotypes for genetic studies of AD.  Addnl. CSF analytes may also serve as useful endophenotypes that capture other aspects of AD pathophysiol.  Here we have conducted a genome-wide assocn. study of CSF levels of 59 AD-related analytes.  All analytes were measured using the Rules Based Medicine Human Discovery MAP Panel, which includes analytes relevant to several disease-related processes.  Data from two independently collected and measured datasets, the Knight Alzheimer's Disease Research Center (ADRC) and Alzheimer's Disease Neuroimaging Initiative (ADNI), were analyzed sep., and combined results were obtained using meta-anal.  We identified genetic assocns. with CSF levels of 5 proteins (Angiotensin-converting enzyme (ACE), Chemokine (C-C motif) ligand 2 (CCL2), Chemokine (C-C motif) ligand 4 (CCL4), Interleukin 6 receptor (IL6R) and Matrix metalloproteinase-3 (MMP3)) with study-wide significant p-values (p<1.46 × 10-10) and significant, consistent evidence for assocn. in both the Knight ADRC and the ADNI samples.  These proteins are involved in amyloid processing and pro-inflammatory signaling.  SNPs assocd. with ACE, IL6R and MMP3 protein levels are located within the coding regions of the corresponding structural gene.  The SNPs assocd. with CSF levels of CCL4 and CCL2 are located in known chemokine binding proteins.  The genetic assocns. reported here are novel and suggest mechanisms for genetic control of CSF and plasma levels of these disease-related proteins.  Significant SNPs in ACE and MMP3 also showed assocn. with AD risk.  Our findings suggest that these proteins/pathways may be valuable therapeutic targets for AD.  Robust assocns. in cognitively normal individuals suggest that these SNPs also influence regulation of these proteins more generally and may therefore be relevant to other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCS7PMBQWOu7Vg90H21EOLACvtfcHk0liu24m9shxUng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyiu7%252FI&md5=f33126cbf1a0308383dab6353c405728</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1004758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1004758%26sid%3Dliteratum%253Aachs%26aulast%3DKauwe%26aufirst%3DJ.%2BS.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DRidge%26aufirst%3DP.%2BG.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DWadsworth%26aufirst%3DM.%2BE.%26aulast%3DHoyt%26aufirst%3DK.%2BL.%26aulast%3DStaley%26aufirst%3DL.%2BA.%26aulast%3DKarch%26aufirst%3DC.%2BM.%26aulast%3DHarari%26aufirst%3DO.%26aulast%3DCruchaga%26aufirst%3DC.%26aulast%3DAinscough%26aufirst%3DB.%2BJ.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DPickering%26aufirst%3DE.%2BH.%26aulast%3DBertelsen%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DGoate%26aufirst%3DA.%2BM.%26atitle%3DGenome-wide%2520association%2520study%2520of%2520CSF%2520levels%2520of%252059%2520alzheimer%25E2%2580%2599s%2520disease%2520candidate%2520proteins%253A%2520significant%2520associations%2520with%2520proteins%2520involved%2520in%2520amyloid%2520processing%2520and%2520inflammation%26jtitle%3DPLoS%2520Genet.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.pgen.1004758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warden, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, C. E.</span></span> <span> </span><span class="NLM_article-title">Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer’s disease</span>. <i>Brain Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1750-3639.2008.00188.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1750-3639.2008.00188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18637012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ojtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=392-8&author=A.+Sokolovaauthor=M.+D.+Hillauthor=F.+Rahimiauthor=L.+A.+Wardenauthor=G.+M.+Hallidayauthor=C.+E.+Shepherd&title=Monocyte+chemoattractant+protein-1+plays+a+dominant+role+in+the+chronic+inflammation+observed+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1750-3639.2008.00188.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease</span></div><div class="casAuthors">Sokolova, Anna; Hill, Michelle D.; Rahimi, Farid; Warden, Lolita A.; Halliday, Glenda M.; Shepherd, Claire E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392-398</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chronic neuroinflammation correlates with cognitive decline and brain atrophy in Alzheimer's disease (AD), and cytokines and chemokines mediate the inflammatory response.  However, quantitation of cytokines and chemokines in AD brain tissue has only been carried out for a small no. of mediators with variable results.  We simultaneously quantified 17 cytokines and chemokines in brain tissue exts. from controls (n = 10) and from patients with and without genetic forms of AD (n = 12).  Group comparisons accounting for multiple testing revealed that monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and interleukin-8 (IL-8) were consistently upregulated in AD brain tissue.  Immunohistochem. for MCP-1, IL-6 and IL-8 confirmed this increase and detd. localization of these factors in neurons (MCP-1, IL-6, IL-8), astrocytes (MCP-1, IL-6) and plaque pathol. (MCP-1, IL-8).  Logistic linear regression modeling detd. that MCP-1 was the most reliable predictor of disease.  Our data support previous work on significant increases in IL-6 and IL-8 in AD but indicate that MCP-1 may play a more dominant role in chronic inflammation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGWUAUz-BNr7Vg90H21EOLACvtfcHk0liu24m9shxUng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ojtrg%253D&md5=18451e32fc070f2cf260ccf74d9e5294</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2008.00188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2008.00188.x%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DRahimi%26aufirst%3DF.%26aulast%3DWarden%26aufirst%3DL.%2BA.%26aulast%3DHalliday%26aufirst%3DG.%2BM.%26aulast%3DShepherd%26aufirst%3DC.%2BE.%26atitle%3DMonocyte%2520chemoattractant%2520protein-1%2520plays%2520a%2520dominant%2520role%2520in%2520the%2520chronic%2520inflammation%2520observed%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D2009%26volume%3D19%26spage%3D392%26epage%3D8%26doi%3D10.1111%2Fj.1750-3639.2008.00188.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.tips.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18835047" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=626-632&author=J.+E.+Khouryauthor=A.+D.+Luster&title=Mechanisms+of+microglia+accumulation+in+Alzheimer%E2%80%99s+disease%3A+therapeutic+implications&doi=10.1016%2Fj.tips.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DKhoury%26aufirst%3DJ.%2BE.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DMechanisms%2520of%2520microglia%2520accumulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520therapeutic%2520implications%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D626%26epage%3D632%26doi%3D10.1016%2Fj.tips.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charo, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubman, M. B.</span></span> <span> </span><span class="NLM_article-title">Chemokines in the pathogenesis of vascular disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000146672.10582.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1161%2F01.RES.0000146672.10582.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15514167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslSksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=858-66&author=I.+F.+Charoauthor=M.+B.+Taubman&title=Chemokines+in+the+pathogenesis+of+vascular+disease&doi=10.1161%2F01.RES.0000146672.10582.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines in the Pathogenesis of Vascular Disease</span></div><div class="casAuthors">Charo, Israel F.; Taubman, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">858-866</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Our increasing appreciation of the importance of inflammation in vascular disease has focused attention on the mols. that direct the migration of leukocytes from the blood stream to the vessel wall.  In this review, we summarize roles of the chemokines, a family of small secreted proteins that selectively recruit monocytes, neutrophils, and lymphocytes to sites of vascular injury, inflammation, and developing atherosclerosis.  Chemokines induce chemotaxis through the activation of G-protein-coupled receptors, and the receptors that a given leukocyte expresses dets. the chemokines to which it will respond.  Monocyte chemoattractant protein 1 (MCP-1), acting through its receptor CCR2, appears to play an early and important role in the recruitment of monocytes to atherosclerotic lesions and in the formation of intimal hyperplasia after arterial injury.  Acute thrombosis is an often fatal complication of atherosclerotic plaque rupture, and recent evidence suggests that MCP-1 contributes to thrombin generation and thrombus formation by generating tissue factor.  Because of their crit. roles in monocyte recruitment in vascular and nonvascular diseases, MCP-1 and CCR2 have become important therapeutic targets, and efforts are underway to develop potent and specific antagonists of these and related chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG_5Vr4htmjbVg90H21EOLACvtfcHk0liu24m9shxUng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslSksr4%253D&md5=80568fae46052fafd52b27a3476c9e02</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000146672.10582.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000146672.10582.17%26sid%3Dliteratum%253Aachs%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DTaubman%26aufirst%3DM.%2BB.%26atitle%3DChemokines%2520in%2520the%2520pathogenesis%2520of%2520vascular%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D95%26spage%3D858%26epage%3D66%26doi%3D10.1161%2F01.RES.0000146672.10582.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoshima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egashira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, N.</span></span> <span> </span><span class="NLM_article-title">Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice</span>. <i>Am. J. Physiol Lung Cell Mol. Physiol</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">L1038</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00167.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1152%2Fajplung.00167.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15064241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=L1038-44&author=I.+Inoshimaauthor=K.+Kuwanoauthor=N.+Hamadaauthor=N.+Hagimotoauthor=M.+Yoshimiauthor=T.+Maeyamaauthor=A.+Takeshitaauthor=S.+Kitamotoauthor=K.+Egashiraauthor=N.+Hara&title=Anti-monocyte+chemoattractant+protein-1+gene+therapy+attenuates+pulmonary+fibrosis+in+mice&doi=10.1152%2Fajplung.00167.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00167.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00167.2003%26sid%3Dliteratum%253Aachs%26aulast%3DInoshima%26aufirst%3DI.%26aulast%3DKuwano%26aufirst%3DK.%26aulast%3DHamada%26aufirst%3DN.%26aulast%3DHagimoto%26aufirst%3DN.%26aulast%3DYoshimi%26aufirst%3DM.%26aulast%3DMaeyama%26aufirst%3DT.%26aulast%3DTakeshita%26aufirst%3DA.%26aulast%3DKitamoto%26aufirst%3DS.%26aulast%3DEgashira%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DN.%26atitle%3DAnti-monocyte%2520chemoattractant%2520protein-1%2520gene%2520therapy%2520attenuates%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2004%26volume%3D286%26spage%3DL1038%26epage%3D44%26doi%3D10.1152%2Fajplung.00167.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galimberti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenoglio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalabrini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerici, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresolin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpini, E.</span></span> <span> </span><span class="NLM_article-title">Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2005.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2005.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16307829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1763-8&author=D.+Galimbertiauthor=C.+Fenoglioauthor=C.+Lovatiauthor=E.+Venturelliauthor=I.+Guidiauthor=B.+Corraauthor=D.+Scalabriniauthor=F.+Clericiauthor=C.+Marianiauthor=N.+Bresolinauthor=E.+Scarpini&title=Serum+MCP-1+levels+are+increased+in+mild+cognitive+impairment+and+mild+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2005.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease</span></div><div class="casAuthors">Galimberti, Daniela; Fenoglio, Chiara; Lovati, Carlo; Venturelli, Eliana; Guidi, Ilaria; Corra, Barbara; Scalabrini, Diego; Clerici, Francesca; Mariani, Claudio; Bresolin, Nereo; Scarpini, Elio</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1763-1768</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Upregulation of a no. of chemokines, including monocyte chemotactic protein-1 (MCP-1), is assocd. with Alzheimer's disease (AD) pathol. changes.  Emerging evidence suggests that inflammatory events precede the clin. development of AD, as cytokine dysregulation has been obsd. also in patients with mild cognitive impairment (MCI).  MCP-1 levels were evaluated in serum samples from 48 subjects with MCI, 94 AD patients and 24 age-matched controls.  Significantly increased MCP-1 levels were found in MCI and mild AD, but not in severe AD patients as compared with controls.  MRNA levels in peripheral blood mononuclear cells (PBMC), evaluated by quant. RT-PCR anal., paralleled serum MCP-1 levels.  Moreover, a progressive MCP-1 decrease was obsd. over a 1-yr follow up in a subgroup of MCI subjects converted to AD.  MCP-1 upregulation is likely to be a very early event in AD pathogenesis, by far preceding the clin. onset of the disease.  Nevertheless, as MCP-1 is likely to play a role in several pathologies with an inflammatory component, a possible usefulness as an early AD biomarker would be possible only in combination with other mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJfq-7q2EabVg90H21EOLACvtfcHk0lhwfhwCx17cxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7zL&md5=35d5be25ab132fddc7b7d957b4f760d5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2005.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2005.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DGalimberti%26aufirst%3DD.%26aulast%3DFenoglio%26aufirst%3DC.%26aulast%3DLovati%26aufirst%3DC.%26aulast%3DVenturelli%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DI.%26aulast%3DCorra%26aufirst%3DB.%26aulast%3DScalabrini%26aufirst%3DD.%26aulast%3DClerici%26aufirst%3DF.%26aulast%3DMariani%26aufirst%3DC.%26aulast%3DBresolin%26aufirst%3DN.%26aulast%3DScarpini%26aufirst%3DE.%26atitle%3DSerum%2520MCP-1%2520levels%2520are%2520increased%2520in%2520mild%2520cognitive%2520impairment%2520and%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2006%26volume%3D27%26spage%3D1763%26epage%3D8%26doi%3D10.1016%2Fj.neurobiolaging.2005.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khannazer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">The potential role of chemokines in Alzheimer’s disease pathogenesis</span>. <i>Am. J. Alzheimers Dis Other Demen</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1177/1533317513518651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1177%2F1533317513518651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24408754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2czjs12ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=415-25&author=G.+Aziziauthor=N.+Khannazerauthor=A.+Mirshafiey&title=The+potential+role+of+chemokines+in+Alzheimer%E2%80%99s+disease+pathogenesis&doi=10.1177%2F1533317513518651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis</span></div><div class="casAuthors">Azizi Gholamreza; Khannazer Nikoo; Mirshafiey Abbas</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder and leading cause of dementia, which begins with impaired memory.  The neuropathological hallmarks of AD include destructive alterations of neurons by neurofibrillary tangles, neuritic amyloid plaques, and neuroinflammatory process in the brain.  Chemokines have a major role in inflammatory cell attraction and glial cell activation and/or modulation in the central nervous system.  Moreover, the clinical and immunopathological evidence could show dual key role of chemokines in their pro- and anti-inflammatory properties in AD.  However, their effects in neurodegeneration and/or neuroprotection remain an area of investigation.  This review article provides an overview of characteristic, cellular source and activity of chemokines, and their roles in neuronal glial cell interaction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9ruWa1xgAXCjiVMCqkKxVfW6udTcc2eas1Oh_tmYBjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjs12ltA%253D%253D&md5=780f307296062745c3c0e8ab1d1119db</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1177%2F1533317513518651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317513518651%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DG.%26aulast%3DKhannazer%26aufirst%3DN.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520chemokines%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis%2520Other%2520Demen%26date%3D2014%26volume%3D29%26spage%3D415%26epage%3D25%26doi%3D10.1177%2F1533317513518651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Severini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passeri, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florenzano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Possenti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Matteo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calissano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercanti, D.</span></span> <span> </span><span class="NLM_article-title">Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-beta-induced toxicity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.3233/JAD-131070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-131070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=281-93&author=C.+Severiniauthor=P.+P.+Passeriauthor=M.+Ciottiauthor=F.+Florenzanoauthor=R.+Possentiauthor=C.+Zonaauthor=A.+Di+Matteoauthor=A.+Guglielmottiauthor=P.+Calissanoauthor=J.+Pachterauthor=D.+Mercanti&title=Bindarit%2C+inhibitor+of+CCL2+synthesis%2C+protects+neurons+against+amyloid-beta-induced+toxicity&doi=10.3233%2FJAD-131070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3233%2FJAD-131070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131070%26sid%3Dliteratum%253Aachs%26aulast%3DSeverini%26aufirst%3DC.%26aulast%3DPasseri%26aufirst%3DP.%2BP.%26aulast%3DCiotti%26aufirst%3DM.%26aulast%3DFlorenzano%26aufirst%3DF.%26aulast%3DPossenti%26aufirst%3DR.%26aulast%3DZona%26aufirst%3DC.%26aulast%3DDi%2BMatteo%26aufirst%3DA.%26aulast%3DGuglielmotti%26aufirst%3DA.%26aulast%3DCalissano%26aufirst%3DP.%26aulast%3DPachter%26aufirst%3DJ.%26aulast%3DMercanti%26aufirst%3DD.%26atitle%3DBindarit%252C%2520inhibitor%2520of%2520CCL2%2520synthesis%252C%2520protects%2520neurons%2520against%2520amyloid-beta-induced%2520toxicity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D38%26spage%3D281%26epage%3D93%26doi%3D10.3233%2FJAD-131070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navabi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shukaili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyedzadeh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">The role of inflammatory mediators in the pathogenesis of Alzheimer’s disease</span>. <i>Sultan Qaboos Univ Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.18295/squmj.2015.15.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.18295%2Fsqumj.2015.15.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=305-316&author=G.+Aziziauthor=S.+S.+Navabiauthor=A.+Al-Shukailiauthor=M.+H.+Seyedzadehauthor=R.+Yazdaniauthor=A.+Mirshafiey&title=The+role+of+inflammatory+mediators+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.18295%2Fsqumj.2015.15.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.18295%2Fsqumj.2015.15.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18295%252Fsqumj.2015.15.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DG.%26aulast%3DNavabi%26aufirst%3DS.%2BS.%26aulast%3DAl-Shukaili%26aufirst%3DA.%26aulast%3DSeyedzadeh%26aufirst%3DM.%2BH.%26aulast%3DYazdani%26aufirst%3DR.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520inflammatory%2520mediators%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSultan%2520Qaboos%2520Univ%2520Med.%2520J.%26date%3D2015%26volume%3D15%26spage%3D305%26epage%3D316%26doi%3D10.18295%2Fsqumj.2015.15.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.</span></span> <span> </span><span class="NLM_article-title">Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1007/s12272-013-0161-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs12272-013-0161-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23771498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsV2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=1039-50&author=S.+Boseauthor=J.+Cho&title=Role+of+chemokine+CCL2+and+its+receptor+CCR2+in+neurodegenerative+diseases&doi=10.1007%2Fs12272-013-0161-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</span></div><div class="casAuthors">Bose, Shambhunath; Cho, Jungsook</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1039-1050</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Chemokines are members of the chemoattractant cytokine family.  They play key roles in the trafficking of leukocytes and in the induction of chemotaxis through the activation of G protein-coupled receptor.  Considerable interest has been paid to these mols. to elucidate their roles in the unique inflammatory responses elicited in the central nervous system (CNS).  Chemokine CCL2 (also known as monocyte chemoattractant protein-1, MCP-1) is one of the vital chemokines that control the migration and infiltration of monocytes/macrophages.  CCL2 and its receptor CCR2 have been shown to be induced and involved in various neurodegenerative disorders including Alzheimer's disease, multiple sclerosis, and ischemic brain injury.  The present review will focus on the biol. and pathophysiol. aspects of CCL2 and CCR2 in the CNS and the possible therapeutic approaches for targeting these two proteins to combat neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJgYCZBXSnbVg90H21EOLACvtfcHk0lh4h7B4afeANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsV2mtL4%253D&md5=60608bb9d4308f3a4f4eac2831fb2cd5</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0161-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0161-z%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%26atitle%3DRole%2520of%2520chemokine%2520CCL2%2520and%2520its%2520receptor%2520CCR2%2520in%2520neurodegenerative%2520diseases%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2013%26volume%3D36%26spage%3D1039%26epage%3D50%26doi%3D10.1007%2Fs12272-013-0161-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivest, S.</span></span> <span> </span><span class="NLM_article-title">A deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjt028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Fjmcb%2Fmjt028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23892208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=284-93&author=G.+Naertauthor=S.+Rivest&title=A+deficiency+in+CCR2%2B+monocytes%3A+the+hidden+side+of+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fjmcb%2Fmjt028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease</span></div><div class="casAuthors">Naert, Gaelle; Rivest, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disorder characterized by intracellular neurofibrillary tangle formation and extracellular amyloid-β (Aβ) deposition.  To date, microglia seem to act as double-edged swords, being either beneficial (e.g. clearance of Aβ) or detrimental (e.g. secretion of neurotoxic factors) in AD.  Following a rather intense debate on the question, a consensus has emerged that microglia can renew themselves via proliferation of already differentiated microglia as well as via the de novo recruitment of monocytes of mouse models of AD.  However, recent advances suggest distinct function for resident and bone marrow-derived microglia (BMDM), and have emphasized the neuroprotective functions of BMDM.  BMDM is the only subset of cells that restrict cerebral amyloidosis in the AD brain, which has been recently attributed to CCR2+ monocytes.  Moreover, an impaired recruitment of CCR2+ monocytes has been reported in AD patients, as seen from the CCR2+ monocytopenia found in the bloodstream and BM.  The present review summarizes the current knowledge on the roles and dysfunctions of CCR2+ monocytes in AD and their potential as key therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoO0Diwah7f7Vg90H21EOLACvtfcHk0lh4h7B4afeANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ltrjK&md5=d81962085e0a29ea37fd291f95a91b29</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjt028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjt028%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DRivest%26aufirst%3DS.%26atitle%3DA%2520deficiency%2520in%2520CCR2%252B%2520monocytes%253A%2520the%2520hidden%2520side%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D5%26spage%3D284%26epage%3D93%26doi%3D10.1093%2Fjmcb%2Fmjt028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark-Lewis, I.</span></span> <span> </span><span class="NLM_article-title">Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1084/jem.181.2.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1084%2Fjem.181.2.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7836918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1995&pages=631-40&author=J.+H.+Gongauthor=I.+Clark-Lewis&title=Antagonists+of+monocyte+chemoattractant+protein+1+identified+by+modification+of+functionally+critical+NH2-terminal+residues&doi=10.1084%2Fjem.181.2.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues</span></div><div class="casAuthors">Gong, Jiang-Hong; Clark-Lewis, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">631-40</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Monocyte chemoattractant protein (MCP)-1 analogs were designed to det. the role of the NH2-terminal region in structure and function.  The NH2-terminal residue was important for function and receptor binding, as it could not be deleted or extended.  However the NH2-terminal pyroglutamate residue of the wild type was not essential as it could be replaced by several other noncyclic amino acids without loss of activity.  Residues 7-10 were essential for receptor desensitization, but were not sufficient for function, and the integrity of residues 1-6 were required for functional activity.  A peptide corresponding to MCP-1, 1-10 lacked detectable receptor-binding activities, indicating that residues 1-10 are essential for MCP-1 function, but that other residues are also involved.  Several truncated analogs, including 8-76, 9-76, and 10-76, desensitized MCP-1-induced Ca2+ induction, but were not significantly active.  These analogs were antagonists of MCP-1 activity with the most potent being the 9-76 analog (IC50 = 20 nM).  The 9-76 specifically bound to MCP-1 receptors with a Kd of 8.3 nM, which was three-fold higher than MCP-1 (Kd 2.8 nM).  The 9-76 analog desensitized the Ca2+ response to MCP-1 and MCP-3, but not to other CC chemokines, suggesting that it is MCP receptor specific.  The availability of these compds. will be helpful in evaluating MCP receptor antagonists as anti-inflammatory therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gFvj58xiarVg90H21EOLACvtfcHk0lh4h7B4afeANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFygsr0%253D&md5=e0f174b47d5bb79fac66342e6bc21aaa</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1084%2Fjem.181.2.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.181.2.631%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DClark-Lewis%26aufirst%3DI.%26atitle%3DAntagonists%2520of%2520monocyte%2520chemoattractant%2520protein%25201%2520identified%2520by%2520modification%2520of%2520functionally%2520critical%2520NH2-terminal%2520residues%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1995%26volume%3D181%26spage%3D631%26epage%3D40%26doi%3D10.1084%2Fjem.181.2.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvreur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span> <span> </span><span class="NLM_article-title">Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6–76) as a natural chemokine inhibitor</span>. <i>J. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">4034</span>– <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9558113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXis1CisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=4034-41&author=P.+Proostauthor=S.+Struyfauthor=M.+Couvreurauthor=J.+P.+Lenaertsauthor=R.+Coningsauthor=P.+Mentenauthor=P.+Verhaertauthor=A.+Wuytsauthor=J.+Van+Damme&title=Posttranslational+modifications+affect+the+activity+of+the+human+monocyte+chemotactic+proteins+MCP-1+and+MCP-2%3A+identification+of+MCP-2%286%E2%80%9376%29+as+a+natural+chemokine+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor</span></div><div class="casAuthors">Proost, Paul; Struyf, Sofie; Couvreur, Mikael; Lenaerts, Jean-Pierre; Conings, Rene; Menten, Patricia; Verhaert, Peter; Wuyts, Anja; Van Damme, Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4034-4041</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Chemokines are important mediators in infection and inflammation.  The monocyte chemotactic proteins (MCPs) form a subclass of structurally related C-C chemokines.  MCPs select specific target cells due to binding to a distinct set of chemokine receptors.  Recombinant and synthetic MCP-1 variants have been shown to function as chemokine antagonists.  Here, posttranslationally modified immunoreactive MCP-1 and MCP-2 were isolated from mononuclear cells.  Natural forms of MCP-1 and MCP-2 were biochem. identified by Edman degrdn. and mass spectrometry and functionally characterized in chemotaxis and Ca2+-mobilization assays.  Glycosylated MCP-1 (12 and 13.5 kDa) was 2-3-fold less chemotactic for monocytes and THP-1 cells than nonglycosylated MCP-1 (10 kDa).  Natural, N-terminally truncated MCP-1(5-76) and MCP-1(6-76) were practically devoid of bioactivity, whereas C-terminally processed MCP-1(1-69) fully retained its chemotactic and Ca2+-inducing capacity.  The capability of naturally modified MCP-1 forms to desensitize the Ca2+ response induced by intact MCP-1 in THP-1 cells correlated with their agonistic potency.  In contrast, naturally modified MCP-2(6-76) was devoid of activity, but could completely block the chemotactic effect of intact MCP-2 as well as that of MCP-1, MCP-3, and RANTES.  C-terminally processed MCP-2-(1-74) did retain its chemotactic potency.  Although comparable as a chemoattractant, natural intact MCP-2 was 10-fold less potent than MCP-1 in inducing an intracellular Ca2+ increase.  Thus, under physiol. or pathol. conditions, posttranslational modification affects chemokine potency and natural MCP-2(6-76) is a functional C-C chemokine inhibitor that might be useful as an inhibitor of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfZaSLeX4v7Vg90H21EOLACvtfcHk0lh4h7B4afeANg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1CisLo%253D&md5=740cf869c57f95c89099e1cd3b55e387</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProost%26aufirst%3DP.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DCouvreur%26aufirst%3DM.%26aulast%3DLenaerts%26aufirst%3DJ.%2BP.%26aulast%3DConings%26aufirst%3DR.%26aulast%3DMenten%26aufirst%3DP.%26aulast%3DVerhaert%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26atitle%3DPosttranslational%2520modifications%2520affect%2520the%2520activity%2520of%2520the%2520human%2520monocyte%2520chemotactic%2520proteins%2520MCP-1%2520and%2520MCP-2%253A%2520identification%2520of%2520MCP-2%25286%25E2%2580%259376%2529%2520as%2520a%2520natural%2520chemokine%2520inhibitor%26jtitle%3DJ.%2520Immunol%26date%3D1998%26volume%3D160%26spage%3D4034%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Coillie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span> <span> </span><span class="NLM_article-title">The role of CD26/DPP IV in chemokine processing</span>. <i>Chem. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1159/000058725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1159%2F000058725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10550929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=42-56&author=J.+Van+Dammeauthor=S.+Struyfauthor=A.+Wuytsauthor=E.+Van+Coillieauthor=P.+Mentenauthor=D.+Scholsauthor=S.+Sozzaniauthor=I.+De+Meesterauthor=P.+Proost&title=The+role+of+CD26%2FDPP+IV+in+chemokine+processing&doi=10.1159%2F000058725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CD26/DPP IV in chemokine processing</span></div><div class="casAuthors">Van Damme, Jo; Struyf, Sofie; Wuyts, Anja; Van Coillie, Els; Menten, Patricia; Schols, Dominique; Sozzani, Silvano; De Meester, Ingrid; Proost, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">Chemokines</span>),
    <span class="NLM_cas:pages">42-56</span>CODEN:
                <span class="NLM_cas:coden">CHMIEP</span>;
        ISSN:<span class="NLM_cas:issn">1015-0145</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review with 30 refs. describing the effects of dipeptidyl peptidase IV (DPP IV) on a large group of small inflammatory cytokines, chemokines.  For each individual chemoattractant the different biol. consequences of processing by CD26/DPP IV are evaluated in comparison with the intact mol.  These examples show that chemokines are important natural substrates for CD26/DPP IV and illustrate the impact of this serine protease in immune processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr355UtDqr_l7Vg90H21EOLACvtfcHk0ljiChqwydexsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSntLs%253D&md5=606fca67ff327c49b71dc2d5cff9c082</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1159%2F000058725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000058725%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DVan%2BCoillie%26aufirst%3DE.%26aulast%3DMenten%26aufirst%3DP.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DProost%26aufirst%3DP.%26atitle%3DThe%2520role%2520of%2520CD26%252FDPP%2520IV%2520in%2520chemokine%2520processing%26jtitle%3DChem.%2520Immunol%26date%3D1999%26volume%3D72%26spage%3D42%26epage%3D56%26doi%3D10.1159%2F000058725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morty, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1042/BJ20051593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20051593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16248854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVemtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2006&pages=635-45&author=R.+E.+Mortyauthor=P.+Bulauauthor=R.+Pelleauthor=S.+Wilkauthor=K.+Abe&title=Pyroglutamyl+peptidase+type+I+from+Trypanosoma+brucei%3A+a+new+virulence+factor+from+African+trypanosomes+that+de-blocks+regulatory+peptides+in+the+plasma+of+infected+hosts&doi=10.1042%2FBJ20051593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts</span></div><div class="casAuthors">Morty, Rory E.; Bulau, Patrick; Pelle, Roger; Wilk, Sherwin; Abe, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-645</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Peptidases of parasitic protozoans are emerging as novel virulence factors and therapeutic targets in parasitic infections.  A trypanosome-derived aminopeptidase that exclusively hydrolyzed substrates with Glp (pyroglutamic acid) in P1 was purified 9248-fold from the plasma of rats infected with Trypanosoma brucei brucei.  The enzyme responsible was cloned from a T. brucei brucei genomic DNA library and identified as type I PGP (pyroglutamyl peptidase), belonging to the C15 family of cysteine peptidases.  We showed that PGP is expressed in all life cycle stages of T. brucei brucei and is expressed in four other blood-stream-form African trypanosomes.  Trypanosome PGP was optimally active and stable at bloodstream pH, and was insensitive to host plasma cysteine peptidase inhibitors.  Native purified and recombinant hyper-expressed trypanosome PGP removed the N-terminal Glp blocking groups from TRH (TSH-releasing hormone) and GnRH (gonadotropin-releasing hormone) with a kcat/Km value of 0.5 and 0.1 s-1·μM-1 resp.  The half-life of TRH and GnRH was dramatically reduced in the plasma of trypanosome-infected rats, both in vitro and in vivo.  Employing an activity-neutralizing anti-trypanosome PGP antibody, and pyroglutamyl diazomethyl ketone, a specific inhibitor of type I PGP, we demonstrated that trypanosome PGP is entirely responsible for the reduced plasma half-life of TRH, and partially responsible for the reduced plasma half-life of GnRH in a rodent model of African trypanosomiasis.  The abnormal degrdn. of TRH and GnRH, and perhaps other neuropeptides N-terminally blocked with a pyroglutamyl moiety, by trypanosome PGP, may contribute to some of the endocrine lesions obsd. in African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP81Dkgd4tTLVg90H21EOLACvtfcHk0ljiChqwydexsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVemtbk%253D&md5=b3178bda663c10250215cb1d87577e45</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1042%2FBJ20051593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20051593%26sid%3Dliteratum%253Aachs%26aulast%3DMorty%26aufirst%3DR.%2BE.%26aulast%3DBulau%26aufirst%3DP.%26aulast%3DPelle%26aufirst%3DR.%26aulast%3DWilk%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DPyroglutamyl%2520peptidase%2520type%2520I%2520from%2520Trypanosoma%2520brucei%253A%2520a%2520new%2520virulence%2520factor%2520from%2520African%2520trypanosomes%2520that%2520de-blocks%2520regulatory%2520peptides%2520in%2520the%2520plasma%2520of%2520infected%2520hosts%26jtitle%3DBiochem.%2520J.%26date%3D2006%26volume%3D394%26spage%3D635%26epage%3D45%26doi%3D10.1042%2FBJ20051593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1007/s00401-015-1395-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-015-1395-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25666182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2MrktVCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2015&pages=565-83&author=M.+Hartlage-Rubsamenauthor=A.+Waniekauthor=J.+Meissnerauthor=M.+Morawskiauthor=S.+Schillingauthor=C.+Jagerauthor=M.+Kleinschmidtauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=H.+U.+Demuthauthor=S.+Rossner&title=Isoglutaminyl+cyclase+contributes+to+CCL2-driven+neuroinflammation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-015-1395-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease</span></div><div class="casAuthors">Hartlage-Rubsamen Maike; Waniek Alexander; Meissner Juliane; Morawski Markus; Schilling Stephan; Jager Carsten; Kleinschmidt Martin; Cynis Holger; Kehlen Astrid; Arendt Thomas; Demuth Hans-Ulrich; Rossner Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">565-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The brains of Alzheimer's disease (AD) patients are characterized by deposits of Abeta peptides and by accompanying chronic inflammation.  Here, we provide evidence that the enzyme isoglutaminyl cyclase (isoQC) is a novel factor contributing to both aspects of AD pathology.  Two putative substrates of isoQC, N-truncated Abeta peptides and the monocyte chemoattractant chemokine CCL2, undergo isoQC-catalyzed pyroglutamate (pGlu) modification.  This triggers Abeta aggregation and facilitates the biological activity of CCL2, which collectively results in the formation of high molecular weight Abeta aggregates, glial cell activation, neuroinflammation and neuronal cell death.  In mouse brain, we found isoQC to be neuron-specifically expressed in neocortical, hippocampal and subcortical structures, localized to the endoplasmic reticulum and Golgi apparatus as well as co-expressed with its substrate CCL2.  In aged APP transgenic Tg2576 mice, both isoQC and CCL2 mRNA levels are up-regulated and isoQC and CCL2 proteins were found to be co-induced in Abeta plaque-associated reactive astrocytes.  Also, in mouse primary astrocyte culture, a simultaneous up-regulation of isoQC and CCL2 expression was revealed upon Abeta and pGlu-Abeta stimulation.  In brains of AD patients, the expression of isoQC and CCL2 mRNA and protein is up-regulated compared to controls and correlates with pGlu-Abeta load and with the decline in mini-mental state examination.  Our observations provide evidence for a dual involvement of isoQC in AD pathogenesis by catalysis of pGlu-Abeta and pGlu-CCL2 formation which mutually stimulate inflammatory events and affect cognition.  We conclude that isoQC inhibition may target both major pathological events in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKSXYAxDU0oENoizSOkG_FfW6udTcc2eYf5JVmUsheBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrktVCqsA%253D%253D&md5=ab30e02a5766b18080d5e5542d74d5a8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs00401-015-1395-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-015-1395-2%26sid%3Dliteratum%253Aachs%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DMeissner%26aufirst%3DJ.%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DIsoglutaminyl%2520cyclase%2520contributes%2520to%2520CCL2-driven%2520neuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2015%26volume%3D129%26spage%3D565%26epage%3D83%26doi%3D10.1007%2Fs00401-015-1395-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellvard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maresz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydel, P.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclases as novel targets for the treatment of septic arthritis</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1093/infdis/jis729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Finfdis%2Fjis729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23204180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2013&pages=768-77&author=A.+Hellvardauthor=K.+Mareszauthor=S.+Schillingauthor=S.+Graubnerauthor=U.+Heiserauthor=R.+Jonssonauthor=H.+Cynisauthor=H.+U.+Demuthauthor=J.+Potempaauthor=P.+Mydel&title=Glutaminyl+cyclases+as+novel+targets+for+the+treatment+of+septic+arthritis&doi=10.1093%2Finfdis%2Fjis729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclases as Novel Targets for the Treatment of Septic Arthritis</span></div><div class="casAuthors">Hellvard, Annelie; Maresz, Katarzyna; Schilling, Stephan; Graubner, Sigrid; Heiser, Ulrich; Jonsson, Roland; Cynis, Holger; Demuth, Hans-Ulrich; Potempa, Jan; Mydel, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">768-777</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Septic arthritis is a severe and rapidly debilitating disease mainly caused by Staphylococcus aureus.  Here, we assess the antiarthritic efficiency of glutaminyl cyclase (QC) inhibitors.  Methods. Mice were inoculated with an arthritogenic amt. of S. aureus i.v. or by local administration into the knee joint.  Animals were treated with QC inhibitors (PBD155 and PQ529) via chow during the expt.  QC and isoQC knockout mice were also analyzed for arthritis symptoms after local administration of bacteria.  Results. Both QC inhibitors significantly delayed the onset of clin. signs of arthritis, and inhibitors significantly decreased wt. loss in treated animals.  Following intraarticular injection of S. aureus, PBD155-treated mice had lower levels of synovitis and bone erosion, as well as less myeloperoxidase in synovial tissue.  Fluorescence-activated cell sorter anal. revealed that PBD155 treatment affected the expression pattern of adhesion mols., preventing the upregulation of cells expressing CD11b/CD18.  Conclusion.  The compds. investigated here represent a novel class of small mol. antiarthritic inhibitors.  In our studies, they exerted strong antiinflammatory actions, and therefore they might be suited for disease-modifying treatment of infectious arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo4yVYVMrBzLVg90H21EOLACvtfcHk0lgB3py-iWQwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wmtbk%253D&md5=2c10eb602ffb85bd1bb984ce8b688084</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjis729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjis729%26sid%3Dliteratum%253Aachs%26aulast%3DHellvard%26aufirst%3DA.%26aulast%3DMaresz%26aufirst%3DK.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DJonsson%26aufirst%3DR.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26atitle%3DGlutaminyl%2520cyclases%2520as%2520novel%2520targets%2520for%2520the%2520treatment%2520of%2520septic%2520arthritis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D207%26spage%3D768%26epage%3D77%26doi%3D10.1093%2Finfdis%2Fjis729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamohara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span> <span> </span><span class="NLM_article-title">MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1002/jlb.65.5.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fjlb.65.5.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10331497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=671-9&author=S.+Yamashiroauthor=H.+Kamoharaauthor=T.+Yoshimura&title=MCP-1+is+selectively+expressed+in+the+late+phase+by+cytokine-stimulated+human+neutrophils%3A+TNF-alpha+plays+a+role+in+maximal+MCP-1+mRNA+expression&doi=10.1002%2Fjlb.65.5.671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in maximal MCP-1 mRNA expression</span></div><div class="casAuthors">Yamashiro, Shigeo; Kamohara, Hidenobu; Yoshimura, Teizo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">671-679</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Culture supernatants of phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PHA-sup) induced monocyte chemoattractant protein-1 (MCP-1) mRNA expression in human neutrophils.  MCP-1 mRNA was first detected by Northern anal. at 8 h, and the peak level was detected at 16 h and sustained until 72 h.  Cycloheximide and genistein, but not pertussis toxin, inhibited the expression of MCP-1 mRNA.  Recombinant tumor necrosis factor α (TNF-α) induced a low level MCP-1 mRNA accumulation in neutrophils, and addn. of anti-TNF-α IgG blocked 30-70% of MCP-1 mRNA expression induced with PHA-sup.  PHA-sup-stimulated PMN synthesized and secreted 3.1±1.3 ng/5×106 PMN MCP-1 within the first 24 h.  Hybridization of 32P-labeled cDNA prepns. to an array of human cytokine cDNAs further indicated that MCP-1 mRNA was selectively up-regulated in the late phase after stimulation with the PHA-sup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOaYzQILY_F7Vg90H21EOLACvtfcHk0lgB3py-iWQwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGhtrY%253D&md5=27687e01ed597defda59b9e46f7a3bad</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fjlb.65.5.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.65.5.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamashiro%26aufirst%3DS.%26aulast%3DKamohara%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DT.%26atitle%3DMCP-1%2520is%2520selectively%2520expressed%2520in%2520the%2520late%2520phase%2520by%2520cytokine-stimulated%2520human%2520neutrophils%253A%2520TNF-alpha%2520plays%2520a%2520role%2520in%2520maximal%2520MCP-1%2520mRNA%2520expression%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1999%26volume%3D65%26spage%3D671%26epage%3D9%26doi%3D10.1002%2Fjlb.65.5.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Novel approach to inhibiting chemokine function</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1002/emmm.201100161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Femmm.201100161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21882341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=510-2&author=M.+F.+Lingauthor=A.+D.+Luster&title=Novel+approach+to+inhibiting+chemokine+function&doi=10.1002%2Femmm.201100161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approach to inhibiting chemokine function</span></div><div class="casAuthors">Ling, Morris F.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">510-512</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The research of Cynis et al. (2011) entitled 'The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions' is reviewed with commentary and refs.  Cynis et al. present evidence that enzymes, such as metalloenzyme transferases, specifically glutaminyl cyclase and iso-glutaminyl cyclase, play a role in the in vivo biol. activity of CCL2 by catalyzing the formation of N-terminal pyroglutamate, which confers resistance against aminopeptidase degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkFprrwJffrVg90H21EOLACvtfcHk0lgB3py-iWQwmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7jL&md5=5d91c7ee3aefdcb4bf3778177d12a02f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100161%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DM.%2BF.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DNovel%2520approach%2520to%2520inhibiting%2520chemokine%2520function%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D510%26epage%3D2%26doi%3D10.1002%2Femmm.201100161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardiman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">A new class of membrane-bound chemokine with a CX3C motif</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/385640a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F385640a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9024663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2sXht1yks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=640-4&author=J.+F.+Bazanauthor=K.+B.+Baconauthor=G.+Hardimanauthor=W.+Wangauthor=K.+Sooauthor=D.+Rossiauthor=D.+R.+Greavesauthor=A.+Zlotnikauthor=T.+J.+Schall&title=A+new+class+of+membrane-bound+chemokine+with+a+CX3C+motif&doi=10.1038%2F385640a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of membrane-bound chemokine with a CX3C motif</span></div><div class="casAuthors">Bazan, J. Fernando; Bacon, Kevin B.; Hardiman, Gary; Wang, Wei; Soo, Ken; Rossl, Devora; Greaves, David R.; Zlotnik, Albert; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">6617</span>),
    <span class="NLM_cas:pages">640-644</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Chemokines direct the trafficking of white blood cells in immune surveillance, playing a key role in inflammatory and infectious diseases such as AIDS.  All chemokines studied so far are secreted proteins of relative mol. mass ∼7K-15K and fall into three families that are defined by a cysteine signature motif: CXC, CC and C (refs 3, 6, 7), where C is a cysteine and X any amino-acid residue.  The authors report here the identification and characterization of a fourth human chemokine type, derived from non-hemopoietic cells and bearing a new CX3C fingerprint.  Unlike other chemokine types the polypeptide chain of the human CX3C chemokine is predicted to be part of a 373-amino-acid protein that carries the chemokine domain on top of an extended mucin-like stalk.  This mol. can exist in two forms: either membrane-anchored or as a shed 95K glycoprotein.  The sol. CX3C chemokine has potent chemoattractant activity for T cells and monocytes, and the cell-surface-bound protein, which is induced on activated primary endothelial cells, promotes strong adhesion of those leukocytes.  The structure, biochem. features, tissue distribution and chromosomal localization of CX3C chemokine all indicate that it represents a unique class of chemokine that may contribute part of the mol. control of leukocyte traffic at the endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGCDgNU9IybVg90H21EOLACvtfcHk0liVTTkgOVsVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1yks7w%253D&md5=95e350c92137d13c11d36d72989cf52b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2F385640a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385640a0%26sid%3Dliteratum%253Aachs%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26aulast%3DHardiman%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSoo%26aufirst%3DK.%26aulast%3DRossi%26aufirst%3DD.%26aulast%3DGreaves%26aufirst%3DD.%2BR.%26aulast%3DZlotnik%26aufirst%3DA.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DA%2520new%2520class%2520of%2520membrane-bound%2520chemokine%2520with%2520a%2520CX3C%2520motif%26jtitle%3DNature%26date%3D1997%26volume%3D385%26spage%3D640%26epage%3D4%26doi%3D10.1038%2F385640a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alperin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culpepper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Ramos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, D.</span></span> <span> </span><span class="NLM_article-title">Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1038/42491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F42491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9177350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2sXktFCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=611-7&author=Y.+Panauthor=C.+Lloydauthor=H.+Zhouauthor=S.+Dolichauthor=J.+Deedsauthor=J.+A.+Gonzaloauthor=J.+Vathauthor=M.+Gosselinauthor=J.+Maauthor=B.+Dussaultauthor=E.+Woolfauthor=G.+Alperinauthor=J.+Culpepperauthor=J.+C.+Gutierrez-Ramosauthor=D.+Gearing&title=Neurotactin%2C+a+membrane-anchored+chemokine+upregulated+in+brain+inflammation&doi=10.1038%2F42491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation</span></div><div class="casAuthors">Pan, Yang; Lloyd, Clare; Zhou, Hong; Dolich, Sylvia; Deeds, Jim; Gonzalo, Jose-Angel; Vath, Jim; Gosselin, Mike; Ma, Jingya; Dussault, Barry; Woolf, Elizabeth; Alperin, Geoff; Culpepper, Janice; Gutierrez-Ramos, Jose Carlos; Gearing, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6633</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Chemokines are small secreted proteins that stimulate the directional migration of leukocytes and mediate inflammation.  During screening of a murine choroid plexus complementary DNA library, the authors identified a new chemokine, designated neurotactin.  Unlike other chemokines, neurotactin has a unique cysteine pattern, Cys-X-X-X-Cys, and is predicted to be a type 1 membrane protein.  Full-length recombinant neurotactin is localized on the surface of transfected 293 cells.  Recombinant neurotactin contg. the chemokine domain is chemotactic for neutrophils both in vitro and in vivo.  Neurotactin mRNA is predominantly expressed in normal murine brain and its protein expression in activated brain microglia is upregulated in mice with exptl. autoimmune encephalomyelitis, as well as in mice treated with lipopolysaccharide.  Distinct from all other chemokine genes, the neurotactin gene is localized to human chromosome 16q.  Consequently the authors propose that neurotactin represents a new δ-chemokine family and that it may play a role in brain inflammation processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrieudM4ZMZibVg90H21EOLACvtfcHk0liVTTkgOVsVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFCitLc%253D&md5=0206dad37fdb5558cc0f1fa6faceb048</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2F42491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F42491%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDolich%26aufirst%3DS.%26aulast%3DDeeds%26aufirst%3DJ.%26aulast%3DGonzalo%26aufirst%3DJ.%2BA.%26aulast%3DVath%26aufirst%3DJ.%26aulast%3DGosselin%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DDussault%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DE.%26aulast%3DAlperin%26aufirst%3DG.%26aulast%3DCulpepper%26aufirst%3DJ.%26aulast%3DGutierrez-Ramos%26aufirst%3DJ.%2BC.%26aulast%3DGearing%26aufirst%3DD.%26atitle%3DNeurotactin%252C%2520a%2520membrane-anchored%2520chemokine%2520upregulated%2520in%2520brain%2520inflammation%26jtitle%3DNature%26date%3D1997%26volume%3D387%26spage%3D611%26epage%3D7%26doi%3D10.1038%2F42491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steeber, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span> <span> </span><span class="NLM_article-title">Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1084/jem.188.8.1413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1084%2Fjem.188.8.1413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9782118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXmslKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1998&pages=1413-9&author=A.+M.+Fongauthor=L.+A.+Robinsonauthor=D.+A.+Steeberauthor=T.+F.+Tedderauthor=O.+Yoshieauthor=T.+Imaiauthor=D.+D.+Patel&title=Fractalkine+and+CX3CR1+mediate+a+novel+mechanism+of+leukocyte+capture%2C+firm+adhesion%2C+and+activation+under+physiologic+flow&doi=10.1084%2Fjem.188.8.1413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow</span></div><div class="casAuthors">Fong, Alan M.; Robinson, Lisa A.; Steeber, Douglas A.; Tedder, Thomas F.; Yoshie, Osamu; Imai, Toshio; Patel, Dhavalkumar D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1413-1419</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Leukocyte migration into sites of inflammation involves multiple mol. interactions between leukocytes and vascular endothelial cells, mediating sequential leukocyte capture, rolling, and firm adhesion.  Here, the authors tested the role of mol. interactions between fractalkine (FKN), a transmembrane mucin-chemokine hybrid mol. expressed on activated endothelium, and its receptor (CX3CR1) in leukocyte capture, firm adhesion, and activation under physiol. flow conditions.  Immobilized FKN fusion proteins captured resting peripheral blood mononuclear cells at physiol. wall shear stresses and induced firm adhesion of resting monocytes, resting and interleukin (IL)-2-activated CD8+ T lymphocytes, and IL-2-activated NK cells.  FKN also induced cell shape change in firmly adherent monocytes and IL-2-activated lymphocytes.  CX3CR1-transfected K562 cells, but not control K562 cells, firmly adhered to FKN-expressing ECV-304 cells (ECV-FKN) and tumor necrosis factor α-activated human umbilical vein endothelial cells.  This firm adhesion was not inhibited by pertussis toxin, EDTA/EGTA, or anti-integrin antibodies, indicating that the firm adhesion was integrin independent.  Thus, FKN mediated the rapid capture, integrin-independent firm adhesion, and activation of circulating leukocytes under flow.  Thus, FKN and CX3CR1 mediate a novel pathway for leukocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHofbf-vgcLVg90H21EOLACvtfcHk0liVTTkgOVsVnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslKltb8%253D&md5=caf11c991d6ab42759e8d08491b42474</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1084%2Fjem.188.8.1413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.188.8.1413%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DA.%2BM.%26aulast%3DRobinson%26aufirst%3DL.%2BA.%26aulast%3DSteeber%26aufirst%3DD.%2BA.%26aulast%3DTedder%26aufirst%3DT.%2BF.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26atitle%3DFractalkine%2520and%2520CX3CR1%2520mediate%2520a%2520novel%2520mechanism%2520of%2520leukocyte%2520capture%252C%2520firm%2520adhesion%252C%2520and%2520activation%2520under%2520physiologic%2520flow%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D188%26spage%3D1413%26epage%3D9%26doi%3D10.1084%2Fjem.188.8.1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallon-Eberhard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zigmond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farache, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shezen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span> <span> </span><span class="NLM_article-title">In vivo structure/function and expression analysis of the CX3C chemokine fractalkine</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">e156</span>– <span class="NLM_lpage">e167</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-04-348946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1182%2Fblood-2011-04-348946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21951685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=e156-e167&author=K.+W.+Kimauthor=A.+Vallon-Eberhardauthor=E.+Zigmondauthor=J.+Faracheauthor=E.+Shezenauthor=G.+Shakharauthor=A.+Ludwigauthor=S.+A.+Liraauthor=S.+Jung&title=In+vivo+structure%2Ffunction+and+expression+analysis+of+the+CX3C+chemokine+fractalkine&doi=10.1182%2Fblood-2011-04-348946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo structure/function and expression analysis of the CX3C chemokine fractalkine</span></div><div class="casAuthors">Kim, Ki-Wook; Vallon-Eberhard, Alexandra; Zigmond, Ehud; Farache, Julia; Shezen, Elias; Shakhar, Guy; Ludwig, Andreas; Lira, Sergio A.; Jung, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e156-e167</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The CX3C chemokine family is composed of only one member, CX3CL1, also known as fractalkine, which in mice is the sole ligand of the G protein-coupled, 7-transmembrane receptor CX3CR1.  Unlike classic small peptide chemokines, CX3CL1 is synthesized as a membrane-anchored protein that can promote integrin-independent adhesion.  Subsequent cleavage by metalloproteases, either constitutive or induced, can generate shed CX3CL1 entities that potentially have chemoattractive activity.  To study the CX3C interface in tissues of live animals, we generated transgenic mice (CX3CL1cherry:CX3CR1gfp), which express red and green fluorescent reporter genes under the resp. control of the CX3CL1 and CX3CR1 promoters.  Furthermore, we performed a structure/function anal. to differentiate the in vivo functions of membrane-tethered vs. shed CX3CL1 moieties by comparing their resp. ability to correct established defects in macrophage function and leukocyte survival in CX3CL1-deficient mice.  Specifically, expression of CX3CL1105Δ, an obligatory sol. CX3CL1 isoform, reconstituted the formation of transepithelial dendrites by intestinal macrophages but did not rescue circulating Ly6Clo CX3CR1hi blood monocytes in CX3CR1gfp/gfp mice.  Instead, monocyte survival required the full-length membrane-anchored CX3CL1, suggesting differential activities of tethered and shed CX3CL1 entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGuqon47Z_d7Vg90H21EOLACvtfcHk0lg3jtjFqDEAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfL&md5=ff6bba2a0a30f127f461fcfd788aeb68</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-04-348946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-04-348946%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DVallon-Eberhard%26aufirst%3DA.%26aulast%3DZigmond%26aufirst%3DE.%26aulast%3DFarache%26aufirst%3DJ.%26aulast%3DShezen%26aufirst%3DE.%26aulast%3DShakhar%26aufirst%3DG.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DLira%26aufirst%3DS.%2BA.%26aulast%3DJung%26aufirst%3DS.%26atitle%3DIn%2520vivo%2520structure%252Ffunction%2520and%2520expression%2520analysis%2520of%2520the%2520CX3C%2520chemokine%2520fractalkine%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3De156%26epage%3De167%26doi%3D10.1182%2Fblood-2011-04-348946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1042/BSR20170712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBSR20170712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=37&author=A.+Kehlenauthor=M.+Haegeleauthor=L.+Bohmeauthor=H.+Cynisauthor=T.+Hoffmannauthor=H.+U.+Demuth&title=N-terminal+pyroglutamate+formation+in+CX3CL1+is+essential+for+its+full+biologic+activity&doi=10.1042%2FBSR20170712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBSR20170712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20170712%26sid%3Dliteratum%253Aachs%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DN-terminal%2520pyroglutamate%2520formation%2520in%2520CX3CL1%2520is%2520essential%2520for%2520its%2520full%2520biologic%2520activity%26jtitle%3DBiosci.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D37%26doi%3D10.1042%2FBSR20170712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immel, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang-Vu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klonisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Role of glutaminyl cyclases in thyroid carcinomas</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1530/ERC-12-0053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1530%2FERC-12-0053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23183267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Wnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=79-90&author=A.+Kehlenauthor=M.+Haegeleauthor=K.+Mengeauthor=K.+Gansauthor=U.+D.+Immelauthor=C.+Hoang-Vuauthor=T.+Klonischauthor=H.+U.+Demuth&title=Role+of+glutaminyl+cyclases+in+thyroid+carcinomas&doi=10.1530%2FERC-12-0053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glutaminyl cyclases in thyroid carcinomas</span></div><div class="casAuthors">Kehlen, Astrid; Haegele, Monique; Menge, Katja; Gans, Kathrin; Immel, Uta-Dorothee; Hoang-Vu, Cuong; Klonisch, Thomas; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-90</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">CCL2 is a chemokine known to recruit monocytes/macrophages to sites of inflammation.  CCL2 is also assocd. with tumor progression in several cancer types.  Recently, we showed that the N-terminus of CCL2 is modified to a pyroglutamate (pE)-residue by both glutaminyl cyclases (QC (QPCT)) and its isoenzyme (isoQC (QPCTL)).  The pE-residue increases stability against N-terminal degrdn. by aminopeptidases.  Here, we report an upregulation of QPCT expression in tissues of patients with thyroid carcinomas compared with goiter tissues, whereas QPCTL was not regulated.  In thyroid carcinoma cell lines, QPCT gene expression correlates with the mRNA levels of its substrate CCL2.  Both QPCT and CCL2 are regulated in a NF-κB-dependent pathway shown by stimulation with TNFa and IL1b as well as by inhibition with the IKK2 inhibitor and RNAi of p50.  In the culture supernatant of thyroid carcinoma cells, equal amts. of pECCL2 and total CCL2 were detected by two ELISAs discriminating between total CCL2 and pECCL2, concluding that all CCL2 is secreted as pECCL2.  Activation of the CCL2/CCR2 pathway by recombinant CCL2 increased tumor cell migration of FTC238 cells in scratch assays as well as thyroid carcinoma cell-derived CCL2-induced migration of monocytic THP1 cells.  Suppression of CCL2 signaling by CCR2 antagonist, IKK2 inhibitor, and QPCT RNAi reduced FTC238 cell growth measured by WST8 proliferation assays.  Our results reveal new evidence for a novel role of QC in thyroid carcinomas and provide an intriguing rationale for the use of QC inhibitors as a means of blocking pECCL2 formation and preventing thyroid cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomPAfI_6VjirVg90H21EOLACvtfcHk0lg3jtjFqDEAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Wnsrk%253D&md5=5581d4220e8d7bf0479765cebabf9a2b</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1530%2FERC-12-0053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FERC-12-0053%26sid%3Dliteratum%253Aachs%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DMenge%26aufirst%3DK.%26aulast%3DGans%26aufirst%3DK.%26aulast%3DImmel%26aufirst%3DU.%2BD.%26aulast%3DHoang-Vu%26aufirst%3DC.%26aulast%3DKlonisch%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DRole%2520of%2520glutaminyl%2520cyclases%2520in%2520thyroid%2520carcinomas%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2013%26volume%3D20%26spage%3D79%26epage%3D90%26doi%3D10.1530%2FERC-12-0053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Berg, T. K.</span></span> <span> </span><span class="NLM_article-title">The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1146%2Fannurev-immunol-032713-120142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24215318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=25-50&author=A.+N.+Barclayauthor=T.+K.+Van+den+Berg&title=The+interaction+between+signal+regulatory+protein+alpha+%28SIRPalpha%29+and+CD47%3A+structure%2C+function%2C+and+therapeutic+target&doi=10.1146%2Fannurev-immunol-032713-120142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target</span></div><div class="casAuthors">Barclay, A. Neil; van den Berg, Timo K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-50</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  CD47 is a broadly expressed membrane protein that interacts with the myeloid inhibitory immunoreceptor SIRPα (also termed CD172a or SHPS-1).  SIRPα is the prototypic member of the SIRP paired receptor family of closely related SIRP proteins.  Engagement of SIRPα by CD47 provides a downregulatory signal that inhibits host cell phagocytosis, and CD47 therefore functions as a "don't-eat-me" signal.  Here, we discuss recent structural anal. of CD47-SIRPα interactions and implications of this for the function and evolution of SIRPα and paired receptors in general.  Furthermore, we review the proposed roles of CD47-SIRPα interactions in phagocytosis, (auto)immunity, and host defense, as well as its potential significance as a therapeutic target in cancer and inflammation and for improving graft survival in xenotransplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNJXce0UL47Vg90H21EOLACvtfcHk0lg3jtjFqDEAVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemtro%253D&md5=473668c1b298de00984d39ce76a1eee2</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120142%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DA.%2BN.%26aulast%3DVan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26atitle%3DThe%2520interaction%2520between%2520signal%2520regulatory%2520protein%2520alpha%2520%2528SIRPalpha%2529%2520and%2520CD47%253A%2520structure%252C%2520function%252C%2520and%2520therapeutic%2520target%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D25%26epage%3D50%26doi%3D10.1146%2Fannurev-immunol-032713-120142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Identification of glutaminyl cyclase isoenzyme isoQC as a regulator of SIRPalpha-CD47 axis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0177-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fs41422-019-0177-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31089204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BB3M7lvVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=502-505&author=Z.+Wuauthor=L.+Wengauthor=T.+Zhangauthor=H.+Tianauthor=L.+Fangauthor=H.+Tengauthor=W.+Zhangauthor=J.+Gaoauthor=Y.+Haoauthor=Y.+Liauthor=H.+Zhouauthor=P.+Wang&title=Identification+of+glutaminyl+cyclase+isoenzyme+isoQC+as+a+regulator+of+SIRPalpha-CD47+axis&doi=10.1038%2Fs41422-019-0177-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis</span></div><div class="casAuthors">Wu Zhiqiang; Weng Linjun; Zhang Tengbo; Tian Hongling; Fang Lan; Teng Hongqi; Zhang Wen; Hao Yun; Li Yaxu; Wang Ping; Gao Jing; Zhou Hu</div><div class="citationInfo"><span class="NLM_cas:title">Cell research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">502-505</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl7MGHClp5dOQ4Pl9hzjQhfW6udTcc2eZj5ADb3kSJkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7lvVSmsA%253D%253D&md5=c84d45212623bb116f3a804f4bd5f8ff</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0177-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0177-0%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DTeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520glutaminyl%2520cyclase%2520isoenzyme%2520isoQC%2520as%2520a%2520regulator%2520of%2520SIRPalpha-CD47%2520axis%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D502%26epage%3D505%26doi%3D10.1038%2Fs41422-019-0177-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Logtenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raaben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toebes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsma, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matlung, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Eerland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Schot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marijt, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Berg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummelkamp, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leusen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, T. N.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPalpha axis and a target for cancer immunotherapy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/s41591-019-0356-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fs41591-019-0356-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=30833751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsV2isbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=612-619&author=M.+Logtenbergauthor=J.+Jansenauthor=M.+Raabenauthor=M.+Toebesauthor=K.+Frankeauthor=A.+M.+Brandsmaauthor=H.+L.+Matlungauthor=A.+Fausterauthor=R.+Gomez-Eerlandauthor=N.+Bakkerauthor=S.+van+der+Schotauthor=K.+A.+Marijtauthor=M.+Verdoesauthor=J.+Haanenauthor=J.+H.+van+den%0ABergauthor=J.+Neefjesauthor=T.+K.+van+den+Bergauthor=T.+R.+Brummelkampauthor=J.+Leusenauthor=F.+A.+Scheerenauthor=T.+N.+Schumacher&title=Glutaminyl+cyclase+is+an+enzymatic+modifier+of+the+CD47-+SIRPalpha+axis+and+a+target+for+cancer+immunotherapy&doi=10.1038%2Fs41591-019-0356-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy</span></div><div class="casAuthors">Logtenberg, Meike E. W.; Jansen, J. H. Marco; Raaben, Matthijs; Toebes, Mireille; Franke, Katka; Brandsma, Arianne M.; Matlung, Hanke L.; Fauster, Astrid; Gomez-Eerland, Raquel; Bakker, Noor A. M.; van der Schot, Simone; Marijt, Koen A.; Verdoes, Martijn; Haanen, John B. A. G.; van den Berg, Joost H.; Neefjes, Jacques; van den Berg, Timo K.; Brummelkamp, Thijn R.; Leusen, Jeanette H. W.; Scheeren, Ferenc A.; Schumacher, Ton N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">612-619</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Cancer cells can evade immune surveillance through the expression of inhibitory ligands that bind their cognate receptors on immune effector cells.  Expression of programmed death ligand 1 in tumor microenvironments is a major immune checkpoint for tumor-specific T cell responses as it binds to programmed cell death protein-1 on activated and dysfunctional T cells1.  The activity of myeloid cells such as macrophages and neutrophils is likewise regulated by a balance between stimulatory and inhibitory signals.  In particular, cell surface expression of the CD47 protein creates a 'don't eat me' signal on tumor cells by binding to SIRPα expressed on myeloid cells2-5.  Using a haploid genetic screen, we here identify glutaminyl-peptide cyclotransferase-like protein (QPCTL) as a major component of the CD47-SIRPα checkpoint.  Biochem. anal. demonstrates that QPCTL is crit. for pyroglutamate formation on CD47 at the SIRPα binding site shortly after biosynthesis.  Genetic and pharmacol. interference with QPCTL activity enhances antibody-dependent cellular phagocytosis and cellular cytotoxicity of tumor cells.  Furthermore, interference with QPCTL expression leads to a major increase in neutrophil-mediated killing of tumor cells in vivo.  These data identify QPCTL as a novel target to interfere with the CD47 pathway and thereby augment antibody therapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1nAWsTLtLXrVg90H21EOLACvtfcHk0liRU3_ViQY_iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsV2isbs%253D&md5=31633e74a28064cd223eaee966f99b49</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fs41591-019-0356-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-019-0356-z%26sid%3Dliteratum%253Aachs%26aulast%3DLogtenberg%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DJ.%26aulast%3DRaaben%26aufirst%3DM.%26aulast%3DToebes%26aufirst%3DM.%26aulast%3DFranke%26aufirst%3DK.%26aulast%3DBrandsma%26aufirst%3DA.%2BM.%26aulast%3DMatlung%26aufirst%3DH.%2BL.%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DGomez-Eerland%26aufirst%3DR.%26aulast%3DBakker%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BSchot%26aufirst%3DS.%26aulast%3DMarijt%26aufirst%3DK.%2BA.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DHaanen%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DJ.%2BH.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DLeusen%26aufirst%3DJ.%26aulast%3DScheeren%26aufirst%3DF.%2BA.%26aulast%3DSchumacher%26aufirst%3DT.%2BN.%26atitle%3DGlutaminyl%2520cyclase%2520is%2520an%2520enzymatic%2520modifier%2520of%2520the%2520CD47-%2520SIRPalpha%2520axis%2520and%2520a%2520target%2520for%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D612%26epage%3D619%26doi%3D10.1038%2Fs41591-019-0356-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. S.</span></span> <span> </span><span class="NLM_article-title">Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">27</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-4-27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F1479-5876-4-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16820060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BD28rhslCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=27&author=J.+S.+Gillis&title=Microarray+evidence+of+glutaminyl+cyclase+gene+expression+in+melanoma%3A+implications+for+tumor+antigen+specific+immunotherapy&doi=10.1186%2F1479-5876-4-27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy</span></div><div class="casAuthors">Gillis John Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  In recent years encouraging progress has been made in developing vaccine treatments for cancer, particularly with melanoma.  However, the overall rate of clinically significant results has remained low.  The present research used microarray datasets from previous investigations to examine gene expression patterns in cancer cell lines with the goal of better understanding the tumor microenvironment.  METHODS:  Principal Components Analyses with Promax rotational transformations were carried out with 90 cancer cell lines from 3 microarray datasets, which had been made available on the internet as supplementary information from prior publications.  RESULTS:  In each of the analyses a well defined melanoma component was identified that contained a gene coding for the enzyme, glutaminyl cyclase, which was as highly expressed as genes from a variety of well established biomarkers for melanoma, such as MAGE-3 and MART-1, which have frequently been used in clinical trials of melanoma vaccines.  CONCLUSION:  Since glutaminyl cyclase converts glutamine and glutamic acid into a pyroglutamic form, it may interfere with the tumor destructive process of vaccines using peptides having glutamine or glutamic acid at their N-terminals.  Finding ways of inhibiting the activity of glutaminyl cyclase in the tumor microenvironment may help to increase the effectiveness of some melanoma vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwd2DRJfoRkdenUz0lpNqnfW6udTcc2eZj5ADb3kSJkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhslCluw%253D%253D&md5=7d6217cdc9dcdcea6a8f644e31166683</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-4-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-4-27%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DJ.%2BS.%26atitle%3DMicroarray%2520evidence%2520of%2520glutaminyl%2520cyclase%2520gene%2520expression%2520in%2520melanoma%253A%2520implications%2520for%2520tumor%2520antigen%2520specific%2520immunotherapy%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2006%26volume%3D4%26spage%3D27%26doi%3D10.1186%2F1479-5876-4-27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muthusamy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curley, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosenberg, M.</span></span> <span> </span><span class="NLM_article-title">Epigenetic silencing of novel tumor suppressors in malignant melanoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">11187</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-1274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1158%2F0008-5472.CAN-06-1274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=17145863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11187-93&author=V.+Muthusamyauthor=S.+Duraisamyauthor=C.+M.+Bradburyauthor=C.+Hobbsauthor=D.+P.+Curleyauthor=B.+Nelsonauthor=M.+Bosenberg&title=Epigenetic+silencing+of+novel+tumor+suppressors+in+malignant+melanoma&doi=10.1158%2F0008-5472.CAN-06-1274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma</span></div><div class="casAuthors">Muthusamy, Viswanathan; Duraisamy, Sekhar; Bradbury, C. Matthew; Hobbs, Cara; Curley, David P.; Nelson, Betsy; Bosenberg, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11187-11193</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant melanoma is a common and frequently lethal disease.  Current therapeutic interventions have little effect on survival, emphasizing the need for a better understanding of the genetic, epigenetic, and phenotypic changes in melanoma formation and progression.  We identified 17 genes that were not previously known to be silenced by methylation in melanoma using a microarray-based screen following treatment of melanoma cell lines with the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.  Eight of these genes have not been previously shown to undergo DNA methylation in any form of cancer.  Three of the genes, QPCT, CYP1B1, and LXN, are densely methylated in >95% of uncultured melanoma tumor samples.  Reexpression of either of two of the silenced genes, HOXB13 and SYK, resulted in reduced colony formation in vitro and diminished tumor formation in vivo, indicating that these genes function as tumor suppressors in melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytm6jFv95CrVg90H21EOLACvtfcHk0lhNFkh-ke59rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnsL7E&md5=c611ca8d4653a07d4c30a416568c8cc2</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-1274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-1274%26sid%3Dliteratum%253Aachs%26aulast%3DMuthusamy%26aufirst%3DV.%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DBradbury%26aufirst%3DC.%2BM.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DCurley%26aufirst%3DD.%2BP.%26aulast%3DNelson%26aufirst%3DB.%26aulast%3DBosenberg%26aufirst%3DM.%26atitle%3DEpigenetic%2520silencing%2520of%2520novel%2520tumor%2520suppressors%2520in%2520malignant%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11187%26epage%3D93%26doi%3D10.1158%2F0008-5472.CAN-06-1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emi, M.</span></span> <span> </span><span class="NLM_article-title">Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1359/JBMR.040324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1359%2FJBMR.040324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15231017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=1296-301&author=Y.+Ezuraauthor=M.+Kajitaauthor=R.+Ishidaauthor=S.+Yoshidaauthor=H.+Yoshidaauthor=T.+Suzukiauthor=T.+Hosoiauthor=S.+Inoueauthor=M.+Shirakiauthor=H.+Orimoauthor=M.+Emi&title=Association+of+multiple+nucleotide+variations+in+the+pituitary+glutaminyl+cyclase+gene+%28QPCT%29+with+low+radial+BMD+in+adult+women&doi=10.1359%2FJBMR.040324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women</span></div><div class="casAuthors">Ezura, Yoichi; Kajita, Mitsuko; Ishida, Ryota; Yoshida, Shoko; Yoshida, Hideyo; Suzuki, Takao; Hosoi, Takayuki; Inoue, Satoshi; Shiraki, Masataka; Orimo, Hajime; Emi, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1296-1301</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Alterations in homeostatic regulation of estrogen through the hypothalamus-pituitary-gonadal axis (HPG axis) importantly affect the pathogenesis of osteoporosis.  Osteoporosis-susceptibility genes have been proposed in this hormonal axis, such as estrogen receptor genes and the gonadotropin-releasing hormone gene (GnRH).  Here the authors report another example of genes: glutaminyl-peptide cyclotransferase gene (QPCT), an essential modifier of pituitary peptide hormones, including GnRH.  Analyses of assocn. of 13 single nucleotide polymorphisms (SNPs) at the QPCT locus with adjusted areal BMD (adj-aBMD) were carried out among 384 adult women.  Linkage disequil. (LD) was analyzed by haplotype estn. and calcn. of D' and R2.  Multiple regression anal. was applied for evaluating the combined effects of the variations.  LD anal. indicated strong linkage disequil. within the entire 30-kb region of the QPCT gene.  Significant correlations were obsd. between the genotypes of the six SNPs and the radial adj-aBMD, among which R54W (nt + 160C> T) presented the most prominent assocn.  Striking assocn. was obsd. for these SNPs among the 309 subjects >50 yr of age (R54W, -1095T> C, - 1844C> T).  Multiple regression analyses indicated that multiple SNPs in the gene might act in combination to det. the radial adj-aBMD.  These results indicate that genetic variations in QPCT are the important factors affecting the BMD of adult women that contribute to susceptibility for osteoporosis.  The data should provide new insight into the etiol. of the disease and may suggest a new target to be considered during treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYPn7wtTboLVg90H21EOLACvtfcHk0lhNFkh-ke59rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFGqurg%253D&md5=48108525531b6bfc3a2679ef0fa03018</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1359%2FJBMR.040324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252FJBMR.040324%26sid%3Dliteratum%253Aachs%26aulast%3DEzura%26aufirst%3DY.%26aulast%3DKajita%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHosoi%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DShiraki%26aufirst%3DM.%26aulast%3DOrimo%26aufirst%3DH.%26aulast%3DEmi%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520multiple%2520nucleotide%2520variations%2520in%2520the%2520pituitary%2520glutaminyl%2520cyclase%2520gene%2520%2528QPCT%2529%2520with%2520low%2520radial%2520BMD%2520in%2520adult%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2004%26volume%3D19%26spage%3D1296%26epage%3D301%26doi%3D10.1359%2FJBMR.040324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batliwalla, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baechler, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalili, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortmann, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulko, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregersen, P. K.</span></span> <span> </span><span class="NLM_article-title">Peripheral blood gene expression profiling in rheumatoid arthritis</span>. <i>Genes Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1038/sj.gene.6364209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fsj.gene.6364209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15973463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=388-97&author=F.+M.+Batliwallaauthor=E.+C.+Baechlerauthor=X.+Xiaoauthor=W.+Liauthor=S.+Balasubramanianauthor=H.+Khaliliauthor=A.+Damleauthor=W.+A.+Ortmannauthor=A.+Perroneauthor=A.+B.+Kantorauthor=P.+S.+Gulkoauthor=M.+Kernauthor=R.+Furieauthor=T.+W.+Behrensauthor=P.+K.+Gregersen&title=Peripheral+blood+gene+expression+profiling+in+rheumatoid+arthritis&doi=10.1038%2Fsj.gene.6364209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral blood gene expression profiling in rheumatoid arthritis</span></div><div class="casAuthors">Batliwalla, F. M.; Baechler, E. C.; Xiao, X.; Li, W.; Balasubramanian, S.; Khalili, H.; Damle, A.; Ortmann, W. A.; Perrone, A.; Kantor, A. B.; Gulko, P. S.; Kern, M.; Furie, R.; Behrens, T. W.; Gregersen, P. K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">GEIMA2</span>;
        ISSN:<span class="NLM_cas:issn">1466-4879</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors carried out gene expression profiling of peripheral blood mononuclear cells (PBMCs) in 29 patients with active rheumatoid arthritis (RA) and 21 control subjects using Affymetrix U95Av2 arrays.  Using cluster anal., the authors obsd. a significant alteration in the expression pattern of 81 genes in the PBMCs of RA patients compared with controls.  Many of these genes correlated with differences in monocyte counts between the two study populations, and the authors show that a large fraction of these genes are specifically expressed at high levels in monocytes.  In addn., a logistic regression anal. was performed to identify genes that performed best in the categorization of RA and control samples.  Glutaminyl cyclase, IL1RA, S100A12 (also known as calgranulin or EN-RAGE) and Grb2-assocd. binding protein (GAB2) were among the top discriminators.  Along with previous data, the overexpression of S100A12 in RA patients emphasizes the likely importance of RAGE pathways in disease pathogenesis.  The altered expression of GAB2, an intracellular adaptor mol. involved in regulating phosphatase function, is of particular interest given the recent identification of the intracellular phosphatase PTPN22 as a risk gene for RA.  These data suggest that a detailed study of gene expression patterns in peripheral blood can provide insight into disease pathogenesis.  However, it is also clear that substantially larger sample sizes will be required to evaluate fully gene expression profiling as a means of identifying disease subsets, or defining biomarkers of outcome and response to therapy in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra4PsSqC88CLVg90H21EOLACvtfcHk0lhNFkh-ke59rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFCht70%253D&md5=ef85af46c9cb0f4406068ea751b0ffbf</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.gene.6364209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gene.6364209%26sid%3Dliteratum%253Aachs%26aulast%3DBatliwalla%26aufirst%3DF.%2BM.%26aulast%3DBaechler%26aufirst%3DE.%2BC.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DKhalili%26aufirst%3DH.%26aulast%3DDamle%26aufirst%3DA.%26aulast%3DOrtmann%26aufirst%3DW.%2BA.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DKantor%26aufirst%3DA.%2BB.%26aulast%3DGulko%26aufirst%3DP.%2BS.%26aulast%3DKern%26aufirst%3DM.%26aulast%3DFurie%26aufirst%3DR.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DGregersen%26aufirst%3DP.%2BK.%26atitle%3DPeripheral%2520blood%2520gene%2520expression%2520profiling%2520in%2520rheumatoid%2520arthritis%26jtitle%3DGenes%2520Immun.%26date%3D2005%26volume%3D6%26spage%3D388%26epage%3D97%26doi%3D10.1038%2Fsj.gene.6364209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taudte, N.</span>; <span class="NLM_string-name">Linnert, M.</span>; <span class="NLM_string-name">Rahfeld, J. U.</span>; <span class="NLM_string-name">Piechotta, A.</span>; <span class="NLM_string-name">Ramsbeck, D.</span>; <span class="NLM_string-name">Buchholz, M.</span>; <span class="NLM_string-name">Kolenko, P.</span>; <span class="NLM_string-name">Parthier, C.</span>; <span class="NLM_string-name">Houston, J. A.</span>; <span class="NLM_string-name">Veillard, F.</span>; <span class="NLM_string-name">Eick, S.</span>; <span class="NLM_string-name">Potempa, J.</span>; <span class="NLM_string-name">Schilling, S.</span>; <span class="NLM_string-name">Demuth, H. U.</span>; <span class="NLM_string-name">Stubbs, M. N.</span></span> <span> </span><span class="NLM_article-title">Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis</span>.  <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>. <span class="NLM_volume">296</span> <span class="NLM_fpage">100263</span><span class="refDoi"> DOI: 10.1016/j.jbc.2021.100263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jbc.2021.100263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=33837744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3MXjvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2021&pages=100263&author=N.+Taudte&author=M.+Linnert&author=J.+U.+Rahfeld&author=A.+Piechotta&author=D.+Ramsbeck&author=M.+Buchholz&author=P.+Kolenko&author=C.+Parthier&author=J.+A.+Houston&author=F.+Veillard&author=S.+Eick&author=J.+Potempa&author=S.+Schilling&author=H.+U.+Demuth&author=M.+N.+Stubbs&title=Mammalian-like+type+II+glutaminyl+cyclases+in+Porphyromonas+gingivalis+and+other+oral+pathogenic+bacteria+as+targets+for+treatment+of+periodontitis&doi=10.1016%2Fj.jbc.2021.100263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis</span></div><div class="casAuthors">Taudte, Nadine; Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Kolenko, Petr; Parthier, Christoph; Houston, John A.; Veillard, Florian; Eick, Sigrun; Potempa, Jan; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100263</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The development of a targeted therapy would significantly improve the treatment of periodontitis and its assocd. diseases including Alzheimer's disease, rheumatoid arthritis, and cardiovascular diseases.  Glutaminyl cyclases (QCs) from the oral pathogens Porphyromonas gingivalis, Tannerella forsythia, and Prevotella intermedia represent attractive target enzymes for small-mol. inhibitor development, as their action is likely to stabilize essential periplasmic and outer membrane proteins by N-terminal pyroglutamination.  In contrast to other microbial QCs that utilize the so-called type I enzymes, these oral pathogens possess sequences corresponding to type II QCs, obsd. hitherto only in animals.  However, whether differences between these bacteroidal QCs and animal QCs are sufficient to enable development of selective inhibitors is not clear.  To learn more, we recombinantly expressed all three QCs.  They exhibit comparable catalytic efficiencies and are inhibited by metal chelators.  Crystal structures of the enzymes from P. gingivalis (PgQC) and T. forsythia (TfQC) reveal a tertiary structure composed of an eight-stranded β-sheet surrounded by seven α-helixes, typical of animal type II QCs.  In each case, an active site Zn ion is tetrahedrally coordinated by conserved residues.  Nevertheless, significant differences to mammalian enzymes are found around the active site of the bacteroidal enzymes.  Application of a PgQC-selective inhibitor described here for the first time results in growth inhibition of two P. gingivalis clin. isolates in a dose-dependent manner.  The insights gained by these studies will assist in the development of highly specific small-mol. bacteroidal QC inhibitors, paving the way for alternative therapies against periodontitis and assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUiS9Dkp14z7Vg90H21EOLACvtfcHk0lik0kBV4Iei2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXjvVClsbg%253D&md5=69972c56def59106454fc03e68554db6</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.jbc.2021.100263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbc.2021.100263%26sid%3Dliteratum%253Aachs%26aulast%3DTaudte%26aufirst%3DN.%26atitle%3DMammalian-like%2520type%2520II%2520glutaminyl%2520cyclases%2520in%2520Porphyromonas%2520gingivalis%2520and%2520other%2520oral%2520pathogenic%2520bacteria%2520as%2520targets%2520for%2520treatment%2520of%2520periodontitis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2021%26volume%3D296%26spage%3D100263%26doi%3D10.1016%2Fj.jbc.2021.100263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobral, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, J. A.</span></span> <span> </span><span class="NLM_article-title">An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3179</span>– <span class="NLM_lpage">3194</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.4155%2Ffmc-2019-0163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31838899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3179-3194&author=J.+R.+Coimbraauthor=P.+J.+Sobralauthor=A.+E.+Santosauthor=P.+I.+Moreiraauthor=J.+A.+Salvador&title=An+overview+of+glutaminyl+cyclase+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2019-0163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of glutaminyl cyclase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Coimbra, Judite R. M.; Sobral, Pedro J. M.; Santos, Armanda E.; Moreira, Paula I.; Salvador, Jorge A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3179-3194</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  A diverse range of N-terminally truncated and modified forms of amyloid-beta oligomers have been discovered in Alzheimer's disease brains, including the pyroglutamate-Abeta (AbetapE3).  AbetapE3 species are shown to be more neurotoxic when compared with the full-length Abeta peptide.  Findings visibly suggest that glutaminyl cyclase (QC) catalyzed the generation of cerebral AbetapE3, and therapeutic effects are achieved by reducing its activity.  In recent years, efforts to effectively develop QC inhibitors have been pursued worldwide.  The inhibitory activity of current QC inhibitors is mainly triggered by zinc-binding groups that coordinate Zn2+ ion in the active site and other common features.  Herein, we summarized the current state of discovery and evolution of QC inhibitors as a potential Alzheimer's disease-modifying strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJEVzG-EOcLVg90H21EOLACvtfcHk0lik0kBV4Iei2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygurnP&md5=9b00581d2eebd176a457359e1d906d76</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0163%26sid%3Dliteratum%253Aachs%26aulast%3DCoimbra%26aufirst%3DJ.%2BR.%26aulast%3DSobral%26aufirst%3DP.%2BJ.%26aulast%3DSantos%26aufirst%3DA.%2BE.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DSalvador%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520overview%2520of%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D3179%26epage%3D3194%26doi%3D10.4155%2Ffmc-2019-0163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">104342</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.104342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.phrs.2019.104342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31288079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2019&pages=104342&author=D.+K.+Vijayanauthor=K.+Zhang&title=Human+glutaminyl+cyclase%3A+Structure%2C+function%2C+inhibitors+and+involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.phrs.2019.104342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease</span></div><div class="casAuthors">Vijayan, Dileep K.; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104342</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Human glutaminyl cyclase (hQC) is an important enzyme for post-translational modification by converting the N-terminal glutaminyl and glutamyl into pyroglutamate (pGlu) through cyclization.  The two isoforms of hQC, secretory glutaminyl cyclase (sQC) and golgi resident glutaminyl cyclase (gQC), are involved in various pathol. conditions esp. in Alzheimer's disease (AD).  The sQC is known to mediate the formation of pyroglutamate contg. amyloid beta (pGlu-Aβ) peptides while gQC mediates the maturation of C-C motif chemokine ligand 2 (CCL2).  Therefore, hQC (both sQC and gQC) inhibition is considered to be an attractive strategy to prevent the formation of pGlu-Aβ and to reduce neuroinflammation and hence provides a new opportunity for the treatment of AD.  In this review, we summarize our current understanding on the structure, function and inhibitors of hQC and its involvement in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb9DQ27eP80LVg90H21EOLACvtfcHk0lik0kBV4Iei2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjs7jJ&md5=af10a7c83d600e00a02713a45c64eb2c</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.104342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.104342%26sid%3Dliteratum%253Aachs%26aulast%3DVijayan%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DHuman%2520glutaminyl%2520cyclase%253A%2520Structure%252C%2520function%252C%2520inhibitors%2520and%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D147%26spage%3D104342%26doi%3D10.1016%2Fj.phrs.2019.104342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niestroj, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunkel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-77&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0lik0kBV4Iei2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D77%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-46&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0linwDKxM9ntww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D46%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7069</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-80&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0linwDKxM9ntww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D80%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6613</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-25&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0linwDKxM9ntww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D25%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3821</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-30&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0lig6zaD0UgYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D30%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokorny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glund, K.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span>. <i>Alzheimers Dement (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29854937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+Buhringauthor=T.+Hoffmannauthor=K.+Kuhn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesaauthor=K.+Glund&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span></div><div class="casAuthors">Lues Inge; Weber Frank; Meyer Antje; Buhring Uli; Hoffmann Torsten; Kuhn-Wache Kerstin; Manhart Susanne; Heiser Ulrich; Glund Konrad; Pokorny Rolf; Chiesa Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-195</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Pyroglutamate-amyloid-β (pE-Aβ) peptides are major components of Aβ-oligomers and Aβ-plaques, which are regarded as key culprits of Alzheimer's disease (AD) pathology.  PQ912 is a competitive inhibitor of the enzyme glutaminyl cyclase (QC), essential for the formation of pE-Aβ peptides.  Methods:  A randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study investigated the safety, pharmacokinetics, and pharmacodynamics of PQ912 in healthy nonelderly and elderly subjects.  Results:  PQ912 was considered safe and well tolerated with dose-proportional pharmacokinetics up to doses of 200 mg.  At higher doses up to 1800 mg, exposure was supraproportional and exposure in elderly subjects was approximately 1.5- to 2.1-fold higher.  Exposure in cerebrospinal fluid (CSF) was approximately 20% of the unbound drug in plasma, and both serum and CSF QC activity was inhibited in a dose-related manner.  Discussion:  This first-in-man study of a compound-targeting QC inhibition justifies further development of PQ912 for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_8LDrMzHWYDjk2McQZ6XmfW6udTcc2eanzQRpHfnL8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D&md5=49cc7018331e760dfef1b844f93cc31c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26aulast%3DGlund%26aufirst%3DK.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimers%2520Dement%2520%2528N%2520Y%2529%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of Alzheimer’s ddisease-studies on relation to effective target cccupancy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.240614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1124%2Fjpet.117.240614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=28446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=119-130&author=T.+Hoffmannauthor=A.+Meyerauthor=U.+Heiserauthor=S.+Kuratauthor=L.+Bohmeauthor=M.+Kleinschmidtauthor=K.+U.+Buhringauthor=B.+Hutter-Paierauthor=M.+Farcherauthor=H.+U.+Demuthauthor=I.+Luesauthor=S.+Schilling&title=Glutaminyl+cyclase+inhibitor+PQ912+improves+cognition+in+mouse+models+of+Alzheimer%E2%80%99s+ddisease-studies+on+relation+to+effective+target+cccupancy&doi=10.1124%2Fjpet.117.240614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of alzheimer's disease-studies on relation to effective target occupancy</span></div><div class="casAuthors">Hoffmann, Torsten; Meyer, Antje; Heiser, Ulrich; Kurat, Stephan; Boehme, Livia; Kleinschmidt, Martin; Buehring, Karl-Ulrich; Hutter-Paier, Birgit; Farcher, Martina; Demuth, Hans-Ulrich; Lues, Inge; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Numerous studies suggest that the majority of amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) are truncated and post-translationally modified at the N terminus.  Among these modified species, pyroglutamyl-Aβ(pE-Aβ, including N3pE-Aβ40/42 and N11pE-Aβ40/42) has been identified as particularly neurotoxic.  The N-terminal modification renders the peptide hydrophobic, accelerates formation of oligomers, and reduces degrdn. by peptidases, leading ultimately to the accumulation of the peptide and progression of AD.  It has been shown that the formation of pyroglutamyl residues is catalyzed by glutaminyl cyclase (QC).  Here, we present data about the pharmacol. in vitro and in vivo efficacy of the QC inhibitor (S)-1-(1H-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one (PQ912), the first-in-class compd. that is in clin. development.  PQ912 inhibits human, rat, and mouse QC activity, with Ki values ranging between 20 and 65 nM.  Chronic oral treatment of hAPPSLxhQC double-transgenic mice with approx. 200 mg/kg/day via chow shows a significant redn. of pE-Aβ levels and concomitant improvement of spatial learning in a Morris water maze test paradigm.  This dose results in a brain and cerebrospinal fluid concn. of PQ912 which relates to a QC target occupancy of about 60%.  Thus, we conclude that >50% inhibition of QC activity in the brain leads to robust treatment effects.  Secondary pharmacol. expts. in mice indicate a fairly large potency difference for Aβ cyclization compared with cyclization of physiol. substrates, suggesting a robust therapeutic window in humans.  This information constitutes an important translational guidance for predicting the therapeutic dose range in clin. studies with PQ912.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9VVUSISdmtrVg90H21EOLACvtfcHk0lig6zaD0UgYTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J&md5=080e83d1ac24b892e74a556f04db9232</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.240614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.240614%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKurat%26aufirst%3DS.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DBuhring%26aufirst%3DK.%2BU.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DFarcher%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520improves%2520cognition%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520ddisease-studies%2520on%2520relation%2520to%2520effective%2520target%2520cccupancy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D119%26epage%3D130%26doi%3D10.1124%2Fjpet.117.240614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duning, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teunissen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Baal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, N. D.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">107</span>, <span class="refDoi"> DOI: 10.1186/s13195-018-0431-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13195-018-0431-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=107&author=P.+Scheltensauthor=M.+Hallikainenauthor=T.+Grimmerauthor=T.+Duningauthor=A.+A.+Gouwauthor=C.+E.+Teunissenauthor=A.+M.+Winkauthor=P.+Maruffauthor=J.+Harrisonauthor=C.+M.+van+Baalauthor=S.+Bruinsauthor=I.+Luesauthor=N.+D.+Prins&title=Safety%2C+tolerability+and+efficacy+of+the+glutaminyl+cyclase+inhibitor+PQ912+in+Alzheimer%E2%80%99s+disease%3A+results+of+a+randomized%2C+double-blind%2C+placebo-controlled+phase+2a+study&doi=10.1186%2Fs13195-018-0431-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study</span></div><div class="casAuthors">Scheltens, Philip; Hallikainen, Merja; Grimmer, Timo; Duning, Thomas; Gouw, Alida A.; Teunissen, Charlotte E.; Wink, Alle Meije; Maruff, Paul; Harrison, John; van Baal, Caroline M.; Bruins, Suzanne; Lues, Inge; Prins, Niels D.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107/1-107/14</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">PQ912 is an inhibitor of the glutaminyl cyclase enzyme that plays a central role in the formation of synaptotoxic pyroglutamate-A-beta oligomers.  We report on the first clin. study with PQ912 in subjects with biomarker-proven Alzheimer's disease (AD).  The aim was to det. the maximal tolerated dose, target occupancy and treatment-related pharmacodynamic effects.  The exploratory efficacy readouts selected were tailored to the patient population with early AD.  The therapeutic approach focuses on synaptic dysfunction as captured by various measures such as electroencephalog. (EEG), synaptic biomarkers and sensitive cognitive tests.  This was a randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability and efficacy of PQ912 800 mg twice daily (bid) for 12 wk in subjects with mild cognitive impairment or mild dementia due to AD.  The 120 enrolled subjects were treatment-naive at the start of the study, had confirmed AD biomarkers in their cerebrospinal fluid at screening and had a Mini Mental State Examn. score between 21 and 30.  After 1 wk of treatment with 400 mg bid, patients were up-titrated to 800 mg bid for 11 wk.  Patients were randomized 1:1 to either PQ912 or placebo.  The primary composite endpoints were to assess safety and tolerability based on the no. of patients who discontinued due to (serious) adverse events (safety), and based on dose adjustment during the treatment period and/or nonadherence to randomized treatment (tolerability).  All randomized subjects who took at least one dose of the study treatment or placebo were used for safety analyses.  There was no significant difference between treatments in the no. of subjects with (serious) adverse events, although there were slightly more patients with a serious adverse event in the PQ912 group compared to placebo.  More subjects treated with PQ912 discontinued treatment due to adverse events, mostly related to gastrointestinal and skin/s.c. tissue disorders.  PQ912 treatment resulted in a significant redn. in glutaminyl cyclase activity, which resulted in an av. target occupancy of > 90%.  A significant redn. of theta power in the EEG frequency anal. and a significant improvement in the One Back test of our Neuropsychol. Test Battery was obsd.  The exploratory biomarker readouts, neurogranin for synaptic toxicity and YKL-40 as a marker of inflammation, appear to be sensitive enough to serve as efficacy markers in the next phase 2b study.  The maximal tolerated dose of PQ912 has been identified and the results support future studies at still lower doses reaching > 50% target occupancy, a longer up-titrn. phase to potentially induce adaptation and longer treatment periods to confirm the early signals of efficacy as seen in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9X6Ko8VxX17Vg90H21EOLACvtfcHk0lioM5dHugK4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFSitrY%253D&md5=80d2d7b91cf2b62e3cfda6f60cec80d3</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1186%2Fs13195-018-0431-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-018-0431-6%26sid%3Dliteratum%253Aachs%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DHallikainen%26aufirst%3DM.%26aulast%3DGrimmer%26aufirst%3DT.%26aulast%3DDuning%26aufirst%3DT.%26aulast%3DGouw%26aufirst%3DA.%2BA.%26aulast%3DTeunissen%26aufirst%3DC.%2BE.%26aulast%3DWink%26aufirst%3DA.%2BM.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DJ.%26aulast%3Dvan%2BBaal%26aufirst%3DC.%2BM.%26aulast%3DBruins%26aufirst%3DS.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DPrins%26aufirst%3DN.%2BD.%26atitle%3DSafety%252C%2520tolerability%2520and%2520efficacy%2520of%2520the%2520glutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520results%2520of%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25202a%2520study%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2018%26volume%3D10%26spage%3D107%26doi%3D10.1186%2Fs13195-018-0431-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6664</span>– <span class="NLM_lpage">6677</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6664-6677&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Liauthor=Y.+Zouauthor=Y.+Zhengauthor=Z.+Heauthor=Z.+Liuauthor=J.+Quanauthor=X.+Buauthor=H.+Wu&title=Synthesis+and+evaluation+of+diphenyl+conjugated+imidazole+derivatives+as+potential+glutaminyl+cyclase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Li, Yue; Zou, Yongdong; Zheng, Yizhi; He, Zhendan; Liu, Zhigang; Quan, Junmin; Bu, Xianzhang; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6664-6677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer's disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides.  Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD.  In this work, a series of di-Ph conjugated imidazole derivs. (DPCIs) was rationally designed and synthesized.  Analogs with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood-brain barrier (BBB) permeability.  Further assessments corroborated that the selected hQC inhibitor I inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrmUpYJCVhrVg90H21EOLACvtfcHk0lioM5dHugK4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE&md5=8ffec76fc13fbe8520675ee884c12772</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520conjugated%2520imidazole%2520derivatives%2520as%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6664%26epage%3D6677%26doi%3D10.1021%2Facs.jmedchem.7b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer’s agents based on rational design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2573-2590&author=V.+H.+Hoangauthor=P.+T.+Tranauthor=M.+Cuiauthor=V.+T.+Ngoauthor=J.+Annauthor=J.+Parkauthor=J.+Leeauthor=K.+Choiauthor=H.+Choauthor=H.+Kimauthor=H.+J.+Haauthor=H.+S.+Hongauthor=S.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Discovery+of+potent+human+glutaminyl+cyclase+inhibitors+as+anti-Alzheimer%E2%80%99s+agents+based+on+rational+design&doi=10.1021%2Facs.jmedchem.7b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design</span></div><div class="casAuthors">Hoang, Van-Hai; Tran, Phuong-Thao; Cui, Minghua; Ngo, Van T. H.; Ann, Jihyae; Park, Jongmi; Lee, Jiyoun; Choi, Kwanghyun; Cho, Hanyang; Kim, Hee; Ha, Hee-Jin; Hong, Hyun-Seok; Choi, Sun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2573-2590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer's disease (AD).  The authors designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E-42.  An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor.  When tested in mouse models of AD, compd. 212 (I) significantly reduced the brain concns. of pyroform Aβ and total Aβ and restored cognitive functions.  This potent Aβ-lowering effect was achieved by incorporating an addnl. binding region into the authors' previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu 327 in the QC binding site.  The authors' study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqaMS-1r-2bVg90H21EOLACvtfcHk0lioM5dHugK4JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D&md5=856a0159f8249b82f8b79d25ab162973</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DNgo%26aufirst%3DV.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520based%2520on%2520rational%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2573%26epage%3D2590%26doi%3D10.1021%2Facs.jmedchem.7b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer’s agents: Structure-activity relationship study of Arg-mimetic region</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29398442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1035-1049&author=V.+Ngoauthor=V.+H.+Hoangauthor=P.+T.+Tranauthor=J.+Annauthor=M.+Cuiauthor=G.+Parkauthor=S.+Choiauthor=J.+Leeauthor=H.+Kimauthor=H.+J.+Haauthor=K.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Potent+human+glutaminyl+cyclase+inhibitors+as+potential+anti-Alzheimer%E2%80%99s+agents%3A+Structure-activity+relationship+study+of+Arg-mimetic+region&doi=10.1016%2Fj.bmc.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region</span></div><div class="casAuthors">Ngo, Van T. H.; Hoang, Van-Hai; Tran, Phuong-Thao; Ann, Jihyae; Cui, Minghua; Park, Gyungseo; Choi, Sun; Lee, Jiyoun; Kim, Hee; Ha, Hee-Jin; Choi, Kwanghyun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1049</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pyroglutamate-modified amyloid β peptides (pGlu-Aβ) are highly neurotoxic and promote the formation of amyloid plaques.  The pGlu-Aβ peptides are generated by glutaminyl cyclase (QC), and recent clin. studies indicate that QC represents an alternative therapeutic target to treat Alzheimer's disease (AD).  We have previously developed a series of QC inhibitors with an extended pharmacophoric scaffold, termed the Arg-mimetic D-region.  In the present study, we focused on the structure activity relationship (SAR) of analogs with modifications in the D-region and evaluated their biol. activity.  Most compds. in this series exhibited potent activity in vitro, and our SAR anal. and the mol. docking studies identified compd. 202 as a potential candidate because it forms an addnl. hydrophobic interaction in the hQC active site.  Overall, our study provides valuable insights into the Arg-mimetic pharmacophore that will guide the design of novel QC inhibitors as potential treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozmm9ncHC6lLVg90H21EOLACvtfcHk0lg8I0CAmFchiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSitb8%253D&md5=84704aa18b76f7af3d5671ab578702e2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DPotent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520agents%253A%2520Structure-activity%2520relationship%2520study%2520of%2520Arg-mimetic%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1035%26epage%3D1049%26doi%3D10.1016%2Fj.bmc.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Manh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2018.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29705377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3133-3144&author=V.+Ngoauthor=V.+H.+Hoangauthor=P.+T.+Tranauthor=N.+Van+Manhauthor=J.+Annauthor=E.+Kimauthor=M.+Cuiauthor=S.+Choiauthor=J.+Leeauthor=H.+Kimauthor=H.+J.+Haauthor=K.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Structure-activity+relationship+investigation+of+Phe-Arg+mimetic+region+of+human+glutaminyl+cyclase+inhibitors&doi=10.1016%2Fj.bmc.2018.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Ngo, Van T. H.; Hoang, Van-Hai; Tran, Phuong-Thao; Van Manh, Nguyen; Ann, Jihyae; Kim, Eunhye; Cui, Minghua; Choi, Sun; Lee, Jiyoun; Kim, Hee; Ha, Hee-Jin; Choi, Kwanghyun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3133-3144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) is a promising therapeutic target because of its involvement in the pathogenesis of Alzheimer's disease.  In this study, the authors developed novel QC inhibitors that contain 3-aminoalkyloxy-4-methoxyphenyl and 4-aminoalkyloxyphenyl groups to replace the previously developed pharmacophore.  Several potent inhibitors were identified, showing IC50 values in a low nanomolar range, and were further studied for in vitro toxicity and in vivo activity.  Among these, inhibitors 51 (N-(3-(2-aminoethoxy)-4-methoxyphenyl)-N'-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea) and 53 (N-(3-(4-aminobutoxy)-4-methoxyphenyl)-N'-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea) displayed the most potent AβN3pE-40-lowering effects in in vivo acute model with reasonable BBB penetration, without showing cytotoxicity and hERG inhibition.  The mol. modeling anal. of 53 indicated that the salt bridge interaction and the hydrogen bonding in the active site provided a high potency.  Given the potent activity and favorable BBB penetration with low cytotoxicity, the authors believe that compd. 53 may serve as a potential candidate for anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4mNvlTQiobVg90H21EOLACvtfcHk0lg8I0CAmFchiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFWgs7g%253D&md5=a9926b0f68904525e84928917e770334</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DVan%2BManh%26aufirst%3DN.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520investigation%2520of%2520Phe-Arg%2520mimetic%2520region%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3133%26epage%3D3144%26doi%3D10.1016%2Fj.bmc.2018.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span> <span> </span><span class="NLM_article-title">The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1007/s00775-018-1605-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00775-018-1605-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=30132075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1219-1226&author=C.+Pozziauthor=F.+Di+Pisaauthor=M.+Benvenutiauthor=S.+Mangani&title=The+structure+of+the+human+glutaminyl+cyclase-SEN177+complex+indicates+routes+for+developing+new+potent+inhibitors+as+possible+agents+for+the+treatment+of+neurological+disorders&doi=10.1007%2Fs00775-018-1605-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders</span></div><div class="casAuthors">Pozzi, Cecilia; Di Pisa, Flavio; Benvenuti, Manuela; Mangani, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1219-1226</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent evidence links the role of human glutaminyl cyclase (hQC) to the amyloidogenic process involved in Alzheimer's disease (AD).  HQC is a zinc enzyme present in neuronal tissue and its activity is responsible for the cyclization of N-terminal Gln or Glu β-amyloid peptides, leading to N-pyroglutamic acid peptides (pE-Aβ) that is probably a crucial event in the initiation and progress of the disease.  Indeed, pE-contg. peptides exhibit an elevated neurotoxicity and a tendency to aggregate.  These observations render hQC inhibition an attractive strategy for developing new mols. active against AD.  The authors present here the crystal structure of hQC in complex with SEN177, a newly designed mol.  The SEN177-binding mode to hQC differs from that of the known hQC inhibitors.  SEN177 Ki on hQC is 20 nM, comparable or better than that of the most potent known hQC inhibitors PBD150 and PQ912.  In addn., SEN177 already demonstrated relevant pharmacol. properties in in vivo models of Huntington's disease.  All these properties make SEN177 an important scaffold for developing mols. acting on AD and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC4vrTtxA_rVg90H21EOLACvtfcHk0lgLlV3KejbRSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqt7bM&md5=dd4fac1d9264d75f5e8a0b18dd19ca3f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2Fs00775-018-1605-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-018-1605-1%26sid%3Dliteratum%253Aachs%26aulast%3DPozzi%26aufirst%3DC.%26aulast%3DDi%2BPisa%26aufirst%3DF.%26aulast%3DBenvenuti%26aufirst%3DM.%26aulast%3DMangani%26aufirst%3DS.%26atitle%3DThe%2520structure%2520of%2520the%2520human%2520glutaminyl%2520cyclase-SEN177%2520complex%2520indicates%2520routes%2520for%2520developing%2520new%2520potent%2520inhibitors%2520as%2520possible%2520agents%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2018%26volume%3D23%26spage%3D1219%26epage%3D1226%26doi%3D10.1007%2Fs00775-018-1605-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally restricted human glutaminyl cyclase inhibitors as potent anti-Alzheimer’s agents by structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8011-8027&author=V.+H.+Hoangauthor=V.+Ngoauthor=M.+Cuiauthor=N.+V.+Manhauthor=P.+T.+Tranauthor=J.+Annauthor=H.+J.+Haauthor=H.+Kimauthor=K.+Choiauthor=Y.+H.+Kimauthor=H.+Changauthor=S.+Macalinoauthor=J.+Leeauthor=S.+Choiauthor=J.+Lee&title=Discovery+of+conformationally+restricted+human+glutaminyl+cyclase+inhibitors+as+potent+anti-Alzheimer%E2%80%99s+agents+by+structure-based+design&doi=10.1021%2Facs.jmedchem.9b00751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design</span></div><div class="casAuthors">Hoang, Van-Hai; Ngo, Van T. H.; Cui, Minghua; Manh, Nguyen Van; Tran, Phuong-Thao; Ann, Jihyae; Ha, Hee-Jin; Kim, Hee; Choi, Kwanghyun; Kim, Young-Ho; Chang, Hyerim; Macalino, Stephani Joy Y.; Lee, Jiyoun; Choi, Sun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8011-8027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD.  Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients.  On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivs. were developed.  The structure-activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogs, and several selected compds. demonstrated desirable therapeutic activity in an AD mouse model.  The conformational anal. of a representative inhibitor indicated that the inhibitor appeared to maintain the Z-E conformation at the active site, as it is crit. for its potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKWajqMIkJrVg90H21EOLACvtfcHk0lgLlV3KejbRSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP&md5=5830439908c727943bfc534ff1030308</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DManh%26aufirst%3DN.%2BV.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DMacalino%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520conformationally%2520restricted%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potent%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8011%26epage%3D8027%26doi%3D10.1021%2Facs.jmedchem.9b00751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antidementia effects of a new Zn(II) coordination polymer</span>. <i>Biomedical Research</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1237-1239&issue=4&author=C.+L.+Hanauthor=R.+Fuauthor=W.+F.+Lei&title=Synthesis+and+antidementia+effects+of+a+new+Zn%28II%29+coordination+polymer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antidementia effects of a new Zn(II) coordination polymer</span></div><div class="casAuthors">Han, Chuan-Lai; Fu, Rong; Lei, Wei-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Research (Aligarh, India)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1237-1239</span>CODEN:
                <span class="NLM_cas:coden">BIRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0970-938X</span>.
    
            (<span class="NLM_cas:orgname">Scientific Publishers of India</span>)
        </div><div class="casAbstract">A new 2D layered framework structure, namely, {[Zn(TPA)2](DMA)3}n (1, HTPA = 4-(1,2,4-triazol-4-yl)phenylacetic acid; DMA = N,N-Dimethylacetamide) were obtained under solvothermal conditions and structurally characterized.  The x-ray studies shown that 1 possess a stair-shaped 2D (4,4) network.  In addn., cholinesterase inhibitory activities in vitro of the title compd. and its corresponding org. ligand toward Glutaminyl cyclase (GC), Neprilysin (NeP) and Acetylcholine esterase (AChE) were further detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMH9VHvpqdbVg90H21EOLACvtfcHk0lgLlV3KejbRSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWqtL3M&md5=bfaa0acb885bb3bc56c9de937c8e2e9d</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%2BL.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DW.%2BF.%26atitle%3DSynthesis%2520and%2520antidementia%2520effects%2520of%2520a%2520new%2520Zn%2528II%2529%2520coordination%2520polymer%26jtitle%3DBiomedical%2520Research%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D1237%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayana, M. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, S.</span></span> <span> </span><span class="NLM_article-title">3D-QSAR CoMFA Study on Human Glutaminyl Cyclase Inhibitors</span>. <i>Internet Electronic Journal of Molecular Design</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=6&author=M.+R.+S.+Nayanaauthor=Y.+N.+Sekharauthor=N.+S.+Kumariauthor=S.+Mahmood&title=3D-QSAR+CoMFA+Study+on+Human+Glutaminyl+Cyclase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayana%26aufirst%3DM.%2BR.%2BS.%26aulast%3DSekhar%26aufirst%3DY.%2BN.%26aulast%3DKumari%26aufirst%3DN.%2BS.%26aulast%3DMahmood%26aufirst%3DS.%26atitle%3D3D-QSAR%2520CoMFA%2520Study%2520on%2520Human%2520Glutaminyl%2520Cyclase%2520Inhibitors%26jtitle%3DInternet%2520Electronic%2520Journal%2520of%2520Molecular%2520Design%26date%3D2007%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, Y. S.</span></span> <span> </span><span class="NLM_article-title">CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.3109/14756366.2011.654111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3109%2F14756366.2011.654111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22304474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=515-22&author=V.+Kumarauthor=M.+K.+Guptaauthor=G.+Singhauthor=Y.+S.+Prabhakar&title=CP-MLR%2FPLS+directed+QSAR+study+on+the+glutaminyl+cyclase+inhibitory+activity+of+imidazoles%3A+rationales+to+advance+the+understanding+of+activity+profile&doi=10.3109%2F14756366.2011.654111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile</span></div><div class="casAuthors">Kumar, Viney; Gupta, Manish K.; Singh, Gagandip; Prabhakar, Yenamandra S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-522</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The glutaminyl cyclase inhibitory activity of a series of imidazoles has been analyzed through combinatorial protocol in multiple linear regressions (CP-MLR) and partial least square using different topol. and structural descriptors.  The QC activity was found to be correlated with 2D-autocorrelation (2DAUTO) and atom centered fragments (ACF) descriptors.  The descriptor from 2DAUTO class showed that mol. structure frames of one, six and seven path length assocd. with at. van der Waals vols. and polarizability hold scope for modulating QC inhibitory activity.  The ACF descriptors suggested that the unsubstituted alkyl fragments and Me substituted imidazole ring are favorable, while unsatn. in the same and C=N-C N are unfavorable for activity.  The molar refractivity (MR) is conducive for activity.  The descriptors identified in the study collectively highlight the significance of mol. vol. and polarizability to the QC inhibitory activity of imidazoles.  The models are statistically significant and showed good predictivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcOu9-1FQb2bVg90H21EOLACvtfcHk0lg9cTPST5KDSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKms7s%253D&md5=e7a71a4755b7d9dbd3a0882d0ad4f739</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.654111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.654111%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DPrabhakar%26aufirst%3DY.%2BS.%26atitle%3DCP-MLR%252FPLS%2520directed%2520QSAR%2520study%2520on%2520the%2520glutaminyl%2520cyclase%2520inhibitory%2520activity%2520of%2520imidazoles%253A%2520rationales%2520to%2520advance%2520the%2520understanding%2520of%2520activity%2520profile%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D515%26epage%3D22%26doi%3D10.3109%2F14756366.2011.654111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szaszko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flachner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorincz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmany, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorman, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs11030-016-9717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=28070724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=175-186&author=M.+Szaszkoauthor=I.+Hajduauthor=B.+Flachnerauthor=K.+Dobiauthor=C.+Magyarauthor=I.+Simonauthor=Z.+Lorinczauthor=Z.+Kapuiauthor=T.+Pazmanyauthor=S.+Csehauthor=G.+Dorman&title=Identification+of+potential+glutaminyl+cyclase+inhibitors+from+lead-like+libraries+by+in+silico+and+in+vitro+fragment-based+screening&doi=10.1007%2Fs11030-016-9717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span></div><div class="casAuthors">Szaszko, Maria; Hajdu, Istvan; Flachner, Beata; Dobi, Krisztina; Magyar, Csaba; Simon, Istvan; Lorincz, Zsolt; Kapui, Zoltan; Pazmany, Tamas; Cseh, Sandor; Dorman, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A glutaminyl cyclase (QC) fragment library was in silico selected by disconnection of the structure of known QC inhibitors and by lead-like 2D virtual screening of the same set.  The resulting fragment library (204 compds.) was acquired from com. suppliers and pre-screened by differential scanning fluorimetry followed by functional in vitro assays.  In this way, 10 fragment hits were identified ( ∼ 5% hit rate, best inhibitory activity: 16μM).  The in vitro hits were then docked to the active site of QC, and the best scoring compds. were analyzed for binding interactions.  Two fragments bound to different regions in a complementary manner, and thus, linking those fragments offered a rational strategy to generate novel QC inhibitors.  Based on the structure of the virtual linked fragment, a 77-membered QC target focused library was selected from vendor databases and docked to the active site of QC.  A PubChem search confirmed that the best scoring analogs are novel, potential QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VdqwKUctWrVg90H21EOLACvtfcHk0lg9cTPST5KDSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D&md5=1eb4a1423d7e0bc0cf4ea621848d4580</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9717-4%26sid%3Dliteratum%253Aachs%26aulast%3DSzaszko%26aufirst%3DM.%26aulast%3DHajdu%26aufirst%3DI.%26aulast%3DFlachner%26aufirst%3DB.%26aulast%3DDobi%26aufirst%3DK.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DI.%26aulast%3DLorincz%26aufirst%3DZ.%26aulast%3DKapui%26aufirst%3DZ.%26aulast%3DPazmany%26aufirst%3DT.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DDorman%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520from%2520lead-like%2520libraries%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520fragment-based%2520screening%26jtitle%3DMol.%2520Diversity%26date%3D2017%26volume%3D21%26spage%3D175%26epage%3D186%26doi%3D10.1007%2Fs11030-016-9717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dileep, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Murayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2020.12.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.ijbiomac.2020.12.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=33373636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3MXnsVyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2021&pages=415-423&author=K.+V.+Dileepauthor=N.+Sakaiauthor=K.+Iharaauthor=M.+Kato-Murayamaauthor=A.+Nakataauthor=A.+Itoauthor=D.+M.+Sivaramanauthor=J.+W.+Shinauthor=M.+Yoshidaauthor=M.+Shirouzuauthor=K.+Zhang&title=Piperidine-4-carboxamide+as+a+new+scaffold+for+designing+secretory+glutaminyl+cyclase+inhibitors&doi=10.1016%2Fj.ijbiomac.2020.12.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Dileep, K. V.; Sakai, Naoki; Ihara, Kentaro; Kato-Murayama, Miyuki; Nakata, Akiko; Ito, Akihiro; Sivaraman, D. M.; Shin, Jay W.; Yoshida, Minoru; Shirouzu, Mikako; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), a common chronic neurodegenerative disease, has become a major public health concern.  Despite years of research, therapeutics for AD are limited.  Overexpression of secretory glutaminyl cyclase (sQC) in AD brain leads to the formation of a highly neurotoxic pyroglutamate variant of amyloid beta, pGlu-Aβ, which acts as a potential seed for the aggregation of full length Aβ.  Preventing the formation of pGlu-Aβ through inhibition of sQC has become an attractive disease-modifying therapy in AD.  In this current study, through a pharmacophore assisted high throughput virtual screening, we report a novel sQC inhibitor (Cpd-41) with a piperidine-4-carboxamide moiety (IC50 = 34μM).  Systematic mol. docking, MD simulations and X-ray crystallog. anal. provided atomistic details of the binding of Cpd-41 in the active site of sQC.  The unique mode of binding and moderate toxicity of Cpd-41 make this mol. an attractive candidate for designing high affinity sQC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCqnlfPuM22rVg90H21EOLACvtfcHk0lg9cTPST5KDSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXnsVyhsw%253D%253D&md5=75f69b90092bd20e73ba69e57f3da9f7</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2020.12.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2020.12.118%26sid%3Dliteratum%253Aachs%26aulast%3DDileep%26aufirst%3DK.%2BV.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DIhara%26aufirst%3DK.%26aulast%3DKato-Murayama%26aufirst%3DM.%26aulast%3DNakata%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DSivaraman%26aufirst%3DD.%2BM.%26aulast%3DShin%26aufirst%3DJ.%2BW.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DPiperidine-4-carboxamide%2520as%2520a%2520new%2520scaffold%2520for%2520designing%2520secretory%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2021%26volume%3D170%26spage%3D415%26epage%3D423%26doi%3D10.1016%2Fj.ijbiomac.2020.12.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luccarini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigacci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Marca, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ed Dami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casamenti, F.</span></span> <span> </span><span class="NLM_article-title">Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2014.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25293421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=648-63&author=I.+Luccariniauthor=C.+Grossiauthor=S.+Rigacciauthor=E.+Coppiauthor=A.+M.+Puglieseauthor=D.+Pantanoauthor=G.+la+Marcaauthor=T.+Ed+Damiauthor=A.+Bertiauthor=M.+Stefaniauthor=F.+Casamenti&title=Oleuropein+aglycone+protects+against+pyroglutamylated-3+amyloid-ss+toxicity%3A+biochemical%2C+epigenetic+and+functional+correlates&doi=10.1016%2Fj.neurobiolaging.2014.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates</span></div><div class="casAuthors">Luccarini, Ilaria; Grossi, Cristina; Rigacci, Stefania; Coppi, Elisabetta; Pugliese, Anna Maria; Pantano, Daniela; la Marca, Giancarlo; Ed Dami, Teresa; Berti, Andrea; Stefani, Massimo; Casamenti, Fiorella</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">648-663</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid-ss (Ass) fragments, oligomeric Ass aggregates, and pyroglutamylated-Ass peptides, as well as epigenetic mechanisms and autophagy dysfunction all appear to contribute in various ways to Alzheimer's disease progression.  We previously showed that dietary supplementation of oleuropein aglycon, a natural phenol abundant in the extra virgin olive oil, can be protective by reducing Ass42 deposits in the brain of young and middle-aged TgCRND8 mice.  Here, we extended our study to aged TgCRND8 mice showing increased pE3-Ass in the brain deposits.  We report that oleuropein aglycon is active against glutaminylcyclase-catalyzed pE3-Ass generation reducing enzyme expression and interferes both with Ass42 and pE3-Ass aggregation.  Moreover, the phenol astonishingly activates neuronal autophagy even in mice at advanced stage of pathol., where it increases histone 3 and 4 acetylation, which matches both a decrease of histone deacetylase 2 expression and a significant improvement of synaptic function.  The occurrence of these functional, epigenetic, and histopathol. beneficial effects even at a late stage of the pathol. suggests that the phenol could be beneficial at the therapeutic, in addn. to the prevention, level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkebeX-Tuok7Vg90H21EOLACvtfcHk0li_OB6ojzD08A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsr%252FI&md5=7c5114fb73e9ebf19cea9823ec7158ca</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DLuccarini%26aufirst%3DI.%26aulast%3DGrossi%26aufirst%3DC.%26aulast%3DRigacci%26aufirst%3DS.%26aulast%3DCoppi%26aufirst%3DE.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPantano%26aufirst%3DD.%26aulast%3Dla%2BMarca%26aufirst%3DG.%26aulast%3DEd%2BDami%26aufirst%3DT.%26aulast%3DBerti%26aufirst%3DA.%26aulast%3DStefani%26aufirst%3DM.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DOleuropein%2520aglycone%2520protects%2520against%2520pyroglutamylated-3%2520amyloid-ss%2520toxicity%253A%2520biochemical%252C%2520epigenetic%2520and%2520functional%2520correlates%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D648%26epage%3D63%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hielscher-Michael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griehl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span> <span> </span><span class="NLM_article-title">Natural products from microalgae with potential against Alzheimer’s disease: sulfolipids are potent glutaminyl cyclase inhibitors</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">203</span>, <span class="refDoi"> DOI: 10.3390/md14110203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3390%2Fmd14110203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=203&author=S.+Hielscher-Michaelauthor=C.+Griehlauthor=M.+Buchholzauthor=H.+U.+Demuthauthor=N.+Arnoldauthor=L.+A.+Wessjohann&title=Natural+products+from+microalgae+with+potential+against+Alzheimer%E2%80%99s+disease%3A+sulfolipids+are+potent+glutaminyl+cyclase+inhibitors&doi=10.3390%2Fmd14110203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products from microalgae with potential against Alzheimer's disease: sulfolipids are potent glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Hielscher-Michael, Stephanie; Griehl, Carola; Buchholz, Mirko; Demuth, Hans-Ulrich; Arnold, Norbert; Wessjohann, Ludger A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">203/1-203/16</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In recent years, many new enzymes, like glutaminyl cyclase (QC), could be assocd. with pathophysiol. processes and represent targets for many diseases, so that enzyme-inhibiting properties of natural substances are becoming increasingly important.  In different studies, the pathophysiol. connection of QC to various diseases including Alzheimer's disease (AD) was described.  Algae are known for the ability to synthesize complex and highly-diverse compds. with specific enzyme inhibition properties.  Therefore, we screened different algae species for the presence of QC inhibiting metabolites using a new "Reverse Metabolomics" technique including an Activity-correlation Anal. (AcorA), which is based on the correlation of bioactivities to mass spectral data with the aid of mathematic informatics deconvolution.  Thus, three QC inhibiting compds. from microalgae belonging to the family of sulfolipids were identified.  The compds. showed a QC inhibition of 81% and 76% at concns. of 0.25 mg/mL and 0.025 mg/mL, resp.  Thus, for the first time, sulfolipids are identified as QC inhibiting compds. and possess substructures with the required pharmacophore qualities.  They represent a new lead structure for QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruC1d9bEVkyrVg90H21EOLACvtfcHk0li_OB6ojzD08A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM&md5=3097fbf425c5ff891dd01e9186d8c817</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3390%2Fmd14110203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd14110203%26sid%3Dliteratum%253Aachs%26aulast%3DHielscher-Michael%26aufirst%3DS.%26aulast%3DGriehl%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26atitle%3DNatural%2520products%2520from%2520microalgae%2520with%2520potential%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520sulfolipids%2520are%2520potent%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DMar.%2520Drugs%26date%3D2016%26volume%3D14%26spage%3D203%26doi%3D10.3390%2Fmd14110203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2280</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-6&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0li_OB6ojzD08A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D6%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worbs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederichsen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tittmann, K.</span></span> <span> </span><span class="NLM_article-title">Hydrazides are potent transition-state analogues for glutaminyl cyclase implicated in the pathogenesis of Alzheimer’s disease</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.0c00337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.0c00337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOrur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=2585-2591&author=O.+Kupskiauthor=L.+M.+Funkauthor=V.+Sautnerauthor=F.+Seifertauthor=B.+Worbsauthor=D.+Ramsbeckauthor=F.+Meyerauthor=U.+Diederichsenauthor=M.+Buchholzauthor=S.+Schillingauthor=H.+U.+Demuthauthor=K.+Tittmann&title=Hydrazides+are+potent+transition-state+analogues+for+glutaminyl+cyclase+implicated+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.biochem.0c00337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease</span></div><div class="casAuthors">Kupski, Oliver; Funk, Lisa-Marie; Sautner, Viktor; Seifert, Franziska; Worbs, Brigitte; Ramsbeck, Daniel; Meyer, Franc; Diederichsen, Ulf; Buchholz, Mirko; Schilling, Stephan; Demuth, Hans-Ulrich; Tittmann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">2585-2591</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloidogenic plaques are hallmarks of Alzheimer's disease (AD) and typically consist of high percentages of modified Aβ peptides bearing N-terminally cyclized glutamate residues.  The human zinc(II) enzyme glutaminyl cyclase (QC) was shown in vivo to catalyze the cyclization of N-terminal glutamates of Aβ peptides in a pathophysiol. side reaction establishing QC as a druggable target for therapeutic treatment of AD.  Here, we report crystallog. snapshots of human QC catalysis acting on the neurohormone neurotensin that delineate the stereochem. course of catalysis and suggest that hydrazides could mimic the transition state of peptide cyclization and deamidation.  This hypothesis is validated by a sparse-matrix inhibitor screening campaign that identifies hydrazides as the most potent metal-binding group compared to classic Zn binders.  The structural basis of hydrazide inhibition is illuminated by X-ray structure anal. of human QC in complex with a hydrazide-bearing peptide inhibitor and reveals a pentacoordinated Zn complex.  Our findings inform novel strategies in the design of potent and highly selective QC inhibitors by employing hydrazides as the metal-binding warhead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNZLV8i2BO5LVg90H21EOLACvtfcHk0lijRnVaPLOVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOrur%252FJ&md5=2d5f778e8ed7e4a148518c6065506dfa</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.0c00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.0c00337%26sid%3Dliteratum%253Aachs%26aulast%3DKupski%26aufirst%3DO.%26aulast%3DFunk%26aufirst%3DL.%2BM.%26aulast%3DSautner%26aufirst%3DV.%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DWorbs%26aufirst%3DB.%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DF.%26aulast%3DDiederichsen%26aufirst%3DU.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DTittmann%26aufirst%3DK.%26atitle%3DHydrazides%2520are%2520potent%2520transition-state%2520analogues%2520for%2520glutaminyl%2520cyclase%2520implicated%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26spage%3D2585%26epage%3D2591%26doi%3D10.1021%2Facs.biochem.0c00337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1764</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2006.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bbapap.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=17005457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1764&publication_year=2006&pages=1618-25&author=H.+Cynisauthor=S.+Schillingauthor=M.+Bodnarauthor=T.+Hoffmannauthor=U.+Heiserauthor=T.+C.+Saidoauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+alters+pyroglutamate+formation+in+mammalian+cells&doi=10.1016%2Fj.bbapap.2006.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells</span></div><div class="casAuthors">Cynis, Holger; Schilling, Stephan; Bodnar, Mandy; Hoffmann, Torsten; Heiser, Ulrich; Saido, Takaomi C.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1764</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1618-1625</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mammalian cell lines were examd. concerning their Glutaminyl Cyclase (QC) activity using a HPLC method.  The enzyme activity was suppressed by a QC specific inhibitor in all homogenates.  Aim of the study was to prove whether inhibition of QC modifies the posttranslational maturation of N-glutamine and N-glutamate peptide substrates.  Therefore, the impact of QC-inhibition on amino-terminal pyroglutamate (pGlu) formation of the modified amyloid peptides Aβ(N3E-42) and Aβ(N3Q-42) was investigated.  These amyloid-β peptides were expressed as fusion proteins with either the pre-pro sequence of TRH, to be released by a prohormone convertase, or as engineered amyloid precursor protein for subsequent liberation of Aβ(N3Q-42) after β- and γ-secretase cleavage during posttranslational processing.  Inhibition of QC leads in both expression systems to significantly reduced pGlu-formation of differently processed Aβ-peptides.  This reveals the importance of QC-activity during cellular maturation of pGlu-contg. peptides.  Thus, QC-inhibition should impact bioactivity, stability or even toxicity of pyroglutamyl peptides preventing glutamine and glutamate cyclization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG_EpKM28U2rVg90H21EOLACvtfcHk0lijRnVaPLOVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrrL&md5=dc19263014a0cb7e7820dc135fc19bf4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DBodnar%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520alters%2520pyroglutamate%2520formation%2520in%2520mammalian%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2006%26volume%3D1764%26spage%3D1618%26epage%3D25%26doi%3D10.1016%2Fj.bbapap.2006.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7405</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1021/bi800250p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800250p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFGrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7405-13&author=H.+Cynisauthor=E.+Scheelauthor=T.+C.+Saidoauthor=S.+Schillingauthor=H.+U.+Demuth&title=Amyloidogenic+processing+of+amyloid+precursor+protein%3A+evidence+of+a+pivotal+role+of+glutaminyl+cyclase+in+generation+of+pyroglutamate-modified+amyloid-beta&doi=10.1021%2Fbi800250p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β</span></div><div class="casAuthors">Cynis, Holger; Scheel, Eike; Saido, Takaomi C.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7405-7413</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compelling evidence suggests that N-terminally truncated and pyroglutamyl-modified amyloid-β (Aβ) peptides play a major role in the development of Alzheimer's disease.  Posttranslational formation of pyroglutamic acid (pGlu) at position 3 or 11 of Aβ implies cyclization of an N-terminal glutamate residue rendering the modified peptide degrdn. resistant, more hydrophobic, and prone to aggregation.  Previous studies using artificial peptide substrates suggested the potential involvement of the enzyme glutaminyl cyclase in generation of pGlu-Aβ.  Here we show that glutaminyl cyclase (QC) catalyzes the formation of Aβ3(pE)-40/42 after amyloidogenic processing of APP in two different cell lines, applying specific ELISAs and Western blotting based on urea-PAGE.  Inhibition of QC by the imidazole deriv. PBD150 led to a blockage of Aβ3(pE)-42 formation.  Apparently, the QC-catalyzed formation of N-terminal pGlu is favored in the acidic environment of secretory compartments, which is also supported by double-immunofluorescence labeling of QC and APP revealing partial colocalization.  Finally, initial investigations focusing on the mol. pathway leading to the generation of truncated Aβ peptides imply an important role of the amino acid sequence near the β-secretase cleavage site.  Introduction of a single-point mutation, resulting in an amino acid substitution, APP(E599Q), i.e., at position 3 of Aβ, resulted in significant formation of Aβ3(pE)-40/42.  Introduction of the APP KM595/596NL "Swedish" mutation causing overprodn. of Aβ, however, surprisingly diminished the concn. of Aβ3(pE)-40/42.  The study provides new cell-based assays for the profiling of small mol. inhibitors of QC and points to conspicuous differences in processing of APP depending on sequence at the β-secretase cleavage site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOytVkntb_7Vg90H21EOLACvtfcHk0lijRnVaPLOVXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFGrsr8%253D&md5=fdb24bc6e3ff6ad74f6d7db1f84a5a24</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fbi800250p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800250p%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DAmyloidogenic%2520processing%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520of%2520a%2520pivotal%2520role%2520of%2520glutaminyl%2520cyclase%2520in%2520generation%2520of%2520pyroglutamate-modified%2520amyloid-beta%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D7405%26epage%3D13%26doi%3D10.1021%2Fbi800250p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokesch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-11&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0lh0UmiTCrYfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D11%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer’s disease via the modulation of gamma-secretase activity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.3233/JAD-141356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-141356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=797-807&author=H.+Songauthor=Y.+J.+Changauthor=M.+Moonauthor=S.+K.+Parkauthor=P.+T.+Tranauthor=V.+H.+Hoangauthor=J.+Leeauthor=I.+Mook-Jung&title=Inhibition+of+glutaminyl+cyclase+ameliorates+amyloid+pathology+in+an+animal+model+of+Alzheimer%E2%80%99s+disease+via+the+modulation+of+gamma-secretase+activity&doi=10.3233%2FJAD-141356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3233%2FJAD-141356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141356%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520ameliorates%2520amyloid%2520pathology%2520in%2520an%2520animal%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520the%2520modulation%2520of%2520gamma-secretase%2520activity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D43%26spage%3D797%26epage%3D807%26doi%3D10.3233%2FJAD-141356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoneyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice</span>. <i>Int. J. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1111/iep.12020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fiep.12020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23560443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2msrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=217-25&author=H.+Cynisauthor=A.+Kehlenauthor=M.+Haegeleauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Fujiiauthor=Y.+Shibazakiauthor=H.+Yoneyamaauthor=S.+Schillingauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclases+alleviates+CCL2-mediated+inflammation+of+non-alcoholic+fatty+liver+disease+in+mice&doi=10.1111%2Fiep.12020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice</span></div><div class="casAuthors">Cynis, Holger; Kehlen, Astrid; Haegele, Monique; Hoffmann, Torsten; Heiser, Ulrich; Fujii, Masato; Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-225</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Inflammation is an integral part of non-alc. fatty liver disease (NAFLD), the most prevalent form of hepatic pathol. found in the general population.  In this context, recently we have examd. the potential role of Glutaminyl Cyclases (QC and isoQC), and their inhibitors, in the maturation of chemokines, for example, monocyte chemoattractant protein 1 (MCP-1, CCL2), to generate their bioactive conformation.  Catalysis by isoQC leads to the formation of an N-terminal pyroglutamate residue protecting CCL2 against degrdn. by aminopeptidases.  This is of importance because truncated forms possess a reduced potential to attract immune cells.  Since liver inflammation is characterized by the up-regulation of different chemokine pathways, and within this CCL2 is known to be a prominent example, we hypothesised that application of QC/isoQC inhibitors may alleviate liver inflammation by destabilizing CCL2.  Therefore, we investigated the role of QC/isoQC inhibition, in comparison with the angiotensin receptor blocker Telmisartan, during development of pathol. in a mouse model of non-alc. fatty liver disease.  Application of a QC/isoQC inhibitor led to a significant redn. in circulating alanine aminotransferase and NAFLD activity score accompanied by an inhibitory effect on hepatocyte ballooning.  Further anal. revealed a specific redn. of inflammation by decreasing the no. of F4/80-pos. macrophages, which is in agreement with the proposed CCL2-related mechanism of action of QC/isoQC inhibitors.  Finally, QC/isoQC inhibitor application attenuated liver fibrosis as characterized by reduced collagen deposition in the liver parenchyma.  Thus in conclusion, QC/isoQC inhibitors are a promising novel class of anti-non-alc. steatohepatitis drugs which have a comparable disease-modifying effect to that of Telmisartan, which is probably mediated via specific interference with a comparable monocyte/macrophage infiltration that occurs under inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5NY5cI92GLVg90H21EOLACvtfcHk0lh0UmiTCrYfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2msrw%253D&md5=83f4bc66086de14e4ebd33e86a17b1ac</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fiep.12020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fiep.12020%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DShibazaki%26aufirst%3DY.%26aulast%3DYoneyama%26aufirst%3DH.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclases%2520alleviates%2520CCL2-mediated%2520inflammation%2520of%2520non-alcoholic%2520fatty%2520liver%2520disease%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2013%26volume%3D94%26spage%3D217%26epage%3D25%26doi%3D10.1111%2Fiep.12020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>442</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1042/BJ20110535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20110535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22060158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1Oksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2012&pages=403-12&author=Y.+L.+Chenauthor=K.+F.+Huangauthor=W.+C.+Kuoauthor=Y.+C.+Loauthor=Y.+M.+Leeauthor=A.+H.+Wang&title=Inhibition+of+glutaminyl+cyclase+attenuates+cell+migration+modulated+by+monocyte+chemoattractant+proteins&doi=10.1042%2FBJ20110535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins</span></div><div class="casAuthors">Chen, Yi-Ling; Huang, Kai-Fa; Kuo, Wen-Chih; Lo, Yan-Chung; Lee, Yu-May; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">442</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-412</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QC (glutaminyl cyclase) catalyzes the formation of N-terminal pGlu (pyroglutamate) in peptides and proteins. pGlu formation in chemoattractants may participate in the regulation of macrophage activation and migration.  However, a clear mol. mechanism for the regulation is lacking.  The present study examines the role of QC-mediated pGlu formation on MCPs (monocyte chemoattractant proteins) in inflammation.  We demonstrated in vitro the pGlu formation on MCPs by QC using MS.  A potent QC inhibitor, PBD150, significantly reduced the N-terminal uncyclized-MCP-stimulated monocyte migration, whereas pGlu-contg. MCP-induced cell migration was unaffected.  QC small interfering RNA revealed a similar inhibitory effect.  Lastly, we demonstrated that inhibiting QC can attenuate cell migration by lipopolysaccharide.  These results strongly suggest that QC-catalyzed N-terminal pGlu formation of MCPs is required for monocyte migration and provide new insights into the role of QC in the inflammation process.  Our results also suggest that QC could be a drug target for some inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXEYfFQC1-rVg90H21EOLACvtfcHk0lh0UmiTCrYfvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1Oksbc%253D&md5=7a0672432b18da7d9dd384f965e0b1f9</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1042%2FBJ20110535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110535%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DKuo%26aufirst%3DW.%2BC.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520attenuates%2520cell%2520migration%2520modulated%2520by%2520monocyte%2520chemoattractant%2520proteins%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D442%26spage%3D403%26epage%3D12%26doi%3D10.1042%2FBJ20110535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropog, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [(11)C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid beta aggregation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+Scott&title=Synthesis+and+evaluation+of+%5B%2811%29C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+beta+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0li3BslRcSS4Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B%252811%2529C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520beta%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Primary sequence alignment of human QC (361 amino acids) and iso-QC (382 amino acids).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of QC and iso-QC. (A) A ribbon diagram of the overall structure of QC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB">3PBB</a>). The central six β-strands are colored yellow. The surrounding 10 α-helices located on the top, bottom, and edge are colored blue. The zinc ion is shown as a golden sphere. The coils and loops are colored light pink. (B) A stereo view of the QC catalytic region. The main residues coordinated with the zinc ion are labeled. (C) A ribbon diagram of the overall structure of iso-QC (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PB7">3PB7</a>). (D) A stereo view of the iso-QC catalytic region.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Possible catalyzing process in the QC active pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Upregulated QC contributes to the initiation of diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Generation and roles of pE-Aβ in the initiation of AD. A: The generation of pE-Aβ catalyzed by upregulated QC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Generation and roles of pE-CCL2 in the initiation of inflammatory reactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. QC inhibitors based on imidazole and triazole.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/medium/jm1c00325_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Natural products exhibited QC inhibitory potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.1c00325/20210520/images/large/jm1c00325_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00325&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 157 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens-Volant, D.</span></span> <span> </span><span class="NLM_article-title">Detection of three wound-induced proteins in papaya latex</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2003.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.phytochem.2003.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15003415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhslehsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=525-34&author=M.+Azarkanauthor=R.+Wintjensauthor=Y.+Loozeauthor=D.+Baeyens-Volant&title=Detection+of+three+wound-induced+proteins+in+papaya+latex&doi=10.1016%2Fj.phytochem.2003.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of three wound-induced proteins in papaya latex</span></div><div class="casAuthors">Azarkan, Mohamed; Wintjens, Rene; Looze, Yvan; Baeyens-Volant, Danielle</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">525-534</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The effects of routine mech. wounding for latex collection from unripe fruits of the tropical Carica papaya tree were investigated.  For that purpose, the protein compn. of three different latexes was analyzed.  The first one, com. available, was provided in the form of a spray-dried powder, the second one was harvested from fully grown but unripe papaya fruits that are regularly tapped for latex prodn. and the last one, was obtained from similar fruits wounded for the first time.  Repeated mech. wounding profoundly affected the protein content of the latex inducing, among others, activation of papain.  Regularly tapped latexes also accumulated several low-mol.-wt. proteins not yet identified, as well as three proteins identified as a trypsin inhibitor, a class-II chitinase and a glutaminyl cyclase on the basis of their enzymic or inhibitory activities and chromatog. elution profiles.  This latter was found here, for the first time, to be a wound-induced protein.  The roles of these proteins in the plant defense mechanism are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmBwW_0nMArLVg90H21EOLACvtfcHk0lh6CAC2NSHivA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhslehsLo%253D&md5=b1c6f5b612fc016601fbcba24be326c9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2003.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2003.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DLooze%26aufirst%3DY.%26aulast%3DBaeyens-Volant%26aufirst%3DD.%26atitle%3DDetection%2520of%2520three%2520wound-induced%2520proteins%2520in%2520papaya%2520latex%26jtitle%3DPhytochemistry%26date%3D2004%26volume%3D65%26spage%3D525%26epage%3D34%26doi%3D10.1016%2Fj.phytochem.2003.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messer, M.</span></span> <span> </span><span class="NLM_article-title">Enzymatic cyclization of L-glutamine and L-glutaminyl peptides</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">1299</span>, <span class="refDoi"> DOI: 10.1038/1971299a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F1971299a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=13935130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaF3sXnsVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=1963&pages=1299&author=M.+Messer&title=Enzymatic+cyclization+of+L-glutamine+and+L-glutaminyl+peptides&doi=10.1038%2F1971299a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymic cyclization of L-glutamine and L-glutaminyl peptides</span></div><div class="casAuthors">Messer, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1299</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">At the optimum pH of 10, 1 mg. of the sol. fraction of crude papain (I) liberated 0.057 micromole NH3/min. from a 0.025M L-glutamine (II) soln. at 30°.  Paper chromatography showed that II was converted to a ninhydrin-neg. compd. which had the same Rf as proline.  D-Glutamine was not affected and I was made inactive by heating for 20 min. at 90°.  Dialysis of I or pretreatment with iodoacetate or ethylenediaminetetraacetic acid had no effect and pure I and chymopapain were inactive.  L-Glutaminyl dipeptides were deamidated and cyclized more rapidly and at a lower pH than II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ay7t_MIodrVg90H21EOLACvtfcHk0lh6CAC2NSHivA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXnsVCqtw%253D%253D&md5=a0fbeb450c6d1992be19930ff36f8176</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F1971299a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1971299a0%26sid%3Dliteratum%253Aachs%26aulast%3DMesser%26aufirst%3DM.%26atitle%3DEnzymatic%2520cyclization%2520of%2520L-glutamine%2520and%2520L-glutaminyl%2520peptides%26jtitle%3DNature%26date%3D1963%26volume%3D197%26spage%3D1299%26doi%3D10.1038%2F1971299a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bockers, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span>. <i>J. Neuroendocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2826.1995.tb00780.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1365-2826.1995.tb00780.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7550291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=445-53&author=T.+M.+Bockersauthor=M.+R.+Kreutzauthor=T.+Pohl&title=Glutaminyl-cyclase+expression+in+the+bovine%2Fporcine+hypothalamus+and+pituitary&doi=10.1111%2Fj.1365-2826.1995.tb00780.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl-cyclase expression in the bovine/porcine hypothalamus and pituitary</span></div><div class="casAuthors">Bockers T M; Kreutz M R; Pohl T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroendocrinology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">445-53</span>
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    </div><div class="casAbstract">The expression of the glutaminyl cyclase (QC), an enzyme responsible for the post-translational modification of N-terminal pyroglutamyl residues of neuropeptide precursors, was examined in bovine/porcine hypothalamic and pituitary tissue by means of immunocytochemistry and in situ hybridization.  In the anterior pituitary a distinct pattern of QC immunoreactivity and mRNA expression was found associated exclusively with somatotrophs.  In corticotrophs of the pars intermedia QC expression was undetectable, whereas a small portion of putative pars tuberalis cells in the rostral part of the pars distalis were heavily labelled.  The neurointermediate lobe was devoid of signals for QC mRNA, but showed significant QC-immunoreactivity on secretory granules of axonal nerve endings.  Also nuclei of the hypothalamus were found to be positive for QC-immunoreactivity.  Intense labelling was observed in the nucleus supraopticus and nucleus paraventricularis.  Staining of the nucleus periventricularis was found to be moderate, whereas no labelling of perikarya in the nucleus arcuatus, the preoptic area and the nucleus suprachiasmaticus was detectable.  Moreover, varicose fibers stained positive for QC-immunoreactivity and could be identified in the main transport route from the hypothalamus to the pars neuronalis (tractus hypothalamo hypophysialis).  These results suggest that the enzyme is transported via the same routes as its substrate/product to the median eminence or the neural lobe.  Furthermore, the mapping of the cellular QC distribution reveals a strikingly distinctive expression pattern, that should be useful for the identification of yet undiscovered places of peptide synthesis and processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvTdinpe-TVvEeosoOnpOLfW6udTcc2eYRtkhYDPaherntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FgvVSkuw%253D%253D&md5=623044c0c3d4e838cf9b833b04722f41</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.1995.tb00780.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.1995.tb00780.x%26sid%3Dliteratum%253Aachs%26aulast%3DBockers%26aufirst%3DT.%2BM.%26aulast%3DKreutz%26aufirst%3DM.%2BR.%26aulast%3DPohl%26aufirst%3DT.%26atitle%3DGlutaminyl-cyclase%2520expression%2520in%2520the%2520bovine%252Fporcine%2520hypothalamus%2520and%2520pituitary%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D1995%26volume%3D7%26spage%3D445%26epage%3D53%26doi%3D10.1111%2Fj.1365-2826.1995.tb00780.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, I. H.</span></span> <span> </span><span class="NLM_article-title">Snake venom glutaminyl cyclases: purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme</span>. <i>Toxicon</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.toxicon.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.toxicon.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24814012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=40-50&author=Y.+M.+Wangauthor=K.+F.+Huangauthor=I.+H.+Tsai&title=Snake+venom+glutaminyl+cyclases%3A+purification%2C+cloning%2C+kinetic+study%2C+recombinant+expression%2C+and+comparison+with+the+human+enzyme&doi=10.1016%2Fj.toxicon.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Snake venom glutaminyl cyclases: Purification, cloning, kinetic study, recombinant expression, and comparison with the human enzyme</span></div><div class="casAuthors">Wang, Ying-Ming; Huang, Kai-Fa; Tsai, Inn-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Toxicon</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">40-50</span>CODEN:
                <span class="NLM_cas:coden">TOXIA6</span>;
        ISSN:<span class="NLM_cas:issn">0041-0101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among various snake venom components, glutaminyl cyclase (vQC) is one of the least understood protein family and none of its members has been purified or characterized.  Here we confirmed the presence of vQC activity in a wide spectrum of venom species via enzymic assay using a synthetic fluorogenic substrate.  We have also cloned novel vQC cDNAs from seven species including Crotalus atrox.  The results revealed more than 96% sequence similarities among vQCs and ∼75% sequence identities between vQCs and human secretory QC (hQC).  The vQC glycoprotein of 43 kDa was isolated from C. atrox venom, and its N-terminal sequence was detd.  The optimal pH range for vQC reaction was 7.5-8.0, and the enzymes were stable up to 50 °C.  Similar to hQC, vQCs were substantially inactivated by 1 mM 1,10-phenanthroline but slightly affected by 20 mM EDTA, suggestive of a similar zinc-catalytic environment for these enzymes.  Although their catalytic residues were highly conserved, vQCs were less susceptible to inhibition by synthetic imidazole derivs. which potently inhibited hQC.  The 3D-models revealed that vQC and hQC structures display different surface charge distributions around the active sites, which might affect substrate and inhibitor binding affinities.  The recombinant vQCs prepd. from Escherichia coli displayed weaker substrate binding affinities relative to the native vQCs, possibly due to the lack of glycosylation.  The present report offers new structural and functional insights into vQCs and sheds light on the specificity differences between vQCs and hQC.  Eight nucleotide sequences encoding the vQCs of Crotalus atrox, Micrurus fulvius, Cerrophidion godmani, Daboia russelii, Trimeresurus gracilis, Protobothrops mucrosquamatus, and Sistrurus catenatus tergeminus have been deposited in GenBank with the accession nos. JF979132-JF979139.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_hWv4ACaTvLVg90H21EOLACvtfcHk0lhDw14XWJLvkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWqsLrE&md5=88cce226e13aea8f914edf63a094c2d8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.toxicon.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxicon.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DTsai%26aufirst%3DI.%2BH.%26atitle%3DSnake%2520venom%2520glutaminyl%2520cyclases%253A%2520purification%252C%2520cloning%252C%2520kinetic%2520study%252C%2520recombinant%2520expression%252C%2520and%2520comparison%2520with%2520the%2520human%2520enzyme%26jtitle%3DToxicon%26date%3D2014%26volume%3D86%26spage%3D40%26epage%3D50%26doi%3D10.1016%2Fj.toxicon.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayasarathy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basheer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaram, P.</span></span> <span> </span><span class="NLM_article-title">Cone snail glutaminyl cyclase sequences from transcriptomic analysis and mass spectrometric characterization of two pyroglutamyl conotoxins</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2695</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/acs.jproteome.8b00132</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jproteome.8b00132" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252Fit1Khtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=2695-2703&author=M.+Vijayasarathyauthor=S.+M.+Basheerauthor=P.+Balaram&title=Cone+snail+glutaminyl+cyclase+sequences+from+transcriptomic+analysis+and+mass+spectrometric+characterization+of+two+pyroglutamyl+conotoxins&doi=10.1021%2Facs.jproteome.8b00132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cone Snail Glutaminyl Cyclase Sequences from Transcriptomic Analysis and Mass Spectrometric Characterization of Two Pyroglutamyl Conotoxins</span></div><div class="casAuthors">Vijayasarathy Marimuthu; Basheer Soorej M; Balaram Padmanabhan; Vijayasarathy Marimuthu; Balaram Padmanabhan; Basheer Soorej M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of proteome research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2695-2703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The post-translational modification of N-terminal glutamine (Q) to a pyroglutamyl (Z) residue is observed in the conotoxins produced by marine cone snails.  This conversion requires the action of the enzyme glutaminyl cyclase (QC).  Four complete QC sequences from the species C. araneosus, C. frigidus, C. litteratus, and C. monile and two partial sequences from C. amadis and C. miles have been obtained by analysis of transcriptomic data.  Comparisons with mammalian enzyme sequences establish a high level of identity and complete conservation of functional active site residues, including a cluster of hydrogen-bonded acidic side chains.  Mass spectrometric analysis of crude venom samples coupled to conotoxin precursor protein sequences obtained from transcriptomic data establishes the presence of pyroglutamyl conotoxins in the venom of C. frigidus and C. amadis.  The C. frigidus peptide belongs to the M superfamily, with cysteine framework III, whereas the C. amadis peptide belongs to the divergent superfamily with cysteine framework VI/VII.  Additionally, gamma carboxylation of glutamic acid and hydroxylation of proline are observed in the C. frigidus peptide.  Mass spectral data are available via ProteomeXchange with identifier PXD009006.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnaHX7csKbJ6cY7HFp97qMfW6udTcc2eYPCDINpuyYwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252Fit1Khtw%253D%253D&md5=6e236da3ba3997cea4ed84020453e4d8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jproteome.8b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jproteome.8b00132%26sid%3Dliteratum%253Aachs%26aulast%3DVijayasarathy%26aufirst%3DM.%26aulast%3DBasheer%26aufirst%3DS.%2BM.%26aulast%3DBalaram%26aufirst%3DP.%26atitle%3DCone%2520snail%2520glutaminyl%2520cyclase%2520sequences%2520from%2520transcriptomic%2520analysis%2520and%2520mass%2520spectrometric%2520characterization%2520of%2520two%2520pyroglutamyl%2520conotoxins%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2018%26volume%3D17%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Facs.jproteome.8b00132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for tissue-specific forms of glutaminyl cyclase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>455</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(99)00872-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0014-5793%2899%2900872-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10428492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXltFWnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=1999&pages=159-61&author=P.+A.+Sykesauthor=S.+J.+Watsonauthor=J.+S.+Templeauthor=R.+J.+Bateman&title=Evidence+for+tissue-specific+forms+of+glutaminyl+cyclase&doi=10.1016%2FS0014-5793%2899%2900872-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for tissue-specific forms of glutaminyl cyclase</span></div><div class="casAuthors">Sykes, Paul A.; Watson, Stephanie J.; Temple, Jeffrey S.; Bateman, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">455</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">159-161</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) is responsible for the presence of pyroglutamyl residues in many neuroendocrine peptides.  An examn. of the bovine tissue distribution of QC immunoreactivity, enzyme activity, and mRNA confirmed that QC was abundant in brain and pituitary by all three measures.  However, enzymic activity was considerably more widespread than either immunoreactivity or mRNA, suggesting multiple enzyme forms.  Partially purified QC from bovine spleen differed significantly from the known bovine pituitary QC in phys. and catalytic properties.  We propose that this form of glutaminyl cyclase plays a role in the posttranslational processing of constitutively secreted pGlu-contg. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAVzEsGk7lzLVg90H21EOLACvtfcHk0lhDw14XWJLvkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFWnur0%253D&md5=6a10132cc48d48f352b96c0d531d25e3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2899%2900872-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252899%252900872-8%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DP.%2BA.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DTemple%26aufirst%3DJ.%2BS.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DEvidence%2520for%2520tissue-specific%2520forms%2520of%2520glutaminyl%2520cyclase%26jtitle%3DFEBS%2520Lett.%26date%3D1999%26volume%3D455%26spage%3D159%26epage%3D61%26doi%3D10.1016%2FS0014-5793%2899%2900872-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Crystal structure and functional analysis of the glutaminyl cyclase from <i>Xanthomonas campestris</i></span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>401</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2010.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20558177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFOnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2010&pages=374-88&author=W.+L.+Huangauthor=Y.+R.+Wangauthor=T.+P.+Koauthor=C.+Y.+Chiaauthor=K.+F.+Huangauthor=A.+H.+Wang&title=Crystal+structure+and+functional+analysis+of+the+glutaminyl+cyclase+from+Xanthomonas+campestris&doi=10.1016%2Fj.jmb.2010.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure and Functional Analysis of the Glutaminyl Cyclase from Xanthomonas campestris</span></div><div class="casAuthors">Huang, Wei-Lin; Wang, Yu-Ruei; Ko, Tzu-Ping; Chia, Cho-Yun; Huang, Kai-Fa; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">374-388</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) (EC 2.3.2.5) catalyze the formation of pyroglutamate (pGlu) at the N-terminus of many proteins and peptides, a crit. step for the maturation of these bioactive mols.  Proteins having QC activity have been identified in animals and plants, but not in bacteria.  Here, we report the first bacterial QC from the plant pathogen Xanthomonas campestris (Xc).  The crystal structure of the enzyme was solved and refined to 1.44-Å resoln.  The structure shows a five-bladed β-propeller and exhibits a scaffold similar to that of papaya QC (pQC), but with some sequence deletions and conformational changes.  In contrast to the pQC structure, the active site of XcQC has a wider substrate-binding pocket, but its accessibility is modulated by a protruding loop acting as a flap.  Enzyme activity analyses showed that the wild-type XcQC possesses only 3% QC activity compared to that of pQC.  Superposition of those two structures revealed that an active-site glutamine residue in pQC is substituted by a glutamate (Glu45) in XcQC, although position 45 is a glutamine in most bacterial QC sequences.  The E45Q mutation increased the QC activity by an order of magnitude, but the mutation E45A led to a drop in the enzyme activity, indicating the crit. catalytic role of this residue.  Further mutagenesis studies support the catalytic role of Glu89 as proposed previously and confirm the importance of several conserved amino acids around the substrate-binding pocket.  XcQC was shown to be weakly resistant to guanidine hydrochloride, extreme pH, and heat denaturations, in contrast to the extremely high stability of pQC, despite their similar scaffold.  On the basis of structure comparison, the low stability of XcQC may be attributed to the absence of both a disulfide linkage and some hydrogen bonds in the closure of β-propeller structure.  These results significantly improve our understanding of the catalytic mechanism and extreme stability of type I QCs, which will be useful in further applications of QC enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5lSDy2DJ5ELVg90H21EOLACvtfcHk0li_ST3vd-2JTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFOnsLk%253D&md5=da272da9d25ebcc7254e8a565eef6f91</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DKo%26aufirst%3DT.%2BP.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCrystal%2520structure%2520and%2520functional%2520analysis%2520of%2520the%2520glutaminyl%2520cyclase%2520from%2520Xanthomonas%2520campestris%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D401%26spage%3D374%26epage%3D88%26doi%3D10.1016%2Fj.jmb.2010.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oberg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruysschaert, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smolders, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerhouni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amrani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span> <span> </span><span class="NLM_article-title">Papaya glutamine cyclase, a plant enzyme highly resistant to proteolysis, adopts an all-beta conformation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">214</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1046/j.1432-1327.1998.2580214.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1046%2Fj.1432-1327.1998.2580214.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9851712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFCnsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1998&pages=214-22&author=K.+A.+Obergauthor=J.+M.+Ruysschaertauthor=M.+Azarkanauthor=N.+Smoldersauthor=S.+Zerhouniauthor=R.+Wintjensauthor=A.+Amraniauthor=Y.+Looze&title=Papaya+glutamine+cyclase%2C+a+plant+enzyme+highly+resistant+to+proteolysis%2C+adopts+an+all-beta+conformation&doi=10.1046%2Fj.1432-1327.1998.2580214.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Papaya glutamine cyclase, a plant enzyme highly resistant to proteolysis, adopts an all-β conformation</span></div><div class="casAuthors">Oberg, Keith A.; Ruysschaert, Jean-Marie; Azarkan, Mohamed; Smolders, Nicole; Zerhouni, Samira; Wintjens, Rene; Amrani, Amina; Looze, Yvan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-222</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Glutamine cyclase (EC 2.3.2.5) (I) catalyzes the conversion of L-glutaminyl-peptides into 5-oxoprolyl-peptides with the concomitant liberation of NH3.  Here, the biophys. characterization of I present in the laticiferous cells of Carica papaya is reported.  After purifn. to near homogeneity, I was subjected to limited proteolysis and found to exhibit a high resistance to degrdn. and nicking.  The structural reasons for this property were examd. using CD and IR spectroscopies.  By combining the analyses of the IR and CD spectra of papaya I, its susceptibility to proteolysis, and its H-D exchange characteristics, it was concluded that I contains extensive β-sheet structure and is likely to have only short immobile loops connecting its β-strands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqix5YuYvuoTLVg90H21EOLACvtfcHk0lgZOm78GEefDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFCnsbk%253D&md5=460130fc378466d6b833b6f6274202ca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1998.2580214.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1998.2580214.x%26sid%3Dliteratum%253Aachs%26aulast%3DOberg%26aufirst%3DK.%2BA.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DSmolders%26aufirst%3DN.%26aulast%3DZerhouni%26aufirst%3DS.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DAmrani%26aufirst%3DA.%26aulast%3DLooze%26aufirst%3DY.%26atitle%3DPapaya%2520glutamine%2520cyclase%252C%2520a%2520plant%2520enzyme%2520highly%2520resistant%2520to%2520proteolysis%252C%2520adopts%2520an%2520all-beta%2520conformation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1998%26volume%3D258%26spage%3D214%26epage%3D22%26doi%3D10.1046%2Fj.1432-1327.1998.2580214.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wintjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belrhali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clantin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azarkan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bompard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baeyens-Volant, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looze, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villeret, V.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of papaya glutaminyl cyclase, an archetype for plant and bacterial glutaminyl cyclases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2005.12.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2005.12.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16438985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2006&pages=457-70&author=R.+Wintjensauthor=H.+Belrhaliauthor=B.+Clantinauthor=M.+Azarkanauthor=C.+Bompardauthor=D.+Baeyens-Volantauthor=Y.+Loozeauthor=V.+Villeret&title=Crystal+structure+of+papaya+glutaminyl+cyclase%2C+an+archetype+for+plant+and+bacterial+glutaminyl+cyclases&doi=10.1016%2Fj.jmb.2005.12.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of Papaya Glutaminyl Cyclase, an Archetype for Plant and Bacterial Glutaminyl Cyclases</span></div><div class="casAuthors">Wintjens, Rene; Belrhali, Hassan; Clantin, Bernard; Azarkan, Mohamed; Bompard, Coralie; Baeyens-Volant, Danielle; Looze, Yvan; Villeret, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-470</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) (E.C. 2.3.2.5) catalyze the intramol. cyclization of protein N-terminal glutamine residues into pyroglutamic acid with the concomitant liberation of ammonia.  QCs may be classified in two groups contg., resp., the mammalian enzymes, and the enzymes from plants, bacteria, and parasites.  The crystal structure of the QC from the latex of Carica papaya (PQC) has been detd. at 1.7 Å resoln.  The structure was solved by the single wavelength anomalous diffraction technique using sulfur and zinc as anomalous scatterers.  The enzyme folds into a five-bladed β-propeller, with two addnl. α-helixes and one β hairpin.  The propeller closure is achieved via an original mol. velcro, which links the last two blades into a large eight stranded β-sheet.  The zinc ion present in the PQC is bound via an octahedral coordination into an elongated cavity located along the pseudo 5-fold axis of the β-propeller fold.  This zinc ion presumably plays a structural role and may contribute to the exceptional stability of PQC, along with an extended hydrophobic packing, the absence of long loops, the three-joint mol. velcro and the overall folding itself.  Multiple sequence alignments combined with structural analyses have allowed us to tentatively locate the active site, which is filled in the crystal structure either by a Tris mol. or an acetate ion.  These analyses are further supported by the exptl. evidence that Tris is a competitive inhibitor of PQC.  The active site is located at the C-terminal entrance of the PQC central tunnel.  W83, W110, W169, Q24, E69, N155, K225, F22 and F67 are highly conserved residues in the C-terminal entrance, and their putative role in catalysis is discussed.  The PQC structure is representative of the plants, bacterial and parasite enzymes and contrasts with that of mammalian enzymes, that may possibly share a conserved scaffold of the bacterial aminopeptidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAbHbFLn_XvbVg90H21EOLACvtfcHk0lgZOm78GEefDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGhsbc%253D&md5=7223abf4574b696d2a18286e962130d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2005.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2005.12.029%26sid%3Dliteratum%253Aachs%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DBelrhali%26aufirst%3DH.%26aulast%3DClantin%26aufirst%3DB.%26aulast%3DAzarkan%26aufirst%3DM.%26aulast%3DBompard%26aufirst%3DC.%26aulast%3DBaeyens-Volant%26aufirst%3DD.%26aulast%3DLooze%26aufirst%3DY.%26aulast%3DVilleret%26aufirst%3DV.%26atitle%3DCrystal%2520structure%2520of%2520papaya%2520glutaminyl%2520cyclase%252C%2520an%2520archetype%2520for%2520plant%2520and%2520bacterial%2520glutaminyl%2520cyclases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D357%26spage%3D457%26epage%3D70%26doi%3D10.1016%2Fj.jmb.2005.12.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pohl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mugele, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Primary structure and functional expression of a glutaminyl cyclase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">10059</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.22.10059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.88.22.10059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1946423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=10059-63&author=T.+Pohlauthor=M.+Zimmerauthor=K.+Mugeleauthor=J.+Spiess&title=Primary+structure+and+functional+expression+of+a+glutaminyl+cyclase&doi=10.1073%2Fpnas.88.22.10059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure and functional expression of a glutaminyl cyclase</span></div><div class="casAuthors">Pohl, Thomas; Zimmer, Michael; Mugele, Katrin; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10059-63</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A glutaminyl cyclase (QC) that is probably involved in the biosynthesis of pyroglutamyl peptides such as gonadotropin-releasing hormone and TSH-releasing hormone has been purified to homogeneity from bovine anterior pituitary.  On the basis of N-terminal sequence anal., a 2088-base-pair cDNA clone was isolated from a bovine anterior pituitary library.  From the nucleotide sequence of this clone, the primary structure of a 330-residue protein and a preceding 31-residue prepropeptide sequence was deduced.  By transfection of COS-7 monkey cells with a QC cDNA/pCDM8 vector construct, QC activity was expressed.  Hybridization with mRNAs of various bovine tissues revealed expression of QC mainly in brain tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdQGThtNPlPLVg90H21EOLACvtfcHk0lgZOm78GEefDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVCnsQ%253D%253D&md5=3d0e422d9b00b1184d8646c5a12bf353</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.22.10059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.22.10059%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DT.%26aulast%3DZimmer%26aufirst%3DM.%26aulast%3DMugele%26aufirst%3DK.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DPrimary%2520structure%2520and%2520functional%2520expression%2520of%2520a%2520glutaminyl%2520cyclase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D10059%26epage%3D63%26doi%3D10.1073%2Fpnas.88.22.10059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">10849</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1021/bi0260381</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0260381" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10849-57&author=S.+Schillingauthor=T.+Hoffmannauthor=F.+Roscheauthor=S.+Manhartauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Heterologous+expression+and+characterization+of+human+glutaminyl+cyclase%3A+evidence+for+a+disulfide+bond+with+importance+for+catalytic+activity&doi=10.1021%2Fbi0260381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heterologous Expression and Characterization of Human Glutaminyl Cyclase: Evidence for a Disulfide Bond with Importance for Catalytic Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Rosche, Fred; Manhart, Susanne; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">10849-10857</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC, EC 2.3.2.5) catalyzes the formation of pyroglutamate residues from glutamine at the N-terminus of peptides and proteins.  In the current study, human QC was functionally expressed in the secretory pathway of Pichia pastoris, yielding milligram quantities after purifn. from the supernatant of a 5 L fermn.  Initial characterization studies of the recombinant QC using MALDI-TOF mass spectrometry revealed correct proteolytic processing and N-glycosylation at both potential sites with similar 2 kDa extensions.  CD spectral anal. indicated a high α-helical content, which contrasts with plant QC from Carica papaya.  The kinetic parameters for conversion of H-Gln-Tyr-Ala-OH by recombinant human QC were almost identical to those previously reported for purified bovine pituitary QC.  However, the results obtained for conversion of H-Gln-Gln-OH, H-Gln-NH2, and H-Gln-AMC were found to be contradictory to previous studies on human QC expressed intracellularly in E. coli.  Expression of QC in E. coli showed that approx. 50% of the protein did not contain a disulfide bond that is present in the entire QC expressed in P. pastoris.  Further, the enzyme was consistently inactivated by treatment with 15 mM DTT, whereas deglycosylation had no effect on enzymic activity.  Anal. of the fluorescence spectra of the native, reduced, and unfolded human QC point to a conformational change of the protein upon treatment with DTT.  In terms of the different enzymic properties, the consequences of QC expression in different environments are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJohsxahWb8bVg90H21EOLACvtfcHk0lgDdHWPRxrHNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFSmtro%253D&md5=c7d449a36576aec362a0b17bb7de2d4c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi0260381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0260381%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DRosche%26aufirst%3DF.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DHeterologous%2520expression%2520and%2520characterization%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520evidence%2520for%2520a%2520disulfide%2520bond%2520with%2520importance%2520for%2520catalytic%2520activity%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10849%26epage%3D57%26doi%3D10.1021%2Fbi0260381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of glutaminyl cyclases from plants and animals</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>384</i></span>,  <span class="NLM_fpage">1583</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1515/BC.2003.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1515%2FBC.2003.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=14719800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2003&pages=1583-92&author=S.+Schillingauthor=S.+Manhartauthor=T.+Hoffmannauthor=H.+H.+Ludwigauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Substrate+specificity+of+glutaminyl+cyclases+from+plants+and+animals&doi=10.1515%2FBC.2003.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of glutaminyl cyclases from plants and animals</span></div><div class="casAuthors">Schilling, Stephan; Manhart, Susanne; Hoffmann, Torsten; Ludwig, Hans-henning; Wasternack, Claus; Demuth, Hans-ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1583-1592</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QC) catalyze the intramol. cyclization of N-terminal glutamine residues of peptides and proteins.  For a comparison of the substrate specificity of human and papaya QC enzymes, a novel continuous assay was established by adapting an existing discontinuous method.  Specificity consts. (kcat/Km) of dipeptides and dipeptide surrogates were higher for plant QC, whereas the selectivity for oligopeptides was similar for both enzymes.  However, only the specificity consts. of mammalian QC were dependent on size and compn. of the substrates.  Specificity consts. of both enzymes were equally pH-dependent in the acidic pH-region, revealing a pKa value identical to the pKa of the substrate, suggesting similarities in the substrate conversion mode.  Accordingly, both QCs converted the L-βhomoglutaminyl residue in the peptide H-βhomoGln-Phe-Lys-Arg-Leu-Ala-NH2 and the glutaminyl residues of the branched peptide H-Gln-Lys(Gln)-Arg-Leu-Ala-NH2 as well as the partially cyclized peptide H-Gln-cyclo(Nε-Lys-Arg-Pro-Ala-Gly-Phe).  In contrast, only QC from C. papaya was able to cyclize a methylated glutamine residue, while this compd. did not even inhibit human QC-catalysis, suggesting distinct substrate recognition pattern.  The conversion of the potential physiol. substrates [Gln1]-gastrin, [Gln1]-neurotensin and [Gln1]-fertilization promoting peptide indicates that human QC may play a key role in posttranslational modification of most if not all pGlu-contg. hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWs7SWbYbyQLVg90H21EOLACvtfcHk0lgDdHWPRxrHNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVSksQ%253D%253D&md5=3e011093800699f46513a309b29647c8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1515%2FBC.2003.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FBC.2003.175%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DSubstrate%2520specificity%2520of%2520glutaminyl%2520cyclases%2520from%2520plants%2520and%2520animals%26jtitle%3DBiol.%2520Chem.%26date%3D2003%26volume%3D384%26spage%3D1583%26epage%3D92%26doi%3D10.1515%2FBC.2003.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Isolation of an isoenzyme of human glutaminyl cyclase: retention in the Golgi complex suggests involvement in the protein maturation machinery</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">966</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2008.03.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jmb.2008.03.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18486145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=966-80&author=H.+Cynisauthor=J.+U.+Rahfeldauthor=A.+Stephanauthor=A.+Kehlenauthor=B.+Kochauthor=M.+Wermannauthor=H.+U.+Demuthauthor=S.+Schilling&title=Isolation+of+an+isoenzyme+of+human+glutaminyl+cyclase%3A+retention+in+the+Golgi+complex+suggests+involvement+in+the+protein+maturation+machinery&doi=10.1016%2Fj.jmb.2008.03.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of an Isoenzyme of Human Glutaminyl Cyclase: Retention in the Golgi Complex Suggests Involvement in the Protein Maturation Machinery</span></div><div class="casAuthors">Cynis, Holger; Rahfeld, Jens-Ulrich; Stephan, Anett; Kehlen, Astrid; Koch, Birgit; Wermann, Michael; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">966-980</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mammalian glutaminyl cyclase isoenzymes (isoQCs) were identified.  The anal. of the primary structure of human isoQC (h-isoQC) revealed conservation of the zinc-binding motif of the human QC (hQC).  In contrast to hQC, h-isoQC carries an N-terminal signal anchor.  The cDNAs of human and murine isoQCs were isolated and h-isoQC, lacking the N-terminal signal anchor and the short cytosolic tail, was expressed as a fusion protein in Escherichia coli. h-isoQC exhibits 10-fold lower activity compared to hQC.  Similar to hQC, h-isoQC was competitively inhibited by imidazoles and cysteamines.  Inactivation by metal chelators suggests a conserved metal-dependent catalytic mechanism of both isoenzymes.  A comparison of the expression pattern of m-isoQC and murine QC revealed ubiquitous expression of both enzymes.  However, murine QC transcript formation was higher in neuronal tissue, whereas the amt. of m-isoQC transcripts did not vary significantly between different organs. h-isoQC was exclusively localized within the Golgi complex, obviously retained by the N-terminus.  Similar resident enzymes of the Golgi complex are the glycosyltransferases.  Golgi app. retention implies a "housekeeping" protein maturation machinery conducting glycosylation and pyroglutamyl formation.  For these enzymes, apparently similar strategies evolved to retain the proteins in the Golgi complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZeVmaPE9cw7Vg90H21EOLACvtfcHk0lgDdHWPRxrHNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtL4%253D&md5=707e10bf9a6f5b84ac8c455dd86ec4cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.03.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.03.078%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsolation%2520of%2520an%2520isoenzyme%2520of%2520human%2520glutaminyl%2520cyclase%253A%2520retention%2520in%2520the%2520Golgi%2520complex%2520suggests%2520involvement%2520in%2520the%2520protein%2520maturation%2520machinery%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D966%26epage%3D80%26doi%3D10.1016%2Fj.jmb.2008.03.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niestroj, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunkel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">49773</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1074/jbc.M309077200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M309077200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=14522962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49773-9&author=S.+Schillingauthor=A.+J.+Niestrojauthor=J.+U.+Rahfeldauthor=T.+Hoffmannauthor=M.+Wermannauthor=K.+Zunkelauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Identification+of+human+glutaminyl+cyclase+as+a+metalloenzyme.+Potent+inhibition+by+imidazole+derivatives+and+heterocyclic+chelators&doi=10.1074%2Fjbc.M309077200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Human Glutaminyl Cyclase as a Metalloenzyme: Potent inhibition by imidazole derivatives and heterocyclic chelators</span></div><div class="casAuthors">Schilling, Stephan; Niestroj, Andre J.; Rahfeld, Jens-Ulrich; Hoffmann, Torsten; Wermann, Michael; Zunkel, Katrin; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">49773-49779</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human glutaminyl cyclase (QC) was identified as a metalloenzyme as suggested by the time-dependent inhibition by the heterocyclic chelators 1,10-phenanthroline and dipicolinic acid.  The effect of EDTA on QC catalysis was negligible.  Inactivated enzyme could be fully restored by the addn. of Zn2+ in the presence of equimolar concns. of EDTA.  Little reactivation was obsd. with Co2+ and Mn2+.  Other metal ions such as K+, Ca2+, and Ni2+ were inactive under the same conditions.  Addnl., imidazole and imidazole derivs. were identified as competitive inhibitors of QC.  An initial structure activity-based inhibitor screening of imidazole-derived compds. revealed potent inhibition of QC by imidazole N-1 derivs.  Subsequent data base screening led to the identification of two highly potent inhibitors, 3-[3-(1H-imidazol-1-yl)propyl]-2-thioxoimidazolidin-4-one and 1,4-bis-(imidazol-1-yl)-methyl-2,5-dimethylbenzene, which exhibited resp. Ki values of 818 and 295 nM.  The binding properties of the imidazole derivs. were further analyzed by the pH dependence of QC inhibition.  The kinetically obtained pKa values of 6.94, 6.93, and 5.60 for imidazole, methylimidazole, and benzimidazole, resp., match the values obtained by titrimetric pKa detn., indicating the requirement for an unprotonated nitrogen for binding to QC.  Similarly, the pH dependence of the kinetic parameter Km for the QC-catalyzed conversion of H-Gln-7-amino-4-methylcoumarin also implies that only N-terminally unprotonated substrate mols. are bound to the active site of the enzyme, whereas turnover is not affected.  The results reveal human QC as a metal-dependent transferase, suggesting that the active site-bound metal is a potential site for interaction with novel, highly potent competitive inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolRoNA9eEuXrVg90H21EOLACvtfcHk0lhPeWESTamWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslSrurw%253D&md5=372bdb3cf7603da16c3c2cc888a54cb1</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309077200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309077200%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DIdentification%2520of%2520human%2520glutaminyl%2520cyclase%2520as%2520a%2520metalloenzyme.%2520Potent%2520inhibition%2520by%2520imidazole%2520derivatives%2520and%2520heterocyclic%2520chelators%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49773%26epage%3D9%26doi%3D10.1074%2Fjbc.M309077200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Bohlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07337.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1742-4658.2009.07337.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19804409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6522-36&author=A.+Stephanauthor=M.+Wermannauthor=A.+von+Bohlenauthor=B.+Kochauthor=H.+Cynisauthor=H.+U.+Demuthauthor=S.+Schilling&title=Mammalian+glutaminyl+cyclases+and+their+isoenzymes+have+identical+enzymatic+characteristics&doi=10.1111%2Fj.1742-4658.2009.07337.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian glutaminyl cyclases and their isoenzymes have identical enzymatic characteristics</span></div><div class="casAuthors">Stephan, Anett; Wermann, Michael; von Bohlen, Alex; Koch, Birgit; Cynis, Holger; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6522-6536</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminly cyclases (QCs) catalyze the formation of pyroglutamate residues at the N-terminus of several peptides and proteins from plants and animals.  Recently, isoenzymes of mammalian QCs have been identified.  In order to gain further insight into the biochem. characteristics of isoQCs, the human and murine enzymes were expressed in the secretory pathway of Pichia pastoris.  Replacement of the N-terminal signal anchor by an α-factor prepropeptide from Saccharomyces cerevisiae resulted in poor secretion of the protein.  Insertion of an N-terminal glycosylation site and shortening of the N-terminus improved isoQC secretion 100-fold.  A comparison of different recombinant isoQC proteins did not reveal an influence of mutagenic changes on catalytic activity.  An initial characterization showed identical modes of substrate conversion of human isoQC and murine isoQC.  Both proteins displayed a broad substrate specificity and preference for hydrophobic substrates, similar to the related QC.  Likewise, a detn. of the zinc content and reactivation of the apo-isoQC revealed equimolar zinc present in QC and isoQC.  Far-UV CD spectroscopic anal. of murine QC and isoQC indicated virtually identical structural components.  The present investigation provides the first enzymic characterization of mammalian isoQCs.  QC and isoQC represent very similar proteins, which are both present in the secretory pathway of cells.  The functions of QCs and isoQC probably complement each other, suggesting a pivotal role of pyroglutamate modification for protein and peptide maturation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSMUn-pkjU0rVg90H21EOLACvtfcHk0lhPeWESTamWFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsL3E&md5=33eaa1762bd0916b96f6fc4087515b27</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07337.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07337.x%26sid%3Dliteratum%253Aachs%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3Dvon%2BBohlen%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DMammalian%2520glutaminyl%2520cyclases%2520and%2520their%2520isoenzymes%2520have%2520identical%2520enzymatic%2520characteristics%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6522%26epage%3D36%26doi%3D10.1111%2Fj.1742-4658.2009.07337.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hofling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Indrischek, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopcke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span> <span> </span><span class="NLM_article-title">Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC</span>. <i>Int. J. Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.ijdevneu.2014.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.ijdevneu.2014.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24886834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2cjnvFOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2014&pages=64-73&author=C.+Hoflingauthor=H.+Indrischekauthor=T.+Hopckeauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=S.+Schillingauthor=M.+Morawskiauthor=H.+U.+Demuthauthor=S.+Rossnerauthor=M.+Hartlage-Rubsamen&title=Mouse+strain+and+brain+region-specific+expression+of+the+glutaminyl+cyclases+QC+and+isoQC&doi=10.1016%2Fj.ijdevneu.2014.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse strain and brain region-specific expression of the glutaminyl cyclases QC and isoQC</span></div><div class="casAuthors">Hofling Corinna; Indrischek Henrike; Hopcke Theodor; Waniek Alexander; Morawski Markus; Hartlage-Rubsamen Maike; Cynis Holger; Koch Birgit; Schilling Stephan; Demuth Hans-Ulrich; Rossner Steffen</div><div class="citationInfo"><span class="NLM_cas:title">International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) from glutamine precursors at the N-terminus of a number of peptide hormones, neuropeptides and chemokines.  This post-translational modification stabilizes these peptides, protects them from proteolytical degradation or is important for their biological activity.  However, QC is also involved in a pathogenic pGlu modification of peptides accumulating in protein aggregation disorders such as Alzheimer's disease and familial Danish and familial British dementia.  Its isoenzyme (isoQC) was shown to contribute to aspects of inflammation by pGlu-modifying and thereby stabilizing the monocyte chemoattractant protein CCL2.  For the generation of respective animal models and for pharmacological treatment studies the characterization of the mouse strain and brain region-specific expression of QC and isoQC is indispensible.  In order to address this issue, we used enzymatic activity assays and specific antibodies to detect both QC variants by immunohistochemistry in nine different mouse strains.  Comparing different brain regions, the highest enzymatic QC/isoQC activity was detected in ventral brain, followed by cortex and hippocampus.  Immunohistochemical stainings revealed that QC/isoQC activity in cortex mostly arises from isoQC expression.  For most brain regions, the highest QC/isoQC activity was detected in C3H and FVB mice, whereas low QC/isoQC activity was present in CD1, SJL and C57 mice.  Quantification of QC- and isoQC-immunoreactive cells by unbiased stereology revealed a higher abundance of isoQC- than of QC-immunoreactive neurons in Edinger-Westphal nucleus and in substantia nigra.  In the locus coeruleus, however, there were comparable densities of QC- and of isoQC-immunoreactive neurons.  These observations are of considerable importance with regard to the selection of appropriate mouse strains for the study of QC/isoQC relevance in mouse models of neurodegeneration and neuroinflammation and for the testing of therapeutical interventions in these models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnyg1T54g0JQaK-_ZudimnfW6udTcc2eYA6JTnziAi8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjnvFOktQ%253D%253D&md5=5978f4ce52b53f6fb3873f9d984842ac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2014.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2014.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DHofling%26aufirst%3DC.%26aulast%3DIndrischek%26aufirst%3DH.%26aulast%3DHopcke%26aufirst%3DT.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26atitle%3DMouse%2520strain%2520and%2520brain%2520region-specific%2520expression%2520of%2520the%2520glutaminyl%2520cyclases%2520QC%2520and%2520isoQC%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2014%26volume%3D36%26spage%3D64%26epage%3D73%26doi%3D10.1016%2Fj.ijdevneu.2014.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">14199</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.229385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M111.229385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21330373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=14199-208&author=S.+Schillingauthor=S.+Kohlmannauthor=C.+Bauscherauthor=R.+Sedlmeierauthor=B.+Kochauthor=R.+Eichentopfauthor=A.+Beckerauthor=H.+Cynisauthor=T.+Hoffmannauthor=S.+Bergauthor=E.+J.+Freyseauthor=S.+von+Horstenauthor=S.+Rossnerauthor=S.+Graubnerauthor=H.+U.+Demuth&title=Glutaminyl+cyclase+knock-out+mice+exhibit+slight+hypothyroidism+but+no+hypogonadism%3A+implications+for+enzyme+function+and+drug+development&doi=10.1074%2Fjbc.M111.229385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase Knock-out Mice Exhibit Slight Hypothyroidism but No Hypogonadism: Implications for Enzyme Function and Drug Development</span></div><div class="casAuthors">Schilling, Stephan; Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Koch, Birgit; Eichentopf, Rico; Becker, Andreas; Cynis, Holger; Hoffmann, Torsten; Berg, Sabine; Freyse, Ernst-Joachim; von Hoersten, Stephan; Rossner, Steffen; Graubner, Sigrid; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14199-14208</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) residues at the N terminus of peptides and proteins.  Hypothalamic pGlu hormones, such as TSH-releasing hormone and gonadotropin-releasing hormone are essential for regulation of metab. and fertility in the hypothalamic pituitary thyroid and gonadal axes, resp.  Here, we analyzed the consequences of constitutive genetic QC ablation on endocrine functions and on the behavior of adult mice.  Adult homozygous QC knock-out mice are fertile and behave indistinguishably from wild type mice in tests of motor function, cognition, general activity, and ingestion behavior.  The QC knock-out results in a dramatic drop of enzyme activity in the brain, esp. in hypothalamus and in plasma.  Other peripheral organs like liver and spleen still contain QC activity, which is most likely caused by its homolog isoQC.  The serum gonadotropin-releasing hormone, TSH, and testosterone concns. were not changed by QC depletion.  The serum thyroxine was decreased by 24% in homozygous QC knock-out animals, suggesting a mild hypothyroidism.  QC knock-out mice were indistinguishable from wild type with regard to blood glucose and glucose tolerance, thus differing from reports of TSH-releasing hormone knock-out mice significantly.  The results suggest a significant formation of the hypothalamic pGlu hormones by alternative mechanisms, like spontaneous cyclization or conversion by isoQC.  The different effects of QC depletion on the hypothalamic pituitary thyroid and gonadal axes might indicate slightly different modes of substrate conversion of both enzymes.  The absence of significant abnormalities in QC knock-out mice suggests the presence of a therapeutic window for suppression of QC activity in current drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCNjZy_kF7J7Vg90H21EOLACvtfcHk0lhfGO8NkeU1Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWju7g%253D&md5=5eb82b2b939e6adc4cf8970155237aaf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.229385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.229385%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclase%2520knock-out%2520mice%2520exhibit%2520slight%2520hypothyroidism%2520but%2520no%2520hypogonadism%253A%2520implications%2520for%2520enzyme%2520function%2520and%2520drug%2520development%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D14199%26epage%3D208%26doi%3D10.1074%2Fjbc.M111.229385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robert, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouet, P.</span></span> <span> </span><span class="NLM_article-title">Deciphering key features in protein structures with the new ENDscript server</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">W320</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1093/nar/gku316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Fnar%2Fgku316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24753421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=W320-4&author=X.+Robertauthor=P.+Gouet&title=Deciphering+key+features+in+protein+structures+with+the+new+ENDscript+server&doi=10.1093%2Fnar%2Fgku316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Deciphering key features in protein structures with the new ENDscript server</span></div><div class="casAuthors">Robert, Xavier; Gouet, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W320-W324</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ENDscript 2 is a friendly Web server for extg. and rendering a comprehensive anal. of primary to quaternary protein structure information in an automated way.  This major upgrade has been fully re-engineered to enhance speed, accuracy and usability with interactive 3D visualization.  It takes advantage of the new version 3 of ESPript, our well-known sequence alignment renderer, improved to handle a large no. of data with reduced computation time.  From a single PDB entry or file, ENDscript produces high quality figures displaying multiple sequence alignment of proteins homologous to the query, colored according to residue conservation.  Furthermore, the exptl. secondary structure elements and a detailed set of relevant biophys. and structural data are depicted.  All this information and more are now mapped on interactive 3D PyMOL representations.  Thanks to its adaptive and rigorous algorithm, beginner to expert users can modify settings to fine-tune ENDscript to their needs.  ENDscript has also been upgraded as an open platform for the visualization of multiple biochem. and structural data coming from external biotool Web servers, with both 2D and 3D representations.  ENDscript 2 and ESPript 3 are freely available at http://endscript.ibcp.fr and http://espript.ibcp.fr, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5lD0RT2rA9rVg90H21EOLACvtfcHk0lhfGO8NkeU1Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCqs7vK&md5=96c315b6732a2be7fb72fa44be3511da</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgku316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgku316%26sid%3Dliteratum%253Aachs%26aulast%3DRobert%26aufirst%3DX.%26aulast%3DGouet%26aufirst%3DP.%26atitle%3DDeciphering%2520key%2520features%2520in%2520protein%2520structures%2520with%2520the%2520new%2520ENDscript%2520server%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2014%26volume%3D42%26spage%3DW320%26epage%3D4%26doi%3D10.1093%2Fnar%2Fgku316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Consalvo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamburini, P. P.</span></span> <span> </span><span class="NLM_article-title">A rapid fluorometric assay for N-terminal glutaminyl cyclase activity using high-performance liquid chromatography</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/0003-2697(88)90370-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0003-2697%2888%2990370-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3245563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXltleqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1988&pages=131-8&author=A.+P.+Consalvoauthor=S.+D.+Youngauthor=B.+N.+Jonesauthor=P.+P.+Tamburini&title=A+rapid+fluorometric+assay+for+N-terminal+glutaminyl+cyclase+activity+using+high-performance+liquid+chromatography&doi=10.1016%2F0003-2697%2888%2990370-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A rapid fluorometric assay for N-terminal glutaminyl cyclase activity using high-performance liquid chromatography</span></div><div class="casAuthors">Consalvo, Angelo P.; Young, Stanley D.; Jones, Barry N.; Tamburini, Paul P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-8</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">A rapid, sensitive method for the quantification of glutaminyl cyclase activity has been developed.  The assay involves enzymic conversion of the model peptide Gln-Leu-Tyr-Glu-Asn-Lys-ε-(Dns)-OH (DNS = dansyl) to pyroglutamyl-Leu-Tyr-Glu-Asn-Lys-ε-(Dns)-OH.  Both the product and substrate of this reaction are detected in a single assay in quantities as low as 100 fmol using isocratic reverse-phase HPLC with fluorometric detection.  The method is highly reproducible and ideally suited for the rapid anal. of large nos. of samples.  The applications of the assay to both the detection of glutaminyl cyclase activity during enzyme purifn. and the more rigorous enzymol. studies dependent on the precise measurement of initial reaction velocities are demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbxYTBka9XZrVg90H21EOLACvtfcHk0lhfGO8NkeU1Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXltleqtQ%253D%253D&md5=f1eb108267eab034391b490a18d05bfd</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2888%2990370-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252888%252990370-3%26sid%3Dliteratum%253Aachs%26aulast%3DConsalvo%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DS.%2BD.%26aulast%3DJones%26aufirst%3DB.%2BN.%26aulast%3DTamburini%26aufirst%3DP.%2BP.%26atitle%3DA%2520rapid%2520fluorometric%2520assay%2520for%2520N-terminal%2520glutaminyl%2520cyclase%2520activity%2520using%2520high-performance%2520liquid%2520chromatography%26jtitle%3DAnal.%2520Biochem.%26date%3D1988%26volume%3D175%26spage%3D131%26epage%3D8%26doi%3D10.1016%2F0003-2697%2888%2990370-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busby, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quackenbush, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>262</i></span>,  <span class="NLM_fpage">8532</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0021-9258(18)47446-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0021-9258%2818%2947446-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3597387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8532-6&author=W.+J.+Busbyauthor=G.+E.+Quackenbushauthor=J.+Hummauthor=W.+W.+Youngbloodauthor=J.+S.+Kizer&title=An+enzyme%28s%29+that+converts+glutaminyl-peptides+into+pyroglutamyl-peptides.+Presence+in+pituitary%2C+brain%2C+adrenal+medulla%2C+and+lymphocytes&doi=10.1016%2FS0021-9258%2818%2947446-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides.  Presence in pituitary, brain, adrenal medulla, and lymphocytes</span></div><div class="casAuthors">Busby, Walker H., Jr.; Quackenbush, Gail E.; Humm, Jane; Youngblood, William W.; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8532-6</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">The mechanism for the post-translational conversion of glutamine to pyroglutamic acid on the N-terminus of newly synthesized peptides and proteins is unknown.  An assay is reported here that permits measurement of the rate of conversion of Gln-His-Pro-NH2 to <Glu-His-Pro-NH2 (TRH), where <Glu is pyroglutamate.  Using this assay, it was demonstrated that the spontaneous cyclization of the N-terminal glutamine of this peptide occurs only slowly under physiol. conditions.  Furthermore, the presence in rat brain, porcine pituitary, and human B lymphocytes of a glutaminyl-peptide cyclase which converts Gln-His-Pro-NH2 into <Glu-His-Pro-NH2, is described.  The enzyme(s) appears to be a glycoprotein, is maximally active at neutral pH, has a mol. wt. of 55,000, and contains catalytically significant SH groups.  The product of the enzymic reaction was confirmed by high-resoln. fast atom bombardment-mass spectrometry.  In preliminary studies, it was found that >90% of the enzyme in bovine adrenal medulla is contained in the sol. chromaffin vesicle fraction.  These findings indicate that in vivo the post-translational conversion of a glutaminyl-peptide into a pyroglutamyl-peptide is neither spontaneous nor abiotic as has been previously proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRgXDyJEuhjrVg90H21EOLACvtfcHk0lgYQcCxM2gyRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt12lsLs%253D&md5=8a8b35c61b2c94f4437fd06fc400656e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2947446-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252947446-7%26sid%3Dliteratum%253Aachs%26aulast%3DBusby%26aufirst%3DW.%2BJ.%26aulast%3DQuackenbush%26aufirst%3DG.%2BE.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DW.%2BW.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAn%2520enzyme%2528s%2529%2520that%2520converts%2520glutaminyl-peptides%2520into%2520pyroglutamyl-peptides.%2520Presence%2520in%2520pituitary%252C%2520brain%252C%2520adrenal%2520medulla%252C%2520and%2520lymphocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8532%26epage%3D6%26doi%3D10.1016%2FS0021-9258%2818%2947446-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koger, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizer, J. S.</span></span> <span> </span><span class="NLM_article-title">Assay of glutaminylpeptide cyclase</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1016/0076-6879(89)68027-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0076-6879%2889%2968027-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=2498615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXktVejsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1989&pages=358-65&author=J.+B.+Kogerauthor=J.+Hummauthor=J.+S.+Kizer&title=Assay+of+glutaminylpeptide+cyclase&doi=10.1016%2F0076-6879%2889%2968027-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Assay of glutaminylpeptide cyclase</span></div><div class="casAuthors">Koger, Jeanne B.; Humm, Jane; Kizer, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">Horm. Action:  Pt. K</span>),
    <span class="NLM_cas:pages">358-65</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    </div><div class="casAbstract">A RIA for the title enzyme is described which is applicable to a no. of different tissues.  The assay is based on the conversion of the substrate, Gln-His-Pro-NH2, to the product, TSH-releasing hormone (TRH).  The assay is complicated by the presence of prolyl endopeptidase (EC 3.4.21.26) and approaches to resolving the problem are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8FEhRnx0Y2rVg90H21EOLACvtfcHk0lgYQcCxM2gyRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVejsb8%253D&md5=58b0934b8352d180b5b501e820217a94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0076-6879%2889%2968027-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0076-6879%252889%252968027-5%26sid%3Dliteratum%253Aachs%26aulast%3DKoger%26aufirst%3DJ.%2BB.%26aulast%3DHumm%26aufirst%3DJ.%26aulast%3DKizer%26aufirst%3DJ.%2BS.%26atitle%3DAssay%2520of%2520glutaminylpeptide%2520cyclase%26jtitle%3DMethods%2520Enzymol.%26date%3D1989%26volume%3D168%26spage%3D358%26epage%3D65%26doi%3D10.1016%2F0076-6879%2889%2968027-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/0165-0270(89)90070-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0165-0270%2889%2990070-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=2811431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL1MXmt1Oltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1989&pages=23-8&author=R.+J.+Bateman&title=A+spectrophotometric+assay+for+glutaminyl-peptide+cyclizing+enzymes&doi=10.1016%2F0165-0270%2889%2990070-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes</span></div><div class="casAuthors">Bateman, Robert C., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-8</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    </div><div class="casAbstract">Current assays for the glutaminyl-peptide cyclizing enzyme, glutaminyl cyclase, have several shortcomings.  In this report, a rapid spectrophotometric assay for cyclization of glutaminyl-peptides to pyroglutamyl-peptides by glutaminyl cyclase is described which overcomes many of these shortcomings.  This coupled assay utilizes glutamate dehydrogenase, α-ketoglutarate, and NADH to measure the NH3 released during cyclization of the dipeptide substrate, Gln-Gln.  Glutaminyl cyclase from bovine pituitary gland, partially purified by ion-exchange chromatog., exhibited a Km for this substrate of 0.6 mM and a Vmax of 9.6 nmol/min/mg protein.  These values were comparable to those previously reported using other glutaminyl-peptide substrates and either RIA or HPLC to measure glutaminyl cyclase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsV8sQEnSvGbVg90H21EOLACvtfcHk0lgYQcCxM2gyRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmt1Oltrw%253D&md5=43a7a246d089a3d2fcc6e098c0c18360</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0165-0270%2889%2990070-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-0270%252889%252990070-8%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DA%2520spectrophotometric%2520assay%2520for%2520glutaminyl-peptide%2520cyclizing%2520enzymes%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D1989%26volume%3D30%26spage%3D23%26epage%3D8%26doi%3D10.1016%2F0165-0270%2889%2990070-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gololobov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span> <span> </span><span class="NLM_article-title">Steady-state kinetics of glutamine cyclotransferase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>309</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1006/abbi.1994.1117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1006%2Fabbi.1994.1117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=8135542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFOgtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=1994&pages=300-7&author=M.+Gololobovauthor=I.+Songauthor=W.+Wangauthor=R.+J.+Bateman&title=Steady-state+kinetics+of+glutamine+cyclotransferase&doi=10.1006%2Fabbi.1994.1117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Steady-state kinetics of glutamine cyclotransferase</span></div><div class="casAuthors">Gololobov, Mikhail Yu.; Song, Inseok; Wang, Wenying; Bateman, Robert C., Mr.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-7</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    </div><div class="casAbstract">The reaction mechanism of papaya latex glutamine cyclotransferase (EC 2.3.2.5) (I) was studied using pH and temp. dependencies, a proton inventory technique, and mol. modeling.  The pH-dependence of the Michaelis-Menten parameters showed that the published pH dependence of the enzyme activity was mainly the result of pH-dependent change in the active (unprotonated) substrate concn.  I activity as such changed very slightly in the pH range of 4.5-10.  The solvent kinetic isotope effect reflected a change in Vmax, whereas the proton inventory was found to be linear with a fractionation factor of the exchangeable proton(s) in the transition state of 0.785.  The results were not consistent with an acyl-enzyme mechanism, but rather favored a simple intramol. cyclization of the glutamine residue to the pyroglutamic acid residue.  The proposed mechanism consisted of the following main steps: (1) intramol. nucleophilic attack on the γ-C:O C atom by the N atom of the α-NH2 group, (2) transfer of a proton from the α-NH2 group to the N atom of the amide group, facilitated by an acidic group of the enzyme, and (3) expulsion of the NH3-leaving group promoted by this or another acidic enzyme group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre7tjE-wpstLVg90H21EOLACvtfcHk0lhz6qrRmfOtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFOgtb0%253D&md5=02f9a0b7c654a64372bf9b3a69ddde6c</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1994.1117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1994.1117%26sid%3Dliteratum%253Aachs%26aulast%3DGololobov%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26atitle%3DSteady-state%2520kinetics%2520of%2520glutamine%2520cyclotransferase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1994%26volume%3D309%26spage%3D300%26epage%3D7%26doi%3D10.1006%2Fabbi.1994.1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasternack, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Continuous spectrometric assays for glutaminyl cyclase activity</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1006/abio.2001.5560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1006%2Fabio.2001.5560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=11906150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=49-56&author=S.+Schillingauthor=T.+Hoffmannauthor=M.+Wermannauthor=U.+Heiserauthor=C.+Wasternackauthor=H.+U.+Demuth&title=Continuous+spectrometric+assays+for+glutaminyl+cyclase+activity&doi=10.1006%2Fabio.2001.5560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Continuous Spectrometric Assays for Glutaminyl Cyclase Activity</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Wermann, Michael; Heiser, Ulrich; Wasternack, Claus; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The enzymic conversion of one chromogenic substrate, L-glutamine-p-nitroanilide, and two fluorogenic substrates, L-glutaminyl-2-naphthylamide and L-glutaminyl-4-methylcoumarinylamide, into their resp. pyroglutamic acid derivs. by glutaminyl cyclase (QC) was estd. by introducing a new coupled assay using pyroglutamyl aminopeptidase as the auxiliary enzyme.  For the purified papaya QC, the kinetic parameters were found to be in the range of those previously reported for other glutaminyl peptides, such as Gln-Gln, Gln-Ala, or Gln-tert-Bu ester.  The assay can be performed in the presence of ammonia up to a concn. of 50 mM.  Increasing ionic strength, e.g., potassium chloride up to 300 mM, resulted in an increase in enzymic activity of about 20%.  This is the first report of a fast, continuous, and reliable detn. of QC activity, even in the presence of ammonium ions, during the course of protein purifn. and enzymic anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQW4L1wwLqbVg90H21EOLACvtfcHk0lhz6qrRmfOtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFeisL0%253D&md5=18509903cf5017f855c3c3ea68dc9915</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1006%2Fabio.2001.5560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.2001.5560%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DWasternack%26aufirst%3DC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DContinuous%2520spectrometric%2520assays%2520for%2520glutaminyl%2520cyclase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D2002%26volume%3D303%26spage%3D49%26epage%3D56%26doi%3D10.1006%2Fabio.2001.5560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme</span>. <i>Protein Expression Purif.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.pep.2005.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.pep.2005.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16084398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVGhsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=65-72&author=K.+F.+Huangauthor=Y.+L.+Liuauthor=A.+H.+Wang&title=Cloning%2C+expression%2C+characterization%2C+and+crystallization+of+a+glutaminyl+cyclase+from+human+bone+marrow%3A+a+single+zinc+metalloenzyme&doi=10.1016%2Fj.pep.2005.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: A single zinc metalloenzyme</span></div><div class="casAuthors">Huang, Kai-Fa; Liu, Yi-Liang; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Expression and Purification</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-72</span>CODEN:
                <span class="NLM_cas:coden">PEXPEJ</span>;
        ISSN:<span class="NLM_cas:issn">1046-5928</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) catalyzes the N-terminal pyroglutamate formation of numerous hormones and peptides from their glutaminyl precursor.  Pyroglutamate is a posttranslational or cotranslational modification important in many physiol. and pathol. processes.  Here, we present the cloning of a QC cDNA from human bone marrow cDNA library.  The protein was expressed in Escherichia coli system with the yields higher than ∼10 mg/L bacterial culture, using a thioredoxin-tagged expression vector with several modifications.  Based on high histidine content (∼5%) of the protein, a convenient purifn. step by Ni-affinity chromatog. was designed, leading to near homogeneity of the purified human QC.  The identity of the recombinant human QC was confirmed by mass spectrometry and CD spectroscopy.  The enzyme was active on both synthetic and physiol. substrates, and the activity could be inhibited by several imidazole, triazole, and tetrazole derivs.  An at. absorption anal. demonstrated that human QC contains one zinc ion per protein mol.  We also obtained the human QC crystals, which belong to cubic, tetragonal, and rhombohedral forms.  Our works are useful to acquire new insights into human and animal QCs, particularly for future structural anal. and inhibitor designs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX278EZGXHh7Vg90H21EOLACvtfcHk0lhz6qrRmfOtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVGhsbc%253D&md5=e65da5ffd4de19644c081b0bd147ecbf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.pep.2005.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pep.2005.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCloning%252C%2520expression%252C%2520characterization%252C%2520and%2520crystallization%2520of%2520a%2520glutaminyl%2520cyclase%2520from%2520human%2520bone%2520marrow%253A%2520a%2520single%2520zinc%2520metalloenzyme%26jtitle%3DProtein%2520Expression%2520Purif.%26date%3D2005%26volume%3D43%26spage%3D65%26epage%3D72%26doi%3D10.1016%2Fj.pep.2005.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">13117</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1073/pnas.0504184102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.0504184102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16135565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaqu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13117-22&author=K.+F.+Huangauthor=Y.+L.+Liuauthor=W.+J.+Chengauthor=T.+P.+Koauthor=A.+H.+Wang&title=Crystal+structures+of+human+glutaminyl+cyclase%2C+an+enzyme+responsible+for+protein+N-terminal+pyroglutamate+formation&doi=10.1073%2Fpnas.0504184102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation</span></div><div class="casAuthors">Huang, Kai-Fa; Liu, Yi-Liang; Cheng, Wei-Ju; Ko, Tzu-Ping; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13117-13122</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from its glutaminyl (or glutamyl) precursor is required in the maturation of numerous bioactive peptides.  The aberrant formation of pGlu may be related to several pathol. processes, such as osteoporosis and amyloidotic diseases.  This N-terminal cyclization reaction, once thought to proceed spontaneously, is greatly facilitated by the enzyme glutaminyl cyclase (QC).  To probe this important but poorly understood modification, we present here the structure of human QC in free form and bound to a substrate and three imidazole-derived inhibitors.  The structure reveals an α/β scaffold akin to that of two-zinc exopeptidases but with several insertions and deletions, particularly in the active-site region.  The relatively closed active site displays alternate conformations due to the different indole orientations of Trp-207, resulting in two substrate (glutamine t-Bu ester)-binding modes.  The single zinc ion in the active site is coordinated to three conserved residues and one water mol., which is replaced by an imidazole nitrogen upon binding of the inhibitors.  Together with structural and kinetic analyses of several active-site-mutant enzymes, a catalytic mechanism of the formation of protein N-terminal pGlu is proposed.  Our results provide a structural basis for the rational design of inhibitors against QC-assocd. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv1HJxZ-pQn7Vg90H21EOLACvtfcHk0lhz6qrRmfOtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaqu7fO&md5=916fc9856ef63c399bc32eace3123d88</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504184102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504184102%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%2BL.%26aulast%3DCheng%26aufirst%3DW.%2BJ.%26aulast%3DKo%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DCrystal%2520structures%2520of%2520human%2520glutaminyl%2520cyclase%252C%2520an%2520enzyme%2520responsible%2520for%2520protein%2520N-terminal%2520pyroglutamate%2520formation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D13117%26epage%3D22%26doi%3D10.1073%2Fpnas.0504184102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chia, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">12439</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.208595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.208595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21288892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=12439-49&author=K.+F.+Huangauthor=S.+S.+Liawauthor=W.+L.+Huangauthor=C.+Y.+Chiaauthor=Y.+C.+Loauthor=Y.+L.+Chenauthor=A.+H.+Wang&title=Structures+of+human+Golgi-resident+glutaminyl+cyclase+and+its+complexes+with+inhibitors+reveal+a+large+loop+movement+upon+inhibitor+binding&doi=10.1074%2Fjbc.M110.208595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Golgi-resident Glutaminyl Cyclase and its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding</span></div><div class="casAuthors">Huang, Kai-Fa; Liaw, Su-Sen; Huang, Wei-Lin; Chia, Cho-Yun; Lo, Yan-Chung; Chen, Yi-Ling; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">12439-12449</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant pyroglutamate formation at the N terminus of certain peptides and proteins, catalyzed by glutaminyl cyclases (QCs), is linked to some pathol. conditions, such as Alzheimer disease.  Recently, a glutaminyl cyclase (QC) inhibitor, PBD150, was shown to be able to reduce the deposition of pyroglutamate-modified amyloid-β peptides in brain of transgenic mouse models of Alzheimer disease, leading to a significant improvement of learning and memory in those transgenic animals.  Here, we report the 1.05-1.40 Å resoln. structures, solved by the sulfur single-wavelength anomalous dispersion phasing method, of the Golgi-luminal catalytic domain of the recently identified Golgi-resident QC (gQC) and its complex with PBD150.  We also describe the high-resoln. structures of secretory QC (sQC)-PBD150 complex and two other gQC-inhibitor complexes.  The gQC structure has a scaffold similar to that of sQC but with a relatively wider and neg. charged active site, suggesting a distinct substrate specificity from sQC.  Upon binding to PBD150, a large loop movement in gQC allows the inhibitor to be tightly held in its active site primarily by hydrophobic interactions.  Further comparisons of the inhibitor-bound structures revealed distinct interactions of the inhibitors with gQC and sQC, which are consistent with the results from our inhibitor assays reported here.  Because gQC and sQC may play different biol. roles in vivo, the different inhibitor binding modes allow the design of specific inhibitors toward gQC and sQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeL8K3B1TxsLVg90H21EOLACvtfcHk0lg_nTiB-oJD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVKqu7c%253D&md5=ef9018b9dc4ff40db7cac0ddac9fadb1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.208595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.208595%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DLiaw%26aufirst%3DS.%2BS.%26aulast%3DHuang%26aufirst%3DW.%2BL.%26aulast%3DChia%26aufirst%3DC.%2BY.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructures%2520of%2520human%2520Golgi-resident%2520glutaminyl%2520cyclase%2520and%2520its%2520complexes%2520with%2520inhibitors%2520reveal%2520a%2520large%2520loop%2520movement%2520upon%2520inhibitor%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D12439%26epage%3D49%26doi%3D10.1074%2Fjbc.M110.208595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Carrillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dambe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6280</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bi200249h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi200249h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6280-8&author=D.+Ruiz-Carrilloauthor=B.+Kochauthor=C.+Parthierauthor=M.+Wermannauthor=T.+Dambeauthor=M.+Buchholzauthor=H.+H.+Ludwigauthor=U.+Heiserauthor=J.+U.+Rahfeldauthor=M.+T.+Stubbsauthor=S.+Schillingauthor=H.+U.+Demuth&title=Structures+of+glycosylated+mammalian+glutaminyl+cyclases+reveal+conformational+variability+near+the+active+center&doi=10.1021%2Fbi200249h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Glycosylated Mammalian Glutaminyl Cyclases Reveal Conformational Variability near the Active Center</span></div><div class="casAuthors">Ruiz-Carrillo, David; Koch, Birgit; Parthier, Christoph; Wermann, Michael; Dambe, Tresfore; Buchholz, Mirko; Ludwig, Hans-Henning; Heiser, Ulrich; Rahfeld, Jens-Ulrich; Stubbs, Milton T.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6280-6288</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Formation of N-terminal pyroglutamate (pGlu or pE) from glutaminyl or glutamyl precursors is catalyzed by glutaminyl cyclases (QC).  As the formation of pGlu-amyloid has been linked with Alzheimer's disease, inhibitors of QCs are currently the subject of intense development.  Here, we report three crystal structures of N-glycosylated mammalian QC from humans (hQC) and mice (mQC).  Whereas the overall structures of the enzymes are similar to those reported previously, two surface loops in the neighborhood of the active center exhibit conformational variability.  Furthermore, two conserved cysteine residues form a disulfide bond at the base of the active center that was not present in previous reports of hQC structure.  Site-directed mutagenesis suggests a structure-stabilizing role of the disulfide bond.  At the entrance to the active center, the conserved tryptophan residue, W207, which displayed multiple orientations in previous structure, shows a single conformation in both glycosylated human and murine QCs.  Although mutagenesis of W207 into leucine or glutamine altered substrate conversion significantly, the binding consts. of inhibitors such as the highly potent PQ50 (PBD150) were minimally affected.  The crystal structure of PQ50 bound to the active center of murine QC reveals principal binding determinants provided by the catalytic zinc ion and a hydrophobic funnel.  This study presents a first comparison of two mammalian QCs contg. typical, conserved post-translational modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrsCCptP2CFLVg90H21EOLACvtfcHk0lg_nTiB-oJD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvF2jsbw%253D&md5=2306b3661a368105f6f2dd84f8527efb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbi200249h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200249h%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carrillo%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DDambe%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DStructures%2520of%2520glycosylated%2520mammalian%2520glutaminyl%2520cyclases%2520reveal%2520conformational%2520variability%2520near%2520the%2520active%2520center%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6280%26epage%3D8%26doi%3D10.1021%2Fbi200249h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz Carrillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of glutaminyl cyclases (QCs) from <i>Drosophila melanogaster</i> reveal active site conservation between insect and mammalian QCs</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">7383</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/bi300687g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300687g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=7383-7392&author=B.+Kochauthor=P.+Kolenkoauthor=M.+Buchholzauthor=D.+Ruiz+Carrilloauthor=C.+Parthierauthor=M.+Wermannauthor=J.-U.+Rahfeldauthor=G.+Reuterauthor=S.+Schillingauthor=M.+T.+Stubbsauthor=H.-U.+Demuth&title=Crystal+structures+of+glutaminyl+cyclases+%28QCs%29+from+Drosophila+melanogaster+reveal+active+site+conservation+between+insect+and+mammalian+QCs&doi=10.1021%2Fbi300687g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Glutaminyl Cyclases (QCs) from Drosophila melanogaster Reveal Active Site Conservation between Insect and Mammalian QCs</span></div><div class="casAuthors">Koch, Birgit; Kolenko, Petr; Buchholz, Mirko; Ruiz Carrillo, David; Parthier, Christoph; Wermann, Michael; Rahfeld, Jens-Ulrich; Reuter, Gunter; Schilling, Stephan; Stubbs, Milton T.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">7383-7392</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs), which catalyze the formation of pyroglutamic acid (pGlu) at the N-terminus of a variety of peptides and proteins, have attracted particular attention for their potential role in Alzheimer's disease.  In a transgenic Drosophila melanogaster (Dm) fruit fly model, oral application of the potent competitive QC inhibitor PBD150 was shown to reduce the burden of pGlu-modified Aβ.  In contrast to mammals such as humans and rodents, there are at least three DmQC species, one of which (isoDromeQC) is localized to mitochondria, whereas DromeQC and an isoDromeQC splice variant possess signal peptides for secretion.  Here we present the recombinant expression, characterization, and crystal structure detn. of mature DromeQC and isoDromeQC, revealing an overall fold similar to that of mammalian QCs.  In the case of isoDromeQC, the putative extended substrate binding site might be affected by the proximity of the N-terminal residues.  PBD150 inhibition of DromeQC is roughly 1 order of magnitude weaker than that of the human and murine QCs.  The inhibitor binds to isoDromeQC in a fashion similar to that obsd. for human QCs, whereas it adopts alternative binding modes in a DromeQC variant lacking the conserved cysteines near the active center and shows a disordered dimethoxyphenyl moiety in wild-type DromeQC, providing an explanation for the lower affinity.  Our biophys. and structural data suggest that isoDromeQC and human QC are similar with regard to functional aspects.  The two Dm enzymes represent a suitable model for further in-depth anal. of the catalytic mechanism of animal QCs, and isoDromeQC might serve as a model system for the structure-based design of potential AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbLPrG5mFkZ7Vg90H21EOLACvtfcHk0lg_nTiB-oJD7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1SlsrjO&md5=165e52a111bb9a9667851a1b02d9eb94</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi300687g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300687g%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DKolenko%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DRuiz%2BCarrillo%26aufirst%3DD.%26aulast%3DParthier%26aufirst%3DC.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.-U.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DCrystal%2520structures%2520of%2520glutaminyl%2520cyclases%2520%2528QCs%2529%2520from%2520Drosophila%2520melanogaster%2520reveal%2520active%2520site%2520conservation%2520between%2520insect%2520and%2520mammalian%2520QCs%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D7383%26epage%3D7392%26doi%3D10.1021%2Fbi300687g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kolenko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stubbs, M. T.</span></span> <span> </span><span class="NLM_article-title">Structure of glutaminyl cyclase from <i>Drosophila melanogaster</i> in space group I4</span>. <i>Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1107/S1744309113005575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1107%2FS1744309113005575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23545638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=358-61&author=P.+Kolenkoauthor=B.+Kochauthor=J.+U.+Rahfeldauthor=S.+Schillingauthor=H.+U.+Demuthauthor=M.+T.+Stubbs&title=Structure+of+glutaminyl+cyclase+from+Drosophila+melanogaster+in+space+group+I4&doi=10.1107%2FS1744309113005575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of glutaminyl cyclase from Drosophila melanogaster in space group I4</span></div><div class="casAuthors">Kolenko, Petr; Koch, Birgit; Rahfeld, Jens-Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">358-361</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The structure of ligand-free glutaminyl cyclase (QC) from Drosophila melanogaster (DmQC) has been detd. in a novel crystal form.  The protein crystd. in space group I4, with unit-cell parameters a = b = 122.3, c = 72.7 Å.  The crystal diffracted to a resoln. of 2 Å at the home source.  The structure was solved by mol. replacement and was refined to an R factor of 0.169.  DmQC exhibits a typical α/β-hydrolase fold.  The electron d. of three monosaccharides could be localized.  The accessibility of the active site will facilitate structural studies of novel inhibitor-binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr36ap5VtSWoLVg90H21EOLACvtfcHk0li1e7ZdhVe8qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOkurc%253D&md5=893be471a2da90d4c37cb2855187053e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS1744309113005575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309113005575%26sid%3Dliteratum%253Aachs%26aulast%3DKolenko%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DStubbs%26aufirst%3DM.%2BT.%26atitle%3DStructure%2520of%2520glutaminyl%2520cyclase%2520from%2520Drosophila%2520melanogaster%2520in%2520space%2520group%2520I4%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2013%26volume%3D69%26spage%3D358%26epage%3D61%26doi%3D10.1107%2FS1744309113005575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Structural and functional analyses of a glutaminyl cyclase from Ixodes scapularis reveal metal-independent catalysis and inhibitor binding</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1107/S1399004713033488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1107%2FS1399004713033488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24598748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVOrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=789-801&author=K.+F.+Huangauthor=H.+L.+Hsuauthor=S.+Karimauthor=A.+H.+Wang&title=Structural+and+functional+analyses+of+a+glutaminyl+cyclase+from+Ixodes+scapularis+reveal+metal-independent+catalysis+and+inhibitor+binding&doi=10.1107%2FS1399004713033488"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analyses of a glutaminyl cyclase from Ixodes scapularis reveal metal-independent catalysis and inhibitor binding</span></div><div class="casAuthors">Huang, Kai-Fa; Hsu, Hui-Ling; Karim, Shahid; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-801</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">1399-0047</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) from mammals and Drosophila are zinc-dependent enzymes that catalyze N-terminal pyroglutamate formation of numerous proteins and peptides.  These enzymes have been found to be crit. for the oviposition and embryogenesis of ticks, implying that they are possible physiol. targets for tick control.  Here, 1.10-1.15 Å resoln. structures of a metal-independent QC from the black-legged tick Ixodes scapularis (Is-QC) are reported.  The structures exhibit the typical scaffold of mammalian QCs but have two extra disulfide bridges that stabilize the central β-sheet, resulting in an increased thermal stability.  Is-QC contains ∼0.5 stoichiometric zinc ions, which could be removed by 1 mM EDTA.  Compared with the Zn-bound form, apo-Is-QC has a nearly identical active-site structure and stability, but unexpectedly possesses significantly increased QC activities towards both synthetic and physiol. substrates.  Enzyme-kinetic anal. revealed that apo-Is-QC has a stronger substrate-binding affinity, suggesting that bound zinc interferes with substrate binding during catalysis.  The structures of Is-QC bound to the inhibitor PBD150 revealed similar binding modes to both forms of Is-QC, with the exception of the inhibitor imidazole ring, which is consistent with the comparable inhibition activities of the inhibitor towards both forms of Is-QC.  These findings have implications for the design of new QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq10MjczEJAYLVg90H21EOLACvtfcHk0li1e7ZdhVe8qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVOrtbY%253D&md5=9c8f62caf9841bef66fc49eb79f5178f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS1399004713033488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1399004713033488%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DHsu%26aufirst%3DH.%2BL.%26aulast%3DKarim%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DStructural%2520and%2520functional%2520analyses%2520of%2520a%2520glutaminyl%2520cyclase%2520from%2520Ixodes%2520scapularis%2520reveal%2520metal-independent%2520catalysis%2520and%2520inhibitor%2520binding%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2014%26volume%3D70%26spage%3D789%26epage%3D801%26doi%3D10.1107%2FS1399004713033488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podell, D. N.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">90</span>, Spec No <span class="refDoi"> DOI: 10.1007/BF00235695</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2FBF00235695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=6117006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL3MXlvVagsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1981&pages=181-90&author=G.+N.+Abrahamauthor=D.+N.+Podell&title=Pyroglutamic+acid.+Non-metabolic+formation%2C+function+in+proteins+and+peptides%2C+and+characteristics+of+the+enzymes+effecting+its+removal&doi=10.1007%2FBF00235695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamic acid.  Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal</span></div><div class="casAuthors">Abraham, George N.; Podell, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">181-90</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    </div><div class="casAbstract">A review with 47 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMLXS-HyhxmbVg90H21EOLACvtfcHk0li1e7ZdhVe8qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlvVagsbc%253D&md5=283bf5d569fe662a06f9f7a7c3e3c670</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2FBF00235695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00235695%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DG.%2BN.%26aulast%3DPodell%26aufirst%3DD.%2BN.%26atitle%3DPyroglutamic%2520acid.%2520Non-metabolic%2520formation%252C%2520function%2520in%2520proteins%2520and%2520peptides%252C%2520and%2520characteristics%2520of%2520the%2520enzymes%2520effecting%2520its%2520removal%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D1981%26volume%3D38%26spage%3D181%26epage%3D90%26doi%3D10.1007%2FBF00235695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pospisilik, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pederson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntosh, C. H.</span></span> <span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">3827</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.6.3827</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.275.6.3827" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10660533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3cXht12gsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=3827-34&author=S.+A.+Hinkeauthor=J.+A.+Pospisilikauthor=H.+U.+Demuthauthor=S.+Mannhartauthor=K.+Kuhn-Wacheauthor=T.+Hoffmannauthor=E.+Nishimuraauthor=R.+A.+Pedersonauthor=C.+H.+McIntosh&title=Dipeptidyl+peptidase+IV+%28DPIV%2FCD26%29+degradation+of+glucagon.+Characterization+of+glucagon+degradation+products+and+DPIV-resistant+analogs&doi=10.1074%2Fjbc.275.6.3827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs</span></div><div class="casAuthors">Hinke, Simon Amadeus; Pospisilik, J. Andrew; Demuth, Hans-Ulrich; Mannhart, Susanne; Kuhn-Wache, Kerstin; Hoffmann, Torsten; Nishimura, Erica; Pederson, Raymond A.; McIntosh, Christopher H. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3827-3834</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Over the past decade, numerous studies have been targeted at defining structure-activity relationships of glucagon.  Recently, the authors have found that glucagon1-29 is hydrolyzed by dipeptidyl peptidase IV (DPIV) to produce glucagon3-29 and glucagon5-29; in human serum, [pyroglutamyl (pGlu)3]glucagon3-29 is formed from glucagon3-29, and this prevents further hydrolysis of glucagon by DPIV.  In the current study, the biol. activity of these peptides was examd. in vitro.  The N-terminally truncated peptides all behaved as partial agonists in cAMP stimulation assays, with Chinese hamster ovary K1 cells overexpressing the human glucagon receptor (potency: glucagon1-29 > [pGlu3]glucagon3-29 > glucagon3-29 > glucagon5-29 > [Glu9]glucagon2-29).  In competition binding expts., [pGlu3]glucagon3-29 and glucagon5-29 both demonstrated 5-fold lower affinity for the receptor than glucagon1-29, whereas glucagon3-29 exhibited 18-fold lower affinity.  Of the peptides tested, only glucagon5-29 showed antagonist activity, and this was weak compared with the classical glucagon antagonist, [Glu9]glucagon2-29.  Hence, DPIV hydrolysis of glucagon yields low affinity agonists of the glucagon receptor.  As a corollary to evidence indicating that DPIV degrades glucagon, DPIV-resistant analogs were synthesized.  Matrix-assisted laser desorption/ionization-time of flight mass spectrometry was used to assess DPIV resistance, and it allowed kinetic anal. of degrdn.  Of several analogs generated, only [D-Ser2] and [Gly2]glucagon retained high affinity binding and biol. potency, similar to native glucagon in vitro.  [D-Ser2]Glucagon exhibited enhanced hyperglycemic activity in a bioassay, whereas [Gly2]glucagon was not completely resistant to DPIV degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtJF8IaVlxU7Vg90H21EOLACvtfcHk0lgzHLUPcjighg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXht12gsrw%253D&md5=a6d31a71cd5a3410df7b5dcc9213a9fe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.6.3827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.6.3827%26sid%3Dliteratum%253Aachs%26aulast%3DHinke%26aufirst%3DS.%2BA.%26aulast%3DPospisilik%26aufirst%3DJ.%2BA.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DMannhart%26aufirst%3DS.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DNishimura%26aufirst%3DE.%26aulast%3DPederson%26aufirst%3DR.%2BA.%26aulast%3DMcIntosh%26aufirst%3DC.%2BH.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528DPIV%252FCD26%2529%2520degradation%2520of%2520glucagon.%2520Characterization%2520of%2520glucagon%2520degradation%2520products%2520and%2520DPIV-resistant%2520analogs%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D3827%26epage%3D34%26doi%3D10.1074%2Fjbc.275.6.3827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koshimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawley, N. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yergy, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, Y. P.</span></span> <span> </span><span class="NLM_article-title">Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">303</span>, <span class="refDoi"> DOI: 10.1007/s12031-011-9521-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs12031-011-9521-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21537909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2011&pages=294-303&author=H.+Koshimizuauthor=N.+X.+Cawleyauthor=A.+L.+Yergyauthor=Y.+P.+Loh&title=Role+of+pGlu-serpinin%2C+a+novel+chromogranin+A-derived+peptide+in+inhibition+of+cell+death&doi=10.1007%2Fs12031-011-9521-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pGlu-Serpinin, a Novel Chromogranin A-Derived Peptide in Inhibition of Cell Death</span></div><div class="casAuthors">Koshimizu, Hisatsugu; Cawley, Niamh X.; Yergy, Alfred L.; Loh, Y. Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">294-303</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Chromogranin A (CgA) is a member of the granin family of mols. found in secretory granules of endocrine and neuro-endocrine cells.  Here, we have identified a new 23-mer CgA-derived peptide secreted from pituitary AtT-20 cells, which we named pyroGlu-serpinin (pGlu-serpinin).  LC-MS studies of peptides in conditioned medium of AtT-20 cells indicate that pGlu-serpinin is derived from initial processing of mouse CgA at paired basic residues, Arg461-Arg462 and Arg433-Arg434, to yield a previously described 26 amino acid peptide, serpinin.  Three amino acids are then cleaved from the N terminus of serpinin, yielding a peptide with an N-terminal glutamine, which is then subsequently pyroglutaminated.  Immunocytochem. showed co-localization of pGlu-serpinin with ACTH in secretory granules of AtT-20 cells, and it was released in an activity-dependent manner.  Functional studies demonstrated that pGlu-serpinin was able to prevent radical oxygen species (hydrogen peroxide)-induced cell death of AtT-20 cells and cultured rat cerebral cortical neurons at a concn. of 1 and 10 nM, resp.  These data indicate that pGlu-serpinin has anti-apoptotic effects that may be important in neuroprotection of central nervous system neurons and pituitary cells.  Furthermore, pGlu-serpinin added to the media of AtT-20 cells up-regulated the transcription of the serine protease inhibitor, protease nexin-1 (PN-1) mRNA.  PGlu-serpinin's ability to increase levels of PN-1, a potent inhibitor of plasmin released during inflammatory processes causing cell death, may play a role in protecting cells under adverse pathophysiol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprmtQBBn1KtbVg90H21EOLACvtfcHk0lgzHLUPcjighg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtr3I&md5=7608895439ab095571925f5fe48f0617</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs12031-011-9521-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-011-9521-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoshimizu%26aufirst%3DH.%26aulast%3DCawley%26aufirst%3DN.%2BX.%26aulast%3DYergy%26aufirst%3DA.%2BL.%26aulast%3DLoh%26aufirst%3DY.%2BP.%26atitle%3DRole%2520of%2520pGlu-serpinin%252C%2520a%2520novel%2520chromogranin%2520A-derived%2520peptide%2520in%2520inhibition%2520of%2520cell%2520death%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D45%26spage%3D294%26epage%3D303%26doi%3D10.1007%2Fs12031-011-9521-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dana, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dotson-Fagerstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roche, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kal, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chokhawala, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. S.</span></span> <span> </span><span class="NLM_article-title">The importance of pyroglutamate in cellulase Cel7A</span>. <i>Biotechnol. Bioeng.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1002/bit.25178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fbit.25178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24375151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12jt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=842-7&author=C.+M.+Danaauthor=A.+Dotson-Fagerstromauthor=C.+M.+Rocheauthor=S.+M.+Kalauthor=H.+A.+Chokhawalaauthor=H.+W.+Blanchauthor=D.+S.+Clark&title=The+importance+of+pyroglutamate+in+cellulase+Cel7A&doi=10.1002%2Fbit.25178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The importance of pyroglutamate in cellulase Cel7A</span></div><div class="casAuthors">Dana, Craig M.; Dotson-Fagerstrom, Alexandra; Roche, Christine M.; Kal, Sarala M.; Chokhawala, Harshal A.; Blanch, Harvey W.; Clark, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology and Bioengineering</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">842-847</span>CODEN:
                <span class="NLM_cas:coden">BIBIAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3592</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The commercialization of lignocellulosic biofuels relies in part on the ability to engineer cellulase enzymes to have properties compatible with practical processing conditions.  The cellulase Cel7A has been a common engineering target because it is present in very high concns. in com. cellulase cocktails.  Significant effort has thus been focused on its recombinant expression.  In particular, the yeast Saccharomyces cerevisiae has often been used both in the engineering and basic study of Cel7A.  However, the expression titer and extent of glycosylation of Cel7A expressed in S. cerevisiae vary widely for Cel7A genes from different organisms, and the recombinant enzymes tend to be less active and less stable than their native counterparts.  These observations motivate further study of recombinant expression of Cel7A in S. cerevisiae.  Here, we compare the properties of Cel7A from Talaromyces emersonii expressed in both the budding yeast S. cerevisiae and the filamentous fungus Neurospora crassa.  The Cel7A expressed in N. crassa had a higher melting temp. (by 10°C) and higher specific activity (twofold at 65°C) than the Cel7A expressed in S. cerevisiae.  We examd. several post-translational modifications and found that the underlying cause of this disparity was the lack of N-terminal glutamine cyclization in the Cel7A expressed in S. cerevisiae.  Treating the enzyme in vitro with glutaminyl cyclase improved the properties of Cel7A expressed in S. cerevisiae to match those of Cel7A expressed in N. crassa.  Biotechnol Bioeng. 2014;111: 842-847. © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJU_uVOSzwYbVg90H21EOLACvtfcHk0lgzHLUPcjighg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12jt78%253D&md5=58807cfea81e0f978223da5d86fcc07f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fbit.25178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbit.25178%26sid%3Dliteratum%253Aachs%26aulast%3DDana%26aufirst%3DC.%2BM.%26aulast%3DDotson-Fagerstrom%26aufirst%3DA.%26aulast%3DRoche%26aufirst%3DC.%2BM.%26aulast%3DKal%26aufirst%3DS.%2BM.%26aulast%3DChokhawala%26aufirst%3DH.%2BA.%26aulast%3DBlanch%26aufirst%3DH.%2BW.%26aulast%3DClark%26aufirst%3DD.%2BS.%26atitle%3DThe%2520importance%2520of%2520pyroglutamate%2520in%2520cellulase%2520Cel7A%26jtitle%3DBiotechnol.%2520Bioeng.%26date%3D2014%26volume%3D111%26spage%3D842%26epage%3D7%26doi%3D10.1002%2Fbit.25178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shih, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e94812</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0094812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0094812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24733552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFemtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=Y.+P.+Shihauthor=C.+C.+Chouauthor=Y.+L.+Chenauthor=K.+F.+Huangauthor=A.+H.+Wang&title=Linked+production+of+pyroglutamate-modified+proteins+via+self-cleavage+of+fusion+tags+with+TEV+protease+and+autonomous+N-terminal+cyclization+with+glutaminyl+cyclase+in+vivo&doi=10.1371%2Fjournal.pone.0094812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo</span></div><div class="casAuthors">Shih, Yan-Ping; Chou, Chi-Chi; Chen, Yi-Ling; Huang, Kai-Fa; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e94812/1-e94812/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Overprodn. of N-terminal pyroglutamate (pGlu)-modified proteins utilizing Escherichia coli or eukaryotic cells is a challenging work owing to the fact that the recombinant proteins need to be recovered by proteolytic removal of fusion tags to expose the N-terminal glutaminyl or glutamyl residue, which is then converted into pGlu catalyzed by the enzyme glutaminyl cyclase.  Herein we describe a new method for prodn. of N-terminal pGlu-contg. proteins in vivo via intracellular self-cleavage of fusion tags by tobacco etch virus (TEV) protease and then immediate N-terminal cyclization of passenger target proteins by a bacterial glutaminyl cyclase.  To combine with the sticky-end PCR cloning strategy, this design allows the gene of target proteins to be efficiently inserted into the expression vector using two unique cloning sites (i.e., SnaB I and Xho I), and the sol. and N-terminal pGlu-contg. proteins are then produced in vivo.  Our method has been successfully applied to the prodn. of pGlu-modified enhanced green fluorescence protein and monocyte chemoattractant proteins.  This design will facilitate the prodn. of protein drugs and drug target proteins that possess an N-terminal pGlu residue required for their physiol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrcimU5vrYbVg90H21EOLACvtfcHk0ljZb2VcOOyELg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFemtbzP&md5=705f4101ecbb5811c6196f196d2f6e95</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0094812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0094812%26sid%3Dliteratum%253Aachs%26aulast%3DShih%26aufirst%3DY.%2BP.%26aulast%3DChou%26aufirst%3DC.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DLinked%2520production%2520of%2520pyroglutamate-modified%2520proteins%2520via%2520self-cleavage%2520of%2520fusion%2520tags%2520with%2520TEV%2520protease%2520and%2520autonomous%2520N-terminal%2520cyclization%2520with%2520glutaminyl%2520cyclase%2520in%2520vivo%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0094812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tittmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2015.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bioorg.2015.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25981125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntlWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=98-101&author=F.+Seifertauthor=H.+U.+Demuthauthor=T.+Weichlerauthor=H.+H.+Ludwigauthor=K.+Tittmannauthor=S.+Schilling&title=Phosphate+ions+and+glutaminyl+cyclases+catalyze+the+cyclization+of+glutaminyl+residues+by+facilitating+synchronized+proton+transfers&doi=10.1016%2Fj.bioorg.2015.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphate ions and glutaminyl cyclases catalyze the cyclization of glutaminyl residues by facilitating synchronized proton transfers</span></div><div class="casAuthors">Seifert, Franziska; Demuth, Hans-Ulrich; Weichler, Teresa; Ludwig, Hans-Henning; Tittmann, Kai; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-101</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphate ions and glutaminyl cyclase (QC) both catalyze the formation of pyroglutamate (pE, pGlu) from N-terminal glutamine residues of peptides and proteins.  Here, we studied the mechanism of glutamine cyclization using kinetic secondary deuterium and solvent isotope effects.  The data suggest that proton transfer(s) are rate detg. for the spontaneous reaction, and that phosphate and QC accelerating the reaction by promoting synchronized proton transfers in a concerted mechanism.  Thus, non-enzymic and enzymic catalysis of pyroglutamate formation exploit a similar mode of transition-state stabilization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAWnU0v0_IwbVg90H21EOLACvtfcHk0ljZb2VcOOyELg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntlWnsrk%253D&md5=0540ccf95e5434c3125c43d85277e403</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2015.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2015.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DWeichler%26aufirst%3DT.%26aulast%3DLudwig%26aufirst%3DH.%2BH.%26aulast%3DTittmann%26aufirst%3DK.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DPhosphate%2520ions%2520and%2520glutaminyl%2520cyclases%2520catalyze%2520the%2520cyclization%2520of%2520glutaminyl%2520residues%2520by%2520facilitating%2520synchronized%2520proton%2520transfers%26jtitle%3DBioorg.%2520Chem.%26date%3D2015%26volume%3D60%26spage%3D98%26epage%3D101%26doi%3D10.1016%2Fj.bioorg.2015.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiess, J.</span></span> <span> </span><span class="NLM_article-title">Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">3628</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1073/pnas.84.11.3628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.84.11.3628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=3473473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaL2sXksFKhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=1987&pages=3628-32&author=W.+H.+Fischerauthor=J.+Spiess&title=Identification+of+a+mammalian+glutaminyl+cyclase+converting+glutaminyl+into+pyroglutamyl+peptides&doi=10.1073%2Fpnas.84.11.3628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides</span></div><div class="casAuthors">Fischer, Wolfgang H.; Spiess, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3628-32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Exts. from bovine pituitary were found to contain an activity catalyzing the conversion of glutaminyl peptides such as [Gln1]gonadotropin-releasing hormone, [Gln1, Gly4]TRH (H-Gln-His-Pro-Gly-OH), and H-Gln-Tyr-Ala-OH to the resp. pyroglutamyl peptides.  The TRH precursor fragment H-Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-OH and the D-glutaminyl stereoisomer of H-Gln-Tyr-Ala-OH did not react under the same conditions.  The conversion products were identified by Edman degrdn., amino acid anal., and reversed-phase HPLC.  That this activity was exhibited by an enzyme, glutaminyl cyclase (I), was concluded from the protein character of the activity (revealed by its abolition with trypsin and heat), the Michaelis-Menten relationship between substrate concn. and conversion rate, and the substrate specificity.  I was detd. to have mol. wt. of 43,000-50,000, a pH optimum at pH 8, and Km and Vmax values in the range of 60-130 μM and 390-690 pmol/μg/h, resp.  I was not obsd. to require ATP and could be inhibited with 1.0M NH4Cl, which increased the Km and decreased the Vmax value.  The subcellular distribution of I corresponded to that of peptidylglycine α-amidating monooxygenase believed to catalyze C-terminal amidations during posttranslational precursor processing.  The formation of pyroglutamyl from glutaminyl peptides was also obsd. to occur nonenzymically; however, the enzymic reaction carried out with crude ext. was found to be ≈70-fold faster than the nonenzymic reaction enhanced by phosphate.  Hence, I, may participate in the posttranslational processing of hormonal precursors to pyroglutamyl peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8xCeLL2CMc7Vg90H21EOLACvtfcHk0ljZb2VcOOyELg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFKhu7w%253D&md5=23063d67c7719362641c12bb3836d2e7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.84.11.3628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.84.11.3628%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%2BH.%26aulast%3DSpiess%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520a%2520mammalian%2520glutaminyl%2520cyclase%2520converting%2520glutaminyl%2520into%2520pyroglutamyl%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1987%26volume%3D84%26spage%3D3628%26epage%3D32%26doi%3D10.1073%2Fpnas.84.11.3628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>563</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00300-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0014-5793%2804%2900300-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15063747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=563&publication_year=2004&pages=191-6&author=S.+Schillingauthor=T.+Hoffmannauthor=S.+Manhartauthor=M.+Hoffmannauthor=H.+U.+Demuth&title=Glutaminyl+cyclases+unfold+glutamyl+cyclase+activity+under+mild+acid+conditions&doi=10.1016%2FS0014-5793%2804%2900300-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclases unfold glutamyl cyclase activity under mild acid conditions</span></div><div class="casAuthors">Schilling, Stephan; Hoffmann, Torsten; Manhart, Susanne; Hoffmann, Matthias; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">563</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">N-terminal pyroglutamate (pGlu) formation from glutaminyl precursors is a posttranslational event in the processing of bioactive neuropeptides such as TSH-releasing hormone and neurotensin during their maturation in the secretory pathway.  The reaction is facilitated by glutaminyl cyclase (QC), an enzyme highly abundant in mammalian brain.  Here, we describe for the first time that human and papaya QC also catalyze N-terminal glutamate cyclization.  Surprisingly, the enzymic Glu1 conversion is favored at pH 6.0 while Gln1 conversion occurs with an optimum at pH 8.0.  This unexpected finding might be of importance for deciphering the events leading to deposition of highly toxic pyroglutamyl peptides in amyloidotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUU5BTU0iZI7Vg90H21EOLACvtfcHk0lgqajyX9zXceA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGgsrY%253D&md5=43c6d9f6def6e4a6948171a58e961471</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900300-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900300-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DGlutaminyl%2520cyclases%2520unfold%2520glutamyl%2520cyclase%2520activity%2520under%2520mild%2520acid%2520conditions%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D563%26spage%3D191%26epage%3D6%26doi%3D10.1016%2FS0014-5793%2804%2900300-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvaresi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garavelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottoni, A.</span></span> <span> </span><span class="NLM_article-title">Computational evidence for the catalytic mechanism of glutaminyl cyclase. A DFT investigation</span>. <i>Proteins: Struct., Funct., Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">527</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1002/prot.22061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fprot.22061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18470930" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=527-38&author=M.+Calvaresiauthor=M.+Garavelliauthor=A.+Bottoni&title=Computational+evidence+for+the+catalytic+mechanism+of+glutaminyl+cyclase.+A+DFT+investigation&doi=10.1002%2Fprot.22061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fprot.22061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22061%26sid%3Dliteratum%253Aachs%26aulast%3DCalvaresi%26aufirst%3DM.%26aulast%3DGaravelli%26aufirst%3DM.%26aulast%3DBottoni%26aufirst%3DA.%26atitle%3DComputational%2520evidence%2520for%2520the%2520catalytic%2520mechanism%2520of%2520glutaminyl%2520cyclase.%2520A%2520DFT%2520investigation%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2008%26volume%3D73%26spage%3D527%26epage%3D38%26doi%3D10.1002%2Fprot.22061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>411</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1042/BJ20071073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20071073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18072935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2008&pages=181-90&author=K.+F.+Huangauthor=Y.+R.+Wangauthor=E.+C.+Changauthor=T.+L.+Chouauthor=A.+H.+Wang&title=A+conserved+hydrogen-bond+network+in+the+catalytic+centre+of+animal+glutaminyl+cyclases+is+critical+for+catalysis&doi=10.1042%2FBJ20071073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis</span></div><div class="casAuthors">Huang, Kai-Fa; Wang, Yu-Ruei; Chang, En-Cheng; Chou, Tsung-Lin; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-190</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QCs (glutaminyl cyclases; glutaminyl-peptide cyclotransferases, E.C. 2.3.2.5) catalyze N-terminal pyroglutamate formation in numerous bioactive peptides and proteins.  The enzymes were reported to be involved in several pathol. conditions such as amyloidotic disease, osteoporosis, rheumatoid arthritis and melanoma.  The crystal structure of human QC revealed an unusual H-bond (hydrogen-bond) network in the active site, formed by several highly conserved residues (Ser160, Glu201, Asp248, Asp305 and His319), within which Glu201 and Asp248 were found to bind to substrate.  In the present study we combined steady-state enzyme kinetic and x-ray structural analyses of 11 single-mutation human QCs to investigate the roles of the H-bond network in catalysis.  Our results showed that disrupting one or both of the central H-bonds, i.e., Glu201···Asp305 and Asp248···Asp305, reduced the steady-state catalysis dramatically.  The roles of these two COOH···COOH bonds on catalysis could be partly replaced by COOH···water bonds, but not by COOH···CONH2 bonds, reminiscent of the low-barrier Asp···Asp H-bond in the active site of pepsin-like aspartic peptidases.  Mutations on Asp305, a residue located at the center of the H-bond network, raised the Km value of the enzyme by 4.4-19-fold, but decreased the kcat value by 79-2842-fold, indicating that Asp305 primarily plays a catalytic role.  In addn., results from mutational studies on Ser160 and His319 suggest that these two residues might help to stabilize the conformations of Asp248 and Asp305 resp.  These data allow us to propose an essential proton transfer between Glu201, Asp305 and Asp248 during the catalysis by animal QCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4EKjUIwutAbVg90H21EOLACvtfcHk0lgqajyX9zXceA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1ers7w%253D&md5=2e5104776acc97f920d9502be3a041b4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2FBJ20071073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20071073%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BR.%26aulast%3DChang%26aufirst%3DE.%2BC.%26aulast%3DChou%26aufirst%3DT.%2BL.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DA%2520conserved%2520hydrogen-bond%2520network%2520in%2520the%2520catalytic%2520centre%2520of%2520animal%2520glutaminyl%2520cyclases%2520is%2520critical%2520for%2520catalysis%26jtitle%3DBiochem.%2520J.%26date%3D2008%26volume%3D411%26spage%3D181%26epage%3D90%26doi%3D10.1042%2FBJ20071073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temple, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misquitta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booth, R. E.</span></span> <span> </span><span class="NLM_article-title">Evidence for essential histidines in human pituitary glutaminyl cyclase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">11246</span>– <span class="NLM_lpage">11250</span>, <span class="refDoi"> DOI: 10.1021/bi011177o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011177o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtFGju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11246-11250&author=R.+J.+Batemanauthor=J.+S.+Templeauthor=S.+A.+Misquittaauthor=R.+E.+Booth&title=Evidence+for+essential+histidines+in+human+pituitary+glutaminyl+cyclase&doi=10.1021%2Fbi011177o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for essential histidines in human pituitary glutaminyl cyclase</span></div><div class="casAuthors">Bateman, Robert C., Jr.; Temple, Jeffrey S.; Misquitta, Stephanie A.; Booth, Rachell E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11246-11250</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (EC 2.3.2.5) (I) catalyzes the formation of the pyroglutamyl residue present at the N-terminus of numerous secretory peptides and proteins.  Treatment with di-Et pyrocarbonate inactivated recombinant human I with the apparent modification of 3 essential His residues.  Comparisons of the protein sequences of I from a variety of eukaryotic species showed 4 completely conserved His residues.  Mutation of each of these residues to Gln resulted in 2 mutant enzymes that were inactive (H140Q and H330Q), suggesting a role in catalysis, and 2 that exhibited increased Km values (H307Q and H319Q), suggesting a role in substrate binding.  Consistent with these results was the prediction that I possessed a Zn-aminopeptidase domain in which the 4 His residues identified here were present in the active site.  Mammalian I may, therefore, have structural and catalytic similarities to a family of bacterial Zn-aminopeptidases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm51nCGNk_sLVg90H21EOLACvtfcHk0lgqajyX9zXceA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtFGju7c%253D&md5=c4b4e68d5158d5619d269a41668ea963</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fbi011177o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011177o%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DTemple%26aufirst%3DJ.%2BS.%26aulast%3DMisquitta%26aufirst%3DS.%2BA.%26aulast%3DBooth%26aufirst%3DR.%2BE.%26atitle%3DEvidence%2520for%2520essential%2520histidines%2520in%2520human%2520pituitary%2520glutaminyl%2520cyclase%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11246%26epage%3D11250%26doi%3D10.1021%2Fbi011177o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gliozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giliberto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armirotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrassa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markesbery, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaton, M.</span></span> <span> </span><span class="NLM_article-title">beta-amyloid is different in normal aging and in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">34186</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501694200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M501694200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16103127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKitr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=34186-92&author=A.+Picciniauthor=C.+Russoauthor=A.+Gliozziauthor=A.+Reliniauthor=A.+Vitaliauthor=R.+Borghiauthor=L.+Gilibertoauthor=A.+Armirottiauthor=C.+D%E2%80%99Arrigoauthor=A.+Bachiauthor=A.+Cattaneoauthor=C.+Canaleauthor=S.+Torrassaauthor=T.+C.+Saidoauthor=W.+Markesberyauthor=P.+Gambettiauthor=M.+Tabaton&title=beta-amyloid+is+different+in+normal+aging+and+in+Alzheimer+disease&doi=10.1074%2Fjbc.M501694200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid Is Different in Normal Aging and in Alzheimer Disease</span></div><div class="casAuthors">Piccini, Alessandra; Russo, Claudio; Gliozzi, Alessandra; Relini, Annalisa; Vitali, Antonella; Borghi, Roberta; Giliberto, Luca; Armirotti, Andrea; D'Arrigo, Cristina; Bachi, Angela; Cattaneo, Angela; Canale, Claudio; Torrassa, Silvia; Saido, Takaomi C.; Markesbery, William; Gambetti, Pierluigi; Tabaton, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">34186-34192</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mechanism of neurodegeneration caused by β-amyloid in Alzheimer disease is controversial.  Neuronal toxicity is exerted mostly by various species of sol. β-amyloid oligomers that differ in their N- and C-terminal domains.  However, abundant accumulation of β-amyloid also occurs in the brains of cognitively normal elderly people, in the absence of obvious neuronal dysfunction.  We postulated that neuronal toxicity depends on the mol. compn., rather than the amt., of the sol. β-amyloid oligomers.  Here we show that sol. β-amyloid aggregates that accumulate in Alzheimer disease are different from those of normal aging in regard to the compn. as well as the aggregation and toxicity properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHqsevn1QyAbVg90H21EOLACvtfcHk0lh8Nvrz3jhJSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKitr7K&md5=cec2b2f5f959c6de421968d24a4f4176</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501694200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501694200%26sid%3Dliteratum%253Aachs%26aulast%3DPiccini%26aufirst%3DA.%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DGliozzi%26aufirst%3DA.%26aulast%3DRelini%26aufirst%3DA.%26aulast%3DVitali%26aufirst%3DA.%26aulast%3DBorghi%26aufirst%3DR.%26aulast%3DGiliberto%26aufirst%3DL.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DBachi%26aufirst%3DA.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DCanale%26aufirst%3DC.%26aulast%3DTorrassa%26aufirst%3DS.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DMarkesbery%26aufirst%3DW.%26aulast%3DGambetti%26aufirst%3DP.%26aulast%3DTabaton%26aufirst%3DM.%26atitle%3Dbeta-amyloid%2520is%2520different%2520in%2520normal%2520aging%2520and%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D34186%26epage%3D92%26doi%3D10.1074%2Fjbc.M501694200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawashima, S.</span></span> <span> </span><span class="NLM_article-title">Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">457</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/0896-6273(95)90301-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2F0896-6273%2895%2990301-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7857653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=457-66&author=T.+C.+Saidoauthor=T.+Iwatsuboauthor=D.+M.+Mannauthor=H.+Shimadaauthor=Y.+Iharaauthor=S.+Kawashima&title=Dominant+and+differential+deposition+of+distinct+beta-amyloid+peptide+species%2C+A+beta+N3%28pE%29%2C+in+senile+plaques&doi=10.1016%2F0896-6273%2895%2990301-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Dominant and differential deposition of distinct β-amyloid peptide species, AβN3(pE), in senile plaques</span></div><div class="casAuthors">Saido, Takaomi C.; Iwatsubo, Takeshi; Mann, David M. A.; Shimada, Hiroyuki; Ihara, Yasuo; Kawashima, Selichi</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-66</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We analyzed an amino-terminal modification of β-amyloid (Aβ) peptide in brain, using anti-Aβ antibodies that distinguish distinct mol. species.  Examn. of cortical sections from 28 aged individuals with a wide range in senile plaque d. revealed that a mol. species distinct from the std. Aβ is deposited in the brain in a dominant and differential manner.  This modified Aβ peptide (AβN3(pE)) starts at the 3rd amino-terminal residue of the std. αβ, glutamate, converted to pyroglutamate through intramol. dehydration.  Because plaques composed of αβN3(pE) are present in equiv. or greater densities than those composed of std. Aβ bearing the first amino-terminal residue (AβN1) and because deposition of the former species appears to precede deposition of the latter, as confirmed with specimens from Down's syndrome patients, the processes involved in AβNe(pE) prodn. and retention may play an early and crit. role in senile plaque formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEs7XnR_KCcbVg90H21EOLACvtfcHk0lh8Nvrz3jhJSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvFejsLk%253D&md5=8405ddfabcebe721ccd5b1dc1e222069</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2895%2990301-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252895%252990301-1%26sid%3Dliteratum%253Aachs%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIhara%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DS.%26atitle%3DDominant%2520and%2520differential%2520deposition%2520of%2520distinct%2520beta-amyloid%2520peptide%2520species%252C%2520A%2520beta%2520N3%2528pE%2529%252C%2520in%2520senile%2520plaques%26jtitle%3DNeuron%26date%3D1995%26volume%3D14%26spage%3D457%26epage%3D66%26doi%3D10.1016%2F0896-6273%2895%2990301-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lalowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philipson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nochlin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellenberg, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brundin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olofsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliymani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span> <span> </span><span class="NLM_article-title">The Arctic AbetaPP mutation leads to Alzheimer’s disease pathology with highly variable topographic deposition of differentially truncated Abeta</span>. <i>Acta Neuropathol Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">60</span>, <span class="refDoi"> DOI: 10.1186/2051-5960-1-60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F2051-5960-1-60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24252272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c3mvFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=60&author=H.+Kalimoauthor=M.+Lalowskiauthor=N.+Bogdanovicauthor=O.+Philipsonauthor=T.+D.+Birdauthor=D.+Nochlinauthor=G.+D.+Schellenbergauthor=R.+Brundinauthor=T.+Olofssonauthor=R.+Soliymaniauthor=M.+Baumannauthor=O.+Wirthsauthor=T.+A.+Bayerauthor=L.+N.+Nilssonauthor=H.+Basunauthor=L.+Lannfeltauthor=M.+Ingelsson&title=The+Arctic+AbetaPP+mutation+leads+to+Alzheimer%E2%80%99s+disease+pathology+with+highly+variable+topographic+deposition+of+differentially+truncated+Abeta&doi=10.1186%2F2051-5960-1-60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ</span></div><div class="casAuthors">Kalimo Hannu; Lalowski Maciej; Bogdanovic Nenad; Philipson Ola; Bird Thomas D; Nochlin David; Schellenberg Gerard D; Brundin Rosemarie; Olofsson Tommie; Soliymani Rabah; Baumann Marc; Wirths Oliver; Bayer Thomas A; Nilsson Lars N G; Basun Hans; Lannfelt Lars; Ingelsson Martin</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Arctic mutation (p.E693G/p.E22G)fs within the β-amyloid (Aβ) region of the β-amyloid precursor protein gene causes an autosomal dominant disease with clinical picture of typical Alzheimer's disease.  Here we report the special character of Arctic AD neuropathology in four deceased patients.  RESULTS:  Aβ deposition in the brains was wide-spread (Thal phase 5) and profuse.  Virtually all parenchymal deposits were composed of non-fibrillar, Congo red negative Aβ aggregates.  Congo red only stained angiopathic vessels.  Mass spectrometric analyses showed that Aβ deposits contained variably truncated and modified wild type and mutated Aβ species.  In three of four Arctic AD brains, most cerebral cortical plaques appeared targetoid with centres containing C-terminally (beyond aa 40) and variably N-terminally truncated Aβ surrounded by coronas immunopositive for Aβx-42.  In the fourth patient plaque centres contained almost no Aβ making the plaques ring-shaped.  The architectural pattern of plaques also varied between different anatomic regions.  Tau pathology corresponded to Braak stage VI, and appeared mainly as delicate neuropil threads (NT) enriched within Aβ plaques.  Dystrophic neurites were scarce, while neurofibrillary tangles were relatively common.  Neuronal perikarya within the Aβ plaques appeared relatively intact.  CONCLUSIONS:  In Arctic AD brain differentially truncated abundant Aβ is deposited in plaques of variable numbers and shapes in different regions of the brain (including exceptional targetoid plaques in neocortex).  The extracellular non-fibrillar Aβ does not seem to cause overt damage to adjacent neurons or to induce formation of neurofibrillary tangles, supporting the view that intracellular Aβ oligomers are more neurotoxic than extracellular Aβ deposits.  However, the enrichment of NTs within plaques suggests some degree of intra-plaque axonal damage including accumulation of hp-tau, which may impair axoplasmic transport, and thereby contribute to synaptic loss.  Finally, similarly as the cotton wool plaques in AD resulting from exon 9 deletion in the presenilin-1 gene, the Arctic plaques induced only modest glial and inflammatory tissue reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrC1-S7O0marFU0A1HOshhfW6udTcc2eafQ3cmDZsL9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3mvFKlsg%253D%253D&md5=2ad58213d689cb0a3ccaef01898ddc45</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1186%2F2051-5960-1-60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-5960-1-60%26sid%3Dliteratum%253Aachs%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DLalowski%26aufirst%3DM.%26aulast%3DBogdanovic%26aufirst%3DN.%26aulast%3DPhilipson%26aufirst%3DO.%26aulast%3DBird%26aufirst%3DT.%2BD.%26aulast%3DNochlin%26aufirst%3DD.%26aulast%3DSchellenberg%26aufirst%3DG.%2BD.%26aulast%3DBrundin%26aufirst%3DR.%26aulast%3DOlofsson%26aufirst%3DT.%26aulast%3DSoliymani%26aufirst%3DR.%26aulast%3DBaumann%26aufirst%3DM.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DNilsson%26aufirst%3DL.%2BN.%26aulast%3DBasun%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DIngelsson%26aufirst%3DM.%26atitle%3DThe%2520Arctic%2520AbetaPP%2520mutation%2520leads%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathology%2520with%2520highly%2520variable%2520topographic%2520deposition%2520of%2520differentially%2520truncated%2520Abeta%26jtitle%3DActa%2520Neuropathol%2520Commun.%26date%3D2013%26volume%3D1%26spage%3D60%26doi%3D10.1186%2F2051-5960-1-60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutsuga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of AbetapN3 deposition in the brains of dogs of various ages and other animal species</span>. <i>Amyloid</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.3109/13506129.2011.570385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3109%2F13506129.2011.570385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21557687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=63-71&author=J.+K.+Chambersauthor=M.+Mutsugaauthor=K.+Uchidaauthor=H.+Nakayama&title=Characterization+of+AbetapN3+deposition+in+the+brains+of+dogs+of+various+ages+and+other+animal+species&doi=10.3109%2F13506129.2011.570385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AβpN3 deposition in the brains of dogs of various ages and other animal species</span></div><div class="casAuthors">Chambers, James K.; Mutsuga, Mayu; Uchida, Kazuyuki; Nakayama, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Amyloid</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">AIJIET</span>;
        ISSN:<span class="NLM_cas:issn">1350-6129</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Senile plaques (SP) are characteristic histopathol. manifestations of Alzheimer's disease (AD), but are also found in normal aging (NA).  Recent studies have demonstrated that beta amyloid (Aβ) proteins that have been truncated at the N-terminal position 3 (AβpN3) are the predominant component of SP in AD, but not in NA.  The present study revealed that AβpN3 was deposited in an age-dependent manner in canine brains.  Moreover, AβpN3 was the main component of the SP that developed in very old dogs.  The deposition of AβpN3 increased in accordance with the no. of SP, but that of N-terminally intact Aβ (AβN1) did not.  In addn., AβpN3 was also deposited in the SP of a Japanese macaque and an American black bear, but not in a feline brain.  Focal microvascular cerebral amyloid angiopathy was also obsd. in the deep cortices and the white matter of the dogs and a woodpecker.  Those were always composed of both AβpN3 and AβN1.  In conclusion, though non-human animals do not develop full pathol. of AD of the human type, AβpN3 is widely deposited in the brains of senescent vertebrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaat2PPPj2frVg90H21EOLACvtfcHk0lgC5RH3n-qIZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWktLg%253D&md5=77c621b6495fe4bf0e9448bcf204acf3</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3109%2F13506129.2011.570385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F13506129.2011.570385%26sid%3Dliteratum%253Aachs%26aulast%3DChambers%26aufirst%3DJ.%2BK.%26aulast%3DMutsuga%26aufirst%3DM.%26aulast%3DUchida%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520AbetapN3%2520deposition%2520in%2520the%2520brains%2520of%2520dogs%2520of%2520various%2520ages%2520and%2520other%2520animal%2520species%26jtitle%3DAmyloid%26date%3D2011%26volume%3D18%26spage%3D63%26epage%3D71%26doi%3D10.3109%2F13506129.2011.570385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willbold, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7072</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/bi900818a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi900818a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=7072-8&author=D.+Schlenzigauthor=S.+Manhartauthor=Y.+Cinarauthor=M.+Kleinschmidtauthor=G.+Hauseauthor=D.+Willboldauthor=S.+A.+Funkeauthor=S.+Schillingauthor=H.+U.+Demuth&title=Pyroglutamate+formation+influences+solubility+and+amyloidogenicity+of+amyloid+peptides&doi=10.1021%2Fbi900818a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Formation Influences Solubility and Amyloidogenicity of Amyloid Peptides</span></div><div class="casAuthors">Schlenzig, Dagmar; Manhart, Susanne; Cinar, Yeliz; Kleinschmidt, Martin; Hause, Gerd; Willbold, Dieter; Funke, Susanne Aileen; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">7072-7078</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Terminally truncated and pyroglutamate (pGlu) modified amyloid β (Aβ) peptides are major constituents of amyloid deposits in sporadic and inherited Alzheimer's disease (AD).  Formation of pGlu at the N-terminus confers resistance against cleavage by most aminopeptidases, increases toxicity of the peptides, and may seed Aβ aggregate formation.  Similarly, the deposited amyloid peptides ABri and ADan, which cause a very similar histopathol. in familial British dementia (FBD) and familial Danish dementia (FDD), are N-terminally blocked by pGlu.  Triggered by the coincidence of pGlu-modified amyloid peptides and similar pathol. in AD, FBD, and FDD, we investigated the impact of N-terminal pGlu on biochem. and biophys. properties of Aβ, ABri, and ADan.  N-Terminal pGlu increases the hydrophobicity and changes the pH-dependent soly. profile, rendering the pGlu-modified peptides less sol. in the basic pH range.  The pGlu residue increases the aggregation propensity of all amyloid peptides as evidenced by ThT fluorescence assays and dynamic light scattering.  The far-UV CD spectroscopic anal. points toward an enhanced β-sheet structure of the pGlu-Aβ.  Importantly, changes in fibril morphol. are clearly caused by the N-terminal pGlu, resulting in the formation of short fibers, which are frequently arranged in bundles.  The effect of pGlu on the morphol. is virtually indistinguishable between ABri, ADan, and Aβ.  The data provide evidence for a comparable influence of the pGlu modification on the aggregation process of structurally different amyloid peptides, thus likely contributing to the molecularly distinct neurodegenerative diseases AD, FBD, and FDD.  The main driving force for the aggregation is apparently an increase in the hydrophobicity and thus an accelerated seed formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo01m64gYKSRLVg90H21EOLACvtfcHk0lgC5RH3n-qIZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWkurk%253D&md5=f32a500d5c6e5f44fa2809256c8a90ca</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fbi900818a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900818a%26sid%3Dliteratum%253Aachs%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DCinar%26aufirst%3DY.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DHause%26aufirst%3DG.%26aulast%3DWillbold%26aufirst%3DD.%26aulast%3DFunke%26aufirst%3DS.%2BA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DPyroglutamate%2520formation%2520influences%2520solubility%2520and%2520amyloidogenicity%2520of%2520amyloid%2520peptides%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D7072%26epage%3D8%26doi%3D10.1021%2Fbi900818a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galante, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florio, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbrana, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassalli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span> <span> </span><span class="NLM_article-title">Differential toxicity, conformation and morphology of typical initial aggregation states of Abeta1–42 and Abetapy3–42 beta-amyloids</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">2085</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2012.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.biocel.2012.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22903022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlKku7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=2085-93&author=D.+Galanteauthor=A.+Corsaroauthor=T.+Florioauthor=S.+Vellaauthor=A.+Paganoauthor=F.+Sbranaauthor=M.+Vassalliauthor=A.+Pericoauthor=C.+D%E2%80%99Arrigo&title=Differential+toxicity%2C+conformation+and+morphology+of+typical+initial+aggregation+states+of+Abeta1%E2%80%9342+and+Abetapy3%E2%80%9342+beta-amyloids&doi=10.1016%2Fj.biocel.2012.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids</span></div><div class="casAuthors">Galante, Denise; Corsaro, Alessandro; Florio, Tullio; Vella, Serena; Pagano, Aldo; Sbrana, Francesca; Vassalli, Massimo; Perico, Angelo; D'Arrigo, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2085-2093</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among the different species of water-sol. β-peptides (Aβ1-42, Aβ1-40 and N-terminal truncated Aβ-peptides), Aβpy3-42 is thought to play a relevant role in Alzheimer's pathogenesis due to its abundance, resistance to proteolysis, fast aggregation kinetics, dynamic structure and high neurotoxicity.  To evaluate the specific structural characteristics and neurotoxicity of Aβpy3-42, we sepd. different aggregation states of Aβ1-42 and Aβpy3-42 using fast protein liq. chromatog., isolating in both cases three peaks that corresponded to sa (small), ma (medium) and la (large) aggregates.  Conformational anal., by CD showed a prevailing random coil conformation for sa and ma, and typical β-sheet conformation for la.  AFM and TEM show differential structural features between the three aggregates of a given β-peptide and among the aggregate of the two β-peptides.  The potential toxic effects of the different aggregates were evaluated using human neuroblastoma SH-SY5Y cells in the MTT redn., in the xCELLigence System, and in the Annexin V binding expts.  In the case of Aβ1-42 the most toxic aggregate is la, while in the case of Aβpy3-42 both sa and la are equally toxic.  Aβ aggregates were found to be internalized in the cells, as estd. by confocal immunofluorescence microscopy, with a higher effect obsd. for Aβpy3-42, showing a good correlation with the toxic effects.  Together these expts. allowed the discrimination of the intermediate states more responsible of oligomer toxicity, providing new insights on the correlation between the aggregation process and the toxicity and confirming the peculiar role in the pathogenesis of Alzheimer disease of Aβpy3-42 peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoegpcu687lKrVg90H21EOLACvtfcHk0lgC5RH3n-qIZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlKku7nE&md5=f716bfe0a7f64e951ed4d228f4ef26a1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2012.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2012.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DGalante%26aufirst%3DD.%26aulast%3DCorsaro%26aufirst%3DA.%26aulast%3DFlorio%26aufirst%3DT.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DPagano%26aufirst%3DA.%26aulast%3DSbrana%26aufirst%3DF.%26aulast%3DVassalli%26aufirst%3DM.%26aulast%3DPerico%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26atitle%3DDifferential%2520toxicity%252C%2520conformation%2520and%2520morphology%2520of%2520typical%2520initial%2520aggregation%2520states%2520of%2520Abeta1%25E2%2580%259342%2520and%2520Abetapy3%25E2%2580%259342%2520beta-amyloids%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D2085%26epage%3D93%26doi%3D10.1016%2Fj.biocel.2012.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hosoda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otvos, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwatsubo, T.</span></span> <span> </span><span class="NLM_article-title">Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1089</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1097/00005072-199811000-00012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1097%2F00005072-199811000-00012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9825946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXnslSnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1998&pages=1089-95&author=R.+Hosodaauthor=T.+C.+Saidoauthor=L.+J.+Otvosauthor=T.+Araiauthor=D.+M.+Mannauthor=V.+M.+Leeauthor=J.+Q.+Trojanowskiauthor=T.+Iwatsubo&title=Quantification+of+modified+amyloid+beta+peptides+in+Alzheimer+disease+and+Down+syndrome+brains&doi=10.1097%2F00005072-199811000-00012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of modified amyloid β peptides in Alzheimer disease and Down syndrome brains</span></div><div class="casAuthors">Hosoda, Ritsuko; Saido, Takaomi C.; Otvos, Laszlo, Jr.; Arai, Takao; Mann, David M. A.; Lee, Virginia M. -Y.; Trojanowski, John Q.; Iwatsubo, Takeshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1089-1095</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">To gain insights into the different forms of modified amyloid β peptides (Aβ) in the Alzheimer disease (AD) and Down syndrome (DS) brain, the authors used two-site ELISAs with antibodies specific for isomerized ( Aβ with L-isoaspartate at positions 1 and 7) and pyroglutamate-modified (Aβ beginning with pyroglutamate at position 3) forms of Aβ to quantitate the levels of these different Aβ peptides in formic acid exts. of AD and DS frontal cortex.  Despite variations in the proportions of distinct forms of Aβ in AD and DS frontal cortex, the major species of Aβ in these samples were AβN3(pyroGlu)-42 as well as Aβx-42 (where x is a residue at position 2 or less in Aβ), whereas isomerized Aβ was a minor species.  Further, the levels of isomerized and pyroglutamate-modified forms of Aβ terminating at amino acid 42 were higher than those ending at amino acid 40.  The abundance of the distinct forms of Aβ reported here in formic acid exts. of AD and DS frontal cortex suggests that these Aβ species could play important roles in the deposition of Aβ in AD and DS brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYOTtqyCCqLVg90H21EOLACvtfcHk0ljgwuG1fojbVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslSnt7s%253D&md5=d7d44778fd35d7fbf1a645c8581fc934</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1097%2F00005072-199811000-00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005072-199811000-00012%26sid%3Dliteratum%253Aachs%26aulast%3DHosoda%26aufirst%3DR.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DOtvos%26aufirst%3DL.%2BJ.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DIwatsubo%26aufirst%3DT.%26atitle%3DQuantification%2520of%2520modified%2520amyloid%2520beta%2520peptides%2520in%2520Alzheimer%2520disease%2520and%2520Down%2520syndrome%2520brains%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D1998%26volume%3D57%26spage%3D1089%26epage%3D95%26doi%3D10.1097%2F00005072-199811000-00012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venezia, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolcini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benatti, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arrigo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schettini, G.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)-- strongly affect cultured neuron and astrocyte survival</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01107.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1046%2Fj.1471-4159.2002.01107.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=12354296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1480-9&author=C.+Russoauthor=E.+Violaniauthor=S.+Salisauthor=V.+Veneziaauthor=V.+Dolciniauthor=G.+Damonteauthor=U.+Benattiauthor=C.+D%E2%80%99Arrigoauthor=E.+Patroneauthor=P.+Carloauthor=G.+Schettini&title=Pyroglutamate-modified+amyloid+beta-peptides%2D%2DAbetaN3%28pE%29%2D%2D+strongly+affect+cultured+neuron+and+astrocyte+survival&doi=10.1046%2Fj.1471-4159.2002.01107.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-modified amyloid β-peptides - AβN3(pE) -strongly affect cultured neuron and astrocyte survival</span></div><div class="casAuthors">Russo, Claudio; Violani, Elisabetta; Salis, Serena; Venezia, Valentina; Dolcini, Virginia; Damonte, Gianluca; Benatti, Umberto; D'Arrigo, Cristina; Patrone, Eligio; Carlo, Pia; Schettini, Gennaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1480-1489</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">N-terminally truncated amyloid-β (Aβ) peptides are present in early and diffuse plaques of individuals with Alzheimer's disease (AD), are overproduced in early onset familial AD and their amt. seems to be directly correlated to the severity and the progression of the disease in AD and Down's syndrome (DS).  The pyroglutamate-contg. isoforms at position 3 [AβN3(pE)-40/42] represent the prominent form among the N-truncated species, and may account for more than 50% of Aβ accumulated in plaques.  In this study, the authors compared the toxic properties, fibrillogenic capabilities, and in vitro degrdn. profile of Aβ1-40, Aβ1-42, AβN3(pE)-40 and AβN3(pE)-42.  The authors' data show that fiber morphol. of Aβ peptides is greatly influenced by the C-terminus while toxicity, interaction with cell membranes and degrdn. are influenced by the N-terminus.  AβN3(pE)-40 induced significantly more cell loss than the other species both in neuronal and glial cell cultures.  Aggregated AβN3(pE) peptides were heavily distributed on plasma membrane and within the cytoplasm of treated cells.  AβN3(pE)-40/42 peptides showed a significant resistance to degrdn. by cultured astrocytes, while full-length peptides resulted partially degraded.  These findings suggest that formation of N-terminally modified peptides may enhance β-amyloid aggregation and toxicity, likely worsening the onset and progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR0uvn5GQRVLVg90H21EOLACvtfcHk0ljgwuG1fojbVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs7g%253D&md5=41ad79cbdbb8f5debcec7c93035a709d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01107.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01107.x%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DC.%26aulast%3DViolani%26aufirst%3DE.%26aulast%3DSalis%26aufirst%3DS.%26aulast%3DVenezia%26aufirst%3DV.%26aulast%3DDolcini%26aufirst%3DV.%26aulast%3DDamonte%26aufirst%3DG.%26aulast%3DBenatti%26aufirst%3DU.%26aulast%3DD%25E2%2580%2599Arrigo%26aufirst%3DC.%26aulast%3DPatrone%26aufirst%3DE.%26aulast%3DCarlo%26aufirst%3DP.%26aulast%3DSchettini%26aufirst%3DG.%26atitle%3DPyroglutamate-modified%2520amyloid%2520beta-peptides--AbetaN3%2528pE%2529--%2520strongly%2520affect%2520cultured%2520neuron%2520and%2520astrocyte%2520survival%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1480%26epage%3D9%26doi%3D10.1046%2Fj.1471-4159.2002.01107.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauber, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaupp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">On the seeding and oligomerization of pGlu-amyloid peptides (in vitro)</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">12393</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1021/bi0612667</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0612667" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=12393-9&author=S.+Schillingauthor=T.+Lauberauthor=M.+Schauppauthor=S.+Manhartauthor=E.+Scheelauthor=G.+Bohmauthor=H.+U.+Demuth&title=On+the+seeding+and+oligomerization+of+pGlu-amyloid+peptides+%28in+vitro%29&doi=10.1021%2Fbi0612667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">On the Seeding and Oligomerization of pGlu-Amyloid Peptides (in vitro)</span></div><div class="casAuthors">Schilling, Stephan; Lauber, Thomas; Schaupp, Michael; Manhart, Susanne; Scheel, Eike; Boehm, Gerald; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12393-12399</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oligomerization of amyloid β (Aβ) peptides is the decisive event in the development of Alzheimer's disease (AD), the most common neuro-generative disorder in developed countries.  Recent evidence links this conformation-driven process to primary- and secondary-structure modifications of Aβ.  The N and C terminus of deposited Aβ has been shown to possess conspicuous heterogeneity.  While the C-terminally longer form of Aβ, i.e., Aβ (42), is considered more amyloidogenic, the role of the N-terminal modifications, e.g., truncation and glutamate cyclization accounting for the majority of the deposited peptides, is less understood.  In the present study, we characterized the oligomerization and seeding capacity of pGlu-amyloid peptides using two unrelated techniques based on flow cytometry or fluorescence dye binding.  Under different conditions and irresp. of the C terminus of Aβ, i.e., Aβ40 or 42, pGlu-modified peptides displayed an up to 250-fold accelerated initial formation of aggregates compared to unmodified Aβ.  The accelerated seed formation is accompanied by a change in the oligomerization kinetics because of N-terminal pGlu formation.  Furthermore, the formation of mixed aggregates consisting of either pGlu-Aβ (3-42) or ADan or ABri and Aβ (1-42) was investigated by Aβ fluorescence labeling in flow cytometry.  The results suggest that pGlu-modified peptides are potential seeding species of aggregate formation in vivo.  The data presented here and the abundance of pGlu peptides in amyloidoses, such as FBD and AD, suggest pGlu-amyloid peptides as a species with biophys. characteristics that might be in particular crucial for the initiation of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6CurUnBcAULVg90H21EOLACvtfcHk0ljgwuG1fojbVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslWns70%253D&md5=3c41f4ad0b1cbe27a9dbc55bab2be8f4</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi0612667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0612667%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DLauber%26aufirst%3DT.%26aulast%3DSchaupp%26aufirst%3DM.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DBohm%26aufirst%3DG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DOn%2520the%2520seeding%2520and%2520oligomerization%2520of%2520pGlu-amyloid%2520peptides%2520%2528in%2520vitro%2529%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D12393%26epage%3D9%26doi%3D10.1021%2Fbi0612667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sergeant, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Kolk, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vingtdeux, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Steeg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ret, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobecq, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonici, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delacourte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benavides, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradier, L.</span></span> <span> </span><span class="NLM_article-title">Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63388-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0002-9440%2810%2963388-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15466394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFSmtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2004&pages=1289-300&author=C.+Casasauthor=N.+Sergeantauthor=J.+M.+Itierauthor=V.+Blanchardauthor=O.+Wirthsauthor=N.+van+der+Kolkauthor=V.+Vingtdeuxauthor=E.+van+de+Steegauthor=G.+Retauthor=T.+Cantonauthor=H.+Drobecqauthor=A.+Clarkauthor=B.+Boniciauthor=A.+Delacourteauthor=J.+Benavidesauthor=C.+Schmitzauthor=G.+Trempauthor=T.+A.+Bayerauthor=P.+Benoitauthor=L.+Pradier&title=Massive+CA1%2F2+neuronal+loss+with+intraneuronal+and+N-terminal+truncated+Abeta42+accumulation+in+a+novel+Alzheimer+transgenic+model&doi=10.1016%2FS0002-9440%2810%2963388-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model</span></div><div class="casAuthors">Casas, Caty; Sergean, Nicolas; Itier, Jean-Michel; Blanchard, Veronique; Wirths, Oliver; van der Kolk, Nicolien; Vingtdeux, Valerie; van de Steeg, Evita; Ret, Gwenaelle; Canton, Thierry; Drobecq, Herve; Clark, Allan; Bonici, Bruno; Delacourte, Andre; Benavides, Jesus; Schmitz, Christoph; Tremp, Gunter; Bayer, Thomas A.; Benoit, Patrick; Pradier, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1289-1300</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by a substantial degeneration of pyramidal neurons and the appearance of neuritic plaques and neurofibrillary tangles.  Here we present a novel transgenic mouse model, APPSLPS1KI that closely mimics the development of AD-related neuropathol. features including a significant hippocampal neuronal loss.  This transgenic mouse model carries M233T/L235P knocked-in mutations in presenilin-1 and overexpresses mutated human β-amyloid (Aβ) precursor protein.  Aβx-42 is the major form of Aβ species present in this model with progressive development of a complex pattern of N-truncated variants and dimers, similar to those obsd. in AD brain.  At 10 mo of age, an extensive neuronal loss (>50%) is present in the CA1/2 hippocampal pyramidal cell layer that correlates with strong accumulation of intraneuronal Aβ and thioflavine-S-pos. intracellular material but not with extracellular Aβ deposits.  A strong reactive astrogliosis develops together with the neuronal loss.  This loss is already detectable at 6 mo of age and is PSIK1 gene dosage-dependent.  Thus, APPSLPS1KI mice further confirm the crit. role of intraneuronal Aβ42 in neuronal loss and provide an excellent tool to investigate therapeutic strategies designed to prevent AD neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptm502eRFGE7Vg90H21EOLACvtfcHk0lhk9I-gkqV5eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFSmtbc%253D&md5=702535c93c978acadadbc6b9f9acad54</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963388-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963388-3%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DC.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DItier%26aufirst%3DJ.%2BM.%26aulast%3DBlanchard%26aufirst%3DV.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3Dvan%2Bder%2BKolk%26aufirst%3DN.%26aulast%3DVingtdeux%26aufirst%3DV.%26aulast%3Dvan%2Bde%2BSteeg%26aufirst%3DE.%26aulast%3DRet%26aufirst%3DG.%26aulast%3DCanton%26aufirst%3DT.%26aulast%3DDrobecq%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DA.%26aulast%3DBonici%26aufirst%3DB.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DBenavides%26aufirst%3DJ.%26aulast%3DSchmitz%26aufirst%3DC.%26aulast%3DTremp%26aufirst%3DG.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DBenoit%26aufirst%3DP.%26aulast%3DPradier%26aufirst%3DL.%26atitle%3DMassive%2520CA1%252F2%2520neuronal%2520loss%2520with%2520intraneuronal%2520and%2520N-terminal%2520truncated%2520Abeta42%2520accumulation%2520in%2520a%2520novel%2520Alzheimer%2520transgenic%2520model%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D165%26spage%3D1289%26epage%3D300%26doi%3D10.1016%2FS0002-9440%2810%2963388-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">38825</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1074/jbc.R111.288308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.R111.288308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21965666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=38825-32&author=S.+Jawharauthor=O.+Wirthsauthor=T.+A.+Bayer&title=Pyroglutamate+amyloid-beta+%28Abeta%29%3A+a+hatchet+man+in+Alzheimer+disease&doi=10.1074%2Fjbc.R111.288308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">38825-38832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Pyroglutamate-modified amyloid-β (AβpE3) peptides are gaining considerable attention as potential key participants in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Transgenic mice that produce high levels of AβpE3-42 show severe neuron loss.  Recent in vitro and in vivo expts. have proven that the enzyme glutaminyl cyclase catalyzes the formation of AβpE3.  In this minireview, we summarize the current knowledge on AβpE3, discussing its discovery, biochem. properties, mol. events detg. formation, prevalence in the brains of AD patients, Alzheimer mouse models, and potential as a target for therapy and as a diagnostic marker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9SRHPGwO6ErVg90H21EOLACvtfcHk0lhk9I-gkqV5eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSqt7vE&md5=e7b0363724dd2e7cbbfc2071abdc8241</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.288308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.288308%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520amyloid-beta%2520%2528Abeta%2529%253A%2520a%2520hatchet%2520man%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D38825%26epage%3D32%26doi%3D10.1074%2Fjbc.R111.288308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Antonios, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiepour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouter, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verkkoniemi-Ahola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillot, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody</span>. <i>Acta Neuropathol Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">56</span>, <span class="refDoi"> DOI: 10.1186/2051-5960-1-56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F2051-5960-1-56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24252153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c3mvFKgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=56&author=G.+Antoniosauthor=N.+Saiepourauthor=Y.+Bouterauthor=B.+C.+Richardauthor=A.+Paetauauthor=A.+Verkkoniemi-Aholaauthor=L.+Lannfeltauthor=M.+Ingelssonauthor=G.+G.+Kovacsauthor=T.+Pillotauthor=O.+Wirthsauthor=T.+A.+Bayer&title=N-truncated+Abeta+starting+with+position+four%3A+early+intraneuronal+accumulation+and+rescue+of+toxicity+using+NT4X-167%2C+a+novel+monoclonal+antibody&doi=10.1186%2F2051-5960-1-56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody</span></div><div class="casAuthors">Antonios Gregory; Saiepour Nasrin; Bouter Yvonne; Richard Bernhard C; Paetau Anders; Verkkoniemi-Ahola Auli; Lannfelt Lars; Ingelsson Martin; Kovacs Gabor G; Pillot Thierry; Wirths Oliver; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">56</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The amyloid hypothesis in Alzheimer disease (AD) considers amyloid β peptide (Aβ) deposition causative in triggering down-stream events like neurofibrillary tangles, cell loss, vascular damage and memory decline.  In the past years N-truncated Aβ peptides especially N-truncated pyroglutamate AβpE3-42 have been extensively studied.  Together with full-length Aβ1-42 and Aβ1-40, N-truncated AβpE3-42 and Aβ4-42 are major variants in AD brain.  Although Aβ4-42 has been known for a much longer time, there is a lack of studies addressing the question whether AβpE3-42 or Aβ4-42 may precede the other in Alzheimer's disease pathology.  RESULTS:  Using different Aβ antibodies specific for the different N-termini of N-truncated Aβ, we discovered that Aβ4-x preceded AβpE3-x intraneuronal accumulation in a transgenic mouse model for AD prior to plaque formation.  The novel Aβ4-x immunoreactive antibody NT4X-167 detected high molecular weight aggregates derived from N-truncated Aβ species.  While NT4X-167 significantly rescued Aβ4-42 toxicity in vitro no beneficial effect was observed against Aβ1-42 or AβpE3-42 toxicity.  Phenylalanine at position four of Aβ was imperative for antibody binding, because its replacement with alanine or proline completely prevented binding.  Although amyloid plaques were observed using NT4X-167 in 5XFAD transgenic mice, it barely reacted with plaques in the brain of sporadic AD patients and familial cases with the Arctic, Swedish and the presenilin-1 PS1Δ9 mutation.  A consistent staining was observed in blood vessels in all AD cases with cerebral amyloid angiopathy.  There was no cross-reactivity with other aggregates typical for other common neurodegenerative diseases showing that NT4X-167 staining is specific for AD.  CONCLUSIONS:  Aβ4-x precedes AβpE3-x in the well accepted 5XFAD AD mouse model underlining the significance of N-truncated species in AD pathology.  NT4X-167 therefore is the first antibody reacting with Aβ4-x and represents a novel tool in Alzheimer research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQrC1-S7O0maj69zv1FsJFMfW6udTcc2eaqVj6r-lT0xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3mvFKgtw%253D%253D&md5=75219c438a3b1ee3422a7b75b1f45ed3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1186%2F2051-5960-1-56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2051-5960-1-56%26sid%3Dliteratum%253Aachs%26aulast%3DAntonios%26aufirst%3DG.%26aulast%3DSaiepour%26aufirst%3DN.%26aulast%3DBouter%26aufirst%3DY.%26aulast%3DRichard%26aufirst%3DB.%2BC.%26aulast%3DPaetau%26aufirst%3DA.%26aulast%3DVerkkoniemi-Ahola%26aufirst%3DA.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DKovacs%26aufirst%3DG.%2BG.%26aulast%3DPillot%26aufirst%3DT.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DN-truncated%2520Abeta%2520starting%2520with%2520position%2520four%253A%2520early%2520intraneuronal%2520accumulation%2520and%2520rescue%2520of%2520toxicity%2520using%2520NT4X-167%252C%2520a%2520novel%2520monoclonal%2520antibody%26jtitle%3DActa%2520Neuropathol%2520Commun.%26date%3D2013%26volume%3D1%26spage%3D56%26doi%3D10.1186%2F2051-5960-1-56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johanssen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span> <span> </span><span class="NLM_article-title">Amyloid-beta peptide Abeta3pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">6134</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.655183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M115.655183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26697885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVShsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6134-45&author=A.+P.+Gunnauthor=B.+X.+Wongauthor=T.+Johanssenauthor=J.+C.+Griffithauthor=C.+L.+Mastersauthor=A.+I.+Bushauthor=K.+J.+Barnhamauthor=J.+A.+Duceauthor=R.+A.+Cherny&title=Amyloid-beta+peptide+Abeta3pE-42+induces+lipid+peroxidation%2C+membrane+permeabilization%2C+and+calcium+influx+in+neurons&doi=10.1074%2Fjbc.M115.655183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons</span></div><div class="casAuthors">Gunn, Adam P.; Wong, Bruce X.; Johanssen, Timothy; Griffith, James C.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6134-6145</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified amyloid-β (pE-Aβ) is a highly neurotoxic amyloid-β (Aβ) isoform and is enriched in the brains of individuals with Alzheimer disease compared with healthy aged controls.  Pyroglutamate formation increases the rate of Aβ oligomerization and alters the interactions of Aβ with Cu2+ and lipids; however, a link between these properties and the toxicity of pE-Aβ peptides has not been established.  We report here that Aβ3pE-42 has an enhanced capacity to cause lipid peroxidn. in primary cortical mouse neurons compared with the full-length isoform (Aβ(1-42)).  In contrast, Aβ(1-42) caused a significant elevation in cytosolic reactive oxygen species, whereas Aβ3pE-42 did not.  We also report that Aβ3pE-42 preferentially assocs. with neuronal membranes and triggers Ca2+ influx that can be partially blocked by the N-methyl-D-aspartate receptor antagonist MK-801.  Aβ3pE-42 further caused a loss of plasma membrane integrity and remained bound to neurons at significantly higher levels than Aβ(1-42) over extended incubations.  Pyroglutamate formation was addnl. found to increase the relative efficiency of Aβ-dityrosine oligomer formation mediated by copper-redox cycling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrC0SqkhFqZrVg90H21EOLACvtfcHk0lgCD1vDPtH-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVShsLg%253D&md5=4a396499836d982384e8ca3d01e39212</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.655183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.655183%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DWong%26aufirst%3DB.%2BX.%26aulast%3DJohanssen%26aufirst%3DT.%26aulast%3DGriffith%26aufirst%3DJ.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DAmyloid-beta%2520peptide%2520Abeta3pE-42%2520induces%2520lipid%2520peroxidation%252C%2520membrane%2520permeabilization%252C%2520and%2520calcium%2520influx%2520in%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D6134%26epage%3D45%26doi%3D10.1074%2Fjbc.M115.655183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">4454</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.185819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.185819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21148560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=4454-60&author=S.+Jawharauthor=O.+Wirthsauthor=S.+Schillingauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=T.+A.+Bayer&title=Overexpression+of+glutaminyl+cyclase%2C+the+enzyme+responsible+for+pyroglutamate+A%7Bbeta%7D+formation%2C+induces+behavioral+deficits%2C+and+glutaminyl+cyclase+knock-out+rescues+the+behavioral+phenotype+in+5XFAD+mice&doi=10.1074%2Fjbc.M110.185819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice</span></div><div class="casAuthors">Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4454-4460</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Pyroglutamate-modified Aβ (AβpE3-42) peptides are gaining considerable attention as potential key players in the pathol. of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity.  Overexpressing AβpE3-42 induced a severe neuron loss and neurol. phenotype in TBA2 mice.  In vitro and in vivo expts. have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of AβpE3-42.  The aim of the present work was to analyze the role of QC in an AD mouse model with abundant AβpE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-sol. AβpE3-42 peptides and aggregation in plaques.  In 6-mo-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD.  The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC.  These data clearly demonstrate that QC is crucial for modulating AβpE3-42 levels in vivo and prove on a genetic base the concept that redn. of QC activity is a promising new therapeutic approach for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMeSo62btLh7Vg90H21EOLACvtfcHk0lgCD1vDPtH-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGltL8%253D&md5=7b704a92ffab37146126e9d101df9a1e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.185819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.185819%26sid%3Dliteratum%253Aachs%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOverexpression%2520of%2520glutaminyl%2520cyclase%252C%2520the%2520enzyme%2520responsible%2520for%2520pyroglutamate%2520A%257Bbeta%257D%2520formation%252C%2520induces%2520behavioral%2520deficits%252C%2520and%2520glutaminyl%2520cyclase%2520knock-out%2520rescues%2520the%2520behavioral%2520phenotype%2520in%25205XFAD%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D4454%26epage%3D60%26doi%3D10.1074%2Fjbc.M110.185819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canneva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">108</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-14-108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F1471-2202-14-108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24083638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FisFOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=108&author=A.+Beckerauthor=S.+Kohlmannauthor=A.+Alexandruauthor=W.+Jaglaauthor=F.+Cannevaauthor=C.+Bauscherauthor=H.+Cynisauthor=R.+Sedlmeierauthor=S.+Graubnerauthor=S.+Schillingauthor=H.+U.+Demuthauthor=S.+von+Horsten&title=Glutaminyl+cyclase-mediated+toxicity+of+pyroglutamate-beta+amyloid+induces+striatal+neurodegeneration&doi=10.1186%2F1471-2202-14-108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration</span></div><div class="casAuthors">Becker Andreas; Kohlmann Stephanie; Alexandru Anca; Jagla Wolfgang; Canneva Fabio; Bauscher Christoph; Cynis Holger; Sedlmeier Reinhard; Graubner Sigrid; Schilling Stephan; Demuth Hans-Ulrich; von Horsten Stephan</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties.  One of these modifications is N-terminal pyroglutamate (pE) formation.  Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ.  Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic.  In addition, it accelerates aggregation of other Aβ species.  To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3-42) were generated and comprehensively characterized.  To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice.  RESULTS:  Expression of truncated Aβ(3-42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ.  This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation.  Neuropathology in ETNA mice was associated with behavioral alterations.  In particular, hyperactivity and impaired acoustic sensorimotor gating were detected.  Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss.  CONCLUSIONS:  ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ.  Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology.  The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAH7LIm5FQO9LIORRPd5lbfW6udTcc2ebnsrfahCNI_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FisFOnsw%253D%253D&md5=2d2b53b9af3975fbe5c43ce490f2559d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-14-108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-14-108%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DCanneva%26aufirst%3DF.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase-mediated%2520toxicity%2520of%2520pyroglutamate-beta%2520amyloid%2520induces%2520striatal%2520neurodegeneration%26jtitle%3DBMC%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D108%26doi%3D10.1186%2F1471-2202-14-108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider-Axmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman-Gunnarsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Abeta in plasma of patients with Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1379</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2009.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2009.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19781815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWhsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1379-87&author=A.+Marcelloauthor=O.+Wirthsauthor=T.+Schneider-Axmannauthor=M.+Degerman-Gunnarssonauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Reduced+levels+of+IgM+autoantibodies+against+N-truncated+pyroglutamate+Abeta+in+plasma+of+patients+with+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2009.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease</span></div><div class="casAuthors">Marcello, Andrea; Wirths, Oliver; Schneider-Axmann, Thomas; Degerman-Gunnarsson, Malin; Lannfelt, Lars; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1379-1387</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In the present work, we investigated the level of IgM autoantibodies directed against different Aβ epitopes as potential diagnostic biomarker for Alzheimer's disease (AD).  Anti-Aβ autoantibody levels were measured in 75 plasma samples from patients with AD, individuals with mild cognitive impairment (MCI), and healthy age- and sex-matched controls (HC).  To validate the presence of anti-Aβ IgMs, pooled plasma samples were subjected to gel-filtration anal.  The mean level of pGluAβ-IgM (N-terminal truncated starting at position three with pyroglutamate) was significantly decreased in AD patients as compared to HC.  In the group of MCI patients there was a significant pos. correlation between pGluAβ-IgM and cognitive decline analyzed by MMSE (rho = 0.58, d.f. = 13, p = 0.022).  These observations indicate that the level of IgM autoantibodies against pGluAβ is a promising plasma biomarker for AD and correlates with the cognitive status of individuals at risk to develop AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphObmvQ1IrErVg90H21EOLACvtfcHk0lhE1_hXe_drRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWhsLw%253D&md5=86e0d9d00a9ee4a8f637c6e6cdfe54e9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2009.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2009.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DMarcello%26aufirst%3DA.%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DSchneider-Axmann%26aufirst%3DT.%26aulast%3DDegerman-Gunnarsson%26aufirst%3DM.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DReduced%2520levels%2520of%2520IgM%2520autoantibodies%2520against%2520N-truncated%2520pyroglutamate%2520Abeta%2520in%2520plasma%2520of%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2011%26volume%3D32%26spage%3D1379%26epage%3D87%26doi%3D10.1016%2Fj.neurobiolaging.2009.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Kimpe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haastert, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoozemans, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, W.</span></span> <span> </span><span class="NLM_article-title">Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Abeta pathology at the lysosome</span>. <i>Age (Dordr)</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1007/s11357-012-9403-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs11357-012-9403-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22477259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC38risVClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=673-87&author=L.+De%0AKimpeauthor=E.+S.+van+Haastertauthor=A.+Kaminariauthor=R.+Zwartauthor=H.+Rutjesauthor=J.+J.+Hoozemansauthor=W.+Scheper&title=Intracellular+accumulation+of+aggregated+pyroglutamate+amyloid+beta%3A+convergence+of+aging+and+Abeta+pathology+at+the+lysosome&doi=10.1007%2Fs11357-012-9403-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome</span></div><div class="casAuthors">De Kimpe Line; van Haastert Elise S; Kaminari Archontia; Zwart Rob; Rutjes Helma; Hoozemans Jeroen J M; Scheper Wiep</div><div class="citationInfo"><span class="NLM_cas:title">Age (Dordrecht, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Deposition of aggregated amyloid beta (Aβ) is a major hallmark of Alzheimer's disease (AD)-a common age-related neurodegenerative disorder.  Typically, Aβ is generated as a peptide of varying lengths.  However, a major fraction of Aβ peptides in the brains of AD patients has undergone posttranslational modifications, which often radically change the properties of the peptides.  Aβ3(pE)-42 is an N-truncated, pyroglutamate-modified variant that is abundantly present in AD brain and was suggested to play a role early in the pathogenesis.  Here we show that intracellular accumulation of oligomeric aggregates of Aβ3(pE)-42 results in loss of lysosomal integrity.  Using a novel antibody specific for aggregates of AβpE3, we show that in postmortem human brain tissue, aggregated AβpE3 is predominantly found in the lysosomes of both neurons and glial cells.  Our data further demonstrate that AβpE3 is relatively resistant to lysosomal degradation, which may explain its accumulation in the lysosomes.  The intracellular AβpE3 aggregates increase in an age-dependent manner.  The results presented in this study support a model where Aβ pathology and aging converge, leading to accumulation of the degradation-resistant pE-modified Aβ in the lysosomes, lysosomal dysfunction, and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRWm6uxvJOLUPI-fCgwosgfW6udTcc2eYCh4WW2uFMs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38risVClsQ%253D%253D&md5=406886b2162c06a3de2a838ef80c285e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs11357-012-9403-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11357-012-9403-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DL.%26aulast%3Dvan%2BHaastert%26aufirst%3DE.%2BS.%26aulast%3DKaminari%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DR.%26aulast%3DRutjes%26aufirst%3DH.%26aulast%3DHoozemans%26aufirst%3DJ.%2BJ.%26aulast%3DScheper%26aufirst%3DW.%26atitle%3DIntracellular%2520accumulation%2520of%2520aggregated%2520pyroglutamate%2520amyloid%2520beta%253A%2520convergence%2520of%2520aging%2520and%2520Abeta%2520pathology%2520at%2520the%2520lysosome%26jtitle%3DAge%2520%2528Dordr%2529%26date%3D2013%26volume%3D35%26spage%3D673%26epage%3D87%26doi%3D10.1007%2Fs11357-012-9403-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussbaum, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wangsanut, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tayler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltgen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatami, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronicke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glabe, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, G. S.</span></span> <span> </span><span class="NLM_article-title">Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">5</span>, <span class="refDoi"> DOI: 10.1038/nature11060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnature11060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22660329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=651-5&author=J.+M.+Nussbaumauthor=S.+Schillingauthor=H.+Cynisauthor=A.+Silvaauthor=E.+Swansonauthor=T.+Wangsanutauthor=K.+Taylerauthor=B.+Wiltgenauthor=A.+Hatamiauthor=R.+Ronickeauthor=K.+Reymannauthor=B.+Hutter-Paierauthor=A.+Alexandruauthor=W.+Jaglaauthor=S.+Graubnerauthor=C.+G.+Glabeauthor=H.+U.+Demuthauthor=G.+S.+Bloom&title=Prion-like+behaviour+and+tau-dependent+cytotoxicity+of+pyroglutamylated+amyloid-beta&doi=10.1038%2Fnature11060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Prion-like behavior and tau-dependent cytotoxicity of pyroglutamylated amyloid-β</span></div><div class="casAuthors">Nussbaum, Justin M.; Schilling, Stephan; Cynis, Holger; Silva, Antonia; Swanson, Eric; Wangsanut, Tanaporn; Tayler, Kaycie; Wiltgen, Brian; Hatami, Asa; Roenicke, Raik; Reymann, Klaus; Hutter-Paier, Birgit; Alexandru, Anca; Jagla, Wolfgang; Graubner, Sigrid; Glabe, Charles G.; Demuth, Hans-Ulrich; Bloom, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7400</span>),
    <span class="NLM_cas:pages">651-655</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Extracellular plaques of amyloid-β and intraneuronal neurofibrillary tangles made from tau are the histopathol. signatures of Alzheimer's disease.  Plaques comprise amyloid-β fibrils that assemble from monomeric and oligomeric intermediates, and are prognostic indicators of Alzheimer's disease.  Despite the importance of plaques to Alzheimer's disease, oligomers are considered to be the principal toxic forms of amyloid-β.  Interestingly, many adverse responses to amyloid-β, such as cytotoxicity, microtubule loss, impaired memory and learning, and neuritic degeneration, are greatly amplified by tau expression.  Amino-terminally truncated, pyroglutamylated (pE) forms of amyloid-β are strongly assocd. with Alzheimer's disease, are more toxic than amyloid-β, residues 1-42 (Aβ1-42) and Aβ1-40, and have been proposed as initiators of Alzheimer's disease pathogenesis.  Here we report a mechanism by which pE-Aβ may trigger Alzheimer's disease.  Aβ3(pE)-42 co-oligomerizes with excess Aβ1-42 to form metastable low-n oligomers (LNOs) that are structurally distinct and far more cytotoxic to cultured neurons than comparable LNOs made from Aβ1-42 alone.  Tau is required for cytotoxicity, and LNOs comprising 5% Aβ3(pE)-42 plus 95% Aβ1-42 (5% pE-Aβ) seed new cytotoxic LNOs through multiple serial dilns. into Aβ1-42 monomers in the absence of addnl. Aβ3(pE)-42.  LNOs isolated from human Alzheimer's disease brain contained Aβ3(pE)-42, and enhanced Aβ3(pE)-42 formation in mice triggered neuron loss and gliosis at 3 mo, but not in a tau-null background.  We conclude that Aβ3(pE)-42 confers tau-dependent neuronal death and causes template-induced misfolding of Aβ1-42 into structurally distinct LNOs that propagate by a prion-like mechanism.  Our results raise the possibility that Aβ3(pE)-42 acts similarly at a primary step in Alzheimer's disease pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotg6vra9ty9rVg90H21EOLACvtfcHk0lhE1_hXe_drRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVymsbc%253D&md5=67ba093a16fe5db1bea9f3873bd92ee5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnature11060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11060%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaum%26aufirst%3DJ.%2BM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DWangsanut%26aufirst%3DT.%26aulast%3DTayler%26aufirst%3DK.%26aulast%3DWiltgen%26aufirst%3DB.%26aulast%3DHatami%26aufirst%3DA.%26aulast%3DRonicke%26aufirst%3DR.%26aulast%3DReymann%26aufirst%3DK.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DAlexandru%26aufirst%3DA.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DGlabe%26aufirst%3DC.%2BG.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBloom%26aufirst%3DG.%2BS.%26atitle%3DPrion-like%2520behaviour%2520and%2520tau-dependent%2520cytotoxicity%2520of%2520pyroglutamylated%2520amyloid-beta%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D651%26epage%3D5%26doi%3D10.1038%2Fnature11060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mandler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santic, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhaya, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colloby, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneeberger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attems, J.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamylated amyloid-beta is associated with hyperphosphorylated tau and severity of Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1296-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-014-1296-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24861310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVehtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2014&pages=67-79&author=M.+Mandlerauthor=L.+Walkerauthor=R.+Santicauthor=P.+Hansonauthor=A.+R.+Upadhayaauthor=S.+J.+Collobyauthor=C.+M.+Morrisauthor=D.+R.+Thalauthor=A.+J.+Thomasauthor=A.+Schneebergerauthor=J.+Attems&title=Pyroglutamylated+amyloid-beta+is+associated+with+hyperphosphorylated+tau+and+severity+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1296-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease</span></div><div class="casAuthors">Mandler, Markus; Walker, Lauren; Santic, Radmila; Hanson, Peter; Upadhaya, Ajeet Rijal; Colloby, Sean J.; Morris, Christopher M.; Thal, Dietmar R.; Thomas, Alan J.; Schneeberger, Achim; Attems, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-79</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Pyroglutamylated amyloid-β (pE(3)-Aβ) has been suggested to play a major role in Alzheimer's disease (AD) pathogenesis as amyloid-β (Aβ) oligomers contg. pE(3)-Aβ might initiate tau-dependent cytotoxicity.  We aimed to further elucidate the assocns. among pE(3)-Aβ, full-length Aβ and hyperphosphorylated tau (HP-τ) in human brain tissue.  We examd. 41 post mortem brains of both AD (n = 18) and controls.  Sections from frontal and entorhinal cortices were stained with pE(3)-Aβ, HP-τ and full-length Aβ antibodies.  The resp. loads were assessed using image anal. and western blot anal. was performed in a subset of cases.  All loads were significantly higher in AD, but when using Aβ loads as independent variables only frontal pE(3)-Aβ load predicted AD.  In frontal and entorhinal cortices pE(3)-Aβ load independently predicted HP-τ load while non-pE(3)-Aβ failed to do so.  All loads correlated with the severity of AD neuropathol.  However, partial correlation anal. revealed resp. correlations in the frontal cortex only for pE(3)-Aβ load only while in the entorhinal cortex resp. correlations were seen for both HP-τ and non-pE(3)-Aβ loads.  Mini Mental State Examn. scores were independently predicted by entorhinal HP-τ load and by frontal pE(3)-Aβ load.  Here, we report an assocn. between pE(3)-Aβ and HP-τ in human brain tissue and an influence of frontal pE(3)-Aβ on both the severity of AD neuropathol. and clin. dementia.  Our findings further support the notion that pE(3)-Aβ may represent an important link between Aβ and HP-τ, and investigations into its role as diagnostic and therapeutic target in AD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVA8GD8hapLVg90H21EOLACvtfcHk0ljHXQh5dTgvLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVehtrg%253D&md5=917c2c678b84af1626e2cb3668fde987</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1296-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1296-9%26sid%3Dliteratum%253Aachs%26aulast%3DMandler%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DL.%26aulast%3DSantic%26aufirst%3DR.%26aulast%3DHanson%26aufirst%3DP.%26aulast%3DUpadhaya%26aufirst%3DA.%2BR.%26aulast%3DColloby%26aufirst%3DS.%2BJ.%26aulast%3DMorris%26aufirst%3DC.%2BM.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DThomas%26aufirst%3DA.%2BJ.%26aulast%3DSchneeberger%26aufirst%3DA.%26aulast%3DAttems%26aufirst%3DJ.%26atitle%3DPyroglutamylated%2520amyloid-beta%2520is%2520associated%2520with%2520hyperphosphorylated%2520tau%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D128%26spage%3D67%26epage%3D79%26doi%3D10.1007%2Fs00401-014-1296-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span> <span> </span><span class="NLM_article-title">Prophylactic vaccine based on pyroglutamate-3 amyloid beta generates strong antibody response and rescues cognitive decline in Alzheimer’s disease model mice</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">459</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00336</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00336" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=454-459&author=G.+Liauthor=Z.+W.+Huauthor=P.+G.+Chenauthor=Z.+Y.+Sunauthor=Y.+X.+Chenauthor=Y.+F.+Zhaoauthor=Y.+M.+Li&title=Prophylactic+vaccine+based+on+pyroglutamate-3+amyloid+beta+generates+strong+antibody+response+and+rescues+cognitive+decline+in+Alzheimer%E2%80%99s+disease+model+mice&doi=10.1021%2Facschemneuro.6b00336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic vaccine based on pyroglutamate-3 amyloid β generates strong antibody response and rescues cognitive decline in Alzheimer's disease model mice</span></div><div class="casAuthors">Li, Gao; Hu, Zhi-Wen; Chen, Pu-Guang; Sun, Zhan-Yi; Chen, Yong-Xiang; Zhao, Yu-Fen; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">454-459</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clearance of amyloid β (Aβ) by immunotherapy is one of the fancy methods to treat Alzheimer's disease (AD).  However, the failure of some clin. trials suggested that there may be something ignored in the past development of immunotherapy.  Pyroglutamate-3 Aβ (AβpE3-X), which was found to be abundant in the patients' brain, has attracted much attention after the report that AβpE3-42 could serve as a template to exacerbate the aggregation of Aβ.  In addn., AβpE3-X could not be recognized by the antibodies targeting the N-terminus of Aβ, suggesting that AβpE3-X maybe the ignored one.  Indeed, passive immunization targeting AβpE3-X has shown some beneficial results, while active immunotherapy has not been extensively studied.  In the present study, we designed and synthesized a novel peptide vaccine targeting AβpE3-X, which contains AβpE3-15 as B cell epitope and P2 as T cell epitope.  We showed that this vaccine could induce strong antibody response to AβpE3-X.  We also showed that prophylactic immunization of AD model mice with our vaccine could reduce Aβ plaques and rescue cognitive decline.  This new kind of Aβ vaccine will open up new directions for AD immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVZXohuDfFI7Vg90H21EOLACvtfcHk0ljHXQh5dTgvLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSmurvK&md5=4939d98accb4a9080fe7f8fb22a7e218</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00336%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DZ.%2BW.%26aulast%3DChen%26aufirst%3DP.%2BG.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DChen%26aufirst%3DY.%2BX.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DProphylactic%2520vaccine%2520based%2520on%2520pyroglutamate-3%2520amyloid%2520beta%2520generates%2520strong%2520antibody%2520response%2520and%2520rescues%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%2520mice%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D454%26epage%3D459%26doi%3D10.1021%2Facschemneuro.6b00336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crehan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemere, C. A.</span></span> <span> </span><span class="NLM_article-title">Immunotherapy targeting pyroglutamate-3 Abeta: prospects and challenges</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">48</span>, <span class="refDoi"> DOI: 10.1186/s13024-016-0115-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13024-016-0115-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=27363697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWltr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=48&author=H.+Cynisauthor=J.+L.+Frostauthor=H.+Crehanauthor=C.+A.+Lemere&title=Immunotherapy+targeting+pyroglutamate-3+Abeta%3A+prospects+and+challenges&doi=10.1186%2Fs13024-016-0115-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges</span></div><div class="casAuthors">Cynis, Holger; Frost, Jeffrey L.; Crehan, Helen; Lemere, Cynthia A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48/1-48/11</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Immunization against amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) has shown considerable therapeutic effect in animal models however, the translation into human Alzheimer's patients is challenging.  In recent years, a no. of promising Aβ immunotherapy trials failed to reach primary study endpoints.  Aside from uncertainties in the selection of patients and the start and duration of treatment, these results also suggest that the mechanisms underlying AD are still not fully understood.  Thorough characterizations of protein aggregates in AD brain have revealed a conspicuous heterogeneity of Aβ peptides enabling the study of the toxic potential of each of the major forms.  One such form, amino-terminally truncated and modified pyroglutamate (pGlu)-3 Aβ peptide appears to play a seminal role for disease initiation, qualifying it as novel target for immunotherapy approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8P-lGVQnDbVg90H21EOLACvtfcHk0ljHXQh5dTgvLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWltr3E&md5=70a2e8e30e1375163078899d6e0f228b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1186%2Fs13024-016-0115-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-016-0115-2%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DFrost%26aufirst%3DJ.%2BL.%26aulast%3DCrehan%26aufirst%3DH.%26aulast%3DLemere%26aufirst%3DC.%2BA.%26atitle%3DImmunotherapy%2520targeting%2520pyroglutamate-3%2520Abeta%253A%2520prospects%2520and%2520challenges%26jtitle%3DMol.%2520Neurodegener.%26date%3D2016%26volume%3D11%26spage%3D48%26doi%3D10.1186%2Fs13024-016-0115-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acero, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manoutcharian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilevko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munguia, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govezensky, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coronas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luz-Madrigal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cribbs, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkian, G.</span></span> <span> </span><span class="NLM_article-title">Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits</span>. <i>J. Neuroimmunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>213</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/j.jneuroim.2009.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jneuroim.2009.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19545911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1Whs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2009&pages=39-46&author=G.+Aceroauthor=K.+Manoutcharianauthor=V.+Vasilevkoauthor=M.+E.+Munguiaauthor=T.+Govezenskyauthor=G.+Coronasauthor=A.+Luz-Madrigalauthor=D.+H.+Cribbsauthor=G.+Gevorkian&title=Immunodominant+epitope+and+properties+of+pyroglutamate-modified+Abeta-specific+antibodies+produced+in+rabbits&doi=10.1016%2Fj.jneuroim.2009.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits</span></div><div class="casAuthors">Acero, G.; Manoutcharian, K.; Vasilevko, V.; Munguia, M. E.; Govezensky, T.; Coronas, G.; Luz-Madrigal, A.; Cribbs, D. H.; Gevorkian, G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">39-46</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid beta (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) and Down's syndrome patients as well as transgenic mouse models of AD.  Although the pathol. significance of these shortened forms Aβ is not completely understood, previous studies have demonstrated that these peptides are significantly more resistant to degrdn., aggregate more rapidly in vitro and exhibit similar or, in some cases, increased toxicity in hippocampal neuronal cultures compared to the full length peptides.  In the present study we further investigated the mechanisms of toxicity of one of the most abundant N-truncated/modified Aβ peptide bearing amino-terminal pyroglutamate at position 3 (AβN3(pE)).  We demonstrated that AβN3(pE) oligomers induce phosphatidyl serine externalization and membrane damage in SH-SY5Y cells.  Also, we produced AβN3(pE)-specific polyclonal antibodies in rabbit and identified an immunodominant epitope recognized by anti-AβN3(pE) antibodies.  Our results are important for developing new immunotherapeutic compds. specifically targeting AβN3(pE) aggregates since the most commonly used immunogens in the majority of vaccines for AD have been shown to induce antibodies that recognize the N-terminal immunodominant epitope (EFRH) of the full length Aβ, which is absent in N-amino truncated peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPGPTix89HrVg90H21EOLACvtfcHk0lgJvpTcq1EaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1Whs7g%253D&md5=0b9a1bee6ba2f766c253ef687ce54c18</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2009.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2009.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAcero%26aufirst%3DG.%26aulast%3DManoutcharian%26aufirst%3DK.%26aulast%3DVasilevko%26aufirst%3DV.%26aulast%3DMunguia%26aufirst%3DM.%2BE.%26aulast%3DGovezensky%26aufirst%3DT.%26aulast%3DCoronas%26aufirst%3DG.%26aulast%3DLuz-Madrigal%26aufirst%3DA.%26aulast%3DCribbs%26aufirst%3DD.%2BH.%26aulast%3DGevorkian%26aufirst%3DG.%26atitle%3DImmunodominant%2520epitope%2520and%2520properties%2520of%2520pyroglutamate-modified%2520Abeta-specific%2520antibodies%2520produced%2520in%2520rabbits%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2009%26volume%3D213%26spage%3D39%26epage%3D46%26doi%3D10.1016%2Fj.jneuroim.2009.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geumann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman-Gunnarsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huitinga, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">41517</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.178707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1074%2Fjbc.M110.178707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20971852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Wju7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=41517-24&author=O.+Wirthsauthor=C.+Erckauthor=H.+Martensauthor=A.+Harmeierauthor=C.+Geumannauthor=S.+Jawharauthor=S.+Kumarauthor=G.+Multhaupauthor=J.+Walterauthor=M.+Ingelssonauthor=M.+Degerman-Gunnarssonauthor=H.+Kalimoauthor=I.+Huitingaauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Identification+of+low+molecular+weight+pyroglutamate+A%7Bbeta%7D+oligomers+in+Alzheimer+disease%3A+a+novel+tool+for+therapy+and+diagnosis&doi=10.1074%2Fjbc.M110.178707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease: A Novel Tool for Therapy and Diagnosis</span></div><div class="casAuthors">Wirths, Oliver; Erck, Christian; Martens, Henrik; Harmeier, Anja; Geumann, Constanze; Jawhar, Sadim; Kumar, Sathish; Multhaup, Gerd; Walter, Jochen; Ingelsson, Martin; Degerman-Gunnarsson, Malin; Kalimo, Hannu; Huitinga, Inge; Lannfelt, Lars; Bayer, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">41517-41524</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">N-terminally truncated Aβ peptides starting with pyroglutamate (AβpE3) represent a major fraction of all Aβ peptides in the brain of Alzheimer disease (AD) patients.  AβpE3 has a higher aggregation propensity and stability and shows increased toxicity compared with full-length Aβ.  In the present work, we generated a novel monoclonal antibody (9D5) that selectively recognizes oligomeric assemblies of AβpE3 and studied the potential involvement of oligomeric AβpE3 in vivo using transgenic mouse models as well as human brains from sporadic and familial AD cases.  9D5 showed an unusual staining pattern with almost nondetectable plaques in sporadic AD patients and non-demented controls.  Interestingly, in sporadic and familial AD cases prominent intraneuronal and blood vessel staining was obsd.  Using a novel sandwich ELISA significantly decreased levels of oligomers in plasma samples from patients with AD compared with healthy controls were identified.  Moreover, passive immunization of 5XFAD mice with 9D5 significantly reduced overall Aβ plaque load and AβpE3 levels, and normalized behavioral deficits.  These data indicate that 9D5 is a therapeutically and diagnostically effective monoclonal antibody targeting low mol. wt. AβpE3 oligomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru1picri8TbrVg90H21EOLACvtfcHk0lgJvpTcq1EaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Wju7nI&md5=60f258b115f9ef56f3592c641fdd2e9d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.178707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.178707%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DErck%26aufirst%3DC.%26aulast%3DMartens%26aufirst%3DH.%26aulast%3DHarmeier%26aufirst%3DA.%26aulast%3DGeumann%26aufirst%3DC.%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DDegerman-Gunnarsson%26aufirst%3DM.%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DHuitinga%26aufirst%3DI.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DIdentification%2520of%2520low%2520molecular%2520weight%2520pyroglutamate%2520A%257Bbeta%257D%2520oligomers%2520in%2520Alzheimer%2520disease%253A%2520a%2520novel%2520tool%2520for%2520therapy%2520and%2520diagnosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D41517%26epage%3D24%26doi%3D10.1074%2Fjbc.M110.178707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-Abeta: role in the natural history of Alzheimer’s disease</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1915</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.biocel.2010.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.biocel.2010.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20833262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=1915-8&author=A.+P.+Gunnauthor=C.+L.+Mastersauthor=R.+A.+Cherny&title=Pyroglutamate-Abeta%3A+role+in+the+natural+history+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2010.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Aβ: Role in the natural history of Alzheimer's disease</span></div><div class="casAuthors">Gunn, Adam P.; Masters, Colin L.; Cherny, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1915-1918</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The accumulation of amyloid-beta (Aβ) peptides is believed to be a central contributor to the neurodegeneration typically seen in Alzheimer's disease (AD) brain.  Aβ extd. from AD brains invariably possesses extensive truncations, yielding peptides of differing N- and C-terminal compn.  While Aβ is often abundant in the brains of cognitively normal elderly people, the brains of AD patients are highly enriched for N-terminally truncated Aβ bearing the pyroglutamate modification.  Pyroglutamate-Aβ (pE-Aβ) has a higher propensity for oligomerization and aggregation than full-length Aβ, potentially seeding the accumulation of neurotoxic Aβ oligomers and amyloid deposits.  In addn., pE-Aβ has increased resistance to clearance by peptidases, causing these peptides to persist in biol. fluids and tissues.  The extensive deposition of pE-Aβ in human AD brain is under-represented in many transgenic mouse models of AD, reflecting major differences in the prodn. and processing of Aβ peptides in these models compared to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorztlGScimnrVg90H21EOLACvtfcHk0lgJvpTcq1EaiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2itLrO&md5=1139e1d56c89eed8e3ac3b08bd3b89ed</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2010.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2010.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DGunn%26aufirst%3DA.%2BP.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26atitle%3DPyroglutamate-Abeta%253A%2520role%2520in%2520the%2520natural%2520history%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D1915%26epage%3D8%26doi%3D10.1016%2Fj.biocel.2010.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethge, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcello, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmeier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jawhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucassen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Multhaup, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brody, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esparza, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases</span>. <i>J. Neural Transm (Vienna)</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1007/s00702-009-0314-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00702-009-0314-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19823761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fjs12rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2010&pages=85-96&author=O.+Wirthsauthor=T.+Bethgeauthor=A.+Marcelloauthor=A.+Harmeierauthor=S.+Jawharauthor=P.+J.+Lucassenauthor=G.+Multhaupauthor=D.+L.+Brodyauthor=T.+Esparzaauthor=M.+Ingelssonauthor=H.+Kalimoauthor=L.+Lannfeltauthor=T.+A.+Bayer&title=Pyroglutamate+Abeta+pathology+in+APP%2FPS1KI+mice%2C+sporadic+and+familial+Alzheimer%E2%80%99s+disease+cases&doi=10.1007%2Fs00702-009-0314-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases</span></div><div class="casAuthors">Wirths Oliver; Bethge Tobias; Marcello Andrea; Harmeier Anja; Jawhar Sadim; Lucassen Paul J; Multhaup Gerd; Brody David L; Esparza Thomas; Ingelsson Martin; Kalimo Hannu; Lannfelt Lars; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission (Vienna, Austria : 1996)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The presence of Abeta(pE3) (N-terminal truncated Abeta starting with pyroglutamate) in Alzheimer's disease (AD) has received considerable attention since the discovery that this peptide represents a dominant fraction of Abeta peptides in senile plaques of AD brains.  This was later confirmed by other reports investigating AD and Down's syndrome postmortem brain tissue.  Importantly, Abeta(pE3) has a higher aggregation propensity, and stability, and shows an increased toxicity compared to full-length Abeta.  We have recently shown that intraneuronal accumulation of Abeta(pE3) peptides induces a severe neuron loss and an associated neurological phenotype in the TBA2 mouse model for AD.  Given the increasing interest in Abeta(pE3), we have generated two novel monoclonal antibodies which were characterized as highly specific for Abeta(pE3) peptides and herein used to analyze plaque deposition in APP/PS1KI mice, an AD model with severe neuron loss and learning deficits.  This was compared with the plaque pattern present in brain tissue from sporadic and familial AD cases.  Abundant plaques positive for Abeta(pE3) were present in patients with sporadic AD and familial AD including those carrying mutations in APP (arctic and Swedish) and PS1.  Interestingly, in APP/PS1KI mice we observed a continuous increase in Abeta(pE3) plaque load with increasing age, while the density for Abeta(1-x ) plaques declined with aging.  We therefore assume that, in particular, the peptides starting with position 1 of Abeta are N-truncated as disease progresses, and that, Abeta(pE3) positive plaques are resistant to age-dependent degradation likely due to their high stability and propensity to aggregate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjW5Q4fJpSSJp6t8nS6Nc3fW6udTcc2eZMUFbpD_k5BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fjs12rsA%253D%253D&md5=3ba8522b5584f2ec517d51607c939f4b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00702-009-0314-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-009-0314-x%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DBethge%26aufirst%3DT.%26aulast%3DMarcello%26aufirst%3DA.%26aulast%3DHarmeier%26aufirst%3DA.%26aulast%3DJawhar%26aufirst%3DS.%26aulast%3DLucassen%26aufirst%3DP.%2BJ.%26aulast%3DMulthaup%26aufirst%3DG.%26aulast%3DBrody%26aufirst%3DD.%2BL.%26aulast%3DEsparza%26aufirst%3DT.%26aulast%3DIngelsson%26aufirst%3DM.%26aulast%3DKalimo%26aufirst%3DH.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DPyroglutamate%2520Abeta%2520pathology%2520in%2520APP%252FPS1KI%2520mice%252C%2520sporadic%2520and%2520familial%2520Alzheimer%25E2%2580%2599s%2520disease%2520cases%26jtitle%3DJ.%2520Neural%2520Transm%2520%2528Vienna%2529%26date%3D2010%26volume%3D117%26spage%3D85%26epage%3D96%26doi%3D10.1007%2Fs00702-009-0314-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartig, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span> <span> </span><span class="NLM_article-title">Oligomeric pyroglutamate amyloid-beta is present in microglia and a subfraction of vessels in patients with Alzheimer’s disease: implications for immunotherapy</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">741</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.3233/JAD-121945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-121945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23481684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=741-9&author=O.+Wirthsauthor=A.+Hillmannauthor=L.+Pradierauthor=W.+Hartigauthor=T.+A.+Bayer&title=Oligomeric+pyroglutamate+amyloid-beta+is+present+in+microglia+and+a+subfraction+of+vessels+in+patients+with+Alzheimer%E2%80%99s+disease%3A+implications+for+immunotherapy&doi=10.3233%2FJAD-121945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Oligomeric pyroglutamate amyloid-β is present in microglia and a subfraction of vessels in patients with Alzheimer's disease: implications for immunotherapy</span></div><div class="casAuthors">Wirths Oliver; Hillmann Antje; Pradier Laurent; Hartig Wolfgang; Bayer Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">741-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">N-terminally truncated pyroglutamate amyloid-β (Aβ) starting at position 3 (AβpE3) represents a major fraction of Aβ peptides in Alzheimer's disease (AD).  Recently, we have identified low molecular weight AβpE3 oligomers, which can be detected by 9D5, a novel mouse monoclonal antibody.  In the present study, we analyzed the immunohistochemical staining profile in the brain of patients with AD and in the APP/PS1KI mouse model, as well as in aged rhesus monkeys. 9D5-positive microglia and blood vessels were found in many AD cases, in the transgenic mouse model, and in an aged macaque.  The presence of 9D5-immunoreactivity in microglia indicates that low molecular weight AβpE3 oligomers may be phagocytosed, since in the APP/PS1KI model, Aβ is exclusively produced in neurons due to neuronal expression of transgenic AβPP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSrGT8hETg2JZoeNcnHOQ9fW6udTcc2eYXzU5JsWd2zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svltlWhsg%253D%253D&md5=944c79a17a2570d10b12d39fdf73c264</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.3233%2FJAD-121945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-121945%26sid%3Dliteratum%253Aachs%26aulast%3DWirths%26aufirst%3DO.%26aulast%3DHillmann%26aufirst%3DA.%26aulast%3DPradier%26aufirst%3DL.%26aulast%3DHartig%26aufirst%3DW.%26aulast%3DBayer%26aufirst%3DT.%2BA.%26atitle%3DOligomeric%2520pyroglutamate%2520amyloid-beta%2520is%2520present%2520in%2520microglia%2520and%2520a%2520subfraction%2520of%2520vessels%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520immunotherapy%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D35%26spage%3D741%26epage%3D9%26doi%3D10.3233%2FJAD-121945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bayer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1007/s00401-014-1287-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-014-1287-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24803226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=787-801&author=T.+A.+Bayerauthor=O.+Wirths&title=Focusing+the+amyloid+cascade+hypothesis+on+N-truncated+Abeta+peptides+as+drug+targets+against+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-014-1287-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease</span></div><div class="casAuthors">Bayer, Thomas A.; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">787-801</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Although N-truncated Aβ variants are known to be the main constituent of amyloid plaques in the brains of patients with Alzheimer's disease, their potential as targets for pharmacol. intervention has only recently been investigated.  In the last few years, the Alzheimer field has experienced a paradigm shift with the ever increasing understanding that targeting amyloid plaques has not led to a successful immunotherapy.  On the other hand, there can be no doubt that the amyloid cascade hypothesis is central to the etiol. of Alzheimer's disease, raising the question as to why it is apparently failing to translate into the clinic.  In this review, we aim to refocus the amyloid hypothesis integrating N-truncated Aβ peptides based on mounting evidence that they may represent better targets than full-length Aβ.  In addn. to Aβ peptides starting with an Asp at position 1, a variety of different N-truncated Aβ peptides have been identified starting with amino residue Ala-2, pyroglutamylated Glu-3, Phe-4, Arg-5, His-6, Asp-7, Ser-8, Gly-9, Tyr-10 and pyroglutamylated Glu-11.  Certain forms of N-truncated species are better correlates for early pathol. changes found pre-symptomatically more often than others.  There is also evidence that, together with full-length Aβ, they might be physiol. detectable and are naturally secreted by neurons.  Others are known to form sol. aggregates, which have neurotoxic properties in transgenic mouse models.  It has been clearly demonstrated by several groups that some N-truncated Aβs dominate full-length Aβ in the brains of Alzheimer's patients.  We try to address which of the N-truncated variants may be promising therapeutic targets and which enzymes might be involved in the generation of these peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONpP9jWQ-X7Vg90H21EOLACvtfcHk0lhVybJm1veYnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSrsLs%253D&md5=5374727ba0b50e40ed87a122da1c65bd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2Fs00401-014-1287-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-014-1287-x%26sid%3Dliteratum%253Aachs%26aulast%3DBayer%26aufirst%3DT.%2BA.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DFocusing%2520the%2520amyloid%2520cascade%2520hypothesis%2520on%2520N-truncated%2520Abeta%2520peptides%2520as%2520drug%2520targets%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2014%26volume%3D127%26spage%3D787%26epage%3D801%26doi%3D10.1007%2Fs00401-014-1287-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluhm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piechotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofling, C.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical evidence from APP-transgenic mice for glutaminyl cyclase as drug target to diminish pE-Abeta formation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">924</span>, <span class="refDoi"> DOI: 10.3390/molecules23040924</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3390%2Fmolecules23040924" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=924&author=M.+Hartlage-Rubsamenauthor=A.+Bluhmauthor=A.+Piechottaauthor=M.+Linnertauthor=J.+U.+Rahfeldauthor=H.+U.+Demuthauthor=I.+Luesauthor=P.+H.+Kuhnauthor=S.+F.+Lichtenthalerauthor=S.+Rossnerauthor=C.+Hofling&title=Immunohistochemical+evidence+from+APP-transgenic+mice+for+glutaminyl+cyclase+as+drug+target+to+diminish+pE-Abeta+formation&doi=10.3390%2Fmolecules23040924"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23040924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23040924%26sid%3Dliteratum%253Aachs%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DBluhm%26aufirst%3DA.%26aulast%3DPiechotta%26aufirst%3DA.%26aulast%3DLinnert%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DKuhn%26aufirst%3DP.%2BH.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3DHofling%26aufirst%3DC.%26atitle%3DImmunohistochemical%2520evidence%2520from%2520APP-transgenic%2520mice%2520for%2520glutaminyl%2520cyclase%2520as%2520drug%2520target%2520to%2520diminish%2520pE-Abeta%2520formation%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D924%26doi%3D10.3390%2Fmolecules23040924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funkelstein, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toneff, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hook, V.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate-amyloid-beta and glutaminyl cyclase are colocalized with amyloid-beta in secretory vesicles and undergo activity-dependent, regulated secretion</span>. <i>Neurodegener. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1159/000358430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1159%2F000358430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24943989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVeisbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=85-97&author=H.+Cynisauthor=L.+Funkelsteinauthor=T.+Toneffauthor=C.+Mosierauthor=M.+Zieglerauthor=B.+Kochauthor=H.+U.+Demuthauthor=V.+Hook&title=Pyroglutamate-amyloid-beta+and+glutaminyl+cyclase+are+colocalized+with+amyloid-beta+in+secretory+vesicles+and+undergo+activity-dependent%2C+regulated+secretion&doi=10.1159%2F000358430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate-Amyloid-β and Glutaminyl Cyclase Are Colocalized with Amyloid-β in Secretory Vesicles and Undergo Activity-Dependent, Regulated Secretion</span></div><div class="casAuthors">Cynis, Holger; Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Ziegler, Michael; Koch, Birgit; Demuth, Hans-Ulrich; Hook, Vivian</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-97</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background and Aims: N-truncated pyroglutamate (pGlu)-amyloid-β [Aβ(3-40/42)] peptides are key components that promote Aβ peptide accumulation, leading to neurodegeneration and memory loss in Alzheimer's disease.  Because Aβ deposition in the brain occurs in an activity-dependent manner, it is important to define the subcellular organelle for pGlu-Aβ(3-40/42) prodn. by glutaminyl cyclase (QC) and their colocalization with full-length Aβ(1-40/42) peptides for activity-dependent, regulated secretion.  Therefore, the objective of this study was to investigate the hypothesis that pGlu-Aβ and QC are colocalized with Aβ in dense-core secretory vesicles (DCSV) for activity-dependent secretion with neurotransmitters.  Methods: Purified DCSV were assessed for pGlu-Aβ(3-40/42), Aβ(1-40/42), QC, and neurotransmitter secretion.  Neuron-like chromaffin cells were analyzed for cosecretion of pGlu-Aβ, QC, Aβ, and neuropeptides.  The cells were treated with a QC inhibitor, and pGlu-Aβ prodn. was measured.  Human neuroblastoma cells were also examd. for pGlu-Aβ and QC secretion.  Results: Isolated DCSV contain pGlu-Aβ(3-40/42), QC, and Aβ(1-40/42) with neuropeptide and catecholamine neurotransmitters.  Cellular pGlu-Aβ and QC undergo activity-dependent cosecretion with Aβ and enkephalin and galanin neurotransmitters.  The QC inhibitor decreased the level of secreted pGlu-Aβ.  The human neuroblastoma cells displayed regulated secretion of pGlu-Aβ that was colocalized with QC.  Conclusions: pGlu-Aβ and QC are present with Aβ in DCSV and undergo activity-dependent, regulated cosecretion with neurotransmitters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBgzRae5qNo7Vg90H21EOLACvtfcHk0lifFjXczizgzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVeisbfL&md5=f9e004a29d90cc16d8aac5ca75c981eb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1159%2F000358430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000358430%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DFunkelstein%26aufirst%3DL.%26aulast%3DToneff%26aufirst%3DT.%26aulast%3DMosier%26aufirst%3DC.%26aulast%3DZiegler%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHook%26aufirst%3DV.%26atitle%3DPyroglutamate-amyloid-beta%2520and%2520glutaminyl%2520cyclase%2520are%2520colocalized%2520with%2520amyloid-beta%2520in%2520secretory%2520vesicles%2520and%2520undergo%2520activity-dependent%252C%2520regulated%2520secretion%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D85%26epage%3D97%26doi%3D10.1159%2F000358430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Hrsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H.-U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2008.05471.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1471-4159.2008.05471.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18627432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2008&pages=1225-36&author=S.+Schillingauthor=T.+Applauthor=T.+Hoffmannauthor=H.+Cynisauthor=K.+Schulzauthor=W.+Jaglaauthor=D.+Friedrichauthor=M.+Wermannauthor=M.+Buchholzauthor=U.+Heiserauthor=S.+von+Hrstenauthor=H.-U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+prevents+pGlu-Abeta+formation+after+intracortical%2Fhippocampal+microinjection+in+vivo%2Fin+situ&doi=10.1111%2Fj.1471-4159.2008.05471.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase prevents pGlu-Aβ formation after intracortical/hippocampal microinjection in vivo/in situ</span></div><div class="casAuthors">Schilling, Stephan; Appl, Thomas; Hoffmann, Torsten; Cynis, Holger; Schulz, Katrin; Jagla, Wolfgang; Friedrich, Daniel; Wermann, Michael; Buchholz, Mirko; Heiser, Ulrich; von Hoersten, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1225-1236</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Modified amyloid β (Aβ) peptides represent major constituents of the amyloid deposits in Alzheimer's disease and Down's syndrome.  In particular, N-terminal pyroglutamate (pGlu) following truncation renders Aβ more stable, increases hydrophobicity and the aggregation velocity.  Recent evidence based on in vitro studies suggests that the cyclization of glutamic acid, leading to pGlu-Aβ, is catalyzed by the enzyme glutaminyl cyclase (QC) following limited proteolysis of Aβ at the N-terminus.  Here, we studied the pGlu-formation by rat QC in vitro as well as after microinjection of Aβ(1-40) and Aβ(3-40) into the rat cortex in vivo/in situ with and without pharmacol. QC inhibition.  Significant pGlu-Aβ formation was obsd. following injection of Aβ(3-40) after 24 h, indicating a catalyzed process.  The generation of pGlu-Aβ from Aβ(3-40) was significantly inhibited by intracortical microinjection of a QC inhibitor.  The study provides first evidence that generation of pGlu-Aβ is a QC-catalyzed process in vivo.  The approach per se offers a strategy for a rapid evaluation of compds. targeting a redn. of pGlu formation at the N-terminus of amyloid peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIz9fnOIjlVbVg90H21EOLACvtfcHk0lifFjXczizgzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsFOis7Y%253D&md5=8450718510d281c928abaa1e20a870ad</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05471.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05471.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DAppl%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DK.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3Dvon%2BHrsten%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.-U.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520prevents%2520pGlu-Abeta%2520formation%2520after%2520intracortical%252Fhippocampal%2520microinjection%2520in%2520vivo%252Fin%2520situ%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D106%26spage%3D1225%26epage%3D36%26doi%3D10.1111%2Fj.1471-4159.2008.05471.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGeer, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1007/s00401-010-0685-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-010-0685-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20383514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVKnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=195-207&author=M.+Morawskiauthor=M.+Hartlage-Rubsamenauthor=C.+Jagerauthor=A.+Waniekauthor=S.+Schillingauthor=C.+Schwabauthor=P.+L.+McGeerauthor=T.+Arendtauthor=H.+U.+Demuthauthor=S.+Rossner&title=Distinct+glutaminyl+cyclase+expression+in+Edinger-Westphal+nucleus%2C+locus+coeruleus+and+nucleus+basalis+Meynert+contributes+to+pGlu-Abeta+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-010-0685-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Aβ pathology in Alzheimer's disease</span></div><div class="casAuthors">Morawski, Markus; Hartlage-Ruebsamen, Maike; Jaeger, Carsten; Waniek, Alexander; Schilling, Stephan; Schwab, Claudia; McGeer, Patrick L.; Arendt, Thomas; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-207</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) was discovered recently as the enzyme catalyzing the pyroglutamate (pGlu or pE) modification of N-terminally truncated Alzheimer's disease (AD) Aβ peptides in vivo.  This modification confers resistance to proteolysis, rapid aggregation and neurotoxicity and can be prevented by QC inhibitors in vitro and in vivo, as shown in transgenic animal models.  However, in mouse brain QC is only expressed by a relatively low proportion of neurons in most neocortical and hippocampal subregions.  Here, we demonstrate that QC is highly abundant in subcortical brain nuclei severely affected in AD.  In particular, QC is expressed by virtually all urocortin-1-pos., but not by cholinergic neurons of the Edinger-Westphal nucleus, by noradrenergic locus coeruleus and by cholinergic nucleus basalis magnocellularis neurons in mouse brain.  In human brain, QC is expressed by both, urocortin-1 and cholinergic Edinger-Westphal neurons and by locus coeruleus and nucleus basalis Meynert neurons.  In brains from AD patients, these neuronal populations displayed intraneuronal pE-Aβ immunoreactivity and morphol. signs of degeneration as well as extracellular pE-Aβ deposits.  Adjacent AD brain structures lacking QC expression and brains from control subjects were devoid of such aggregates.  This is the first demonstration of QC expression and pE-Aβ formation in subcortical brain regions affected in AD.  Our results may explain the high vulnerability of defined subcortical neuronal populations and their central target areas in AD as a consequence of QC expression and pE-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0C-HGTvXnbVg90H21EOLACvtfcHk0lifFjXczizgzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVKnsb0%253D&md5=63307c6e13e3b0f367da4f35da4b020f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0685-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0685-y%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DSchwab%26aufirst%3DC.%26aulast%3DMcGeer%26aufirst%3DP.%2BL.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DDistinct%2520glutaminyl%2520cyclase%2520expression%2520in%2520Edinger-Westphal%2520nucleus%252C%2520locus%2520coeruleus%2520and%2520nucleus%2520basalis%2520Meynert%2520contributes%2520to%2520pGlu-Abeta%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D120%26spage%3D195%26epage%3D207%26doi%3D10.1007%2Fs00401-010-0685-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-beta load and cognitive decline in Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.3233/JAD-131535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-131535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24164736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=385-400&author=M.+Morawskiauthor=S.+Schillingauthor=M.+Kreuzbergerauthor=A.+Waniekauthor=C.+Jagerauthor=B.+Kochauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=M.+Hartlage-Rubsamenauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+in+human+cortex%3A+correlation+with+%28pGlu%29-amyloid-beta+load+and+cognitive+decline+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-131535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclase in Human Cortex: Correlation with (pGlu)-Amyloid-β Load and Cognitive Decline in Alzheimer's Disease</span></div><div class="casAuthors">Morawski, Markus; Schilling, Stephan; Kreuzberger, Moritz; Waniek, Alexander; Jaeger, Carsten; Koch, Birgit; Cynis, Holger; Kehlen, Astrid; Arendt, Thomas; Hartlage-Ruebsamen, Maike; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Brains of Alzheimer's disease (AD) patients are characterized in part by the formation of high mol. wt. aggregates of amyloid-β (Aβ) peptides, which interfere with neuronal function and provoke neuronal cell death.  The pyroglutamate (pGlu) modification of Aβ was demonstrated to be catalyzed by the enzyme glutaminyl cyclase (QC) and to enhance pathogenicity and neurotoxicity.  Here, we addressed the role of QC in AD pathogenesis in human cortex.  Two sets of human postmortem brain tissue from a total of 13 non-demented controls and 11 AD cases were analyzed by immunohistochem. and unbiased stereol., quant. RT-PCR, and enzymic activity assays for the expression level of QC in temporal and entorhinal cortex.  Addnl., cortical Aβ and pGlu-Aβ concns. were quantified by ELISA.  Data on QC expression and Aβ peptide concns. were correlated with each other and with the Mini-Mental State Examn. (MMSE) of individual cases.  In control cases, QC expression was higher in the more vulnerable entorhinal cortex than in temporal cortex.  In AD brains, QC mRNA expression and the immunoreactivity of QC were increased in both cortical regions and frequently assocd. with pGlu-Aβ deposits.  The analyses of individual cases revealed significant correlations between QC mRNA levels and the concn. of insol. pGlu-Aβ aggregates, but not of unmodified Aβ peptides.  Elevated pGlu-Aβ load showed a better correlation with the decline in MMSE than elevated concn. of unmodified Aβ.  Our observations provide evidence for an involvement of QC in AD pathogenesis and cognitive decline by QC-catalyzed pGlu-Aβ formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS8tVHNEV2BbVg90H21EOLACvtfcHk0ljMHCka2xk0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKls7k%253D&md5=6500fe542f7ccbc6b61c9a4c862cde6d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3233%2FJAD-131535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131535%26sid%3Dliteratum%253Aachs%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DKreuzberger%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520in%2520human%2520cortex%253A%2520correlation%2520with%2520%2528pGlu%2529-amyloid-beta%2520load%2520and%2520cognitive%2520decline%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D39%26spage%3D385%26epage%3D400%26doi%3D10.3233%2FJAD-131535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieux, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koel-Simmelink, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teunissen, C. E.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase activity correlates with levels of Abeta peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">38</span>, <span class="refDoi"> DOI: 10.1186/s13195-017-0266-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13195-017-0266-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVOmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=38&author=C.+Bridelauthor=T.+Hoffmannauthor=A.+Meyerauthor=S.+Durieuxauthor=M.+A.+Koel-Simmelinkauthor=M.+Orthauthor=P.+Scheltensauthor=I.+Luesauthor=C.+E.+Teunissen&title=Glutaminyl+cyclase+activity+correlates+with+levels+of+Abeta+peptides+and+mediators+of+angiogenesis+in+cerebrospinal+fluid+of+Alzheimer%E2%80%99s+disease+patients&doi=10.1186%2Fs13195-017-0266-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients</span></div><div class="casAuthors">Bridel, Claire; Hoffmann, Torsten; Meyer, Antje; Durieux, Sisi; Koel-Simmelink, Marleen A.; Orth, Matthias; Scheltens, Philip; Lues, Inge; Teunissen, Charlotte E.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38/1-38/10</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Pyroglutamylation of truncated Aβ peptides, which is catalyzed by enzyme glutaminyl cyclase (QC), generates pE-Aβ species with enhanced aggregation propensities and resistance to most amino-peptidases and endo-peptidases.  PE-Aβ species have been identified as major constituents of Aβ plaques and redn. of pE-Aβ species is assocd. with improvement of cognitive tasks in animal models of Alzheimer's disease (AD).  Pharmacol. inhibition of QC has thus emerged as a promising therapeutic approach for AD.  Here, we question whether cerebrospinal fluid (CSF) QC enzymic activity differs between AD patients and controls and whether inflammatory or angiogenesis mediators, some of which are potential QC substrates, and/or Aβ peptides may serve as pharmacodynamic read-outs for QC inhibition.  QC activity, Aβ peptides and inflammatory or angiogenesis mediators were measured in CSF of a clin. well-characterized cohort of 20 mild AD patients, 20 moderate AD patients and 20 subjective memory complaints (SMC) controls.  Correlation of these parameters with core diagnostic CSF AD biomarkers (Aβ42, tau and p-tau) and clin. features was evaluated.  QC activity shows a tendency to decrease with AD progression (p = 0.129).  The addn. of QC activity to biomarkers tau and p-tau significantly increases diagnostic power (ROC-AUCTAU = 0.878, ROC-AUCTAU&QC = 0.939 and ROC-AUCpTAU = 0.820, ROC-AUCpTAU&QC = 0.948).  In AD and controls, QC activity correlates with Aβ38 (r = 0.83, p < 0.0001) and Aβ40 (r = 0.84, p < 0.0001), angiogenesis mediators (Flt1, Tie2, VEGFD, VCAM-1 and ICAM-1, r > 0.5, p < 0.0001) and core diagnostic biomarkers (r > 0.35, p = <0.0057).  QC activity does not correlate with MMSE or ApoE genotype.  Aβ38, Aβ40 and angiogenesis mediators (Flt1, Tie2, VEGFD, VCAM-1 and ICAM-1) are potential pharmacodynamic markers of QC inhibition, because their levels closely correlate with QC activity in AD patients.  The addn. of QC activity to core diagnostic CSF biomarkers may be of specific interest in clin. cases with discordant imaging and biochem. biomarker results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNvF7vzkCkWbVg90H21EOLACvtfcHk0ljMHCka2xk0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVOmsLs%253D&md5=f330a6c4c5bed6b837fa92d269e181e1</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2Fs13195-017-0266-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-017-0266-6%26sid%3Dliteratum%253Aachs%26aulast%3DBridel%26aufirst%3DC.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DDurieux%26aufirst%3DS.%26aulast%3DKoel-Simmelink%26aufirst%3DM.%2BA.%26aulast%3DOrth%26aufirst%3DM.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DTeunissen%26aufirst%3DC.%2BE.%26atitle%3DGlutaminyl%2520cyclase%2520activity%2520correlates%2520with%2520levels%2520of%2520Abeta%2520peptides%2520and%2520mediators%2520of%2520angiogenesis%2520in%2520cerebrospinal%2520fluid%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2017%26volume%3D9%26spage%3D38%26doi%3D10.1186%2Fs13195-017-0266-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Kimpe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Haastert, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoozemans, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheper, W.</span></span> <span> </span><span class="NLM_article-title">Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer’s disease in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e44674</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0044674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0044674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22970285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGksrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=L.+De%0AKimpeauthor=A.+Bennisauthor=R.+Zwartauthor=E.+S.+van+Haastertauthor=J.+J.+Hoozemansauthor=W.+Scheper&title=Disturbed+Ca2%2B+homeostasis+increases+glutaminyl+cyclase+expression%3B+connecting+two+early+pathogenic+events+in+Alzheimer%E2%80%99s+disease+in+vitro&doi=10.1371%2Fjournal.pone.0044674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Disturbed Ca2+ homeostasis increases glutaminyl cyclase expression; connecting two early pathogenic events in Alzheimer's disease in vitro</span></div><div class="casAuthors">De Kimpe, Line; Bennis, Anna; Zwart, Rob; van Haastert, Elise S.; Hoozemans, Jeroen J. M.; Scheper, Wiep</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e44674</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A major neuropathol. hallmark of Alzheimer's disease (AD) is the deposition of aggregated β amyloid (Aβ) peptide in the senile plaques.  Aβ is a peptide of 38-43 amino acids and its accumulation and aggregation plays a key role early in the disease.  A large fraction of β amyloid is N-terminally truncated rendering a glutamine that can subsequently be cyclized into pyroglutamate (pE).  This makes the peptide more resistant to proteases, more prone to aggregation and increases its neurotoxicity.  The enzyme glutaminyl cyclase (QC) catalyzes this conversion of glutamine to pE.  In brains of AD patients, the expression of QC is increased in the earliest stages of pathol., which may be an important event in the pathogenesis.  In this study we aimed to investigate the regulatory mechanism underlying the upregulation of QC expression in AD.  Using differentiated SK-N-SH as a neuronal cell model, we found that neither the presence of Aβ peptides nor the unfolded protein response, two early events in AD, leads to increased QC levels.  In contrast, we demonstrated increased QC mRNA levels and enzyme activity in response to another pathogenic factor in AD, perturbed intracellular Ca2+ homeostasis.  The QC promoter contains a putative binding site for the Ca2+ dependent transcription factors c-fos and c-jun.  C-fos and c-jun are induced by the same Ca2+-related stimuli as QC and their upregulation precedes QC expression.  We show that in the human brain QC is predominantly expressed by neurons.  Interestingly, the Ca2+-dependent regulation of both c-fos and QC is not obsd. in non-neuronal cells.  Our results indicate that perturbed Ca2+ homeostasis results in upregulation of QC selectively in neuronal cells via Ca2+-dependent transcription factors.  This suggests that disruption of Ca2+ homeostasis may contribute to the formation of the neurotoxic pE Aβ peptides in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR5j7sYAbAS7Vg90H21EOLACvtfcHk0ljMHCka2xk0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGksrjI&md5=87f90269d2c55ab7693b19e945b13442</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044674%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BKimpe%26aufirst%3DL.%26aulast%3DBennis%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DR.%26aulast%3Dvan%2BHaastert%26aufirst%3DE.%2BS.%26aulast%3DHoozemans%26aufirst%3DJ.%2BJ.%26aulast%3DScheper%26aufirst%3DW.%26atitle%3DDisturbed%2520Ca2%252B%2520homeostasis%2520increases%2520glutaminyl%2520cyclase%2520expression%253B%2520connecting%2520two%2520early%2520pathogenic%2520events%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0044674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P. Q.</span></span> <span> </span><span class="NLM_article-title">Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1456</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1097/WNR.0b013e328332024a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1097%2FWNR.0b013e328332024a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=19809370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2009&pages=1456-60&author=J.+T.+Yeauthor=R.+B.+Piauthor=X.+X.+Maoauthor=X.+H.+Chenauthor=J.+Qinauthor=S.+W.+Xuauthor=P.+Q.+Liu&title=Alterations+in+mRNA+expression+of+BACE1%2C+cathepsin+B%2C+and+glutaminyl+cyclase+in+mice+ischemic+brain&doi=10.1097%2FWNR.0b013e328332024a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain</span></div><div class="casAuthors">Ye, Jian-tao; Pi, Rong-biao; Mao, Xue-xuan; Chen, Xiao-hong; Qin, Jian; Xu, Suo-wen; Liu, Pei-qing</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1456-1460</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The relationship between cerebral ischemia and Alzheimer's disease has been evaluated extensively.  However, the assocn. between cerebral ischemia and the deposition of β-amyloid (Aβ) remains to be clarified.  Here, we used mice bilateral common carotid artery ligation model to investigate the alterations in mRNA expression of Aβ precursor protein cleavage enzyme 1(BACE1), cathepsin B, and glutaminyl cyclase after transient global cerebral ischemia.  The reverse-transcriptase PCR assay showed that the expressions of these three Aβ-metab.-related genes were upregulated in brain with different manner.  It indicates that all these three Aβ-metab.-related genes may participate in the acute and chronic Aβ generation after transient cerebral ischemia, and will be helpful to understand the mechanisms underlying the linkage of brain ischemia and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQgZre7NsIbVg90H21EOLACvtfcHk0lgjY4CucVe0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymsL7P&md5=be92b2291e5d9ea22d155a5cee9dbe47</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1097%2FWNR.0b013e328332024a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNR.0b013e328332024a%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DJ.%2BT.%26aulast%3DPi%26aufirst%3DR.%2BB.%26aulast%3DMao%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DP.%2BQ.%26atitle%3DAlterations%2520in%2520mRNA%2520expression%2520of%2520BACE1%252C%2520cathepsin%2520B%252C%2520and%2520glutaminyl%2520cyclase%2520in%2520mice%2520ischemic%2520brain%26jtitle%3DNeuroReport%26date%3D2009%26volume%3D20%26spage%3D1456%26epage%3D60%26doi%3D10.1097%2FWNR.0b013e328332024a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanatta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innamorati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pampanin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanusso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbonare, L. D.</span></span> <span> </span><span class="NLM_article-title">Increased glutaminyl cyclase expression in peripheral blood of Alzheimer’s disease patients</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.3233/JAD-120517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-120517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23207485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=263-71&author=M.+T.+Valentiauthor=S.+Bologninauthor=C.+Zanattaauthor=L.+Donatelliauthor=G.+Innamoratiauthor=M.+Pampaninauthor=G.+Zanussoauthor=P.+Zattaauthor=L.+D.+Carbonare&title=Increased+glutaminyl+cyclase+expression+in+peripheral+blood+of+Alzheimer%E2%80%99s+disease+patients&doi=10.3233%2FJAD-120517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Glutaminyl Cyclase Expression in Peripheral Blood of Alzheimer's Disease Patients</span></div><div class="casAuthors">Valenti, Maria Teresa; Bolognin, Silvia; Zanatta, Cristina; Donatelli, Luca; Innamorati, Giulio; Pampanin, Maria; Zanusso, Gianluigi; Zatta, Paolo; Dalle Carbonare, Luca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-271</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">N-truncated and N-modified forms of amyloid-β (Aβ) peptide are found in diffused and dense core plaques in Alzheimer's disease (AD) brain.  Among them, the most abundant N-truncated peptide starts with pyroglutamyl at residue 3 (AβpE3).  AβpE3 has increased aggregation potential and toxicity and its abundance has been reported to correlate with the severity of the clin. phenotype in AD patients.  N-terminal glutamate conversion generating AβpE3 is catalyzed by glutaminyl cyclase.  This enzyme was found to be upregulated in the cortex of patients with AD.  In the present study, we investigated glutaminyl cyclase mRNA and protein expression in peripheral blood from AD patients and age-matched controls.  Higher levels of glutaminyl cyclase mRNA and protein were present in AD patients compared with controls.  Interestingly, we obsd. a correlation between glutaminyl cyclase expression and the severity of dementia (value of Mini-Mental State Examn.).  Therefore, we propose glutaminyl cyclase dosage in peripheral blood as a potential biomarker of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4A4V35WXLrVg90H21EOLACvtfcHk0lgjY4CucVe0EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wlu7c%253D&md5=3dbaabc4cc2a16e1b3589040578591c1</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3233%2FJAD-120517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-120517%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DM.%2BT.%26aulast%3DBolognin%26aufirst%3DS.%26aulast%3DZanatta%26aufirst%3DC.%26aulast%3DDonatelli%26aufirst%3DL.%26aulast%3DInnamorati%26aufirst%3DG.%26aulast%3DPampanin%26aufirst%3DM.%26aulast%3DZanusso%26aufirst%3DG.%26aulast%3DZatta%26aufirst%3DP.%26aulast%3DCarbonare%26aufirst%3DL.%2BD.%26atitle%3DIncreased%2520glutaminyl%2520cyclase%2520expression%2520in%2520peripheral%2520blood%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D263%26epage%3D71%26doi%3D10.3233%2FJAD-120517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gontsarova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dressel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmuller, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunert-Keil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinkmeier, H.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>389</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2007.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.cca.2007.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18187042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=152-9&author=A.+Gontsarovaauthor=E.+Kaufmannauthor=H.+Tumaniauthor=A.+Dresselauthor=F.+Mandelauthor=K.+H.+Wiesmullerauthor=C.+Kunert-Keilauthor=H.+Brinkmeier&title=Glutaminyl+cyclase+activity+is+a+characteristic+feature+of+human+cerebrospinal+fluid&doi=10.1016%2Fj.cca.2007.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid</span></div><div class="casAuthors">Gontsarova, Anastassia; Kaufmann, Eckhard; Tumani, Hayrettin; Dressel, Alexander; Mandel, Friedrich; Wiesmueller, Karl-Heinz; Kunert-Keil, Christiane; Brinkmeier, Heinrich</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">389</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">152-159</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Proteins and peptides occurring in human body fluids can be useful biol. markers for neurol. diseases and can even contribute to the pathogenesis of such diseases.  However, proteins and peptides are potential substrates of proteases and other enzymes.  Proteolysis and enzymic modification may lead to their degrdn. and modification.  Using mass spectrometry we investigated the degrdn. and modification of indicator peptides in the presence of cerebrospinal fluid (CSF).  We further applied a fluorometric assay to study the activity of the presumed enzyme glutaminyl cyclase.  In CSF we obsd. an aminopeptidase activity that could partially be inhibited by protease inhibitors and EDTA.  In addn., the formation of pyroglutamate (pGlu) from N-terminal glutamine (Gln) was regularly obsd.  The reaction to pGlu was rapid and protected the indicator peptides from further N-terminal degrdn.  The conversion of Gln to pGlu could be attributed to the activity of the enzyme glutaminyl cyclase (QC).  The QC activity was a characteristic feature of all 45 CSF samples collected from multiple sclerosis patients and controls.  Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.  The presence of QC in CSF can stabilize peptides from degrdn. by aminopeptidases.  This may have impact for neurol. disorders that are characterized by both, the presence of QC and the occurrence of appropriate peptide substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4sKaCoJ94bbVg90H21EOLACvtfcHk0lg1JgZidGoynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVyju74%253D&md5=c42851f4ac40788e0ef63d724a8f89b4</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2007.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2007.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DGontsarova%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DE.%26aulast%3DTumani%26aufirst%3DH.%26aulast%3DDressel%26aufirst%3DA.%26aulast%3DMandel%26aufirst%3DF.%26aulast%3DWiesmuller%26aufirst%3DK.%2BH.%26aulast%3DKunert-Keil%26aufirst%3DC.%26aulast%3DBrinkmeier%26aufirst%3DH.%26atitle%3DGlutaminyl%2520cyclase%2520activity%2520is%2520a%2520characteristic%2520feature%2520of%2520human%2520cerebrospinal%2520fluid%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D389%26spage%3D152%26epage%3D9%26doi%3D10.1016%2Fj.cca.2007.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agopyan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutekunst, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LePiane, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singaraja, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCutcheon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosemond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">A YAC mouse model for Huntington’s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80764-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0896-6273%2800%2980764-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10402204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVSjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=181-92&author=J.+G.+Hodgsonauthor=N.+Agopyanauthor=C.+A.+Gutekunstauthor=B.+R.+Leavittauthor=F.+LePianeauthor=R.+Singarajaauthor=D.+J.+Smithauthor=N.+Bissadaauthor=K.+McCutcheonauthor=J.+Nasirauthor=L.+Jamotauthor=X.+J.+Liauthor=M.+E.+Stevensauthor=E.+Rosemondauthor=J.+C.+Roderauthor=A.+G.+Phillipsauthor=E.+M.+Rubinauthor=S.+M.+Herschauthor=M.+R.+Hayden&title=A+YAC+mouse+model+for+Huntington%E2%80%99s+disease+with+full-length+mutant+huntingtin%2C+cytoplasmic+toxicity%2C+and+selective+striatal+neurodegeneration&doi=10.1016%2FS0896-6273%2800%2980764-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A YAC mouse model for Huntington's disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration</span></div><div class="casAuthors">Hodgson, J. Graeme; Agopyan, Nadia; Gutekunst, Claire-Anne; Leavitt, Blair R.; LePiane, Fred; Singaraja, Roshni; Smith, Desmond J.; Bissada, Nagat; McCutcheon, Krista; Nasir, Jamal; Jamot, Laure; Li, Xiao-Jiang; Stevens, Mary E.; Rosemond, Erica; Roder, John C.; Phillips, Anthony G.; Rubin, Edward M.; Hersch, Steven M.; Hayden, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have produced yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant (YAC46 and YAC72) huntingtin (htt) in a developmental and tissue-specific manner identical to that obsd. in Huntington's disease (HD).  YAC46 and YAC72 mice show early electrophysiol. abnormalities, indicating cytoplasmic dysfunction prior to obsd. nuclear inclusions or neurodegeneration.  By 12 mo of age, YAC72 mice have a selective degeneration of medium spiny neurons in the lateral striatum assocd. with the translocation of N-terminal htt fragments to the nucleus.  Neurodegeneration can be present in the absence of macro- or microaggregates, clearly showing that aggregates are not essential to initiation of neuronal death.  These mice demonstrate that initial neuronal cytoplasmic toxicity is followed by cleavage of htt, nuclear translocation of htt N-terminal fragments, and selective neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp622XRIsJp3LVg90H21EOLACvtfcHk0lg1JgZidGoynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVSjurw%253D&md5=b46803cd9543251d6581473599d9097b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980764-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980764-3%26sid%3Dliteratum%253Aachs%26aulast%3DHodgson%26aufirst%3DJ.%2BG.%26aulast%3DAgopyan%26aufirst%3DN.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DLePiane%26aufirst%3DF.%26aulast%3DSingaraja%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DD.%2BJ.%26aulast%3DBissada%26aufirst%3DN.%26aulast%3DMcCutcheon%26aufirst%3DK.%26aulast%3DNasir%26aufirst%3DJ.%26aulast%3DJamot%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%2BJ.%26aulast%3DStevens%26aufirst%3DM.%2BE.%26aulast%3DRosemond%26aufirst%3DE.%26aulast%3DRoder%26aufirst%3DJ.%2BC.%26aulast%3DPhillips%26aufirst%3DA.%2BG.%26aulast%3DRubin%26aufirst%3DE.%2BM.%26aulast%3DHersch%26aufirst%3DS.%2BM.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DA%2520YAC%2520mouse%2520model%2520for%2520Huntington%25E2%2580%2599s%2520disease%2520with%2520full-length%2520mutant%2520huntingtin%252C%2520cytoplasmic%2520toxicity%252C%2520and%2520selective%2520striatal%2520neurodegeneration%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D181%26epage%3D92%26doi%3D10.1016%2FS0896-6273%2800%2980764-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuccato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, E.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms and potential therapeutical targets in Huntington’s disease</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1152/physrev.00041.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1152%2Fphysrev.00041.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=20664076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVyku7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=905-81&author=C.+Zuccatoauthor=M.+Valenzaauthor=E.+Cattaneo&title=Molecular+mechanisms+and+potential+therapeutical+targets+in+Huntington%E2%80%99s+disease&doi=10.1152%2Fphysrev.00041.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms and potential therapeutical targets in Huntington's disease</span></div><div class="casAuthors">Zuccato, Chiara; Valenza, Marta; Cattaneo, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">905-981</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat expansion in the gene encoding for huntingtin protein.  A lot has been learned about this disease since its first description in 1872 and the identification of its causative gene and mutation in 1993.  We now know that the disease is characterized by several mol. and cellular abnormalities whose precise timing and relative roles in pathogenesis have yet to be understood.  HD is triggered by the mutant protein, and both gain-of-function (of the mutant protein) and loss-of-function (of the normal protein) mechanisms are involved.  Here we review the data that describe the emergence of the ancient huntingtin gene and of the polyglutamine trait during the last 800 million years of evolution.  We focus on the known functions of wild-type huntingtin that are fundamental for the survival and functioning of the brain neurons that predominantly degenerate in HD.  We summarize data indicating how the loss of these beneficial activities reduces the ability of these neurons to survive.  We also review the different mechanisms by which the mutation in huntingtin causes toxicity.  This may arise both from cell-autonomous processes and dysfunction of neuronal circuitries.  We then focus on novel therapeutical targets and pathways and on the attractive option to counteract HD at its primary source, i.e., by blocking the prodn. of the mutant protein.  Strategies and technologies used to screen for candidate HD biomarkers and their potential application are presented.  Furthermore, we discuss the opportunities offered by intracerebral cell transplantation and the likely need for these multiple routes into therapies to converge at some point as, ideally, one would wish to stop the disease process and, at the same time, possibly replace the damaged neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIVf2Q0bRrHrVg90H21EOLACvtfcHk0ljgR8hXtU-Rsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVyku7rN&md5=91ce71cab5ce8c79a4877629e9441e4a</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00041.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00041.2009%26sid%3Dliteratum%253Aachs%26aulast%3DZuccato%26aufirst%3DC.%26aulast%3DValenza%26aufirst%3DM.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DMolecular%2520mechanisms%2520and%2520potential%2520therapeutical%2520targets%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D905%26epage%3D81%26doi%3D10.1152%2Fphysrev.00041.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnichsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imarisio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarditi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzies, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ed Dami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Couto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeroni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamanti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satagopam, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caramelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardone, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caradonna, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcari, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Kane, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caricasole, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinsztein, D. C.</span></span> <span> </span><span class="NLM_article-title">siRNA screen identifies QPCT as a druggable target for Huntington’s disease</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnchembio.1790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25848931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=347-354&author=M.+Jimenez-Sanchezauthor=W.+Lamauthor=M.+Hannusauthor=B.+Sonnichsenauthor=S.+Imarisioauthor=A.+Flemingauthor=A.+Tarditiauthor=F.+Menziesauthor=T.+Ed+Damiauthor=C.+Xuauthor=E.+Gonzalez-Coutoauthor=G.+Lazzeroniauthor=F.+Heitzauthor=D.+Diamantiauthor=L.+Massaiauthor=V.+P.+Satagopamauthor=G.+Marconiauthor=C.+Caramelliauthor=A.+Nenciniauthor=M.+Andreiniauthor=G.+L.+Sardoneauthor=N.+P.+Caradonnaauthor=V.+Porcariauthor=C.+Scaliauthor=R.+Schneiderauthor=G.+Pollioauthor=C.+J.+O%E2%80%99Kaneauthor=A.+Caricasoleauthor=D.+C.+Rubinsztein&title=siRNA+screen+identifies+QPCT+as+a+druggable+target+for+Huntington%E2%80%99s+disease&doi=10.1038%2Fnchembio.1790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">siRNA screen identifies QPCT as a druggable target for Huntington's disease</span></div><div class="casAuthors">Jimenez-Sanchez, Maria; Lam, Wun; Hannus, Michael; Sonnichsen, Birte; Imarisio, Sara; Fleming, Angeleen; Tarditi, Alessia; Menzies, Fiona; Ed Dami, Teresa; Xu, Catherine; Gonzalez-Couto, Eduardo; Lazzeroni, Giulia; Heitz, Freddy; Diamanti, Daniela; Massai, Luisa; Satagopam, Venkata P.; Marconi, Guido; Caramelli, Chiara; Nencini, Arianna; Andreini, Matteo; Sardone, Gian Luca; Caradonna, Nicola P.; Porcari, Valentina; Scali, Carla; Schneider, Reinhard; Pollio, Giuseppe; O'Kane, Cahir J.; Caricasole, Andrea; Rubinsztein, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-354</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a currently incurable neurodegenerative condition caused by an abnormally expanded polyglutamine tract in huntingtin (HTT).  We identified new modifiers of mutant HTT toxicity by performing a large-scale 'druggable genome' siRNA screen in human cultured cells, followed by hit validation in Drosophila.  We focused on glutaminyl cyclase (QPCT), which had one of the strongest effects on mutant HTT-induced toxicity and aggregation in the cell-based siRNA screen and also rescued these phenotypes in Drosophila.  We found that QPCT inhibition induced the levels of the mol. chaperone αB-crystallin and reduced the aggregation of diverse proteins.  We generated new QPCT inhibitors using in silico methods followed by in vitro screening, which rescued the HD-related phenotypes in cell, Drosophila and zebrafish HD models.  Our data reveal a new HD druggable target affecting mutant HTT aggregation and provide proof of principle for a discovery pipeline from druggable genome screen to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz5Pncahjf0LVg90H21EOLACvtfcHk0ljgR8hXtU-Rsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFWqs7Y%253D&md5=1566a7af4210e871931ed7bbae6ba42a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1790%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Sanchez%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DW.%26aulast%3DHannus%26aufirst%3DM.%26aulast%3DSonnichsen%26aufirst%3DB.%26aulast%3DImarisio%26aufirst%3DS.%26aulast%3DFleming%26aufirst%3DA.%26aulast%3DTarditi%26aufirst%3DA.%26aulast%3DMenzies%26aufirst%3DF.%26aulast%3DEd%2BDami%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DGonzalez-Couto%26aufirst%3DE.%26aulast%3DLazzeroni%26aufirst%3DG.%26aulast%3DHeitz%26aufirst%3DF.%26aulast%3DDiamanti%26aufirst%3DD.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DSatagopam%26aufirst%3DV.%2BP.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DCaramelli%26aufirst%3DC.%26aulast%3DNencini%26aufirst%3DA.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DSardone%26aufirst%3DG.%2BL.%26aulast%3DCaradonna%26aufirst%3DN.%2BP.%26aulast%3DPorcari%26aufirst%3DV.%26aulast%3DScali%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DPollio%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Kane%26aufirst%3DC.%2BJ.%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DRubinsztein%26aufirst%3DD.%2BC.%26atitle%3DsiRNA%2520screen%2520identifies%2520QPCT%2520as%2520a%2520druggable%2520target%2520for%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D347%26epage%3D354%26doi%3D10.1038%2Fnchembio.1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houlden, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span> <span> </span><span class="NLM_article-title">Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0002-9440(10)63993-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2FS0002-9440%2810%2963993-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=11159188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsFWmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=515-26&author=J.+L.+Holtonauthor=J.+Ghisoauthor=T.+Lashleyauthor=A.+Rostagnoauthor=C.+J.+Guerinauthor=G.+Gibbauthor=H.+Houldenauthor=H.+Aylingauthor=L.+Martinianauthor=B.+H.+Andertonauthor=N.+W.+Woodauthor=R.+Vidalauthor=G.+Plantauthor=B.+Frangioneauthor=T.+Revesz&title=Regional+distribution+of+amyloid-Bri+deposition+and+its+association+with+neurofibrillary+degeneration+in+familial+British+dementia&doi=10.1016%2FS0002-9440%2810%2963993-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia</span></div><div class="casAuthors">Holton, Janice L.; Ghiso, Jorge; Lashley, Tammaryn; Rostagno, Agueda; Guerin, Christopher J.; Gibb, Graham; Houlden, Henry; Ayling, Hilary; Martinian, Lillian; Anderton, Brian H.; Wood, Nicholas W.; Vidal, Ruben; Plant, Gordon; Frangione, Blas; Revesz, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">515-526</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Familial British dementia (FBD), pathol. characterized by cerebral amyloid angiopathy (CAA), amyloid plaques, and neurofibrillary degeneration, is assocd. with a stop codon mutation in the BRI gene resulting in the prodn. of an amyloidogenic fragment, amyloid-Bri (ABri).  The aim of this study was to assess the distribution of ABri fibrillar and nonfibrillar lesions and their relation to neurofibrillary pathol., astroglial and microglial response using immunohistochem., confocal microscopy, and immunoelectron microscopy in five cases of FBD.  Abnormal tau was studied with immunoblotting.  The authors present evidence that ABri is deposited throughout the central nervous system in blood vessels and parenchyma where both amyloid (fibrillar) and preamyloid (nonfibrillar) lesions are formed.  Ultrastructurally amyloid lesions appear as bundles of fibrils recognized by an antibody raised against ABri, whereas Thioflavin S-neg. diffuse deposits consist of amorphous electron-dense material with sparse, dispersed fibrils.  In contrast to nonfibrillar lesions, fibrillar ABri is assocd. with a marked astrocytic and microglial response.  Neurofibrillary tangles and neuropil threads occurring mainly in limbic structures, are found in areas affected by all types of ABri lesions whereas abnormal neurites are present around amyloid lesions.  Immunoblotting for tau revealed a triplet electrophoretic migration pattern.  The authors' observations confirm a close link between Abri deposition and neurodegeneration in FBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3Uc6ChjDtFbVg90H21EOLACvtfcHk0ljXHM3WcP6cVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsFWmt7o%253D&md5=5fc204aace9a06bcd00a36c7d86a997f</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963993-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963993-4%26sid%3Dliteratum%253Aachs%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGuerin%26aufirst%3DC.%2BJ.%26aulast%3DGibb%26aufirst%3DG.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DAyling%26aufirst%3DH.%26aulast%3DMartinian%26aufirst%3DL.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DVidal%26aufirst%3DR.%26aulast%3DPlant%26aufirst%3DG.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DRegional%2520distribution%2520of%2520amyloid-Bri%2520deposition%2520and%2520its%2520association%2520with%2520neurofibrillary%2520degeneration%2520in%2520familial%2520British%2520dementia%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2001%26volume%3D158%26spage%3D515%26epage%3D26%26doi%3D10.1016%2FS0002-9440%2810%2963993-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coomaraswamy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirths, O.</span></span> <span> </span><span class="NLM_article-title">Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1416</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2012.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23261769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWhtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1416-25&author=A.+Saulauthor=T.+Lashleyauthor=T.+Reveszauthor=J.+Holtonauthor=J.+A.+Ghisoauthor=J.+Coomaraswamyauthor=O.+Wirths&title=Abundant+pyroglutamate-modified+ABri+and+ADan+peptides+in+extracellular+and+vascular+amyloid+deposits+in+familial+British+and+Danish+dementias&doi=10.1016%2Fj.neurobiolaging.2012.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias</span></div><div class="casAuthors">Saul, Anika; Lashley, Tammaryn; Revesz, Tamas; Holton, Janice; Ghiso, Jorge A.; Coomaraswamy, Janaky; Wirths, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1416-1425</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Familial British and familial Danish dementia (FDD) are progressive neurodegenerative disorders characterized by cerebral deposition of the amyloidogenic peptides ABri and ADan, resp.  These amyloid peptides start with an N-terminal glutamate residue, which can be posttranslationally converted into a pyroglutamate (pGlu) modified form, a mechanism which has been extensively described to be relevant for amyloid-beta (Aβ) peptides in Alzheimer's disease.  Like pGlu-Aβ peptides, pGlu-ABri peptides have an increased aggregation propensity and show higher toxicity on human neuroblastoma cells as their nonmodified counterparts.  We have generated novel N-terminal specific antibodies detecting the pGlu-modified forms of ABri and ADan peptides.  With these antibodies we were able to identify abundant extracellular amyloid plaques, vascular, and parenchymal deposits in human familial British dementia and FDD brain tissue, and in a mouse model for FDD.  Double-stainings using C-terminal specific antibodies in human samples revealed that highly aggregated pGlu-ABri and pGlu-ADan peptides are mainly present in plaque cores and central vascular deposits, leading to the assumption that these peptides have seeding properties.  Furthermore, in an FDD-mouse model ADan peptides were detected in presynaptic terminals of the hippocampus where they might contribute to impaired synaptic transmission.  These similarities of ABri and ADan to Aβ in Alzheimer's disease suggest that the posttranslational pGlu-modification of amyloid peptides might represent a general pathol. mechanism leading to increased aggregation and toxicity in these forms of degenerative dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowwpcn4AtF5LVg90H21EOLACvtfcHk0ljXHM3WcP6cVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWhtL3F&md5=85dbf0acfc50170d4af3f1918aeef051</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DSaul%26aufirst%3DA.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DHolton%26aufirst%3DJ.%26aulast%3DGhiso%26aufirst%3DJ.%2BA.%26aulast%3DCoomaraswamy%26aufirst%3DJ.%26aulast%3DWirths%26aufirst%3DO.%26atitle%3DAbundant%2520pyroglutamate-modified%2520ABri%2520and%2520ADan%2520peptides%2520in%2520extracellular%2520and%2520vascular%2520amyloid%2520deposits%2520in%2520familial%2520British%2520and%2520Danish%2520dementias%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1416%26epage%3D25%26doi%3D10.1016%2Fj.neurobiolaging.2012.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tomidokoro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lashley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamate formation at the N-termini of Abri molecules in Familial British Dementia is not restricted to the central nervous system</span>. <i>Hirosaki Igaku</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">S262</span>– <span class="NLM_lpage">S269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21037969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2nt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2010&pages=S262-S269&author=Y.+Tomidokoroauthor=A.+Tamaokaauthor=J.+L.+Holtonauthor=T.+Lashleyauthor=B.+Frangioneauthor=T.+Reveszauthor=A.+Rostagnoauthor=J.+Ghiso&title=Pyroglutamate+formation+at+the+N-termini+of+Abri+molecules+in+Familial+British+Dementia+is+not+restricted+to+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamate formation at the N-termini of Abri molecules in familial British dementia is not restricted to the central nervous system</span></div><div class="casAuthors">Tomidokoro, Yasushi; Tamaoka, Akira; Holton, Janice L.; Lashley, Tammaryn; Frangione, Blas; Revesz, Tamas; Rostagno, Agueda; Ghiso, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Hirosaki Igaku</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Supplement</span>),
    <span class="NLM_cas:pages">S262-S269</span>CODEN:
                <span class="NLM_cas:coden">HIRIA6</span>;
        ISSN:<span class="NLM_cas:issn">0439-1721</span>.
    
            (<span class="NLM_cas:orgname">Hirosaki Daigaku Shuppankai</span>)
        </div><div class="casAbstract">Amyloid mols. harboring pyroglutamate (pGlu) residue at the N-termini are considered to be important for the development of cerebral amyloidosis such as Alzheimer's disease and thought to be either spontaneously generated or being catalyzed by glutaminyl cyclase.  Familial British dementia (FBD) is an autosomal dominant form of dementia neuropathol. characterized by parenchymal amyloid and preamyloid deposits, extensive cerebral amyloid angiopathy, and neurofibrillary tangles.  FBD is caused by a stop to Arg mutation in the BRI2 gene, generating de novo created amyloid mol. ABri which accumulates in FBD brains but is not present in the normal population.  Sol. ABri mols. present in the circulation of carriers of the BRI2 mutation are 34 amino acids long exclusively harboring Glu residue at the N-termini (ABri1-34E), whereas water- and formic acid-sol. ABri mols. extd. from FBD brains have abundant ABri species bearing pGlu residue (ABri1-34pE), suggesting that pyroglutamate formation occurs at the site of deposition.  In order to further clarify the mechanism (s) of ABri deposition, we studied whether pyroglutamate formation indeed occurs outside the central nervous system taking advantage that FBD is also a systemic amyloidosis.  Sol. and fibrillar ABri mols. extd. from systemic organs and analyzed biochem. using a combination of immunopptn., mass spectrometry, and western blot anal. were oligomeric in size and contained a large proportion of ABri1-34pE.  The data indicate that pyroglutamate formation at the N-termini of ABri mols. is an early step in the process of FBD amyloid deposition, and its formation is not restricted to the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovfx0TSR1d0bVg90H21EOLACvtfcHk0ljXHM3WcP6cVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2nt7jI&md5=fd8742ef59fc8c6fb3f2bb8ac2857dd4</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomidokoro%26aufirst%3DY.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DLashley%26aufirst%3DT.%26aulast%3DFrangione%26aufirst%3DB.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26atitle%3DPyroglutamate%2520formation%2520at%2520the%2520N-termini%2520of%2520Abri%2520molecules%2520in%2520Familial%2520British%2520Dementia%2520is%2520not%2520restricted%2520to%2520the%2520central%2520nervous%2520system%26jtitle%3DHirosaki%2520Igaku%26date%3D2010%26volume%3D61%26spage%3DS262%26epage%3DS269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holton, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojsen-Moller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braendgaard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plant, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frangione, B.</span></span> <span> </span><span class="NLM_article-title">A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">4920</span>– <span class="NLM_lpage">4925</span>, <span class="refDoi"> DOI: 10.1073/pnas.080076097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1073%2Fpnas.080076097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10781099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFKisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4920-4925&author=R.+Vidalauthor=T.+Reveszauthor=A.+Rostagnoauthor=E.+Kimauthor=J.+L.+Holtonauthor=T.+Bekauthor=M.+Bojsen-Mollerauthor=H.+Braendgaardauthor=G.+Plantauthor=J.+Ghisoauthor=B.+Frangione&title=A+decamer+duplication+in+the+3%E2%80%B2+region+of+the+BRI+gene+originates+an+amyloid+peptide+that+is+associated+with+dementia+in+a+Danish+kindred&doi=10.1073%2Fpnas.080076097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred</span></div><div class="casAuthors">Vidal, Ruben; Revesz, Tamas; Rostagno, Agueda; Kim, Eugene; Holton, Janice L.; Bek, Toke; Bojsen-Moller, Marie; Braendgaard, Hans; Plant, Gordon; Ghiso, Jorge; Frangione, Blas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4920-4925</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Familial Danish dementia (FDD), also known as heredopathia ophthalmo-oto-encephalica, is an autosomal dominant disorder characterized by cataracts, deafness, progressive ataxia, and dementia.  Neuropathol. findings include severe widespread cerebral amyloid angiopathy, hippocampal plaques, and neurofibrillary tangles, similar to Alzheimer's disease.  N-terminal sequence anal. of isolated leptomeningeal amyloid fibrils revealed homol. to ABri, the peptide originated by a point mutation at the stop codon of gene BRI in familial British dementia.  Mol. genetic anal. of the BRI gene in the Danish kindred showed a different defect, namely the presence of a 10-nt duplication (795-796insTTTAATTTGT) between codons 265 and 266, one codon before the normal stop codon 267.  The decamer duplication mutation produces a frame-shift in the BRI sequence generating a larger-than-normal precursor protein, of which the amyloid subunit (designated ADan) comprises the last 34 C-terminal amino acids.  This de novo-created amyloidogenic peptide, assocd. with a genetic defect in the Danish kindred, stresses the importance of amyloid formation as a causative factor in neurodegeneration and dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9RGX9PDH5LVg90H21EOLACvtfcHk0lhQyQ2TkxkIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFKisr8%253D&md5=864d3b966321d563365d2b57b1c2c955</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1073%2Fpnas.080076097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.080076097%26sid%3Dliteratum%253Aachs%26aulast%3DVidal%26aufirst%3DR.%26aulast%3DRevesz%26aufirst%3DT.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DBek%26aufirst%3DT.%26aulast%3DBojsen-Moller%26aufirst%3DM.%26aulast%3DBraendgaard%26aufirst%3DH.%26aulast%3DPlant%26aufirst%3DG.%26aulast%3DGhiso%26aufirst%3DJ.%26aulast%3DFrangione%26aufirst%3DB.%26atitle%3DA%2520decamer%2520duplication%2520in%2520the%25203%25E2%2580%25B2%2520region%2520of%2520the%2520BRI%2520gene%2520originates%2520an%2520amyloid%2520peptide%2520that%2520is%2520associated%2520with%2520dementia%2520in%2520a%2520Danish%2520kindred%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D4920%26epage%3D4925%26doi%3D10.1073%2Fpnas.080076097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahfeld, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quax, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trautwein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollert, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1002/emmm.201100158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Femmm.201100158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21774078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=545-58&author=H.+Cynisauthor=T.+Hoffmannauthor=D.+Friedrichauthor=A.+Kehlenauthor=K.+Gansauthor=M.+Kleinschmidtauthor=J.+U.+Rahfeldauthor=R.+Wolfauthor=M.+Wermannauthor=A.+Stephanauthor=M.+Haegeleauthor=R.+Sedlmeierauthor=S.+Graubnerauthor=W.+Jaglaauthor=A.+Mullerauthor=R.+Eichentopfauthor=U.+Heiserauthor=F.+Seifertauthor=P.+H.+Quaxauthor=M.+R.+de+Vriesauthor=I.+Hesseauthor=D.+Trautweinauthor=U.+Wollertauthor=S.+Bergauthor=E.+J.+Freyseauthor=S.+Schillingauthor=H.+U.+Demuth&title=The+isoenzyme+of+glutaminyl+cyclase+is+an+important+regulator+of+monocyte+infiltration+under+inflammatory+conditions&doi=10.1002%2Femmm.201100158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions</span></div><div class="casAuthors">Cynis, Holger; Hoffmann, Torsten; Friedrich, Daniel; Kehlen, Astrid; Gans, Kathrin; Kleinschmidt, Martin; Rahfeld, Jens-Ulrich; Wolf, Raik; Wermann, Michael; Stephan, Anett; Haegele, Monique; Sedlmeier, Reinhard; Graubner, Sigrid; Jagla, Wolfgang; Mueller, Anke; Eichentopf, Rico; Heiser, Ulrich; Seifert, Franziska; Quax, Paul H. A.; de Vries, Margreet R.; Hesse, Isabel; Trautwein, Daniela; Wollert, Ulrich; Berg, Sabine; Freyse, Ernst-Joachim; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">545-558</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Acute and chronic inflammatory disorders are characterized by detrimental cytokine and chemokine expression.  Frequently, the chemotactic activity of cytokines depends on a modified N-terminus of the polypeptide.  Among those, the N-terminus of monocyte chemoattractant protein 1 (CCL2 and MCP-1) is modified to a pyroglutamate (pE-) residue protecting against degrdn. in vivo.  Here, we show that the N-terminal pE-formation depends on glutaminyl cyclase activity.  The pE-residue increases stability against N-terminal degrdn. by aminopeptidases and improves receptor activation and signal transduction in vitro.  Genetic ablation of the glutaminyl cyclase iso-enzymes QC (QPCT) or isoQC (QPCTL) revealed a major role of isoQC for pE1-CCL2 formation and monocyte infiltration.  Consistently, administration of QC-inhibitors in inflammatory models, such as thioglycollate-induced peritonitis reduced monocyte infiltration.  The pharmacol. efficacy of QC/isoQC-inhibition was assessed in accelerated atherosclerosis in ApoE3*Leiden mice, showing attenuated atherosclerotic pathol. following chronic oral treatment.  Current strategies targeting CCL2 are mainly based on antibodies or spiegelmers.  The application of small, orally available inhibitors of glutaminyl cyclases represents an alternative therapeutic strategy to treat CCL2-driven disorders such as atherosclerosis/restenosis and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-5dgkTUSzbVg90H21EOLACvtfcHk0lhQyQ2TkxkIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7nM&md5=84ba6e9618d7ad05e2f79d0c29354693</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100158%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DFriedrich%26aufirst%3DD.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DGans%26aufirst%3DK.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DRahfeld%26aufirst%3DJ.%2BU.%26aulast%3DWolf%26aufirst%3DR.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DMuller%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DQuax%26aufirst%3DP.%2BH.%26aulast%3Dde%2BVries%26aufirst%3DM.%2BR.%26aulast%3DHesse%26aufirst%3DI.%26aulast%3DTrautwein%26aufirst%3DD.%26aulast%3DWollert%26aufirst%3DU.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520isoenzyme%2520of%2520glutaminyl%2520cyclase%2520is%2520an%2520important%2520regulator%2520of%2520monocyte%2520infiltration%2520under%2520inflammatory%2520conditions%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D545%26epage%3D58%26doi%3D10.1002%2Femmm.201100158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Coillie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Aelst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polfliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opdenakker, G.</span></span> <span> </span><span class="NLM_article-title">Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">12672</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/bi980497d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi980497d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXltFKqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=12672-80&author=E.+Van%0ACoillieauthor=P.+Proostauthor=I.+Van+Aelstauthor=S.+Struyfauthor=M.+Polflietauthor=I.+De+Meesterauthor=D.+J.+Harveyauthor=J.+Van+Dammeauthor=G.+Opdenakker&title=Functional+comparison+of+two+human+monocyte+chemotactic+protein-2+isoforms%2C+role+of+the+amino-terminal+pyroglutamic+acid+and+processing+by+CD26%2Fdipeptidyl+peptidase+IV&doi=10.1021%2Fbi980497d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV</span></div><div class="casAuthors">Van Coillie, Els; Proost, Paul; Van Aelst, Ilse; Struyf, Sofie; Polfliet, Machteld; De Meester, Ingrid; Harvey, David J.; Van Damme, Jo; Opdenakker, Ghislain</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">12672-12680</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human Monocyte Chemotactic Protein (MCP)-2 has originally been isolated from stimulated osteosarcoma cells as a chemokine coproduced with MCP-1 and MCP-3.  Here, a 5'-end extended MCP-2 cDNA was cloned from a human testis cDNA library.  It encoded a 76 residue MCP-2 protein, but differed from the reported bone marrow-derived MCP-2 cDNA sequence in codon 46, which coded for a Lys instead of a Gln.  This MCP-2Lys46 variant, caused by a single nucleotide polymorphism (SNP), was biol. compared with MCP-2Gln46.  The coding regions were subcloned into the bacterial expression vector pHEN1, and after transformation of Escherichia coli, the two MCP-2 protein variants were recovered from the periplasm.  The recombinant proteins were purified to homogeneity by heparin-Sepharose affinity chromatog. and reversed-phase HPLC.  Edman degrdn. revealed a Gln residue at the NH2 terminus instead of a pGlu.  To evaluate the influence of the cyclization, this Gln was chem. converted into pGlu in both MCP-2 variants.  The conversion was confirmed by electrospray mass spectrometry.  RMCP-2Gln46 and rMCP-2Lys46 and the NH2-terminal cyclic counterparts were tested on monocytic cells in calcium mobilization and chemotaxis assays.  No significant difference in biol. activity was obsd. between the rMCP-2Gln46 and rMCP-2Lys46 isoforms.  However, for both MCP-2 variants the NH2-terminal pyroglutamate was shown to be essential for chemotaxis, but not for calcium mobilization.  NH2-terminal truncation of rMCP-2Lys46 by the serine protease CD26/dipeptidyl peptidase IV (CD26/DPP IV) resulted in the cleavage of the NH2-terminal Gln-Pro dipeptide, whereas synthetic MCP-2 with an amino-terminal pGlu remained unaffected.  CD26/DPP IV-clipped rMCP-2Lys46(3-76) was almost completely inactive in both chemotaxis and signaling assays.  These observations indicate that the NH2-terminal pGlu in MCP-2 is necessary for chemotactic activity but also that it protects the protein against degrdn. by CD26/DPP IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3ObUqyDOb9rVg90H21EOLACvtfcHk0lhQyQ2TkxkIRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFKqtbs%253D&md5=e7e265f6200b804239240868b255443f</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fbi980497d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980497d%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCoillie%26aufirst%3DE.%26aulast%3DProost%26aufirst%3DP.%26aulast%3DVan%2BAelst%26aufirst%3DI.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DPolfliet%26aufirst%3DM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DHarvey%26aufirst%3DD.%2BJ.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DOpdenakker%26aufirst%3DG.%26atitle%3DFunctional%2520comparison%2520of%2520two%2520human%2520monocyte%2520chemotactic%2520protein-2%2520isoforms%252C%2520role%2520of%2520the%2520amino-terminal%2520pyroglutamic%2520acid%2520and%2520processing%2520by%2520CD26%252Fdipeptidyl%2520peptidase%2520IV%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D12672%26epage%3D80%26doi%3D10.1021%2Fbi980497d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichentopf, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedlmeier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauscher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freyse, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plank, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Horsten, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>397</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1515/hsz-2015-0192</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1515%2Fhsz-2015-0192" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26351917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=397&publication_year=2016&pages=45-55&author=A.+Beckerauthor=R.+Eichentopfauthor=R.+Sedlmeierauthor=A.+Waniekauthor=H.+Cynisauthor=B.+Kochauthor=A.+Stephanauthor=C.+Bauscherauthor=S.+Kohlmannauthor=T.+Hoffmannauthor=A.+Kehlenauthor=S.+Bergauthor=E.+J.+Freyseauthor=A.+Osmandauthor=A.+C.+Plankauthor=S.+Rossnerauthor=S.+von+Horstenauthor=S.+Graubnerauthor=H.+U.+Demuthauthor=S.+Schilling&title=IsoQC+%28QPCTL%29+knock-out+mice+suggest+differential+substrate+conversion+by+glutaminyl+cyclase+isoenzymes&doi=10.1515%2Fhsz-2015-0192"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes</span></div><div class="casAuthors">Becker, Andreas; Eichentopf, Rico; Sedlmeier, Reinhard; Waniek, Alexander; Cynis, Holger; Koch, Birgit; Stephan, Anett; Baeuscher, Christoph; Kohlmann, Stephanie; Hoffmann, Torsten; Kehlen, Astrid; Berg, Sabine; Freyse, Ernst-Joachim; Osmand, Alexander; Plank, Anne-Christine; Rossner, Steffen; von Hoersten, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">397</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">BICHF3</span>;
        ISSN:<span class="NLM_cas:issn">1431-6730</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">Secretory peptides and proteins are frequently modified by pyroglutamic acid (pE, pGlu) at their N-terminus.  This modification is catalyzed by the glutaminyl cyclases QC and isoQC.  Here, we decipher the roles of the isoenzymes by characterization of IsoQC-/- mice.  These mice show a significant redn. of glutaminyl cyclase activity in brain and peripheral tissue, suggesting ubiquitous expression of the isoQC enzyme.  An assay of substrate conversion in vivo reveals impaired generation of the pGlu-modified C-C chemokine ligand 2 (CCL2, MCP-1) in isoQC-/- mice.  The pGlu-formation was also impaired in primary neurons, which express significant levels of QC.  Interestingly, however, the formation of the neuropeptide hormone TSH-releasing hormone (TRH), assessed by immunohistochem. and hormonal anal. of hypothalamic-pituitary-thyroid axis, was not affected in isoQC-/-, which contrasts to QC-/-.  Thus, the results reveal differential functions of isoQC and QC in the formation of the pGlu-peptides CCL2 and TRH.  Substrates requiring extensive prohormone processing in secretory granules, such as TRH, are primarily converted by QC.  In contrast, protein substrates such as CCL2 appear to be primarily converted by isoQC.  The results provide a new example, how subtle differences in subcellular localization of enzymes and substrate precursor maturation might influence pGlu-product formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6FvRmQrpJjbVg90H21EOLACvtfcHk0liUTEKpQfCKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKjtbrN&md5=d49367e240255a8fa1546bae79865508</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2015-0192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2015-0192%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DEichentopf%26aufirst%3DR.%26aulast%3DSedlmeier%26aufirst%3DR.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DStephan%26aufirst%3DA.%26aulast%3DBauscher%26aufirst%3DC.%26aulast%3DKohlmann%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DFreyse%26aufirst%3DE.%2BJ.%26aulast%3DOsmand%26aufirst%3DA.%26aulast%3DPlank%26aufirst%3DA.%2BC.%26aulast%3DRossner%26aufirst%3DS.%26aulast%3Dvon%2BHorsten%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DIsoQC%2520%2528QPCTL%2529%2520knock-out%2520mice%2520suggest%2520differential%2520substrate%2520conversion%2520by%2520glutaminyl%2520cyclase%2520isoenzymes%26jtitle%3DBiol.%2520Chem.%26date%3D2016%26volume%3D397%26spage%3D45%26epage%3D55%26doi%3D10.1515%2Fhsz-2015-0192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiyota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendelman, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span> <span> </span><span class="NLM_article-title">CCL2 affects beta-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2012.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23040664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgtL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1060-8&author=T.+Kiyotaauthor=H.+E.+Gendelmanauthor=R.+A.+Weirauthor=E.+E.+Higginsauthor=G.+Zhangauthor=M.+Jain&title=CCL2+affects+beta-amyloidosis+and+progressive+neurocognitive+dysfunction+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2012.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Kiyota, Tomomi; Gendelman, Howard E.; Weir, Robert A.; Higgins, E. Elizabeth; Zhang, Gang; Jain, Mohit</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1060-1068</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Neuroinflammation affects the pathobiol. of Alzheimer's disease (AD).  Notably, β-amyloid (Aβ) deposition induces microglial activation and the subsequent prodn. of proinflammatory neurotoxic factors.  In maintaining brain homeostasis, microglial plasticity also enables phenotypic transition between toxic and trophic activation states.  One important control for such cell activation is through the CC-chemokine ligand 2 (CCL2) and its receptor, the CC-chemokine receptor 2.  Both affect microglia and peripheral macrophage immune responses and for the latter, cell ingress across the blood-brain barrier.  However, how CCL2-CC-chemokine receptor 2 signaling contributes to AD pathogenesis is not well understood.  To this end, we now report that CCL2 deficiency influences behavioral abnormalities and disease progression in Aβ precursor protein/presenilin-1 double-transgenic mice.  Here, increased cortical and hippocampal Aβ deposition is coincident with the formulation of Aβ oligomers.  Deficits in peripheral Aβ clearance and in scavenger, neuroprogenitor, and microglial cell functions are linked to deficient Aβ uptake.  All serve to accelerate memory dysfunction.  Taken together, these data support a role of CCL2 in innate immune functions relevant to AD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotXohpUrd7QLVg90H21EOLACvtfcHk0liUTEKpQfCKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgtL%252FE&md5=466d072afebe8d092e3a8279ced94dd1</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DKiyota%26aufirst%3DT.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DWeir%26aufirst%3DR.%2BA.%26aulast%3DHiggins%26aufirst%3DE.%2BE.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DM.%26atitle%3DCCL2%2520affects%2520beta-amyloidosis%2520and%2520progressive%2520neurocognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26spage%3D1060%26epage%3D8%26doi%3D10.1016%2Fj.neurobiolaging.2012.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dams-O’Connor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peskind, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yemul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haroutunian, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasinetti, G. M.</span></span> <span> </span><span class="NLM_article-title">Elevated plasma MCP-1 concentration following traumatic brain injury as a potential “predisposition” factor associated with an increased risk for subsequent development of Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.3233/JAD-2012-120598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-2012-120598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22543850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC38rptVSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=301-13&author=L.+Hoauthor=W.+Zhaoauthor=K.+Dams-O%E2%80%99Connorauthor=C.+Y.+Tangauthor=W.+Gordonauthor=E.+R.+Peskindauthor=S.+Yemulauthor=V.+Haroutunianauthor=G.+M.+Pasinetti&title=Elevated+plasma+MCP-1+concentration+following+traumatic+brain+injury+as+a+potential+%E2%80%9Cpredisposition%E2%80%9D+factor+associated+with+an+increased+risk+for+subsequent+development+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2012-120598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease</span></div><div class="casAuthors">Ho Lap; Zhao Wei; Dams-O'Connor Kristen; Tang Cheuk Y; Gordon Wayne; Peskind Elaine R; Yemul Shrishailam; Haroutunian Vahram; Pasinetti Giulio Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We explored whether changes in the expression profile of peripheral blood plasma proteins may provide a clinical, readily accessible "window" into the brain, reflecting molecular alterations following traumatic brain injury (TBI) that might contribute to TBI complications.  We recruited fourteen TBI and ten control civilian participants for the study, and also analyzed banked plasma specimens from 20 veterans with TBI and 20 control cases.  Using antibody arrays and ELISA assays, we explored differentially-regulated protein species in the plasma of TBI compared to healthy controls from the two independent cohorts.  We found three protein biomarker species, monocyte chemotactic protein-1 (MCP-1), insulin-like growth factor-binding protein-3, and epidermal growth factor receptor, that are differentially regulated in plasma specimens of the TBI cases.  A three-biomarker panel using all three proteins provides the best potential criterion for separating TBI and control cases.  Plasma MCP-1 contents are correlated with the severity of TBI and the index of compromised axonal fiber integrity in the frontal cortex.  Based on these findings, we evaluated postmortem brain specimens from 7 mild cognitive impairment (MCI) and 7 neurologically normal cases.  We found elevated MCP-1 expression in the frontal cortex of MCI cases that are at high risk for developing Alzheimer's disease.  Our findings suggest that additional application of the three-biomarker panel to current diagnostic criteria may lead to improved TBI detection and more sensitive outcome measures for clinical trials.  Induction of MCP-1 in response to TBI might be a potential predisposing factor that may increase the risk for development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQS_ypfbdTpNHELvajU9pjPfW6udTcc2eZCfuBcXfRRJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rptVSmug%253D%253D&md5=55e5a6bf5334658aa8829d6e9065e33b</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120598%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DDams-O%25E2%2580%2599Connor%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DC.%2BY.%26aulast%3DGordon%26aufirst%3DW.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DYemul%26aufirst%3DS.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DPasinetti%26aufirst%3DG.%2BM.%26atitle%3DElevated%2520plasma%2520MCP-1%2520concentration%2520following%2520traumatic%2520brain%2520injury%2520as%2520a%2520potential%2520%25E2%2580%259Cpredisposition%25E2%2580%259D%2520factor%2520associated%2520with%2520an%2520increased%2520risk%2520for%2520subsequent%2520development%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D301%26epage%3D13%26doi%3D10.3233%2FJAD-2012-120598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchhave, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minthon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janciauskiene, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, O.</span></span> <span> </span><span class="NLM_article-title">CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e30525</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0030525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pone.0030525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22303443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XisV2nsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=K.+Westinauthor=P.+Buchhaveauthor=H.+Nielsenauthor=L.+Minthonauthor=S.+Janciauskieneauthor=O.+Hansson&title=CCL2+is+associated+with+a+faster+rate+of+cognitive+decline+during+early+stages+of+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0030525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease</span></div><div class="casAuthors">Westin, Karin; Buchhave, Peder; Nielsen, Henrietta; Minthon, Lennart; Janciauskiene, Sabina; Hansson, Oskar</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e30525</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemokine (C-C motif) receptor 2 (CCR2)-signaling can mediate accumulation of microglia at sites affected by neuroinflammation.  CCR2 and its main ligand CCL2 (MCP-1) might also be involved in the altered metab. of beta-amyloid (Aβ) underlying Alzheimer's disease (AD).  We therefore measured the levels of CCL2 and three other CCR2 ligands, i.e. CCL11 (eotaxin), CCL13 (MCP-4) and CCL26 (eotaxin-3), in the cerebrospinal fluid (CSF) and plasma of 30 controls and 119 patients with mild cognitive impairment (MCI) at baseline.  During clin. follow-up 52 MCI patients were clin. stable for five years, 47 developed AD (i.e. cases with prodromal AD at baseline) and 20 developed other dementias.  Only CSF CCL26 was statistically significantly elevated in patients with prodromal AD when compared to controls (p = 0.002).  However, in patients with prodromal AD, the CCL2 levels in CSF at baseline correlated with a faster cognitive decline during follow-up (rs = 0.42, p = 0.004).  Furthermore, prodromal AD patients in the highest tertile of CSF CCL2 exhibited a significantly faster cognitive decline (p < 0.001) and developed AD dementia within a shorter time period (p < 0.003) compared to those in the lowest tertile.  Finally, in the entire MCI cohort, CSF CCL2 could be combined with CSF Tau, P-tau and Aβ42 to predict both future conversion to AD and the rate of cognitive decline.  If these results are corroborated in future studies, CCL2 in CSF could be a candidate biomarker for prediction of future disease progression rate in prodromal AD.  Moreover, CCR2-related signaling pathways might be new therapeutic targets for therapies aiming at slowing down the disease progression rate of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryprsiw1HXTLVg90H21EOLACvtfcHk0lj6V-A96RGw5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisV2nsr8%253D&md5=c8e6db182e8466aafa2f79cce2280826</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030525%26sid%3Dliteratum%253Aachs%26aulast%3DWestin%26aufirst%3DK.%26aulast%3DBuchhave%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DH.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DJanciauskiene%26aufirst%3DS.%26aulast%3DHansson%26aufirst%3DO.%26atitle%3DCCL2%2520is%2520associated%2520with%2520a%2520faster%2520rate%2520of%2520cognitive%2520decline%2520during%2520early%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0030525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kauwe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridge, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyt, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staley, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karch, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruchaga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ainscough, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bales, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertelsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goate, A. M.</span></span> <span> </span><span class="NLM_article-title">Genome-wide association study of CSF levels of 59 alzheimer’s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation</span>. <i>PLoS Genet.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004758</span> <span class="refDoi"> DOI: 10.1371/journal.pgen.1004758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1371%2Fjournal.pgen.1004758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25340798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyiu7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=J.+S.+Kauweauthor=M.+H.+Baileyauthor=P.+G.+Ridgeauthor=R.+Perryauthor=M.+E.+Wadsworthauthor=K.+L.+Hoytauthor=L.+A.+Staleyauthor=C.+M.+Karchauthor=O.+Harariauthor=C.+Cruchagaauthor=B.+J.+Ainscoughauthor=K.+Balesauthor=E.+H.+Pickeringauthor=S.+Bertelsenauthor=A.+M.+Faganauthor=D.+M.+Holtzmanauthor=J.+C.+Morrisauthor=A.+M.+Goate&title=Genome-wide+association+study+of+CSF+levels+of+59+alzheimer%E2%80%99s+disease+candidate+proteins%3A+significant+associations+with+proteins+involved+in+amyloid+processing+and+inflammation&doi=10.1371%2Fjournal.pgen.1004758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation</span></div><div class="casAuthors">Kauwe, John S. K.; Bailey, Matthew H.; Ridge, Perry G.; Perry, Rachel; Wadsworth, Mark E.; Hoyt, Kaitlyn L.; Staley, Lyndsay A.; Karch, Celeste M.; Harari, Oscar; Cruchaga, Carlos; Ainscough, Benjamin J.; Bales, Kelly; Pickering, Eve H.; Bertelsen, Sarah; Fagan, Anne M.; Holtzman, David M.; Morris, John C.; Goate, Alison M.; Weiner, Michael; Aisen, Paul; Petersen, Ronald; Jack, Clifford R.; Jagust, William; Trojanowki, John Q.; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Saykin, Andrew J.; Shaw, Leslie M.; Morris, John</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004758/1-e1004758/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cerebrospinal fluid (CSF) 42 amino acid species of amyloid beta (Aβ42) and tau levels are strongly correlated with the presence of Alzheimer's disease (AD) neuropathol. including amyloid plaques and neurodegeneration and have been successfully used as endophenotypes for genetic studies of AD.  Addnl. CSF analytes may also serve as useful endophenotypes that capture other aspects of AD pathophysiol.  Here we have conducted a genome-wide assocn. study of CSF levels of 59 AD-related analytes.  All analytes were measured using the Rules Based Medicine Human Discovery MAP Panel, which includes analytes relevant to several disease-related processes.  Data from two independently collected and measured datasets, the Knight Alzheimer's Disease Research Center (ADRC) and Alzheimer's Disease Neuroimaging Initiative (ADNI), were analyzed sep., and combined results were obtained using meta-anal.  We identified genetic assocns. with CSF levels of 5 proteins (Angiotensin-converting enzyme (ACE), Chemokine (C-C motif) ligand 2 (CCL2), Chemokine (C-C motif) ligand 4 (CCL4), Interleukin 6 receptor (IL6R) and Matrix metalloproteinase-3 (MMP3)) with study-wide significant p-values (p<1.46 × 10-10) and significant, consistent evidence for assocn. in both the Knight ADRC and the ADNI samples.  These proteins are involved in amyloid processing and pro-inflammatory signaling.  SNPs assocd. with ACE, IL6R and MMP3 protein levels are located within the coding regions of the corresponding structural gene.  The SNPs assocd. with CSF levels of CCL4 and CCL2 are located in known chemokine binding proteins.  The genetic assocns. reported here are novel and suggest mechanisms for genetic control of CSF and plasma levels of these disease-related proteins.  Significant SNPs in ACE and MMP3 also showed assocn. with AD risk.  Our findings suggest that these proteins/pathways may be valuable therapeutic targets for AD.  Robust assocns. in cognitively normal individuals suggest that these SNPs also influence regulation of these proteins more generally and may therefore be relevant to other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCS7PMBQWOu7Vg90H21EOLACvtfcHk0lj6V-A96RGw5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyiu7%252FI&md5=f33126cbf1a0308383dab6353c405728</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1004758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1004758%26sid%3Dliteratum%253Aachs%26aulast%3DKauwe%26aufirst%3DJ.%2BS.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DRidge%26aufirst%3DP.%2BG.%26aulast%3DPerry%26aufirst%3DR.%26aulast%3DWadsworth%26aufirst%3DM.%2BE.%26aulast%3DHoyt%26aufirst%3DK.%2BL.%26aulast%3DStaley%26aufirst%3DL.%2BA.%26aulast%3DKarch%26aufirst%3DC.%2BM.%26aulast%3DHarari%26aufirst%3DO.%26aulast%3DCruchaga%26aufirst%3DC.%26aulast%3DAinscough%26aufirst%3DB.%2BJ.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DPickering%26aufirst%3DE.%2BH.%26aulast%3DBertelsen%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DGoate%26aufirst%3DA.%2BM.%26atitle%3DGenome-wide%2520association%2520study%2520of%2520CSF%2520levels%2520of%252059%2520alzheimer%25E2%2580%2599s%2520disease%2520candidate%2520proteins%253A%2520significant%2520associations%2520with%2520proteins%2520involved%2520in%2520amyloid%2520processing%2520and%2520inflammation%26jtitle%3DPLoS%2520Genet.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.pgen.1004758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sokolova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahimi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warden, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, C. E.</span></span> <span> </span><span class="NLM_article-title">Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer’s disease</span>. <i>Brain Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1111/j.1750-3639.2008.00188.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fj.1750-3639.2008.00188.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18637012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ojtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=392-8&author=A.+Sokolovaauthor=M.+D.+Hillauthor=F.+Rahimiauthor=L.+A.+Wardenauthor=G.+M.+Hallidayauthor=C.+E.+Shepherd&title=Monocyte+chemoattractant+protein-1+plays+a+dominant+role+in+the+chronic+inflammation+observed+in+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1750-3639.2008.00188.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease</span></div><div class="casAuthors">Sokolova, Anna; Hill, Michelle D.; Rahimi, Farid; Warden, Lolita A.; Halliday, Glenda M.; Shepherd, Claire E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">392-398</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Chronic neuroinflammation correlates with cognitive decline and brain atrophy in Alzheimer's disease (AD), and cytokines and chemokines mediate the inflammatory response.  However, quantitation of cytokines and chemokines in AD brain tissue has only been carried out for a small no. of mediators with variable results.  We simultaneously quantified 17 cytokines and chemokines in brain tissue exts. from controls (n = 10) and from patients with and without genetic forms of AD (n = 12).  Group comparisons accounting for multiple testing revealed that monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and interleukin-8 (IL-8) were consistently upregulated in AD brain tissue.  Immunohistochem. for MCP-1, IL-6 and IL-8 confirmed this increase and detd. localization of these factors in neurons (MCP-1, IL-6, IL-8), astrocytes (MCP-1, IL-6) and plaque pathol. (MCP-1, IL-8).  Logistic linear regression modeling detd. that MCP-1 was the most reliable predictor of disease.  Our data support previous work on significant increases in IL-6 and IL-8 in AD but indicate that MCP-1 may play a more dominant role in chronic inflammation in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGWUAUz-BNr7Vg90H21EOLACvtfcHk0lj6V-A96RGw5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ojtrg%253D&md5=18451e32fc070f2cf260ccf74d9e5294</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2008.00188.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2008.00188.x%26sid%3Dliteratum%253Aachs%26aulast%3DSokolova%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%2BD.%26aulast%3DRahimi%26aufirst%3DF.%26aulast%3DWarden%26aufirst%3DL.%2BA.%26aulast%3DHalliday%26aufirst%3DG.%2BM.%26aulast%3DShepherd%26aufirst%3DC.%2BE.%26atitle%3DMonocyte%2520chemoattractant%2520protein-1%2520plays%2520a%2520dominant%2520role%2520in%2520the%2520chronic%2520inflammation%2520observed%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Pathol.%26date%3D2009%26volume%3D19%26spage%3D392%26epage%3D8%26doi%3D10.1111%2Fj.1750-3639.2008.00188.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2008.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.tips.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18835047" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=626-632&author=J.+E.+Khouryauthor=A.+D.+Luster&title=Mechanisms+of+microglia+accumulation+in+Alzheimer%E2%80%99s+disease%3A+therapeutic+implications&doi=10.1016%2Fj.tips.2008.08.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DKhoury%26aufirst%3DJ.%2BE.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DMechanisms%2520of%2520microglia%2520accumulation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520therapeutic%2520implications%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D29%26spage%3D626%26epage%3D632%26doi%3D10.1016%2Fj.tips.2008.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charo, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taubman, M. B.</span></span> <span> </span><span class="NLM_article-title">Chemokines in the pathogenesis of vascular disease</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000146672.10582.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1161%2F01.RES.0000146672.10582.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15514167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXoslSksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=858-66&author=I.+F.+Charoauthor=M.+B.+Taubman&title=Chemokines+in+the+pathogenesis+of+vascular+disease&doi=10.1161%2F01.RES.0000146672.10582.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines in the Pathogenesis of Vascular Disease</span></div><div class="casAuthors">Charo, Israel F.; Taubman, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">858-866</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Our increasing appreciation of the importance of inflammation in vascular disease has focused attention on the mols. that direct the migration of leukocytes from the blood stream to the vessel wall.  In this review, we summarize roles of the chemokines, a family of small secreted proteins that selectively recruit monocytes, neutrophils, and lymphocytes to sites of vascular injury, inflammation, and developing atherosclerosis.  Chemokines induce chemotaxis through the activation of G-protein-coupled receptors, and the receptors that a given leukocyte expresses dets. the chemokines to which it will respond.  Monocyte chemoattractant protein 1 (MCP-1), acting through its receptor CCR2, appears to play an early and important role in the recruitment of monocytes to atherosclerotic lesions and in the formation of intimal hyperplasia after arterial injury.  Acute thrombosis is an often fatal complication of atherosclerotic plaque rupture, and recent evidence suggests that MCP-1 contributes to thrombin generation and thrombus formation by generating tissue factor.  Because of their crit. roles in monocyte recruitment in vascular and nonvascular diseases, MCP-1 and CCR2 have become important therapeutic targets, and efforts are underway to develop potent and specific antagonists of these and related chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG_5Vr4htmjbVg90H21EOLACvtfcHk0lgDpVlTvbr85w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXoslSksr4%253D&md5=80568fae46052fafd52b27a3476c9e02</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000146672.10582.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000146672.10582.17%26sid%3Dliteratum%253Aachs%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DTaubman%26aufirst%3DM.%2BB.%26atitle%3DChemokines%2520in%2520the%2520pathogenesis%2520of%2520vascular%2520disease%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D95%26spage%3D858%26epage%3D66%26doi%3D10.1161%2F01.RES.0000146672.10582.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inoshima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagimoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egashira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, N.</span></span> <span> </span><span class="NLM_article-title">Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice</span>. <i>Am. J. Physiol Lung Cell Mol. Physiol</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">L1038</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1152/ajplung.00167.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1152%2Fajplung.00167.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15064241" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2004&pages=L1038-44&author=I.+Inoshimaauthor=K.+Kuwanoauthor=N.+Hamadaauthor=N.+Hagimotoauthor=M.+Yoshimiauthor=T.+Maeyamaauthor=A.+Takeshitaauthor=S.+Kitamotoauthor=K.+Egashiraauthor=N.+Hara&title=Anti-monocyte+chemoattractant+protein-1+gene+therapy+attenuates+pulmonary+fibrosis+in+mice&doi=10.1152%2Fajplung.00167.2003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1152%2Fajplung.00167.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajplung.00167.2003%26sid%3Dliteratum%253Aachs%26aulast%3DInoshima%26aufirst%3DI.%26aulast%3DKuwano%26aufirst%3DK.%26aulast%3DHamada%26aufirst%3DN.%26aulast%3DHagimoto%26aufirst%3DN.%26aulast%3DYoshimi%26aufirst%3DM.%26aulast%3DMaeyama%26aufirst%3DT.%26aulast%3DTakeshita%26aufirst%3DA.%26aulast%3DKitamoto%26aufirst%3DS.%26aulast%3DEgashira%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DN.%26atitle%3DAnti-monocyte%2520chemoattractant%2520protein-1%2520gene%2520therapy%2520attenuates%2520pulmonary%2520fibrosis%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Physiol%2520Lung%2520Cell%2520Mol.%2520Physiol%26date%3D2004%26volume%3D286%26spage%3DL1038%26epage%3D44%26doi%3D10.1152%2Fajplung.00167.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galimberti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenoglio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venturelli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guidi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scalabrini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clerici, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresolin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpini, E.</span></span> <span> </span><span class="NLM_article-title">Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2005.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2005.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16307829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1763-8&author=D.+Galimbertiauthor=C.+Fenoglioauthor=C.+Lovatiauthor=E.+Venturelliauthor=I.+Guidiauthor=B.+Corraauthor=D.+Scalabriniauthor=F.+Clericiauthor=C.+Marianiauthor=N.+Bresolinauthor=E.+Scarpini&title=Serum+MCP-1+levels+are+increased+in+mild+cognitive+impairment+and+mild+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2005.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease</span></div><div class="casAuthors">Galimberti, Daniela; Fenoglio, Chiara; Lovati, Carlo; Venturelli, Eliana; Guidi, Ilaria; Corra, Barbara; Scalabrini, Diego; Clerici, Francesca; Mariani, Claudio; Bresolin, Nereo; Scarpini, Elio</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1763-1768</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Upregulation of a no. of chemokines, including monocyte chemotactic protein-1 (MCP-1), is assocd. with Alzheimer's disease (AD) pathol. changes.  Emerging evidence suggests that inflammatory events precede the clin. development of AD, as cytokine dysregulation has been obsd. also in patients with mild cognitive impairment (MCI).  MCP-1 levels were evaluated in serum samples from 48 subjects with MCI, 94 AD patients and 24 age-matched controls.  Significantly increased MCP-1 levels were found in MCI and mild AD, but not in severe AD patients as compared with controls.  MRNA levels in peripheral blood mononuclear cells (PBMC), evaluated by quant. RT-PCR anal., paralleled serum MCP-1 levels.  Moreover, a progressive MCP-1 decrease was obsd. over a 1-yr follow up in a subgroup of MCI subjects converted to AD.  MCP-1 upregulation is likely to be a very early event in AD pathogenesis, by far preceding the clin. onset of the disease.  Nevertheless, as MCP-1 is likely to play a role in several pathologies with an inflammatory component, a possible usefulness as an early AD biomarker would be possible only in combination with other mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmJfq-7q2EabVg90H21EOLACvtfcHk0lgDpVlTvbr85w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSlu7zL&md5=35d5be25ab132fddc7b7d957b4f760d5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2005.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2005.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DGalimberti%26aufirst%3DD.%26aulast%3DFenoglio%26aufirst%3DC.%26aulast%3DLovati%26aufirst%3DC.%26aulast%3DVenturelli%26aufirst%3DE.%26aulast%3DGuidi%26aufirst%3DI.%26aulast%3DCorra%26aufirst%3DB.%26aulast%3DScalabrini%26aufirst%3DD.%26aulast%3DClerici%26aufirst%3DF.%26aulast%3DMariani%26aufirst%3DC.%26aulast%3DBresolin%26aufirst%3DN.%26aulast%3DScarpini%26aufirst%3DE.%26atitle%3DSerum%2520MCP-1%2520levels%2520are%2520increased%2520in%2520mild%2520cognitive%2520impairment%2520and%2520mild%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2006%26volume%3D27%26spage%3D1763%26epage%3D8%26doi%3D10.1016%2Fj.neurobiolaging.2005.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khannazer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">The potential role of chemokines in Alzheimer’s disease pathogenesis</span>. <i>Am. J. Alzheimers Dis Other Demen</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1177/1533317513518651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1177%2F1533317513518651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24408754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2czjs12ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2014&pages=415-25&author=G.+Aziziauthor=N.+Khannazerauthor=A.+Mirshafiey&title=The+potential+role+of+chemokines+in+Alzheimer%E2%80%99s+disease+pathogenesis&doi=10.1177%2F1533317513518651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis</span></div><div class="casAuthors">Azizi Gholamreza; Khannazer Nikoo; Mirshafiey Abbas</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder and leading cause of dementia, which begins with impaired memory.  The neuropathological hallmarks of AD include destructive alterations of neurons by neurofibrillary tangles, neuritic amyloid plaques, and neuroinflammatory process in the brain.  Chemokines have a major role in inflammatory cell attraction and glial cell activation and/or modulation in the central nervous system.  Moreover, the clinical and immunopathological evidence could show dual key role of chemokines in their pro- and anti-inflammatory properties in AD.  However, their effects in neurodegeneration and/or neuroprotection remain an area of investigation.  This review article provides an overview of characteristic, cellular source and activity of chemokines, and their roles in neuronal glial cell interaction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9ruWa1xgAXCjiVMCqkKxVfW6udTcc2ebcDnhkAx28Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czjs12ltA%253D%253D&md5=780f307296062745c3c0e8ab1d1119db</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1177%2F1533317513518651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1533317513518651%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DG.%26aulast%3DKhannazer%26aufirst%3DN.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DThe%2520potential%2520role%2520of%2520chemokines%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathogenesis%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis%2520Other%2520Demen%26date%3D2014%26volume%3D29%26spage%3D415%26epage%3D25%26doi%3D10.1177%2F1533317513518651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Severini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passeri, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florenzano, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Possenti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Matteo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guglielmotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calissano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercanti, D.</span></span> <span> </span><span class="NLM_article-title">Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-beta-induced toxicity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.3233/JAD-131070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-131070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=281-93&author=C.+Severiniauthor=P.+P.+Passeriauthor=M.+Ciottiauthor=F.+Florenzanoauthor=R.+Possentiauthor=C.+Zonaauthor=A.+Di+Matteoauthor=A.+Guglielmottiauthor=P.+Calissanoauthor=J.+Pachterauthor=D.+Mercanti&title=Bindarit%2C+inhibitor+of+CCL2+synthesis%2C+protects+neurons+against+amyloid-beta-induced+toxicity&doi=10.3233%2FJAD-131070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3233%2FJAD-131070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-131070%26sid%3Dliteratum%253Aachs%26aulast%3DSeverini%26aufirst%3DC.%26aulast%3DPasseri%26aufirst%3DP.%2BP.%26aulast%3DCiotti%26aufirst%3DM.%26aulast%3DFlorenzano%26aufirst%3DF.%26aulast%3DPossenti%26aufirst%3DR.%26aulast%3DZona%26aufirst%3DC.%26aulast%3DDi%2BMatteo%26aufirst%3DA.%26aulast%3DGuglielmotti%26aufirst%3DA.%26aulast%3DCalissano%26aufirst%3DP.%26aulast%3DPachter%26aufirst%3DJ.%26aulast%3DMercanti%26aufirst%3DD.%26atitle%3DBindarit%252C%2520inhibitor%2520of%2520CCL2%2520synthesis%252C%2520protects%2520neurons%2520against%2520amyloid-beta-induced%2520toxicity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D38%26spage%3D281%26epage%3D93%26doi%3D10.3233%2FJAD-131070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navabi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shukaili, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyedzadeh, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yazdani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirshafiey, A.</span></span> <span> </span><span class="NLM_article-title">The role of inflammatory mediators in the pathogenesis of Alzheimer’s disease</span>. <i>Sultan Qaboos Univ Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.18295/squmj.2015.15.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.18295%2Fsqumj.2015.15.03.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=305-316&author=G.+Aziziauthor=S.+S.+Navabiauthor=A.+Al-Shukailiauthor=M.+H.+Seyedzadehauthor=R.+Yazdaniauthor=A.+Mirshafiey&title=The+role+of+inflammatory+mediators+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.18295%2Fsqumj.2015.15.03.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.18295%2Fsqumj.2015.15.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18295%252Fsqumj.2015.15.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DG.%26aulast%3DNavabi%26aufirst%3DS.%2BS.%26aulast%3DAl-Shukaili%26aufirst%3DA.%26aulast%3DSeyedzadeh%26aufirst%3DM.%2BH.%26aulast%3DYazdani%26aufirst%3DR.%26aulast%3DMirshafiey%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520inflammatory%2520mediators%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSultan%2520Qaboos%2520Univ%2520Med.%2520J.%26date%3D2015%26volume%3D15%26spage%3D305%26epage%3D316%26doi%3D10.18295%2Fsqumj.2015.15.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J.</span></span> <span> </span><span class="NLM_article-title">Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</span>. <i>Arch. Pharmacal Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1007/s12272-013-0161-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs12272-013-0161-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23771498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsV2mtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=1039-50&author=S.+Boseauthor=J.+Cho&title=Role+of+chemokine+CCL2+and+its+receptor+CCR2+in+neurodegenerative+diseases&doi=10.1007%2Fs12272-013-0161-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases</span></div><div class="casAuthors">Bose, Shambhunath; Cho, Jungsook</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1039-1050</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Chemokines are members of the chemoattractant cytokine family.  They play key roles in the trafficking of leukocytes and in the induction of chemotaxis through the activation of G protein-coupled receptor.  Considerable interest has been paid to these mols. to elucidate their roles in the unique inflammatory responses elicited in the central nervous system (CNS).  Chemokine CCL2 (also known as monocyte chemoattractant protein-1, MCP-1) is one of the vital chemokines that control the migration and infiltration of monocytes/macrophages.  CCL2 and its receptor CCR2 have been shown to be induced and involved in various neurodegenerative disorders including Alzheimer's disease, multiple sclerosis, and ischemic brain injury.  The present review will focus on the biol. and pathophysiol. aspects of CCL2 and CCR2 in the CNS and the possible therapeutic approaches for targeting these two proteins to combat neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAJgYCZBXSnbVg90H21EOLACvtfcHk0lgT40AKdWmL7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsV2mtL4%253D&md5=60608bb9d4308f3a4f4eac2831fb2cd5</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0161-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0161-z%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%26atitle%3DRole%2520of%2520chemokine%2520CCL2%2520and%2520its%2520receptor%2520CCR2%2520in%2520neurodegenerative%2520diseases%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2013%26volume%3D36%26spage%3D1039%26epage%3D50%26doi%3D10.1007%2Fs12272-013-0161-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivest, S.</span></span> <span> </span><span class="NLM_article-title">A deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjt028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Fjmcb%2Fmjt028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23892208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=284-93&author=G.+Naertauthor=S.+Rivest&title=A+deficiency+in+CCR2%2B+monocytes%3A+the+hidden+side+of+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fjmcb%2Fmjt028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease</span></div><div class="casAuthors">Naert, Gaelle; Rivest, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disorder characterized by intracellular neurofibrillary tangle formation and extracellular amyloid-β (Aβ) deposition.  To date, microglia seem to act as double-edged swords, being either beneficial (e.g. clearance of Aβ) or detrimental (e.g. secretion of neurotoxic factors) in AD.  Following a rather intense debate on the question, a consensus has emerged that microglia can renew themselves via proliferation of already differentiated microglia as well as via the de novo recruitment of monocytes of mouse models of AD.  However, recent advances suggest distinct function for resident and bone marrow-derived microglia (BMDM), and have emphasized the neuroprotective functions of BMDM.  BMDM is the only subset of cells that restrict cerebral amyloidosis in the AD brain, which has been recently attributed to CCR2+ monocytes.  Moreover, an impaired recruitment of CCR2+ monocytes has been reported in AD patients, as seen from the CCR2+ monocytopenia found in the bloodstream and BM.  The present review summarizes the current knowledge on the roles and dysfunctions of CCR2+ monocytes in AD and their potential as key therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoO0Diwah7f7Vg90H21EOLACvtfcHk0lgT40AKdWmL7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ltrjK&md5=d81962085e0a29ea37fd291f95a91b29</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjt028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjt028%26sid%3Dliteratum%253Aachs%26aulast%3DNaert%26aufirst%3DG.%26aulast%3DRivest%26aufirst%3DS.%26atitle%3DA%2520deficiency%2520in%2520CCR2%252B%2520monocytes%253A%2520the%2520hidden%2520side%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D5%26spage%3D284%26epage%3D93%26doi%3D10.1093%2Fjmcb%2Fmjt028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark-Lewis, I.</span></span> <span> </span><span class="NLM_article-title">Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1084/jem.181.2.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1084%2Fjem.181.2.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=7836918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2MXjtFygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1995&pages=631-40&author=J.+H.+Gongauthor=I.+Clark-Lewis&title=Antagonists+of+monocyte+chemoattractant+protein+1+identified+by+modification+of+functionally+critical+NH2-terminal+residues&doi=10.1084%2Fjem.181.2.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues</span></div><div class="casAuthors">Gong, Jiang-Hong; Clark-Lewis, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">631-40</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Monocyte chemoattractant protein (MCP)-1 analogs were designed to det. the role of the NH2-terminal region in structure and function.  The NH2-terminal residue was important for function and receptor binding, as it could not be deleted or extended.  However the NH2-terminal pyroglutamate residue of the wild type was not essential as it could be replaced by several other noncyclic amino acids without loss of activity.  Residues 7-10 were essential for receptor desensitization, but were not sufficient for function, and the integrity of residues 1-6 were required for functional activity.  A peptide corresponding to MCP-1, 1-10 lacked detectable receptor-binding activities, indicating that residues 1-10 are essential for MCP-1 function, but that other residues are also involved.  Several truncated analogs, including 8-76, 9-76, and 10-76, desensitized MCP-1-induced Ca2+ induction, but were not significantly active.  These analogs were antagonists of MCP-1 activity with the most potent being the 9-76 analog (IC50 = 20 nM).  The 9-76 specifically bound to MCP-1 receptors with a Kd of 8.3 nM, which was three-fold higher than MCP-1 (Kd 2.8 nM).  The 9-76 analog desensitized the Ca2+ response to MCP-1 and MCP-3, but not to other CC chemokines, suggesting that it is MCP receptor specific.  The availability of these compds. will be helpful in evaluating MCP receptor antagonists as anti-inflammatory therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4gFvj58xiarVg90H21EOLACvtfcHk0lh9X8cYPCahaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjtFygsr0%253D&md5=e0f174b47d5bb79fac66342e6bc21aaa</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1084%2Fjem.181.2.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.181.2.631%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DClark-Lewis%26aufirst%3DI.%26atitle%3DAntagonists%2520of%2520monocyte%2520chemoattractant%2520protein%25201%2520identified%2520by%2520modification%2520of%2520functionally%2520critical%2520NH2-terminal%2520residues%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1995%26volume%3D181%26spage%3D631%26epage%3D40%26doi%3D10.1084%2Fjem.181.2.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couvreur, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span> <span> </span><span class="NLM_article-title">Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6–76) as a natural chemokine inhibitor</span>. <i>J. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">4034</span>– <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9558113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXis1CisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=4034-41&author=P.+Proostauthor=S.+Struyfauthor=M.+Couvreurauthor=J.+P.+Lenaertsauthor=R.+Coningsauthor=P.+Mentenauthor=P.+Verhaertauthor=A.+Wuytsauthor=J.+Van+Damme&title=Posttranslational+modifications+affect+the+activity+of+the+human+monocyte+chemotactic+proteins+MCP-1+and+MCP-2%3A+identification+of+MCP-2%286%E2%80%9376%29+as+a+natural+chemokine+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor</span></div><div class="casAuthors">Proost, Paul; Struyf, Sofie; Couvreur, Mikael; Lenaerts, Jean-Pierre; Conings, Rene; Menten, Patricia; Verhaert, Peter; Wuyts, Anja; Van Damme, Jo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4034-4041</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Chemokines are important mediators in infection and inflammation.  The monocyte chemotactic proteins (MCPs) form a subclass of structurally related C-C chemokines.  MCPs select specific target cells due to binding to a distinct set of chemokine receptors.  Recombinant and synthetic MCP-1 variants have been shown to function as chemokine antagonists.  Here, posttranslationally modified immunoreactive MCP-1 and MCP-2 were isolated from mononuclear cells.  Natural forms of MCP-1 and MCP-2 were biochem. identified by Edman degrdn. and mass spectrometry and functionally characterized in chemotaxis and Ca2+-mobilization assays.  Glycosylated MCP-1 (12 and 13.5 kDa) was 2-3-fold less chemotactic for monocytes and THP-1 cells than nonglycosylated MCP-1 (10 kDa).  Natural, N-terminally truncated MCP-1(5-76) and MCP-1(6-76) were practically devoid of bioactivity, whereas C-terminally processed MCP-1(1-69) fully retained its chemotactic and Ca2+-inducing capacity.  The capability of naturally modified MCP-1 forms to desensitize the Ca2+ response induced by intact MCP-1 in THP-1 cells correlated with their agonistic potency.  In contrast, naturally modified MCP-2(6-76) was devoid of activity, but could completely block the chemotactic effect of intact MCP-2 as well as that of MCP-1, MCP-3, and RANTES.  C-terminally processed MCP-2-(1-74) did retain its chemotactic potency.  Although comparable as a chemoattractant, natural intact MCP-2 was 10-fold less potent than MCP-1 in inducing an intracellular Ca2+ increase.  Thus, under physiol. or pathol. conditions, posttranslational modification affects chemokine potency and natural MCP-2(6-76) is a functional C-C chemokine inhibitor that might be useful as an inhibitor of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZfZaSLeX4v7Vg90H21EOLACvtfcHk0lh9X8cYPCahaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1CisLo%253D&md5=740cf869c57f95c89099e1cd3b55e387</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProost%26aufirst%3DP.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DCouvreur%26aufirst%3DM.%26aulast%3DLenaerts%26aufirst%3DJ.%2BP.%26aulast%3DConings%26aufirst%3DR.%26aulast%3DMenten%26aufirst%3DP.%26aulast%3DVerhaert%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26atitle%3DPosttranslational%2520modifications%2520affect%2520the%2520activity%2520of%2520the%2520human%2520monocyte%2520chemotactic%2520proteins%2520MCP-1%2520and%2520MCP-2%253A%2520identification%2520of%2520MCP-2%25286%25E2%2580%259376%2529%2520as%2520a%2520natural%2520chemokine%2520inhibitor%26jtitle%3DJ.%2520Immunol%26date%3D1998%26volume%3D160%26spage%3D4034%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Damme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struyf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Coillie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sozzani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meester, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proost, P.</span></span> <span> </span><span class="NLM_article-title">The role of CD26/DPP IV in chemokine processing</span>. <i>Chem. Immunol</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1159/000058725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1159%2F000058725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10550929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXntFSntLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=42-56&author=J.+Van+Dammeauthor=S.+Struyfauthor=A.+Wuytsauthor=E.+Van+Coillieauthor=P.+Mentenauthor=D.+Scholsauthor=S.+Sozzaniauthor=I.+De+Meesterauthor=P.+Proost&title=The+role+of+CD26%2FDPP+IV+in+chemokine+processing&doi=10.1159%2F000058725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The role of CD26/DPP IV in chemokine processing</span></div><div class="casAuthors">Van Damme, Jo; Struyf, Sofie; Wuyts, Anja; Van Coillie, Els; Menten, Patricia; Schols, Dominique; Sozzani, Silvano; De Meester, Ingrid; Proost, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">Chemokines</span>),
    <span class="NLM_cas:pages">42-56</span>CODEN:
                <span class="NLM_cas:coden">CHMIEP</span>;
        ISSN:<span class="NLM_cas:issn">1015-0145</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review with 30 refs. describing the effects of dipeptidyl peptidase IV (DPP IV) on a large group of small inflammatory cytokines, chemokines.  For each individual chemoattractant the different biol. consequences of processing by CD26/DPP IV are evaluated in comparison with the intact mol.  These examples show that chemokines are important natural substrates for CD26/DPP IV and illustrate the impact of this serine protease in immune processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr355UtDqr_l7Vg90H21EOLACvtfcHk0lh9X8cYPCahaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFSntLs%253D&md5=606fca67ff327c49b71dc2d5cff9c082</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1159%2F000058725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000058725%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDamme%26aufirst%3DJ.%26aulast%3DStruyf%26aufirst%3DS.%26aulast%3DWuyts%26aufirst%3DA.%26aulast%3DVan%2BCoillie%26aufirst%3DE.%26aulast%3DMenten%26aufirst%3DP.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DSozzani%26aufirst%3DS.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DProost%26aufirst%3DP.%26atitle%3DThe%2520role%2520of%2520CD26%252FDPP%2520IV%2520in%2520chemokine%2520processing%26jtitle%3DChem.%2520Immunol%26date%3D1999%26volume%3D72%26spage%3D42%26epage%3D56%26doi%3D10.1159%2F000058725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morty, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span> <span> </span><span class="NLM_article-title">Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>394</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1042/BJ20051593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20051593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16248854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVemtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=394&publication_year=2006&pages=635-45&author=R.+E.+Mortyauthor=P.+Bulauauthor=R.+Pelleauthor=S.+Wilkauthor=K.+Abe&title=Pyroglutamyl+peptidase+type+I+from+Trypanosoma+brucei%3A+a+new+virulence+factor+from+African+trypanosomes+that+de-blocks+regulatory+peptides+in+the+plasma+of+infected+hosts&doi=10.1042%2FBJ20051593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts</span></div><div class="casAuthors">Morty, Rory E.; Bulau, Patrick; Pelle, Roger; Wilk, Sherwin; Abe, Koji</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">394</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">635-645</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Peptidases of parasitic protozoans are emerging as novel virulence factors and therapeutic targets in parasitic infections.  A trypanosome-derived aminopeptidase that exclusively hydrolyzed substrates with Glp (pyroglutamic acid) in P1 was purified 9248-fold from the plasma of rats infected with Trypanosoma brucei brucei.  The enzyme responsible was cloned from a T. brucei brucei genomic DNA library and identified as type I PGP (pyroglutamyl peptidase), belonging to the C15 family of cysteine peptidases.  We showed that PGP is expressed in all life cycle stages of T. brucei brucei and is expressed in four other blood-stream-form African trypanosomes.  Trypanosome PGP was optimally active and stable at bloodstream pH, and was insensitive to host plasma cysteine peptidase inhibitors.  Native purified and recombinant hyper-expressed trypanosome PGP removed the N-terminal Glp blocking groups from TRH (TSH-releasing hormone) and GnRH (gonadotropin-releasing hormone) with a kcat/Km value of 0.5 and 0.1 s-1·μM-1 resp.  The half-life of TRH and GnRH was dramatically reduced in the plasma of trypanosome-infected rats, both in vitro and in vivo.  Employing an activity-neutralizing anti-trypanosome PGP antibody, and pyroglutamyl diazomethyl ketone, a specific inhibitor of type I PGP, we demonstrated that trypanosome PGP is entirely responsible for the reduced plasma half-life of TRH, and partially responsible for the reduced plasma half-life of GnRH in a rodent model of African trypanosomiasis.  The abnormal degrdn. of TRH and GnRH, and perhaps other neuropeptides N-terminally blocked with a pyroglutamyl moiety, by trypanosome PGP, may contribute to some of the endocrine lesions obsd. in African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP81Dkgd4tTLVg90H21EOLACvtfcHk0lhlFuyJ2lrzeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVemtbk%253D&md5=b3178bda663c10250215cb1d87577e45</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1042%2FBJ20051593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20051593%26sid%3Dliteratum%253Aachs%26aulast%3DMorty%26aufirst%3DR.%2BE.%26aulast%3DBulau%26aufirst%3DP.%26aulast%3DPelle%26aufirst%3DR.%26aulast%3DWilk%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26atitle%3DPyroglutamyl%2520peptidase%2520type%2520I%2520from%2520Trypanosoma%2520brucei%253A%2520a%2520new%2520virulence%2520factor%2520from%2520African%2520trypanosomes%2520that%2520de-blocks%2520regulatory%2520peptides%2520in%2520the%2520plasma%2520of%2520infected%2520hosts%26jtitle%3DBiochem.%2520J.%26date%3D2006%26volume%3D394%26spage%3D635%26epage%3D45%26doi%3D10.1042%2FBJ20051593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rubsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waniek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jager, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1007/s00401-015-1395-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00401-015-1395-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25666182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC2MrktVCqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2015&pages=565-83&author=M.+Hartlage-Rubsamenauthor=A.+Waniekauthor=J.+Meissnerauthor=M.+Morawskiauthor=S.+Schillingauthor=C.+Jagerauthor=M.+Kleinschmidtauthor=H.+Cynisauthor=A.+Kehlenauthor=T.+Arendtauthor=H.+U.+Demuthauthor=S.+Rossner&title=Isoglutaminyl+cyclase+contributes+to+CCL2-driven+neuroinflammation+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00401-015-1395-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease</span></div><div class="casAuthors">Hartlage-Rubsamen Maike; Waniek Alexander; Meissner Juliane; Morawski Markus; Schilling Stephan; Jager Carsten; Kleinschmidt Martin; Cynis Holger; Kehlen Astrid; Arendt Thomas; Demuth Hans-Ulrich; Rossner Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">565-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The brains of Alzheimer's disease (AD) patients are characterized by deposits of Abeta peptides and by accompanying chronic inflammation.  Here, we provide evidence that the enzyme isoglutaminyl cyclase (isoQC) is a novel factor contributing to both aspects of AD pathology.  Two putative substrates of isoQC, N-truncated Abeta peptides and the monocyte chemoattractant chemokine CCL2, undergo isoQC-catalyzed pyroglutamate (pGlu) modification.  This triggers Abeta aggregation and facilitates the biological activity of CCL2, which collectively results in the formation of high molecular weight Abeta aggregates, glial cell activation, neuroinflammation and neuronal cell death.  In mouse brain, we found isoQC to be neuron-specifically expressed in neocortical, hippocampal and subcortical structures, localized to the endoplasmic reticulum and Golgi apparatus as well as co-expressed with its substrate CCL2.  In aged APP transgenic Tg2576 mice, both isoQC and CCL2 mRNA levels are up-regulated and isoQC and CCL2 proteins were found to be co-induced in Abeta plaque-associated reactive astrocytes.  Also, in mouse primary astrocyte culture, a simultaneous up-regulation of isoQC and CCL2 expression was revealed upon Abeta and pGlu-Abeta stimulation.  In brains of AD patients, the expression of isoQC and CCL2 mRNA and protein is up-regulated compared to controls and correlates with pGlu-Abeta load and with the decline in mini-mental state examination.  Our observations provide evidence for a dual involvement of isoQC in AD pathogenesis by catalysis of pGlu-Abeta and pGlu-CCL2 formation which mutually stimulate inflammatory events and affect cognition.  We conclude that isoQC inhibition may target both major pathological events in the development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKSXYAxDU0oENoizSOkG_FfW6udTcc2eYwaFTnjdCmdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrktVCqsA%253D%253D&md5=ab30e02a5766b18080d5e5542d74d5a8</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs00401-015-1395-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-015-1395-2%26sid%3Dliteratum%253Aachs%26aulast%3DHartlage-Rubsamen%26aufirst%3DM.%26aulast%3DWaniek%26aufirst%3DA.%26aulast%3DMeissner%26aufirst%3DJ.%26aulast%3DMorawski%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DJager%26aufirst%3DC.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DArendt%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DIsoglutaminyl%2520cyclase%2520contributes%2520to%2520CCL2-driven%2520neuroinflammation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neuropathol.%26date%3D2015%26volume%3D129%26spage%3D565%26epage%3D83%26doi%3D10.1007%2Fs00401-015-1395-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellvard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maresz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graubner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potempa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mydel, P.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclases as novel targets for the treatment of septic arthritis</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1093/infdis/jis729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1093%2Finfdis%2Fjis729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23204180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1Wmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2013&pages=768-77&author=A.+Hellvardauthor=K.+Mareszauthor=S.+Schillingauthor=S.+Graubnerauthor=U.+Heiserauthor=R.+Jonssonauthor=H.+Cynisauthor=H.+U.+Demuthauthor=J.+Potempaauthor=P.+Mydel&title=Glutaminyl+cyclases+as+novel+targets+for+the+treatment+of+septic+arthritis&doi=10.1093%2Finfdis%2Fjis729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl Cyclases as Novel Targets for the Treatment of Septic Arthritis</span></div><div class="casAuthors">Hellvard, Annelie; Maresz, Katarzyna; Schilling, Stephan; Graubner, Sigrid; Heiser, Ulrich; Jonsson, Roland; Cynis, Holger; Demuth, Hans-Ulrich; Potempa, Jan; Mydel, Piotr</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">768-777</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background.  Septic arthritis is a severe and rapidly debilitating disease mainly caused by Staphylococcus aureus.  Here, we assess the antiarthritic efficiency of glutaminyl cyclase (QC) inhibitors.  Methods. Mice were inoculated with an arthritogenic amt. of S. aureus i.v. or by local administration into the knee joint.  Animals were treated with QC inhibitors (PBD155 and PQ529) via chow during the expt.  QC and isoQC knockout mice were also analyzed for arthritis symptoms after local administration of bacteria.  Results. Both QC inhibitors significantly delayed the onset of clin. signs of arthritis, and inhibitors significantly decreased wt. loss in treated animals.  Following intraarticular injection of S. aureus, PBD155-treated mice had lower levels of synovitis and bone erosion, as well as less myeloperoxidase in synovial tissue.  Fluorescence-activated cell sorter anal. revealed that PBD155 treatment affected the expression pattern of adhesion mols., preventing the upregulation of cells expressing CD11b/CD18.  Conclusion.  The compds. investigated here represent a novel class of small mol. antiarthritic inhibitors.  In our studies, they exerted strong antiinflammatory actions, and therefore they might be suited for disease-modifying treatment of infectious arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo4yVYVMrBzLVg90H21EOLACvtfcHk0lhlFuyJ2lrzeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1Wmtbk%253D&md5=2c10eb602ffb85bd1bb984ce8b688084</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjis729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjis729%26sid%3Dliteratum%253Aachs%26aulast%3DHellvard%26aufirst%3DA.%26aulast%3DMaresz%26aufirst%3DK.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DGraubner%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DJonsson%26aufirst%3DR.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DMydel%26aufirst%3DP.%26atitle%3DGlutaminyl%2520cyclases%2520as%2520novel%2520targets%2520for%2520the%2520treatment%2520of%2520septic%2520arthritis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D207%26spage%3D768%26epage%3D77%26doi%3D10.1093%2Finfdis%2Fjis729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamohara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, T.</span></span> <span> </span><span class="NLM_article-title">MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1002/jlb.65.5.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Fjlb.65.5.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10331497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=671-9&author=S.+Yamashiroauthor=H.+Kamoharaauthor=T.+Yoshimura&title=MCP-1+is+selectively+expressed+in+the+late+phase+by+cytokine-stimulated+human+neutrophils%3A+TNF-alpha+plays+a+role+in+maximal+MCP-1+mRNA+expression&doi=10.1002%2Fjlb.65.5.671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in maximal MCP-1 mRNA expression</span></div><div class="casAuthors">Yamashiro, Shigeo; Kamohara, Hidenobu; Yoshimura, Teizo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">671-679</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Culture supernatants of phytohemagglutinin (PHA)-stimulated human peripheral blood mononuclear cells (PHA-sup) induced monocyte chemoattractant protein-1 (MCP-1) mRNA expression in human neutrophils.  MCP-1 mRNA was first detected by Northern anal. at 8 h, and the peak level was detected at 16 h and sustained until 72 h.  Cycloheximide and genistein, but not pertussis toxin, inhibited the expression of MCP-1 mRNA.  Recombinant tumor necrosis factor α (TNF-α) induced a low level MCP-1 mRNA accumulation in neutrophils, and addn. of anti-TNF-α IgG blocked 30-70% of MCP-1 mRNA expression induced with PHA-sup.  PHA-sup-stimulated PMN synthesized and secreted 3.1±1.3 ng/5×106 PMN MCP-1 within the first 24 h.  Hybridization of 32P-labeled cDNA prepns. to an array of human cytokine cDNAs further indicated that MCP-1 mRNA was selectively up-regulated in the late phase after stimulation with the PHA-sup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOaYzQILY_F7Vg90H21EOLACvtfcHk0lhshF8PNOQ3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGhtrY%253D&md5=27687e01ed597defda59b9e46f7a3bad</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fjlb.65.5.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlb.65.5.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamashiro%26aufirst%3DS.%26aulast%3DKamohara%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DT.%26atitle%3DMCP-1%2520is%2520selectively%2520expressed%2520in%2520the%2520late%2520phase%2520by%2520cytokine-stimulated%2520human%2520neutrophils%253A%2520TNF-alpha%2520plays%2520a%2520role%2520in%2520maximal%2520MCP-1%2520mRNA%2520expression%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D1999%26volume%3D65%26spage%3D671%26epage%3D9%26doi%3D10.1002%2Fjlb.65.5.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luster, A. D.</span></span> <span> </span><span class="NLM_article-title">Novel approach to inhibiting chemokine function</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1002/emmm.201100161</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1002%2Femmm.201100161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21882341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=510-2&author=M.+F.+Lingauthor=A.+D.+Luster&title=Novel+approach+to+inhibiting+chemokine+function&doi=10.1002%2Femmm.201100161"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approach to inhibiting chemokine function</span></div><div class="casAuthors">Ling, Morris F.; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">510-512</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The research of Cynis et al. (2011) entitled 'The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions' is reviewed with commentary and refs.  Cynis et al. present evidence that enzymes, such as metalloenzyme transferases, specifically glutaminyl cyclase and iso-glutaminyl cyclase, play a role in the in vivo biol. activity of CCL2 by catalyzing the formation of N-terminal pyroglutamate, which confers resistance against aminopeptidase degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmkFprrwJffrVg90H21EOLACvtfcHk0lhshF8PNOQ3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtF2hs7jL&md5=5d91c7ee3aefdcb4bf3778177d12a02f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1002%2Femmm.201100161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201100161%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DM.%2BF.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DNovel%2520approach%2520to%2520inhibiting%2520chemokine%2520function%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D510%26epage%3D2%26doi%3D10.1002%2Femmm.201100161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacon, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardiman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlotnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schall, T. J.</span></span> <span> </span><span class="NLM_article-title">A new class of membrane-bound chemokine with a CX3C motif</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>385</i></span>,  <span class="NLM_fpage">640</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/385640a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F385640a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9024663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2sXht1yks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1997&pages=640-4&author=J.+F.+Bazanauthor=K.+B.+Baconauthor=G.+Hardimanauthor=W.+Wangauthor=K.+Sooauthor=D.+Rossiauthor=D.+R.+Greavesauthor=A.+Zlotnikauthor=T.+J.+Schall&title=A+new+class+of+membrane-bound+chemokine+with+a+CX3C+motif&doi=10.1038%2F385640a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">A new class of membrane-bound chemokine with a CX3C motif</span></div><div class="casAuthors">Bazan, J. Fernando; Bacon, Kevin B.; Hardiman, Gary; Wang, Wei; Soo, Ken; Rossl, Devora; Greaves, David R.; Zlotnik, Albert; Schall, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">6617</span>),
    <span class="NLM_cas:pages">640-644</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Chemokines direct the trafficking of white blood cells in immune surveillance, playing a key role in inflammatory and infectious diseases such as AIDS.  All chemokines studied so far are secreted proteins of relative mol. mass ∼7K-15K and fall into three families that are defined by a cysteine signature motif: CXC, CC and C (refs 3, 6, 7), where C is a cysteine and X any amino-acid residue.  The authors report here the identification and characterization of a fourth human chemokine type, derived from non-hemopoietic cells and bearing a new CX3C fingerprint.  Unlike other chemokine types the polypeptide chain of the human CX3C chemokine is predicted to be part of a 373-amino-acid protein that carries the chemokine domain on top of an extended mucin-like stalk.  This mol. can exist in two forms: either membrane-anchored or as a shed 95K glycoprotein.  The sol. CX3C chemokine has potent chemoattractant activity for T cells and monocytes, and the cell-surface-bound protein, which is induced on activated primary endothelial cells, promotes strong adhesion of those leukocytes.  The structure, biochem. features, tissue distribution and chromosomal localization of CX3C chemokine all indicate that it represents a unique class of chemokine that may contribute part of the mol. control of leukocyte traffic at the endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZGCDgNU9IybVg90H21EOLACvtfcHk0lhshF8PNOQ3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXht1yks7w%253D&md5=95e350c92137d13c11d36d72989cf52b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2F385640a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F385640a0%26sid%3Dliteratum%253Aachs%26aulast%3DBazan%26aufirst%3DJ.%2BF.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26aulast%3DHardiman%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSoo%26aufirst%3DK.%26aulast%3DRossi%26aufirst%3DD.%26aulast%3DGreaves%26aufirst%3DD.%2BR.%26aulast%3DZlotnik%26aufirst%3DA.%26aulast%3DSchall%26aufirst%3DT.%2BJ.%26atitle%3DA%2520new%2520class%2520of%2520membrane-bound%2520chemokine%2520with%2520a%2520CX3C%2520motif%26jtitle%3DNature%26date%3D1997%26volume%3D385%26spage%3D640%26epage%3D4%26doi%3D10.1038%2F385640a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alperin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culpepper, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Ramos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, D.</span></span> <span> </span><span class="NLM_article-title">Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>387</i></span>,  <span class="NLM_fpage">611</span>– <span class="NLM_lpage">7</span>, <span class="refDoi"> DOI: 10.1038/42491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2F42491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9177350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK2sXktFCitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=1997&pages=611-7&author=Y.+Panauthor=C.+Lloydauthor=H.+Zhouauthor=S.+Dolichauthor=J.+Deedsauthor=J.+A.+Gonzaloauthor=J.+Vathauthor=M.+Gosselinauthor=J.+Maauthor=B.+Dussaultauthor=E.+Woolfauthor=G.+Alperinauthor=J.+Culpepperauthor=J.+C.+Gutierrez-Ramosauthor=D.+Gearing&title=Neurotactin%2C+a+membrane-anchored+chemokine+upregulated+in+brain+inflammation&doi=10.1038%2F42491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation</span></div><div class="casAuthors">Pan, Yang; Lloyd, Clare; Zhou, Hong; Dolich, Sylvia; Deeds, Jim; Gonzalo, Jose-Angel; Vath, Jim; Gosselin, Mike; Ma, Jingya; Dussault, Barry; Woolf, Elizabeth; Alperin, Geoff; Culpepper, Janice; Gutierrez-Ramos, Jose Carlos; Gearing, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">6633</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Chemokines are small secreted proteins that stimulate the directional migration of leukocytes and mediate inflammation.  During screening of a murine choroid plexus complementary DNA library, the authors identified a new chemokine, designated neurotactin.  Unlike other chemokines, neurotactin has a unique cysteine pattern, Cys-X-X-X-Cys, and is predicted to be a type 1 membrane protein.  Full-length recombinant neurotactin is localized on the surface of transfected 293 cells.  Recombinant neurotactin contg. the chemokine domain is chemotactic for neutrophils both in vitro and in vivo.  Neurotactin mRNA is predominantly expressed in normal murine brain and its protein expression in activated brain microglia is upregulated in mice with exptl. autoimmune encephalomyelitis, as well as in mice treated with lipopolysaccharide.  Distinct from all other chemokine genes, the neurotactin gene is localized to human chromosome 16q.  Consequently the authors propose that neurotactin represents a new δ-chemokine family and that it may play a role in brain inflammation processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrieudM4ZMZibVg90H21EOLACvtfcHk0li_JMYjbij_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFCitLc%253D&md5=0206dad37fdb5558cc0f1fa6faceb048</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2F42491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F42491%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DDolich%26aufirst%3DS.%26aulast%3DDeeds%26aufirst%3DJ.%26aulast%3DGonzalo%26aufirst%3DJ.%2BA.%26aulast%3DVath%26aufirst%3DJ.%26aulast%3DGosselin%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DDussault%26aufirst%3DB.%26aulast%3DWoolf%26aufirst%3DE.%26aulast%3DAlperin%26aufirst%3DG.%26aulast%3DCulpepper%26aufirst%3DJ.%26aulast%3DGutierrez-Ramos%26aufirst%3DJ.%2BC.%26aulast%3DGearing%26aufirst%3DD.%26atitle%3DNeurotactin%252C%2520a%2520membrane-anchored%2520chemokine%2520upregulated%2520in%2520brain%2520inflammation%26jtitle%3DNature%26date%3D1997%26volume%3D387%26spage%3D611%26epage%3D7%26doi%3D10.1038%2F42491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fong, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steeber, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedder, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span> <span> </span><span class="NLM_article-title">Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>188</i></span>,  <span class="NLM_fpage">1413</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1084/jem.188.8.1413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1084%2Fjem.188.8.1413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=9782118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADyaK1cXmslKltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1998&pages=1413-9&author=A.+M.+Fongauthor=L.+A.+Robinsonauthor=D.+A.+Steeberauthor=T.+F.+Tedderauthor=O.+Yoshieauthor=T.+Imaiauthor=D.+D.+Patel&title=Fractalkine+and+CX3CR1+mediate+a+novel+mechanism+of+leukocyte+capture%2C+firm+adhesion%2C+and+activation+under+physiologic+flow&doi=10.1084%2Fjem.188.8.1413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow</span></div><div class="casAuthors">Fong, Alan M.; Robinson, Lisa A.; Steeber, Douglas A.; Tedder, Thomas F.; Yoshie, Osamu; Imai, Toshio; Patel, Dhavalkumar D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1413-1419</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Leukocyte migration into sites of inflammation involves multiple mol. interactions between leukocytes and vascular endothelial cells, mediating sequential leukocyte capture, rolling, and firm adhesion.  Here, the authors tested the role of mol. interactions between fractalkine (FKN), a transmembrane mucin-chemokine hybrid mol. expressed on activated endothelium, and its receptor (CX3CR1) in leukocyte capture, firm adhesion, and activation under physiol. flow conditions.  Immobilized FKN fusion proteins captured resting peripheral blood mononuclear cells at physiol. wall shear stresses and induced firm adhesion of resting monocytes, resting and interleukin (IL)-2-activated CD8+ T lymphocytes, and IL-2-activated NK cells.  FKN also induced cell shape change in firmly adherent monocytes and IL-2-activated lymphocytes.  CX3CR1-transfected K562 cells, but not control K562 cells, firmly adhered to FKN-expressing ECV-304 cells (ECV-FKN) and tumor necrosis factor α-activated human umbilical vein endothelial cells.  This firm adhesion was not inhibited by pertussis toxin, EDTA/EGTA, or anti-integrin antibodies, indicating that the firm adhesion was integrin independent.  Thus, FKN mediated the rapid capture, integrin-independent firm adhesion, and activation of circulating leukocytes under flow.  Thus, FKN and CX3CR1 mediate a novel pathway for leukocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHofbf-vgcLVg90H21EOLACvtfcHk0li_JMYjbij_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmslKltb8%253D&md5=caf11c991d6ab42759e8d08491b42474</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1084%2Fjem.188.8.1413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.188.8.1413%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DA.%2BM.%26aulast%3DRobinson%26aufirst%3DL.%2BA.%26aulast%3DSteeber%26aufirst%3DD.%2BA.%26aulast%3DTedder%26aufirst%3DT.%2BF.%26aulast%3DYoshie%26aufirst%3DO.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26atitle%3DFractalkine%2520and%2520CX3CR1%2520mediate%2520a%2520novel%2520mechanism%2520of%2520leukocyte%2520capture%252C%2520firm%2520adhesion%252C%2520and%2520activation%2520under%2520physiologic%2520flow%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1998%26volume%3D188%26spage%3D1413%26epage%3D9%26doi%3D10.1084%2Fjem.188.8.1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallon-Eberhard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zigmond, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farache, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shezen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span> <span> </span><span class="NLM_article-title">In vivo structure/function and expression analysis of the CX3C chemokine fractalkine</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">e156</span>– <span class="NLM_lpage">e167</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-04-348946</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1182%2Fblood-2011-04-348946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=21951685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=e156-e167&author=K.+W.+Kimauthor=A.+Vallon-Eberhardauthor=E.+Zigmondauthor=J.+Faracheauthor=E.+Shezenauthor=G.+Shakharauthor=A.+Ludwigauthor=S.+A.+Liraauthor=S.+Jung&title=In+vivo+structure%2Ffunction+and+expression+analysis+of+the+CX3C+chemokine+fractalkine&doi=10.1182%2Fblood-2011-04-348946"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo structure/function and expression analysis of the CX3C chemokine fractalkine</span></div><div class="casAuthors">Kim, Ki-Wook; Vallon-Eberhard, Alexandra; Zigmond, Ehud; Farache, Julia; Shezen, Elias; Shakhar, Guy; Ludwig, Andreas; Lira, Sergio A.; Jung, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e156-e167</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The CX3C chemokine family is composed of only one member, CX3CL1, also known as fractalkine, which in mice is the sole ligand of the G protein-coupled, 7-transmembrane receptor CX3CR1.  Unlike classic small peptide chemokines, CX3CL1 is synthesized as a membrane-anchored protein that can promote integrin-independent adhesion.  Subsequent cleavage by metalloproteases, either constitutive or induced, can generate shed CX3CL1 entities that potentially have chemoattractive activity.  To study the CX3C interface in tissues of live animals, we generated transgenic mice (CX3CL1cherry:CX3CR1gfp), which express red and green fluorescent reporter genes under the resp. control of the CX3CL1 and CX3CR1 promoters.  Furthermore, we performed a structure/function anal. to differentiate the in vivo functions of membrane-tethered vs. shed CX3CL1 moieties by comparing their resp. ability to correct established defects in macrophage function and leukocyte survival in CX3CL1-deficient mice.  Specifically, expression of CX3CL1105Δ, an obligatory sol. CX3CL1 isoform, reconstituted the formation of transepithelial dendrites by intestinal macrophages but did not rescue circulating Ly6Clo CX3CR1hi blood monocytes in CX3CR1gfp/gfp mice.  Instead, monocyte survival required the full-length membrane-anchored CX3CL1, suggesting differential activities of tethered and shed CX3CL1 entities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGuqon47Z_d7Vg90H21EOLACvtfcHk0li_JMYjbij_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfL&md5=ff6bba2a0a30f127f461fcfd788aeb68</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-04-348946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-04-348946%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BW.%26aulast%3DVallon-Eberhard%26aufirst%3DA.%26aulast%3DZigmond%26aufirst%3DE.%26aulast%3DFarache%26aufirst%3DJ.%26aulast%3DShezen%26aufirst%3DE.%26aulast%3DShakhar%26aufirst%3DG.%26aulast%3DLudwig%26aufirst%3DA.%26aulast%3DLira%26aufirst%3DS.%2BA.%26aulast%3DJung%26aufirst%3DS.%26atitle%3DIn%2520vivo%2520structure%252Ffunction%2520and%2520expression%2520analysis%2520of%2520the%2520CX3C%2520chemokine%2520fractalkine%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26spage%3De156%26epage%3De167%26doi%3D10.1182%2Fblood-2011-04-348946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">37</span>, <span class="refDoi"> DOI: 10.1042/BSR20170712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBSR20170712" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=37&author=A.+Kehlenauthor=M.+Haegeleauthor=L.+Bohmeauthor=H.+Cynisauthor=T.+Hoffmannauthor=H.+U.+Demuth&title=N-terminal+pyroglutamate+formation+in+CX3CL1+is+essential+for+its+full+biologic+activity&doi=10.1042%2FBSR20170712"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBSR20170712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20170712%26sid%3Dliteratum%253Aachs%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DN-terminal%2520pyroglutamate%2520formation%2520in%2520CX3CL1%2520is%2520essential%2520for%2520its%2520full%2520biologic%2520activity%26jtitle%3DBiosci.%2520Rep.%26date%3D2017%26volume%3D37%26spage%3D37%26doi%3D10.1042%2FBSR20170712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gans, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immel, U. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang-Vu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klonisch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Role of glutaminyl cyclases in thyroid carcinomas</span>. <i>Endocr.-Relat. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1530/ERC-12-0053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1530%2FERC-12-0053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23183267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1Wnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=79-90&author=A.+Kehlenauthor=M.+Haegeleauthor=K.+Mengeauthor=K.+Gansauthor=U.+D.+Immelauthor=C.+Hoang-Vuauthor=T.+Klonischauthor=H.+U.+Demuth&title=Role+of+glutaminyl+cyclases+in+thyroid+carcinomas&doi=10.1530%2FERC-12-0053"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Role of glutaminyl cyclases in thyroid carcinomas</span></div><div class="casAuthors">Kehlen, Astrid; Haegele, Monique; Menge, Katja; Gans, Kathrin; Immel, Uta-Dorothee; Hoang-Vu, Cuong; Klonisch, Thomas; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-90</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">CCL2 is a chemokine known to recruit monocytes/macrophages to sites of inflammation.  CCL2 is also assocd. with tumor progression in several cancer types.  Recently, we showed that the N-terminus of CCL2 is modified to a pyroglutamate (pE)-residue by both glutaminyl cyclases (QC (QPCT)) and its isoenzyme (isoQC (QPCTL)).  The pE-residue increases stability against N-terminal degrdn. by aminopeptidases.  Here, we report an upregulation of QPCT expression in tissues of patients with thyroid carcinomas compared with goiter tissues, whereas QPCTL was not regulated.  In thyroid carcinoma cell lines, QPCT gene expression correlates with the mRNA levels of its substrate CCL2.  Both QPCT and CCL2 are regulated in a NF-κB-dependent pathway shown by stimulation with TNFa and IL1b as well as by inhibition with the IKK2 inhibitor and RNAi of p50.  In the culture supernatant of thyroid carcinoma cells, equal amts. of pECCL2 and total CCL2 were detected by two ELISAs discriminating between total CCL2 and pECCL2, concluding that all CCL2 is secreted as pECCL2.  Activation of the CCL2/CCR2 pathway by recombinant CCL2 increased tumor cell migration of FTC238 cells in scratch assays as well as thyroid carcinoma cell-derived CCL2-induced migration of monocytic THP1 cells.  Suppression of CCL2 signaling by CCR2 antagonist, IKK2 inhibitor, and QPCT RNAi reduced FTC238 cell growth measured by WST8 proliferation assays.  Our results reveal new evidence for a novel role of QC in thyroid carcinomas and provide an intriguing rationale for the use of QC inhibitors as a means of blocking pECCL2 formation and preventing thyroid cancer metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomPAfI_6VjirVg90H21EOLACvtfcHk0lgyeuhdwmDzlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1Wnsrk%253D&md5=5581d4220e8d7bf0479765cebabf9a2b</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1530%2FERC-12-0053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FERC-12-0053%26sid%3Dliteratum%253Aachs%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DMenge%26aufirst%3DK.%26aulast%3DGans%26aufirst%3DK.%26aulast%3DImmel%26aufirst%3DU.%2BD.%26aulast%3DHoang-Vu%26aufirst%3DC.%26aulast%3DKlonisch%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DRole%2520of%2520glutaminyl%2520cyclases%2520in%2520thyroid%2520carcinomas%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2013%26volume%3D20%26spage%3D79%26epage%3D90%26doi%3D10.1530%2FERC-12-0053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barclay, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van den Berg, T. K.</span></span> <span> </span><span class="NLM_article-title">The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-032713-120142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1146%2Fannurev-immunol-032713-120142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=24215318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVemtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=25-50&author=A.+N.+Barclayauthor=T.+K.+Van+den+Berg&title=The+interaction+between+signal+regulatory+protein+alpha+%28SIRPalpha%29+and+CD47%3A+structure%2C+function%2C+and+therapeutic+target&doi=10.1146%2Fannurev-immunol-032713-120142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target</span></div><div class="casAuthors">Barclay, A. Neil; van den Berg, Timo K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-50</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  CD47 is a broadly expressed membrane protein that interacts with the myeloid inhibitory immunoreceptor SIRPα (also termed CD172a or SHPS-1).  SIRPα is the prototypic member of the SIRP paired receptor family of closely related SIRP proteins.  Engagement of SIRPα by CD47 provides a downregulatory signal that inhibits host cell phagocytosis, and CD47 therefore functions as a "don't-eat-me" signal.  Here, we discuss recent structural anal. of CD47-SIRPα interactions and implications of this for the function and evolution of SIRPα and paired receptors in general.  Furthermore, we review the proposed roles of CD47-SIRPα interactions in phagocytosis, (auto)immunity, and host defense, as well as its potential significance as a therapeutic target in cancer and inflammation and for improving graft survival in xenotransplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxNJXce0UL47Vg90H21EOLACvtfcHk0lgyeuhdwmDzlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVemtro%253D&md5=473668c1b298de00984d39ce76a1eee2</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-032713-120142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-032713-120142%26sid%3Dliteratum%253Aachs%26aulast%3DBarclay%26aufirst%3DA.%2BN.%26aulast%3DVan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26atitle%3DThe%2520interaction%2520between%2520signal%2520regulatory%2520protein%2520alpha%2520%2528SIRPalpha%2529%2520and%2520CD47%253A%2520structure%252C%2520function%252C%2520and%2520therapeutic%2520target%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D32%26spage%3D25%26epage%3D50%26doi%3D10.1146%2Fannurev-immunol-032713-120142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Identification of glutaminyl cyclase isoenzyme isoQC as a regulator of SIRPalpha-CD47 axis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">505</span>, <span class="refDoi"> DOI: 10.1038/s41422-019-0177-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fs41422-019-0177-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31089204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BB3M7lvVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=502-505&author=Z.+Wuauthor=L.+Wengauthor=T.+Zhangauthor=H.+Tianauthor=L.+Fangauthor=H.+Tengauthor=W.+Zhangauthor=J.+Gaoauthor=Y.+Haoauthor=Y.+Liauthor=H.+Zhouauthor=P.+Wang&title=Identification+of+glutaminyl+cyclase+isoenzyme+isoQC+as+a+regulator+of+SIRPalpha-CD47+axis&doi=10.1038%2Fs41422-019-0177-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis</span></div><div class="casAuthors">Wu Zhiqiang; Weng Linjun; Zhang Tengbo; Tian Hongling; Fang Lan; Teng Hongqi; Zhang Wen; Hao Yun; Li Yaxu; Wang Ping; Gao Jing; Zhou Hu</div><div class="citationInfo"><span class="NLM_cas:title">Cell research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">502-505</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl7MGHClp5dOQ4Pl9hzjQhfW6udTcc2eboLsW9v4olV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M7lvVSmsA%253D%253D&md5=c84d45212623bb116f3a804f4bd5f8ff</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fs41422-019-0177-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41422-019-0177-0%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DWeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DTeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520glutaminyl%2520cyclase%2520isoenzyme%2520isoQC%2520as%2520a%2520regulator%2520of%2520SIRPalpha-CD47%2520axis%26jtitle%3DCell%2520Res.%26date%3D2019%26volume%3D29%26spage%3D502%26epage%3D505%26doi%3D10.1038%2Fs41422-019-0177-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Logtenberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raaben, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toebes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsma, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matlung, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauster, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Eerland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Schot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marijt, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdoes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haanen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Berg, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefjes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Berg, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummelkamp, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leusen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheeren, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumacher, T. N.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPalpha axis and a target for cancer immunotherapy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">612</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/s41591-019-0356-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fs41591-019-0356-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=30833751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmsV2isbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=612-619&author=M.+Logtenbergauthor=J.+Jansenauthor=M.+Raabenauthor=M.+Toebesauthor=K.+Frankeauthor=A.+M.+Brandsmaauthor=H.+L.+Matlungauthor=A.+Fausterauthor=R.+Gomez-Eerlandauthor=N.+Bakkerauthor=S.+van+der+Schotauthor=K.+A.+Marijtauthor=M.+Verdoesauthor=J.+Haanenauthor=J.+H.+van+den%0ABergauthor=J.+Neefjesauthor=T.+K.+van+den+Bergauthor=T.+R.+Brummelkampauthor=J.+Leusenauthor=F.+A.+Scheerenauthor=T.+N.+Schumacher&title=Glutaminyl+cyclase+is+an+enzymatic+modifier+of+the+CD47-+SIRPalpha+axis+and+a+target+for+cancer+immunotherapy&doi=10.1038%2Fs41591-019-0356-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy</span></div><div class="casAuthors">Logtenberg, Meike E. W.; Jansen, J. H. Marco; Raaben, Matthijs; Toebes, Mireille; Franke, Katka; Brandsma, Arianne M.; Matlung, Hanke L.; Fauster, Astrid; Gomez-Eerland, Raquel; Bakker, Noor A. M.; van der Schot, Simone; Marijt, Koen A.; Verdoes, Martijn; Haanen, John B. A. G.; van den Berg, Joost H.; Neefjes, Jacques; van den Berg, Timo K.; Brummelkamp, Thijn R.; Leusen, Jeanette H. W.; Scheeren, Ferenc A.; Schumacher, Ton N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">612-619</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Cancer cells can evade immune surveillance through the expression of inhibitory ligands that bind their cognate receptors on immune effector cells.  Expression of programmed death ligand 1 in tumor microenvironments is a major immune checkpoint for tumor-specific T cell responses as it binds to programmed cell death protein-1 on activated and dysfunctional T cells1.  The activity of myeloid cells such as macrophages and neutrophils is likewise regulated by a balance between stimulatory and inhibitory signals.  In particular, cell surface expression of the CD47 protein creates a 'don't eat me' signal on tumor cells by binding to SIRPα expressed on myeloid cells2-5.  Using a haploid genetic screen, we here identify glutaminyl-peptide cyclotransferase-like protein (QPCTL) as a major component of the CD47-SIRPα checkpoint.  Biochem. anal. demonstrates that QPCTL is crit. for pyroglutamate formation on CD47 at the SIRPα binding site shortly after biosynthesis.  Genetic and pharmacol. interference with QPCTL activity enhances antibody-dependent cellular phagocytosis and cellular cytotoxicity of tumor cells.  Furthermore, interference with QPCTL expression leads to a major increase in neutrophil-mediated killing of tumor cells in vivo.  These data identify QPCTL as a novel target to interfere with the CD47 pathway and thereby augment antibody therapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1nAWsTLtLXrVg90H21EOLACvtfcHk0lgBL4NFhzhoIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmsV2isbs%253D&md5=31633e74a28064cd223eaee966f99b49</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fs41591-019-0356-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-019-0356-z%26sid%3Dliteratum%253Aachs%26aulast%3DLogtenberg%26aufirst%3DM.%26aulast%3DJansen%26aufirst%3DJ.%26aulast%3DRaaben%26aufirst%3DM.%26aulast%3DToebes%26aufirst%3DM.%26aulast%3DFranke%26aufirst%3DK.%26aulast%3DBrandsma%26aufirst%3DA.%2BM.%26aulast%3DMatlung%26aufirst%3DH.%2BL.%26aulast%3DFauster%26aufirst%3DA.%26aulast%3DGomez-Eerland%26aufirst%3DR.%26aulast%3DBakker%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BSchot%26aufirst%3DS.%26aulast%3DMarijt%26aufirst%3DK.%2BA.%26aulast%3DVerdoes%26aufirst%3DM.%26aulast%3DHaanen%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DJ.%2BH.%26aulast%3DNeefjes%26aufirst%3DJ.%26aulast%3Dvan%2Bden%2BBerg%26aufirst%3DT.%2BK.%26aulast%3DBrummelkamp%26aufirst%3DT.%2BR.%26aulast%3DLeusen%26aufirst%3DJ.%26aulast%3DScheeren%26aufirst%3DF.%2BA.%26aulast%3DSchumacher%26aufirst%3DT.%2BN.%26atitle%3DGlutaminyl%2520cyclase%2520is%2520an%2520enzymatic%2520modifier%2520of%2520the%2520CD47-%2520SIRPalpha%2520axis%2520and%2520a%2520target%2520for%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D612%26epage%3D619%26doi%3D10.1038%2Fs41591-019-0356-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, J. S.</span></span> <span> </span><span class="NLM_article-title">Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">27</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-4-27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2F1479-5876-4-27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=16820060" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BD28rhslCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=27&author=J.+S.+Gillis&title=Microarray+evidence+of+glutaminyl+cyclase+gene+expression+in+melanoma%3A+implications+for+tumor+antigen+specific+immunotherapy&doi=10.1186%2F1479-5876-4-27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy</span></div><div class="casAuthors">Gillis John Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of translational medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  In recent years encouraging progress has been made in developing vaccine treatments for cancer, particularly with melanoma.  However, the overall rate of clinically significant results has remained low.  The present research used microarray datasets from previous investigations to examine gene expression patterns in cancer cell lines with the goal of better understanding the tumor microenvironment.  METHODS:  Principal Components Analyses with Promax rotational transformations were carried out with 90 cancer cell lines from 3 microarray datasets, which had been made available on the internet as supplementary information from prior publications.  RESULTS:  In each of the analyses a well defined melanoma component was identified that contained a gene coding for the enzyme, glutaminyl cyclase, which was as highly expressed as genes from a variety of well established biomarkers for melanoma, such as MAGE-3 and MART-1, which have frequently been used in clinical trials of melanoma vaccines.  CONCLUSION:  Since glutaminyl cyclase converts glutamine and glutamic acid into a pyroglutamic form, it may interfere with the tumor destructive process of vaccines using peptides having glutamine or glutamic acid at their N-terminals.  Finding ways of inhibiting the activity of glutaminyl cyclase in the tumor microenvironment may help to increase the effectiveness of some melanoma vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwd2DRJfoRkdenUz0lpNqnfW6udTcc2eZ5rJozLy5ngLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhslCluw%253D%253D&md5=7d6217cdc9dcdcea6a8f644e31166683</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-4-27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-4-27%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DJ.%2BS.%26atitle%3DMicroarray%2520evidence%2520of%2520glutaminyl%2520cyclase%2520gene%2520expression%2520in%2520melanoma%253A%2520implications%2520for%2520tumor%2520antigen%2520specific%2520immunotherapy%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2006%26volume%3D4%26spage%3D27%26doi%3D10.1186%2F1479-5876-4-27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muthusamy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curley, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosenberg, M.</span></span> <span> </span><span class="NLM_article-title">Epigenetic silencing of novel tumor suppressors in malignant melanoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">11187</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-1274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1158%2F0008-5472.CAN-06-1274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=17145863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11187-93&author=V.+Muthusamyauthor=S.+Duraisamyauthor=C.+M.+Bradburyauthor=C.+Hobbsauthor=D.+P.+Curleyauthor=B.+Nelsonauthor=M.+Bosenberg&title=Epigenetic+silencing+of+novel+tumor+suppressors+in+malignant+melanoma&doi=10.1158%2F0008-5472.CAN-06-1274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic Silencing of Novel Tumor Suppressors in Malignant Melanoma</span></div><div class="casAuthors">Muthusamy, Viswanathan; Duraisamy, Sekhar; Bradbury, C. Matthew; Hobbs, Cara; Curley, David P.; Nelson, Betsy; Bosenberg, Marcus</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11187-11193</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Malignant melanoma is a common and frequently lethal disease.  Current therapeutic interventions have little effect on survival, emphasizing the need for a better understanding of the genetic, epigenetic, and phenotypic changes in melanoma formation and progression.  We identified 17 genes that were not previously known to be silenced by methylation in melanoma using a microarray-based screen following treatment of melanoma cell lines with the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.  Eight of these genes have not been previously shown to undergo DNA methylation in any form of cancer.  Three of the genes, QPCT, CYP1B1, and LXN, are densely methylated in >95% of uncultured melanoma tumor samples.  Reexpression of either of two of the silenced genes, HOXB13 and SYK, resulted in reduced colony formation in vitro and diminished tumor formation in vivo, indicating that these genes function as tumor suppressors in melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrytm6jFv95CrVg90H21EOLACvtfcHk0lgBL4NFhzhoIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnsL7E&md5=c611ca8d4653a07d4c30a416568c8cc2</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-1274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-1274%26sid%3Dliteratum%253Aachs%26aulast%3DMuthusamy%26aufirst%3DV.%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DBradbury%26aufirst%3DC.%2BM.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DCurley%26aufirst%3DD.%2BP.%26aulast%3DNelson%26aufirst%3DB.%26aulast%3DBosenberg%26aufirst%3DM.%26atitle%3DEpigenetic%2520silencing%2520of%2520novel%2520tumor%2520suppressors%2520in%2520malignant%2520melanoma%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11187%26epage%3D93%26doi%3D10.1158%2F0008-5472.CAN-06-1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ezura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiraki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orimo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emi, M.</span></span> <span> </span><span class="NLM_article-title">Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women</span>. <i>J. Bone Miner. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1296</span>– <span class="NLM_lpage">301</span>, <span class="refDoi"> DOI: 10.1359/JBMR.040324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1359%2FJBMR.040324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15231017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=1296-301&author=Y.+Ezuraauthor=M.+Kajitaauthor=R.+Ishidaauthor=S.+Yoshidaauthor=H.+Yoshidaauthor=T.+Suzukiauthor=T.+Hosoiauthor=S.+Inoueauthor=M.+Shirakiauthor=H.+Orimoauthor=M.+Emi&title=Association+of+multiple+nucleotide+variations+in+the+pituitary+glutaminyl+cyclase+gene+%28QPCT%29+with+low+radial+BMD+in+adult+women&doi=10.1359%2FJBMR.040324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult women</span></div><div class="casAuthors">Ezura, Yoichi; Kajita, Mitsuko; Ishida, Ryota; Yoshida, Shoko; Yoshida, Hideyo; Suzuki, Takao; Hosoi, Takayuki; Inoue, Satoshi; Shiraki, Masataka; Orimo, Hajime; Emi, Mitsuru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1296-1301</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Alterations in homeostatic regulation of estrogen through the hypothalamus-pituitary-gonadal axis (HPG axis) importantly affect the pathogenesis of osteoporosis.  Osteoporosis-susceptibility genes have been proposed in this hormonal axis, such as estrogen receptor genes and the gonadotropin-releasing hormone gene (GnRH).  Here the authors report another example of genes: glutaminyl-peptide cyclotransferase gene (QPCT), an essential modifier of pituitary peptide hormones, including GnRH.  Analyses of assocn. of 13 single nucleotide polymorphisms (SNPs) at the QPCT locus with adjusted areal BMD (adj-aBMD) were carried out among 384 adult women.  Linkage disequil. (LD) was analyzed by haplotype estn. and calcn. of D' and R2.  Multiple regression anal. was applied for evaluating the combined effects of the variations.  LD anal. indicated strong linkage disequil. within the entire 30-kb region of the QPCT gene.  Significant correlations were obsd. between the genotypes of the six SNPs and the radial adj-aBMD, among which R54W (nt + 160C> T) presented the most prominent assocn.  Striking assocn. was obsd. for these SNPs among the 309 subjects >50 yr of age (R54W, -1095T> C, - 1844C> T).  Multiple regression analyses indicated that multiple SNPs in the gene might act in combination to det. the radial adj-aBMD.  These results indicate that genetic variations in QPCT are the important factors affecting the BMD of adult women that contribute to susceptibility for osteoporosis.  The data should provide new insight into the etiol. of the disease and may suggest a new target to be considered during treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtYPn7wtTboLVg90H21EOLACvtfcHk0lisdmpPpP48zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFGqurg%253D&md5=48108525531b6bfc3a2679ef0fa03018</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1359%2FJBMR.040324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252FJBMR.040324%26sid%3Dliteratum%253Aachs%26aulast%3DEzura%26aufirst%3DY.%26aulast%3DKajita%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DR.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHosoi%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DS.%26aulast%3DShiraki%26aufirst%3DM.%26aulast%3DOrimo%26aufirst%3DH.%26aulast%3DEmi%26aufirst%3DM.%26atitle%3DAssociation%2520of%2520multiple%2520nucleotide%2520variations%2520in%2520the%2520pituitary%2520glutaminyl%2520cyclase%2520gene%2520%2528QPCT%2529%2520with%2520low%2520radial%2520BMD%2520in%2520adult%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2004%26volume%3D19%26spage%3D1296%26epage%3D301%26doi%3D10.1359%2FJBMR.040324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Batliwalla, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baechler, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khalili, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortmann, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulko, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregersen, P. K.</span></span> <span> </span><span class="NLM_article-title">Peripheral blood gene expression profiling in rheumatoid arthritis</span>. <i>Genes Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1038/sj.gene.6364209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fsj.gene.6364209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=15973463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsFCht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=388-97&author=F.+M.+Batliwallaauthor=E.+C.+Baechlerauthor=X.+Xiaoauthor=W.+Liauthor=S.+Balasubramanianauthor=H.+Khaliliauthor=A.+Damleauthor=W.+A.+Ortmannauthor=A.+Perroneauthor=A.+B.+Kantorauthor=P.+S.+Gulkoauthor=M.+Kernauthor=R.+Furieauthor=T.+W.+Behrensauthor=P.+K.+Gregersen&title=Peripheral+blood+gene+expression+profiling+in+rheumatoid+arthritis&doi=10.1038%2Fsj.gene.6364209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral blood gene expression profiling in rheumatoid arthritis</span></div><div class="casAuthors">Batliwalla, F. M.; Baechler, E. C.; Xiao, X.; Li, W.; Balasubramanian, S.; Khalili, H.; Damle, A.; Ortmann, W. A.; Perrone, A.; Kantor, A. B.; Gulko, P. S.; Kern, M.; Furie, R.; Behrens, T. W.; Gregersen, P. K.</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">GEIMA2</span>;
        ISSN:<span class="NLM_cas:issn">1466-4879</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors carried out gene expression profiling of peripheral blood mononuclear cells (PBMCs) in 29 patients with active rheumatoid arthritis (RA) and 21 control subjects using Affymetrix U95Av2 arrays.  Using cluster anal., the authors obsd. a significant alteration in the expression pattern of 81 genes in the PBMCs of RA patients compared with controls.  Many of these genes correlated with differences in monocyte counts between the two study populations, and the authors show that a large fraction of these genes are specifically expressed at high levels in monocytes.  In addn., a logistic regression anal. was performed to identify genes that performed best in the categorization of RA and control samples.  Glutaminyl cyclase, IL1RA, S100A12 (also known as calgranulin or EN-RAGE) and Grb2-assocd. binding protein (GAB2) were among the top discriminators.  Along with previous data, the overexpression of S100A12 in RA patients emphasizes the likely importance of RAGE pathways in disease pathogenesis.  The altered expression of GAB2, an intracellular adaptor mol. involved in regulating phosphatase function, is of particular interest given the recent identification of the intracellular phosphatase PTPN22 as a risk gene for RA.  These data suggest that a detailed study of gene expression patterns in peripheral blood can provide insight into disease pathogenesis.  However, it is also clear that substantially larger sample sizes will be required to evaluate fully gene expression profiling as a means of identifying disease subsets, or defining biomarkers of outcome and response to therapy in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra4PsSqC88CLVg90H21EOLACvtfcHk0lisdmpPpP48zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsFCht70%253D&md5=ef85af46c9cb0f4406068ea751b0ffbf</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fsj.gene.6364209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.gene.6364209%26sid%3Dliteratum%253Aachs%26aulast%3DBatliwalla%26aufirst%3DF.%2BM.%26aulast%3DBaechler%26aufirst%3DE.%2BC.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DKhalili%26aufirst%3DH.%26aulast%3DDamle%26aufirst%3DA.%26aulast%3DOrtmann%26aufirst%3DW.%2BA.%26aulast%3DPerrone%26aufirst%3DA.%26aulast%3DKantor%26aufirst%3DA.%2BB.%26aulast%3DGulko%26aufirst%3DP.%2BS.%26aulast%3DKern%26aufirst%3DM.%26aulast%3DFurie%26aufirst%3DR.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DGregersen%26aufirst%3DP.%2BK.%26atitle%3DPeripheral%2520blood%2520gene%2520expression%2520profiling%2520in%2520rheumatoid%2520arthritis%26jtitle%3DGenes%2520Immun.%26date%3D2005%26volume%3D6%26spage%3D388%26epage%3D97%26doi%3D10.1038%2Fsj.gene.6364209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taudte, N.</span>; <span class="NLM_string-name">Linnert, M.</span>; <span class="NLM_string-name">Rahfeld, J. U.</span>; <span class="NLM_string-name">Piechotta, A.</span>; <span class="NLM_string-name">Ramsbeck, D.</span>; <span class="NLM_string-name">Buchholz, M.</span>; <span class="NLM_string-name">Kolenko, P.</span>; <span class="NLM_string-name">Parthier, C.</span>; <span class="NLM_string-name">Houston, J. A.</span>; <span class="NLM_string-name">Veillard, F.</span>; <span class="NLM_string-name">Eick, S.</span>; <span class="NLM_string-name">Potempa, J.</span>; <span class="NLM_string-name">Schilling, S.</span>; <span class="NLM_string-name">Demuth, H. U.</span>; <span class="NLM_string-name">Stubbs, M. N.</span></span> <span> </span><span class="NLM_article-title">Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis</span>.  <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>. <span class="NLM_volume">296</span> <span class="NLM_fpage">100263</span><span class="refDoi"> DOI: 10.1016/j.jbc.2021.100263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.jbc.2021.100263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=33837744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3MXjvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2021&pages=100263&author=N.+Taudte&author=M.+Linnert&author=J.+U.+Rahfeld&author=A.+Piechotta&author=D.+Ramsbeck&author=M.+Buchholz&author=P.+Kolenko&author=C.+Parthier&author=J.+A.+Houston&author=F.+Veillard&author=S.+Eick&author=J.+Potempa&author=S.+Schilling&author=H.+U.+Demuth&author=M.+N.+Stubbs&title=Mammalian-like+type+II+glutaminyl+cyclases+in+Porphyromonas+gingivalis+and+other+oral+pathogenic+bacteria+as+targets+for+treatment+of+periodontitis&doi=10.1016%2Fj.jbc.2021.100263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis</span></div><div class="casAuthors">Taudte, Nadine; Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Kolenko, Petr; Parthier, Christoph; Houston, John A.; Veillard, Florian; Eick, Sigrun; Potempa, Jan; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">100263</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The development of a targeted therapy would significantly improve the treatment of periodontitis and its assocd. diseases including Alzheimer's disease, rheumatoid arthritis, and cardiovascular diseases.  Glutaminyl cyclases (QCs) from the oral pathogens Porphyromonas gingivalis, Tannerella forsythia, and Prevotella intermedia represent attractive target enzymes for small-mol. inhibitor development, as their action is likely to stabilize essential periplasmic and outer membrane proteins by N-terminal pyroglutamination.  In contrast to other microbial QCs that utilize the so-called type I enzymes, these oral pathogens possess sequences corresponding to type II QCs, obsd. hitherto only in animals.  However, whether differences between these bacteroidal QCs and animal QCs are sufficient to enable development of selective inhibitors is not clear.  To learn more, we recombinantly expressed all three QCs.  They exhibit comparable catalytic efficiencies and are inhibited by metal chelators.  Crystal structures of the enzymes from P. gingivalis (PgQC) and T. forsythia (TfQC) reveal a tertiary structure composed of an eight-stranded β-sheet surrounded by seven α-helixes, typical of animal type II QCs.  In each case, an active site Zn ion is tetrahedrally coordinated by conserved residues.  Nevertheless, significant differences to mammalian enzymes are found around the active site of the bacteroidal enzymes.  Application of a PgQC-selective inhibitor described here for the first time results in growth inhibition of two P. gingivalis clin. isolates in a dose-dependent manner.  The insights gained by these studies will assist in the development of highly specific small-mol. bacteroidal QC inhibitors, paving the way for alternative therapies against periodontitis and assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUiS9Dkp14z7Vg90H21EOLACvtfcHk0lhT_rTg01lNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXjvVClsbg%253D&md5=69972c56def59106454fc03e68554db6</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.jbc.2021.100263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbc.2021.100263%26sid%3Dliteratum%253Aachs%26aulast%3DTaudte%26aufirst%3DN.%26atitle%3DMammalian-like%2520type%2520II%2520glutaminyl%2520cyclases%2520in%2520Porphyromonas%2520gingivalis%2520and%2520other%2520oral%2520pathogenic%2520bacteria%2520as%2520targets%2520for%2520treatment%2520of%2520periodontitis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2021%26volume%3D296%26spage%3D100263%26doi%3D10.1016%2Fj.jbc.2021.100263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coimbra, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobral, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, J. A.</span></span> <span> </span><span class="NLM_article-title">An overview of glutaminyl cyclase inhibitors for Alzheimer’s disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3179</span>– <span class="NLM_lpage">3194</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.4155%2Ffmc-2019-0163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31838899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3179-3194&author=J.+R.+Coimbraauthor=P.+J.+Sobralauthor=A.+E.+Santosauthor=P.+I.+Moreiraauthor=J.+A.+Salvador&title=An+overview+of+glutaminyl+cyclase+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.4155%2Ffmc-2019-0163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of glutaminyl cyclase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Coimbra, Judite R. M.; Sobral, Pedro J. M.; Santos, Armanda E.; Moreira, Paula I.; Salvador, Jorge A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3179-3194</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  A diverse range of N-terminally truncated and modified forms of amyloid-beta oligomers have been discovered in Alzheimer's disease brains, including the pyroglutamate-Abeta (AbetapE3).  AbetapE3 species are shown to be more neurotoxic when compared with the full-length Abeta peptide.  Findings visibly suggest that glutaminyl cyclase (QC) catalyzed the generation of cerebral AbetapE3, and therapeutic effects are achieved by reducing its activity.  In recent years, efforts to effectively develop QC inhibitors have been pursued worldwide.  The inhibitory activity of current QC inhibitors is mainly triggered by zinc-binding groups that coordinate Zn2+ ion in the active site and other common features.  Herein, we summarized the current state of discovery and evolution of QC inhibitors as a potential Alzheimer's disease-modifying strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJEVzG-EOcLVg90H21EOLACvtfcHk0lhT_rTg01lNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygurnP&md5=9b00581d2eebd176a457359e1d906d76</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0163%26sid%3Dliteratum%253Aachs%26aulast%3DCoimbra%26aufirst%3DJ.%2BR.%26aulast%3DSobral%26aufirst%3DP.%2BJ.%26aulast%3DSantos%26aufirst%3DA.%2BE.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DSalvador%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520overview%2520of%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26spage%3D3179%26epage%3D3194%26doi%3D10.4155%2Ffmc-2019-0163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vijayan, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer’s disease</span>. <i>Pharmacol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">104342</span>, <span class="refDoi"> DOI: 10.1016/j.phrs.2019.104342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.phrs.2019.104342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=31288079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWjs7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2019&pages=104342&author=D.+K.+Vijayanauthor=K.+Zhang&title=Human+glutaminyl+cyclase%3A+Structure%2C+function%2C+inhibitors+and+involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.phrs.2019.104342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease</span></div><div class="casAuthors">Vijayan, Dileep K.; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104342</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Human glutaminyl cyclase (hQC) is an important enzyme for post-translational modification by converting the N-terminal glutaminyl and glutamyl into pyroglutamate (pGlu) through cyclization.  The two isoforms of hQC, secretory glutaminyl cyclase (sQC) and golgi resident glutaminyl cyclase (gQC), are involved in various pathol. conditions esp. in Alzheimer's disease (AD).  The sQC is known to mediate the formation of pyroglutamate contg. amyloid beta (pGlu-Aβ) peptides while gQC mediates the maturation of C-C motif chemokine ligand 2 (CCL2).  Therefore, hQC (both sQC and gQC) inhibition is considered to be an attractive strategy to prevent the formation of pGlu-Aβ and to reduce neuroinflammation and hence provides a new opportunity for the treatment of AD.  In this review, we summarize our current understanding on the structure, function and inhibitors of hQC and its involvement in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb9DQ27eP80LVg90H21EOLACvtfcHk0lhT_rTg01lNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWjs7jJ&md5=af10a7c83d600e00a02713a45c64eb2c</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2019.104342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2019.104342%26sid%3Dliteratum%253Aachs%26aulast%3DVijayan%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DHuman%2520glutaminyl%2520cyclase%253A%2520Structure%252C%2520function%252C%2520inhibitors%2520and%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%26date%3D2019%26volume%3D147%26spage%3D104342%26doi%3D10.1016%2Fj.phrs.2019.104342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niestroj, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunkel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">664</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1021/jm050756e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050756e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=664-77&author=M.+Buchholzauthor=U.+Heiserauthor=S.+Schillingauthor=A.+J.+Niestrojauthor=K.+Zunkelauthor=H.+U.+Demuth&title=The+first+potent+inhibitors+for+human+glutaminyl+cyclase%3A+synthesis+and+structure-activity+relationship&doi=10.1021%2Fjm050756e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship</span></div><div class="casAuthors">Buchholz, Mirko; Heiser, Ulrich; Schilling, Stephan; Niestroj, Andre J.; Zunkel, Katrin; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">664-677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first effective inhibitors for human glutaminyl cyclase (QC) are described.  The structures are developed by applying a ligand-based optimization approach starting from imidazole.  Screening of derivs. of that heterocycle led to compds. of the imidazol-1-yl-alkyl thiourea type as a lead scaffold.  A library of thiourea derivs. was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor.  Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors.  A flexible alignment of the most potent compds. of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the mols., which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo88OPnC7vM57Vg90H21EOLACvtfcHk0lhT_rTg01lNig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWrug%253D%253D&md5=584302fd2d356f680bb4df9e10f26b93</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm050756e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050756e%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DNiestroj%26aufirst%3DA.%2BJ.%26aulast%3DZunkel%26aufirst%3DK.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DThe%2520first%2520potent%2520inhibitors%2520for%2520human%2520glutaminyl%2520cyclase%253A%2520synthesis%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D664%26epage%3D77%26doi%3D10.1021%2Fjm050756e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fcbdd.12046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22967026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=937-46&author=B.+Kochauthor=M.+Buchholzauthor=M.+Wermannauthor=U.+Heiserauthor=S.+Schillingauthor=H.+U.+Demuth&title=Probing+secondary+glutaminyl+cyclase+%28QC%29+inhibitor+interactions+applying+an+in+silico-modeling%2Fsite-directed+mutagenesis+approach%3A+implications+for+drug+development&doi=10.1111%2Fcbdd.12046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development</span></div><div class="casAuthors">Koch, Birgit; Buchholz, Mirko; Wermann, Michael; Heiser, Ulrich; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">937-946</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate-modified amyloid peptides deposited in neurodegenerative disorders such as Alzheimer's disease.  Inhibitors of QC are currently in development as potential therapeutics.  The crystal structures of the potent inhibitor PBD150 bound to human and murine QC (hQC, mQC) have been described recently.  The binding modes of a dimethoxyphenyl moiety of the inhibitor are significantly different between the structures, which contrasts with a similar Ki value.  We show the conformation of PBD150 prone to disturbance by protein-protein interactions within the crystals.  Semi-empirical calcns. of the enzyme-inhibitor interaction within the crystal suggest significant differences in the dissocn. consts. between the binding modes.  To probe for interactions in soln., a site-directed mutagenesis on hQC was performed.  The replacement of F325 and I303 by alanine or asparagine resulted in a 800-fold lower activity of the inhibitor, whereas the exchange of S323 by alanine or valine led to a 20-fold higher activity of PBD150.  The results provide an example of deciphering the interaction mode between a target enzyme and lead substance in soln., if co-crystn. does not mirror such interactions properly.  Thus, the study might provide implications for rapid screening of binding modes also for other drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1xHVETpdubVg90H21EOLACvtfcHk0lhVr2Zl0mW1Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCmu7fE&md5=826cc42ff98381d0a09f6bec93f2a878</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12046%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DProbing%2520secondary%2520glutaminyl%2520cyclase%2520%2528QC%2529%2520inhibitor%2520interactions%2520applying%2520an%2520in%2520silico-modeling%252Fsite-directed%2520mutagenesis%2520approach%253A%2520implications%2520for%2520drug%2520development%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D80%26spage%3D937%26epage%3D46%26doi%3D10.1111%2Fcbdd.12046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aust, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7069</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/jm900969p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900969p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7069-80&author=M.+Buchholzauthor=A.+Hamannauthor=S.+Austauthor=W.+Brandtauthor=L.+Bohmeauthor=T.+Hoffmannauthor=S.+Schillingauthor=H.+U.+Demuthauthor=U.+Heiser&title=Inhibitors+for+human+glutaminyl+cyclase+by+structure+based+design+and+bioisosteric+replacement&doi=10.1021%2Fjm900969p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement</span></div><div class="casAuthors">Buchholz, Mirko; Hamann, Antje; Aust, Susanne; Brandt, Wolfgang; Boehme, Livia; Hoffmann, Torsten; Schilling, Stephan; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7069-7080</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of human glutaminyl cyclase (hQC) has come into focus as a new potential approach for the treatment of Alzheimer's disease.  The hallmark of this principle is the prevention of the formation of Aβ3,11(pE)-40,42, as these Aβ-species were shown to be of elevated neurotoxicity and likely to act as a seeding core leading to an accelerated formation of Aβ-oligomers and fibrils.  Starting from 1-(3-(1H-imidazol-1-yl)propyl)-3-(3,4-dimethoxyphenyl)thiourea, bioisosteric replacements led to the development of new classes of inhibitors.  The optimization of the metal-binding group was achieved by homol. modeling and afforded a first insight into the probable binding mode of the inhibitors in the hQC active site.  The efficacy assessment of the hQC inhibitors was performed in cell culture, directly monitoring the inhibition of Aβ3,11(pE)-40,42 formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZG_jswBXx2LVg90H21EOLACvtfcHk0lhVr2Zl0mW1Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlagsbnJ&md5=262248c3c91f344aacb530288aa46471</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm900969p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900969p%26sid%3Dliteratum%253Aachs%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DHamann%26aufirst%3DA.%26aulast%3DAust%26aufirst%3DS.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DInhibitors%2520for%2520human%2520glutaminyl%2520cyclase%2520by%2520structure%2520based%2520design%2520and%2520bioisosteric%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7069%26epage%3D80%26doi%3D10.1021%2Fjm900969p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">6613</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1021/jm4001709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6613-25&author=D.+Ramsbeckauthor=M.+Buchholzauthor=B.+Kochauthor=L.+Bohmeauthor=T.+Hoffmannauthor=H.+U.+Demuthauthor=U.+Heiser&title=Structure-activity+relationships+of+benzimidazole-based+glutaminyl+cyclase+inhibitors+featuring+a+heteroaryl+scaffold&doi=10.1021%2Fjm4001709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships of Benzimidazole-Based Glutaminyl Cyclase Inhibitors Featuring a Heteroaryl Scaffold</span></div><div class="casAuthors">Ramsbeck, Daniel; Buchholz, Mirko; Koch, Birgit; Boehme, Livia; Hoffmann, Torsten; Demuth, Hans-Ulrich; Heiser, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6613-6625</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (hQC) has emerged as a new potential target for the treatment of Alzheimer's disease (AD).  The inhibition of hQC prevents of the formation of the Aβ3(pE)-40,42 species which were shown to be of elevated neurotoxicity and are likely to act as a seeding core, leading to an accelerated formation of Aβ-oligomers and fibrils.  This work presents a new class of inhibitors of hQC, resulting from a pharmacophore-based screen.  Hit mols. were identified, contg. benzimidazole as the metal binding group connected to 1,3,4-oxadiazole as the central scaffold.  The subsequent optimization resulted in benzimidazolyl-1,3,4-thiadiazoles and -1,2,3-triazoles with an inhibitory potency in the nanomolar range.  Further investigation into the potential binding mode of the new compd. classes combined mol. docking and site directed mutagenesis studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj2cbdhUrX_bVg90H21EOLACvtfcHk0liPkZpjh12IJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOltrvL&md5=eaff2e3df3c955881a158b5efd012c0d</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm4001709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001709%26sid%3Dliteratum%253Aachs%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DKoch%26aufirst%3DB.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DHeiser%26aufirst%3DU.%26atitle%3DStructure-activity%2520relationships%2520of%2520benzimidazole-based%2520glutaminyl%2520cyclase%2520inhibitors%2520featuring%2520a%2520heteroaryl%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6613%26epage%3D25%26doi%3D10.1021%2Fjm4001709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorat, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3821</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2013.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23643900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3821-30&author=P.+T.+Tranauthor=V.+H.+Hoangauthor=S.+A.+Thoratauthor=S.+E.+Kimauthor=J.+Annauthor=Y.+J.+Changauthor=D.+W.+Namauthor=H.+Songauthor=I.+Mook-Jungauthor=J.+Leeauthor=J.+Lee&title=Structure-activity+relationship+of+human+glutaminyl+cyclase+inhibitors+having+an+N-%285-methyl-1H-imidazol-1-yl%29propyl+thiourea+template&doi=10.1016%2Fj.bmc.2013.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template</span></div><div class="casAuthors">Tran, Phuong-Thao; Hoang, Van-Hai; Thorat, Shivaji A.; Kim, Sung Eun; Ann, Jihyae; Chang, Yu Jin; Nam, Dong Woo; Song, Hyundong; Mook-Jung, Inhee; Lee, Jiyoun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3821-3830</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In an effort to design inhibitors of human glutaminyl cyclase (QC), the authors have synthesized a library of N-aryl N-(5-methyl-1H-imidazol-1-yl)propyl thioureas and investigated the contribution of the aryl region of these compds. to their structure-activity relationships as cyclase inhibitors.  The authors' design was guided by the proposed binding mode of the preferred substrate for the cyclase.  In this series, 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea (compd. 52) was identified as the most potent QC inhibitor with an IC50 value of 58 nM, which was two-fold more potent than the previously reported lead (II).  Compd. 52 is a most promising candidate for future evaluation to monitor its ability to reduce the formation of pGlu-Aβ and Aβ plaques in cells and transgenic animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aCpSObyf3rVg90H21EOLACvtfcHk0liPkZpjh12IJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2mtL0%253D&md5=a8d7ad244e262c7bb26681c64393551a</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DThorat%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BE.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DNam%26aufirst%3DD.%2BW.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DMook-Jung%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520having%2520an%2520N-%25285-methyl-1H-imidazol-1-yl%2529propyl%2520thiourea%2520template%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3821%26epage%3D30%26doi%3D10.1016%2Fj.bmc.2013.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn-Wache, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manhart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokorny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiesa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glund, K.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span>. <i>Alzheimers Dement (N Y)</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1016/j.trci.2015.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.trci.2015.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29854937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=182-195&author=I.+Luesauthor=F.+Weberauthor=A.+Meyerauthor=U.+Buhringauthor=T.+Hoffmannauthor=K.+Kuhn-Wacheauthor=S.+Manhartauthor=U.+Heiserauthor=R.+Pokornyauthor=J.+Chiesaauthor=K.+Glund&title=A+phase+1+study+to+evaluate+the+safety+and+pharmacokinetics+of+PQ912%2C+a+glutaminyl+cyclase+inhibitor%2C+in+healthy+subjects&doi=10.1016%2Fj.trci.2015.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects</span></div><div class="casAuthors">Lues Inge; Weber Frank; Meyer Antje; Buhring Uli; Hoffmann Torsten; Kuhn-Wache Kerstin; Manhart Susanne; Heiser Ulrich; Glund Konrad; Pokorny Rolf; Chiesa Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia (New York, N. Y.)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-195</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction:  Pyroglutamate-amyloid-β (pE-Aβ) peptides are major components of Aβ-oligomers and Aβ-plaques, which are regarded as key culprits of Alzheimer's disease (AD) pathology.  PQ912 is a competitive inhibitor of the enzyme glutaminyl cyclase (QC), essential for the formation of pE-Aβ peptides.  Methods:  A randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study investigated the safety, pharmacokinetics, and pharmacodynamics of PQ912 in healthy nonelderly and elderly subjects.  Results:  PQ912 was considered safe and well tolerated with dose-proportional pharmacokinetics up to doses of 200 mg.  At higher doses up to 1800 mg, exposure was supraproportional and exposure in elderly subjects was approximately 1.5- to 2.1-fold higher.  Exposure in cerebrospinal fluid (CSF) was approximately 20% of the unbound drug in plasma, and both serum and CSF QC activity was inhibited in a dose-related manner.  Discussion:  This first-in-man study of a compound-targeting QC inhibition justifies further development of PQ912 for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_8LDrMzHWYDjk2McQZ6XmfW6udTcc2eYxyC1TAvVbLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbisFyhsA%253D%253D&md5=49cc7018331e760dfef1b844f93cc31c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.trci.2015.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trci.2015.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DLues%26aufirst%3DI.%26aulast%3DWeber%26aufirst%3DF.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DBuhring%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DKuhn-Wache%26aufirst%3DK.%26aulast%3DManhart%26aufirst%3DS.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DPokorny%26aufirst%3DR.%26aulast%3DChiesa%26aufirst%3DJ.%26aulast%3DGlund%26aufirst%3DK.%26atitle%3DA%2520phase%25201%2520study%2520to%2520evaluate%2520the%2520safety%2520and%2520pharmacokinetics%2520of%2520PQ912%252C%2520a%2520glutaminyl%2520cyclase%2520inhibitor%252C%2520in%2520healthy%2520subjects%26jtitle%3DAlzheimers%2520Dement%2520%2528N%2520Y%2529%26date%3D2015%26volume%3D1%26spage%3D182%26epage%3D195%26doi%3D10.1016%2Fj.trci.2015.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohme, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinschmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhring, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of Alzheimer’s ddisease-studies on relation to effective target cccupancy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>362</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.240614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1124%2Fjpet.117.240614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=28446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2017&pages=119-130&author=T.+Hoffmannauthor=A.+Meyerauthor=U.+Heiserauthor=S.+Kuratauthor=L.+Bohmeauthor=M.+Kleinschmidtauthor=K.+U.+Buhringauthor=B.+Hutter-Paierauthor=M.+Farcherauthor=H.+U.+Demuthauthor=I.+Luesauthor=S.+Schilling&title=Glutaminyl+cyclase+inhibitor+PQ912+improves+cognition+in+mouse+models+of+Alzheimer%E2%80%99s+ddisease-studies+on+relation+to+effective+target+cccupancy&doi=10.1124%2Fjpet.117.240614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibitor PQ912 improves cognition in mouse models of alzheimer's disease-studies on relation to effective target occupancy</span></div><div class="casAuthors">Hoffmann, Torsten; Meyer, Antje; Heiser, Ulrich; Kurat, Stephan; Boehme, Livia; Kleinschmidt, Martin; Buehring, Karl-Ulrich; Hutter-Paier, Birgit; Farcher, Martina; Demuth, Hans-Ulrich; Lues, Inge; Schilling, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Numerous studies suggest that the majority of amyloid-β (Aβ) peptides deposited in Alzheimer's disease (AD) are truncated and post-translationally modified at the N terminus.  Among these modified species, pyroglutamyl-Aβ(pE-Aβ, including N3pE-Aβ40/42 and N11pE-Aβ40/42) has been identified as particularly neurotoxic.  The N-terminal modification renders the peptide hydrophobic, accelerates formation of oligomers, and reduces degrdn. by peptidases, leading ultimately to the accumulation of the peptide and progression of AD.  It has been shown that the formation of pyroglutamyl residues is catalyzed by glutaminyl cyclase (QC).  Here, we present data about the pharmacol. in vitro and in vivo efficacy of the QC inhibitor (S)-1-(1H-benzo[d]imidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one (PQ912), the first-in-class compd. that is in clin. development.  PQ912 inhibits human, rat, and mouse QC activity, with Ki values ranging between 20 and 65 nM.  Chronic oral treatment of hAPPSLxhQC double-transgenic mice with approx. 200 mg/kg/day via chow shows a significant redn. of pE-Aβ levels and concomitant improvement of spatial learning in a Morris water maze test paradigm.  This dose results in a brain and cerebrospinal fluid concn. of PQ912 which relates to a QC target occupancy of about 60%.  Thus, we conclude that >50% inhibition of QC activity in the brain leads to robust treatment effects.  Secondary pharmacol. expts. in mice indicate a fairly large potency difference for Aβ cyclization compared with cyclization of physiol. substrates, suggesting a robust therapeutic window in humans.  This information constitutes an important translational guidance for predicting the therapeutic dose range in clin. studies with PQ912.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9VVUSISdmtrVg90H21EOLACvtfcHk0lgizzX5vkXsoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOqsb3J&md5=080e83d1ac24b892e74a556f04db9232</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.240614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.240614%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKurat%26aufirst%3DS.%26aulast%3DBohme%26aufirst%3DL.%26aulast%3DKleinschmidt%26aufirst%3DM.%26aulast%3DBuhring%26aufirst%3DK.%2BU.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DFarcher%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DSchilling%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520improves%2520cognition%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520ddisease-studies%2520on%2520relation%2520to%2520effective%2520target%2520cccupancy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D362%26spage%3D119%26epage%3D130%26doi%3D10.1124%2Fjpet.117.240614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallikainen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimmer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duning, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouw, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teunissen, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Baal, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lues, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prins, N. D.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study</span>. <i>Alzheimer's Res. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">107</span>, <span class="refDoi"> DOI: 10.1186/s13195-018-0431-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1186%2Fs13195-018-0431-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtFSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=107&author=P.+Scheltensauthor=M.+Hallikainenauthor=T.+Grimmerauthor=T.+Duningauthor=A.+A.+Gouwauthor=C.+E.+Teunissenauthor=A.+M.+Winkauthor=P.+Maruffauthor=J.+Harrisonauthor=C.+M.+van+Baalauthor=S.+Bruinsauthor=I.+Luesauthor=N.+D.+Prins&title=Safety%2C+tolerability+and+efficacy+of+the+glutaminyl+cyclase+inhibitor+PQ912+in+Alzheimer%E2%80%99s+disease%3A+results+of+a+randomized%2C+double-blind%2C+placebo-controlled+phase+2a+study&doi=10.1186%2Fs13195-018-0431-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study</span></div><div class="casAuthors">Scheltens, Philip; Hallikainen, Merja; Grimmer, Timo; Duning, Thomas; Gouw, Alida A.; Teunissen, Charlotte E.; Wink, Alle Meije; Maruff, Paul; Harrison, John; van Baal, Caroline M.; Bruins, Suzanne; Lues, Inge; Prins, Niels D.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107/1-107/14</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">PQ912 is an inhibitor of the glutaminyl cyclase enzyme that plays a central role in the formation of synaptotoxic pyroglutamate-A-beta oligomers.  We report on the first clin. study with PQ912 in subjects with biomarker-proven Alzheimer's disease (AD).  The aim was to det. the maximal tolerated dose, target occupancy and treatment-related pharmacodynamic effects.  The exploratory efficacy readouts selected were tailored to the patient population with early AD.  The therapeutic approach focuses on synaptic dysfunction as captured by various measures such as electroencephalog. (EEG), synaptic biomarkers and sensitive cognitive tests.  This was a randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability and efficacy of PQ912 800 mg twice daily (bid) for 12 wk in subjects with mild cognitive impairment or mild dementia due to AD.  The 120 enrolled subjects were treatment-naive at the start of the study, had confirmed AD biomarkers in their cerebrospinal fluid at screening and had a Mini Mental State Examn. score between 21 and 30.  After 1 wk of treatment with 400 mg bid, patients were up-titrated to 800 mg bid for 11 wk.  Patients were randomized 1:1 to either PQ912 or placebo.  The primary composite endpoints were to assess safety and tolerability based on the no. of patients who discontinued due to (serious) adverse events (safety), and based on dose adjustment during the treatment period and/or nonadherence to randomized treatment (tolerability).  All randomized subjects who took at least one dose of the study treatment or placebo were used for safety analyses.  There was no significant difference between treatments in the no. of subjects with (serious) adverse events, although there were slightly more patients with a serious adverse event in the PQ912 group compared to placebo.  More subjects treated with PQ912 discontinued treatment due to adverse events, mostly related to gastrointestinal and skin/s.c. tissue disorders.  PQ912 treatment resulted in a significant redn. in glutaminyl cyclase activity, which resulted in an av. target occupancy of > 90%.  A significant redn. of theta power in the EEG frequency anal. and a significant improvement in the One Back test of our Neuropsychol. Test Battery was obsd.  The exploratory biomarker readouts, neurogranin for synaptic toxicity and YKL-40 as a marker of inflammation, appear to be sensitive enough to serve as efficacy markers in the next phase 2b study.  The maximal tolerated dose of PQ912 has been identified and the results support future studies at still lower doses reaching > 50% target occupancy, a longer up-titrn. phase to potentially induce adaptation and longer treatment periods to confirm the early signals of efficacy as seen in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9X6Ko8VxX17Vg90H21EOLACvtfcHk0lgizzX5vkXsoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtFSitrY%253D&md5=80d2d7b91cf2b62e3cfda6f60cec80d3</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1186%2Fs13195-018-0431-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13195-018-0431-6%26sid%3Dliteratum%253Aachs%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DHallikainen%26aufirst%3DM.%26aulast%3DGrimmer%26aufirst%3DT.%26aulast%3DDuning%26aufirst%3DT.%26aulast%3DGouw%26aufirst%3DA.%2BA.%26aulast%3DTeunissen%26aufirst%3DC.%2BE.%26aulast%3DWink%26aufirst%3DA.%2BM.%26aulast%3DMaruff%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DJ.%26aulast%3Dvan%2BBaal%26aufirst%3DC.%2BM.%26aulast%3DBruins%26aufirst%3DS.%26aulast%3DLues%26aufirst%3DI.%26aulast%3DPrins%26aufirst%3DN.%2BD.%26atitle%3DSafety%252C%2520tolerability%2520and%2520efficacy%2520of%2520the%2520glutaminyl%2520cyclase%2520inhibitor%2520PQ912%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520results%2520of%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25202a%2520study%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2018%26volume%3D10%26spage%3D107%26doi%3D10.1186%2Fs13195-018-0431-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of diphenyl conjugated imidazole derivatives as potential glutaminyl cyclase inhibitors for treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6664</span>– <span class="NLM_lpage">6677</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6664-6677&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Liauthor=Y.+Zouauthor=Y.+Zhengauthor=Z.+Heauthor=Z.+Liuauthor=J.+Quanauthor=X.+Buauthor=H.+Wu&title=Synthesis+and+evaluation+of+diphenyl+conjugated+imidazole+derivatives+as+potential+glutaminyl+cyclase+inhibitors+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Li, Yue; Zou, Yongdong; Zheng, Yizhi; He, Zhendan; Liu, Zhigang; Quan, Junmin; Bu, Xianzhang; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6664-6677</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High expression of glutaminyl cyclase (QC) contributes to the initiation of Alzheimer's disease (AD) by catalyzing the generation of neurotoxic pyroglutamate (pE)-modified β-amyloid (Aβ) peptides.  Preventing the generation of pE-Aβs by QC inhibition has been suggested as a novel approach to a disease-modifying therapy for AD.  In this work, a series of di-Ph conjugated imidazole derivs. (DPCIs) was rationally designed and synthesized.  Analogs with this scaffold exhibited potent inhibitory activity against human QC (hQC) and good in vitro blood-brain barrier (BBB) permeability.  Further assessments corroborated that the selected hQC inhibitor I inhibits the activity of hQC, dramatically reduces the generation of pE-Aβs in cultured cells and in vivo, and improves the behavior of AD mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMrmUpYJCVhrVg90H21EOLACvtfcHk0lhjJf1luN6NYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKkurrE&md5=8ffec76fc13fbe8520675ee884c12772</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00648%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520diphenyl%2520conjugated%2520imidazole%2520derivatives%2520as%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6664%26epage%3D6677%26doi%3D10.1021%2Facs.jmedchem.7b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer’s agents based on rational design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2573</span>– <span class="NLM_lpage">2590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00098</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00098" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2573-2590&author=V.+H.+Hoangauthor=P.+T.+Tranauthor=M.+Cuiauthor=V.+T.+Ngoauthor=J.+Annauthor=J.+Parkauthor=J.+Leeauthor=K.+Choiauthor=H.+Choauthor=H.+Kimauthor=H.+J.+Haauthor=H.+S.+Hongauthor=S.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Discovery+of+potent+human+glutaminyl+cyclase+inhibitors+as+anti-Alzheimer%E2%80%99s+agents+based+on+rational+design&doi=10.1021%2Facs.jmedchem.7b00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design</span></div><div class="casAuthors">Hoang, Van-Hai; Tran, Phuong-Thao; Cui, Minghua; Ngo, Van T. H.; Ann, Jihyae; Park, Jongmi; Lee, Jiyoun; Choi, Kwanghyun; Cho, Hanyang; Kim, Hee; Ha, Hee-Jin; Hong, Hyun-Seok; Choi, Sun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2573-2590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer's disease (AD).  The authors designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E-42.  An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor.  When tested in mouse models of AD, compd. 212 (I) significantly reduced the brain concns. of pyroform Aβ and total Aβ and restored cognitive functions.  This potent Aβ-lowering effect was achieved by incorporating an addnl. binding region into the authors' previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu 327 in the QC binding site.  The authors' study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolqaMS-1r-2bVg90H21EOLACvtfcHk0lhjJf1luN6NYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCnurw%253D&md5=856a0159f8249b82f8b79d25ab162973</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00098%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DNgo%26aufirst%3DV.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DHong%26aufirst%3DH.%2BS.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520based%2520on%2520rational%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2573%26epage%3D2590%26doi%3D10.1021%2Facs.jmedchem.7b00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer’s agents: Structure-activity relationship study of Arg-mimetic region</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1035</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2018.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29398442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=1035-1049&author=V.+Ngoauthor=V.+H.+Hoangauthor=P.+T.+Tranauthor=J.+Annauthor=M.+Cuiauthor=G.+Parkauthor=S.+Choiauthor=J.+Leeauthor=H.+Kimauthor=H.+J.+Haauthor=K.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Potent+human+glutaminyl+cyclase+inhibitors+as+potential+anti-Alzheimer%E2%80%99s+agents%3A+Structure-activity+relationship+study+of+Arg-mimetic+region&doi=10.1016%2Fj.bmc.2018.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region</span></div><div class="casAuthors">Ngo, Van T. H.; Hoang, Van-Hai; Tran, Phuong-Thao; Ann, Jihyae; Cui, Minghua; Park, Gyungseo; Choi, Sun; Lee, Jiyoun; Kim, Hee; Ha, Hee-Jin; Choi, Kwanghyun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1049</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pyroglutamate-modified amyloid β peptides (pGlu-Aβ) are highly neurotoxic and promote the formation of amyloid plaques.  The pGlu-Aβ peptides are generated by glutaminyl cyclase (QC), and recent clin. studies indicate that QC represents an alternative therapeutic target to treat Alzheimer's disease (AD).  We have previously developed a series of QC inhibitors with an extended pharmacophoric scaffold, termed the Arg-mimetic D-region.  In the present study, we focused on the structure activity relationship (SAR) of analogs with modifications in the D-region and evaluated their biol. activity.  Most compds. in this series exhibited potent activity in vitro, and our SAR anal. and the mol. docking studies identified compd. 202 as a potential candidate because it forms an addnl. hydrophobic interaction in the hQC active site.  Overall, our study provides valuable insights into the Arg-mimetic pharmacophore that will guide the design of novel QC inhibitors as potential treatments for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozmm9ncHC6lLVg90H21EOLACvtfcHk0li1Iu40ZS7y1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSitb8%253D&md5=84704aa18b76f7af3d5671ab578702e2</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DPotent%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potential%2520anti-Alzheimer%25E2%2580%2599s%2520agents%253A%2520Structure-activity%2520relationship%2520study%2520of%2520Arg-mimetic%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D1035%26epage%3D1049%26doi%3D10.1016%2Fj.bmc.2018.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Manh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3133</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2018.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=29705377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3133-3144&author=V.+Ngoauthor=V.+H.+Hoangauthor=P.+T.+Tranauthor=N.+Van+Manhauthor=J.+Annauthor=E.+Kimauthor=M.+Cuiauthor=S.+Choiauthor=J.+Leeauthor=H.+Kimauthor=H.+J.+Haauthor=K.+Choiauthor=Y.+H.+Kimauthor=J.+Lee&title=Structure-activity+relationship+investigation+of+Phe-Arg+mimetic+region+of+human+glutaminyl+cyclase+inhibitors&doi=10.1016%2Fj.bmc.2018.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship investigation of Phe-Arg mimetic region of human glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Ngo, Van T. H.; Hoang, Van-Hai; Tran, Phuong-Thao; Van Manh, Nguyen; Ann, Jihyae; Kim, Eunhye; Cui, Minghua; Choi, Sun; Lee, Jiyoun; Kim, Hee; Ha, Hee-Jin; Choi, Kwanghyun; Kim, Young-Ho; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3133-3144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) is a promising therapeutic target because of its involvement in the pathogenesis of Alzheimer's disease.  In this study, the authors developed novel QC inhibitors that contain 3-aminoalkyloxy-4-methoxyphenyl and 4-aminoalkyloxyphenyl groups to replace the previously developed pharmacophore.  Several potent inhibitors were identified, showing IC50 values in a low nanomolar range, and were further studied for in vitro toxicity and in vivo activity.  Among these, inhibitors 51 (N-(3-(2-aminoethoxy)-4-methoxyphenyl)-N'-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea) and 53 (N-(3-(4-aminobutoxy)-4-methoxyphenyl)-N'-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea) displayed the most potent AβN3pE-40-lowering effects in in vivo acute model with reasonable BBB penetration, without showing cytotoxicity and hERG inhibition.  The mol. modeling anal. of 53 indicated that the salt bridge interaction and the hydrogen bonding in the active site provided a high potency.  Given the potent activity and favorable BBB penetration with low cytotoxicity, the authors believe that compd. 53 may serve as a potential candidate for anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm4mNvlTQiobVg90H21EOLACvtfcHk0li1Iu40ZS7y1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFWgs7g%253D&md5=a9926b0f68904525e84928917e770334</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DVan%2BManh%26aufirst%3DN.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520investigation%2520of%2520Phe-Arg%2520mimetic%2520region%2520of%2520human%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3133%26epage%3D3144%26doi%3D10.1016%2Fj.bmc.2018.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benvenuti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangani, S.</span></span> <span> </span><span class="NLM_article-title">The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1226</span>, <span class="refDoi"> DOI: 10.1007/s00775-018-1605-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs00775-018-1605-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=30132075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=1219-1226&author=C.+Pozziauthor=F.+Di+Pisaauthor=M.+Benvenutiauthor=S.+Mangani&title=The+structure+of+the+human+glutaminyl+cyclase-SEN177+complex+indicates+routes+for+developing+new+potent+inhibitors+as+possible+agents+for+the+treatment+of+neurological+disorders&doi=10.1007%2Fs00775-018-1605-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders</span></div><div class="casAuthors">Pozzi, Cecilia; Di Pisa, Flavio; Benvenuti, Manuela; Mangani, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1219-1226</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent evidence links the role of human glutaminyl cyclase (hQC) to the amyloidogenic process involved in Alzheimer's disease (AD).  HQC is a zinc enzyme present in neuronal tissue and its activity is responsible for the cyclization of N-terminal Gln or Glu β-amyloid peptides, leading to N-pyroglutamic acid peptides (pE-Aβ) that is probably a crucial event in the initiation and progress of the disease.  Indeed, pE-contg. peptides exhibit an elevated neurotoxicity and a tendency to aggregate.  These observations render hQC inhibition an attractive strategy for developing new mols. active against AD.  The authors present here the crystal structure of hQC in complex with SEN177, a newly designed mol.  The SEN177-binding mode to hQC differs from that of the known hQC inhibitors.  SEN177 Ki on hQC is 20 nM, comparable or better than that of the most potent known hQC inhibitors PBD150 and PQ912.  In addn., SEN177 already demonstrated relevant pharmacol. properties in in vivo models of Huntington's disease.  All these properties make SEN177 an important scaffold for developing mols. acting on AD and related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjC4vrTtxA_rVg90H21EOLACvtfcHk0li1Iu40ZS7y1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqt7bM&md5=dd4fac1d9264d75f5e8a0b18dd19ca3f</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2Fs00775-018-1605-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-018-1605-1%26sid%3Dliteratum%253Aachs%26aulast%3DPozzi%26aufirst%3DC.%26aulast%3DDi%2BPisa%26aufirst%3DF.%26aulast%3DBenvenuti%26aufirst%3DM.%26aulast%3DMangani%26aufirst%3DS.%26atitle%3DThe%2520structure%2520of%2520the%2520human%2520glutaminyl%2520cyclase-SEN177%2520complex%2520indicates%2520routes%2520for%2520developing%2520new%2520potent%2520inhibitors%2520as%2520possible%2520agents%2520for%2520the%2520treatment%2520of%2520neurological%2520disorders%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2018%26volume%3D23%26spage%3D1219%26epage%3D1226%26doi%3D10.1007%2Fs00775-018-1605-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macalino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally restricted human glutaminyl cyclase inhibitors as potent anti-Alzheimer’s agents by structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8011-8027&author=V.+H.+Hoangauthor=V.+Ngoauthor=M.+Cuiauthor=N.+V.+Manhauthor=P.+T.+Tranauthor=J.+Annauthor=H.+J.+Haauthor=H.+Kimauthor=K.+Choiauthor=Y.+H.+Kimauthor=H.+Changauthor=S.+Macalinoauthor=J.+Leeauthor=S.+Choiauthor=J.+Lee&title=Discovery+of+conformationally+restricted+human+glutaminyl+cyclase+inhibitors+as+potent+anti-Alzheimer%E2%80%99s+agents+by+structure-based+design&doi=10.1021%2Facs.jmedchem.9b00751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimer's Agents by Structure-Based Design</span></div><div class="casAuthors">Hoang, Van-Hai; Ngo, Van T. H.; Cui, Minghua; Manh, Nguyen Van; Tran, Phuong-Thao; Ann, Jihyae; Ha, Hee-Jin; Kim, Hee; Choi, Kwanghyun; Kim, Young-Ho; Chang, Hyerim; Macalino, Stephani Joy Y.; Lee, Jiyoun; Choi, Sun; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8011-8027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease whose pathogenesis cannot be defined by one single element but consists of various factors; thus, there is a call for alternative approaches to tackle the multifaceted aspects of AD.  Among the potential alternative targets, we aim to focus on glutaminyl cyclase (QC), which reduces the toxic pyroform of β-amyloid in the brains of AD patients.  On the basis of a putative active conformation of the prototype inhibitor 1, a series of N-substituted thiourea, urea, and α-substituted amide derivs. were developed.  The structure-activity relationship analyses indicated that conformationally restrained inhibitors demonstrated much improved QC inhibition in vitro compared to nonrestricted analogs, and several selected compds. demonstrated desirable therapeutic activity in an AD mouse model.  The conformational anal. of a representative inhibitor indicated that the inhibitor appeared to maintain the Z-E conformation at the active site, as it is crit. for its potent activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyKWajqMIkJrVg90H21EOLACvtfcHk0lirEhjRiSz3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFOqtbbP&md5=5830439908c727943bfc534ff1030308</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00751%26sid%3Dliteratum%253Aachs%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DNgo%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DManh%26aufirst%3DN.%2BV.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DAnn%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DMacalino%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520conformationally%2520restricted%2520human%2520glutaminyl%2520cyclase%2520inhibitors%2520as%2520potent%2520anti-Alzheimer%25E2%2580%2599s%2520agents%2520by%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8011%26epage%3D8027%26doi%3D10.1021%2Facs.jmedchem.9b00751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antidementia effects of a new Zn(II) coordination polymer</span>. <i>Biomedical Research</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1237-1239&issue=4&author=C.+L.+Hanauthor=R.+Fuauthor=W.+F.+Lei&title=Synthesis+and+antidementia+effects+of+a+new+Zn%28II%29+coordination+polymer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antidementia effects of a new Zn(II) coordination polymer</span></div><div class="casAuthors">Han, Chuan-Lai; Fu, Rong; Lei, Wei-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical Research (Aligarh, India)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1237-1239</span>CODEN:
                <span class="NLM_cas:coden">BIRSE8</span>;
        ISSN:<span class="NLM_cas:issn">0970-938X</span>.
    
            (<span class="NLM_cas:orgname">Scientific Publishers of India</span>)
        </div><div class="casAbstract">A new 2D layered framework structure, namely, {[Zn(TPA)2](DMA)3}n (1, HTPA = 4-(1,2,4-triazol-4-yl)phenylacetic acid; DMA = N,N-Dimethylacetamide) were obtained under solvothermal conditions and structurally characterized.  The x-ray studies shown that 1 possess a stair-shaped 2D (4,4) network.  In addn., cholinesterase inhibitory activities in vitro of the title compd. and its corresponding org. ligand toward Glutaminyl cyclase (GC), Neprilysin (NeP) and Acetylcholine esterase (AChE) were further detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMH9VHvpqdbVg90H21EOLACvtfcHk0lirEhjRiSz3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWqtL3M&md5=bfaa0acb885bb3bc56c9de937c8e2e9d</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%2BL.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DW.%2BF.%26atitle%3DSynthesis%2520and%2520antidementia%2520effects%2520of%2520a%2520new%2520Zn%2528II%2529%2520coordination%2520polymer%26jtitle%3DBiomedical%2520Research%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D1237%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nayana, M. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekhar, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, S.</span></span> <span> </span><span class="NLM_article-title">3D-QSAR CoMFA Study on Human Glutaminyl Cyclase Inhibitors</span>. <i>Internet Electronic Journal of Molecular Design</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_fpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=6&author=M.+R.+S.+Nayanaauthor=Y.+N.+Sekharauthor=N.+S.+Kumariauthor=S.+Mahmood&title=3D-QSAR+CoMFA+Study+on+Human+Glutaminyl+Cyclase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNayana%26aufirst%3DM.%2BR.%2BS.%26aulast%3DSekhar%26aufirst%3DY.%2BN.%26aulast%3DKumari%26aufirst%3DN.%2BS.%26aulast%3DMahmood%26aufirst%3DS.%26atitle%3D3D-QSAR%2520CoMFA%2520Study%2520on%2520Human%2520Glutaminyl%2520Cyclase%2520Inhibitors%26jtitle%3DInternet%2520Electronic%2520Journal%2520of%2520Molecular%2520Design%26date%3D2007%26spage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prabhakar, Y. S.</span></span> <span> </span><span class="NLM_article-title">CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.3109/14756366.2011.654111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3109%2F14756366.2011.654111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22304474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFKms7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=515-22&author=V.+Kumarauthor=M.+K.+Guptaauthor=G.+Singhauthor=Y.+S.+Prabhakar&title=CP-MLR%2FPLS+directed+QSAR+study+on+the+glutaminyl+cyclase+inhibitory+activity+of+imidazoles%3A+rationales+to+advance+the+understanding+of+activity+profile&doi=10.3109%2F14756366.2011.654111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">CP-MLR/PLS directed QSAR study on the glutaminyl cyclase inhibitory activity of imidazoles: rationales to advance the understanding of activity profile</span></div><div class="casAuthors">Kumar, Viney; Gupta, Manish K.; Singh, Gagandip; Prabhakar, Yenamandra S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">515-522</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The glutaminyl cyclase inhibitory activity of a series of imidazoles has been analyzed through combinatorial protocol in multiple linear regressions (CP-MLR) and partial least square using different topol. and structural descriptors.  The QC activity was found to be correlated with 2D-autocorrelation (2DAUTO) and atom centered fragments (ACF) descriptors.  The descriptor from 2DAUTO class showed that mol. structure frames of one, six and seven path length assocd. with at. van der Waals vols. and polarizability hold scope for modulating QC inhibitory activity.  The ACF descriptors suggested that the unsubstituted alkyl fragments and Me substituted imidazole ring are favorable, while unsatn. in the same and C=N-C N are unfavorable for activity.  The molar refractivity (MR) is conducive for activity.  The descriptors identified in the study collectively highlight the significance of mol. vol. and polarizability to the QC inhibitory activity of imidazoles.  The models are statistically significant and showed good predictivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcOu9-1FQb2bVg90H21EOLACvtfcHk0lirEhjRiSz3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFKms7s%253D&md5=e7a71a4755b7d9dbd3a0882d0ad4f739</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.3109%2F14756366.2011.654111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2011.654111%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DGupta%26aufirst%3DM.%2BK.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DPrabhakar%26aufirst%3DY.%2BS.%26atitle%3DCP-MLR%252FPLS%2520directed%2520QSAR%2520study%2520on%2520the%2520glutaminyl%2520cyclase%2520inhibitory%2520activity%2520of%2520imidazoles%253A%2520rationales%2520to%2520advance%2520the%2520understanding%2520of%2520activity%2520profile%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26spage%3D515%26epage%3D22%26doi%3D10.3109%2F14756366.2011.654111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Szaszko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flachner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorincz, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmany, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorman, G.</span></span> <span> </span><span class="NLM_article-title">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-016-9717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1007%2Fs11030-016-9717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=28070724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=175-186&author=M.+Szaszkoauthor=I.+Hajduauthor=B.+Flachnerauthor=K.+Dobiauthor=C.+Magyarauthor=I.+Simonauthor=Z.+Lorinczauthor=Z.+Kapuiauthor=T.+Pazmanyauthor=S.+Csehauthor=G.+Dorman&title=Identification+of+potential+glutaminyl+cyclase+inhibitors+from+lead-like+libraries+by+in+silico+and+in+vitro+fragment-based+screening&doi=10.1007%2Fs11030-016-9717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening</span></div><div class="casAuthors">Szaszko, Maria; Hajdu, Istvan; Flachner, Beata; Dobi, Krisztina; Magyar, Csaba; Simon, Istvan; Lorincz, Zsolt; Kapui, Zoltan; Pazmany, Tamas; Cseh, Sandor; Dorman, Gyorgy</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A glutaminyl cyclase (QC) fragment library was in silico selected by disconnection of the structure of known QC inhibitors and by lead-like 2D virtual screening of the same set.  The resulting fragment library (204 compds.) was acquired from com. suppliers and pre-screened by differential scanning fluorimetry followed by functional in vitro assays.  In this way, 10 fragment hits were identified ( ∼ 5% hit rate, best inhibitory activity: 16μM).  The in vitro hits were then docked to the active site of QC, and the best scoring compds. were analyzed for binding interactions.  Two fragments bound to different regions in a complementary manner, and thus, linking those fragments offered a rational strategy to generate novel QC inhibitors.  Based on the structure of the virtual linked fragment, a 77-membered QC target focused library was selected from vendor databases and docked to the active site of QC.  A PubChem search confirmed that the best scoring analogs are novel, potential QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VdqwKUctWrVg90H21EOLACvtfcHk0lgxPUjOcZr_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovV2iuw%253D%253D&md5=1eb4a1423d7e0bc0cf4ea621848d4580</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs11030-016-9717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-016-9717-4%26sid%3Dliteratum%253Aachs%26aulast%3DSzaszko%26aufirst%3DM.%26aulast%3DHajdu%26aufirst%3DI.%26aulast%3DFlachner%26aufirst%3DB.%26aulast%3DDobi%26aufirst%3DK.%26aulast%3DMagyar%26aufirst%3DC.%26aulast%3DSimon%26aufirst%3DI.%26aulast%3DLorincz%26aufirst%3DZ.%26aulast%3DKapui%26aufirst%3DZ.%26aulast%3DPazmany%26aufirst%3DT.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DDorman%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520potential%2520glutaminyl%2520cyclase%2520inhibitors%2520from%2520lead-like%2520libraries%2520by%2520in%2520silico%2520and%2520in%2520vitro%2520fragment-based%2520screening%26jtitle%3DMol.%2520Diversity%26date%3D2017%26volume%3D21%26spage%3D175%26epage%3D186%26doi%3D10.1007%2Fs11030-016-9717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dileep, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato-Murayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaraman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span> <span> </span><span class="NLM_article-title">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors</span>. <i>Int. J. Biol. Macromol.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>170</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">423</span>, <span class="refDoi"> DOI: 10.1016/j.ijbiomac.2020.12.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.ijbiomac.2020.12.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=33373636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3MXnsVyhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2021&pages=415-423&author=K.+V.+Dileepauthor=N.+Sakaiauthor=K.+Iharaauthor=M.+Kato-Murayamaauthor=A.+Nakataauthor=A.+Itoauthor=D.+M.+Sivaramanauthor=J.+W.+Shinauthor=M.+Yoshidaauthor=M.+Shirouzuauthor=K.+Zhang&title=Piperidine-4-carboxamide+as+a+new+scaffold+for+designing+secretory+glutaminyl+cyclase+inhibitors&doi=10.1016%2Fj.ijbiomac.2020.12.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Dileep, K. V.; Sakai, Naoki; Ihara, Kentaro; Kato-Murayama, Miyuki; Nakata, Akiko; Ito, Akihiro; Sivaraman, D. M.; Shin, Jay W.; Yoshida, Minoru; Shirouzu, Mikako; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Macromolecules</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">415-423</span>CODEN:
                <span class="NLM_cas:coden">IJBMDR</span>;
        ISSN:<span class="NLM_cas:issn">0141-8130</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), a common chronic neurodegenerative disease, has become a major public health concern.  Despite years of research, therapeutics for AD are limited.  Overexpression of secretory glutaminyl cyclase (sQC) in AD brain leads to the formation of a highly neurotoxic pyroglutamate variant of amyloid beta, pGlu-Aβ, which acts as a potential seed for the aggregation of full length Aβ.  Preventing the formation of pGlu-Aβ through inhibition of sQC has become an attractive disease-modifying therapy in AD.  In this current study, through a pharmacophore assisted high throughput virtual screening, we report a novel sQC inhibitor (Cpd-41) with a piperidine-4-carboxamide moiety (IC50 = 34μM).  Systematic mol. docking, MD simulations and X-ray crystallog. anal. provided atomistic details of the binding of Cpd-41 in the active site of sQC.  The unique mode of binding and moderate toxicity of Cpd-41 make this mol. an attractive candidate for designing high affinity sQC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCqnlfPuM22rVg90H21EOLACvtfcHk0lgxPUjOcZr_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXnsVyhsw%253D%253D&md5=75f69b90092bd20e73ba69e57f3da9f7</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ijbiomac.2020.12.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijbiomac.2020.12.118%26sid%3Dliteratum%253Aachs%26aulast%3DDileep%26aufirst%3DK.%2BV.%26aulast%3DSakai%26aufirst%3DN.%26aulast%3DIhara%26aufirst%3DK.%26aulast%3DKato-Murayama%26aufirst%3DM.%26aulast%3DNakata%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DSivaraman%26aufirst%3DD.%2BM.%26aulast%3DShin%26aufirst%3DJ.%2BW.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DK.%26atitle%3DPiperidine-4-carboxamide%2520as%2520a%2520new%2520scaffold%2520for%2520designing%2520secretory%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DInt.%2520J.%2520Biol.%2520Macromol.%26date%3D2021%26volume%3D170%26spage%3D415%26epage%3D423%26doi%3D10.1016%2Fj.ijbiomac.2020.12.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luccarini, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigacci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">la Marca, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ed Dami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casamenti, F.</span></span> <span> </span><span class="NLM_article-title">Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.neurobiolaging.2014.08.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=25293421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=648-63&author=I.+Luccariniauthor=C.+Grossiauthor=S.+Rigacciauthor=E.+Coppiauthor=A.+M.+Puglieseauthor=D.+Pantanoauthor=G.+la+Marcaauthor=T.+Ed+Damiauthor=A.+Bertiauthor=M.+Stefaniauthor=F.+Casamenti&title=Oleuropein+aglycone+protects+against+pyroglutamylated-3+amyloid-ss+toxicity%3A+biochemical%2C+epigenetic+and+functional+correlates&doi=10.1016%2Fj.neurobiolaging.2014.08.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates</span></div><div class="casAuthors">Luccarini, Ilaria; Grossi, Cristina; Rigacci, Stefania; Coppi, Elisabetta; Pugliese, Anna Maria; Pantano, Daniela; la Marca, Giancarlo; Ed Dami, Teresa; Berti, Andrea; Stefani, Massimo; Casamenti, Fiorella</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">648-663</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Amyloid-ss (Ass) fragments, oligomeric Ass aggregates, and pyroglutamylated-Ass peptides, as well as epigenetic mechanisms and autophagy dysfunction all appear to contribute in various ways to Alzheimer's disease progression.  We previously showed that dietary supplementation of oleuropein aglycon, a natural phenol abundant in the extra virgin olive oil, can be protective by reducing Ass42 deposits in the brain of young and middle-aged TgCRND8 mice.  Here, we extended our study to aged TgCRND8 mice showing increased pE3-Ass in the brain deposits.  We report that oleuropein aglycon is active against glutaminylcyclase-catalyzed pE3-Ass generation reducing enzyme expression and interferes both with Ass42 and pE3-Ass aggregation.  Moreover, the phenol astonishingly activates neuronal autophagy even in mice at advanced stage of pathol., where it increases histone 3 and 4 acetylation, which matches both a decrease of histone deacetylase 2 expression and a significant improvement of synaptic function.  The occurrence of these functional, epigenetic, and histopathol. beneficial effects even at a late stage of the pathol. suggests that the phenol could be beneficial at the therapeutic, in addn. to the prevention, level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkebeX-Tuok7Vg90H21EOLACvtfcHk0lgxPUjOcZr_nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2lsr%252FI&md5=7c5114fb73e9ebf19cea9823ec7158ca</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DLuccarini%26aufirst%3DI.%26aulast%3DGrossi%26aufirst%3DC.%26aulast%3DRigacci%26aufirst%3DS.%26aulast%3DCoppi%26aufirst%3DE.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPantano%26aufirst%3DD.%26aulast%3Dla%2BMarca%26aufirst%3DG.%26aulast%3DEd%2BDami%26aufirst%3DT.%26aulast%3DBerti%26aufirst%3DA.%26aulast%3DStefani%26aufirst%3DM.%26aulast%3DCasamenti%26aufirst%3DF.%26atitle%3DOleuropein%2520aglycone%2520protects%2520against%2520pyroglutamylated-3%2520amyloid-ss%2520toxicity%253A%2520biochemical%252C%2520epigenetic%2520and%2520functional%2520correlates%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D648%26epage%3D63%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hielscher-Michael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griehl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span> <span> </span><span class="NLM_article-title">Natural products from microalgae with potential against Alzheimer’s disease: sulfolipids are potent glutaminyl cyclase inhibitors</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">203</span>, <span class="refDoi"> DOI: 10.3390/md14110203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3390%2Fmd14110203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=203&author=S.+Hielscher-Michaelauthor=C.+Griehlauthor=M.+Buchholzauthor=H.+U.+Demuthauthor=N.+Arnoldauthor=L.+A.+Wessjohann&title=Natural+products+from+microalgae+with+potential+against+Alzheimer%E2%80%99s+disease%3A+sulfolipids+are+potent+glutaminyl+cyclase+inhibitors&doi=10.3390%2Fmd14110203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Natural products from microalgae with potential against Alzheimer's disease: sulfolipids are potent glutaminyl cyclase inhibitors</span></div><div class="casAuthors">Hielscher-Michael, Stephanie; Griehl, Carola; Buchholz, Mirko; Demuth, Hans-Ulrich; Arnold, Norbert; Wessjohann, Ludger A.</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">203/1-203/16</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In recent years, many new enzymes, like glutaminyl cyclase (QC), could be assocd. with pathophysiol. processes and represent targets for many diseases, so that enzyme-inhibiting properties of natural substances are becoming increasingly important.  In different studies, the pathophysiol. connection of QC to various diseases including Alzheimer's disease (AD) was described.  Algae are known for the ability to synthesize complex and highly-diverse compds. with specific enzyme inhibition properties.  Therefore, we screened different algae species for the presence of QC inhibiting metabolites using a new "Reverse Metabolomics" technique including an Activity-correlation Anal. (AcorA), which is based on the correlation of bioactivities to mass spectral data with the aid of mathematic informatics deconvolution.  Thus, three QC inhibiting compds. from microalgae belonging to the family of sulfolipids were identified.  The compds. showed a QC inhibition of 81% and 76% at concns. of 0.25 mg/mL and 0.025 mg/mL, resp.  Thus, for the first time, sulfolipids are identified as QC inhibiting compds. and possess substructures with the required pharmacophore qualities.  They represent a new lead structure for QC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruC1d9bEVkyrVg90H21EOLACvtfcHk0liDfzY_Zfw_2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWru7zM&md5=3097fbf425c5ff891dd01e9186d8c817</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3390%2Fmd14110203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd14110203%26sid%3Dliteratum%253Aachs%26aulast%3DHielscher-Michael%26aufirst%3DS.%26aulast%3DGriehl%26aufirst%3DC.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26atitle%3DNatural%2520products%2520from%2520microalgae%2520with%2520potential%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520sulfolipids%2520are%2520potent%2520glutaminyl%2520cyclase%2520inhibitors%26jtitle%3DMar.%2520Drugs%26date%3D2016%26volume%3D14%26spage%3D203%26doi%3D10.3390%2Fmd14110203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effect of flavonoids on human glutaminyl cyclase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2280</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bmc.2016.03.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=27061673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2280-6&author=M.+Liauthor=Y.+Dongauthor=X.+Yuauthor=Y.+Zouauthor=Y.+Zhengauthor=X.+Buauthor=J.+Quanauthor=Z.+Heauthor=H.+Wu&title=Inhibitory+effect+of+flavonoids+on+human+glutaminyl+cyclase&doi=10.1016%2Fj.bmc.2016.03.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of flavonoids on human glutaminyl cyclase</span></div><div class="casAuthors">Li, Manman; Dong, Yao; Yu, Xi; Zou, Yongdong; Zheng, Yizhi; Bu, Xianzhang; Quan, Junmin; He, Zhendan; Wu, Haiqiang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2280-2286</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glutaminyl cyclase (QC) plays an important role in the pathogenesis of Alzheimer's disease (AD) and can be a potential target for the development of novel anti-AD agents.  However, the study of QC inhibitors are still less.  Here, phenol-4' (R1-), C5-OH (R2-) and C7-OH (R3-) modified apigenin derivs. were synthesized as a new class of human QC (hQC) inhibitors.  The efficacy investigation of these compds. was performed by spectrophotometric assessment and the structure-activity relationship (SAR) was evaluated.  Mol. docking was also carried out to analyze the binding mode of the synthesized flavonoid to the active site of hQC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjo3dENiH0N7Vg90H21EOLACvtfcHk0liDfzY_Zfw_2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2lsLk%253D&md5=86df2e8e2c427d483dea92e747ddf116</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.064%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DInhibitory%2520effect%2520of%2520flavonoids%2520on%2520human%2520glutaminyl%2520cyclase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2280%26epage%3D6%26doi%3D10.1016%2Fj.bmc.2016.03.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kupski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sautner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worbs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsbeck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederichsen, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tittmann, K.</span></span> <span> </span><span class="NLM_article-title">Hydrazides are potent transition-state analogues for glutaminyl cyclase implicated in the pathogenesis of Alzheimer’s disease</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2591</span>, <span class="refDoi"> DOI: 10.1021/acs.biochem.0c00337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.0c00337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFOrur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2020&pages=2585-2591&author=O.+Kupskiauthor=L.+M.+Funkauthor=V.+Sautnerauthor=F.+Seifertauthor=B.+Worbsauthor=D.+Ramsbeckauthor=F.+Meyerauthor=U.+Diederichsenauthor=M.+Buchholzauthor=S.+Schillingauthor=H.+U.+Demuthauthor=K.+Tittmann&title=Hydrazides+are+potent+transition-state+analogues+for+glutaminyl+cyclase+implicated+in+the+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.biochem.0c00337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrazides Are Potent Transition-State Analogues for Glutaminyl Cyclase Implicated in the Pathogenesis of Alzheimer's Disease</span></div><div class="casAuthors">Kupski, Oliver; Funk, Lisa-Marie; Sautner, Viktor; Seifert, Franziska; Worbs, Brigitte; Ramsbeck, Daniel; Meyer, Franc; Diederichsen, Ulf; Buchholz, Mirko; Schilling, Stephan; Demuth, Hans-Ulrich; Tittmann, Kai</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">2585-2591</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloidogenic plaques are hallmarks of Alzheimer's disease (AD) and typically consist of high percentages of modified Aβ peptides bearing N-terminally cyclized glutamate residues.  The human zinc(II) enzyme glutaminyl cyclase (QC) was shown in vivo to catalyze the cyclization of N-terminal glutamates of Aβ peptides in a pathophysiol. side reaction establishing QC as a druggable target for therapeutic treatment of AD.  Here, we report crystallog. snapshots of human QC catalysis acting on the neurohormone neurotensin that delineate the stereochem. course of catalysis and suggest that hydrazides could mimic the transition state of peptide cyclization and deamidation.  This hypothesis is validated by a sparse-matrix inhibitor screening campaign that identifies hydrazides as the most potent metal-binding group compared to classic Zn binders.  The structural basis of hydrazide inhibition is illuminated by X-ray structure anal. of human QC in complex with a hydrazide-bearing peptide inhibitor and reveals a pentacoordinated Zn complex.  Our findings inform novel strategies in the design of potent and highly selective QC inhibitors by employing hydrazides as the metal-binding warhead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNZLV8i2BO5LVg90H21EOLACvtfcHk0liDfzY_Zfw_2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOrur%252FJ&md5=2d5f778e8ed7e4a148518c6065506dfa</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.0c00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.0c00337%26sid%3Dliteratum%253Aachs%26aulast%3DKupski%26aufirst%3DO.%26aulast%3DFunk%26aufirst%3DL.%2BM.%26aulast%3DSautner%26aufirst%3DV.%26aulast%3DSeifert%26aufirst%3DF.%26aulast%3DWorbs%26aufirst%3DB.%26aulast%3DRamsbeck%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DF.%26aulast%3DDiederichsen%26aufirst%3DU.%26aulast%3DBuchholz%26aufirst%3DM.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DTittmann%26aufirst%3DK.%26atitle%3DHydrazides%2520are%2520potent%2520transition-state%2520analogues%2520for%2520glutaminyl%2520cyclase%2520implicated%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochemistry%26date%3D2020%26volume%3D59%26spage%3D2585%26epage%3D2591%26doi%3D10.1021%2Facs.biochem.0c00337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodnar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1764</i></span>,  <span class="NLM_fpage">1618</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2006.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1016%2Fj.bbapap.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=17005457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1764&publication_year=2006&pages=1618-25&author=H.+Cynisauthor=S.+Schillingauthor=M.+Bodnarauthor=T.+Hoffmannauthor=U.+Heiserauthor=T.+C.+Saidoauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclase+alters+pyroglutamate+formation+in+mammalian+cells&doi=10.1016%2Fj.bbapap.2006.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells</span></div><div class="casAuthors">Cynis, Holger; Schilling, Stephan; Bodnar, Mandy; Hoffmann, Torsten; Heiser, Ulrich; Saido, Takaomi C.; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1764</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1618-1625</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mammalian cell lines were examd. concerning their Glutaminyl Cyclase (QC) activity using a HPLC method.  The enzyme activity was suppressed by a QC specific inhibitor in all homogenates.  Aim of the study was to prove whether inhibition of QC modifies the posttranslational maturation of N-glutamine and N-glutamate peptide substrates.  Therefore, the impact of QC-inhibition on amino-terminal pyroglutamate (pGlu) formation of the modified amyloid peptides Aβ(N3E-42) and Aβ(N3Q-42) was investigated.  These amyloid-β peptides were expressed as fusion proteins with either the pre-pro sequence of TRH, to be released by a prohormone convertase, or as engineered amyloid precursor protein for subsequent liberation of Aβ(N3Q-42) after β- and γ-secretase cleavage during posttranslational processing.  Inhibition of QC leads in both expression systems to significantly reduced pGlu-formation of differently processed Aβ-peptides.  This reveals the importance of QC-activity during cellular maturation of pGlu-contg. peptides.  Thus, QC-inhibition should impact bioactivity, stability or even toxicity of pyroglutamyl peptides preventing glutamine and glutamate cyclization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG_EpKM28U2rVg90H21EOLACvtfcHk0li9nnT0Td82pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrrL&md5=dc19263014a0cb7e7820dc135fc19bf4</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DBodnar%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520alters%2520pyroglutamate%2520formation%2520in%2520mammalian%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2006%26volume%3D1764%26spage%3D1618%26epage%3D25%26doi%3D10.1016%2Fj.bbapap.2006.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7405</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1021/bi800250p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi800250p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFGrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=7405-13&author=H.+Cynisauthor=E.+Scheelauthor=T.+C.+Saidoauthor=S.+Schillingauthor=H.+U.+Demuth&title=Amyloidogenic+processing+of+amyloid+precursor+protein%3A+evidence+of+a+pivotal+role+of+glutaminyl+cyclase+in+generation+of+pyroglutamate-modified+amyloid-beta&doi=10.1021%2Fbi800250p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β</span></div><div class="casAuthors">Cynis, Holger; Scheel, Eike; Saido, Takaomi C.; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">7405-7413</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compelling evidence suggests that N-terminally truncated and pyroglutamyl-modified amyloid-β (Aβ) peptides play a major role in the development of Alzheimer's disease.  Posttranslational formation of pyroglutamic acid (pGlu) at position 3 or 11 of Aβ implies cyclization of an N-terminal glutamate residue rendering the modified peptide degrdn. resistant, more hydrophobic, and prone to aggregation.  Previous studies using artificial peptide substrates suggested the potential involvement of the enzyme glutaminyl cyclase in generation of pGlu-Aβ.  Here we show that glutaminyl cyclase (QC) catalyzes the formation of Aβ3(pE)-40/42 after amyloidogenic processing of APP in two different cell lines, applying specific ELISAs and Western blotting based on urea-PAGE.  Inhibition of QC by the imidazole deriv. PBD150 led to a blockage of Aβ3(pE)-42 formation.  Apparently, the QC-catalyzed formation of N-terminal pGlu is favored in the acidic environment of secretory compartments, which is also supported by double-immunofluorescence labeling of QC and APP revealing partial colocalization.  Finally, initial investigations focusing on the mol. pathway leading to the generation of truncated Aβ peptides imply an important role of the amino acid sequence near the β-secretase cleavage site.  Introduction of a single-point mutation, resulting in an amino acid substitution, APP(E599Q), i.e., at position 3 of Aβ, resulted in significant formation of Aβ3(pE)-40/42.  Introduction of the APP KM595/596NL "Swedish" mutation causing overprodn. of Aβ, however, surprisingly diminished the concn. of Aβ3(pE)-40/42.  The study provides new cell-based assays for the profiling of small mol. inhibitors of QC and points to conspicuous differences in processing of APP depending on sequence at the β-secretase cleavage site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqOytVkntb_7Vg90H21EOLACvtfcHk0li9nnT0Td82pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFGrsr8%253D&md5=fdb24bc6e3ff6ad74f6d7db1f84a5a24</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fbi800250p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800250p%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DScheel%26aufirst%3DE.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DAmyloidogenic%2520processing%2520of%2520amyloid%2520precursor%2520protein%253A%2520evidence%2520of%2520a%2520pivotal%2520role%2520of%2520glutaminyl%2520cyclase%2520in%2520generation%2520of%2520pyroglutamate-modified%2520amyloid-beta%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D7405%26epage%3D13%26doi%3D10.1021%2Fbi800250p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeitschel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter-Paier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokesch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windisch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagla, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montag, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossner, S.</span></span> <span> </span><span class="NLM_article-title">Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer’s disease-like pathology</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1106</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1038/nm.1872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1038%2Fnm.1872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=18836460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1106-11&author=S.+Schillingauthor=U.+Zeitschelauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Franckeauthor=A.+Kehlenauthor=M.+Holzerauthor=B.+Hutter-Paierauthor=M.+Prokeschauthor=M.+Windischauthor=W.+Jaglaauthor=D.+Schlenzigauthor=C.+Lindnerauthor=T.+Rudolphauthor=G.+Reuterauthor=H.+Cynisauthor=D.+Montagauthor=H.+U.+Demuthauthor=S.+Rossner&title=Glutaminyl+cyclase+inhibition+attenuates+pyroglutamate+Abeta+and+Alzheimer%E2%80%99s+disease-like+pathology&doi=10.1038%2Fnm.1872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology</span></div><div class="casAuthors">Schilling, Stephan; Zeitschel, Ulrike; Hoffmann, Torsten; Heiser, Ulrich; Francke, Mike; Kehlen, Astrid; Holzer, Max; Hutter-Paier, Birgit; Prokesch, Manuela; Windisch, Manfred; Jagla, Wolfgang; Schlenzig, Dagmar; Lindner, Christiane; Rudolph, Thomas; Reuter, Gunter; Cynis, Holger; Montag, Dirk; Demuth, Hans-Ulrich; Rossner, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1106-1111</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Because of their abundance, resistance to proteolysis, rapid aggregation and neurotoxicity, N-terminally truncated and, in particular, pyroglutamate (pE)-modified Aβ peptides have been suggested as being important in the initiation of pathol. cascades resulting in the development of Alzheimer's disease.  We found that the N-terminal pE-formation is catalyzed by glutaminyl cyclase in vivo.  Glutaminyl cyclase expression was upregulated in the cortices of individuals with Alzheimer's disease and correlated with the appearance of pE-modified Aβ.  Oral application of a glutaminyl cyclase inhibitor resulted in reduced Aβ3(pE)-42 burden in two different transgenic mouse models of Alzheimer's disease and in a new Drosophila model.  Treatment of mice was accompanied by redns. in Aβx-40/42, diminished plaque formation and gliosis and improved performance in context memory and spatial learning tests.  These observations are consistent with the hypothesis that Aβ3(pE)-42 acts as a seed for Aβ aggregation by self-aggregation and co-aggregation with Aβ1-40/42.  Therefore, Aβ3(pE)-40/42 peptides seem to represent Aβ forms with exceptional potency for disturbing neuronal function.  The redn. of brain pE-Aβ by inhibition of glutaminyl cyclase offers a new therapeutic option for the treatment of Alzheimer's disease and provides implications for other amyloidoses, such as familial Danish dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQl4XiuOJSmrVg90H21EOLACvtfcHk0lho2MAKw7Ucow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Slu7zL&md5=30f8f53b27c6c9580fe71f867e1ab670</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1038%2Fnm.1872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.1872%26sid%3Dliteratum%253Aachs%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DZeitschel%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFrancke%26aufirst%3DM.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DProkesch%26aufirst%3DM.%26aulast%3DWindisch%26aufirst%3DM.%26aulast%3DJagla%26aufirst%3DW.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DLindner%26aufirst%3DC.%26aulast%3DRudolph%26aufirst%3DT.%26aulast%3DReuter%26aufirst%3DG.%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DMontag%26aufirst%3DD.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DRossner%26aufirst%3DS.%26atitle%3DGlutaminyl%2520cyclase%2520inhibition%2520attenuates%2520pyroglutamate%2520Abeta%2520and%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520pathology%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D1106%26epage%3D11%26doi%3D10.1038%2Fnm.1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook-Jung, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase ameliorates amyloid pathology in an animal model of Alzheimer’s disease via the modulation of gamma-secretase activity</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">807</span>, <span class="refDoi"> DOI: 10.3233/JAD-141356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.3233%2FJAD-141356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=797-807&author=H.+Songauthor=Y.+J.+Changauthor=M.+Moonauthor=S.+K.+Parkauthor=P.+T.+Tranauthor=V.+H.+Hoangauthor=J.+Leeauthor=I.+Mook-Jung&title=Inhibition+of+glutaminyl+cyclase+ameliorates+amyloid+pathology+in+an+animal+model+of+Alzheimer%E2%80%99s+disease+via+the+modulation+of+gamma-secretase+activity&doi=10.3233%2FJAD-141356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.3233%2FJAD-141356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141356%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DY.%2BJ.%26aulast%3DMoon%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DTran%26aufirst%3DP.%2BT.%26aulast%3DHoang%26aufirst%3DV.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMook-Jung%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520ameliorates%2520amyloid%2520pathology%2520in%2520an%2520animal%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520via%2520the%2520modulation%2520of%2520gamma-secretase%2520activity%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D43%26spage%3D797%26epage%3D807%26doi%3D10.3233%2FJAD-141356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cynis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haegele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiser, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoneyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demuth, H. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice</span>. <i>Int. J. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1111/iep.12020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1111%2Fiep.12020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=23560443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvV2msrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=217-25&author=H.+Cynisauthor=A.+Kehlenauthor=M.+Haegeleauthor=T.+Hoffmannauthor=U.+Heiserauthor=M.+Fujiiauthor=Y.+Shibazakiauthor=H.+Yoneyamaauthor=S.+Schillingauthor=H.+U.+Demuth&title=Inhibition+of+glutaminyl+cyclases+alleviates+CCL2-mediated+inflammation+of+non-alcoholic+fatty+liver+disease+in+mice&doi=10.1111%2Fiep.12020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice</span></div><div class="casAuthors">Cynis, Holger; Kehlen, Astrid; Haegele, Monique; Hoffmann, Torsten; Heiser, Ulrich; Fujii, Masato; Shibazaki, Yuichiro; Yoneyama, Hiroyuki; Schilling, Stephan; Demuth, Hans-Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-225</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Inflammation is an integral part of non-alc. fatty liver disease (NAFLD), the most prevalent form of hepatic pathol. found in the general population.  In this context, recently we have examd. the potential role of Glutaminyl Cyclases (QC and isoQC), and their inhibitors, in the maturation of chemokines, for example, monocyte chemoattractant protein 1 (MCP-1, CCL2), to generate their bioactive conformation.  Catalysis by isoQC leads to the formation of an N-terminal pyroglutamate residue protecting CCL2 against degrdn. by aminopeptidases.  This is of importance because truncated forms possess a reduced potential to attract immune cells.  Since liver inflammation is characterized by the up-regulation of different chemokine pathways, and within this CCL2 is known to be a prominent example, we hypothesised that application of QC/isoQC inhibitors may alleviate liver inflammation by destabilizing CCL2.  Therefore, we investigated the role of QC/isoQC inhibition, in comparison with the angiotensin receptor blocker Telmisartan, during development of pathol. in a mouse model of non-alc. fatty liver disease.  Application of a QC/isoQC inhibitor led to a significant redn. in circulating alanine aminotransferase and NAFLD activity score accompanied by an inhibitory effect on hepatocyte ballooning.  Further anal. revealed a specific redn. of inflammation by decreasing the no. of F4/80-pos. macrophages, which is in agreement with the proposed CCL2-related mechanism of action of QC/isoQC inhibitors.  Finally, QC/isoQC inhibitor application attenuated liver fibrosis as characterized by reduced collagen deposition in the liver parenchyma.  Thus in conclusion, QC/isoQC inhibitors are a promising novel class of anti-non-alc. steatohepatitis drugs which have a comparable disease-modifying effect to that of Telmisartan, which is probably mediated via specific interference with a comparable monocyte/macrophage infiltration that occurs under inflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5NY5cI92GLVg90H21EOLACvtfcHk0lho2MAKw7Ucow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvV2msrw%253D&md5=83f4bc66086de14e4ebd33e86a17b1ac</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1111%2Fiep.12020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fiep.12020%26sid%3Dliteratum%253Aachs%26aulast%3DCynis%26aufirst%3DH.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DHaegele%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DFujii%26aufirst%3DM.%26aulast%3DShibazaki%26aufirst%3DY.%26aulast%3DYoneyama%26aufirst%3DH.%26aulast%3DSchilling%26aufirst%3DS.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclases%2520alleviates%2520CCL2-mediated%2520inflammation%2520of%2520non-alcoholic%2520fatty%2520liver%2520disease%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2013%26volume%3D94%26spage%3D217%26epage%3D25%26doi%3D10.1111%2Fiep.12020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>442</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1042/BJ20110535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1042%2FBJ20110535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=22060158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1Oksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=442&publication_year=2012&pages=403-12&author=Y.+L.+Chenauthor=K.+F.+Huangauthor=W.+C.+Kuoauthor=Y.+C.+Loauthor=Y.+M.+Leeauthor=A.+H.+Wang&title=Inhibition+of+glutaminyl+cyclase+attenuates+cell+migration+modulated+by+monocyte+chemoattractant+proteins&doi=10.1042%2FBJ20110535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins</span></div><div class="casAuthors">Chen, Yi-Ling; Huang, Kai-Fa; Kuo, Wen-Chih; Lo, Yan-Chung; Lee, Yu-May; Wang, Andrew H.-J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">442</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-412</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">QC (glutaminyl cyclase) catalyzes the formation of N-terminal pGlu (pyroglutamate) in peptides and proteins. pGlu formation in chemoattractants may participate in the regulation of macrophage activation and migration.  However, a clear mol. mechanism for the regulation is lacking.  The present study examines the role of QC-mediated pGlu formation on MCPs (monocyte chemoattractant proteins) in inflammation.  We demonstrated in vitro the pGlu formation on MCPs by QC using MS.  A potent QC inhibitor, PBD150, significantly reduced the N-terminal uncyclized-MCP-stimulated monocyte migration, whereas pGlu-contg. MCP-induced cell migration was unaffected.  QC small interfering RNA revealed a similar inhibitory effect.  Lastly, we demonstrated that inhibiting QC can attenuate cell migration by lipopolysaccharide.  These results strongly suggest that QC-catalyzed N-terminal pGlu formation of MCPs is required for monocyte migration and provide new insights into the role of QC in the inflammation process.  Our results also suggest that QC could be a drug target for some inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxXEYfFQC1-rVg90H21EOLACvtfcHk0lho2MAKw7Ucow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1Oksbc%253D&md5=7a0672432b18da7d9dd384f965e0b1f9</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1042%2FBJ20110535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20110535%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DHuang%26aufirst%3DK.%2BF.%26aulast%3DKuo%26aufirst%3DW.%2BC.%26aulast%3DLo%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520glutaminyl%2520cyclase%2520attenuates%2520cell%2520migration%2520modulated%2520by%2520monocyte%2520chemoattractant%2520proteins%26jtitle%3DBiochem.%2520J.%26date%3D2012%26volume%3D442%26spage%3D403%26epage%3D12%26doi%3D10.1042%2FBJ20110535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropog, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, P. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of [(11)C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer’s disease prior to amyloid beta aggregation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1068</span>, <span class="refDoi"> DOI: 10.1039/C5MD00148J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=10.1039%2FC5MD00148J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=26101580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1065-1068&author=A.+F.+Brooksauthor=I.+M.+Jacksonauthor=X.+Shaoauthor=G.+W.+Kropogauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=P.+J.+Scott&title=Synthesis+and+evaluation+of+%5B%2811%29C%5DPBD150%2C+a+radiolabeled+glutaminyl+cyclase+inhibitor+for+the+potential+detection+of+Alzheimer%E2%80%99s+disease+prior+to+amyloid+beta+aggregation&doi=10.1039%2FC5MD00148J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid β aggregation</span></div><div class="casAuthors">Brooks, Allen F.; Jackson, Isaac M.; Shao, Xia; Kropog, George W.; Sherman, Phillip; Quesada, Carole A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1065-1068</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The hydroxy moiety of 1-[3-(1H-imidazol-1-yl)propyl]-3-(4-hydroxy-3-methoxyphenyl)thiourea was selectively carbon-11 labeled to generate [11C]PBD150 in 7.3% yield from [11C]methyl triflate (non-decay cor.; radiochem. purity ≥95%, specific activity = 5.7 Ci μmol-1, n = 5).  Evaluation of [11C]PBD150 by small animal PET imaging (mouse and rat) detd. that it did not permeate the blood brain barrier, indicating that a previously described therapeutic effect in transgenic mice was likely not the result of inhibiting central nervous system glutaminyl cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmg-DpdoFU-7Vg90H21EOLACvtfcHk0ljoLqCzWB7Ixg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFartLk%253D&md5=eaea24571848b33c06b92756ff873161</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1039%2FC5MD00148J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00148J%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DJackson%26aufirst%3DI.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DKropog%26aufirst%3DG.%2BW.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%255B%252811%2529C%255DPBD150%252C%2520a%2520radiolabeled%2520glutaminyl%2520cyclase%2520inhibitor%2520for%2520the%2520potential%2520detection%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520prior%2520to%2520amyloid%2520beta%2520aggregation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1065%26epage%3D1068%26doi%3D10.1039%2FC5MD00148J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PBB','PDB','3PBB'); return false;">PDB: 3PBB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3PB7','PDB','3PB7'); return false;">PDB: 3PB7</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00325&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-10%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00325%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00325" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679950e22cc33cdc","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
